Identifier,StructureData,,,,,,,,,,,,,,,Polymer EntityData,,,,,,
Entry ID,EM Resolution (Å),Experimental Method,Matthews Coefficient,Percent Solvent Content,Crystallization Method,pH,Crystal Growth Procedure,Temp (K),DOI,Ligand,PDB ID,Molecular Weight per Deposited Model,Resolution (Å),High Resolution Limit,Structure Title,Sequence,Source Organism,Gene Name,Macromolecule Name,Entity ID,Entry Id (Polymer Entity Identifiers),
"4BUT",,"X-RAY DIFFRACTION",2.45,49.71,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","31F","4BUT",56.11,"1.9","1.9","Crystal structure of human tankyrase 2 in complex with 4-(4-oxo-3,4- dihydroquinazolin-2-yl)benzene-1-sulfonamide","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUT"
"4BUU",,"X-RAY DIFFRACTION",2.44,49.59,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","F38","4BUU",56.13,"1.6","1.6","Crystal structure of human tankyrase 2 in complex with (4-(4-oxo-3,4- dihydroquinazolin-2-yl)phenyl)methanesulfonamide","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUU"
"4BUV",,"X-RAY DIFFRACTION",2.44,49.52,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","16I","4BUV",56.11,"1.8","1.8","Crystal structure of human tankyrase 2 in complex with N-(4-(4-oxo-3, 4-dihydroquinazolin-2-yl)phenyl)thiophene-2-carboxamide","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUV"
"4BUW",,"X-RAY DIFFRACTION",2.43,49.31,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","F33","4BUW",56.02,"1.85","1.85","Crystal structure of human tankyrase 2 in complex with 2-(4-(2-oxo-1, 3-oxazolidin-3-yl)phenyl)-3,4-dihydroquinazolin-4-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUW"
"4BUX",,"X-RAY DIFFRACTION",2.42,49.25,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","F35","4BUX",55.88,"1.95","1.95","Crystal structure of human tankyrase 2 in complex with 3-((4-(4-oxo-3, 4-dihydroquinazolin-2-yl)phenyl)methyl)imidazolidine-2,4-dione","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUX"
"4BUY",,"X-RAY DIFFRACTION",2.43,49.41,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","F37","4BUY",56.09,"1.9","1.9","Crystal structure of human tankyrase 2 in complex with 5-methyl-5-(4-(4-oxo-3,4-dihydroquinazolin-2-yl)phenyl)imidazolidine-2,4-dione","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUY"
"4BV3",,"X-RAY DIFFRACTION",2.03,39.55,,,"0.2 M (NH4)2SO4, 20% PEG 3350",,"10.1073/pnas.1303628110","OCZ","4BV3",33.33,"2","2","CRYSTAL STRUCTURE OF SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND NAD","GSSDKGKLSLQDVAELIRARACQRVVVMVGAGISTPSGIPDFRSPGSGLYSNLQQYDLPYPEAIFELPFFFHNPKPFFTLAKELYPGNYKPNVTHYFLRLLHDKGLLLRLYTQNIDGLERVSGIPASKLVEAHGTFASATCTVCQRPFPGEDIRADVMADRVPRCPVCTGVVKPDIVFFGEPLPQRFLLHVVDFPMADLLLILGTSLEVEPFASLTEAVRSSVPRLLINRDLVGPLAWHPRSRDVAQLGDVVHGVESLVELLGWTEEMRDLVQRETGKLDGPDK","Homo sapiens","SIRT3, SIR2L3","NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL","1","4BV3"
"4BV5",,"X-RAY DIFFRACTION",1.7,29,,4.6,"30% PEG400, 0.1M CACL2, 0.1M NAOAC PH 4.6",,,,"4BV5",18.9,"2.1","2.1","Identification of small molecule inhibitors selective for apo(a) kringles KIV-7, KIV-10 and KV.","QCYHGNGQSYRGTFSTTVTGRTCQSWSSMTPHRHQRTPENYPNDGLTMNYCRNPDADTGPWCFTMDPSIRWEYCALTRC","Homo sapiens","LPA","APOLIPOPROTEIN(A)","1","4BV5"
"4BV6",,"X-RAY DIFFRACTION",2.57,52.25,,,,,"10.1021/bi500343r",,"4BV6",54.82,"1.8","1.8","Refined crystal structure of the human Apoptosis inducing factor","EEVPQDKAPSHVPFLLIGGGTAAFAAARSIRARDPGARVLIVSEDPELPYMRPPLSKELWFSDDPNVTKTLRFKQWNGKERSIYFQPPSFYVSAQDLPHIENGGVAVLTGKKVVQLDVRDNMVKLNDGSQITYEKCLIATGGTPRSLSAIDRAGAEVKSRTTLFRKIGDFRSLEKISREVKSITIIGGGFLGSELACALGRKARALGTEVIQLFPEKGNMGKILPEYLSNWTMEKVRREGVKVMPNAIVQSVGVSSGKLLIKLKDGRKVETDHIVAAVGLEPNVELAKTGGLEIDSDFGGFRVNAELQARSNIWVAGDAACFYDIKLGRRRVEHHDHAVVSGRLAGENMTGAAKPYWHQSMFWSDLGPDVGYEAIGLVDSSLPTVGVFAKATAQDNPKSATEQSGTGIRSESETESEASEITIPPSTPAVPQAPVQGEDYGKGVIFYLRDKVVVGIVLWNIFNRMPIARKIIKDGEQHEDLNEVAKLFNIHED","Homo sapiens","AIFM1, AIF, PDCD8","APOPTOSIS-INDUCING FACTOR 1, MITOCHONDRIAL","1","4BV6"
"4BV7",,"X-RAY DIFFRACTION",1.6,23,,,"25 % PEG4000, 0.1M NAOAC, 8% 2-PROPANOL",,,,"4BV7",9.43,"1.7","1.7","Identification of small molecule inhibitors selective for apo(a) kringles KIV-7, KIV-10 and KV.","QCYHGNGQSYRGTFSTTVTGRTCQSWSSMTPHRHQRTPENYPNDGLTMNYCRNPDADTGPWCFTMDPSIRWEYCALTRC","Homo sapiens","LPA","APOLIPOPROTEIN(A)","1","4BV7"
"4BVB",,"X-RAY DIFFRACTION",2.12,42.11,,,"0.08 M KH2PO4 18 % PEG 8000 20% GLYCEROL",,"10.1073/pnas.1303628110","OCZ","4BVB",32.36,"2","2","CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND ADP-RIBOSE","GSSDKGKLSLQDVAELIRARACQRVVVMVGAGISTPSGIPDFRSPGSGLYSNLQQYDLPYPEAIFELPFFFHNPKPFFTLAKELYPGNYKPNVTHYFLRLLHDKGLLLRLYTQNIDGLERVSGIPASKLVEAHGTFASATCTVCQRPFPGEDIRADVMADRVPRCPVCTGVVKPDIVFFGEPLPQRFLLHVVDFPMADLLLILGTSLEVEPFASLTEAVRSSVPRLLINRDLVGPLAWHPRSRDVAQLGDVVHGVESLVELLGWTEEMRDLVQRETGKLDGPDK","Homo sapiens","SIRT3, SIR2L3","NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL","1","4BVB"
"4BVC",,"X-RAY DIFFRACTION",1.7,28,,8.5,"8% PEG8000, 0.1M TRIS PH8.5, 0.2M LISO4",,,,"4BVC",9.68,"1.6","1.6","Identification of small molecule inhibitors selective for apo(a) kringles KIV-7, KIV-10 and KV.","QCYHGNGQSYRGTFSTTVTGRTCQSWSSMTPHRHQRTPENYPNDGLTMNYCRNPDADTGPWCFTMDPSIRWEYCALTRC","Homo sapiens","LPA","APOLIPOPROTEIN(A)","1","4BVC"
"4BVD",,"X-RAY DIFFRACTION",1.7,28,,7.5,"25% PEG4000, 0.1M TRIS PH 8.5, 0.2 M CACL2",,,,"4BVD",9.55,"1.68","1.68","Identification of small molecule inhibitors selective for apo(a) kringles KIV-7, KIV-10 and KV.","QCYHGNGQSYRGTFSTTVTGRTCQSWSSMTPHRHQRTPENYPNDGLTMNYCRNPDADTGPWCFTMDPSIRWEYCALTRC","Homo sapiens","LPA","APOLIPOPROTEIN(A)","1","4BVD"
"4BVH",,"X-RAY DIFFRACTION",2.26,45.52,,7,"20% PEG 6000, 0.1 M HEPES PH7",,"10.1073/pnas.1303628110","OCZ","4BVH",97.65,"1.9","1.9","CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND 2'-O-ACETYL-ADP-RIBOSE","GSSDKGKLSLQDVAELIRARACQRVVVMVGAGISTPSGIPDFRSPGSGLYSNLQQYDLPYPEAIFELPFFFHNPKPFFTLAKELYPGNYKPNVTHYFLRLLHDKGLLLRLYTQNIDGLERVSGIPASKLVEAHGTFASATCTVCQRPFPGEDIRADVMADRVPRCPVCTGVVKPDIVFFGEPLPQRFLLHVVDFPMADLLLILGTSLEVEPFASLTEAVRSSVPRLLINRDLVGPLAWHPRSRDVAQLGDVVHGVESLVELLGWTEEMRDLVQRETGKLDGPDK","Homo sapiens","SIRT3, SIR2L3","NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL","1","4BVH"
"4BVM",,"X-RAY DIFFRACTION",2.85,56.9,,5,"pH 5",,"10.1107/S1399004713027910",,"4BVM",15.91,"0.93","0.93","The peripheral membrane protein P2 from human myelin at atomic resolution","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","MYELIN P2 PROTEIN","1","4BVM"
"4BVV",,"X-RAY DIFFRACTION",2,39,,,"30% PEG8000, 0.2M (NH4)2SO4",,,,"4BVV",9.61,"1.8","1.8","Identification of small molecule inhibitors selective for apo(a) kringles KIV-7, KIV-10 and KV.","DCMFGNGKGYRGKKATTVTGTPCQEWAAQEPHRHSTFIPGTNKWAGLEKNYCRNPDGDINGPWCYTMNPRKLFDYCDIPLC","Homo sapiens","LPA","APOLIPOPROTEIN(A)","1","4BVV"
"4BVW",,"X-RAY DIFFRACTION",2.3,46,,,"19% PEG 6000, 0.1 M NAOAC, 12% ETHYLENE GLYCOL, 1M LISO4",,,,"4BVW",23.15,"2","2","Identification of small molecule inhibitors selective for apo(a) kringles KIV-7, KIV-10 and KV.","SIAAKEEGVSLEKRSIARSDCYHGDGQSYRGSFSTTVTGRTCQSWSSMTPHWHQRTTEYYPNGGLTRNYCRNPDAEIRPWCYTMDPSVRWEYCALTQC","Homo sapiens","LPA","APOLIPOPROTEIN(A)","1","4BVW"
"4BW1",,"X-RAY DIFFRACTION",2.15,42.92,,6,"25% PEG1500, 0.1M SPG BUFFER PH6.0",,"10.1002/cmdc.201300259","S5B","4BW1",15.7,"1.4","1.4","The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4BW1"
"4BW2",,"X-RAY DIFFRACTION",2.16,42.99,,6,"0.1M MES PH8.6, 20% PEG6000, 0.2M MGCL2, pH 6.0",,"10.1002/cmdc.201300259","UTH","4BW2",15.58,"1.92","1.92","The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4BW2"
"4BW3",,"X-RAY DIFFRACTION",2.15,42.8,,8.5,"20% PEG3350, 0.2M NANO3, 0.1M BIS-TRIS-PROPANE PH8.5",,"10.1002/cmdc.201300259","9BM","4BW3",15.73,"1.5","1.5","The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4BW3"
"4BW4",,"X-RAY DIFFRACTION",2.14,42.58,,8,"0.1M TRIS PH8.0, 25% PE6000, 0.2M MGCL2",,"10.1002/cmdc.201300259","9B6","4BW4",15.57,"1.67","1.67","The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4BW4"
"4BW5",,"X-RAY DIFFRACTION",3.55,65,,8,"0.001M CADMIUM CHLORIDE, 0.2M POTASSIUM CHLORIDE,31%(V/V) PEG400,0.1M HEPES PH 8.0, 2% (W/V) BENZAMIDINE, TEMPERATURE 277K",277,"10.1126/science.1261512",,"4BW5",126.36,"3.2","3.2","Crystal structure of human two pore domain potassium ion channel TREK2 (K2P10.1)","MGLQTVMKWKTVVAIFVVVVVYLVTGGLVFRALEQPFESSQKNTIALEKAEFLRDHVCVSPQELETLIQHALDADNAGVSPIGNSSNNSSHWDLGSAFFFAGTVITTIGYGNIAPSTEGGKIFCILYAIFGIPLFGFLLAGIGDQLGTIFGKSIARVEKVFRKKQVSQTKIRVISTILFILAGCIVFVTIPAVIFKYIEGWTALESIYFVVVTLTTVGFGDFVAGGNAGINYREWYKPLVWFWILVGLAYFAAVLSMIGDWLRVLSKKTKEEVGEAENLYFQ","Homo sapiens","KCNK10, TREK2","POTASSIUM CHANNEL SUBFAMILY K MEMBER 10","1","4BW5"
"4BW7",,"X-RAY DIFFRACTION",2.29,46.32,,4,"pH 4",,"10.1107/S1399004713024437",,"4BW7",34.49,"1.81","1.81","Calmodulin in complex with strontium","MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","CALMODULIN","1","4BW7"
"4BW8",,"X-RAY DIFFRACTION",2.29,46.29,,4,"pH 4",,"10.1107/S1399004713024437",,"4BW8",34.03,"1.8","1.8","Calmodulin with small bend in central helix","MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","CALMODULIN","1","4BW8"
"4BWD",,"X-RAY DIFFRACTION",3,59.2,,4.6,"0.01 M COBALT CHLORIDE 0.1 M SODIUM ACETATE PH 4.63, 0.7 M 1,6 HEXANEDIOL",,"10.1371/journal.pone.0076355",,"4BWD",28.15,"2.702","2.702","Human short coiled coil protein","MMNADMDAVDAENQVELEEKTRLINQVMELQHTLEDLSARVDAVKEENLKLKSENQVLGQYIENLMSASSVFQTTDTKSKRK","Homo sapiens","SCOC, SCOCO, HRIHFB2072","SHORT COILED-COIL PROTEIN","1","4BWD"
"4BWE",,"X-RAY DIFFRACTION",2.53,51.4,,8,"13 % PEG 6000, 0.1 M TRIS-HCL PH 8 & 0.2 M CACL2",,"10.1107/S0907444913025250",,"4BWE",216.1,"2.46","2.46","Crystal structure of C-terminally truncated glypican-1 after controlled dehydration to 86 percent relative humidity","APQLHHHHHHDLYENLYFQGKLDPASKSRSCGEVRQIYGAKGFSLSDVPQAEISGEHLRICPQGYTCCTSEMEENLANRSHAELETALRDSSRVLQAMLATQLRSFDDHFQHLLNDSERTLQATFPGAFGELYTQNARAFRDLYSELRLYYRGANLHLEETLAEFWARLLERLFKQLHPQLLLPDDYLDCLGKQAEALRPFGEAPRELRLRATRAFVAARSFVQGLGVASDVVRKVAQVPLGPECSRAVMKLVYCAHCLGVPGARPCPDYCRNVLKGCLANQADLDAEWRNLLDSMVLITDKFWGTSGVESVIGSVHTWLAEAINALQDNRDTLTAKVIQGCGNPKVNPQGPGPEEKRRRGKLAPRERPPSGTLEKLVSEAKAQLRDVQDFWISLPGTLCSEKMALSTASDDRCWNGMARGRYLPEVMGDGLANQINNPEVEVDITKPDMTIRQQIMQLKIMTNRLRSAYNGNDVDFQ","Homo sapiens","GPC1","Glypican-1","1","4BWE"
"4BWN",,"X-RAY DIFFRACTION",1.4,12,,7.5,"100 MM LITHIUM CHLORIDE, 10MM HEPES PH 7,5 AND 25% PEG 6000",,,,"4BWN",25.62,"2.27","2.27","NEMO CC2-LZ DOMAIN","MGSSHHHHHHSSGLVPRGSHMARMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHNIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLK","Homo sapiens","IKBKG, FIP3, NEMO","NF-KAPPA-B ESSENTIAL MODULATOR","1","4BWN"
"4BX8",,"X-RAY DIFFRACTION",2.43,49.47,"VAPOR DIFFUSION, SITTING DROP",,"CRYSTALS WERE GROWN IN SITTING DROPS AT 20 C. VPS33A-HIS10 (200 NL; 3.2 MG/ML) WAS EQUILIBRATED AGAINST 80 UL RESERVOIRS CONTAINING 14.3-12.8% (W/V) PEG 3350 AND 143-128 MM AMMONIUM ACETATE (HAMPTON RESEARCH). CRYSTALS WERE CRYOPROTECTED BY ADDING RESERVOIR SOLUTION SUPPLEMENTED WITH 30% (V/V) ETHYLENE GLYCOL TO THE MOTHER LIQUOR IMMEDIATELY BEFORE HARVESTING AND CRYO-COOLING BY PLUNGING INTO LIQUID NITROGEN. ANNEALING BY BLOCKING THE CRYOSTREAM FOR 5 S GREATLY ENHANCED THE DIFFRACTION OF VPS33A CRYSTALS.",293,"10.1073/pnas.1307074110",,"4BX8",138.5,"2.4","2.4","Human Vps33A","MAAHLSYGRVNLNVLREAVRRELREFLDKCAGSKAIVWDEYLTGPFGLIAQYSLLKEHEVEKMFTLKGNRLPAADVKNIIFFVRPRLELMDIIAENVLSEDRRGPTRDFHILFVPRRSLLCEQRLKDLGVLGSFIHREEYSLDLIPFDGDLLSMESEGAFKECYLEGDQTSLYHAAKGLMTLQALYGTIPQIFGKGECARQVANMMIRMKREFTGSQNSIFPVFDNLLLLDRNVDLLTPLATQLTYEGLIDEIYGIQNSYVKLPPEKFAPKKQGDGGKDLPTEAKKLQLNSAEELYAEIRDKNFNAVGSVLSKKAKIISAAFEERHNAKTVGEIKQFVSQLPHMQAARGSLANHTSIAELIKDVTTSEDFFDKLTVEQEFMSGIDTDKVNNYIEDCIAQKHSLIKVLRLVCLQSVCNSGLKQKVLDYYKREILQTYGYEHILTLHNLEKAGLLKPQTGGRNNYPTIRKTLRLWMDDVNEQNPTDISYVYSGYAPLSVRLAQLLSRPGWRSIEEVLRILPGPHFEERQPLPTGLQKKRQPGENRVTLIFFLGGVTFAEIAALRFLSQLEDGGTEYVIATTKLMNGTSWIEALMEKPFHHHHHHHHHHH","Homo sapiens","VPS33A","VACUOLAR PROTEIN SORTING-ASSOCIATED PROTEIN 33A","1","4BX8"
"4BXK",,"X-RAY DIFFRACTION",2.95,58,,8.5,"0.06 M DIVALENT CATIONS, 0.1 M TRIS/BICINE PH 8.5, 30 % PEG550MME/PEG20000",,"10.1042/CS20130403","1IU","4BXK",150.42,"2.2","2.2","Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with a domain-specific inhibitor","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPQKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","4BXK"
"4BXN",,"X-RAY DIFFRACTION",2.69,54.23,,6.8,"0.02 M CACL2, 0.02 M CADMIUM CHLORIDE, 0.02 M COBALT(II) CHLORIDE, 20% W/V PEG-3350, pH 6.8",,"10.1021/jm4006274","6LX","4BXN",86.76,"2.793","2.793","Eg5(WT) complex","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","4BXN"
"4BY3",,"X-RAY DIFFRACTION",2.4,49,,7,"pH 7",,"10.1016/j.str.2013.10.016",,"4BY3",43.36,"1.73","1.73","Crystal structure of the dihydroorotase domain of human CAD in apo- form obtained recombinantly from E. coli.","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","DIHYDROOROTASE","1","4BY3"
"4BYH",,"X-RAY DIFFRACTION",4.01,69.3,,4,"4M NACL, 0.1 M CITRATE PH 4.0",,"10.1073/pnas.1310657110",,"4BYH",56.49,"2.3","2.3","Crystal structure of sialylated IgG Fc","GTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGTKHHHHHH","Homo sapiens","IGHG1","IG GAMMA-1 CHAIN C REGION","1","4BYH"
"4BYI",,"X-RAY DIFFRACTION",2.83,51.42,,,,,"10.1021/jm401115g","FH3","4BYI",33.34,"2.6","2.6","Aurora A kinase bound to a highly selective imidazopyridine inhibitor","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","AURORA KINASE A","1","4BYI"
"4BYJ",,"X-RAY DIFFRACTION",2.63,53.23,,,,,"10.1021/jm401115g","FH5","4BYJ",33.32,"2.75","2.75","Aurora A kinase bound to a highly selective imidazopyridine inhibitor","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","AURORA KINASE A","1","4BYJ"
"4BZB",,"X-RAY DIFFRACTION",2.3,46,,7.4,"100 MM SPG BUFFER, PH 7.4, 25% PEG 1500",,"10.1038/nsmb.2692",,"4BZB",259.99,"1.83","1.83","Crystal structure of the tetrameric dGTP-bound SAMHD1 mutant catalytic core","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1","1","4BZB"
"4BZC",,"X-RAY DIFFRACTION",2.3,46,,6.7,"100 MM BIS-TRIS PH 6.7 AND 25% (W/V) PEG1500",,"10.1038/nsmb.2692",,"4BZC",260.23,"2.88","2.88","Crystal structure of the tetrameric dGTP-bound wild type SAMHD1 catalytic core","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1","1","4BZC"
"4BZD",,"X-RAY DIFFRACTION",2,40,,,"12% PEG3350, 0.1M HEPES PH 7.5, 0.05M AMMONIUM ACETATE",,,,"4BZD",34.45,"1.83","1.83","Structure of CDK2 in complex with a benzimidazopyrimidine","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CYCLIN-DEPENDENT KINASE 2","1","4BZD"
"4BZN",,"X-RAY DIFFRACTION",3.19,61.15,,,"20% PEG 3350K, 0.3 M NACL, 0.1 M TRISHCL PH 7.6",,"10.1016/j.bmc.2013.09.054","UGX","4BZN",36.18,"1.9","1.9","Crystal structure of PIM1 in complex with a Pyrrolo(1,2-a)Pyrazinone inhibitor","GPLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","SERINE/THREONINE-PROTEIN KINASE PIM-1","1","4BZN"
"4BZO",,"X-RAY DIFFRACTION",3.36,63,,,"20% PEG 3350K, 0.3 M NACL, 0.1 M TRISHCL PH 7.6",,"10.1016/j.bmc.2013.09.054","676","4BZO",36.24,"2.1","2.1","Crystal structure of PIM1 in complex with a Pyrrolo-Pyrazinone inhibitor","GPLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","SERINE/THREONINE-PROTEIN KINASE PIM-1","1","4BZO"
"4BZR",,"X-RAY DIFFRACTION",2.3,47,,4.7,"50MM SODIUM ACETATE PH 4.7, 16% PEG4000, 10UM ZNSO4",,"10.1021/ml4004588","K26","4BZR",70.11,"1.84","1.84","Human testis angiotensin converting enzyme in complex with K-26","LVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNS","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","4BZR"
"4BZS",,"X-RAY DIFFRACTION",2.8,56,,8.5,"MORPHEUS A9 (0.06M DIVALENTS, 0.1M TRIS/BICINE PH 8.5, 30% PEG550MME/PEG20K) SILVER BULLET G3 SOLUTION (HAMPTON RESEARCH) ADDITIVE. 1:1:1 PROTEIN:RESERVOIR:ADDITIVE",,"10.1021/ml4004588","K26","4BZS",150.57,"2.1","2.1","Human angiotenisn converting enzyme N-domain in complex with K-26","LDPGLQPGNFSADEAGAQLFAQSYNSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQNFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSNMSRIYSTAKVCLPNKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWNATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLQAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","4BZS"
"4BZY",,"X-RAY DIFFRACTION",3.18,61,,,"22% PEG 3350, 0.05M SODIUM SUCCINATE",,"10.1093/hmg/ddv280",,"4BZY",241.64,"2.75","2.75","Crystal structure of human glycogen branching enzyme (GBE1)","MAAPMTPAARPEDYEAALNAALADVPELARLLEIDPYLKPYAVDFQRRYKQFSQILKNIGENEGGIDKFSRGYESFGVHRCADGGLYCKEWAPGAEGVFLTGDFNGWNPFSYPYKKLDYGKWELYIPPKQNKSVLVPHGSKLKVVITSKSGEILYRISPWAKYVVREGDNVNYDWIHWDPEHSYEFKHSRPKKPRSLRIYESHVGISSHEGKVASYKHFTCNVLPRIKGLGYNCIQLMAIMEHAYYASFGYQITSFFAASSRYGSPEELQELVDTAHSMGIIVLLDVVHSHASKNSADGLNMFDGTDSCYFHSGPRGTHDLWDSRLFAYSSWEVLRFLLSNIRWWLEEYRFDGFRFDGVTSMLYHHHGVGQGFSGDYSEYFGLQVDEDALTYLMLANHLVHTLCPDSITIAEDVSGMPALCSPISQGGGGFDYRLAMAIPDKWIQLLKEFKDEDWNMGDIVYTLTNRRYLEKCIAYAESHDQALVGDKSLAFWLMDAEMYTNMSVLTPFTPVIDRGIQLHKMIRLITHGLGGEGYLNFMGNEFGHPEWLDFPRKGNNESYHYARRQFHLTDDDLLRYKFLNNFDRDMNRLEERYGWLAAPQAYVSEKHEGNKIIAFERAGLLFIFNFHPSKSYTDYRVGTALPGKFKIVLDSDAAEYGGHQRLDHSTDFFSEAFEHNGRPYSLLVYIPSRVALILQNVDLPN","Homo sapiens","GBE1","1,4-ALPHA-GLUCAN-BRANCHING ENZYME","1","4BZY"
"4C0F",,"X-RAY DIFFRACTION",2.7,54.4,,5.6,"100MM TRI-SODIUM CITRATE PH=5.6, 10% PEG4000, 10% ISOPROPANOL",,"10.1038/nsmb.2681",,"4C0F",56.39,"2.4","2.4","Structure of the NOT-box domain of human CNOT2","QGPHMDKLAAIKLGRYGEDLLFYLYYMNGGDVLQLLAAVELFNRDWRYHKEERVWITRAPGMEPTMKTNTYERGTYYFFDCLNWRKVAKEFHLEYDKLEERPHLPSTFNYNPAQQAF","Homo sapiens","CNOT2, CDC36, NOT2, HSPC131, MSTP046","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 2","1","4C0F"
"4C0G",,"X-RAY DIFFRACTION",3,59.1,,7.8,"100 MM HEPES PH=7.8, 13% PEG4000, 2% GLYCEROL, 12% ISOPROPANOL",,"10.1038/nsmb.2681",,"4C0G",77.03,"2.4","2.4","Structure of the NOT-box domain of human CNOT3","GAMAHSDTVEFYQRLSTETLFFIFYYLEGTKAQYLAAKALKKQSWRFHTKYMMWFQRHEEPKTITDEFEQGTYIYFDYEKWGQRKKEGFTFEYRYLEDRDLQ","Homo sapiens","CNOT3, KIAA0691, LENG2, NOT3","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3","1","4C0G"
"4C0M",,"X-RAY DIFFRACTION",2.26,45.7,,,"0.1 M BIS TRIS PH 6.6, 150 MM NACL AND 21% PEG 3350",,"10.1107/S0907444913022385",,"4C0M",68.08,"2.8","2.8","Crystal Structure of the N terminal domain of wild type TRIF (TIR- domain-containing adapter-inducing interferon-beta)","SNAMACTGPSLPSAFDILGAAGQDKLLYLKHKLKTPRPGCQGQDLLHAMVLLKLGQETEARISLEALKADAVARLVARQWAGVDSTEDPEEPPDVSWAVARLYHLLAEEKLCPASLRDVAYQEAVRTLSSRDDHRLGELQDEARNRCGWDIAGDPG","Homo sapiens","TICAM1, PRVTIRB, TRIF","TIR DOMAIN-CONTAINING ADAPTER MOLECULE 1","1","4C0M"
"4C0P",,"X-RAY DIFFRACTION",2.88,57.3,,8.2,"20% (W/V) PEG3350, 0.2 M NABR, 10 MM DTT, 2 MM EDTA, 0.1 M BIS-TRIS PROPANE, PH8.2",,"10.1073/pnas.1320755111",,"4C0P",417.74,"2.95","2.95","Unliganded Transportin 3","MEGAKPTLQLVYQAVQALYHDPDPSGKERASFWLGELQRSVHAWEISDQLLQIRQDVESCYFAAQTMKMKIQTSFYELPTDSHASLRDSLLTHIQNLKDLSPVIVTQLALAIADLALQMPSWKGCVQTLVEKYSNDVTSLPFLLEILTVLPEEVHSRSLRIGANRRTEIIEDLAFYSSTVVSLLMTCVEKAGTDEKMLMKVFRCLGSWFNLGVLDSNFMANNKLLALLFEVLQQDKTSSNLHEAASDCVCSALYAIENVETNLPLAMQLFQGVLTLETAYHMAVAREDLDKVLNYCRIFTELCETFLEKIVCTPGQGLGDLRTLELLLICAGHPQYEVVEISFNFWYRLGEHLYKTNDEVIHGIFKAYIQRLLHALARHCQLEPDHEGVPEETDDFGEFRMRVSDLVKDLIFLIGSMECFAQLYSTLKEGNPPWEVTEAVLFIMAAIAKSVDPENNPTLVEVLEGVVRLPETVHTAVRYTSIELVGEMSEVVDRNPQFLDPVLGYLMKGLAEKPLASAAAKAIHNICSVCRDHMAQHFNGLLEIARSLDSFLLSPEAAVGLLKGTALVLARLPLDKITECLSELCSVQVMALKKLLSQEPSNGISSDPTVFLDRLAVIFRHTNPIVENGQTHPCQKVIQEIWPVLSETLNKHRADNRIVERCCRCLRFAVRCVGKGSAALLQPLVTQMVNVYHVHQHSCFLYLGSILVDEYGMEEGCRQGLLDMLQALCIPTFQLLEQQNGLQNHPDTVDDLFRLATRFIQRSPVTLLRSQVVIPILQWAIASTTLDHRDANCSVMRFLRDLIHTGVANDHEEDFELRKELIGQVMNQLGQQLVSQLLHTCCFCLPPYTLPDVAEVLWEIMQVDRPTFCRWLENSLKGLPKETTVGAVTVTHKQLTDFHKQVTSAEECKQVCWALRDFTRLFR","Homo sapiens","TNPO3, IPO12","TRANSPORTIN-3","1","4C0P"
"4C16",,"X-RAY DIFFRACTION",2.75,55.36,,,"PEG8000, HEPES, MOPS PH 6.2, CACL2, ANTAGONIST",,"10.1093/jmcb/mjv046",,"4C16",67.08,"1.93","1.93","E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic antagonist","WSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVWVWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSYNSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPWNTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKA","Homo sapiens","SELE, ELAM1","E-SELECTIN","1","4C16"
"4C1I",,"X-RAY DIFFRACTION",2,39,,8.6,"14% PEG 3350, 0.2 M MAGNESIUM CHLORIDE, 0.1 M TRIS HYDROCHLORIDE PH 8.6",,,,"4C1I",167.2,"2.4","2.4","Selective Inhibitors of PDE2, PDE9, and PDE10: Modulators of Activity of the Central Nervous System","MGSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYERHHHHHH","Homo sapiens","PDE2A","CGMP-DEPENDENT 3', 5'-CYCLIC PHOSPHODIESTERASE","1","4C1I"
"4C1M",,"X-RAY DIFFRACTION",2.5,51,,,,,"10.1074/jbc.M113.507756","NIH","4C1M",137.15,"2","2","Myeloperoxidase in complex with the revesible inhibitor HX1","VTCPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAAR","Homo sapiens","MPO","MYELOPEROXIDASE LIGHT CHAIN","1","4C1M"
,,,,,,,,,,,,,,,,"VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREAS","Homo sapiens","MPO","MYELOPEROXIDASE HEAVY CHAIN","2","4C1M"
"4C29",,"X-RAY DIFFRACTION",2.06,40.2,,4.6,"CRYSTALS OF A1/SS APPEARED IN DROPS CONTAINING 25% PEG3350 AND 0.2 M CALCIUM ACETATE. THESE CRYSTALS WERE CRUSHED AND USED FOR SEEDING. CRYSTALS GROWN IN 8 MG/ML PROTEIN, 15% PEG3350, AND 0.2 M CALCIUM ACETATE WERE HARVESTED, AND SOAKED IN THE SAME BUFFER CONTAINING 20% GLYCEROL FOR CRYOPROTECTION., pH 4.6",,"10.1074/jbc.M113.511220",,"4C29",50.02,"2.202","2.202","Crystal Structure of High-Affinity von Willebrand Factor A1 domain with Disulfide Mutation","MEPPLHDFCRSRLLDLVFLLDGSSRLSEAEFEVLKAFVVDMMERLRISQKWVRVAVVEYHDGSHAYIGLKDRKRPSELRRIASQVKYAGSQVASTSEVLKYTLFQIFSKIDRPEASRIALLLMASQEPQRMSRNFVRYVQGLKKKKVIVIPVGIGPHANLKQIRLIEKQAPENKAFVLSSVDELEQQRDEIVSYLCDLAPEAPPPTLPPHHHHHH","Homo sapiens","VWF, F8VWF","VON WILLEBRAND FACTOR","1","4C29"
"4C2J",,"X-RAY DIFFRACTION",2.37,48.19,,6.6,"100 MM MES PH 6.6, 14% MME-PEG 5000",,"10.1107/S1399004714023827",,"4C2J",180.71,"2","2","Crystal structure of human mitochondrial 3-ketoacyl-CoA thiolase in complex with CoA","MGSSHHHHHHSSGLVPRGSHMALLRGVFVVAAKRTPFGAYGGLLKDFTATDLSEFAAKAALSAGKVSPETVDSVIMGNVLQSSSDAIYLARHVGLRVGIPKETPALTINRLCGSGFQSIVNGCQEICVKEAEVVLCGGTESMSQAPYCVRNVRFGTKLGSDIKLEDSLWVSLTDQHVQLPMAMTAENLAVKHKISREECDKYALQSQQRWKAANDAGYFNDEMAPIEVKTKKGKQTMQVDEHARPQTTLEQLQKLPPVFKKDGTVTAGNASGVADGAGAVIIASEDAVKKHNFTPLARIVGYFVSGCDPSIMGIGPVPAISGALKKAGLSLKDMDLVEVNEAFAPQYLAVERSLDLDISKTNVNGGAIALGHPLGGSGSRITAHLVHELRRRGGKYAVGSACIGGGQGIAVIIQSTA","Homo sapiens","ACAA2","3-KETOACYL-COA THIOLASE, MITOCHONDRIAL","1","4C2J"
"4C2K",,"X-RAY DIFFRACTION",2.36,48,,6.6,"100 MM MES PH 6.6, 15% MME-PEG5000",,"10.1107/S1399004714023827",,"4C2K",178.82,"2","2","Crystal structure of human mitochondrial 3-ketoacyl-CoA thiolase","MGSSHHHHHHSSGLVPRGSHMALLRGVFVVAAKRTPFGAYGGLLKDFTATDLSEFAAKAALSAGKVSPETVDSVIMGNVLQSSSDAIYLARHVGLRVGIPKETPALTINRLCGSGFQSIVNGCQEICVKEAEVVLCGGTESMSQAPYCVRNVRFGTKLGSDIKLEDSLWVSLTDQHVQLPMAMTAENLAVKHKISREECDKYALQSQQRWKAANDAGYFNDEMAPIEVKTKKGKQTMQVDEHARPQTTLEQLQKLPPVFKKDGTVTAGNASGVADGAGAVIIASEDAVKKHNFTPLARIVGYFVSGCDPSIMGIGPVPAISGALKKAGLSLKDMDLVEVNEAFAPQYLAVERSLDLDISKTNVNGGAIALGHPLGGSGSRITAHLVHELRRRGGKYAVGSACIGGGQGIAVIIQSTA","Homo sapiens","ACAA2","3-KETOACYL-COA THIOLASE, MITOCHONDRIAL","1","4C2K"
"4C2N",,"X-RAY DIFFRACTION",2.3,47,,4,"0.1M MIB BUFFER PH4.0, 10UM ZINC SULFATE, 5% GLYCEROL, 15% PEG3350",,"10.1074/jbc.M113.512335",,"4C2N",69.27,"2.59","2.59","Crystal structure of human testis angiotensin-I converting enzyme mutant E403R","LVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALRRGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNS","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","4C2N"
"4C2O",,"X-RAY DIFFRACTION",2.3,47,,4,"0.1M MIB BUFFER PH4.0, 10UM ZINC SULFATE, 5% GLYCEROL, 15% PEG3350",,"10.1074/jbc.M113.512335",,"4C2O",69.82,"1.8","1.8","Crystal structure of human testis angiotensin-I converting enzyme mutant D465T","LVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVTQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNS","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","4C2O"
"4C2P",,"X-RAY DIFFRACTION",2.3,47,,4,"0.1M MIB BUFFER PH4.0, 10UM ZINC SULFATE, 5% GLYCEROL, 15% PEG3350",,"10.1074/jbc.M113.512335","X8Z","4C2P",69.28,"1.99","1.99","Crystal structure of human testis angiotensin-I converting enzyme mutant R522K in complex with captopril","LVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIKYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNS","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","4C2P"
"4C2Q",,"X-RAY DIFFRACTION",2.3,47,,4,"0.1M MIB BUFFER PH4.0, 10UM ZINC SULFATE, 5% GLYCEROL, 15% PEG3350",,"10.1074/jbc.M113.512335",,"4C2Q",69.38,"2.4","2.4","Crystal structure of human testis angiotensin-I converting enzyme mutant R522K","LVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIKYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNS","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","4C2Q"
"4C2R",,"X-RAY DIFFRACTION",2.3,47,,4,"0.1M MIB BUFFER PH4.0, 10UM ZINC SULFATE, 5% GLYCEROL, 15% PEG3350",,"10.1074/jbc.M113.512335",,"4C2R",69.24,"2.3","2.3","Crystal structure of human testis angiotensin-I converting enzyme mutant R522Q","LVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIQYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNS","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","4C2R"
"4C2S",,"X-RAY DIFFRACTION",2.55,51.8,,7,"5 MM MOPS PH 7.0, 1 MM MNCL2, 1 MM DTT, 0.1 M AMSO4, 10% (W/V) PEG 3350",,,,"4C2S",69.83,"2.48","2.48","Crystal structure of the fucosylgalactoside alpha N- acetylgalactosaminyltransferase (GTA P156L mutant) in complex with UDP and deoxy-H-antigen acceptor","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQLAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYLGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","HISTO-BLOOD GROUP ABO SYSTEM TRANSFERASE","1","4C2S"
"4C2X",,"X-RAY DIFFRACTION",2.26,45.5,,5.5,"25% PEG 3350, 0.2M KCL, 100 MM NA CITRATE PH 5.5",,"10.1038/ncomms5919",,"4C2X",48.61,"2.33","2.33","Human N-myristoyltransferase isoform 2 (NMT2)","MGSSHHHHHHSSGLEVLFQGPHMDEAAKHRYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHRSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYNWRCPGTDSEKVGLVLQ","Homo sapiens","NMT2","GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE 2","1","4C2X"
"4C2Y",,"X-RAY DIFFRACTION",2.26,45.5,,4.5,"22.5% PEG 4000, 5 MM NICL2, 100 MM NA CITRATE PH 4.5, 2.5% GLYCEROL",,"10.1038/ncomms5919",,"4C2Y",98.24,"1.64","1.64","Human N-myristoyltransferase (NMT1) with Myristoyl-CoA co-factor","MGSSHHHHHHSSGLEVLFQGPHMEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYNWKCPSMGAEKVGLVLQ","Homo sapiens","NMT1, NMT","GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE 1","1","4C2Y"
"4C2Z",,"X-RAY DIFFRACTION",2.26,45.5,,4.5,"25% PEG 2000 MME, 0.2 M KBR, 100 MM NA CITRATE PH 4.5, 5% GLYCEROL",,"10.1038/ncomms5919","646","4C2Z",99.24,"2.08","2.08","Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound","MGSSHHHHHHSSGLEVLFQGPHMEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYNWKCPSMGAEKVGLVLQ","Homo sapiens","NMT1, NMT","GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE 1","1","4C2Z"
"4C3F",,"X-RAY DIFFRACTION",2.23,44.49,,,"16 % PEG 8000, 0.1 M NA CACODYLATE PH 6.5, 0.2 M MG ACETATE, 4 C",277,"10.1021/jm401309q",,"4C3F",30.97,"1.72","1.72","Structure of Lck in complex with a compound discovered by Virtual Fragment Linking","GPEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT","Homo sapiens","LCK","TYROSINE-PROTEIN KINASE LCK","1","4C3F"
"4C3R",,"X-RAY DIFFRACTION",2.96,58.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"CRYSTALS OF DEPHOSPHORYLATED A(122-403) IN COMPLEX WITH AMPPCP WERE OBTAINED BY MIXING A 2:1 RATIO OF 570UM (18MG/ML) DEP A(122-403) AND 1MM AMPPCP WITH MOTHER LIQUOR (0.2M AMMONIUM SULFATE, 0.2M TRISHCL PH 7.50, 30% (W/V) PEG3350). THE CRYSTALS WERE GROWN AT 18C BY VAPOR DIFFUSION AND THE HANGING DROP METHOD.",291,"10.7554/eLife.02667",,"4C3R",33.19,"2.79","2.79","Structure of dephosphorylated Aurora A (122-403) bound to AMPPCP","ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","AURORA KINASE A","1","4C3R"
"4C3Z",,"X-RAY DIFFRACTION",2.69,54.91,,5.5,"25% PEG 3.350, 0.2M AMSO4, 0.1M BISTRIS PH5.5",,,,"4C3Z",29.61,"2.1","2.1","Nucleotide-free crystal structure of nucleotide-binding domain 1 from human MRP1 supports a general-base catalysis mechanism for ATP hydrolysis.","MARIHHHHHHGSDSIERRPVKDGGGTNSITVRNATFTWARSDPPTLNGITFSIPEGALVAVVGQVGCGKSSLLSALLAEMDKVEGHVAIKGSVAYVPQQAWIQNDSLRENILFGCQLEEPYYRSVIQACALLPDLEILPSGDRTEIGEKGVNLSGGQKQRVSLARAVYSNADIYLFDDPLSAVDAHVGKHIFENVIGPKGMLKNKTRILVTHSMSYLPQVDVIIVMSGGKISEMGSYQELLARDGAFAEFLRTYASTEQEQDAEEN","Homo sapiens","ABCC1, MRP, MRP1","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","1","4C3Z"
"4C41",,"X-RAY DIFFRACTION",2.36,47.86,,5.3,"15% PEG3350, 0.2M NACL, 50MM MES, PH 5.3",,"10.1371/journal.pone.0113402",,"4C41",41.65,"1.8","1.8","Corticosteroid-binding globulin with engineered disulphide bridge between residues 100 and 236","SNHHRGLASANVDFAFSLYKHLVALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETEIHQGFQHLHQLFAKSDTCLEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNFQDWATASRQINSYVKNKTQGKIVDLFSGLDSPAILVLVNYIFFKGTWTQPFDLASTREENFYVDETTVVKVPMMLQSSTISYLHDSELPCQLVQMNYCGNGTVFFILPDKGKMNTVIAALSRDTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLEEMGIADLFTNQANFSRITQDAQLKSSKVVHKAVLQLNEEGVDTAGSTGVTLNLRSKPIILRFNQPFIIMIFDHFTWSSLFLARVMNPV","Homo sapiens","SERPINA6, CBG","CORTICOSTEROID-BINDING GLOBULIN","1","4C41"
"4C45",,"X-RAY DIFFRACTION",2.51,50.98,,,"2.4 SODIUM MALONATE",,,,"4C45",11.93,"1.45","1.45","Crystal structure of human pterin-4-alpha-carbinolamine dehydratase 2 (PCBD2)","SMSSGTHRLTAEERNQAILDLKAAGWSELSERDAIYKEFSFHNFNQAFGFMSRVALQAEKMNHHPEWFNVYNKVQITLTSHDCGELTKKDVKLAKFIEKAAASV","Homo sapiens","PCBD2, DCOH2, DCOHM","PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 2","1","4C45"
"4C49",,"X-RAY DIFFRACTION",2.32,47,,5.3,"12% PEG 3350, 0.2M NACL, 50 MM MES, PH 5.3",,,"HCY","4C49",167.95,"2.7","2.7","Reactive loop cleaved human CBG in complex with cortisol","SNHHRGLASANVDFAFSLYKHLVALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETEIHQGFQHLHQLFAKSDTSLEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNFQDWATASRQINSYVKNKTQGKIVDLFSGLDSPAILVLVNYIFFKGTWTQPFDLASTREENFYVDETTVVKVPMMLQSSTISYLHDSELPCQLVQMNYVGNGTVFFILPDKGKMNTVIAALSRDTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLEEMGIADLFTNQANFSRITQDAQLKSSKVVHKAVLQLNEEGVDTAGSTGVTLNLRSKPIILRFNQPFIIMIFDHFTWSSLFLARVMNPV","Homo sapiens","SERPINA6, CBG","CORTICOSTEROID-BINDING GLOBULIN","1","4C49"
"4C4E",,"X-RAY DIFFRACTION",3.8,67.5,,7.5,"30-35% AQUEOUS PEG300 ONLY, pH 7.5",,"10.1021/jm401395s","4T9","4C4E",38.01,"2.6","2.6","Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4C4E"
"4C4F",,"X-RAY DIFFRACTION",3.7,67.1,,7.5,"30-35% AQUEOUS PEG300 ONLY, pH 7.5",,"10.1021/jm401395s","7CE","4C4F",37.62,"2.36","2.36","Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4C4F"
"4C4G",,"X-RAY DIFFRACTION",3.8,68,,7.5,"30-35% AQUEOUS PEG300 ONLY, pH 7.5",,"10.1021/jm401395s","7RO","4C4G",37.44,"2.65","2.65","Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4C4G"
"4C4H",,"X-RAY DIFFRACTION",3.5,65.2,,7.5,"30-35% AQUEOUS PEG300 ONLY, pH 7.5",,"10.1021/jm401395s","7RO","4C4H",36.92,"2.8","2.8","Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4C4H"
"4C4I",,"X-RAY DIFFRACTION",3.5,64.9,,7.5,"30-35% AQUEOUS PEG300 ONLY, pH 7.5",,"10.1021/jm401395s","X20","4C4I",36.91,"2.65","2.65","Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4C4I"
"4C4J",,"X-RAY DIFFRACTION",3.5,65.1,,,"14% PEG8000 0.05M MAGNESIUM ACETATE, 0.1M SODIUM ACETATE",,"10.1021/jm401395s","X21","4C4J",36.7,"2.5","2.5","Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4C4J"
"4C4X",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, HANGING DROP",8.3,"HANGING DROP. 1 UL PROTEIN SOLUTION (8 MG/ML SEH IN 100 MM NAPO2, PH 7.4, 5 MM DTT AND 15% GLYCEROL) WAS MIXED WITH 1 UL RESERVOIR SOLUTION (100 MM TRIS-HCL, PH 8.3, 26% PEG4000 AND 200 MM LI2SO4 AND EQUILIBRATED AT 20C. CRYSTALS APPEARED IN ABOUT 2 WEEKS",293,"10.1002/anie.201500671",,"4C4X",75.21,"2.17","2.17","Crystal structure of human bifunctional epoxide hydroxylase 2 complexed with C9","TSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","BIFUNCTIONAL EPOXIDE HYDROLASE 2","1","4C4X"
"4C4Y",,"X-RAY DIFFRACTION",2.11,41.7,"VAPOR DIFFUSION, HANGING DROP",8.3,"HANGING DROP. 1 UL PROTEIN SOLUTION (8 MG/ML SEH IN 100 MM NAPO2, PH 7.4, 5 MM DTT AND 15% GLYCEROL) WAS MIXED WITH 1 UL RESERVOIR SOLUTION (100 MM TRIS-HCL, PH 8.3, 26% PEG4000 AND 200 MM LI2SO4 AND EQUILIBRATED AT 20C. CRYSTALS APPEARED IN ABOUT 2 WEEKS",293,"10.1002/anie.201500671",,"4C4Y",37.6,"2.41","2.41","Crystal structure of human bifunctional epoxide hydroxylase 2 complexed with A4","TSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","BIFUNCTIONAL EPOXIDE HYDROLASE 2","1","4C4Y"
"4C4Z",,"X-RAY DIFFRACTION",2.22,44.6,,8.3,"pH 8.3",,"10.1002/anie.201500671",,"4C4Z",75.17,"2.06","2.06","Crystal structure of human bifunctional epoxide hydroxylase 2 complexed with A8","TSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","BIFUNCTIONAL EPOXIDE HYDROLASE 2","1","4C4Z"
"4C52",,"X-RAY DIFFRACTION",2.2,43,,6.5,"1.4 M (NH4)2SO4, 0.1 M MES PH 6.5, 25% (V/V) ETHYLENE GLYCOL",,"10.1021/jm401948b","X0D","4C52",38.26,"2.049","2.049","Crystal structure of Bcl-xL in complex with benzoylurea compound (39b)","GPLGSMSQSNRELVVDFLSYKLSQKGYSWSQMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","BCL-2-LIKE PROTEIN 1","1","4C52"
"4C54",,"X-RAY DIFFRACTION",2.98,58.75,,6.5,"MES PH6.5. 18-20% PEG 20 000",,"10.1016/j.jmb.2013.10.039",,"4C54",52.37,"1.9","1.9","Crystal structure of recombinant human IgG4 Fc","FLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLGK","Homo sapiens","IGHG4","IG GAMMA-4 CHAIN C REGION","1","4C54"
"4C55",,"X-RAY DIFFRACTION",3.02,59.25,,6.5,"MES PH6.5. 18-20% PEG 20 000",,"10.1016/j.jmb.2013.10.039",,"4C55",52.97,"2.35","2.35","Crystal structure of serum-derived human IgG4 Fc","PAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLGK","Homo sapiens","IGHG4","IG GAMMA-4 CHAIN C REGION","1","4C55"
"4C5D",,"X-RAY DIFFRACTION",2.2,43.9,,6.5,"1.1 M (NH4)2SO4, 0.1 M MES PH 6.5, 25% (V/V) ETHYLENE GLYCOL",,"10.1021/jm401948b","X0R","4C5D",38.26,"2.3","2.3","Crystal structure of Bcl-xL in complex with benzoylurea compound (42)","GPLGSMSQSNRELVVDFLSYKLSQKGYSWSQMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","BCL-2-LIKE PROTEIN 1","1","4C5D"
"4C5W",,"X-RAY DIFFRACTION",2.5,52,"VAPOR DIFFUSION, SITTING DROP",7,"15 % PEG 3350, 1 % 1.6-DIAMINOHEXANE, 200 MM AMMONIUM CITRATE PH 7.0, 10 MM ZNSO4, 8 MM N-OXALYLGLYCINE, 4 MM INHIBITOR, PROTEIN 6.5 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 2-7 DAYS",294,"10.1021/jm401603e","NM3","4C5W",45.46,"1.7","1.7","Three dimensional structure of human gamma-butyrobetaine hydroxylase in complex with 4-(Ethyldimethylammonio)butanoate","MACTIQKAEALDGAHLMQILWYDEEESLYPAVWLRDNCPCSDCYLDSAKARKLLVEALDVNIGIKGLIFDRKKVYITWPDEHYSEFQADWLKKRCFSKQARAKLQRELFFPECQYWGSELQLPTLDFEDVLRYDEHAYKWLSTLKKVGIVRLTGASDKPGEVSKLGKRMGFLYLTFYGHTWQVQDKIDANNVAYTTGKLSFHTDYPALHHPPGVQLLHCIKQTVTGGDSEIVDGFNVCQKLKKNNPQAFQILSSTFVDFTDIGVDYCDFSVQSKHKIIELDDKGQVVRINFNNATRDTIFDVPVERVQPFYAALKEFVDLMNSKESKFTFKMNPGDVITFDNWRLLHGRRSYEAGTEISRHLEGAYADWDVVMSRLRILRQRVENGN","Homo sapiens","BBOX1, BBH, BBOX","GAMMA-BUTYROBETAINE DIOXYGENASE","1","4C5W"
"4C61",,"X-RAY DIFFRACTION",2.86,57,,7,"pH 7",,"10.1021/jm401546n","LMM","4C61",71.14,"2.45","2.45","Inhibitors of Jak2 Kinase domain","AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG","Homo sapiens","JAK2","TYROSINE-PROTEIN KINASE JAK2","1","4C61"
"4C62",,"X-RAY DIFFRACTION",2.82,56.4,,7,"pH 7",,"10.1021/jm401546n",,"4C62",71.17,"2.75","2.75","Inhibitors of Jak2 Kinase domain","AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG","Homo sapiens","JAK2","TYROSINE-PROTEIN KINASE JAK2","1","4C62"
"4C66",,"X-RAY DIFFRACTION",2.08,40.89,,,"1M LICL, 0.1M NAAC (UNBUFFERED), 30% PEG6000",,"10.1021/jm401088k","H4C","4C66",15.31,"1.87","1.87","Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4C66"
"4C67",,"X-RAY DIFFRACTION",2.13,42.36,,6.5,"0.2M CACL2, 0.1M MES PH6.5, 20% PEG6000",,"10.1021/jm401088k",,"4C67",15.5,"1.55","1.55","Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4C67"
"4C6B",,"X-RAY DIFFRACTION",2.4,49,,6,"pH 6",,"10.1016/j.str.2013.10.016",,"4C6B",43.2,"1.656","1.656","Crystal structure of the dihydroorotase domain of human CAD with incomplete active site, obtained recombinantly from E. coli.","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6B"
"4C6C",,"X-RAY DIFFRACTION",2.4,49,,7,"pH 7",,"10.1016/j.str.2013.10.016",,"4C6C",43.36,"1.451","1.451","Crystal structure of the dihydroorotase domain of human CAD in apo- form obtained recombinantly from HEK293 cells.","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6C"
"4C6D",,"X-RAY DIFFRACTION",2.4,49,,6,"pH 6.0",,"10.1016/j.str.2013.10.016",,"4C6D",43.7,"1.298","1.298","Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 6.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6D"
"4C6E",,"X-RAY DIFFRACTION",2.4,49,,5.5,"pH 5.5",,"10.1016/j.str.2013.10.016",,"4C6E",43.57,"1.263","1.263","Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 5.5","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","DIHYDROOROTASE","1","4C6E"
"4C6F",,"X-RAY DIFFRACTION",2.4,49,,6.5,"pH 6.5",,"10.1016/j.str.2013.10.016",,"4C6F",43.7,"1.261","1.261","Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 6.5","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","DIHYDROOROTASE","1","4C6F"
"4C6I",,"X-RAY DIFFRACTION",2.4,49,,7,"pH 7.0",,"10.1016/j.str.2013.10.016",,"4C6I",43.58,"1.35","1.35","Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 7.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6I"
"4C6J",,"X-RAY DIFFRACTION",2.4,49,,7.5,"pH 7.5",,"10.1016/j.str.2013.10.016",,"4C6J",43.58,"1.299","1.299","Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 7.5","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6J"
"4C6K",,"X-RAY DIFFRACTION",2.48,50.33,,8,"pH 8.0",,"10.1016/j.str.2013.10.016",,"4C6K",43.58,"1.478","1.478","Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 8.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6K"
"4C6L",,"X-RAY DIFFRACTION",2.4,49,,6,"pH 6.0",,"10.1016/j.str.2013.10.016",,"4C6L",43.31,"1.55","1.55","Crystal structure of the dihydroorotase domain of human CAD bound to the inhibitor fluoroorotate at pH 6.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6L"
"4C6M",,"X-RAY DIFFRACTION",2.4,49,,7,"pH 7.0",,"10.1016/j.str.2013.10.016",,"4C6M",43.38,"1.62","1.62","Crystal structure of the dihydroorotase domain of human CAD bound to the inhibitor fluoroorotate at pH 7.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6M"
"4C6N",,"X-RAY DIFFRACTION",2.4,49,,6,"pH 6.0",,"10.1016/j.str.2013.10.016",,"4C6N",43.33,"1.899","1.899","Crystal structure of the dihydroorotase domain of human CAD E1637T mutant bound to substrate at pH 6.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCTVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6N"
"4C6O",,"X-RAY DIFFRACTION",2.4,49,,6,"pH 6.0",,"10.1016/j.str.2013.10.016",,"4C6O",43.21,"1.65","1.65","Crystal structure of the dihydroorotase domain of human CAD C1613S mutant in apo-form at pH 6.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHISHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6O"
"4C6P",,"X-RAY DIFFRACTION",2.4,49,,7,"pH 7.0",,"10.1016/j.str.2013.10.016",,"4C6P",43.28,"1.518","1.518","Crystal structure of the dihydroorotase domain of human CAD C1613S mutant in apo-form at pH 7.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHISHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6P"
"4C6Q",,"X-RAY DIFFRACTION",2.4,49,,7,"pH 7.0",,"10.1016/j.str.2013.10.016",,"4C6Q",43.55,"1.659","1.659","Crystal structure of the dihydroorotase domain of human CAD C1613S mutant bound to substrate at pH 7.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHISHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD PROTEIN","1","4C6Q"
"4C7J",,"X-RAY DIFFRACTION",1.9,36,,,,,"10.1021/jm4016729","4YQ","4C7J",123.08,"2.16","2.16","11b-Hydroxysteroid Dehydrogenase Type I in complex with inhibitor","NEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPLVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPSRKILEELYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1","1","4C7J"
"4C7K",,"X-RAY DIFFRACTION",1.9,36,,,,,"10.1021/jm4016729","DZL","4C7K",122.7,"1.91","1.91","11b-Hydroxysteroid Dehydrogenase Type I in complex with inhibitor","NEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPLVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPSRKILEELYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1","1","4C7K"
"4C8B",,"X-RAY DIFFRACTION",2.28,45.98,,,"16% PEG3350, 0.1M AMMONIUM CITRATE",,"10.1016/j.chembiol.2015.07.017","0LI","4C8B",77.9,"2.75","2.75","Structure of the kinase domain of human RIPK2 in complex with ponatinib","MGHHHHHHSSGVDLGTENLYFQSMSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWCMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLKKTKLQSV","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2","1","4C8B"
"4C8D",,"X-RAY DIFFRACTION",2.63,53.31,,,"0.1M BIS-TRIS PH 5.5, 0.1M AMMONIUM ACETATE, 27% PEG 3350",,,,"4C8D",40.73,"2.18","2.18","Crystal structure of JmjC domain of human histone 3 Lysine-specific demethylase 3B (KDM3B)","MTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKQRIHDGKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFAGNLYFQ","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","LYSINE-SPECIFIC DEMETHYLASE 3B","1","4C8D"
"4C8R",,"X-RAY DIFFRACTION",2.82,56.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M AMMONIUM CITRATE, 10MM NISO4, 2% 1,6-DIAMINOHEXANE, 19% PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K, pH 7.5",293,"10.1039/C4SC00020J",,"4C8R",272.79,"2.82","2.82","Human gamma-butyrobetaine dioxygenase (BBOX1) in complex with Ni(II) and N-(3-hydroxypicolinoyl)-S-(pyridin-2-ylmethyl)-L-cysteine (AR692B)","SMACTIQKAEALDGAHLMQILWYDEEESLYPAVWLRDNCPCSDCYLDSAKARKLLVEALDVNIGIKGLIFDRKKVYITWPDEHYSEFQADWLKKRCFSKQARAKLQRELFFPECQYWGSELQLPTLDFEDVLRYDEHAYKWLSTLKKVGIVRLTGASDKPGEVSKLGKRMGFLYLTFYGHTWQVQDKIDANNVAYTTGKLSFHTDYPALHHPPGVQLLHCIKQTVTGGDSEIVDGFNVCQKLKKNNPQAFQILSSTFVDFTDIGVDYCDFSVQSKHKIIELDDKGQVVRINFNNATRDTIFDVPVERVQPFYAALKEFVDLMNSKESKFTFKMNPGDVITFDNWRLLHGRRSYEAGTEISRHLEGAYADWDVVMSRLRILRQRVENGN","Homo sapiens","BBOX1, BBH, BBOX","GAMMA-BUTYROBETAINE DIOXYGENASE","1","4C8R"
"4C9W",,"X-RAY DIFFRACTION",2.04,39.63,,7.5,"0.2M AMMONIUM SULFATE, 30%(W/V) PEG 4000, pH 7.5",,"10.1038/nature13194","VGH","4C9W",19.07,"1.65","1.65","Crystal structure of NUDT1 (MTH1) with R-crizotinib","GAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE","1","4C9W"
"4C9X",,"X-RAY DIFFRACTION",2,39.6,,7.5,"0.2M AMMONIUM SULFATE, 24%(W/V) PEG 4000, pH 7.5",,"10.1038/nature13194","VHS","4C9X",19.07,"1.2","1.2","Crystal structure of NUDT1 (MTH1) with S-crizotinib","GAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE","1","4C9X"
"4C9Y",,"X-RAY DIFFRACTION",2.84,57,,7.5,"0.1M IMIDAZOLE-MES BUFFER, 0.09 M NPS MIX AND 30% EDO_P8K, pH 7.5",,"10.1038/ncomms3964",,"4C9Y",29.31,"2.01","2.01","Structural Basis for the microtubule binding of the human kinetochore Ska complex","SIKEMPFITCDEFNGVPSYMKSRLTYNQINDVIKEINKAVISKYKILHQPKKSMNSVTRNLYHRFIDEETKDTKGRYFIVEADIKEFTTLKADKKFHVLLNILRHCRRLSEVRGGGLTRYVIT","Homo sapiens","SKA1, C18orf24","SPINDLE AND KINETOCHORE-ASSOCIATED PROTEIN 1","1","4C9Y"
"4C9Z",,"X-RAY DIFFRACTION",2.99,59,,,"CRYSTALS GREW FROM EQUAL VOLUMES OF PROTEIN SOLUTION (15 MG ML-1 IN 15 MM TRIS-HCL PH7.5, 30 MM NACL AND 10 MM DTT) AND RESERVOIR SOLUTION (100 MES PH6.5, 1.5 M MGSO4).",,"10.1107/S1744309113031448",,"4C9Z",45.05,"1.95","1.95","Crystal structure of Siah1 at 1.95 A resolution","GHMANSVLFPCKYASSGCEITLPHTEKADHEELCEFRPYSCPCPGASCKWQGSLDAVMPHLMHQHKSITTLQGEDIVFLATDINLPGAVDWVMMQSCFGFHFMLVLEKQEKYDGHQQFFAIVQLIGTRKQAENFAYRLELNGHRRRLTWEATPRSIHEGIATAIMNSDCLVFDTSIAQLFAENGNLGINVTISMC","Homo sapiens","SIAH1, HUMSIAH","E3 UBIQUITIN-PROTEIN LIGASE SIAH1","1","4C9Z"
"4CA0",,"X-RAY DIFFRACTION",2.58,52,,7,"24% PEG 1500 AND 20% GLYCEROL, pH 7",,"10.1038/ncomms3964",,"4CA0",29.29,"2.259","2.259","Structural Basis for the microtubule binding of the human kinetochore Ska complex","MSIKEMPFITCDEFNGVPSYMKSRLTYNQINDVIKEINKAVISKYKILHQPKKSMNSVTRNLYHRFIDEETKDTKGRYFIVEADIKEFTTLKADKKFHVLLNILRHCRRLSEVRGGGLTRYVIT","Homo sapiens","SKA1, C18orf24","SPINDLE AND KINETOCHORE-ASSOCIATED PROTEIN 1","1","4CA0"
"4CA1",,"X-RAY DIFFRACTION",2.99,59,,,"CRYSTALS GREW FROM EQUAL VOLUMES OF PROTEIN SOLUTION (15 MG ML-1 IN 15 MM TRIS-HCL PH7.5, 30 MM NACL AND 10 MM DTT) AND RESERVOIR SOLUTION (100 MM HEPES PH7.0, 1.45 LI2SO4).",,"10.1107/S1744309113031448",,"4CA1",45.8,"1.58","1.58","Crystal structure of Siah1 at 1.58 A resolution.","GHMANSVLFPCKYASSGCEITLPHTEKADHEELCEFRPYSCPCPGASCKWQGSLDAVMPHLMHQHKSITTLQGEDIVFLATDINLPGAVDWVMMQSCFGFHFMLVLEKQEKYDGHQQFFAIVQLIGTRKQAENFAYRLELNGHRRRLTWEATPRSIHEGIATAIMNSDCLVFDTSIAQLFAENGNLGINVTISMC","Homo sapiens","SIAH1, HUMSIAH","E3 UBIQUITIN-PROTEIN LIGASE SIAH1","1","4CA1"
"4CA2",,"X-RAY DIFFRACTION",2.15,42.69,,,,,"10.1021/bi00110a008",,"4CA2",29.56,"2.1","2.1","ENGINEERING THE HYDROPHOBIC POCKET OF CARBONIC ANHYDRASE II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE II","1","4CA2"
"4CA5",,"X-RAY DIFFRACTION",2.4,48,,4,"0.1M MIB PH4.0, 10UM ZINC SULPHATE, 5% GLYCEROL, 15% PEG3350",,"10.1111/febs.12660","3EF","4CA5",69.99,"1.85","1.85","Human Angiotensin converting enzyme in complex with a phosphinic tripeptide FI","LVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNS","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","4CA5"
"4CA6",,"X-RAY DIFFRACTION",2.9,57.6,,8.5,"0.06 M DIVALENT CATIONS, 0.1 M TRIS/BICINE PH 8.5, 30 % PEG550MME/PEG20000",,"10.1111/febs.12660","3EF","4CA6",146.49,"1.91","1.91","Human Angiotensin converting enzyme N-domain in complex with a phosphinic tripeptide FI","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPNKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEG","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME N-DOMAIN","1","4CA6"
"4CAA",,"X-RAY DIFFRACTION",3,59,,5.6,"14% PEG 8000 0.2 M MAGNESIUM ACETATE 0.1 M SODIUM CITRATE PH 5.6",,"10.1021/bi972359e",,"4CAA",42.94,"2.9","2.9","CLEAVED ANTICHYMOTRYPSIN T345R","THVDLGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGREASAATAVKITLL","Homo sapiens","ACT, SERPINA3, AACT, GIG24, GIG25","ANTICHYMOTRYPSIN","1","4CAA"
,,,,,,,,,,,,,,,,"VETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQA","Homo sapiens","ACT, SERPINA3, AACT, GIG24, GIG25","ANTICHYMOTRYPSIN","2","4CAA"
"4CAC",,"X-RAY DIFFRACTION",2.15,42.89,,,,,"10.1002/prot.340040406",,"4CAC",29.22,"2.2","2.2","REFINED STRUCTURE OF HUMAN CARBONIC ANHYDRASE II AT 2.0 ANGSTROMS RESOLUTION","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE FORM C","1","4CAC"
"4CAH",,"X-RAY DIFFRACTION",2.71,54.7,,7.5,"0.04M POTASSIUM DIHYDROGEN PHOSPHATE, 16% PEG 8000, 20% GLYCEROL, 0.2M NABR, pH 7.5",,"10.1186/1472-6807-14-3",,"4CAH",13.89,"1.901","1.901","Structure of inner DysF domain of human dysferlin","SMDAGHLSFVEEVFENQTRLPGGQWIYMSDNYTDVNGEKVLPKDDIECPLGWKWEDEEWSTDLNRAVDEQGWEYSITIPPERKPKHWVPAEKMYYTHRRRRWVRLRRRDLSQ","Homo sapiens","DYSF, FER1L1","DYSFERLIN","1","4CAH"
"4CAI",,"X-RAY DIFFRACTION",2.85,56.8,,7.5,"0.04M SODIUM DIHYDROGEN PHOSPHATE, 16% PEG 8000, 20% GLYCEROL, 0.2M NABR, pH 7.5",,"10.1186/1472-6807-14-3",,"4CAI",41.09,"2.2","2.2","Structure of inner DysF domain of human dysferlin","SMDAGHLSFVEEVFENQTRLPGGQWIYMSDNYTDVNGEKVLPKDDIECPLGWKWEDEEWSTDLNRAVDEQGWEYSITIPPERKPKHWVPAEKMYYTHRRRRWVRLRRRDLSQ","Homo sapiens","DYSF, FER1L1","DYSFERLIN","1","4CAI"
"4CB8",,"X-RAY DIFFRACTION",2.79,56,,8.5,"26% PEG 3350, 0.2M LI2SO4, 0.1M TRIS-HCL PH 8.5",,"10.1016/j.febslet.2013.11.013",,"4CB8",57.41,"2.9","2.9","Structural and mutational analysis reveals that CTNNBL1 binds NLSs in a manner distinct from that of its closest armadillo-relative, karyopherin alpha","MAHHHHHHMLDESSVKKMILTFEKRSYKNQELRIKFPDNPEKFMESELDLNDIIQEMHVVATMPDLYHLLVELNAVQSLLGLLGHDNTDVSIAVVDLLQELTDIDTLHESEEGAEVLIDALVDGQVVALLVQNLERLDESVKEEADGVHNTLAIVENMAEFRPEMCTEGAQQGLLQWLLKRLKAKMPFDANKLYCSEVLAILLQDNDENRELLGELDGIDVLLQQLSVFKRHNPSTAEEQEMMENLFDSLCSCLMLSSNRERFLKGEGLQLMNLMLREKKISRSSALKVLDHAMIGPEGTDNCHKFVDILGLRTIFPLFMKSPRKIKKVGTTEKEHEEHVCSILASLLRNLRGQQRTRLLNKFTENDSEKVDRLMELHFKYLGAMQVADKKIEGEKHDMVRRGEIIDNDTEEEFYLRRLDAGLFVLQHICYIMAEICNANVPQIRQRVHQILNMRGSSIKIVRHIIKEYAENIGDGRSPEFRENEQKRILGLLENF","Homo sapiens","CTNNBL1, C20orf33, PP8304","BETA-CATENIN-LIKE PROTEIN 1","1","4CB8"
"4CB9",,"X-RAY DIFFRACTION",2.86,57.07,,8.5,"0.1M TRIS PH 8.5, 1.1M NAF",,"10.1016/j.febslet.2013.11.013",,"4CB9",66.3,"3","3","Structure of full-length CTNNBL1 in P43212 space group","MAHHHHHHMDVGELLSYQPNRGTKRPRDDEEEEQKMRRKQTGTRERGRYREEEMTVVEEADDDKKRLLQIIDRDGEEEEEEEEPLDESSVKKMILTFEKRSYKNQELRIKFPDNPEKFMESELDLNDIIQEMHVVATMPDLYHLLVELNAVQSLLGLLGHDNTDVSIAVVDLLQELTDIDTLHESEEGAEVLIDALVDGQVVALLVQNLERLDESVKEEADGVHNTLAIVENMAEFRPEMCTEGAQQGLLQWLLKRLKAKMPFDANKLYCSEVLAILLQDNDENRELLGELDGIDVLLQQLSVFKRHNPSTAEEQEMMENLFDSLCSCLMLSSNRERFLKGEGLQLMNLMLREKKISRSSALKVLDHAMIGPEGTDNCHKFVDILGLRTIFPLFMKSPRKIKKVGTTEKEHEEHVCSILASLLRNLRGQQRTRLLNKFTENDSEKVDRLMELHFKYLGAMQVADKKIEGEKHDMVRRGEIIDNDTEEEFYLRRLDAGLFVLQHICYIMAEICNANVPQIRQRVHQILNMRGSSIKIVRHIIKEYAENIGDGRSPEFRENEQKRILGLLENF","Homo sapiens","CTNNBL1, C20orf33, PP8304","BETA-CATENIN-LIKE PROTEIN 1","1","4CB9"
"4CBA",,"X-RAY DIFFRACTION",3.6,65.7,,,"0.12M ETHYLENE GLYCOL, 12.5% PEG 3350, 12.5% PEG 1K, 12.5% MPD, 0.1 M BICINE/TRIZMA BASE",,"10.1016/j.febslet.2013.11.013",,"4CBA",57.66,"3.1","3.1","Structural of delta 1-76 CTNNBL1 in space group I222","MAHHHHHHMLDESSVKKMILTFEKRSYKNQELRIKFPDNPEKFMESELDLNDIIQEMHVVATMPDLYHLLVELNAVQSLLGLLGHDNTDVSIAVVDLLQELTDIDTLHESEEGAEVLIDALVDGQVVALLVQNLERLDESVKEEADGVHNTLAIVENMAEFRPEMCTEGAQQGLLQWLLKRLKAKMPFDANKLYCSEVLAILLQDNDENRELLGELDGIDVLLQQLSVFKRHNPSTAEEQEMMENLFDSLCSCLMLSSNRERFLKGEGLQLMNLMLREKKISRSSALKVLDHAMIGPEGTDNCHKFVDILGLRTIFPLFMKSPRKIKKVGTTEKEHEEHVCSILASLLRNLRGQQRTRLLNKFTENDSEKVDRLMELHFKYLGAMQVADKKIEGEKHDMVRRGEIIDNDTEEEFYLRRLDAGLFVLQHICYIMAEICNANVPQIRQRVHQILNMRGSSIKIVRHIIKEYAENIGDGRSPEFRENEQKRILGLLENF","Homo sapiens","CTNNBL1, C20orf33, PP8304","BETA-CATENIN-LIKE PROTEIN 1","1","4CBA"
"4CBN",,"X-RAY DIFFRACTION",2.03,40,,,"15% PEG 6000, 50 MM MES/NAOH, PH 6.0",,"10.1107/S1399004713032549",,"4CBN",48.98,"1.8","1.8","Crystal structure of Complement Factor D mutant R202A after conventional refinement","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSAVCGNRKKPGIYTRVASYAAWIDSVLA","Homo sapiens","CFD, DF, PFD","COMPLEMENT FACTOR D","1","4CBN"
"4CBO",,"X-RAY DIFFRACTION",3.66,66,,,"15% PEG 6000, 50 MM MES/NAOH PH 6.0",,"10.1107/S1399004713032549",,"4CBO",48.89,"1.8","1.8","Crystal structure of Complement Factor D mutant R202A after ensemble refinement","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSAVCGNRKKPGIYTRVASYAAWIDSVLA","Homo sapiens","CFD, DF, PFD","COMPLEMENT FACTOR D","1","4CBO"
"4CBR",,"X-RAY DIFFRACTION",3.25,62.19,,,"15% PEG 10K; 0.1 M HEPES PH 7.5, 2.5% V/V ISOPROPANOL AND 5% GLYCEROL AS ADDITIVE.",,"10.1042/BJ20140250",,"4CBR",43.49,"2.3","2.3","X-ray structure of the more stable human AGXT triple mutant (AGXT_HEM)","MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGHMSKEMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVMDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL","Homo sapiens","AGXT, AGT1, SPAT","SERINE--PYRUVATE AMINOTRANSFERASE","1","4CBR"
"4CBS",,"X-RAY DIFFRACTION",3.24,62.07,"MICROBATCH",,"15% PEG 10K; 0.1 M HEPES PH 7.5, 2.5% V/V ISOPROPANOL AND 5% GLYCEROL AS ADDITIVE.",291,"10.1042/BJ20140250",,"4CBS",43.39,"2.3","2.3","X-ray structure of quintuple mutant of human alanine glyoxylate aminotransferase, AGXT_RHEAM","MASHKLLVTPPKALLKPLSIPNRLLLGPGPSNLPPRIMAAGGLQMIGHMSKEMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAADIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVMDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL","Homo sapiens","AGXT, AGT1, SPAT","SERINE--PYRUVATE AMINOTRANSFERASE","1","4CBS"
"4CBT",,"X-RAY DIFFRACTION",2.17,43.26,,6.5,"0.1 M BISTRIS PH 6.5, 22% PEG MME 5000",,"10.1021/jm4011884","9F4","4CBT",129.83,"3.03","3.03","Design, synthesis, and biological evaluation of potent and selective Class IIa HDAC inhibitors as a potential therapy for Huntington's disease","MGSTKPRFTTGLVYDTLMLKHQCTCGSSSSHPEHAGRIQSIWSRLQETGLRGKCECIRGRKATLEELQTVHSEAHTLLYGTNPLNRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVELVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWDVHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDPPMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQLMGLAGGRIVLALEGGHDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKVMEIHSKYWRCLQRHHHHHH","Homo sapiens","HDAC4, KIAA0288","HISTONE DEACETYLASE 4","1","4CBT"
"4CBY",,"X-RAY DIFFRACTION",2.13,42.22,,6.5,"18-24% (W/V) PEG 3350, 0.2 M NACL AND 100 MM BIS-TRIS PH 5.5",,"10.1021/jm4011884","KEE","4CBY",173.01,"2.72","2.72","Design, synthesis, and biological evaluation of potent and selective Class IIa HDAC inhibitors as a potential therapy for Huntington's disease","MGSTKPRFTTGLVYDTLMLKHQCTCGSSSSHPEHAGRIQSIWSRLQETGLRGKCECIRGRKATLEELQTVHSEAHTLLYGTNPANRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVELVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWDVHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDPPMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQLMGLAGGRIVLALEGGHDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKVMEIHSKYWRCLQRHHHHHH","Homo sapiens","HDAC4, KIAA0288","HISTONE DEACETYLASE 4","1","4CBY"
"4CBZ",,"X-RAY DIFFRACTION",2.96,58.39,,,,,"10.1016/j.celrep.2013.10.029",,"4CBZ",70.23,"2.5","2.5","Notch ligand, Jagged-1, contains an N-terminal C2 domain","SGQFELEILSMQNVNGELQNGNCCGGARNPGDRKCTRDECDTYFKVCLKEYQSRVTAGGPCSFGSGSTPVIGGNTFNLKASRGNDRNRIVLPFSFAWPRSYTLLVEAWDSSNDTVQPDSIIEKASHSGMINPSRQWQTLKQNTGVAHFEYQIRVTCDDYYYGFGCNKFCRPRDDFFGHYACDQNGNKTCMEGWMGPECNRAICRQGCSPKHGSCKLPGDCRCQYGWQGLYCDKCIPHPGCVHGICNEPWQCLCETNWGGQLCDKDLNYCGTHQPCLNGGTCSNTGPDKYQCSCPEGYSGPNCEIVDHHHHHH","Homo sapiens","JAG1, JAGL1","PROTEIN JAGGED-1","1","4CBZ"
"4CC0",,"X-RAY DIFFRACTION",2.79,55.96,,,,,"10.1016/j.celrep.2013.10.029",,"4CC0",70.31,"2.32","2.32","Notch ligand, Jagged-1, contains an N-terminal C2 domain","SGQFELEILSMQNVNGELQNGNCCGGARNPGDRKCTRDECDTYFKVCLKEYQSRVTAGGPCSFGSGSTPVIGGNTFNLKASRGNDRNRIVLPFSFAWPRSYTLLVEAWDSSNDTVQPDSIIEKASHSGMINPSRQWQTLKQNTGVAHFEYQIRVTCDDYYYGFGCNKFCRPRDDFFGHYACDQNGNKTCMEGWMGPECNRAICRQGCSPKHGSCKLPGDCRCQYGWQGLYCDKCIPHPGCVHGICNEPWQCLCETNWGGQLCDKDLNYCGTHQPCLNGGTCSNTGPDKYQCSCPEGYSGPNCEIVDHHHHHH","Homo sapiens","JAG1, JAGL1","PROTEIN JAGGED-1","1","4CC0"
"4CC1",,"X-RAY DIFFRACTION",2.83,56.47,,,,,"10.1016/j.celrep.2013.10.029",,"4CC1",70.65,"2.84","2.84","Notch ligand, Jagged-1, contains an N-terminal C2 domain","SGQFELEILSMQNVNGELQNGNCCGGARNPGDRKCTRDECDTYFKVCLKEYQSRVTAGGPCSFGSGSTPVIGGNTFNLKASRGNDRNRIVLPFSFAWPRSYTLLVEAWDSSNDTVQPDSIIEKASHSGMINPSRQWQTLKQNTGVAHFEYQIRVTCDDYYYGFGCNKFCRPRDDFFGHYACDQNGNKTCMEGWMGPECNRAICRQGCSPKHGSCKLPGDCRCQYGWQGLYCDKCIPHPGCVHGICNEPWQCLCETNWGGQLCDKDLNYCGTHQPCLNGGTCSNTGPDKYQCSCPEGYSGPNCEIVDHHHHHH","Homo sapiens","JAG1, JAGL1","PROTEIN JAGGED-1","1","4CC1"
"4CCA",,"X-RAY DIFFRACTION",2.42,59.31,"VAPOR DIFFUSION, SITTING DROP",6,"SITTING DROPS CONTAINING 200 NL 8.85 MG/ML MUNC18-2 PLUS 200 NL RESERVOIR SOLUTION (0.1 M MES PH 6, 10% V/V 2-METHYL-2,4-PENTANEDIOL) EQUILIBRATED AGAINST 80 UL RESERVOIRS AT 20C.",293,"10.1073/pnas.1313474110",,"4CCA",67.1,"2.6","2.6","Structure of human Munc18-2","GSPEFMAPSGLKAVVGEKILSGVIRSVKKDGEWKVLIMDHPSMRILSSCCKMSDILAEGITIVEDINKRREPIPSLEAIYLLSPTEKSVQALIKDFQGTPTFTYKAAHIFFTDTCPEPLFSELGRSRLAKVVKTLKEIHLAFLPYEAQVFSLDAPHSTYNLYCPFRAEERTRQLEVLAQQIATLCATLQEYPAIRYRKGPEDTAQLAHAVLAKLNAFKADTPSLGEGPEKTRSQLLIMDRAADPVSPLLHELTFQAMAYDLLDIEQDTYRYETTGLSEAREKAVLLDEDDDLWVELRHMHIADVSKKVTELLRTFCESKRLTTDKANIKDLSQILKKMPQYQKELNKYSTHLHLADDCMKHFKGSVEKLCSVEQDLAMGSDAEGEKIKDSMKLIVPVLLDAAVPAYDKIRVLLLYILLRNGVSEENLAKLIQHANVQAHSSLIRNLEQLGGTVTNPGGSGTSSRLEPRERMEPTYQLSRWTPVIKDVMEDAVEDRLDRNLWPFVSDPAPTASSQAAVSARFGHWHKNKAGIEARAGPRLIVYVMGGVAMSEMRAAYEVTRATEGKWEVLIGSSHILTPTRFLDDLKALDKKLEDIALP","Homo sapiens","STXBP2, UNC18B","SYNTAXIN-BINDING PROTEIN 2","1","4CCA"
"4CCB",,"X-RAY DIFFRACTION",2.1,41.4,"VAPOR DIFFUSION, HANGING DROP",5.6,"CRYSTALLIZATION CONDITIONS: HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 13-15 MG/ML)CONTAINING 0.001 M INHIBITOR COMPOUND WERE COMBINED WITH A SOLUTION CONTAINING: 0.15 M AMMONIUM SULFATE, 9-10.5% MONOMETHYLETHER PEG5K AND 0.1M MES IN THE PH RANGE 5.3-6.5.",286,"10.1021/jm401805h",,"4CCB",37.29,"2.03","2.03","Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)ethoxy)-5-(5-methyl-1H- pyrazol-4-yl)pyridin-2-amine","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4CCB"
"4CCJ",,"X-RAY DIFFRACTION",3.04,59.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"NAPOR DIFFUSION, SITTING DROP 0.1M BIS-TRIS PROPANE PH 5.6-6.5, 0.5-0.7M MAGNESIUM FORMATE, 0.002M MNCL2, TEMPERATURE 293K",293,"10.1038/nature13263",,"4CCJ",213.15,"2.15","2.15","60S ribosomal protein L8 histidine hydroxylase (NO66) in apo form","MSPLRRVLAELNRIPSSRRRAARLFEWLIAPMPPDHFYRRLWEREAVLVRRQDHTYYQGLFSTADLDSMLRNEEVQFGQHLDAARYINGRRETLNPPGRALPAAAWSLYQAGCSLRLLCPQAFSTTVWQFLAVLQEQFGSMAGSNVYLTPPNSQGFAPHYDDIEAFVLQLEGRKLWRVYRPRAPTEELALTSSPNFSQDDLGEPVLQTVLEPGDLLYFPRGFIHQAECQDGVHSLHLTLSTYQRNTWGDFLEAILPLAVQAAMEENVEFRRGLPRDFMDYMGAQHSDSKDPRRTAFMEKVRVLVARLGHFAPVDAVADQRAKDFIHDSLPPVLTDRERALSVYGLPIRWEAGEPVNVGAQLTTETEVHMLQDGIARLVGEGGHLFLYYTVENSRVYHLEEPKCLEIYPQQADAMELLLGSYPEFVRVGDLPCDSVEDQLSLATTLYDKGLLLTKMPLALNAENLYFQ","Homo sapiens","RIOX1, C14orf169, MAPJD, NO66","BIFUNCTIONAL LYSINE-SPECIFIC DEMETHYLASE AND HISTIDYL-HYDROXYLASE NO66","1","4CCJ"
"4CCK",,"X-RAY DIFFRACTION",2.97,58.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"VAPOR DIFFUSION, SITTING DROP 0.1M BIS-TRIS PROPANE PH 5.6-6.5, 0.5-0.7M MAGNESIUM FORMATE, 0.002M MNCL2, TEMPERATURE 293K",293,"10.1038/nature13263",,"4CCK",214.02,"2.15","2.15","60S ribosomal protein L8 histidine hydroxylase (NO66) in complex with Mn(II) and N-oxalylglycine (NOG)","MSPLRRVLAELNRIPSSRRRAARLFEWLIAPMPPDHFYRRLWEREAVLVRRQDHTYYQGLFSTADLDSMLRNEEVQFGQHLDAARYINGRRETLNPPGRALPAAAWSLYQAGCSLRLLCPQAFSTTVWQFLAVLQEQFGSMAGSNVYLTPPNSQGFAPHYDDIEAFVLQLEGRKLWRVYRPRAPTEELALTSSPNFSQDDLGEPVLQTVLEPGDLLYFPRGFIHQAECQDGVHSLHLTLSTYQRNTWGDFLEAILPLAVQAAMEENVEFRRGLPRDFMDYMGAQHSDSKDPRRTAFMEKVRVLVARLGHFAPVDAVADQRAKDFIHDSLPPVLTDRERALSVYGLPIRWEAGEPVNVGAQLTTETEVHMLQDGIARLVGEGGHLFLYYTVENSRVYHLEEPKCLEIYPQQADAMELLLGSYPEFVRVGDLPCDSVEDQLSLATTLYDKGLLLTKMPLALNAENLYFQ","Homo sapiens","RIOX1, C14orf169, MAPJD, NO66","BIFUNCTIONAL LYSINE-SPECIFIC DEMETHYLASE AND HISTIDYL-HYDROXYLASE NO66","1","4CCK"
"4CCU",,"X-RAY DIFFRACTION",2.1,41.4,"VAPOR DIFFUSION, HANGING DROP",5.3,"CRYSTALLIZATION CONDITIONS: HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 13-15 MG/ML)CONTAINING 0.001 M INHIBITOR COMPOUND WERE COMBINED WITH A SOLUTION CONTAINING: 0.15 M AMMONIUM SULFATE, 9-10.5% MONOMETHYLETHER PEG5K AND 0.1M MES IN THE PH RANGE 5.3-6.5.",286,"10.1021/jm401805h",,"4CCU",37.36,"2","2","Structure of the Human Anaplastic Lymphoma Kinase in Complex with 2-(5-(6-amino-5-((R)-1-(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)ethoxy) pyridin-3-yl)-4-methylthiazol-2-yl)propan-2-ol","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4CCU"
"4CCZ",,"X-RAY DIFFRACTION",2.76,55.42,,,"2.4M SODIUM MALONATE",,,,"4CCZ",70.97,"2.7","2.7","Crystal structure of human 5-methyltetrahydrofolate-homocysteine methyltransferase, the homocysteine and folate binding domains","SMKTLRDEINAILQKRIMVLDGGMGTMIQREKLNEEHFRGQEFKDHARPLKGNNDILSITQPDVIYQIHKEYLLAGADIIETNTFSSTSIAQADYGLEHLAYRMNMCSAGVARKAAEEVTLQTGIKRFVAGALGPTNKTLSVSPSVERPDYRNITFDELVEAYQEQAKGLLDGGVDILLIETIFDTANAKAALFALQNLFEEKYAPRPIFISGTIVDKSGRTLSGQTGEGFVISVSHGEPLCIGLNCALGAAEMRPFIEIIGKCTTAYVLCYPNAGLPNTFGDYDETPSMMAKHLKDFAMDGLVNIVGGCCGSTPDHIREIAEAVKNCKPRVPPATAFEGHMLLSGLEPFRIGPYTNFVNIGERCNVAGSRKFAKLIMAGNYEEALCVAKVQVEMGAQVLDVNMDDGMLDGPSAMTRFCNLIASEPDIAKVPLCIDSSNFAVIEAGLKCCQGKCIVNSISLKEGEDDFLEKARKIKKYGAAMVVMAFDEEGQATETDTKIRVCTRAYHLLVKKLGFNPNDIIFDPNILTIGTGMEEHNLYAINFIHATKVIKETLPGARISGGLSNLSFSFRGMEAIREAMHGVFLYHAIKSGMDMGIVNAGNLPVYDDIHKELLQLCEDLIWNKDPEATEKLLRYAQTQGTGG","Homo sapiens","MTR","METHIONINE SYNTHASE","1","4CCZ"
"4CD0",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",8.5,"HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 11.3 MG/ML)CONTAINING 0.001 M INHIBITOR COMPOUND WERE COMBINED WITH A SOLUTION CONTAINING: 0.2 M LITHIUM SULFATE, 18% PEG5K AND 0.1M TRIS PH 8.5.",286,"10.1021/jm401805h","AWJ","4CD0",39.09,"2.23","2.23","Structure of L1196M Mutant Human Anaplastic Lymphoma Kinase in Complex with 2-(5-(6-amino-5-((R)-1-(5-fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl)ethoxy)pyridin-3-yl)-4-methylthiazol-2-yl)propane-1,2-diol","MAHHHHHHDYGIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4CD0"
"4CDC",,"X-RAY DIFFRACTION",2.9,57.57,,,"21% PEG3350, 200MM AMSO4, 100MM NA ACETATE PH 4.5",,"10.1021/jm401705g",,"4CDC",162.15,"2.4","2.4","Human DPP1 in complex with (2S)-2-amino-N-((1S)-1-cyano-2-(4- phenylphenyl)ethyl)butanamide","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVG","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 EXCLUSION DOMAIN CHAIN","1","4CDC"
,,,,,,,,,,,,,,,,"HLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 HEAVY CHAIN","2","4CDC"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 LIGHT CHAIN","3","4CDC"
"4CDD",,"X-RAY DIFFRACTION",2.85,56.81,,,"21% PEG3350, 200MM AMSO4, 100MM NA ACCETATE PH 4.5",,"10.1021/jm401705g",,"4CDD",81.51,"2.35","2.35","Human DPP1 in complex with (2S)-N-((1S)-1-cyano-2-(4-(4-cyanophenyl) phenyl)ethyl)piperidine-2-carboxamide","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVGT","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 EXCLUSION DOMAIN CHAIN","1","4CDD"
,,,,,,,,,,,,,,,,"HLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 HEAVY CHAIN","2","4CDD"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 LIGHT CHAIN","3","4CDD"
"4CDE",,"X-RAY DIFFRACTION",2.91,57.71,,,"21% PEG3350, 200MM AMSO4, 100MM NA ACETATE PH 4.5",,"10.1021/jm401705g",,"4CDE",81.14,"2.4","2.4","Human DPP1 in complex with 4-amino-N-((1S)-1-cyano-2-(4-(4- cyanophenyl)phenyl)ethyl)tetrahydropyran-4-carboxamide","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVG","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 EXCLUSION DOMAIN CHAIN","1","4CDE"
,,,,,,,,,,,,,,,,"HLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 HEAVY CHAIN","2","4CDE"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 LIGHT CHAIN","3","4CDE"
"4CDF",,"X-RAY DIFFRACTION",2.89,75.51,,,"21% PEG3350, 200MM AMSO4, 100MM NA ACETATE PH 4.5",,"10.1021/jm401705g",,"4CDF",81.56,"2.2","2.2","Human DPP1 in complex with (2S,4S)-N-((1S)-1-cyano-2-(4-(4- cyanophenyl)phenyl)ethyl)-4-hydroxy-piperidine-2-carboxamide","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVGT","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 EXCLUSION DOMAIN CHAIN","1","4CDF"
,,,,,,,,,,,,,,,,"LHLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 HEAVY CHAIN","2","4CDF"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","DIPEPTIDYL PEPTIDASE 1 LIGHT CHAIN","3","4CDF"
"4CDH",,"X-RAY DIFFRACTION",2.74,55.06,"VAPOR DIFFUSION, SITTING DROP",,"CRYSTALLIZATION TRIALS WERE PERFORMED AT 18 C BY THE SITTING DROP VAPOUR DIFFUSION METHOD. CRYSTALS GROWN BY MIXING 1 UL OF FC-SIAL (9 MG/ML IN PBS) WITH 3 UL OF PRECIPITANT SOLUTION CONSISTING OF 0.1M HEPES PH7, 16% PEG 6000, VAPOR DIFFUSION, TEMPERATURE 298K",298,"10.1016/j.str.2014.09.001",,"4CDH",59.99,"2.3","2.3","Crystallographic structure of the Human Igg1 alpha 2-6 sialilated Fc-Fragment","MKKTAIAIAVALAGFATVAQADVESKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","IG GAMMA-1 CHAIN C REGION","1","4CDH"
"4CDO",,"X-RAY DIFFRACTION",2.64,53.4,,,,,"10.1038/ncomms4822",,"4CDO",42.66,"2.5","2.5","Crystal structure of PQBP1 bound to spliceosomal U5-15kD","MAHHHHHHMLPHLHNGWQVDQAILSEEDRVVVIRFGHDWDPTCMKMDEVLYSIAEKVKNFAVIYLVDITEVPDFNKMYELYDPCTVMFFFRNKHIMIDLGTGNNNKINWAMEDKQEMVDIIETVYRGARKGRGLVVSPKDYSKRNEAKTGADTTAAGPLFQQRPYPSPGAVLRANAEASRTKQQD","Homo sapiens","PQBP1, NPW38, JM26, TXNL4A, DIM1, TXNL4","THIOREDOXIN-LIKE PROTEIN 4A, POLYGLUTAMINE-BINDING PROTEIN","1","4CDO"
"4CEG",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION",8.5,"PROTEIN WAS CRYSTALLISED IN 0.1 M TRIS-HCL PH 8.5, 0.2 M MGCL2, 0.5 M NACL, 32.5 % PEG 3350 AFTER INCUBATION WITH 5 MM ADP/MGCL2 BY VAPOUR DIFFUSION",,"10.1107/S2053230X15002290",,"4CEG",33.77,"2.1","2.1","Crystal structure of Aurora A 122-403 C290A, C393A bound to ADP","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLAGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNAQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","AURORA KINASE A","1","4CEG"
"4CEK",,"X-RAY DIFFRACTION",2.41,49.1,,6,"100 MM MES PH 6.0, 19% PEG 3350 AND AT A PROTEIN CONCENTRATION OF 8 MG/ML",,"10.1093/nar/gkt1197",,"4CEK",35.61,"2.35","2.35","Crystal structure of the second MIF4G domain of human nonsense mediated decay factor UPF2","GAMGEGGIWEDEDARNFYENLIDLKAFVPAILFKDNEKSCQNKESNKDDTKEAKESKENKEVSSPDDLELELENLEINDDTLELEGGDEAEDLTKKLLDEQEQEDEEASTGSHLKLIVDAFLQQLPNCVNRDLIDKAAMDFCMNMNTKANRKKLVRALFIVPRQRLDLLPFYARLVATLHPCMSDVAEDLCSMLRGDFRFHVRKKDQINIETKNKTVRFIGELTKFKMFTKNDTLHCLKMLLSDFSHHHIEMACTLLETCGRFLFRSPESHLRTSVLLEQMMRKKQAMHLDARYVTMVENAYYYCNP","Homo sapiens","UPF2, KIAA1408, RENT2","REGULATOR OF NONSENSE TRANSCRIPTS 2","1","4CEK"
"4CEM",,"X-RAY DIFFRACTION",2.85,56.8,,9,"100 MM BICINE PH 9, 100 MM NACL, 11% PEG 6000 AND AT A PROTEIN CONCENTRATION OF 16 MG/ML",,"10.1093/nar/gkt1197",,"4CEM",85.93,"2.6","2.6","Crystal structure of the first MIF4G domain of human nonsense mediated decay factor UPF2","GAMGMKEKEESIQLHQEAWERHHLRKELRSKNQNAPDSRPEENFFSRLDSSIKKNTAFVKKLKTITEQQRDSLSHDFNGLNLSKYIAEAVASIVEAKLKISDVNCAVHLCSLFHQRYADFAPSLLQVWKKHFEARKEEKTPNITKLRTDLRFIAELTIVGIFTDKEGLSLIYEQLKNIINADRESHTHVSVVISFCRHCGDDIAGLVPRKVKSAAEKFNLSFPPSEIISPEKQQPFQNLLKEYFTSLTKHLKRDHRELQNTERQNRRILHSKGELSEDRHKQYEEFAMSYQKLLANSQSLADLLDENMPDLPQDKPTPEEHGPGIDIFTPGKPGEYDLEGGIWEDEDARNFYENLIDLKAFVPAILFKDN","Homo sapiens","UPF2, KIAA1408, RENT2","REGULATOR OF NONSENSE TRANSCRIPTS 2","1","4CEM"
"4CET",,"X-RAY DIFFRACTION",1.67,26.37,,7.5,"PROTEIN WAS CRYSTALLIZED FROM 0.005 M CO(II)CL-HEXAHYDRATE, 0.005 M NI(II)CL-HEXAHYDRATE, 0.005 M CDCL-HYDRATE, 0.005 M MGCL-HEAXHYDRATE, 0.1 M HEPES PH 7.5, 12 % PEG-3350 (W/V)",,"10.1111/febs.12975","FAD","4CET",34.19,"2.2","2.2","Crystal structure of the complex of the P187S variant of human NAD(P) H:quinone oxidoreductase with dicoumarol at 2.2 A resolution","MGSSHHHHHHSSGLVPRGSHMVGRRALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDITGKLKDPANFQYPAESVLAYKEGHLSPDIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGGSGSMYSLQGIHGDMNVILWPIQSGILHFCGFQVLESQLTYSIGHTPADARIQILEGWKKRLENIWDETPLYFAPSSLFDLNFQAGFLMKKEVQDEEKNKKFGLSVGHHLGKSIPTDNQIKARK","Homo sapiens","NQO1, DIA4, NMOR1","NAD(P)H DEHYDROGENASE [QUINONE] 1","1","4CET"
"4CF6",,"X-RAY DIFFRACTION",2.4,48.79,,7,"PROTEIN WAS CRYSTALLIZED FROM 60% TACSIMATE PH=7.0",,"10.1111/febs.12975",,"4CF6",69.26,"2.694","2.694","Crystal structure of the complex of the P187S variant of human NAD(P) H:quinone oxidoreductase with Cibacron blue at 2.7 A resolution","MGSSHHHHHHSSGLVPRGSHMVGRRALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDITGKLKDPANFQYPAESVLAYKEGHLSPDIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGGSGSMYSLQGIHGDMNVILWPIQSGILHFCGFQVLESQLTYSIGHTPADARIQILEGWKKRLENIWDETPLYFAPSSLFDLNFQAGFLMKKEVQDEEKNKKFGLSVGHHLGKSIPTDNQIKARK","Homo sapiens","NQO1, DIA4, NMOR1","NAD(P)H DEHYDROGENASE [QUINONE] 1","1","4CF6"
"4CFG",,"X-RAY DIFFRACTION",2,50,,,,,,,"4CFG",142.9,"2.8","2.8","Structure of the TRIM25 coiled-coil","MAELCPLAEELSCSICLEPFKEPVTTPCGHNFCGSCLNETWAVQGSPYLCPQCRAVYQARPQLHKNTVLCNVVEQFLQADLAREPPADVWTPPARASAPSPNAQVACDHCLKEAAVKTCLVCMASFCQEHLQPHFDSPAFQDHPLQPPVRDLLRRKCSQHNRLREFFCPEHSECICHICLVEHKTCSPASLSQASADLEATLRHKLTVMYSQINGASRALDDVRNRQQDVRMTANRKVEQLQQEYTEMKALLDASETTSTRKIKEEEKRVNSQFDTIYQILLKKKSEIQTLKEEIEQSLTKRDEFEFLEKASKLRGISTQPVYIPEVELNHKLIKGIHQSTIDLKNELKQCIGRLQEPTPSSGDPGEHDPASTHKSTRPVKKVSKEEKKSKKPPPVPALPSKLPTFGAPEQLVDLKQAGLEAAAKATSSHPNSTSLKAKVLETFLAKSRPELLEYYIKVILDYNTAHNKVALSECYTVASVAEMPQNYRPHPQRFTYCSQVLGLHCYKKGIHYWEVELQKNNFCGVGICYGSMNRQGPESRLGRNSASWCVEWFNTKISAWHNNVEKTLPSTKATRVGVLLNCDHGFVIFFAVADKVHLMYKFRVDFTEALYPAFWVFSAGATLSICSPK","Homo sapiens","TRIM25, EFP, RNF147, ZNF147","E3 UBIQUITIN/ISG15 LIGASE TRIM25","1","4CFG"
"4CFK",,"X-RAY DIFFRACTION",2.13,42.15,,,"0.2M AMMONIUM SULPHATE, 15% PEG4K, 0.1M TRI-CITRATE PH 5.6 AT 20C",293,"10.1021/cb400789e","LY2","4CFK",15.56,"1.55","1.55","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH LY294002","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BRD4 PROTEIN","1","4CFK"
"4CFL",,"X-RAY DIFFRACTION",2.15,42.72,,,"0.2M AM SULPHATE, 16% PEG4K, 0.1M HEPES PH 7.5, 10% ISOPROPANOL",,"10.1021/cb400789e","8DQ","4CFL",15.56,"1.32","1.32","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH LY303511","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BRD4 PROTEIN","1","4CFL"
"4CG4",,"X-RAY DIFFRACTION",3.35,63.33,,7.5,"0.1 M TRIS-ACOH PH 7.4-8, 0.26% (W/V) CYSTAMINE-HCL, 0.2 M LISO4, 8% (W/V) PEG 20000, 8% (W/V) PEG 550 MME",,"10.1038/srep10819",,"4CG4",257.91,"2.4","2.4","Crystal structure of the CHS-B30.2 domains of TRIM20","XSEVALEHKKKIQKQLEHLKKLRKSGEEQRSYGEEKAVSFLKQTEALKQRVQRKLEQVYYFLEQQEHFFVASLEDVGQMVGQIRKAYDTRVSQDIALLDALIGELEAKECQSEWELLQDIGDILHRAKTVPVPEKWTTPQEIKQKIQLLHQKSEFVEKSTKYFSETLRSEMEMFNVPELIGAQAHAVNVILDAETAYPNLIFSDDLKSVRLGNKWERLPDGPQRFDSCIIVLGSPSFLSGRRYWEVEVGDKTAWILGACKTSISRKGNMTLSPENGYWVVIMMKENEYQASSVPPTRLLIKEPPKRVGIFVDYRVGSISFYNVTARSHIYTFASCSFSGPLQPIFSPGTRDGGKNTAPLTICPVGGQGPDALEVLFQ","Homo sapiens","MEFV, MEF, TRIM20","PYRIN","1","4CG4"
"4CG8",,"X-RAY DIFFRACTION",2.33,47.2,,,,,"10.1021/jm401665x","G8S","4CG8",45.74,"1.75","1.75","Human choline kinase a1 in complex with compound 14","PQPPADEQPEPRTRRRAYLWCKEFLPGAWRGLREDEFHISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSLGPKLYGIFPQGRLEQFIPSRRLDTEELSLPDISAEIAEKMATFHGMKMPFNKEPKWLFGTMEKYLKEVLRIKFTEESRIKKLHKLLSYNLPLELENLRSLLESTPSPVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWMYDYSYEKYPFFRANIRKYPTKKQQLHFISSYLPAFQNDFENLSTEEKSIIKEEMLLEVNRFALASHFLWGLWSIVQAKISSIEFGYMDYAQARFDAYFHQKRKLGV","Homo sapiens","CHKA, CHK, CKI","CHOLINE KINASE ALPHA","1","4CG8"
"4CG9",,"X-RAY DIFFRACTION",2.29,46.24,,,,,"10.1021/jm401665x",,"4CG9",45.24,"1.83","1.83","Human choline kinase a1 in complex with compound 12","PQPPADEQPEPRTRRRAYLWCKEFLPGAWRGLREDEFHISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSLGPKLYGIFPQGRLEQFIPSRRLDTEELSLPDISAEIAEKMATFHGMKMPFNKEPKWLFGTMEKYLKEVLRIKFTEESRIKKLHKLLSYNLPLELENLRSLLESTPSPVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWMYDYSYEKYPFFRANIRKYPTKKQQLHFISSYLPAFQNDFENLSTEEKSIIKEEMLLEVNRFALASHFLWGLWSIVQAKISSIEFGYMDYAQARFDAYFHQKRKLGV","Homo sapiens","CHKA, CHK, CKI","CHOLINE KINASE ALPHA","1","4CG9"
"4CGA",,"X-RAY DIFFRACTION",2.32,47.02,,,,,"10.1021/jm401665x",,"4CGA",45.27,"1.74","1.74","Human choline kinase a1 in complex with compound 5","PQPPADEQPEPRTRRRAYLWCKEFLPGAWRGLREDEFHISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSLGPKLYGIFPQGRLEQFIPSRRLDTEELSLPDISAEIAEKMATFHGMKMPFNKEPKWLFGTMEKYLKEVLRIKFTEESRIKKLHKLLSYNLPLELENLRSLLESTPSPVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWMYDYSYEKYPFFRANIRKYPTKKQQLHFISSYLPAFQNDFENLSTEEKSIIKEEMLLEVNRFALASHFLWGLWSIVQAKISSIEFGYMDYAQARFDAYFHQKRKLGV","Homo sapiens","CHKA, CHK, CKI","CHOLINE KINASE ALPHA","1","4CGA"
"4CGB",,"X-RAY DIFFRACTION",1.86,33.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"CRYSTALS WERE OBTAINED BY THE HANGING DROP VAPOUR DIFFUSION METHOD USING 100 MM BIS-TRIS-PROPANE PH 6.5, 20% PEG 3350, 200 MM POTASSIUM THIOCYANATE IN THE RESERVOIR.",,"10.1042/BJ20150039",,"4CGB",33.78,"2.154","2.154","Crystal structure of the trimerization domain of EML2","GSGMEVDDRVSALEQRLQLQEDELAVLKAALADALRRLRACEEQGAALRAR","Homo sapiens","EML2, EMAP2, EMAPL2","ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 2","1","4CGB"
"4CGC",,"X-RAY DIFFRACTION",1.51,18.61,,8.5,"100 MM TRIS/HCL PH 8.5, 30% PEG 4000, 200 MM MGCL2",,"10.1042/BJ20150039",,"4CGC",19.23,"2.901","2.901","Crystal structure of the trimerization domain of human EML4","GSLDDSISAASTSDVQDRLSALESRVQQQEDEMTVLKAALADVLRRLAISEDHVASVKK","Homo sapiens","EML4, C2orf2, EMAPL4","ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 4","1","4CGC"
"4CHL",,"X-RAY DIFFRACTION",2.85,56.87,,8.5,"10 MG/ML PROTEIN IN 50MM HEPES PH7.5, 100 MM NACL ADDED TO 0.1M TRIS-HCL PH8.5, 0.5M POTASSIUM THIOCYANATE",,"10.1093/hmg/ddv007",,"4CHL",52.47,"2.61","2.61","Human Ethylmalonic Encephalopathy Protein 1 (hETHE1)","GPVDAPILLRQMFEPVSCTFTYLLGDRESREAVLIDPVLETAPRDAQLIKELGLRLLYAVNTHCHADHITGSGLLRSLLPGCQSVISRLSGAQADLHIEDGDSIRFGRFALETRASPGHTPGCVTFVLNDHSMAFTGDALLIRGCGRTDFQQGCAKTLYHSVHEKIFTLPGDCLIYPAHDYHGFTVSTVEEERTLNPRLTLSCEEFVKIMGNLNLPKPQQIDFAVPANMRCGVQTPTA","Homo sapiens","ETHE1, HSCO","PERSULFIDE DIOXYGENASE ETHE1, MITOCHONDRIAL","1","4CHL"
"4CI4",,"X-RAY DIFFRACTION",2.09,41.14,,,"27% PEG 20000, 0.1 M TRIS-HCL PH 7.0",,"10.1016/j.jsb.2015.07.006","Y1N","4CI4",31.42,"2.302","2.302","Structural basis for GL479 a dual Peroxisome Proliferator-Activated Receptor alpha agonist","IEDSETADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA","1","4CI4"
"4CI5",,"X-RAY DIFFRACTION",2.66,53.74,,,"0.8 M SODIUM CITRATE TRIBASIC DIHYDRATE, 0.1 M HEPES PH 8.0",,"10.1016/j.jsb.2015.07.006","Y1N","4CI5",63,"1.77","1.77","Structural basis for GL479 a dual Peroxisome Proliferator-Activated Receptor gamma agonist","PESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","4CI5"
"4CI8",,"X-RAY DIFFRACTION",3.05,59.7,,5.6,"100 MM TRI-SODIUM CITRATE PH 5.6, 2.0 M AMMONIUM SULPHATE, 200 MM POTASSIUM/SODIUM TARTRATE, 2 MM DTT.",,"10.1073/pnas.1322892111",,"4CI8",147.78,"2.6","2.6","Crystal structure of the tandem atypical beta-propeller domain of EML1","GPHMSMGKKNSESKPKEPVFSAEEGYVKMFLRGRPVTMYMPKDQVDSYSLEAKVELPTKRLKLEWVYGYRGRDCRNNLYLLPTGETVYFIASVVVLYNVEEQLQRHYAGHNDDVKCLAVHPDRITIATGQVAGTSKDGKQLPPHVRIWDSVTLNTLHVIGIGFFDRAVTCIAFSKSNGGTNLCAVDDSNDHVLSVWDWQKEEKLADVKCSNEAVFAADFHPTDTNIIVTCGKSHLYFWTLEGSSLNKKQGLFEKQEKPKFVLCVTFSENGDTITGDSSGNILVWGKGTNRISYAVQGAHEGGIFALCMLRDGTLVSGGGKDRKLISWSGNYQKLRKTEIPEQFGPIRTVAEGKGDVILIGTTRNFVLQGTLSGDFTPITQGHTDELWGLAIHASKSQFLTCGHDKHATLWDAVGHRPVWDKIIEDPAQSSGFHPSGSVVAVGTLTGRWFVFDTETKDLVTVHTDGNEQLSVMRYSPDGNFLAIGSHDNCIYIYGVSDNGRKYTRVGKCSGHSSFITHLDWSVNSQFLVSNSGDYEILYWVPSACKQVVSVETTRDIEWATYTCTLGFHVFGVWPEGSDGTDINAVCRAHEKKLLSTGDDFGKVHLFSYPCSQFRAPSHIYGGHSSHVTNVDFLCEDSHLISTGGKDTSIMQWRVI","Homo sapiens","EML1, EMAP1, EMAPL, EMAPL1","ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 1","1","4CI8"
"4CI9",,"X-RAY DIFFRACTION",2.34,47.4,"VAPOR DIFFUSION, HANGING DROP",4.6,"CATHEPSIN A WAS CRYSTALLIZED USING THE HANGING DROP METHOD: 1 UL OF PROTEIN SOLUTION, CONTAINING 6.5 MG/ML CATHEPSIN A, 25 MM TRIS-HCL (PH 8.0) AND 300 MM NACL, WAS MIXED WITH 1 UL RESERVOIR SOLUTION, CONTAINING 100 MM NAACETATE (PH 4.5), 18-20% PEG400 AND 100 MM CDCL2, AND SET TO EQUILIBRATE AT 4DEG.C. ROD-SHAPED CRYSTALS APPEARED IN ABOUT ONE WEEK.",277,"10.1016/j.bbrc.2014.02.014",,"4CI9",53.15,"1.58","1.58","Crystal structure of cathepsin A, apo-structure","SRAPDQDEIQRLPGLAKQPSFRQYSGYLKGSGSKHLHYWFVESQKDPENSPVVLWLNGGPGCSSLDGLLTEHGPFLVQPDGVTLEYNPYSWNLIANVLYLESPAGVGFSYSDDKFYATNDTEVAQSNFEALQDFFRLFPEYKNNKLFLTGESYAGIYIPTLAVLVMQDPSMNLQGLAVGNGLSSYEQNDNSLVYFAYYHGLLGNRLWSSLQTHCCSQNKCNFYDNKDLECVTNLQEVARIVGNSGLNIYNLYAPCAGGVPSHFRYEKDTVVVQDLGNIFTRLPLKRMWHQALLRSGDKVRMDPPCTNTTAASTYLNNPYVRKALNIPEQLPQWDMCNFLVNLQYRRLYRSMNSQYLKLLSSQKYQILLYNGDVDMACNFMGDEWFVDSLNQKMEVQRRPWLVKYGDSGEQIAGFVKEFSHIAFLTIKGAGHMVPTDKPLAAFTMFSRFLNKQPYE","Homo sapiens","CTSA, PPGB","LYSOSOMAL PROTECTIVE PROTEIN","1","4CI9"
"4CIA",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, HANGING DROP",4.6,"CATHEPSIN A WAS CRYSTALLIZED USING THE HANGING DROP METHOD: 1 UL OF PROTEIN SOLUTION, CONTAINING 6.5 MG/ML CATHEPSIN A, 25 MM TRIS-HCL (PH 8.0) AND 300 MM NACL, WAS MIXED WITH 1 UL RESERVOIR SOLUTION, CONTAINING 100 MM NAACETATE (PH 4.5), 18-20% PEG400 AND 100 MM CDCL2, AND SET TO EQUILIBRATE AT 4DEG.C. ROD-SHAPED CRYSTALS APPEARED IN ABOUT ONE WEEK.",277,"10.1016/j.bbrc.2014.02.014",,"4CIA",53.52,"1.98","1.98","Crystal structure of cathepsin A, complexed with compound 1","SRAPDQDEIQRLPGLAKQPSFRQYSGYLKGSGSKHLHYWFVESQKDPENSPVVLWLNGGPGCSSLDGLLTEHGPFLVQPDGVTLEYNPYSWNLIANVLYLESPAGVGFSYSDDKFYATNDTEVAQSNFEALQDFFRLFPEYKNNKLFLTGESYAGIYIPTLAVLVMQDPSMNLQGLAVGNGLSSYEQNDNSLVYFAYYHGLLGNRLWSSLQTHCCSQNKCNFYDNKDLECVTNLQEVARIVGNSGLNIYNLYAPCAGGVPSHFRYEKDTVVVQDLGNIFTRLPLKRMWHQALLRSGDKVRMDPPCTNTTAASTYLNNPYVRKALNIPEQLPQWDMCNFLVNLQYRRLYRSMNSQYLKLLSSQKYQILLYNGDVDMACNFMGDEWFVDSLNQKMEVQRRPWLVKYGDSGEQIAGFVKEFSHIAFLTIKGAGHMVPTDKPLAAFTMFSRFLNKQPYE","Homo sapiens","CTSA, PPGB","LYSOSOMAL PROTECTIVE PROTEIN","1","4CIA"
"4CIB",,"X-RAY DIFFRACTION",2.42,49.2,"VAPOR DIFFUSION, HANGING DROP",4.6,"CATHEPSIN A WAS CRYSTALLIZED USING THE HANGING DROP METHOD: 1 UL OF PROTEIN SOLUTION, CONTAINING 6.5 MG/ML CATHEPSIN A, 25 MM TRIS-HCL (PH 8.0) AND 300 MM NACL, WAS MIXED WITH 1 UL RESERVOIR SOLUTION, CONTAINING 100 MM NAACETATE (PH 4.5), 18-20% PEG400 AND 100 MM CDCL2, AND SET TO EQUILIBRATE AT 4DEG.C. ROD-SHAPED CRYSTALS APPEARED IN ABOUT ONE WEEK.",277,"10.1016/j.bbrc.2014.02.014",,"4CIB",53.44,"1.89","1.89","crystal structure of cathepsin a, complexed with compound 2","SRAPDQDEIQRLPGLAKQPSFRQYSGYLKGSGSKHLHYWFVESQKDPENSPVVLWLNGGPGCSSLDGLLTEHGPFLVQPDGVTLEYNPYSWNLIANVLYLESPAGVGFSYSDDKFYATNDTEVAQSNFEALQDFFRLFPEYKNNKLFLTGESYAGIYIPTLAVLVMQDPSMNLQGLAVGNGLSSYEQNDNSLVYFAYYHGLLGNRLWSSLQTHCCSQNKCNFYDNKDLECVTNLQEVARIVGNSGLNIYNLYAPCAGGVPSHFRYEKDTVVVQDLGNIFTRLPLKRMWHQALLRSGDKVRMDPPCTNTTAASTYLNNPYVRKALNIPEQLPQWDMCNFLVNLQYRRLYRSMNSQYLKLLSSQKYQILLYNGDVDMACNFMGDEWFVDSLNQKMEVQRRPWLVKYGDSGEQIAGFVKEFSHIAFLTIKGAGHMVPTDKPLAAFTMFSRFLNKQPYE","Homo sapiens","CTSA, PPGB","LYSOSOMAL PROTECTIVE PROTEIN","1","4CIB"
"4CIK",,"X-RAY DIFFRACTION",3.23,62,,,,,"10.1021/ml400526d","XO3","4CIK",9.84,"1.78","1.78","plasminogen kringle 1 in complex with inhibitor","KRSECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC","Homo sapiens","PLG","PLASMINOGEN","1","4CIK"
"4CIM",,"X-RAY DIFFRACTION",2.04,39.7,,8,"1 M TRISODIUM CITRATE 0.1 M IMIDAZOLE, PH 8.0",,"10.1074/jbc.M114.610758",,"4CIM",41.27,"1.5","1.5","Complex of a Bcl-w BH3 mutant with a BH3 domain","MATPASAPDTRALVADFVGYKLRQKGYVSGAGPGEGPAADPLGQALRAIGDEFETRFRRTFSDLAAQLHVTPGSAQQRFTQVSDELFQGGPNWGRLVAFFVFGAALCAESVNKEMEPLVGQVQEWMVEYLETRLADWIHSSGGWAEFTALYGDGALEEARRLR","Homo sapiens","BCL2L2, BCLW, KIAA0271","BCL-2-LIKE PROTEIN 2","1","4CIM"
,,,,,,,,,,,,,,,,"AADPLGQALRAIGDEFETRFR","Homo sapiens","BCL2L2, BCLW, KIAA0271","BCL-2-LIKE PROTEIN 2","2","4CIM"
"4CIN",,"X-RAY DIFFRACTION",2.56,51.93,,7.5,"40% (V/V) PEG400, 0.2M CALCIUM ACETATE, 0.1M HEPES, PH7.5",,"10.1074/jbc.M114.610758",,"4CIN",42.36,"2.693","2.693","Complex of Bcl-xL with its BH3 domain","GPLGSMSQSNRELVVDFLSYKLSQKGYSWSQMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","BCL-2-LIKE PROTEIN 1","1","4CIN"
,,,,,,,,,,,,,,,,"EVIPMAAVKQALREAGDEFELRYR","Homo sapiens","BCL2L1, BCL2L, BCLX","BCL-2-LIKE PROTEIN 1","2","4CIN"
"4CIZ",,"X-RAY DIFFRACTION",2.95,58.29,,,,,"10.1021/ja411366w",,"4CIZ",36.95,"3.403","3.403","Crystal structure of the complex of the Cellular Retinal Binding Protein with 9-cis-retinal","MSEGVGTFRMVPEEEQELRAQLEQLTTKDHGPVFGPCSQLPRHTLQKAKDELNEREETREEAVRELQEMVQAQAASGEELAVAVAERVQEKDSGFFLRFIRARKFNVGRAYELLRGYVNFRLQYPELFDSLSPEAVRCTIEAGYPGVLSSRDKYGRVVMLFNIENWQSQEITFDEILQAYCFILEKLLENEETQINGFCIIENFKGFTMQQAASLRTSDLRKMVDMLQDSFPARFKAIHFIHQPWYFTTTYNVVKPFLKSKLLERVFVHGDDLSGFYQEIDENILPSDFGGTLPKYDGKAVAEQLFGPQAQAENTAF","Homo sapiens","RLBP1, CRALBP","RETINALDEHYDE-BINDING PROTEIN 1","1","4CIZ"
"4CJ6",,"X-RAY DIFFRACTION",2.2,44.26,,,,,"10.1021/ja411366w",,"4CJ6",36.83,"1.896","1.896","Crystal structure of the complex of the Cellular Retinal Binding Protein Mutant R234W with 9-cis-retinal","MSEGVGTFRMVPEEEQELRAQLEQLTTKDHGPVFGPCSQLPRHTLQKAKDELNEREETREEAVRELQEMVQAQAASGEELAVAVAERVQEKDSGFFLRFIRARKFNVGRAYELLRGYVNFRLQYPELFDSLSPEAVRCTIEAGYPGVLSSRDKYGRVVMLFNIENWQSQEITFDEILQAYCFILEKLLENEETQINGFCIIENFKGFTMQQAASLRTSDLRKMVDMLQDSFPAWFKAIHFIHQPWYFTTTYNVVKPFLKSKLLERVFVHGDDLSGFYQEIDENILPSDFGGTLPKYDGKAVAEQLFGPQAQAENTAF","Homo sapiens","RLBP1, CRALBP","RETINALDEHYDE-BINDING PROTEIN 1","1","4CJ6"
"4CJM",,"X-RAY DIFFRACTION",2.46,50,,6.5,"0.1 M MES PH 6.5, 0.2 M (NH4)2SO4 AND 26% PEG 5000",,"10.1007/s13238-014-0033-4",,"4CJM",66.74,"2.7","2.7","Crystal structure of human FGF18","KQLRLYQLYSRTSGKHIQVLGRRISARGEDGDKYAQLLVETDTFGSQVRIKGKETEFYLCMNRKGKLVGKPDGTSKECVFIEKVLENNYTALMSAKYSGWYVGFTKKGRPRKGPKTRENQQDVHFMKRYPKGQPELQKPFK","Homo sapiens","FGF18, UNQ420/PRO856","FIBROBLAST GROWTH FACTOR 18","1","4CJM"
"4CKG","15","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.devcel.2014.08.020",,"4CKG",173.34,"12, 15",,"Helical reconstruction of ACAP1(BAR-PH domain) decorated membrane tubules by cryo-electron microscopy","GPLGSMTVKLDFEECLKDSPRFRASIELVEAEVSELETRLEKLLKLGTGLLESGRHYLAASRAFVVGICDLARLGPPEPMMAECLEKFTVSLNHKLDSHAELLDATQHTLQQQIQTLVKEGLRGFREARRDFWRGAESLEAALTHNAEVPRRRAQEAEEAGAALRTARAGYRGRALDYALQINVIEDKRKFDIMEFVLRLVEAQATHFQQGHEELSRLSQYRKELGAQLHQLVLNSAREKRDMEQRHVLLKQKELGGEEPEPSLREGPGGLVMEGHLFKRASNAFKTWSRRWFTIQSNQLVYQKKYKDPVTVVVDDLRLCTVKLCPDSERRFCFEVVSTSKSCLLQADSERLLQLWVSAVQSSIASAFSQARLDDSPRGPGQ","Homo sapiens","ACAP1, CENTB1, KIAA0050","ARF-GAP WITH COILED-COIL, ANK REPEAT AND PH DOMAIN-CONTAINING PROTEIN 1","1","4CKG"
"4CKH","17","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.devcel.2014.08.020",,"4CKH",173.34,"14, 17",,"Helical reconstruction of ACAP1(BAR-PH domain) decorated membrane tubules by cryo-electron microscopy","GPLGSMTVKLDFEECLKDSPRFRASIELVEAEVSELETRLEKLLKLGTGLLESGRHYLAASRAFVVGICDLARLGPPEPMMAECLEKFTVSLNHKLDSHAELLDATQHTLQQQIQTLVKEGLRGFREARRDFWRGAESLEAALTHNAEVPRRRAQEAEEAGAALRTARAGYRGRALDYALQINVIEDKRKFDIMEFVLRLVEAQATHFQQGHEELSRLSQYRKELGAQLHQLVLNSAREKRDMEQRHVLLKQKELGGEEPEPSLREGPGGLVMEGHLFKRASNAFKTWSRRWFTIQSNQLVYQKKYKDPVTVVVDDLRLCTVKLCPDSERRFCFEVVSTSKSCLLQADSERLLQLWVSAVQSSIASAFSQARLDDSPRGPGQ","Homo sapiens","ACAP1, CENTB1, KIAA0050","ARF-GAP WITH COILED-COIL, ANK REPEAT AND PH DOMAIN-CONTAINING PROTEIN 1","1","4CKH"
"4CKI",,"X-RAY DIFFRACTION",2.74,55.16,,5.5,"2M NA FORMATE, 0.1M NA CITRATE, PH 5.5",,"10.1016/j.molcel.2014.01.015",,"4CKI",36.47,"2.116","2.116","Crystal Structure of oncogenic RET tyrosine kinase M918T bound to adenosine","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWTAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","1","4CKI"
"4CKJ",,"X-RAY DIFFRACTION",2.72,54.77,,5.5,"pH 5.5",,"10.1016/j.molcel.2014.01.015",,"4CKJ",36.79,"1.65","1.65","Crystal structure of RET tyrosine kinase domain bound to adenosine","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","1","4CKJ"
"4CKR",,"X-RAY DIFFRACTION",2.2,44,,,"21% PEG3350, 0.1M BIS-TRIS-PROPANE PH 7.2, 0.2M SODIUM/POTASSIUM PHOSPHATE",,"10.1021/cb400430t","DI1","4CKR",36.62,"2.2","2.2","Crystal structure of the human DDR1 kinase domain in complex with DDR1-IN-1","SMPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","1","4CKR"
"4CKV",,"X-RAY DIFFRACTION",3.06,59.8,"VAPOR DIFFUSION",7.5,"VAPOR DIFFUSION METHOD, MOTHER LIQUOR:1MM VEGFR-1-D2,0.1%(W/V) DDM,4MM LAXAPHYCINE-A,5MM HEPES/NAOH PH 7.5. RESERVOIR:18% (W/V) PEG8000,100MM HEPES/NAOH PH 7.5, 18C",291,"10.1371/journal.pone.0167755",,"4CKV",11.12,"2.055","2.055","Crystal structure of VEGFR-1 domain 2 in presence of Zn","GRPFVEMYSEIPEIIHMTEGRELVIPCRVTSPNITVTLKKFPLDTLIPDGKRIIWDSRKGFIISNATYKEIGLLTCEATVNGHLYKTNYLTHRQ","Homo sapiens","FLT1, FLT, FRT, VEGFR1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1","1","4CKV"
"4CL7",,"X-RAY DIFFRACTION",2.36,47.9,"VAPOR DIFFUSION, HANGING DROP",7,"CRYSTAL WERE OBTAINED BY HANGING DROP METHOD FROM 1MM VEGFR1-D2, 5MM HEPES/NAOH PH7.0, 10MM COCL2, 100 MM BIS-TRIS/HCL PH6.5 15%(W/V) PEG3350.",,"10.1371/journal.pone.0167755",,"4CL7",43.83,"2","2","Crystal structure of VEGFR-1 domain 2 in presence of Cobalt","GRPFVEMYSEIPEIIHMTEGRELVIPCRVTSPNITVTLKKFPLDTLIPDGKRIIWDSRKGFIISNATYKEIGLLTCEATVNGHLYKTNYLTHRQ","Homo sapiens","FLT1, FLT, FRT, VEGFR1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1","1","4CL7"
"4CL9",,"X-RAY DIFFRACTION",2.21,44.37,,,"25% PEG6000, 0.1M TRISHCL PH 8.0, 0.2M LICL",,,,"4CL9",15.71,"1.4","1.4","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH I-BET295","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4CL9"
"4CLB",,"X-RAY DIFFRACTION",1.96,37.18,,,"0.1M BTP PH 8.5, 20% PEG3350, 0.2M NAF",,,,"4CLB",15.57,"1.6","1.6","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH IBET-295","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4CLB"
"4CLF",,"X-RAY DIFFRACTION",2.75,55,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1073/pnas.1322778111",,"4CLF",54.42,"1.7","1.7","Crystal structure of human soluble Adenylyl Cyclase (Apo form)","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4CLF"
"4CLI",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",5.5,"HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 13-15 MG/ML)CONTAINING 0.0011M INHIBITOR COMPOUND WERE COMBINED WITH A SOLUTION CONTAINING: 0.15M AMMONIUM SULFATE, 9-10.5% MONOMETHYLETHER PEG5K AND 0.1M MES IN THE PH RANGE 5.3-6.5",286,"10.1021/jm500261q","5P8","4CLI",37.32,"2.05","2.05","Structure of the Human Anaplastic Lymphoma Kinase in Complex with PF- 06463922 ((10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16, 17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile).","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4CLI"
"4CLJ",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",8.5,"HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 11.3 MG/ML)CONTAINING 0.9 MM INHIBITOR COMPOUND WERE COMBINED WITH A SOLUTION CONTAINING: 0.2 M LITHIUM SULFATE, 18% PEG5K AND 0.1M TRIS PH 8.5.",286,"10.1021/jm500261q","5P8","4CLJ",37.33,"1.66","1.66","Structure of L1196M Mutant Human Anaplastic Lymphoma Kinase in Complex with PF-06463922 ((10R)-7-amino-12-fluoro-2,10,16-trimethyl- 15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile).","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4CLJ"
"4CLK",,"X-RAY DIFFRACTION",2.75,55,,4,"100 MM PHOSPHATE/CITRATE PH 4.2, 200 MM NACL, 24 % (W/V) PEG 8000",,"10.1073/pnas.1322778111",,"4CLK",55.16,"2.2","2.2","Crystal structure of human soluble Adenylyl Cyclase in complex with alpha,beta-methyleneadenosine-5'-triphosphate","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4CLK"
"4CLL",,"X-RAY DIFFRACTION",2.75,55,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1073/pnas.1322778111",,"4CLL",55.23,"1.7","1.7","Crystal structure of human soluble Adenylyl Cyclase in complex with bicarbonate","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4CLL"
"4CLP",,"X-RAY DIFFRACTION",2.75,55,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1073/pnas.1322778111","CMP","4CLP",55.64,"1.9","1.9","Crystal structure of human soluble Adenylyl Cyclase complex with adenosine-3',5'-cyclic-monophosphate","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4CLP"
"4CLS",,"X-RAY DIFFRACTION",2.75,55,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",277,"10.1073/pnas.1322778111",,"4CLS",54.78,"1.85","1.85","Crystal structure of human soluble Adenylyl Cyclase with Pyrophosphate","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4CLS"
"4CLT",,"X-RAY DIFFRACTION",2.75,55,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1073/pnas.1322778111","CMP","4CLT",55.23,"1.95","1.95","Crystal structure of human soluble Adenylyl Cyclase with adenosine-3', 5'-cyclic-monophosphate and pyrophosphate","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4CLT"
"4CLU",,"X-RAY DIFFRACTION",2.75,55,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1073/pnas.1322778111",,"4CLU",54.94,"1.9","1.9","Crystal structure of human soluble Adenylyl Cyclase with pyrophosphate","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4CLU"
"4CLW",,"X-RAY DIFFRACTION",2.75,55,,6,"100 MM PHOSPHATE/CITRATE PH 4.2, 200 MM NACL, 24 % (W/V) PEG 8000",,"10.1073/pnas.1322778111",,"4CLW",55.34,"2.15","2.15","Crystal structure of human soluble Adenylyl Cyclase in complex with alpha,beta-methyleneadenosine-5'-triphosphate soaked with bisulfite","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4CLW"
"4CLY",,"X-RAY DIFFRACTION",2.75,55,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1073/pnas.1322778111",,"4CLY",54.78,"2.05","2.05","Crystal structure of human soluble Adenylyl Cyclase soaked with biselenite","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4CLY"
"4CLZ",,"X-RAY DIFFRACTION",2.75,55,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1073/pnas.1322778111",,"4CLZ",56.53,"1.9","1.9","Crystal structure of human soluble Adenylyl Cyclase with Inhibitor 4, 4'-Diisothiocyano-2,2'-stilbenedisulfonic acid","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4CLZ"
"4CM0",,"X-RAY DIFFRACTION",2.75,55,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1073/pnas.1322778111",,"4CM0",54.88,"3.2","3.2","Crystal structure of human soluble Adenylyl Cyclase with alpha,beta- methyleneadenosine-5'-triphosphate soaked with bicarbonate","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPPYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","SOLUBLE ADENYLYL CYCLASE","1","4CM0"
"4CM2",,"X-RAY DIFFRACTION",2.75,55,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1073/pnas.1322778111",,"4CM2",54.76,"1.8","1.8","Crystal structure of human soluble Adenylyl Cyclase soaked with bisulfite","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEEQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4CM2"
"4CML",,"X-RAY DIFFRACTION",5.58,77.98,,7,"1.1 M NA-MALONATE PH 7.0, 0.1 M HEPES PH 7.0, 0.5% JEFFAMINE ED-2001 PH 7.0, 2MM MGSO4, 2MM PTDINS-(3,4,5)-P3 (1,2-DIOCTANOYL)",,"10.1016/j.str.2014.01.013",,"4CML",37.2,"2.3","2.3","Crystal Structure of INPP5B in complex with Phosphatidylinositol 3,4- bisphosphate","MYTYIQNFRFFAGTYNVNGQSPKECLRLWLSNGIQAPDVYCVGFQELDLSKEAFFFHDTPKEEEWFKAVSEGLHPDAKYAKVKLIRLVGIMLLLYVKQEHAAYISEVEAETVGTGIMGRMGNKGGVAIRFQFHNTSICVVNSHLAAHIEEYERRNQDYKDICSRMQFCQPDPSLPPLTISNHDVILWLGDLNYRIEELDVEKVKKLIEEKDFQMLYAYDQLKIQVAAKTVFEGFTEGELTFQPTYKYDTGSDDWDTSEKCRAPAWCDRILWKGKNITQLSYQSHMALKTSDHKPVSSVFDIGVRVVAHHHHHH","Homo sapiens","INPP5B, OCRL2","TYPE II INOSITOL 1,4,5-TRISPHOSPHATE 5- PHOSPHATASE, ISOFORM 2","1","4CML"
"4CMN",,"X-RAY DIFFRACTION",3.22,61.74,,6.5,"0.2 M ZINC ACETATE, 0.1 M NA-CACODYLATE PH 6.5, 10% ISOPROPANOL",,"10.1016/j.str.2014.01.013",,"4CMN",41.85,"3.13","3.13","Crystal structure of OCRL in complex with a phosphate ion","MQSGQREGLIKHILAKREKEYVNIQTFRFFVGTWNVNGQSPDSGLEPWLNCDPNPPDIYCIGFQELDLSTEAFFYFESVKEQEWSMAVERGLHSKAKYKKVQLVRLVGMMLLIFARKDQCRYIRDIATETVGTGIMGKMGNKGGVAVRFVFHNTTFCIVNSHLAAHVEDFERRNQDYKDICARMSFVVPNQTLPQLNIMKHEVVIWLGDLNYRLGMPDANEVKSLINKKDLQRLLKFDQLNIQRTQKKAFVDFNEGEIKFIPTYKYDSKTDRWDSSGKCRVPAWCDRILWRGTNVNQLNYRSHMELKTSDHKPVSALFHIGVKVVDERRYRKVFEDSVRIMDRMENDAHHHHHH","Homo sapiens","OCRL, OCRL1","INOSITOL POLYPHOSPHATE 5-PHOSPHATASE OCRL-1","1","4CMN"
"4CMO",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",5.6,"HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 13-15 MG/ML)CONTAINING 0.0011M INHIBITOR COMPOUND WERE COMBINED WITH A SOLUTION CONTAINING: 0.15M AMMONIUM SULFATE, 9-10.5% MONOMETHYLETHER PEG5K AND 0.1M MES IN THE PH RANGE 5.3-6.5.",286,"10.1021/jm500261q","YPW","4CMO",37.31,"2.05","2.05","Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor 2-((1R)-1-((3-amino-6-(2-methoxypyridin-3-yl)pyrazin-2-yl) oxy)ethyl)-4-fluoro-N-methylbenzamide","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4CMO"
"4CMT",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",6.1,"HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 13-15 MG/ML)CONTAINING 0.001M INHIBITOR COMPOUND WERE COMBINED WITH A SOLUTION CONTAINING: 0.15M AMMONIUM SULFATE, 9-10.5% MONOMETHYLETHER PEG5K AND 0.1M MES IN THE PH RANGE 5.3-6.5.",286,"10.1021/jm500261q","GWH","4CMT",37.36,"1.73","1.73","Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor 3-((1R)-1-(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)ethoxy)- 5-(3-(methylsulfonyl)phenyl)pyridin-2-amine","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4CMT"
"4CMU",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",5.5,"HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 13-15 MG/ML)CONTAINING 0.001M INHIBITOR COMPOUND WERE COMBINED WITH A SOLUTION CONTAINING: 0.15M AMMONIUM SULFATE, 9-10.5% MONOMETHYLETHER PEG5K AND 0.1M MES IN THE PH RANGE 5.3-6.5.",286,"10.1021/jm500261q","IV7","4CMU",37.3,"1.8","1.8","Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor (10R)-7-amino-12-fluoro-1,3,10,16-tetramethyl-16,17-dihydro- 1H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecin-15(10H)-one","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4CMU"
"4CMZ",,"X-RAY DIFFRACTION",2.48,50.31,,7.5,"30% PEG 2000 MME, 0.15 M KBR, pH 7.5",,"10.1074/jbc.M114.554816",,"4CMZ",30.14,"2.7","2.7","An intertwined homodimer of the PDZ homology domain of periaxin","GAELVEIIVETEAQTGVSGINVAGGGKEGIFVRELREDSPAARSLSLQEGDQLLSARVFFENFKYEDALRLLQCAEPYKVSFCLKRTVPTGD","Homo sapiens","PRX, KIAA1620","PERIAXIN","1","4CMZ"
"4CN0",,"X-RAY DIFFRACTION",2.91,57.7,,7.5,"10% PEG8000, 50 MM KH2PO4, pH 7.5",,"10.1074/jbc.M114.554816",,"4CN0",22.28,"1.75","1.75","An intertwined homodimer of the PDZ homology domain of AHNAK2","GQEATEVTLKTEVEAGASGYSVTGGGDQGIFVKQVLKDSSAAKLFNLREGDQLLSTTVFFENIKYEDALKILQYSEPYKVQFKIRRQLPAPQDEEWA","Homo sapiens","AHNAK2, C14orf78, KIAA2019","PROTEIN AHNAK2","1","4CN0"
"4CNC",,"X-RAY DIFFRACTION",1.8,33,"VAPOR DIFFUSION, SITTING DROP",,"THE CRYSTALLIZATION SITTING DROP CONTAINED 100 NL OF CONCENTRATED 5T4/WAIF1 (5 MG/ML IN 20 MM TRIS-HCL, PH 7.5, 150 MM NACL) PLUS 100 NL OF 0.2 M (NH4)2SO4, 30 % W/V PEG 4000.",,"10.1016/j.str.2014.01.009",,"4CNC",70.05,"1.77","1.77","Crystal structure of human 5T4 (Wnt-activated inhibitory factor 1, Trophoblast glycoprotein)","ETGDQCPALCECSEAARTVKCVNRNLTEVPTDLPAYVRNLFLTGNQLAVLPAGAFARRPPLAELAALNLSGSRLDEVRAGAFEHLPSLRQLDLSHNPLADLSPFAFSGSNASVSAPSPLVELILNHIVPPEDERQNRSFEGMVVAALLAGRALQGLRRLELASNHFLYLPRDVLAQLPSLRHLDLSNNSLVSLTYVSFRNLTHLESLHLEDNALKVLHNGTLAELQGLPHIRVFLDNNPWVCDCHMADMVTWLKETEVVQGKDRLTCAYPEKMRNRVLLELNSADLDCDGTETSQVAPA","Homo sapiens","TPBG, 5T4","TROPHOBLAST GLYCOPROTEIN","1","4CNC"
"4CNH",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",6.5,"HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 13-15 MG/ML)CONTAINING 0.001M INHIBITOR COMPOUND WERE COMBINED WITH A SOLUTION CONTAINING: 0.15M AMMONIUM SULFATE, 9-10.5% MONOMETHYLETHER PEG5K AND 0.1M MES IN THE PH RANGE 5.3-6.5.",286,"10.1021/jm500261q","3U9","4CNH",74.85,"1.9","1.9","Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor 3-((1R)-1-(5-fluoro-2-methoxyphenyl)ethoxy)-5-(1-methyl-1H- 1,2,3-triazol-5-yl)pyridin-2-amine","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4CNH"
"4CNM",,"X-RAY DIFFRACTION",1.9,34,,,"THE CRYSTALLIZATION DROP CONTAINED 100 NL OF CONCENTRATED 5T4 (5.5 MG/ML), 100 NL OF 25% W/V POLYETHYLENE GLYCOL (PEG) 3350, 0.1 M CITRATE PH 3.5, AND 0.5 NL OF 0.1 M NAOH",,"10.1016/j.str.2014.01.009",,"4CNM",34.93,"1.75","1.75","Crystal structure of human 5T4 (Wnt-activated inhibitory factor 1, Trophoblast glycoprotein)","ETGDQCPALCECSEAARTVKCVNRNLTEVPTDLPAYVRNLFLTGNQLAVLPAGAFARRPPLAELAALNLSGSRLDEVRAGAFEHLPSLRQLDLSHNPLADLSPFAFSGSNASVSAPSPLVELILNHIVPPEDERQNRSFEGMVVAALLAGRALQGLRRLELASNHFLYLPRDVLAQLPSLRHLDLSNNSLVSLTYVSFRNLTHLESLHLEDNALKVLHNGTLAELQGLPHIRVFLDNNPWVCDCHMADMVTWLKETEVVQGKDRLTCAYPEKMRNRVLLELNSADLDCDGTETSQVAPA","Homo sapiens","TPBG, 5T4","TROPHOBLAST GLYCOPROTEIN","1","4CNM"
"4CNS",,"X-RAY DIFFRACTION",2.41,49,,6.5,"30% (W/V) PEG 3350, 100 MM NA TARTRATE, 100 MM BIS-TRIS PROPANE 6.5",,"10.1107/S1399004714006634",,"4CNS",211.08,"2.4","2.4","Crystal structure of truncated human CRMP-4","SMTSDRLLIKGGRIVNDDQSFYADIYMEDGLIKQIGDNLIVPGGVKTIEANGKMVIPGGIDVHTHYQMPYKGMTTVDDFFQGTKAALAGGTTMIIDHVVPEPESSLTEAYEKWREWADGKSCCDYALHVDITHWNDSVKQEVQNLIKDKGVNSFMVYMAYKDLYQVSNTELYEIFTCLGELGAIAQVHAENGDIIAQEQTRMLEMGITGPEGHVLSRPEELEAEAVFRAITIASQTNCPLYVTKVMSKSAADLISQARKKGNVVFGEPITASLGIDGTHYWSKNWAKAAAFVTSPPLSPDPTTPDYINSLLASGDLQLSGSAHCTFSTAQKAIGKDNFTAIPEGTNGVEERMSVIWDKAVATGKMDENQFVAVTSTNAAKIFNLYPRKGRISVGSDSDLVIWDPDAVKIVSAKNHQSAAEYNIFEGMELRGAPLVVICQGKIMLEDGNLHVTQGAGRFIPCSPFSDYVYKRIKARRKMAD","Homo sapiens","DPYSL3, CRMP4, DRP3, ULIP, ULIP1","DIHYDROPYRIMIDINASE-LIKE 3","1","4CNS"
"4CNT",,"X-RAY DIFFRACTION",2.13,42.4,,7.5,"15% (W/V) PEG 6000, 100 MM NAHEPES PH 7.5, 100 MM KCL",,"10.1107/S1399004714006634",,"4CNT",248.28,"2.65","2.65","CRYSTAL STRUCTURE OF WT HUMAN CRMP-4","MSYQGKKNIPRITSDRLLIKGGRIVNDDQSFYADIYMEDGLIKQIGDNLIVPGGVKTIEANGKMVIPGGIDVHTHYQMPYKGMTTVDDFFQGTKAALAGGTTMIIDHVVPEPESSLTEAYEKWREWADGKSCCDYALHVDITHWNDSVKQEVQNLIKDKGVNSFMVYMAYKDLYQVSNTELYEIFTCLGELGAIAQVHAENGDIIAQEQTRMLEMGITGPEGHVLSRPEELEAEAVFRAITIASQTNCPLYVTKVMSKSAADLISQARKKGNVVFGEPITASLGIDGTHYWSKNWAKAAAFVTSPPLSPDPTTPDYINSLLASGDLQLSGSAHCTFSTAQKAIGKDNFTAIPEGTNGVEERMSVIWDKAVATGKMDENQFVAVTSTNAAKIFNLYPRKGRISVGSDSDLVIWDPDAVKIVSAKNHQSAAEYNIFEGMELRGAPLVVICQGKIMLEDGNLHVTQGAGRFIPCSPFSDYVYKRIKARRKMADLHAVPRGMYDGPVFDLTTTPKGGTPAGSARGSPTRPNPPVRNLHQSGFSLSGTQVDEGVRSASKRIVAPPGGRSNITSLS","Homo sapiens","DPYSL3, CRMP4, DRP3, ULIP, ULIP1","DIHYDROPYRIMIDINASE-LIKE 3","1","4CNT"
"4CNU",,"X-RAY DIFFRACTION",2.43,49.3,,7,"23% (W/V) PEG 3350, 200 MM NA TARTRATE, 100 MM BIS-TRIS PROPANE PH 7.0, 50 MM NA FLUORIDE",,"10.1107/S1399004714006634",,"4CNU",124.1,"2.8","2.8","CRYSTAL STRUCTURE OF WT HUMAN CRMP-4 from lattice translocation","MSYQGKKNIPRITSDRLLIKGGRIVNDDQSFYADIYMEDGLIKQIGDNLIVPGGVKTIEANGKMVIPGGIDVHTHYQMPYKGMTTVDDFFQGTKAALAGGTTMIIDHVVPEPESSLTEAYEKWREWADGKSCCDYALHVDITHWNDSVKQEVQNLIKDKGVNSFMVYMAYKDLYQVSNTELYEIFTCLGELGAIAQVHAENGDIIAQEQTRMLEMGITGPEGHVLSRPEELEAEAVFRAITIASQTNCPLYVTKVMSKSAADLISQARKKGNVVFGEPITASLGIDGTHYWSKNWAKAAAFVTSPPLSPDPTTPDYINSLLASGDLQLSGSAHCTFSTAQKAIGKDNFTAIPEGTNGVEERMSVIWDKAVATGKMDENQFVAVTSTNAAKIFNLYPRKGRISVGSDSDLVIWDPDAVKIVSAKNHQSAAEYNIFEGMELRGAPLVVICQGKIMLEDGNLHVTQGAGRFIPCSPFSDYVYKRIKARRKMADLHAVPRGMYDGPVFDLTTTPKGGTPAGSARGSPTRPNPPVRNLHQSGFSLSGTQVDEGVRSASKRIVAPPGGRSNITSLS","Homo sapiens","DPYSL3, CRMP4, DRP3, ULIP, ULIP1","DIHYDROPYRIMIDINASE-LIKE 3","1","4CNU"
"4CO7",,"X-RAY DIFFRACTION",2.1,40,,7,"100 MM SODIUM PHOSPHATE PH 7.0, 50 MM POTASSIUM CHLORIDE, 10 MM DITHIOTHREITOL",,"10.1021/acs.biochem.5b00366",,"4CO7",27.66,"2","2","Crystal structure of human GATE-16","GSMKWMFKEDHSLEHRCVESAKIRAKYPDRVPVIVEKVSGSQIVDIDKRKYLVPSDITVAQFMWIIRKRIQLPSEKAIFLFVDKTVPQSSLTMGQLYEKEKDEDGFLYVAYSGENTFGF","Homo sapiens","GABARAPL2, FLC3A, GEF2","GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN-LIKE 2","1","4CO7"
"4CO8",,"X-RAY DIFFRACTION",1.61,23.57,,,"0.8 M SODIUM CITRATE TRIBASIC, 0.1 M CACODYLATE PH 6.5.",,"10.1074/jbc.M115.646737",,"4CO8",15.85,"1.05","1.05","Structure of the DNA binding ETS domain of human ETV4","SMRGALQLWQFLVALLDDPTNAHFIAWTGRGMEFKLIEPEEVARLWGIQKNRPAMNYDKLSRSLRYYYEKGIMQKVAGERYVYKFVCEPEALFSLAFPDNQRPALKAEFDRPVSEEDTVPLSHLDESPAYLPELA","Homo sapiens","ETV4, E1AF, PEA3","ETS TRANSLOCATION VARIANT 4","1","4CO8"
"4COF",,"X-RAY DIFFRACTION",4.59,74,,6.5,"11.5% PEG4000 100 MM SODIUM CHLORIDE, 100 MM LITHIUM SULPHATE, 100 MM N-2-ACETAMIDO-IMINODIACETIC ACID, PH 6.5, 2% (W/V) BENZAMIDINE",,"10.1038/nature13293",,"4COF",209.2,"2.97","2.97","Crystal structure of a human gamma-aminobutyric acid receptor, the GABA(A)R-beta3 homopentamer","ETGQSVNDPGNMSFVKETVDKLLKGYDIRLRPDFGGPPVCVGMNIDIASIDMVSEVNMDYTLTMYFQQYWRDKRLAYSGIPLNLTLDNRVADQLWVPDTYFLNDKKSFVHGVTVKNRMIRLHPDGTVLYGLRITTTAACMMDLRRYPLDEQNCTLEIESYGYTTDDIEFYWRGGDKAVTGVERIELPQFSIVEHRLVSRNVVFATGAYPRLSLSFRLKRNIGYFILQTYMPSILITILSWVSFWINYDASAARVALGITTVLTMTTINTHLRETLPKIPYVKAIDMYLMGCFVFVFLALLEYAFVNYIFFSQPARAAAIDRWSRIVFPFTFSLFNLVYWLYYVNGATETSQVAPA","Homo sapiens","GABRB3","GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT BETA-3","1","4COF"
"4COO",,"X-RAY DIFFRACTION",2.89,57.42,,,"18% PEG8000, 0.1 M CACODYLATE, PH 6.6 0.2 M SODIUM ACETATE",,"10.1074/jbc.M114.610782",,"4COO",127.12,"2","2","Crystal structure of human cystathionine beta-synthase (delta516-525) at 2.0 angstrom resolution","MHHHHHHSSGVDLGTENLYFQSMPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQQRQMVFGVVTAIDLLNFVAAQERDQK","Homo sapiens","CBS","CYSTATHIONINE BETA-SYNTHASE","1","4COO"
"4COS",,"X-RAY DIFFRACTION",2.14,42.7,,6.3,"pH 6.3",,"10.1016/j.celrep.2016.11.014",,"4COS",38.21,"1.67","1.67","Crystal structure of the PHD-Bromo-PWWP cassette of human PRKCBP1","SMQDGRNDFYCWVCHREGQVLCCELCPRVYHAKCLRLTSEPEGDWFCPECEKITVAECIETQSKAMTMLTIEQLSYLLKFAIQKMKQPGTDAFQKPVPLEQHPDYAEYIFHPMDLCTLEKNAKKKMYGCTEAFLADAKWILHNCIIYNGGNHKLTQIAKVVIKICEHEMNEIEVCPECYLAACQKRDNWFCEPCSNPHPLVWAKLKGFPFWPAKALRDKDGQVDARFFGQHDRAWVPINNCYLMSKEIPFSVKKTKSIFNSAMQEMEVYVENIRRKFGVFNYSPFRTPYTPNSQYQMLLDPTNPSAGTAKIDKQEKVKLNFDMTAS","Homo sapiens","ZMYND8, KIAA1125, PRKCBP1, RACK7","PROTEIN KINASE C-BINDING PROTEIN 1","1","4COS"
"4CP3",,"X-RAY DIFFRACTION",1.99,38.17,,5,"20% PEG 6000, 100MM SODIUM CITRATE, PH 5.",,"10.1371/journal.pone.0090889",,"4CP3",29.3,"2.3","2.3","The structure of BCL6 BTB (POZ) domain in complex with the ansamycin antibiotic rifabutin.","GASQIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKAS","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-CELL LYMPHOMA 6 PROTEIN","1","4CP3"
"4CPC",,"X-RAY DIFFRACTION",2.87,54.7,,7.5,"PROTEIN WAS CRYSTALLISED FROM 100 MM HEPES PH 7.5, 100 MM NACL, 13.0% (W/V) PEG3350; THEN SOAKED IN 20% GLYCEROL.",,"10.7554/eLife.02963",,"4CPC",159.19,"2.24","2.24","Crystal structure of human synaptonemal complex protein SYCP3","GSMGGEVQNMLEGVGVDINKALLAKRKRLEMYTKASLKTSNQKIEHVWKTQQDQRQKLNQEYSQQFLTLFQQWDLDMQKAEEQEEKILNMFRQQQKILQQSRIVQSQRLKTIKQLYEQFIKSMEELEKNHDNLLTGAQNEFKKEMAMLQKKIMMETQQQEIASVRKS","Homo sapiens","SYCP3, SCP3","SYNAPTONEMAL COMPLEX PROTEIN 3","1","4CPC"
"4CPG",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0113281",,"4CPG",18.49,,,"Solution structure of the SGTA N-terminal domain","MAHHHHHHVDDDDKMDNKKRLAYAIIQFLHDQLRHGGLSSDAQESLEVAIQCLETAFGVTVEDSDLALPQTLPEIFEAAATGK","Homo sapiens","SGTA, SGT, SGT1","SMALL GLUTAMINE-RICH TETRATRICOPEPTIDE REPEAT-CONTAINING PROTEIN ALPHA","1","4CPG"
"4CQ0",,"X-RAY DIFFRACTION",2.11,41.7,,8.5,"THE PROTEIN WAS AT 14 MG/ML. THE RESERVOIR WAS 2.9 M AMMONIUM SULFATE, 100 MM TRIS PH 8.5. THE DROPS WERE 210 NL PROTEIN PLUS 110 NL RESERVOIR PLUS 40 NL COMPOUND. THE CRYSTALS GREW AT 20C.",293,"10.1021/jm500255y","SXS","4CQ0",29.6,"1.45","1.45","Cyclic secondary sulfonamides: unusually good inhibitors of cancer- related carbonic anhydrase enzymes","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","4CQ0"
"4CQ1",,"X-RAY DIFFRACTION",2.28,46,,,"0.1 M TRIS (PH 8.0), 2 MM ZNCL2, 20% PEG 6000",,"10.7717/peerj.305",,"4CQ1",176.66,"1.69","1.69","Crystal structure of the neuronal isoform of PTB","GNTVLLVSNLNEEMVTPQSLFTLFGVYGDVQRVKILYNKKDSALIQMADGNQSQLAMNHLNGQKMYGKIIRVTLSKHQTVQLPREGLDDQGLTKDFGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVAEEDLRTLFANTGGTVKAFKFFQDHKMALLQMATVEEAIQALIDLHNYNLGENHHLRVSFSKSTI","Homo sapiens","PTBP2, NPTB, PTB, PTBLP","POLYPYRIMIDINE TRACT-BINDING PROTEIN 2","1","4CQ1"
"4CQE",,"X-RAY DIFFRACTION",2.63,52.9,"VAPOR DIFFUSION, SITTING DROP",,"0.1M HEPES PH 7.5.0, 0.2 M MGCL2 AND 20% PEG6000, VAPOR DIFFUSION, SITTING DROP,",,"10.1002/cmdc.201402424","CQE","4CQE",64.48,"2.3","2.3","B-Raf Kinase V600E mutant in complex with a diarylthiazole B-Raf Inhibitor","GPDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","SLC45A3-BRAF FUSION PROTEIN","1","4CQE"
"4CR5",,"X-RAY DIFFRACTION",2.76,55.41,,8.5,"2M AMMONIUM SULFATE 0.1M TRIS-CL PH 8.5 0.2M NACL",,"10.1371/journal.pone.0113705","0TU","4CR5",27.6,"2","2","Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","COAGULATION FACTOR XIA","1","4CR5"
"4CR9",,"X-RAY DIFFRACTION",2.76,55.41,,8.5,"2M AMMONIUM SULFATE 0.1M TRIS-CL PH 8.5 0.2M NACL",,"10.1371/journal.pone.0113705","OTW","4CR9",27.5,"1.7","1.7","Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","COAGULATION FACTOR XI","1","4CR9"
"4CRA",,"X-RAY DIFFRACTION",2.76,55.41,,8.5,"2M AMMONIUM SULFATE, 0.1M TRIS-CL PH 8.5, 0.2M NACL",,"10.1371/journal.pone.0113705","XJ8","4CRA",27.73,"1.8","1.8","Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","COAGULATION FACTOR XI","1","4CRA"
"4CRB",,"X-RAY DIFFRACTION",2.76,55.41,,8.5,"2M AMMONIUM SULFATE 0.1M TRIS-CL PH 8.5 0.2M NACL",,"10.1371/journal.pone.0113705","7P0","4CRB",27.88,"1.85","1.85","Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","COAGULATION FACTOR XI","1","4CRB"
"4CRC",,"X-RAY DIFFRACTION",2.76,55.39,,8.5,"2M AMMONIUM SULFATE, 0.1M TRIS-CL PH 8.5, 0.2M NACL",,"10.1371/journal.pone.0113705","OTM","4CRC",27.4,"1.6","1.6","Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGERNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","COAGULATION FACTOR XI","1","4CRC"
"4CRD",,"X-RAY DIFFRACTION",2.73,54.88,,8.5,"2M AMMONIUM SULFATE, 0.1M TRIS-CL PH 8.5, 0.2M NACL",,"10.1371/journal.pone.0113705","OTJ","4CRD",27.56,"2.1","2.1","Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","COAGULATION FACTOR XI","1","4CRD"
"4CRE",,"X-RAY DIFFRACTION",2.76,55.39,,8.5,"2M AMMONIUM SULFATE, 0.1M TRIS-CL PH 8.5, 0.2M NACL",,"10.1371/journal.pone.0113705",,"4CRE",27.73,"1.73","1.73","Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGERNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","COAGULATION FACTOR XI","1","4CRE"
"4CRF",,"X-RAY DIFFRACTION",2.76,55.41,"VAPOR DIFFUSION, HANGING DROP",8.5,"2M AMMONIUM SULFATE, 0.1M TRIS-CL PH 8.5, 0.2M NACL",,"10.1371/journal.pone.0113705","R9B","4CRF",27.99,"2.3","2.3","Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XIa light chain","1","4CRF"
"4CRG",,"X-RAY DIFFRACTION",2.75,55.28,,8.5,"2M AMMONIUM SULFATE, 0.1M TRIS-CL PH 8.5, 0.2M NACL",,"10.1371/journal.pone.0113705",,"4CRG",27.89,"1.25","1.25","Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","COAGULATION FACTOR XI","1","4CRG"
"4CRH",,"X-RAY DIFFRACTION",2,38,,8.4,"17% PEG 2000, MME 0.1M TRIS PH 8.4, 0.15M TMAO",,"10.1042/BCJ20170527",,"4CRH",14.33,"1.72","1.72","Crystal structure of the BTB-T1 domain of human SHKBP1","MHHHHHHSSGVDLGTENLYFQSMGEVIHLNVGGKRFSTSRQTLTWIPDSFFSSLLSGRISTLKDETGAIFIDRDPTVFAPILNFLRTKELDPRGVHGSSLLHEAQFYGLTPLVRRLQLREELDRSS","Homo sapiens","SHKBP1, SB1, PP203","SH3KBP1-BINDING PROTEIN 1","1","4CRH"
"4CRP",,"SOLUTION NMR",,,,,,,"10.1021/jm501307e",,"4CRP",11.79,,,"Solution structure of a TrkAIg2 domain construct for use in drug discovery","DDDDDVSFCASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPCGQASASIMAAFMDNPF","Homo sapiens","NTRK1, MTC, TRK, TRKA","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","1","4CRP"
"4CRS",,"X-RAY DIFFRACTION",3.2,61.6,,5.8,"2.3M AMMONIUM SULPHATE, 0.1M CITRATE PH 5.8, 0.2M SODIUM/POTASSIUM TARTRATE",,,,"4CRS",40.42,"2.75","2.75","Human Protein Kinase N2 (PKN2, PRKCL2) in complex with ATPgammaS","SMSQQRFQFNLQDFRCCAVLLRGHFGKVLLAEYKNTNEMFAIKALKKGDIVARDEVDSLMCEKRIFETVNSVRHPFLVNLFACFQTKEHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEHKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAISIMRRLLRRNPERRLGASEKDAEDVKKHPFFRLIDWSALMDKKVKPPFIPTIRGREDVSNFDDEFTSEAPILTPPREPRILSEEEQEMFRDFDYIADWC","Homo sapiens","PKN2, PRK2, PRKCL2","SERINE/THREONINE-PROTEIN KINASE N2","1","4CRS"
"4CRT",,"X-RAY DIFFRACTION",2.65,54,,6.5,"pH 6.5",,"10.1016/j.bbapap.2014.03.006",,"4CRT",120.14,"1.8","1.8","Crystal structure of human monoamine oxidase B in complex with the multi-target inhibitor ASS234","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","AMINE OXIDASE [FLAVIN-CONTAINING] B","1","4CRT"
"4CSK",,"X-RAY DIFFRACTION",2.79,55.99,,9,"pH 9",,"10.1107/S2053230X14024558",,"4CSK",31.17,"3.28","3.28","human Aquaporin","MGHHHHHHSSGVDLGTENLYFQSMASEFKKKLFWRAVVAEFLATTLFVFISIGSALGFKYPVGNNQTAVQDNVKVSLAFGLSIATLAQSVGHISGAHLNPAVTLGLLLSCQISIFRALMYIIAQCVGAIVATAILSGITSSLTGNSLGRNDLADGVNSGQGLGIEIIGTLQLVLCVLATTDRRRRDLGGSAPLAIGLSVALGHLLAIDYTGCGINPARSFGSAVITHNFSNHWIFWVGPFIGGALAVLIYDFILAPRSSDLTDRVKVWTSGQVEEYDLDADDINSRVEMKPK","Homo sapiens","AQP1, CHIP28","AQUAPORIN-1","1","4CSK"
"4CSY",,"X-RAY DIFFRACTION",2.8,56.1,,,"13 % PEG8000, HEPES, MOPS PH 6.2, CACL2, 10MM SLEX-OTMSE",,"10.1093/jmcb/mjv046",,"4CSY",67.46,"2.41","2.41","E-selectin lectin, EGF-like and two SCR domains complexed with Sialyl Lewis X","WSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVWVWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSYNSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPWNTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKA","Homo sapiens","SELE, ELAM1","E-SELECTIN","1","4CSY"
"4CT1",,"X-RAY DIFFRACTION",2.27,46,,7.5,"1.2 M NA CITRATE, 0.1 M HEPES PH 7.5, 10 MM DTT",,"10.1016/j.chembiol.2014.04.007",,"4CT1",36.47,"1.85","1.85","Human PDK1-PKCzeta Kinase Chimera in Complex with Allosteric Compound PS315 Bound to the PIF-Pocket","GAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIVEKRHVHKENKIPYVQREKDVMSRLDHPFFVKLYFCFQDDEKLYLGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1","1","4CT1"
"4CT2",,"X-RAY DIFFRACTION",2.24,45,,7.5,"1.2 M NA CITRATE, 0.1 M HEPES PH 7.5, 10 MM DTT",,"10.1016/j.chembiol.2014.04.007",,"4CT2",36.05,"1.25","1.25","Human PDK1-PKCzeta Kinase Chimera","GAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIVEKRHVHKENKIPYVQREKDVMSRLDHPFFVKLYFCFQDDEKLYLGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1","1","4CT2"
"4CT5",,"X-RAY DIFFRACTION",2.9,57,,5.5,"17% (W/V) PEG 10000, 100 MM BIS-TRIS PH 5.5 AND 100 MM AMMONIUM ACETATE",,"10.1016/j.molcel.2014.03.036",,"4CT5",86.5,"3","3","DDX6","RSMGNEFEDYCLKRELLMGIFEMGWEKPSPIQEESIPIALSGRDILARAKNGTGKSGAYLIPLLERLDLKKDNIQAMVIVPTRELALQVSQICIQVSKHMGGAKVMATTGGTNLRDDIMRLDDTVHVVIATPGRILDLIKKGVAKVDHVQMIVLDEADKLLSQDFVQIMEDIILTLPKNRQILLYSATFPLSVQKFMNSHLQKPYEINLMEELTLKGVTQYYAYVTERQKVHCLNTLFSRLQINQSIIFCNSSQRVELLAKKISQLGYSCFYIHAKMRQEHRNRVFHDFRNGLCRNLVCTDLFTRGIDIQAVNVVINFDFPKLAETYLHRIGRSGRFGHLGLAINLITYDDRFNLKSIEEQLGTEIKPIPSNIDKSLY","Homo sapiens","DDX6, HLR2, RCK","DDX6","1","4CT5"
"4CTB",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",5.6,"HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 13-15 MG/ML)CONTAINING 0.001M INHIBITOR COMPOUND WERE COMBINED WITH A SOLUTION CONTAINING: 0.15M AMMONIUM SULFATE, 9-10.5% MONOMETHYLETHER PEG5K AND 0.1M MES IN THE PH RANGE 5.3-6.5.",286,"10.1021/jm500261q","KVC","4CTB",37.35,"1.79","1.79","Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor (5R)-8-amino-3-fluoro-5,19-dimethyl-20-oxo-5,18,19,20- tetrahydro-7,11-(azeno)pyrido(2',1':2,3)imidazo(4,5-h)(2,5,11) benzoxadiazacyclotetradecine-14-carbonitrile","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4CTB"
"4CTC",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",5.6,"HANGING DROP VAPOR DIFFUSION AT 13 DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION (APPROXIMATELY 13-15 MG/ML)CONTAINING 0.001M INHIBITOR COMPOUND WERE COMBINED WITH A SOLUTION CONTAINING: 0.15M AMMONIUM SULFATE, 9-10.5% MONOMETHYLETHER PEG5K AND 0.1M MES IN THE PH RANGE 5.3-6.5",286,"10.1021/jm500261q","J99","4CTC",37.33,"2.03","2.03","Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor 7-amino-3-cyclopropyl-12-fluoro-1,10,16-trimethyl-16,17- dihydro-1H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecin-15(10H)-one","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4CTC"
"4CTH",,"X-RAY DIFFRACTION",2.3,48,"VAPOR DIFFUSION, HANGING DROP",7,"HANGING DROP, pH 7.0",,"10.1371/journal.pone.0104001","RDF","4CTH",83.42,"2.15","2.15","Neprilysin variant G399V,G714K in complex with phosphoramidon","HHHHHHHHHHYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYVTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPKNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW","Homo sapiens","MME, EPN","NEPRILYSIN","1","4CTH"
"4CUD",,"X-RAY DIFFRACTION",2.21,44.3,,6,"pH 6.0",,"10.1073/pnas.1319683111",,"4CUD",15.18,"1.85","1.85","Human Notch1 EGF domains 11-13 mutant fucosylated at T466","SAQDVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGPRCEIDVNECVSNPCQNDATCLDQIGEFQCICMPGYEGVHCEVNTDECASSPCLHNGRCLDKINEFQCECPTGFTGHLCQVDLHHILDAQKMVWNHR","Homo sapiens","NOTCH1, TAN1","NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1","1","4CUD"
"4CUE",,"X-RAY DIFFRACTION",2.52,51.31,,5.5,"pH 5.5",,"10.1073/pnas.1319683111",,"4CUE",14.98,"3","3","Human Notch1 EGF domains 11-13 mutant T466V","SAQDVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGPRCEIDVNECVSNPCQNDAVCLDQIGEFQCICMPGYEGVHCEVNTDECASSPCLHNGRCLDKINEFQCECPTGFTGHLCQVDLHHILDAQKMVWNHR","Homo sapiens","NOTCH1, TAN1","NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1","1","4CUE"
"4CUF",,"X-RAY DIFFRACTION",2.35,47.8,,6.5,"pH 6.5",,"10.1073/pnas.1319683111",,"4CUF",15.03,"2.29","2.29","Human Notch1 EGF domains 11-13 mutant T466S","SAQDVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGPRCEIDVNECVSNPCQNDASCLDQIGEFQCICMPGYEGVHCEVNTDECASSPCLHNGRCLDKINEFQCECPTGFTGHLCQVDLHHILDAQKMVWNHR","Homo sapiens","NOTCH1, TAN1","NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1","1","4CUF"
"4CUP",,"X-RAY DIFFRACTION",4.3,70,,6.4,"34% PEG SMEAR LOW, 0.1M MES PH 6.4",,,,"4CUP",13.87,"1.88","1.88","Crystal structure of human BAZ2B in complex with fragment-1 N09421","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B","1","4CUP"
"4CUQ",,"X-RAY DIFFRACTION",4.45,72.39,,6.4,"33% PEG SMEAR LOW, 0.1M MES PH 6.4",,,,"4CUQ",13.8,"2.11","2.11","Crystal structure of human BAZ2B in complex with fragment-2 N09594","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B","1","4CUQ"
"4CUR",,"X-RAY DIFFRACTION",4.38,71.97,,6.5,"31% PEG SMEAR LOW, 0.1M MES PH 6.5",,,,"4CUR",13.82,"1.842","1.842","Crystal structure of human BAZ2B in complex with fragment-3 N09555","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B","1","4CUR"
"4CUS",,"X-RAY DIFFRACTION",4.46,72.45,,6,"30% PEG600, 0.1M MES PH 6.0",,,,"4CUS",14.07,"1.783","1.783","Crystal structure of human BAZ2B in complex with fragment-4 N09496","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B","1","4CUS"
"4CUT",,"X-RAY DIFFRACTION",4.55,73,,6,"30% PEG600, 0.1M MES PH 6.0",,,,"4CUT",14.02,"1.835","1.835","Crystal structure of human BAZ2B in complex with fragment-5 N09428","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B","1","4CUT"
"4CUU",,"X-RAY DIFFRACTION",4.4,72.08,,6,"30% PEG600, 0.1M MES PH 6.0",,,,"4CUU",14.09,"1.801","1.801","Crystal structure of human BAZ2B in complex with fragment-6 N09645","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B","1","4CUU"
"4CV8",,"X-RAY DIFFRACTION",3.77,67.4,,7.5,"0.2M NACO2H, 0.1M BTP PH 7.5, 15% W/V PEG3350, 1% DMSO AND 1MM (N-(2-OXO-5-(PYRIDIN-4-YL)-1, 2-DIHYDROPYRIDIN-3-YL)-4-PIPERIDIN-1-YL)BENZAMIDE. THEN BACK-SOAK IN A NEW SOLUTION OF 0.19M NACO2H, 0.095M BTP PH 7.5, 14.25% PEG3350 AND 2MM 3-AMINO-5-(1-METHYL-1H-PYRAZOL-4-YL) PYRIDIN-2(1H)-ONE FOR 24H ALL AT 18 DEGREES C.",291,,"3D7","4CV8",36.55,"3","3","MPS1 kinase with 3-aminopyridin-2-one inhibitors","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4CV8"
"4CV9",,"X-RAY DIFFRACTION",3.69,66.7,,7.5,"0.2M NACO2H, 0.1M BTP PH 7.5, 15% W/V PEG3350, 1% DMSO AND 1MM 4-(4-METHYLPIPERAZIN-1-YL)-N-(2-OXO-5-(PYRIDIN-4-YL)-1, 2-DIHYDROPYRIDIN-3-YL)BENZAMIDE. 18 DEGREES C.",291,,"W2K","4CV9",36.97,"2.5","2.5","MPS1 kinase with 3-aminopyridin-2-one inhibitors","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4CV9"
"4CVA",,"X-RAY DIFFRACTION",3.61,65.9,,7.5,"0.2M NACO2H, 0.1M BTP PH 7.5, 15% W/V PEG3350, 1% DMSO AND 1MM (N-(2-OXO-5-(PYRIDIN-4-YL)-1, 2-DIHYDROPYRIDIN-3-YL)-4-PIPERIDIN-1-YL)BENZAMIDE.",,,"WBI","4CVA",36.85,"2.5","2.5","MPS1 kinase with 3-aminopyridin-2-one inhibitors","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4CVA"
"4CVH",,"X-RAY DIFFRACTION",2.81,56.6,,,"0.1M BIS-TRIS PH 6.5, 25%(W/V) PEG 3350",,"10.1016/j.chembiol.2015.10.014",,"4CVH",46.23,"2.39","2.39","Crystal structure of human isoprenoid synthase domain-containing protein","SMHPQAVAAVLPAGGCGERMGVPTPKQFCPILERPLISYTLQALERVCWIKDIVVAVTGENMEVMKSIIQKYQHKRISLVEAGVTRHRSIFNGLKALAEDQINSKLSKPEVVIIHDAVRPFVEEGVLLKVVTAAKEHGAAGAIRPLVSTVVSPSADGCLDYSLERARHRASEMPQAFLFDVIYEAYQQCSDYDLEFGTECLQLALKYCCTKAKLVEGSPDLWKVTYKRDLYAAESIIKERISQEICVVMDTEEDNKHVGHLLEEVLKSELNHVKVTSEALGHAGRHLQQIILDQCYNFVCVNVTTSDFQETQKLLSMLEESSLCILYPVVVVSVHFLDFKLVPPSQKMENLMQIREFAKEVKERNILLYGLLISYPQDDQKLQESLRQGAIIIASLIKERNSGLIGQLLIA","Homo sapiens","CRPPA, ISPD","ISOPRENOID SYNTHASE DOMAIN-CONTAINING PROTEIN","1","4CVH"
"4CVO",,"X-RAY DIFFRACTION",3.71,66.84,,,"1.6 M MAGNESIUM SULFATE, 0.1 M MES PH 6.6",,,,"4CVO",8.79,"1.85","1.85","Crystal structure of the N-terminal colied-coil domain of human DNA excision repair protein ERCC-6","SMEPSAQALELQGLGVDVYDQDVLEQGVLQQVDNAIHEASRASQLVDVEKEYRSVLDDLTSCTTSLRQINKIIEQLSPQ","Homo sapiens","ERCC6, CSB","DNA EXCISION REPAIR PROTEIN ERCC-6","1","4CVO"
"4CWD",,"X-RAY DIFFRACTION",2.55,52,,7,"0.2M AMMONIUM CITRATE, 20% PEG 3350, 6% DIAMINE HEXAN, 10MM ZNSO4, PH 7.0, 1MM 4-CARBOXY-1,1-DIMETHYLPIPERIDIN-1-IUM",,"10.1002/anie.201406125",,"4CWD",45.4,"1.899","1.899","CRYSTAL STRUCTURE OF HUMAN GAMMA-BUTYROBETAINE,2-OXOGLUTARATE IN COMPLEX WITH 449, A NOVEL SUBSTRATE","SMACTIQKAEALDGAHLMQILWYDEEESLYPAVWLRDNCPCSDCYLDSAKARKLLVEALDVNIGIKGLIFDRKKVYITWPDEHYSEFQADWLKKRCFSKQARAKLQRELFFPECQYWGSELQLPTLDFEDVLRYDEHAYKWLSTLKKVGIVRLTGASDKPGEVSKLGKRMGFLYLTFYGHTWQVQDKIDANNVAYTTGKLSFHTDYPALHHPPGVQLLHCIKQTVTGGDSEIVDGFNVCQKLKKNNPQAFQILSSTFVDFTDIGVDYCDFSVQSKHKIIELDDKGQVVRINFNNATRDTIFDVPVERVQPFYAALKEFVDLMNSKESKFTFKMNPGDVITFDNWRLLHGRRSYEAGTEISRHLEGAYADWDVVMSRLRILRQRVENGN","Homo sapiens","BBOX1, BBH, BBOX","GAMMA-BUTYROBETAINE DIOXYGENASE","1","4CWD"
"4CWF",,"X-RAY DIFFRACTION",2.9,57,,,,,"10.1016/j.bmc.2014.05.056","H05","4CWF",26.04,"2","2","Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor","GPDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4CWF"
"4CWN",,"X-RAY DIFFRACTION",2.93,57.6,,,,,"10.1016/j.bmc.2014.05.056","6LV","4CWN",26.15,"1.8","1.8","Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor","GPDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4CWN"
"4CWO",,"X-RAY DIFFRACTION",3.2,61,,,,,"10.1016/j.bmc.2014.05.056","T62","4CWO",26.12,"2.31","2.31","Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor","GPDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4CWO"
"4CWP",,"X-RAY DIFFRACTION",3,59,,,,,"10.1016/j.bmc.2014.05.056","TV2","4CWP",26.13,"1.95","1.95","Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor","GPDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4CWP"
"4CWQ",,"X-RAY DIFFRACTION",2.96,58,,,,,"10.1016/j.bmc.2014.05.056","W2D","4CWQ",26.21,"2","2","Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor","GPDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4CWQ"
"4CWR",,"X-RAY DIFFRACTION",2.96,58.2,,,,,"10.1016/j.bmc.2014.05.056","HAJ","4CWR",26.15,"2","2","Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor","GPDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4CWR"
"4CWS",,"X-RAY DIFFRACTION",3.1,60.5,,,,,"10.1016/j.bmc.2014.05.056","G3R","4CWS",26.19,"2.3","2.3","Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor","GPDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4CWS"
"4CWT",,"X-RAY DIFFRACTION",2.98,58.5,,,,,"10.1016/j.bmc.2014.05.056","IK9","4CWT",26.21,"1.9","1.9","Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor","GPDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4CWT"
"4CX7",,"X-RAY DIFFRACTION",5.4,77.3,,6,"1.3M AMMONIUM SULFATE, 50 MM NA CITRATE, PH5.0 30% GLYCEROL 5 MM GSH, pH 6.0",,"10.1021/bi500561h","S71","4CX7",204.99,"3.16","3.16","Structure of human iNOS heme domain in complex with (R)-6-(3-AMINO-2-(5-(2-(6-AMINO-4- METHYLPYRIDIN-2-YL)ETHYL)PYRIDIN-3-YL)PROPYL)-4- METHYLPYRIDIN-2-AMINE","LDATPLSSPRHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQDE","Homo sapiens","NOS2, NOS2A","NITRIC OXIDE SYNTHASE, INDUCIBLE","1","4CX7"
"4CXI",,"X-RAY DIFFRACTION",2.3,46.63,,,,,"10.1371/journal.pone.0098896",,"4CXI",15.29,"2.35","2.35","BTB domain of KEAP1","GSHMGNRTFSYTLEDHTKQAFGIMNELRLSQQLCDVTLQVKYQDAPAAQFMAHKVVLASSSPVFKAMFTNGLREQGMEVVSIEGIHPKVMERLIEFAYTASISMGEKCVLHVMNGAVMYQIDSVVRACADFLVQQLD","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","KELCH-LIKE ECH-ASSOCIATED PROTEIN 1","1","4CXI"
"4CXJ",,"X-RAY DIFFRACTION",2.31,46.73,,,,,"10.1371/journal.pone.0098896",,"4CXJ",15.38,"2.8","2.8","BTB domain of KEAP1 C151W mutant","GSHMGNRTFSYTLEDHTKQAFGIMNELRLSQQLCDVTLQVKYQDAPAAQFMAHKVVLASSSPVFKAMFTNGLREQGMEVVSIEGIHPKVMERLIEFAYTASISMGEKWVLHVMNGAVMYQIDSVVRACADFLVQQLD","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","KELCH-LIKE ECH-ASSOCIATED PROTEIN 1","1","4CXJ"
"4CXL",,"X-RAY DIFFRACTION",3.7,67,,8,"0.1 M TRIS/HCL PH 8.0, 0.2 SODIUM CITRATE, 40% V/V MPD, PROTEIN CONCENTRATION 5MG/ML IN 20 MM HCL",,"10.1021/bi500073z",,"4CXL",5.89,"1.5","1.5","Human insulin analogue (D-ProB8)-insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","4CXL"
,,,,,,,,,,,,,,,,"FVNQHLCPSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","4CXL"
"4CXN",,"X-RAY DIFFRACTION",3.7,67,,8,"0.1 M TRIS/HCL PH 8.0, 0.2 M SODIUM CITRATE, 40% V/V MPD, PROTEIN IN 20 MM HCL AT 7 MG/ML",,"10.1021/bi500073z",,"4CXN",5.85,"1.7","1.7","Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form I","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","4CXN"
,,,,,,,,,,,,,,,,"FVNQHLCASHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","4CXN"
"4CXT",,"X-RAY DIFFRACTION",2.26,45,,,,,"10.1371/journal.pone.0098896",,"4CXT",15.79,"2.66","2.66","BTB domain of KEAP1 in complex with CDDO","GSHMGNRTFSYTLEDHTKQAFGIMNELRLSQQLCDVTLQVKYQDAPAAQFMAHKVVLASSSPVFKAMFTNGLREQGMEVVSIEGIHPKVMERLIEFAYTASISMGEKCVLHVMNGAVMYQIDSVVRACADFLVQQLD","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","KELCH-LIKE ECH-ASSOCIATED PROTEIN 1","1","4CXT"
"4CXW",,"X-RAY DIFFRACTION",2.85,56.84,,,"100 MM SODIUM CITRATE, PH5.6, 10% PEG 3350, 10% T-BUTANOL, 1 MM NISO4, 1.5 MM LIGAND",,"10.1039/c4sc02554g",,"4CXW",57.21,"3.1","3.1","Crystal structure of human FTO in complex with subfamily-selective inhibitor 12","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO","1","4CXW"
"4CXX",,"X-RAY DIFFRACTION",2.8,56.03,,,"100 MM SODIUM CITRATE, PH 5.6, 10% PEG 3350, 10% T-BUTANOL, 1MM NISO4, 1.5 MM LIGAND, 293 K",293,"10.1039/c4sc02554g",,"4CXX",57.26,"2.76","2.76","Crystal structure of human FTO in complex with acylhydrazine inhibitor 16","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO","1","4CXX"
"4CXY",,"X-RAY DIFFRACTION",2.86,57.01,,,"100 MM SODIUM CITRATE, PH5.6, 10% PEG 3350, 10% T-BUTANOL, 1 MM NISO4, 1.5 MM LIGAND",,"10.1039/c4sc02554g",,"4CXY",57.18,"2.65","2.65","Crystal structure of human FTO in complex with acylhydrazine inhibitor 21","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO","1","4CXY"
"4CY7",,"X-RAY DIFFRACTION",2.36,48,,4,"0.0375 M NA2SO4, PH 4.0",,"10.1021/bi500073z",,"4CY7",11.85,"1.4","1.4","Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form II","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","4CY7"
,,,,,,,,,,,,,,,,"FVNQHLCASHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","4CY7"
"4CYF",,"X-RAY DIFFRACTION",3.89,68.4,"VAPOR DIFFUSION, SITTING DROP",6.5,"PROTEIN WAS AT 12 MG/ML IN 50 MM BIS-TRIS PH 6.5 WITH 50 MM NACL. THE RESERVOIR WAS 21% PEG 1500 WITH 10% (V/V) MALATE-MES-TRIS BUFFER AT PH 6.3. 200 NL PLUS 200 NL DROPS IN SITTING DROP PLATES.",,"10.1107/S1399004714022767",,"4CYF",114.43,"2.25","2.25","The structure of vanin-1: defining the link between metabolic disease, oxidative stress and inflammation","ASISARDYKDDDDKQDTFIAAVYEHAAILPNATLTPVSREEALALMNRNLDILEGAITSAADQGAHIIVTPEDAIYGWNFNRDSLYPYLEDIPDPEVNWIPCNNRNRFGQTPVQERLSCLAKNNSIYVVANIGDKKPCDTSDPQCPPDGRYQYNTDVVFDSQGKLVARYHKQNLFMGENQFNVPKEPEIVTFNTTFGSFGIFTCFDILFHDPAVTLVKDFHVDTIVFPTAWMNVLPHLSAVEFHSAWAMGMRVNFLASNIHYPSKKMTGSGIYAPNSSRAFHYDMKTEEGKLLLSQLDSHPSHSAVVNWTSYASSIEALSSGNKEFKGTVFFDEFTFVKLTGVAGNYTVCQKDLCCHLSYKMSENIPNEVYALGAFDGLHTVEGRYYLQICTLLKCKTTNLNTCGDSAETASTRFEMFSLSGTFGTQYVFPEVLLSENQLAPGEFQVSTDGRLFSLKPTSGPVLTVTLFGRLYEKDWASNASSGLTAQARIIMLIVIAPIVCSLSW","Homo sapiens","VNN1","PANTETHEINASE","1","4CYF"
"4CYG",,"X-RAY DIFFRACTION",3.88,68.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"CRYSTALLIZATION CONDITIONS: PROTEIN AT 12 MG/ML IN 50 MM BIS-TRIS PH 6.5 WITH 50 MM NACL. RESERVOIR CONDITIONS WERE 21% PEG 1500 WITH 10% (V/V) MALATE-MES-TRIS BUFFER AT PH 6.3. DROPS WERE 200 NL PLUS 200 NL IN SITTING DROP PLATES AT 8C.",281,"10.1107/S1399004714022767",,"4CYG",115.21,"2.3","2.3","The structure of vanin-1: defining the link between metabolic disease, oxidative stress and inflammation","ASISARDYKDDDDKQDTFIAAVYEHAAILPNATLTPVSREEALALMNRNLDILEGAITSAADQGAHIIVTPEDAIYGWNFNRDSLYPYLEDIPDPEVNWIPCNNRNRFGQTPVQERLSCLAKNNSIYVVANIGDKKPCDTSDPQCPPDGRYQYNTDVVFDSQGKLVARYHKQNLFMGENQFNVPKEPEIVTFNTTFGSFGIFTCFDILFHDPAVTLVKDFHVDTIVFPTAWMNVLPHLSAVEFHSAWAMGMRVNFLASNIHYPSKKMTGSGIYAPNSSRAFHYDMKTEEGKLLLSQLDSHPSHSAVVNWTSYASSIEALSSGNKEFKGTVFFDEFTFVKLTGVAGNYTVCQKDLCCHLSYKMSENIPNEVYALGAFDGLHTVEGRYYLQICTLLKCKTTNLNTCGDSAETASTRFEMFSLSGTFGTQYVFPEVLLSENQLAPGEFQVSTDGRLFSLKPTSGPVLTVTLFGRLYEKDWASNASSGLTAQARIIMLIVIAPIVCSLSW","Homo sapiens","VNN1","PANTETHEINASE","1","4CYG"
"4CYH",,"X-RAY DIFFRACTION",2.63,53.18,,,,,"10.1021/bi960278x",,"4CYH",18.18,"2.1","2.1","CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE HIS-PRO","VNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","CYCLOPHILIN, PPIA, CYPA","CYCLOPHILIN A","1","4CYH"
"4CYY",,"X-RAY DIFFRACTION",3.91,68.6,"VAPOR DIFFUSION, SITTING DROP",6,"THE PROTEIN WAS AT 15 MG/ML. THE RESERVOIR CONDITIONS WERE 25% (W/V) PEG 1500 PLUS 10% (V/V) SUCCINATE-PHOSPHATE-GLYCINE BUFFER AT PH 6.0. THE PLATES WERE SET UP AT 8 C AND THE DROPS WERE 150 NL PLUS 150 NL IN SITTING DROP PLATES.",,"10.1107/S1399004714022767",,"4CYY",57.63,"2.89","2.89","The structure of vanin-1: defining the link between metabolic disease, oxidative stress and inflammation","ASISARDYKDDDDKQDTFIAAVYEHAAILPNATLTPVSREEALALMNRNLDILEGAITSAADQGAHIIVTPEDAIYGWNFNRDSLYPYLEDIPDPEVNWIPCNNRNRFGQTPVQERLSCLAKNNSIYVVANIGDKKPCDTSDPQCPPDGRYQYNTDVVFDSQGKLVARYHKQNLFMGENQFNVPKEPEIVTFNTTFGSFGIFTCFDILFHDPAVTLVKDFHVDTIVFPTAWMNVLPHLSAVEFHSAWAMGMRVNFLASNIHYPSKKMTGSGIYAPNSSRAFHYDMKTEEGKLLLSQLDSHPSHSAVVNWTSYASSIEALSSGNKEFKGTVFFDEFTFVKLTGVAGNYTVCQKDLCCHLSYKMSENIPNEVYALGAFDGLHTVEGRYYLQICTLLKCKTTNLNTCGDSAETASTRFEMFSLSGTFGTQYVFPEVLLSENQLAPGEFQVSTDGRLFSLKPTSGPVLTVTLFGRLYEKDWASNASSGLTAQARIIMLIVIAPIVCSLSW","Homo sapiens","VNN1","PANTETHEINASE","1","4CYY"
"4D01",,"X-RAY DIFFRACTION",2.4,51,,7.5,"100 MM SPG BUFFER PH 6.5, 25% PEG 3350",,"10.1038/nsmb.2900",,"4D01",26,"1.795","1.795","Crystal Structure of the Extracellular Domain of the Human Alpha9 Nicotinic Acetylcholine Receptor","ADGKYAQKLFNDLFEDYSNALRPVEDTDKVLNVTLQITLSQIKDMDERNQILTAYLWIRQIWHDAYLTWDRDQYDGLDSIRIPSDLVWRPDIVLYNKADDESSEPVNTNVVLRYDGLITWDAPAITKSSCVVDVTYFPFDNQQCNLTFGSWTYNGNQVDIFNALDSGDLSDFIEDVEWEVHGMPAVKNVISYGCCSEPYPDVTFTLLLKRRSHHHHHH","Homo sapiens","CHRNA9, NACHRA9","NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-9","1","4D01"
"4D08",,"X-RAY DIFFRACTION",2.33,47.3,,8.2,"0.2 M MAGNESIUM CHLORIDE, 0.1 M HEPES PH8.2, 20% PEG3350.",,"10.1021/ml500262u","Q2T","4D08",167.82,"1.9","1.9","PDE2a catalytic domain in complex with a brain penetrant inhibitor","MGSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYERHHHHHH","Homo sapiens","PDE2A","CGMP-DEPENDENT 3', 5'-CYCLIC PHOSPHODIESTERASE","1","4D08"
"4D09",,"X-RAY DIFFRACTION",2.3,46.4,,7,"0.2 M MGCL2, 0.1 M TRIS-HCL PH 7.0 AND 20 % PEG 3350 IN PRESENCE OF 1 MM LIGAND",,"10.1021/ml500262u","788","4D09",167.66,"2.5","2.5","PDE2a catalytic domain in complex with a brain penetrant inhibitor","MGSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYERHHHHHH","Homo sapiens","PDE2A","CGMP-DEPENDENT 3', 5'-CYCLIC PHOSPHODIESTERASE","1","4D09"
"4D0E",,"X-RAY DIFFRACTION",2.23,44.82,,6,"pH 6.0",,"10.1073/pnas.1319683111",,"4D0E",15.39,"1.61","1.61","Human Notch1 EGF domains 11-13 mutant GlcNAc-fucose disaccharide modified at T466","SAQDVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGPRCEIDVNECVSNPCQNDATCLDQIGEFQCICMPGYEGVHCEVNTDECASSPCLHNGRCLDKINEFQCECPTGFTGHLCQVDLHHILDAQKMVWNHR","Homo sapiens","NOTCH1, TAN1","NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1","1","4D0E"
"4D0F",,"X-RAY DIFFRACTION",2.42,49.23,,4.5,"pH 4.5",,"10.1073/pnas.1319683111",,"4D0F",15.01,"2.8","2.8","Human Notch1 EGF domains 11-13 mutant T466A","SAQDVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGPRCEIDVNECVSNPCQNDAACLDQIGEFQCICMPGYEGVHCEVNTDECASSPCLHNGRCLDKINEFQCECPTGFTGHLCQVDLHHILDAQKMVWNHR","Homo sapiens","NOTCH1, TAN1","NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1","1","4D0F"
"4D0O",,"X-RAY DIFFRACTION",2.41,49,,5.5,"0.2 M AMMONIUM SULPHATE, 0.1 M BIS-TRIS PH 5.5, 25% (W/V) PEG 3350",,"10.1042/BJ20140606",,"4D0O",57.52,"2.75","2.75","AKAP13 (AKAP-Lbc) DH domain","ENLYFQSMEAESWSRIIDSKFLKQQKKDVVKRQEVIYELMQTEFHHVRTLKIMSGVYSQGMMADLLFEQQMVEKLFPCLDELISIHSQFFQRILERKKESLVDKSEKNFLIKRIGDVLVNQFSGENAERLKKTYGKFCGQHNQSVNYFKDLYAKDKRFQAFVKKKMSSSVVRRLGIPECILLVTQRITKYPVLFQRILQCTKDNEVEQEDLAQSLSLVKDVIGAVDSKVASYEKKVRLNEIYTK","Homo sapiens","AKAP13, BRX, HT31, LBC","A-KINASE ANCHOR PROTEIN 13","1","4D0O"
"4D0P",,"X-RAY DIFFRACTION",3.03,0.59,"VAPOR DIFFUSION",7.5,"16 MG/ML PROTEIN IN 50 MM HEPES PH 7.4, 200 MM NACL, 2 MM DTT WAS MIXED EQUALLY WITH 100 MM HEPES PH 7.5, 4.3 M NACL. CRYSTALS WERE GROWN BY VAPOR DIFFUSION",,"10.1038/nature13566",,"4D0P",44.58,"1.6","1.6","Crystal structure of human CSN4","MASWSHPQFEKVDEENLYFQGGGRMAAAVRQDLAQLMNSSGSHKDLAGKYRQILEKAIQLSGAEQLEALKAFVEAMVNENVSLVISRQLLTDFCTHLPNLPDSTAKEIYHFTLEKIQPRVISFEEQVASIRQHLASIYEKEEDWRNAAQVLVGIPLETGQKQYNVDYKLETYLKIARLYLEDDDPVQAEAYINRASLLQNESTNEQLQIHYKVCYARVLDYRRKFIEAAQRYNELSYKTIVHESERLEALKHALHCTILASAGQQRSRMLATLFKDERCQQLAAYGILEKMYLDRIIRGNQLQEFAAMLMPHQKATTADGSSILDRAVIEHNLLSASKLYNNITFEELGALLEIPAAKAEKIASQMITEGRMNGFIDQIDGIVHFET","Homo sapiens","COPS4, CSN4","COP9 SIGNALOSOME COMPLEX SUBUNIT 4","1","4D0P"
"4D0W",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION",7,"1.5-2.2 M SODIUM MALONATE PH 7 VAPOUR DIFFUSION TECHNIQUE 293 K",293,"10.1016/j.bmc.2014.06.025","VVQ","4D0W",35.62,"1.77","1.77","Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors","AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","TYROSINE-PROTEIN KINASE JAK2","1","4D0W"
"4D0X",,"X-RAY DIFFRACTION",2.29,46,"VAPOR DIFFUSION",7,"1.5-2.2 M SODIUM MALONATE PH 7 VAPOUR DIFFUSION 293 K",293,"10.1016/j.bmc.2014.06.025","953","4D0X",35.67,"1.82","1.82","Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors","AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","TYROSINE-PROTEIN KINASE JAK2","1","4D0X"
"4D1E",,"X-RAY DIFFRACTION",3.48,64.65,,,"0.2 M MG FORMATE 5% PEG SMEAR, 0.01 M EDTA",,"10.1016/j.cell.2014.10.056",,"4D1E",101.85,"3.5","3.5","THE CRYSTAL STRUCTURE OF HUMAN MUSCLE ALPHA-ACTININ-2","YMIQEEEWDRDLLLDPAWEKQQRKTFTAWCNSHLRKAGTQIENIEEDFRNGLKLMLLLEVISGERLPKPDRGKMRFHKIANVNKALDYIASKGVKLVSIGAEEIVDGNVKMTLGMIWTIILRFAIQDISVEETSAKEGLLLWCQRKTAPYRNVNIQNFHTSWKDGLGLCALIHRHRPDLIDYSKLNKDDPIGNINLAMEIAEKHLDIPKMLDAEDIVNTPKPDERAIMTYVSCFYHAFAGAEQAETAANRICKVLAVNQENERLMEEYERLASELLEWIRRTIPWLENRTPAATMQAMQKKLEDFRDYRRKHKPPKVQEKCQLEINFNTLQTKLRISNRPAFMPSEGKMVSDIAGAWQRLEQAEKGYEEWLLNEIRRLERLEHLAEKFRQKASTHETWAYGKEQILLQKDYESASLTEVRALLRKHEAFESDLAAHQDRVEQIAAIAQELNELDYHDAVNVNDRCQKICDQWDRLGTLTQKRREALERMEKLLETIDQLHLEFAKRAAPFNNWMEGAMEDLQDMFIVHSIEEIQSLITAHEQFKATLPEADGERQSIMAIQNEVEKVIQSYNIRISSSNPYSTVTMDELRTKWDKVKQLVPIRDQSLQEELARQHANERLRRQFAAQANAIGPWIQNKMEEIARSSIQITGALEDQMNQLKQYEHNIINYKNNIDKLEGDHQLIQEALVFDNKHTNYTMEHIRVGWELLLTTIARTINEVETQILTRDAKGITQEQMNEFRASFNHFDRRKNGLMDHEDFRACLISMGYDLGEAEFARIMTLVDPNGQGTVTFQSFIDFMTRETADTDTAEQVIASFRILASDKPYILAEELRRELPPDQAQYCIKRMPAYSGPGSVPGALDYAAFSSALYGESDL","Homo sapiens","ACTN2","ALPHA-ACTININ-2","1","4D1E"
"4D1N",,"X-RAY DIFFRACTION",3.22,61.8,,5,"11-13% PEG3350, 50MM CITRIC ACID 50MM BIS-TRIS-PROPANE, 10% GLYCEROL, 5 MM TCEP, pH 5.0",,"10.1107/S1399004714017064",,"4D1N",199.53,"2.03","2.03","Structure of human nNOS heme domain with L-Arg bound","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVW","Homo sapiens","NOS1","NITRIC OXIDE SYNTHASE, BRAIN","1","4D1N"
"4D1O",,"X-RAY DIFFRACTION",2.69,54.3,,7.5,"10-12% PEG3350, 0.1M BIS TRIS, PH7.5, 0.3M MG ACETATE, 0.1M GDCL3, 5 MM TCEP",,"10.1107/S1399004714017064",,"4D1O",102.37,"1.819","1.819","Structure of human endothelial nitric oxide synthase heme domain with L-Arg bound","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","NITRIC OXIDE SYNTHASE, ENDOTHELIAL","1","4D1O"
"4D1P",,"X-RAY DIFFRACTION",2.69,54.3,,7.5,"10-12% PEG3350 0.1M BIS TRIS, PH7.5 0.3M MG ACETATE, 0.1M GDCL3, 5 MM TCEP",,"10.1107/S1399004714017064","Q16","4D1P",102.67,"1.731","1.731","Structure of human endothelial nitric oxide synthase heme domain IN COMPLEX WITH 6-((((3S, 5R)-5-(((6-AMINO-4-METHYLPYRIDIN-2-YL)METHOXY) METHYL)PYRROLIDIN-3-YL)OXY) METHYL)-4-METHYLPYRIDIN-2-AMINE","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","NITRIC OXIDE SYNTHASE, ENDOTHELIAL","1","4D1P"
"4D1S",,"X-RAY DIFFRACTION",2.65,54,"VAPOR DIFFUSION",,"1.5-2.2 M SODIUM MALONATE PH 7, VAPOUR DIFFUSION 293 K",293,"10.1016/j.bmc.2014.06.025","BJG","4D1S",35.71,"1.66","1.66","Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors","AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","TYROSINE-PROTEIN KINASE JAK2","1","4D1S"
"4D1X",,"X-RAY DIFFRACTION",2.05,39.98,,,"10 MM HEPES, 20 MM NACL, PH 7.4",,"10.1016/j.ejmech.2015.02.035",,"4D1X",34.26,"2.1","2.1","CDK2 in complex with Luciferin","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CYCLIN-DEPENDENT KINASE 2","1","4D1X"
"4D1Z",,"X-RAY DIFFRACTION",2.1,41.41,,,"0 MM HEPES, 20 MM NACL, PH 7.4",,"10.1016/j.ejmech.2015.02.035",,"4D1Z",34.53,"1.851","1.851","CDK2 in complex with a Luciferin derivate","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CYCLIN-DEPENDENT KINASE 2","1","4D1Z"
"4D2H",,"X-RAY DIFFRACTION",1.86,36.3,,,"200 MM LITHIUM SULPHATE, 100 MM SODIUM ACETATE PH 3.6, 32% (V/V) PEG 400",,"10.1038/nsmb.2937",,"4D2H",37.44,"1.9","1.9","Crystal structure of the tetramerisation domain of human CtIP","GSMSDFKDLWTKLKECHDREVQGLQVKVTKLKQERILD","Homo sapiens","RBBP8, CTIP","RBBP8","1","4D2H"
"4D2N",,"X-RAY DIFFRACTION",2.7,54.7,,7,"CRYSTALS WERE GROWN AT 291K USING A RESERVOIR OF 100MM BIS-TRIS PROPANE PH7.5, 20% PEG 3350 AND 200MM SODIUM CITRATE, AND A PROTEIN CONCENTRATION OF 6MG/ML.",291,"10.1016/j.molimm.2014.05.015",,"4D2N",101.89,"2.7","2.7","Crystal structure of deglycosylated serum-derived human IgG4 Fc","YGPPCPSCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFDSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLGK","Homo sapiens","IGHG4","IG GAMMA-4 CHAIN C REGION","1","4D2N"
"4D2P",,"X-RAY DIFFRACTION",2.26,46,,,,,"10.1021/ml5001245",,"4D2P",165.07,"2.55","2.55","Structure of MELK in complex with inhibitors","MGSSHHHHHHSSGLVPRGSHMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQACCGALAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDTAAALVAKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSS","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4D2P"
"4D2R",,"X-RAY DIFFRACTION",2.41,48.86,"VAPOR DIFFUSION",,"20% PEF3350, 0.2M MGCL2, 0.1M PCTP PH 7.5",,"10.1021/acs.jmedchem.5b00098","DYK","4D2R",35.05,"2.1","2.1","Human IGF in complex with a Dyrk1B inhibitor","DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK","Homo sapiens","IGF1R","INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR","1","4D2R"
"4D2S",,"X-RAY DIFFRACTION",3.33,63.05,"VAPOR DIFFUSION",,"18% PEG3350, 5% ETHANOL, 0.1M NA CITRATE PH 6",,"10.1021/acs.jmedchem.5b00098","DYK","4D2S",33.09,"2.5","2.5","Human TTK in complex with a Dyrk1B inhibitor","GAANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4D2S"
"4D2T",,"X-RAY DIFFRACTION",2.26,46,,,,,"10.1021/ml5001245",,"4D2T",164.85,"2.7","2.7","Structure of MELK in complex with inhibitors","MGSSHHHHHHSSGLVPRGSHMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQACCGALAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDTAAALVAKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSS","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4D2T"
"4D2V",,"X-RAY DIFFRACTION",2.26,46,,,,,"10.1021/ml5001245",,"4D2V",164.96,"2.45","2.45","Structure of MELK in complex with inhibitors","MGSSHHHHHHSSGLVPRGSHMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQACCGALAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDTAAALVAKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSS","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4D2V"
"4D2W",,"X-RAY DIFFRACTION",2.26,46,,,,,"10.1021/ml5001245","NF5","4D2W",164.89,"1.92","1.92","Structure of MELK in complex with inhibitors","MGSSHHHHHHSSGLVPRGSHMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQACCGALAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDTAAALVAKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSS","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4D2W"
"4D3P",,"X-RAY DIFFRACTION",2.27,45.96,,,"1.8M AMMONIUM SULFATE",,,,"4D3P",16.4,"1.27","1.27","crystal structure of point mutated DUSP19 (C150A)","GSHMASQVGVIKPWLLLGSQDAAHDLDTLKKNKVTHILNVAYGVENAFLSDFTYKSISILDLPETNILSYFPECFEFIEEAKRKDGVVLVHANAGVSRAAAIVIGFLMNSEQTSFTSAFSLVKNARPSICPNSGFMEQLRTYQEGKE","Homo sapiens","DUSP19, DUSP17, LMWDSP3, SKRP1","DUAL SPECIFICITY PROTEIN PHOSPHATASE 19","1","4D3P"
"4D3Q",,"X-RAY DIFFRACTION",3.33,63.12,,,"0.2M POTASSIUM SODIUM TARTRATE TETRAHYDRATE, 0.1M SODIUM CITRATE TRIBASIC DEHYDRATE (PH 5.6), 2.0M AMMONIUM SULFATE",,,,"4D3Q",32.46,"1.64","1.64","crystal structure of point mutated DUSP19 (R156A)","GSHMASQVGVIKPWLLLGSQDAAHDLDTLKKNKVTHILNVAYGVENAFLSDFTYKSISILDLPETNILSYFPECFEFIEEAKRKDGVVLVHSNAGVSAAAAIVIGFLMNSEQTSFTSAFSLVKNARPSICPNSGFMEQLRTYQEGKE","Homo sapiens","DUSP19, DUSP17, LMWDSP3, SKRP1","DUAL SPECIFICITY PROTEIN PHOSPHATASE 19","1","4D3Q"
"4D3R",,"X-RAY DIFFRACTION",2.18,43.52,,,"1.9M AMMONIUM SULFATE",,,,"4D3R",15.57,"1.67","1.67","Crystal structure of point mutated DUSP19 (I187A)","QVGVIKPWLLLGSQDAAHDLDTLKKNKVTHILNVAYGVENAFLSDFTYKSISILDLPETNILSYFPECFEFIEEAKRKDGVVLVHSNAGVSRAAAIVIGFLMNSEQTSFTSAFSLVKNARPSACPNSGFMEQLRTYQEGK","Homo sapiens","DUSP19, DUSP17, LMWDSP3, SKRP1","DUAL SPECIFICITY PROTEIN PHOSPHATASE 19","1","4D3R"
"4D4J",,"X-RAY DIFFRACTION",3.76,67.3,,,,,,,"4D4J",52.87,"3","3","human PFKFB3 in complex with a pyrrolopyrimidone compound","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDA","Homo sapiens","PFKFB3","6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3","1","4D4J"
"4D4K",,"X-RAY DIFFRACTION",3.77,67.37,,,,,,,"4D4K",52.82,"3.24","3.24","human PFKFB3 in complex with a pyrrolopyrimidone compound","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDA","Homo sapiens","PFKFB3","6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3","1","4D4K"
"4D4L",,"X-RAY DIFFRACTION",3.72,66.98,,,,,,,"4D4L",52.83,"3.16","3.16","human PFKFB3 in complex with a pyrrolopyrimidone compound","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDA","Homo sapiens","PFKFB3","6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3","1","4D4L"
"4D4M",,"X-RAY DIFFRACTION",3.76,67.3,,,,,,,"4D4M",52.96,"2.32","2.32","human PFKFB3 in complex with a pyrrolopyrimidone compound","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDA","Homo sapiens","PFKFB3","6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3","1","4D4M"
"4D4W",,"SOLUTION NMR",,,,,,,"10.1007/s10858-015-9986-8",,"4D4W",6.69,,,"Solution structure of human MBD1 CXXC1 domain","GPLGSEQRMFKRVGCGECAACQVTEDCGACSTCLLQLPHDVASGLFCKCERRRCLRIVERS","Homo sapiens","MBD1, CXXC3, PCM1","METHYL-CPG-BINDING DOMAIN PROTEIN 1","1","4D4W"
"4D4Z",,"X-RAY DIFFRACTION",2.49,51,,7.2,"30% POLYETHYLENE GLYCOL 6000 (W/V), 100 MM BIS-TRIS PROPANE PH 7.2 - 7.4, 15% GLYCEROL",,"10.1016/j.str.2015.03.002",,"4D4Z",64.71,"1.7","1.7","STRUCTURE OF HUMAN DEOXYHYPUSINE HYDROXYLASE in complex with glycerol","GPLGSMVTEQEVDAIGQTLVDPKQPLQARFRALFTLRGLGGPGAIAWISQAFDDDSALLKHELAYCLGQMQDARAIPMLVDVLQDTRQEPMVRHEAGEALGAIGDPEVLEILKQYSSDPVIEVAETCQLAVRRLEWLQQHGGEPAAGPYLSVDPAPPAEERDVGRLREALLDESRPLFERYRAMFALRNAGGEEAALALAEGLHCGSALFRHEVGYVLGQLQHEAAVPQLAAALARCTENPMVRHECAEALGAIARPACLAALQAHADDPERVVRESCEVALDMYEHETGRAFQ","Homo sapiens","DOHH, HLRC1","DEOXYHYPUSINE HYDROXYLASE","1","4D4Z"
"4D50",,"X-RAY DIFFRACTION",2.14,42,,7.2,"30% POLYETHYLENE GLYCOL 6000 (W/V), 100 MM BIS-TRIS PROPANE PH 7.2 - 7.4, 400 MM GUANIDINE CHLORIDE",,"10.1016/j.str.2015.03.002",,"4D50",64.57,"1.7","1.7","Structure of human deoxyhypusine hydroxylase","GPLGSMVTEQEVDAIGQTLVDPKQPLQARFRALFTLRGLGGPGAIAWISQAFDDDSALLKHELAYCLGQMQDARAIPMLVDVLQDTRQEPMVRHEAGEALGAIGDPEVLEILKQYSSDPVIEVAETCQLAVRRLEWLQQHGGEPAAGPYLSVDPAPPAEERDVGRLREALLDESRPLFERYRAMFALRNAGGEEAALALAEGLHCGSALFRHEVGYVLGQLQHEAAVPQLAAALARCTENPMVRHECAEALGAIARPACLAALQAHADDPERVVRESCEVALDMYEHETGRAFQ","Homo sapiens","DOHH, HLRC1","DEOXYHYPUSINE HYDROXYLASE","1","4D50"
"4D6A",,"X-RAY DIFFRACTION",2.79,55.84,,,,,"10.1371/journal.pone.0128954",,"4D6A",15.66,"1.45","1.45","Human myelin protein P2 after neutron scattering experiments","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","MYELIN P2 PROTEIN","1","4D6A"
"4D6B",,"X-RAY DIFFRACTION",3.5,64.91,,,,,"10.1371/journal.pone.0128954",,"4D6B",15.78,"2.116","2.116","Human myelin protein P2, mutant P38G","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKGTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","MYELIN P2 PROTEIN","1","4D6B"
"4D6K",,"X-RAY DIFFRACTION",2.47,50,"VAPOR DIFFUSION",4.6,"100 MM SODIUM ACETATE PH 4.6 14% PROPAN-2-OL",295,"10.1093/nar/gkv068",,"4D6K",62.55,"2.1","2.1","Structure of DNTTIP1 dimerisation domain.","MTTSFTDPAISMDLLRAVLQPSINEEIQTVFNKYMKFFQKAALNVRDNVGEEVDAEQLIQEACRSCLEQAKLLFSDGEKVIPRLTHELPGIK","Homo sapiens","DNTTIP1, C20orf167, TDIF1","DEOXYNUCLEOTIDYLTRANSFERASE TERMINAL-INTERACTING PROTEIN 1","1","4D6K"
"4D6Q",,"X-RAY DIFFRACTION",2.47,50.24,,7,"27% PEG3350 -- 0.1M HEPES PH 7.0 -- 0.25M AMMONIUM SULFATE",,,"PD2","4D6Q",40.28,"1.292","1.292","crystal structure of human JMJD2D in complex with 2,4-PDCA","SMETMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","LYSINE-SPECIFIC DEMETHYLASE 4D","1","4D6Q"
"4D6R",,"X-RAY DIFFRACTION",2.47,50.24,,7,"28% PEG3350, 0.1M HEPES PH 7.0, 0.2M AMMONIUM SULFATE",,,,"4D6R",40.61,"1.398","1.398","crystal structure of human JMJD2D in complex with N-OXALYLGLYCINE and bound o-toluenesulfonamide","SMETMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","LYSINE-SPECIFIC DEMETHYLASE 4D","1","4D6R"
"4D6S",,"X-RAY DIFFRACTION",2.47,50.24,,7,"28% PEG3350, 0.1M HEPES PH 7.0, 0.25M AMMONIUM SULFATE",,,,"4D6S",40.79,"1.4","1.4","crystal structure of human JMJD2D in complex with N-OXALYLGLYCINE and bound 5,6-Dimethylbenzimidazole","SMETMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","LYSINE-SPECIFIC DEMETHYLASE 4D","1","4D6S"
"4D6Z",,"X-RAY DIFFRACTION",2.55,51.8,,7,"CONDITION A3 FROM THE MORPHEUS CRYSTALLIZATION KIT (MOLECULAR DIMENSIONS), pH 7",,"10.1021/acs.jmedchem.5b01146","PK9","4D6Z",57.02,"1.93","1.93","Cytochrome P450 3A4 bound to imidazole and an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSAETASHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","CYTOCHROME P450 3A4","1","4D6Z"
"4D75",,"X-RAY DIFFRACTION",2.53,51.4,"VAPOR DIFFUSION, SITTING DROP",7,"VAPOR DIFFUSION SITTING DROP AGAINST 80% OF THE E3 SOLUTION FROM MORPHEUS CRYSTALLIZATION KIT (MOLECULAR DIMENSIONS), PH 7",,"10.1021/acs.jmedchem.5b01146","PK9","4D75",56.58,"2.25","2.25","Cytochrome P450 3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSAETASHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","CYTOCHROME P450 3A4","1","4D75"
"4D76",,"X-RAY DIFFRACTION",2.79,55.86,,8.5,"2M AMMONIUM SULFATE, 0.1M TRIS-CL PH 8.5, 0.2M NACL",,,,"4D76",27.8,"1.77","1.77","Human FXIa in complex with small molecule inhibitors.","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","COAGULATION FACTOR XI","1","4D76"
"4D78",,"X-RAY DIFFRACTION",2.38,48.3,"MICROBATCH",5,"MICROBATCH UNDER OIL WITH 10% PEG 3350 AND 80 MM SODIUM MALONATE PH 5.0",,"10.1021/acs.jmedchem.5b01146","J9K","4D78",56.99,"2.8","2.8","Cytochrome P450 3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","CYTOCHROME P450 3A4","1","4D78"
"4D7B",,"X-RAY DIFFRACTION",2.18,43.6,,,,,"10.1038/ncomms10787","TCW","4D7B",28.36,"1.15","1.15","Structure of human transthyretin in complex with Tolcapone","MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","4D7B"
"4D7D",,"X-RAY DIFFRACTION",2.53,51.47,"MICROBATCH",5,"MICROBATCH UNDER OIL WITH 11% PEG 3350 AND 60 MM SODIUM MALONATE PH 5.0",,"10.1021/acs.jmedchem.5b01146","PKT","4D7D",56.84,"2.76","2.76","Cytochrome P450 3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","CYTOCHROME P450 3A4","1","4D7D"
"4D7F",,"X-RAY DIFFRACTION",2.78,55.74,,8.5,"2M AMMONIUM SULFATE, 0.1M TRIS-CL PH 8.5, 0.2M NACL",,,,"4D7F",27.69,"1.62","1.62","Human FXIa in complex with small molecule inhibitors.","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","COAGULATION FACTOR XI","1","4D7F"
"4D7G",,"X-RAY DIFFRACTION",2.75,55.34,,8.5,"2M AMMONIUM SULFATE, 0.1M TRIS-CL PH 8.5, 0.2M NACL",,,,"4D7G",28.36,"2.33","2.33","Human FXIa in complex with small molecule inhibitors.","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","COAGULATION FACTOR XIA","1","4D7G"
"4D83",,"X-RAY DIFFRACTION",3.05,59.69,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.0M ammonium sulfate in water, pH 5.5, vapor diffusion, hanging drop, temperature 292K",292,"10.1021/jm300069y","0GT","4D83",135.85,"2.4","2.4","Crystal Structure of Human Beta Secretase in Complex with NVP-BUR436, derived from a co-crystallization experiment","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4D83"
"4D85",,"X-RAY DIFFRACTION",2.86,57,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M sodium citrate pH 6.5, 0.2M sodium iodide, 25% PEG MME 5,000, vapor diffusion, hanging drop, temperature 292K",292,"10.1021/jm300069y","0GU","4D85",46.13,"2.65","2.65","Crystal Structure of Human Beta Secretase in Complex with NVP-BVI151","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4D85"
"4D86",,"X-RAY DIFFRACTION",2.27,45.8,"VAPOR DIFFUSION, SITTING DROP",,"23% PEG3350, 0.14M NaSCN, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2012.12.019","ADP","4D86",45.56,"2","2","Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphate","SMGGSPAGQKCFSRTVLAPGVVLIVQQGDLARLPVDVVVNASNEDLKHYGGLAAALSKAAGPELQADCDQIVKREGRLLPGNATISKAGKLPYHHVIHAVGPRWSGYEAPRCVYLLRRAVQLSLCLAEKYKYRSIAIPAISSGVFGFPLGRCVETIVSAIKENFQFKKDGHCLKEIYLVDVSEKTVEAFAEAVKTVFKATLPDTAAPPGLPPAAAGPGKTSWEKGSLVSPGGLQMLLVKEGVQNAKTDVVVNSVPLDLVLSRGPLSKSLLEKAGPELQEELDTVGQGVAVSMGTVLKTSSWNLDCRYVLHVVAPEWRNGSTSSLKIMEDIIRECMEITESLSLKSIAFPAIGTGNLGFPKNIFAELIISEVFKFSSKNQLKTLQEVHFLLHPSDHENIQAFSDEFARRANGNLVS","Homo sapiens","BAL2, KIAA1268, PARP14","Poly [ADP-ribose] polymerase 14","1","4D86"
"4D88",,"X-RAY DIFFRACTION",2.14,42.45,"VAPOR DIFFUSION, HANGING DROP",5.2,"15% PEG 1,500 in water, pH 5.2, vapor diffusion, hanging drop, temperature 292K",292,"10.1021/jm300069y","BXQ","4D88",45.32,"1.7","1.7","Crystal Structure of Human Beta Secretase in Complex with NVP-BXQ490","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4D88"
"4D89",,"X-RAY DIFFRACTION",2.04,39.66,"VAPOR DIFFUSION, HANGING DROP",5.2,"15% PEG 1,500, in water, pH 5.2, vapor diffusion, hanging drop, temperature 292K",292,"10.1021/jm300069y","BXD","4D89",45.37,"1.65","1.65","Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a soaking experiment","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4D89"
"4D8C",,"X-RAY DIFFRACTION",3.08,60.1,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.0M ammonium sulfate in water, pH 5.5, vapor diffusion, hanging drop, temperature 292K",292,"10.1021/jm300069y","BXD","4D8C",136.3,"2.07","2.07","Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a co-crystallization experiment","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4D8C"
"4D8K",,"X-RAY DIFFRACTION",2.81,56.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.5M lithium sulfate, 0.1M HEPES pH 7.5, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4D8K",19.87,"2.36","2.36","Crystal structure of a SH3-SH2 domains of a lymphocyte-specific protein tyrosine kinase (LCK) from Homo sapiens at 2.36 A resolution","GGSNPPASPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKANSLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISPRITFPGLHELVRHYTNASDGLCTRLSRPCQT","Homo sapiens","BC013200, LCK","Tyrosine-protein kinase Lck","1","4D8K"
"4D8N",,"X-RAY DIFFRACTION",2.22,44.5,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.05 M Tris-HCl pH8.5, 8% PEG4000 and 10 mM benzamidine, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2012.02.014","0HM","4D8N",24.83,"1.68","1.68","Human Kallikrein 6 Inhibitors with a para-Amidobenzylanmine P1 Group Carry a High Binding Efficiency","LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQAK","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","4D8N"
"4D8O",,"X-RAY DIFFRACTION",2.18,43.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG3350, 0.2M ammonium acetate, 5% n-Octyl-beta-D-glucoside, pH 7.5, vapor diffusion, hanging drop, temperature 289K",289,"10.1073/pnas.1200613109",,"4D8O",66.14,"2.203","2.203","Crystal Structure of the ankyrin-B ZU5-ZU5-UPA-DD tandem","MHHHHHHSSGLEVLFQGPEFSGFLVSFMVDARGGAMRGCRHNGLRIIIPPRKCTAPTRVTCRLVKRHRLATMPPMVEGEGLASRLIEVGPSGAQFLGPVIVEIPHFAALRGKERELVVLRSENGDSWKEHFCDYTEDELNEILNGMDEVLDSPEDLEKKRICRIITRDFPQYFAVVSRIKQDSNLIGPEGGVLSSTVVPQVQAVFPEGALTKRIRVGLQAQPMHSELVKKILGNKATFSPIVTLEPRRRKFHKPITMTIPVPKASGDAPTLRLLCSITGGTTPAQWEDITGTTPLTFVNECVSFTTNVSARFWLIDCRQIQESVTFASQVYREIICVPYMAKFVVFAKSHDPIEARLRCFCMTDDKVDKTLEQQENFAEVARSRDVEVLEGKPIYVDCFGNLVPLTKSGQHHIFSFFAFKENRLPLFVKVRDTTQEPCGRLSFMKEPKSTRGLVHQAICNLNITLPIYTKESESDQEQEEEIDMTSEKNPQDEQERIEERLAYIADHLGFSWTELARELDFTEEQIHQIRIENPNSLQDQSHALLKYWLERDGKHATDTNLVECLTKINRMDIVHLMETNT","Homo sapiens","ANK2","Ankyrin-2","1","4D8O"
,,,,,,,,,,,,,,,,,"Homo sapiens","ANK2"
"4D90",,"X-RAY DIFFRACTION",3.65,66.32,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 mM sodium acetate, 30% PEG 4000, 200 mM ammonium acetate, pH 4.6, vapor diffusion, hanging drop, temperature 298K",298,"10.1096/fj.11-202036",,"4D90",31.78,"2.601","2.601","Crystal Structure of Del-1 EGF domains","DICDPNPCENGGICLPGLADGSFSCECPDGFTDPNCSSVVEVASDEEEPTSAGPCTPNPCHNGGTCEISEAYRGDTFIGYVCKCPRGFNGIHCQHNINECEVEPCKNGGICTDLVANYSCECPGEFMGRNCQYKGGGHHHHHH","Homo sapiens","del-1, DEL1, EDIL3","EGF-like repeat and discoidin I-like domain-containing protein 3","1","4D90"
"4D9T",,"X-RAY DIFFRACTION",2.08,40.97,"hanging drop",8.5,"100mM Tris, pH 8.5, 25% PEG 3350, hanging drop, temperature 298K",298,"10.1038/nchembio.925",,"4D9T",38.89,"2.4","2.4","Rsk2 C-terminal Kinase Domain with inhibitor (E)-methyl 3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)-2-cyanoacrylate","MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGIKKITSTAL","Homo sapiens","ISPK1, MAPKAPK1B, RPS6KA3, RSK2","Ribosomal protein S6 kinase alpha-3","1","4D9T"
"4D9U",,"X-RAY DIFFRACTION",2.08,40.75,"hanging drop",8.5,"100mM Tris, pH 8.5, 25% PEG 3350, hanging drop, temperature 298K",298,"10.1038/nchembio.925",,"4D9U",38.94,"2.4","2.4","Rsk2 C-terminal Kinase Domain, (E)-tert-butyl 3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)-2-cyanoacrylate","MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGIKKITSTAL","Homo sapiens","ISPK1, MAPKAPK1B, RPS6KA3, RSK2","Ribosomal protein S6 kinase alpha-3","1","4D9U"
"4DA1",,"X-RAY DIFFRACTION",3.22,61.83,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris, 19% PEG3350, 0.2 M Magnesium chloride, 20 mM beta-mercaptoethanol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M111.314963",,"4DA1",43.65,"2.383","2.383","Crystal structure of branched-chain alpha-ketoacid dehydrogenase phosphatase with Mg (II) ions at the active site","GHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLMEAFAKRQGKEMDSLRFLYDGIRIQADQAPEDLDMEDNDIIEAHREQIGGENLYFQAGKPIPKISLENVGCASQIGKRKENEDRFDFAQLTDEVLYFAVYDGHGGPAAADFCHTHMEKCIMDLLPKEKNLETLLTLAFLEIDKAFSSHARLSADATLLTSGTTATVALLRDGIELVVASVGDSRAILCRKGKPMKLTIDHTPERKDEKERIKKCGGFVAWNSLGQPHVNGRLAMTRSIGDLDLKTSGVIAEPETKRIKLHHADDSFLVLTTDGINFMVNSQEICDFVNQCHDPNEAAHAVTEQAIQYGTEDNSTAVVVPFGAWGKYKNSEINFS","Homo sapiens","PPM1K, PP2CM","Protein phosphatase 1K, mitochondrial","1","4DA1"
"4DA5",,"X-RAY DIFFRACTION",2.14,42.49,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M bis-Tris (pH 6.5), 25% polyethylene glycol 3350, and 0.1 M magnesium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bbapap.2013.02.008","0H7","4DA5",105.56,"2.4","2.4","Choline Kinase alpha acts through a double-displacement kinetic mechanism involving enzyme isomerisation, as determined through enzyme and inhibitor kinetics and structural biology","MKTKFCTGGEAEPSPLGLLLSCGSGSAAPAPGVGQQRDAASDLESKQLGGQQPPLALPPPPPLPLPLPLPQPPPPQPPADEQPEPRTRRRAYLWCKEFLPGAWRGLREDEFHISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSLGPKLYGIFPQGRLEQFIPSRRLDTEELSLPDISAEIAEKMATFHGMKMPFNKEPKWLFGTMEKYLKEVLRIKFTEESRIKKLHKLLSYNLPLELENLRSLLESTPSPVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWMYDYSYEKYPFFRANIRKYPTKKQQLHFISSYLPAFQNDFENLSTEEKSIIKEEMLLEVNRFALASHFLWGLWSIVQAKISSIEFGYMDYAQARFDAYFHQKRKLGV","Homo sapiens","CHKA, CHK, CKI","Choline kinase alpha","1","4DA5"
"4DAW",,"X-RAY DIFFRACTION",2.46,50.03,"VAPOR DIFFUSION, HANGING DROP",7.5,"25 PEG 4000, 1 M NaCl, 10 mM DTT, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/anie.201108865","0H2","4DAW",33.93,"2","2","Crystal structure of PAK1 kinase domain with the ruthenium phthalimide complex","SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH","Homo sapiens","PAK1","Serine/threonine-protein kinase PAK 1","1","4DAW"
"4DB1",,"X-RAY DIFFRACTION",2.72,54.79,"VAPOR DIFFUSION, HANGING DROP",5.5,"precipitant: 7.5% PEG 8000, 0.05M MES, 0.05M acetate, 0.25M sodium chloride, 0.01M manganese chloride, 0.1% sodium cholate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4DB1",179.33,"2.6","2.6","Cardiac human myosin S1dC, beta isoform complexed with Mn-AMPPNP","GGDSEMAVFGAAAPYLRKSEKERLEAQTRPFDLKKDVFVPDDKQEFVKAKIVSREGGKVTAETEYGKTVTVKEDQVMQQNPPKFDKIEDMAMLTFLHEPAVLYNLKDRYGSWMIYTYSGLFCVTVNPYKWLPVYTPEVVAAYRGKKRSEAPPHIFSISDNAYQYMLTDRENQSILITGESGAGKTVNTKRVIQYFAVIAAIGDRSKKDQSPGKGTLEDQIIQANPALEAFGNAKTVRNDNSSRFGKFIRIHFGATGKLASADIETYLLEKSRVIFQLKAERDYHIFYQILSNKKPELLDMLLITNNPYDYAFISQGETTVASIDDAEELMATDNAFDVLGFTSEEKNSMYKLTGAIMHFGNMKFKLKQREEQAEPDGTEEADKSAYLMGLNSADLLKGLCHPRVKVGNEYVTKGQNVQQVIYATGALAKAVYERMFNWMVTRINATLETKQPRQYFIGVLDIAGFEIFDFNSFEQLCINFTNEKLQQFFNHHMFVLEQEEYKKEGIEWTFIDFGMDLQACIDLIEKPMGIMSILEEECMFPKATDMTFKAKLFDNHLGKSANFQKPRNIKGKPEAHFSLIHYAGIVDYNIIGWLQKNKDPLNETVVGLYQKSSLKLLSTLFANYAGADAPIEKGKGKAKKGSSFQTVSALHRENLNKLMTNLRSTHPHFVRCIIPNETKSPGVMDNPLVMHQLRCNGVLEGIRICRKGFPNRILYGDFRQRYRILNPAAIPEGQFIDSRKGAEKLLSSLDIDHNQYKFGHTKVFFKAGLLGLLEEMRDERLSR","Homo sapiens","MYH7, MYHCB","Myosin-7","1","4DB1"
"4DBN",,"X-RAY DIFFRACTION",3.5,64.87,"VAPOR DIFFUSION, SITTING DROP",8.3,"9.6% PEG 8000, 0.8M LiCl, 100 mM Tris, pH 8.3, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm300126x","0JA","4DBN",65.74,"3.15","3.15","Crystal Structure of the Kinase domain of Human B-raf with a [1,3]thiazolo[5,4-b]pyridine derivative","GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, P94, RAFB1","Serine/threonine-protein kinase B-raf","1","4DBN"
"4DBS",,"X-RAY DIFFRACTION",2.37,48.07,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEG8000, 0.14 M sodium chloride, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.03.085","0HV","4DBS",76.51,"1.852","1.852","Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP+ and 3'-[(4-nitronaphthalen-1-yl)amino]benzoic acid","MDSKQQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEY","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4DBS"
"4DBU",,"X-RAY DIFFRACTION",2.38,48.39,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEG8000, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.03.085","BT9","4DBU",75.84,"2.528","2.528","Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP+ and 3-((4 -(trifluoromethyl)phenyl)amino)benzoic acid","MDSKQQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEY","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4DBU"
"4DBW",,"X-RAY DIFFRACTION",2.37,48.2,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEG8000, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm3017656","511","4DBW",76.65,"1.802","1.802","Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP+ and 2'-desmethyl-indomethacin","MDSKQQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEY","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4DBW"
"4DCE",,"X-RAY DIFFRACTION",2.08,40.91,"VAPOR DIFFUSION, HANGING DROP",6.5,"27% PEG 5000 MME, 100 mM MES, 200 mM ammonium sulfate, 5 mM dithiothreitol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm201565s","0JF","4DCE",76.12,"2.03","2.03","Crystal structure of human anaplastic lymphoma kinase in complex with a piperidine-carboxamide inhibitor","YKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","4DCE"
"4DCH",,"X-RAY DIFFRACTION",2.84,56.64,"VAPOR DIFFUSION, HANGING DROP",5.4,"20% PEG 3350, 0.1A citrate pH 5.4, 0.2M ammonium iodide, 50mM glucose, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1074/jbc.M111.274126","4DC","4DCH",54.14,"1.79","1.79","Insights into Glucokinase Activation Mechanism: Observation of Multiple Distinct Protein Conformations","MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQLEHHHHHH","Homo sapiens","GCK","Glucokinase","1","4DCH"
"4DCJ",,"X-RAY DIFFRACTION",2.62,53.14,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 6000, 100mM sodium citrate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1042/BSR20120009",,"4DCJ",59.74,"1.7","1.7","Crystal structure of caspase 3, L168D mutant","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTEDDCGIETD","Homo sapiens","CASP3, CPP32","Caspase-3 subunit p17","1","4DCJ"
,,,,,,,,,,,,,,,,"SGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHHHHHHH","Homo sapiens","CASP3, CPP32","Caspase-3 subunit p12","2","4DCJ"
,,,,,,,,,,,,,,,,"XDEVX",,,"Caspase Inhibitor AC-DEVD-CHO","3","4DCJ"
"4DCO",,"X-RAY DIFFRACTION",2.64,53.48,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 6000, 100mM sodium citrate pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1042/BSR20120009",,"4DCO",59.84,"1.7","1.7","Crystal Structure of caspase 3, L168Y mutant","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTEYDCGIETD","Homo sapiens","CASP3, CPP32","Caspase-3 subunit p17","1","4DCO"
,,,,,,,,,,,,,,,,"SGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHHHHHHH","Homo sapiens","CASP3, CPP32","Caspase-3 subunit p12","2","4DCO"
,,,,,,,,,,,,,,,,"XDEVX",,,"Caspase Inhibitor AC-DEVD-CHO","3","4DCO"
"4DCP",,"X-RAY DIFFRACTION",2.64,53.33,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 6000, 100mM sodium citrate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1042/BSR20120009",,"4DCP",59.8,"1.7","1.7","Crystal Structure of caspase 3, L168F mutant","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTEFDCGIETD","Homo sapiens","CASP3, CPP32","Caspase-3 subunit p17","1","4DCP"
,,,,,,,,,,,,,,,,"SGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHHHHHHH","Homo sapiens","CASP3, CPP32","Caspase-3 subunit p12","2","4DCP"
,,,,,,,,,,,,,,,,"XDEVX",,,"Caspase Inhibitor AC-DEVD-CHO","3","4DCP"
"4DD8",,"X-RAY DIFFRACTION",2.28,46.03,"VAPOR DIFFUSION, SITTING DROP",8,"Purified ADAM-8/batimastat complex (10mg/mL) was crystallized by the sitting-drop vapor diffusion method, mixing 1uL complex with 1uL of 0.1M Tris pH 8.0, 1M sodium formate, 10% methanol.  Crystals reached usable size in 10 days.  Crystals were then transferred to a cryo solution containing 0.1M Tris pH 8.0, 1.2M sodium formate, 10% methanol, and 10% glycerol.  The crystals were harvested and flash frozen in liquid nitrogen for data collection., VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1107/S1744309112015618",,"4DD8",96.15,"2.1","2.1","ADAM-8 metalloproteinase domain with bound batimastat","SRETRYVELYVVVDNAEFQMLGSEAAVRHRVLEVVNHVDKLYQKLNFRVVLVGLEIWNSQDRFHVSPDPSVTLENLLTWQARQRTRRHLHDNVQLITGVDFTGTTVGFARVSAMCSHSSGAVNQDHSKNPVGVACTMAHEMGHNLGMDHDENVQGCRCQERFEAGRCIMAGSIGSSFPRMFSDCSQAYLESFLERPQSVCLANAPDLS","Homo sapiens","ADAM8, MS2","Disintegrin and metalloproteinase domain-containing protein 8","1","4DD8"
"4DDJ",,"X-RAY DIFFRACTION",3.12,60.56,"VAPOR DIFFUSION",6.5,"1.6 M trisodium citrate, pH 6.5, VAPOR DIFFUSION, temperature 300K",300,"10.1073/pnas.1115743109",,"4DDJ",13.65,"1.9","1.9","Crystal structure of saposin A in complex with lauryldimethylamine-N-oxide (LDAO)","MGSLPCDICKDVVTAAGDMLKDNATEEEILVYLEKTCDWLPKPNMSASCKEIVDSYLPVILDIIKGEMSRPGEVCSALNLCES","Homo sapiens","PSAP, GLBA, SAP1","Saposin-A","1","4DDJ"
"4DDL",,"X-RAY DIFFRACTION",4.34,71.63,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium Sulfate, 
0.1M MES monohydrate, 
10% v/v 1,4-Dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.01.086","0JQ","4DDL",80.33,"2.07","2.07","PDE10a Crystal Structure Complexed with Novel Inhibitor","TSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4DDL"
"4DDP",,"X-RAY DIFFRACTION",1.9,35.24,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG 3350, 0.3M NaCl, 0.1M Tris pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/cr.2012.24",,"4DDP",24.46,"1.547","1.547","crystal structure of Beclin 1 evolutionarily conserved domain(ECD)","LELDDELKSVENQMRYAQTQLDKLKKTNVFNATFHIWHSGQFGTINNFRLGRLPSVPVEWNEINAAWGQTVLLLHALANKMGLKFQRYRLVPYGNHSYLESLTDKSKELPLYCSGGLRFFWDNKFDHAMVAFLDCVQQFKEEVEKGETRFCLPYRMDVEKGKIEDTGGSGGSYSIKTQFNSEEQWTKALKFMLTNLKWGLAWVSSQFYNK","Homo sapiens","BECN1, GT197","Beclin-1","1","4DDP"
"4DDR",,"X-RAY DIFFRACTION",2.53,51.36,"VAPOR DIFFUSION, HANGING DROP",,"2.78M Ammonium sulphate, 100mM K2HPO4, 3%(v/v) Ethanol, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1073/pnas.1204556109","MMV","4DDR",22.46,"2.05","2.05","Human dihydrofolate reductase complexed with NADPH and P218","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","4DDR"
"4DEA",,"X-RAY DIFFRACTION",2.64,53.37,"VAPOR DIFFUSION, HANGING DROP",7,"10 mg/mL AURORA A protein, 1 mM YL1-038-18, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 100 mM sodium tartrate, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm300334d","NHI","4DEA",32.9,"2.45","2.45","Aurora A in complex with YL1-038-18","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AIK, AIRK1, ARK1, AURA, AURKA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4DEA"
"4DEB",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, HANGING DROP",7,"10 mg/mL AURORA A protein, 1 mM RK2-17-01, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 100 mM sodium tartrate, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm300334d","NHJ","4DEB",32.86,"3.05","3.05","Aurora A in complex with RK2-17-01","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4DEB"
"4DED",,"X-RAY DIFFRACTION",2.63,53.15,"VAPOR DIFFUSION, HANGING DROP",7,"10 mg/mL AURORA A protein, 1 mM YL1-038-21, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 100 mM sodium tartrate, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm300334d","NHU","4DED",32.89,"3.05","3.05","Aurora A in complex with YL1-038-21","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4DED"
"4DEE",,"X-RAY DIFFRACTION",2.55,51.79,"VAPOR DIFFUSION, HANGING DROP",7,"10 mg/mL AURORA A protein, 1 mM ADP, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 100 mM sodium tartrate, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm300334d",,"4DEE",32.83,"2.3","2.3","Aurora A in complex with ADP","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4DEE"
"4DEG",,"X-RAY DIFFRACTION",2.03,39.34,"VAPOR DIFFUSION, HANGING DROP",7.8,"15% PEG 4000, 0.1 M HEPES, 6% isopropanol, 3% ethanol, 40 mM beta-mercaptoethanol, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.04.072","0JJ","4DEG",35.62,"2","2","Crystal structure of c-Met in complex with triazolopyridazine inhibitor 2","QNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","4DEG"
"4DEH",,"X-RAY DIFFRACTION",2.02,39.04,"VAPOR DIFFUSION, HANGING DROP",7.8,"15% PEG 4000, 0.1 M HEPES, 6% isopropanol, 3% ethanol, 40 mM beta-mercaptoethanol, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.04.072","0JK","4DEH",35.57,"2","2","Crystal structure of c-Met in complex with triazolopyridinone inhibitor 3","QNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","4DEH"
"4DEI",,"X-RAY DIFFRACTION",2,38.47,"VAPOR DIFFUSION, HANGING DROP",7.8,"15% PEG 4000, 0.1 M HEPES, 6% isopropanol, 3% ethanol, 40 mM beta-mercaptoethanol, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.04.072","0JL","4DEI",35.68,"2.05","2.05","Crystal structure of c-Met in complex with triazolopyridinone inhibitor 24","QNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","4DEI"
"4DEM",,"X-RAY DIFFRACTION",2.43,49.33,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG 300, 0.1M sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm201657x","YS4","4DEM",43.62,"1.85","1.85","Crystal structure of human FPPS in complex with YS_04_70","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4DEM"
"4DEQ",,"X-RAY DIFFRACTION",3.41,63.97,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.5M Na/K phosphate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.331140",,"4DEQ",49.42,"2.649","2.649","Structure of the Neuropilin-1/VEGF-A complex","GSHMKCMEALGMESGEIHSDQITASSQYSTNWSAERSRLNYPENGWTPGEDSYREWIQVDLGLLRFVTAVGTQGAISKETKKKYYVKTYKIDVSSNGEDWITIKEGNKPVLFQGNTNPTDVVVAVFPKPLITRFVRIKPATWETGISMRFEVYGCKITDYVDGSGSGSPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR","Homo sapiens","NRP1, NRP, VEGF165R, VEGF, VEGFA","Neuropilin-1, Vascular endothelial growth factor A","1","4DEQ"
,,,,,,,,,,,,,,,,,"Homo sapiens","NRP1, NRP, VEGF165R, VEGF, VEGFA"
"4DER",,"X-RAY DIFFRACTION",2.33,47.21,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M calcium chloride, 0.1 M HEPES, pH 7.5, 28% PEG400, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2012.07.008","AGI","4DER",26.04,"1.9","1.9","Crystal Structure of the Wild Type TTR Binding Apigenin (TTRwt:API)","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNP","Homo sapiens","PALB, TTR","Transthyretin","1","4DER"
"4DES",,"X-RAY DIFFRACTION",2.18,43.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M calcium chloride, 0.1 M HEPES, pH 7.5, 28% PEG400, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2012.07.008","57D","4DES",25.91,"1.75","1.75","Crystal Structure of the Wild Type TTR Binding Chrysin (TTRwt:CHR)","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNP","Homo sapiens","PALB, TTR","Transthyretin","1","4DES"
"4DET",,"X-RAY DIFFRACTION",2.35,47.66,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M calcium chloride, 0.1 M HEPES, pH 7.5, 28% PEG400, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2012.07.008","KMP","4DET",25.98,"2.05","2.05","Crystal Structure of the Wild Type TTR Binding Kaempferol (TTRwt:KAE)","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNP","Homo sapiens","PALB, TTR","Transthyretin","1","4DET"
"4DEU",,"X-RAY DIFFRACTION",2.37,48.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M calcium chloride, 0.1 M HEPES, pH 7.5, 28% PEG400, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2012.07.008","NAR","4DEU",26.75,"1.599","1.599","Crystal Structure of the Wild Type TTR Binding Naringenin (TTRwt:NAR)","ACPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNP","Homo sapiens","PALB, TTR","Transthyretin","1","4DEU"
"4DEW",,"X-RAY DIFFRACTION",1.88,34.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M calcium chloride, 0.1 M HEPES, pH 7.5, 28% PEG400, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2012.07.008","LU2","4DEW",32.38,"1.899","1.899","Crystal Structure of the Wild Type TTR Binding Luteolin (TTRwt:LUT)","MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4DEW"
"4DFF",,"X-RAY DIFFRACTION",1.87,34.19,"VAPOR DIFFUSION, HANGING DROP",7.4,"100 mM HEPES, 16% PEG3350, 25 mM magnesium chloride, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2012.01.113","0JP","4DFF",81.49,"2.11","2.11","The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia","GMEKLSYHSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4DFF"
"4DFH",,"X-RAY DIFFRACTION",2.04,39.84,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2M ammonium acetate, 0.1M Bis-Tris (pH 5.5), 25% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.4049/jimmunol.1200324",,"4DFH",27.9,"1.85","1.85","Crystal structure of cell adhesion molecule nectin-2/CD112 variable domain","MQDVRVQVLPEVRGQLGGTVELPCHLLPPVPGLYISLVTWQRPDAPANHQNVAAFHPKMGPSFPSPKPGSERLSFVSAKQSTGQDTEAELQDATLALHGLTVEDEGNYTCEFATFPKGSVRGMTWLRV","Homo sapiens","HVEB, PRR2, PVRL2, NECTIN2","Poliovirus receptor-related protein 2","1","4DFH"
"4DFI",,"X-RAY DIFFRACTION",1.88,34.64,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M ammonium sulfate, 0.1M Tris (pH 8.5), 25% (w/v) PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.4049/jimmunol.1200324",,"4DFI",13.85,"1.8","1.8","Crystal structure of cell adhesion molecule nectin-2/CD112 mutant FAMP","MQDVRVQVLPEVRGQLGGTVELPCHLLPPVPGLYISLVTWQRPDAPANHQNVAAFHPKSGPSFSSPKPGSERLSFVSAKQSTGQDTEAELQDATLALHGLTVEDEGNYTCEFSTSPKGSVRGMTWLRV","Homo sapiens","PVRL2, HVEB, PRR2, NECTIN2","Poliovirus receptor-related protein 2","1","4DFI"
"4DFL",,"X-RAY DIFFRACTION",2.5,50.91,,,,,"10.1016/j.bmcl.2012.02.087","0K0","4DFL",32.36,"1.98","1.98","Crystal structure of spleen tyrosine kinase complexed with a sulfonamidopyrazine piperidine inhibitor","VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4DFL"
"4DFN",,"X-RAY DIFFRACTION",2.52,51.28,,,,,"10.1016/j.bmcl.2012.02.087","0K1","4DFN",32.24,"2.48","2.48","Crystal structure of spleen tyrosine kinase complexed with an adamantylpyrazine inhibitor","VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4DFN"
"4DFW",,"X-RAY DIFFRACTION",1.89,35,"VAPOR DIFFUSION, HANGING DROP",5.5,"31% (w/v) PEG 3350, 0.1 M bis-Tris pH 5.5 and 240 mM MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/cb200469a",,"4DFW",28.15,"1.55","1.55","Oxime-based Post Solid-phase Peptide Diversification: Identification of High Affinity Polo-like Kinase 1 (Plk1) Polo-box Domain Binding Peptides","GEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS","Homo sapiens","PLK, PLK1","Serine/threonine-protein kinase PLK1","1","4DFW"
,,,,,,,,,,,,,,,,"XXLHSTX",,,"Peptide","2","4DFW"
"4DG6",,"X-RAY DIFFRACTION",3.25,62.1,"hanging drop",5.9,"20% PEG 8000, 20mM ammonium sulfate, pH 5.9, hanging drop, temperature 292K",292,,,"4DG6",71.07,"2.9","2.9","Crystal structure of domains 1 and 2 of LRP6","APLLLYANRRDLRLVDATNGKENATIVVGGLEDAAAVDFVFSHGLIYWSDVSEEAIKRTEFNKTESVQNVVVSGLLSPDGLACDWLGEKLYWTDSETNRIEVSNLDGSLRKVLFWQELDQPRAIALDPSSGFMYWTDWGEVPKIERAGMDGSSRFIIINSEIYWPNGLTLDYEEQKLYWADAKLNFIHKSNLDGTNRQAVVKGSLPHPFALTLFEDILYWTDWSTHSILACNKYTGEGLREIHSDIFSPMDIHAFSQQRQPNATNPCGIDNGGCSHLCLMSPVKPFYQCACPTGVKLLENGKTCKDGATELLLLARRTDLRRISLDTPDFTDIVLQLEDIRHAIAIDYDPVEGYIYWTDDEVRAIRRSFIDGSGSQFVVTAQIAHPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTMRKILISEDLEEPRAIVLDPMVGYMYWTDWGEIPKIERAALDGSDRVVLVNTSLGWPNGLALDYDEGKIYWGDAKTDKIEVMNTDGTGRRVLVEDKIPHIFGFTLLGDYVYWTDWQRRSIERVHKRSAEREVIIDQLPDLMGLKATNVHRVIGSNPCAEENGGCSHLCLYRPQGLRCACPIGFELISDMKTCIVPEAFLL","Homo sapiens","LRP6","Low-density lipoprotein receptor-related protein 6","1","4DG6"
"4DGJ",,"X-RAY DIFFRACTION",2.77,55.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 16% PEG 10000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1002/prot.24084",,"4DGJ",105.52,"1.9","1.9","Structure of a human enteropeptidase light chain variant","IVGGSDAKEGAWPWVVGLYYDDRLLCGASLVSSDWLVSAAHCVYGRNLEPSKWTAILGLHMKSNLTSPQTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISLPEENQVFPPGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQMPEYNITENMICAGYEEGGIDSCQGDSGGPLMCQENNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWIQSFLH","Homo sapiens","TMPRSS15, ENTK, PRSS7","Enteropeptidase catalytic light chain","1","4DGJ"
"4DGP",,"X-RAY DIFFRACTION",1.98,37.92,"VAPOR DIFFUSION, HANGING DROP",7.3,"20% PEG3350, 300 mM potassium formate, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.450023",,"4DGP",61.76,"2.3","2.3","The wild-type Src homology 2 (SH2)-domain containing protein tyrosine phosphatase-2 (SHP2)","MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRLEHHHHHH","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4DGP"
"4DGX",,"X-RAY DIFFRACTION",2.06,40.22,"VAPOR DIFFUSION, HANGING DROP",7.3,"20% PEG3350, 300 mM potassium formate, 10 mM calcium chloride, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.450023",,"4DGX",61.7,"2.3","2.3","LEOPARD Syndrome-Associated SHP2/Y279C mutant","MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRCKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRLEHHHHHH","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4DGX"
"4DH0",,"X-RAY DIFFRACTION",2.64,53.43,"VAPOR DIFFUSION, HANGING DROP",7.7,"35% ammonium sulphate, 0.1M Na/K phosphate, pH 7.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4DH0",12.76,"2.1","2.1","X-ray Crystal Structure of 28-O-Methylrapamycin complexed with FKBP12: Is the Cyclohexyl Moiety Part of the Effector Domain of Rapamycin?","GVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","Peptidyl-prolyl cis-trans isomerase FKBP1A","1","4DH0"
"4DH6",,"X-RAY DIFFRACTION",2.86,56.99,"VAPOR DIFFUSION, HANGING DROP",6.6,"20 % (w/v) PEG 5000 monomethylethyl ether (MME), 200 mM sodium citrate (pH 6.6) and 200 mM sodium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm300119p","0KN","4DH6",47.58,"2.5","2.5","Structure of Bace-1 (Beta-Secretase) in Complex with (2R)-N-((2S,3R)-1-(benzo[d][1,3]dioxol-5-yl)-3-hydroxy-4-((S)-6'-neopentyl-3',4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridine]-4'-ylamino)butan-2-yl)-2-methoxypropanamide","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4DH6"
"4DHF",,"X-RAY DIFFRACTION",2.55,51.67,"VAPOR DIFFUSION, SITTING DROP",9,"1mM ADP, 2mM MgCl2 addition and set up with 10% PEG550MME, 5% Ethylene glycol, 0.1M TRIS, pH 9, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.bmcl.2012.04.085","0K6","4DHF",63.83,"2.8","2.8","Structure of Aurora A mutant bound to Biogenidec cpd 15","GPLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS","Homo sapiens","AIK, AIRK1, ARK1, AURA, AURKA, AuroraA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4DHF"
"4DHM",,"X-RAY DIFFRACTION",2.72,54.79,"VAPOR DIFFUSION, HANGING DROP",7.7,"0.095M HEPES Na, 0.19M calcium chloride, 5% glycerol, 28% PEG400, pH 7.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c3cc44612c","0KB","4DHM",27.13,"1.7","1.7","Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, SFN","14-3-3 protein sigma","1","4DHM"
"4DHN",,"X-RAY DIFFRACTION",2.7,54.55,"VAPOR DIFFUSION, HANGING DROP",7.3,"0.095M HEPES Na, 0.19M calcium chloride, 5% glycerol, 28% PEG400, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c3cc44612c","0KC","4DHN",27.02,"1.8","1.8","Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, SFN","14-3-3 protein sigma","1","4DHN"
"4DHO",,"X-RAY DIFFRACTION",2.69,54.28,"VAPOR DIFFUSION, HANGING DROP",7.1,"0.095M HEPES Na, 0.19M calcium chloride, 5% glycerol, 28% PEG400, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c3cc44612c","Y09","4DHO",27.08,"1.7","1.7","Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, SFN","14-3-3 protein sigma","1","4DHO"
"4DHP",,"X-RAY DIFFRACTION",2.72,54.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.095M HEPES Na, 0.19M calcium chloride, 5% glycerol, 26% PEG400, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c3cc44612c","Y07","4DHP",27.2,"1.75","1.75","Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, SFN","14-3-3 protein sigma","1","4DHP"
"4DHQ",,"X-RAY DIFFRACTION",2.73,55.02,"VAPOR DIFFUSION, HANGING DROP",7.1,"0.095M HEPES Na, 0.19M calcium chloride, 5% glycerol, 27% PEG400, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c3cc44612c","Y06","4DHQ",27.13,"1.75","1.75","Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, SFN","14-3-3 protein sigma","1","4DHQ"
"4DHR",,"X-RAY DIFFRACTION",2.62,53.15,"VAPOR DIFFUSION, HANGING DROP",7.1,"0.095M HEPES Na, 0.19M calcium chloride, 5% glycerol, 28% PEG400, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c3cc44612c","Y04","4DHR",27.13,"1.4","1.4","Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, SFN","14-3-3 protein sigma","1","4DHR"
"4DHS",,"X-RAY DIFFRACTION",2.7,54.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.095M HEPES Na, 0.19M calcium chloride, 5% glycerol, 28% PEG400, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c3cc44612c","Y03","4DHS",27.11,"1.74","1.74","Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, SFN","14-3-3 PROTEIN SIGMA","1","4DHS"
"4DHT",,"X-RAY DIFFRACTION",2.7,54.93,"VAPOR DIFFUSION, HANGING DROP",7.3,"0.095M HEPES Na, 0.19M calcium chloride, 5% glycerol, 28% PEG400, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c3cc44612c","0KG","4DHT",27.01,"1.8","1.8","Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, SFN","14-3-3 PROTEIN SIGMA","1","4DHT"
"4DHU",,"X-RAY DIFFRACTION",2.73,54.96,"VAPOR DIFFUSION, SITTING DROP",7.1,"0.095M HEPES Na, 0.19M calcium chloride, 5% glycerol, 27% PEG400, pH 7.1, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1039/c3cc44612c","0KH","4DHU",27.16,"1.67","1.67","Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, SFN","14-3-3 PROTEIN SIGMA","1","4DHU"
"4DHY",,"X-RAY DIFFRACTION",2.24,45.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M111.274126","S41","4DHY",53.57,"2.38","2.38","Crystal structure of human glucokinase in complex with glucose and activator","MHHHHHHENLYFQGMKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","4DHY"
"4DI2",,"X-RAY DIFFRACTION",3.11,60.41,"VAPOR DIFFUSION, HANGING DROP",5,"16% polyethylene glycol 8000, 0.1 M sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm300118s","0K9","4DI2",139.71,"2","2","Crystal structure of BACE1 in complex with hydroxyethylamine inhibitor 37","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4DI2"
"4DIJ",,"X-RAY DIFFRACTION",2.86,57.06,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris, 0.2M LiSO4, 22% PEG3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.03.083","BLF","4DIJ",23.49,"1.9","1.9","The Central Valine Concept Provides an Entry in a New Class of Non Peptide Inhibitors of the P53-MDM2 Interaction","GSQIPASEQETLVRPKPELLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4DIJ"
"4DIP",,"X-RAY DIFFRACTION",2.15,42.77,,7.2,"18% PEG_3350, 0.1M HEPES, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4DIP",140.44,"1.82","1.82","Crystal structure of human Peptidyl-prolyl cis-trans isomerase FKBP14","YFQSMGALIPEPEVKIEVLQKPFICHRKTKGGDLMLVHYEGYLEKDGSLFHSTHKHNNGQPIWFTLGILEALKGWDQGLKGMCVGEKRKLIIPPALGYGKEGKGKIPPESTLIFNIDLLEIRNGP","Homo sapiens","FKBP14, FKBP22, UNQ322/PRO381","Peptidyl-prolyl cis-trans isomerase FKBP14","1","4DIP"
"4DIQ",,"X-RAY DIFFRACTION",2.78,55.79,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.05M (NH4)2SO4, 0.05M BIS-TRIS pH 6.5, 30% pentaerythritol ethoxylate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4DIQ",111.89,"2.4","2.4","Crystal Structure of human NO66","LRRRYTMASGPQVDNTGGEPAWDSPLRRVLAELNRIPSSRRRAARLFEWLIAPMPPDHFYRRLWEREAVLVRRQDHTYYQGLFSTADLDSMLRNEEVQFGQHLDAARYINGRRETLNPPGRALPAAAWSLYQAGCSLRLLCPQAFSTTVWQFLAVLQEQFGSMAGSNVYLTPPNSQGFAPHYDDIEAFVLQLEGRKLWRVYRPRAPTEELALTSSPNFSQDDLGEPVLQTVLEPGDLLYFPRGFIHQAECQDGVHSLHLTLSTYQRNTWGDFLEAILPLAVQAAMEENVEFRRGLPRDFMDYMGAQHSDSKDPRRTAFMEKVRVLVARLGHFAPVDAVADQRAKDFIHDSLPPVLTDRERALSVYGLPIRWEAGEPVNVGAQLTTETEVHMLQDGIARLVGEGGHLFLYYTVENSRVYHLEEPKCLEIYPQQADAMELLLGSYPEFVRVGDLPCDSVEDQLSLATTLYDKGLLLTKMPLALNAENLYFQ","Homo sapiens","NO66, C14orf169, RIOX1, MAPJD","Lysine-specific demethylase NO66","1","4DIQ"
"4DIR",,"X-RAY DIFFRACTION",2.16,43.1,"VAPOR DIFFUSION, SITTING DROP",7,"14% PEG 3350, 7.5mM CaCl2, 0.2M Potassium thiocyanate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"4DIR",21.68,"2.6","2.6","2.6 Angstrom X-ray structure of human CA(2+)-S100A5","METPLEKALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGEMKESSIDDLMKSLDKNSDQEIDFKEYSVFLTMLCMAYNDFFLEDNK","Homo sapiens","S100A5, S100D","Protein S100-A5","1","4DIR"
"4DIT",,"X-RAY DIFFRACTION",2.39,48.53,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH 8.0, 15% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"4DIT",43.65,"2.6","2.6","Crystal Structure of GSK3beta in complex with a Imidazopyridine inhibitor","MRGSKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNAAALEHHHHHH","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","4DIT"
"4DJN",,"X-RAY DIFFRACTION",3.12,60.57,"VAPOR DIFFUSION, SITTING DROP",6.5,"2.0M ammonium sulfate, 0.1M sodium cacodylate pH 6.5, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4DJN",73.27,"2.2","2.2","Crystal structure of a ribonucleotide reductase M2 B (RNRR2) from Homo sapiens at 2.20 A resolution","GDQDERSSSDTNESEIKSNEEPLLRKSSRRFVIFPIQYPDIWKMYKQAQASFWTAEEVDLSKDLPHWNKLKADEKYFISHILAFFAASDGIVNENLVERFSQEVQVPEARCFYGFQILIENVHSEMYSLLIDTYIRDPKKREFLFNAIETMPYVKKKADWALRWIADRKSTFGERVVAFAAVEGVFFSGSFAAIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFQYLVNKPSEERVREIIVDAVKIEQEFLTEALPVGLIGMNCILMKQYIEFVADRLLVELGFSKVFQAENPFDFMENISLEGKTN","Homo sapiens","RRM2B, P53R2","Ribonucleoside-diphosphate reductase subunit M2 B","1","4DJN"
"4DJS",,"X-RAY DIFFRACTION",2.72,54.79,"VAPOR DIFFUSION, HANGING DROP",6.2,"1.4-2.0 M sodium chloride, 100 mM Bis-Tris, 100 mM potassium phosphate monobasic, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1208396109",,"4DJS",58.83,"3.029","3.029","Structure of beta-catenin in complex with a stapled peptide inhibitor","LATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSED","Homo sapiens","CTNNB1, CTNNB, OK/SW-cl.35, PRO2286","Catenin beta-1","1","4DJS"
,,,,,,,,,,,,,,,,"RRWPQLILDLHVRRVWR",,,"stapled peptide RRWPQ(MK8)ILD(MK8)HVRRVWR","2","4DJS"
"4DJU",,"X-RAY DIFFRACTION",2.73,54.91,"Hanging Drop",,"Hanging Drop, temperature 277K",277,"10.1016/j.bmcl.2012.02.013","0KK","4DJU",93.33,"1.8","1.8","Structure of BACE Bound to 2-imino-3-methyl-5,5-diphenylimidazolidin-4-one","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4DJU"
"4DJV",,"X-RAY DIFFRACTION",2.75,55.26,"Hanging Drop",,"Hanging Drop, temperature 277K",277,"10.1016/j.bmcl.2012.02.013","0KM","4DJV",93.54,"1.73","1.73","Structure of BACE Bound to 2-imino-5-(3'-methoxy-[1,1'-biphenyl]-3-yl)-3-methyl-5-phenylimidazolidin-4-one","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4DJV"
"4DJW",,"X-RAY DIFFRACTION",2.75,55.23,"Hanging Drop",,"Hanging Drop, temperature 277K",277,"10.1016/j.bmcl.2012.02.013","0KP","4DJW",93.63,"1.9","1.9","Structure of BACE Bound to 2-imino-3-methyl-5-phenyl-5-(3-(pyridin-3-yl)phenyl)imidazolidin-4-one","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4DJW"
"4DJX",,"X-RAY DIFFRACTION",2.74,55.17,"Hanging Drop",,"Hanging Drop, temperature 277K",277,"10.1016/j.bmcl.2012.02.013","0KQ","4DJX",93.48,"1.5","1.5","Structure of BACE Bound to 5-(3-(5-chloropyridin-3-yl)phenyl)-5-cyclopropyl-2-imino-3-methylimidazolidin-4-one","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4DJX"
"4DJY",,"X-RAY DIFFRACTION",2.74,55.16,"Hanging Drop",,"Hanging Drop, temperature 277K",277,"10.1016/j.bmcl.2012.02.013","0KR","4DJY",93.49,"1.86","1.86","Structure of BACE Bound to (R)-5-cyclopropyl-2-imino-3-methyl-5-(3-(5-(prop-1-yn-1-yl)pyridin-3-yl)phenyl)imidazolidin-4-one","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4DJY"
"4DK5",,"X-RAY DIFFRACTION",2.39,48.44,"VAPOR DIFFUSION, HANGING DROP",7.3,"21% polyethylene glycol 3350, 100 mM Tris, 245 mM ammonium sulfate, 1 mM DTT, 2 mM EDTA, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1021/jm300184s","0KO","4DK5",110.54,"2.95","2.95","Crystal structure of human PI3K-gamma in complex with a pyridyl-triazine inhibitor","SEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4DK5"
"4DK9",,"X-RAY DIFFRACTION",2.73,55.01,"VAPOR DIFFUSION",,"0.2M potassium acetate, 20% PEG 3350, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.jmb.2012.04.028",,"4DK9",25.31,"2.76","2.76","Crystal Structure of MBD4 Catalytic Domain Bound to Abasic DNA","GSALSPPRRKAFKKWTPPRSPFNLVQETLFHDPWKLLIATIFLNRTSGKMAIPVLWKFLEKYPSAEVARTADWRDVSELLKPLGLYDLRAKTIVKFSDEYLTKQWKYPIELHGIGKYGNDSYRIFCVNEWKQVHPEDHKLNKYHDWLWENHEKLSLS","Homo sapiens","MBD4, MED1","Methyl-CpG-binding domain protein 4","3","4DK9"
,,,,,,,,,,,,,,,,"AAGACGTGGAC",,,"5'-D(*AP*AP*GP*AP*CP*GP*TP*GP*GP*AP*C)-3'","1","4DK9"
,,,,,,,,,,,,,,,,"TGTCCANGTCT",,,"5'-D(*TP*GP*TP*CP*CP*AP*(3DR)P*GP*TP*CP*T)-3'","2","4DK9"
"4DKC",,"X-RAY DIFFRACTION",2.9,57.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Hepes pH 7.5, 10% w/v Polyethylene glycol 6,000, 5% v/v (+/-)-2-Methyl-2,4-pentanediol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2012.02.010",,"4DKC",44.89,"1.85","1.85","Crystal Structure of Human Interleukin-34","AGSNEPLEMWPLTQNEECTVTGFLRDKLQYRSRLQYMKHYFPINYKISVPYEGVFRIANVTRLQRAQVSERELRYLWVLVSLSATESVQDVLLEGHPSWKYLQEVETLLLNVQQGLTDVEVSPKVESVLSLLNAPGPNLKLVRPKALLDNCFRVMELLYCSCCKQSSVLNWQDCEVGNSGNSDYKDDDDK","Homo sapiens","IL34, C16orf77","Interleukin-34","1","4DKC"
"4DKK",,"X-RAY DIFFRACTION",1.8,31.84,"VAPOR DIFFUSION, HANGING DROP",8,"Drop:130 mM citric acid pH 2.5, 26% (w/v) PEG 6000 (final pH of 4), Reservoir:100 mM citric acid pH 2.5, 35% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.1038/nsmb.2528",,"4DKK",12.7,"1.701","1.701","The X-ray Crystal Structure of the Human STAU1 SSM-'RBD'5 Domain-Swapped Dimer","GPLGSKATVTAMIARELLYGGTSPTAETILKNNISSGHVPHGPLTRPSEQLDYLSRVQGFQVEYKDFPKNNKNEFVSLINCSSQPPLISHGIGKDVESCHDMAALNILKLLSELD","Homo sapiens","STAU, STAU1","Double-stranded RNA-binding protein Staufen homolog 1","1","4DKK"
"4DKT",,"X-RAY DIFFRACTION",2.87,57.18,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M imidazole, pH 8.0, 0.2 M lithium sulfate, 10% w/v PEG1500, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/cb200258q",,"4DKT",75.54,"2.98","2.98","Crystal structure of human peptidylarginine deiminase 4 in complex with N-acetyl-L-threonyl-L-alpha-aspartyl-N5-[(1E)-2-fluoroethanimidoyl]-L-ornithinamide","GPLGSMAQGTLIRVTPEQPTHAVCVLGTLTQLDICSSAPEDCTSFSINASPGVVVDIAHSPPAKKKSTGSSTWPLDPGVEVTLTMKAASGSTGDQKVQISYYGPKTPPVKALLYLTAVEISLCADITRTGKVKPTRAVKDQRTWTWGPCGQGAILLVNCDRDNLESSAMDCEDDEVLDSEDLQDMSLMTLSTKTPKDFFTNHTLVLHVARSEMDKVRVFQATRGKLSSKCSVVLGPKWPSHYLMVPGGKHNMDFYVEALAFPDTDFPGLITLTISLLDTSNLELPEAVVFQDSVVFRVAPWIMTPNTQPPQEVYACSIFENEDFLKSVTTLAMKAKCKLTICPEEENMDDQWMQDEMEIGYIQAPHKTLPVVFDSPRNRGLKEFPIKRVMGPDFGYVTRGPQTGGISGLDSFGNLEVSPPVTVRGKEYPLGRILFGDSCYPSNDSRQMHQALQDFLSAQQVQAPVKLYSDWLSVGHVDEFLSFVPAPDRKGFRLLLASPRSCYKLFQEQQNEGHGEALLFEGIKKKKQQKIKNILSNKTLREHNSFVERCIDWNRELLKRELGLAESDIIDIPQLFKLKEFSKAEAFFPNMVNMLVLGKHLGIPKPFGPVINGRCCLEEKVCSLLEPLGLQCTFINDFFTYHIRHGEVHCGTNVRRKPFSFKWWNMVP","Homo sapiens","PADI4, PADI5, PDI5, PAD4","Protein-arginine deiminase type-4","1","4DKT"
,,,,,,,,,,,,,,,,"XTDXX",,,"Thr-Asp-F-amidine","2","4DKT"
"4DKX",,"X-RAY DIFFRACTION",1.99,38.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG 8000, 200mM Calcium acetate, 100mM Sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bbrc.2012.06.102",,"4DKX",50.2,"1.9","1.9","Crystal Structure of the Rab 6A'(Q72L)","MSTGGDFGNPLRKFKLVFLGEQSVGKTSLITRFMYDSFDNTYQATIGIDFLSKTMYLEDRTIRLQLWDTAGLERFRSLIPSYIRDSAAAVVVYDITNVNSFQQTTKWIDDVRTERGSDVIIMLVGNKTDLADKRQVSIEEGERKAKELNVMFIETSAKAGYNVKQLFRRVAAALPGMESTQDRSREDMIDIKLEKPQEQPVSEGGCSCLEHHHHHH","Homo sapiens","RAB6A, RAB6","Ras-related protein Rab-6A","1","4DKX"
"4DL1",,"X-RAY DIFFRACTION",2.25,45.35,"VAPOR DIFFUSION",5.5,"27% PEG 3350, 0.25 M CaCl2, betaine HCl, pH 5.5, vapor diffusion, temperature 298K",298,"10.1021/bi201872j",,"4DL1",541.36,"2","2","Crystal Structure of human Myeloperoxidase with covalent thioxanthine analog","CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPA","Homo sapiens","MPO","Myeloperoxidase light chain","1","4DL1"
,,,,,,,,,,,,,,,,"VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREA","Homo sapiens","MPO","Myeloperoxidase heavy chain","2","4DL1"
"4DL2",,"X-RAY DIFFRACTION",2.02,39.19,,6,"MES, MgCl2, PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1202681109",,"4DL2",55.83,"2.15","2.15","Human DNA polymerase eta inserting dCMPNPP opposite CG template (GG0a)","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4DL2"
,,,,,,,,,,,,,,,,"ACGGCTCACACT",,,"DNA (5'-D(*AP*CP*GP*GP*CP*TP*CP*AP*CP*AP*CP*T)-3')","2","4DL2"
,,,,,,,,,,,,,,,,"TAGTGTGAG",,,"DNA (5'-D(*TP*AP*GP*TP*GP*TP*GP*AP*G)-3')","3","4DL2"
"4DL3",,"X-RAY DIFFRACTION",2.02,38.97,,6,"MES, MgCl2, PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1202681109",,"4DL3",55.8,"2.1","2.1","Human DNA polymerase eta inserting dCMPNPP opposite GG template (GG0b).","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4DL3"
,,,,,,,,,,,,,,,,"TACGGTCACACT",,,"DNA (5'-D(*TP*AP*CP*GP*GP*TP*CP*AP*CP*AP*CP*T)-3')","2","4DL3"
,,,,,,,,,,,,,,,,"TAGTGTGAC",,,"DNA (5'-D(*TP*AP*GP*TP*GP*TP*GP*AP*C)-3')","3","4DL3"
"4DL4",,"X-RAY DIFFRACTION",2.14,42.63,"VAPOR DIFFUSION, HANGING DROP",6,"MES, MgCl2, PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1202681109",,"4DL4",55.34,"2","2","Human DNA polymerase eta inserting dCMPNPP opposite the 3'G of cisplatin crosslinked Gs (Pt-GG1).","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4DL4"
,,,,,,,,,,,,,,,,"GGCTCACACT",,,"DNA (5'-D(P*GP*GP*CP*TP*CP*AP*CP*AP*CP*T)-3')","2","4DL4"
,,,,,,,,,,,,,,,,"TAGTGTGAG",,,"DNA (5'-D(*TP*AP*GP*TP*GP*TP*GP*AP*G)-3')","3","4DL4"
"4DL5",,"X-RAY DIFFRACTION",2.13,42.21,,6,"MES, MgCl2, PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1202681109",,"4DL5",55.83,"2.92","2.92","Human DNA polymerase eta inserting dCMPNPP opposite the 5'G of cisplatin crosslinked Gs (Pt-GG2).","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4DL5"
,,,,,,,,,,,,,,,,"TACGGTCACACT",,,"DNA (5'-D(*TP*AP*CP*GP*GP*TP*CP*AP*CP*AP*CP*T)-3')","2","4DL5"
,,,,,,,,,,,,,,,,"TAGTGTGAC",,,"DNA (5'-D(P*TP*AP*GP*TP*GP*TP*GP*AP*C)-3')","3","4DL5"
"4DL6",,"X-RAY DIFFRACTION",2.09,41.08,,6,"MES, MgCl2, PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1202681109",,"4DL6",55.84,"2.5","2.5","Human DNA polymerase eta extending primer immediately after cisplatin crosslink (Pt-GG3).","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4DL6"
,,,,,,,,,,,,,,,,"TATCGGCACACT",,,"DNA (5'-D(*TP*AP*TP*CP*GP*GP*CP*AP*CP*AP*CP*T)-3')","2","4DL6"
,,,,,,,,,,,,,,,,"TAGTGTGCC",,,"DNA (5'-D(*TP*AP*GP*TP*GP*TP*GP*CP*C)-3')","3","4DL6"
"4DL7",,"X-RAY DIFFRACTION",2.11,41.62,,6,"MES, MgCl2, PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1202681109",,"4DL7",55.87,"1.97","1.97","Human DNA polymerase eta fails to extend primer 2 nucleotide after cisplatin crosslink (Pt-GG4).","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4DL7"
,,,,,,,,,,,,,,,,"TACTCGGTCACT",,,"DNA (5'-D(*TP*AP*CP*TP*CP*GP*GP*TP*CP*AP*CP*T)-3')","2","4DL7"
,,,,,,,,,,,,,,,,"TAGTGACCG",,,"DNA (5'-D(*TP*AP*GP*TP*GP*AP*CP*CP*G)-3')","3","4DL7"
"4DLI",,"X-RAY DIFFRACTION",2.32,47.01,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, 20-30% PEG4000, 50 mM n-BOG, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0039713","IRG","4DLI",41.82,"1.91","1.91","Human p38 MAP kinase in complex with RL87","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4DLI"
"4DLJ",,"X-RAY DIFFRACTION",2.33,47.27,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, 20-30% PEG4000, 50 mM n-BOG, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0039713","6RG","4DLJ",41.95,"2.6","2.6","Human p38 MAP kinase in complex with RL163","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4DLJ"
"4DLO",,"X-RAY DIFFRACTION",3.66,66.38,"VAPOR DIFFUSION, HANGING DROP",5.5,"15% PEG6000, 0.1M sodium citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2012.26",,"4DLO",89.13,"2.3","2.3","Crystal structure of the GAIN and HormR domains of brain angiogenesis inhibitor 3 (BAI3)","ADPEVRRCSEQRCPAPYEICPEDYLMSMVWKRTPAGDLAFNQCPLNATGTTSRRCSLSLHGVAFWEQPSFARCISNEYRHLQHSIKEHLAKGQRMLAGDGMSQVTKTLLDLTQRKNFYAGDLLMSVEILRNVTDTFKRASYIPASDGVQNFFQIVSNLLDEENKEKWEDAQQIYPGSIELMQVIEDFIHIVGMGMMDFQNSYLMTGNVVASIQKLPAASVLTDINFPMKGRKGMVDWARNSEDRVVIPKSIFTPVSSKELDESSVFVLGAVLYKNLDLILPTLRNYTVINSKIIVVTIRPEPKTTDSFLEIELAHLANGTLNPYCVLWDDSKTNESLGTWSTQGCKTVLTDASHTKCLCDRLSTFAILAQQPREHHHHHHHH","Homo sapiens","BAI3, KIAA0550, ADGRB3","Brain-specific angiogenesis inhibitor 3","1","4DLO"
"4DLR",,"X-RAY DIFFRACTION",2.6,52.68,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 200 mM Ca Acetate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi300509j",,"4DLR",19.75,"1.319","1.319","H-Ras PEG 400/Ca(OAc)2, ordered off","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDEYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4DLR"
"4DLS",,"X-RAY DIFFRACTION",2.73,54.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 200 mM CaCl2, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi300509j",,"4DLS",19.53,"1.819","1.819","H-Ras Set 1 CaCl2 'Mixed'","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4DLS"
"4DLT",,"X-RAY DIFFRACTION",2.69,54.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 200 mM Ca Acetate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi300509j",,"4DLT",19.59,"1.699","1.699","H-Ras Set 2 Ca(OAc)2, on","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4DLT"
"4DLU",,"X-RAY DIFFRACTION",2.71,54.62,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 200 mM CaCl2, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi300509j",,"4DLU",19.59,"1.6","1.6","H-Ras Set 1 Ca(OAc)2, on","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4DLU"
"4DLV",,"X-RAY DIFFRACTION",2.7,54.37,"sitting drop",7.5,"20% PEG 3350, 200 mM Ca Acetate, pH 7.5, sitting drop, temperature 298K",298,"10.1021/bi300509j",,"4DLV",19.67,"1.572","1.572","H-Ras Set 2 CaCl2/DTT, ordered off","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDEYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4DLV"
"4DLW",,"X-RAY DIFFRACTION",2.67,53.89,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 200 mM Ca Acetate, pH 7.5, temperature 298K, VAPOR DIFFUSION, SITTING DROP",298,"10.1021/bi300509j",,"4DLW",19.59,"1.72","1.72","H-Ras Set 2 Ca(OAc)2/DTT, on","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4DLW"
"4DLX",,"X-RAY DIFFRACTION",2.65,53.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350 200 mM CaCl2, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi300509j",,"4DLX",19.67,"1.731","1.731","H-Ras Set 1 CaCl2/DTE, ordered off","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDEYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4DLX"
"4DLY",,"X-RAY DIFFRACTION",2.66,53.76,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 200 mM CaCl2, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi300509j",,"4DLY",19.88,"1.57","1.57","Set 1 CaCl2/DTT, ordered off","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDEYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4DLY"
"4DLZ",,"X-RAY DIFFRACTION",2.67,53.91,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 200 mM Ca Acetate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi300509j",,"4DLZ",19.86,"1.662","1.662","H-Ras Set 2 Ca(OAc)2/DTE, ordered off","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDEYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4DLZ"
"4DM3",,"X-RAY DIFFRACTION",3.37,63.45,,,,,"10.1021/ml300015u","SAH","4DM3",64.82,"2.4001","2.4001","Crystal structure of human PNMT in complex adohcy, resorcinol and imidazole","MSGADRSPNAGAAPDSAPGQAAVASAYQRFEPRAYLRNNYAPPRGDLCNPNGVGPWKLRCLAQTFATGEVSGRTLIDIGSGPTVYQLLSACSHFEDITMTDFLEVNRQELGRWLQEEPGAFNWSMYSQHACLIEGKGECWQDKERQLRARVKRVLPIDVHQPQPLGAGSPAPLPADALVSAFCLEAVSPDLASFQRALDHITTLLRPGGHLLLIGALEESWYLAGEARLTVVPVSEEEVREALVRSGYKVRDLRTYIMPAHLQTGVDDVKGVFFAWAQKVGLEHHHHHH","Homo sapiens","PNMT, PENT","Phenylethanolamine N-methyltransferase","1","4DM3"
"4DM9",,"X-RAY DIFFRACTION",2.31,46.79,"VAPOR DIFFUSION, HANGING DROP",7,"2.4M ammonium sulfate, 0.1M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.bmcl.2012.04.124",,"4DM9",51.53,"2.35","2.35","The Crystal Structure of Ubiquitin Carboxy-terminal hydrolase L1 (UCHL1) bound to a tripeptide fluoromethyl ketone Z-VAE(OMe)-FMK","GPLGSMQLKPMEINPEMLNKVLSRLGVAGQWRFVDVLGLEEESLGSVPAPACALLLLFPLTAQHENFRKKQIEELKGQEVSPKVYFMKQTIGNSCGTIGLIHAVANNQDKLGFEDGSVLKQFLSETEKMSPEDRAKCFEKNEAIQAAHDAVAQEGQCRVDDKVNFHFILFNNVDGHLYELDGRMPFPVNHGASSEDTLLKDAAKVCREFTEREQGEVRFSAVALCKAA","Homo sapiens","UCHL1","Ubiquitin carboxyl-terminal hydrolase isozyme L1","1","4DM9"
,,,,,,,,,,,,,,,,"XVAXX",,,"Tripeptide fluoromethyl ketone inhibitor Z-VAE(OMe)-FMK","2","4DM9"
"4DMB",,"X-RAY DIFFRACTION",2.14,42.6,,6,"Protein solution: 100mM NaCl, 5mM DTT, 0.02% NaN3, 10mM Tris-HCl (pH 7.5) . Reservoir solution:Mg(NO3)2 0.1M, MES 0.1M, PEG4000 40% (w/v), microbatch under oil, temperature 293KK",293,,,"4DMB",48.37,"1.9","1.9","X-ray structure of human hepatitus C virus NS5A-transactivated protein 2 at the resolution 1.9A, Northeast Structural Genomics Consortium (NESG) Target HR6723","MASVSSATFSGHGARSLLQFLRLVGQLKRVPRTGWVYRNVQRPESVSDHMYRMAVMAMVIKDDRLNKDRCVRLALVHDMAECIVGDIAPADNIPKEEKHRREEEAMKQITQLLPEDLRKELYELWEEYETQSSAEAKFVKQLDQCEMILQASEYEDLEHKPGRLQDFYDSTAGKFNHPEIVQLVSELEAERSTNIAAAASEPHS","Homo sapiens","HDDC2, C6orf74, NS5ATP2, CGI-130","HD domain-containing protein 2","1","4DMB"
"4DMU",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM cacodylate, pH 6.5, 1.20 M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.1112388109",,"4DMU",169.1,"2.8","2.8","Crystal structure of the von Willebrand factor A3 domain in complex with a collagen III derived triple-helical peptide","XGPPGPPGPPGPRGQPGVMGFPGPPGPPXXGPPGPPGPPGPRGQPGVMGFPGPPGPPXXGPPGPPGPPGPRGQPGVMGFPGPPGPPX",,,"Collagen III derived triple-helical peptide","1","4DMU"
,,,,,,,,,,,,,,,,"APDCSQPLDVILLLDGSSSFPASYFDEMKSFAKAFISKANIGPRLTQVSVLQYGSITTIDVPWNVVPEKAHLLSLVDVMQREGGPSQIGDALGFAVRYLTSEMHGARPGASKAVVILVTDVSVDSVDAAADAARSNRVTVFPIGIGDRYDAAQLRILAGPAGDSNVVKLQRIEDLPTMVTLGNSFLHKLCSG","Homo sapiens","VWF, F8VWF","von Willebrand factor","2","4DMU"
"4DMX",,"X-RAY DIFFRACTION",1.95,37.06,"VAPOR DIFFUSION",5.5,"PEG, pH 5.5, VAPOR DIFFUSION, temperature 293K",293,"10.1021/jm3007257","0LB","4DMX",24.01,"1.7","1.7","Cathepsin K inhibitor","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","4DMX"
"4DMY",,"X-RAY DIFFRACTION",2.11,41.65,"VAPOR DIFFUSION",5.5,"PEG, pH 5.5, VAPOR DIFFUSION, temperature 293K",293,"10.1021/jm3007257","0LC","4DMY",48.34,"1.63","1.63","Cathepsin K inhibitor","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","4DMY"
"4DN3",,"X-RAY DIFFRACTION",3.17,61,"VAPOR DIFFUSION, SITTING DROP",7.5,"4.3 M SODIUM FORMATE CRYO VAPOR DIFFUSION, SITTING DROP, temperature 293K, pH 7.5",293,"10.1016/j.molimm.2012.03.022",,"4DN3",47.32,"2.6","2.6","Crystal structure of anti-mcp-1 antibody cnto888","EIVLTQSPATLSLSPGERATLSCRASQSVSDAYLAWYQQKPGQAPRLLIYDASSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYIQLHSFTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CNTO888 LIGHT CHAIN","1","4DN3"
,,,,,,,,,,,,,,,,"QVELVQSGAEVKKPGSSVKVSCKASGGTFSSYGISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDGIYGELDFWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKT","Homo sapiens",,"CNTO888 HEAVY CHAIN","2","4DN3"
"4DN5",,"X-RAY DIFFRACTION",2.66,53.83,"VAPOR DIFFUSION, SITTING DROP",5.4,"12.5% polyethylene glycol 3350, 200 mM ammonium sulfate and 0.1 M sodium citrate, pH 5.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M112.366658",,"4DN5",79.91,"2.5","2.5","Crystal Structure of NF-kB-inducing Kinase (NIK)","GAMGSKFSVEEYLVHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRHPPPNQA","Homo sapiens","MAP3K14, NF-kB-inducing Kinase, NIK","Mitogen-activated protein kinase kinase kinase 14","1","4DN5"
"4DND",,"X-RAY DIFFRACTION",1.56,21.26,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG400, 0.1M Tris pH 8.5, 0.2M MgCl2, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4DND",15.32,"1.4","1.4","Crystal structure of syntaxin 10 from Homo sapiens","MHHHHHHSSGVDLGTENLYFQSMSLEDPFFVVRGEVQKAVNTARGLYQRWCELLQESAAVGREELDWTTNELRNGLRSIEWDLEDLEETIGIVEANPGKFKLPAGDLQERKVFVERMREAVQEMKDHMVS","Homo sapiens","AAC05087.1, STX10, SYN10","Syntaxin-10","1","4DND"
"4DNK",,"X-RAY DIFFRACTION",2.83,56.57,"VAPOR DIFFUSION, SITTING DROP",,"20.00% polyethylene glycol 3350, 0.20M magnesium acetate, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4DNK",57.63,"2.2","2.2","Crystal structure of a tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (YWHAB) from homo sapiens at 2.20 A resolution.","GMTMDKSELVQKAKLAEQAERYDDMAAAMKAVTEQGHELSNEERNLLSVAYKNVVGARRSSWRVISSIEQKTERNEKKQQMGKEYREKIEAELQDICNDVLELLDKYLIPNATQPESKVFYLKMKGDYFRYLSEVASGDNKQTTVSNSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLNEESYKDSTLIMQLLRDNLTLWTSENQGDEGDAGEGEN","Homo sapiens","BC001359, YWHAB","14-3-3 protein beta/alpha","1","4DNK"
"4DNL",,"X-RAY DIFFRACTION",2.62,53.07,"VAPOR DIFFUSION, SITTING DROP",5,"30.00% polyethylene glycol 6000, 0.1M sodium citrate pH 5.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4DNL",16.48,"1.9","1.9","Crystal structure of a C2 domain of a protein kinase C alpha (PRKCA) from Homo sapiens at 1.90 A resolution","GHTEKRGRIYLKAEVADEKLHVTVRDAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSTLNPQWNESFTFKLKPSDKDRRLSVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKLLNQEEGEYYNVPIPEG","Homo sapiens","NM_002737, PKCA, PRKACA, PRKCA","Protein kinase C alpha type","1","4DNL"
"4DO0",,"X-RAY DIFFRACTION",3.35,63.32,"VAPOR DIFFUSION",4.5,"0.1M acetate, 2M ammonium sulfate, pH 4.5, VAPOR DIFFUSION, temperature 277K",277,,"DZA","4DO0",44.51,"2.55","2.55","Crystal Structure of human PHF8 in complex with Daminozide","YFQSMPVKTGSPTFVRELRSRTFDSSDEVILKPTGNQLTVEFLEENSFSVPILVLKKDGLGMTLPSPSFTVRDVEHYVGSDKEIDVIDVTRQADCKMKLGDFVKYYYSGKREKVLNVISLEFSDTRLSNLVETPKIVRKLSWVENLWPEECVFERPNVQKYCLMSVRDSYTDFHIDFGGTSVWYHVLKGEKIFYLIRPTNANLTLFECWSSSSNQNEMFFGDQVDKCYKCSVKQGQTLFIPTGWIHAVLTPVDCLAFGGNFLHSLNIEMQLKAYEIEKRLSTADLFRFPNFETICWYVGKHILDIFRGLRENRRHPASYLVHGGKALNLAFRAWTRKEALPDHEDEIPETVRTVQLIKDLAREIRLVEDIFQQN","Homo sapiens","PHF8, KIAA1111, ZNF422","Histone lysine demethylase PHF8","1","4DO0"
"4DO4",,"X-RAY DIFFRACTION",3.31,62.8,"VAPOR DIFFUSION, HANGING DROP",3.4,"8-16% PEG3350, 70mM citric acid, 30mM Bis-Tris propane, pH 3.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1203924109","DJN","4DO4",96.64,"1.4","1.4","Pharmacological chaperones for human alpha-N-acetylgalactosaminidase","LDNGLLQTPPMGWLAWERFRCNINCDEDPKNCISEQLFMEMADRMAQDGWRDMGYTYLNIDDCWIGGRDASGRLMPDPKRFPHGIPFLADYVHSLGLKLGIYADMGNFTCMGYPGTTLDKVVQDAQTFAEWKVDMLKLDGCFSTPEERAQGYPKMAAALNATGRPIAFSCSWPAYEGGLPPRVQYSLLADICNLWRNYDDIQDSWWSVLSILNWFVEHQDILQPVAGPGHWNDPDMLLIGNFGLSLEQSRAQMALWTVLAAPLLMSTDLRTISAQNMDILQNPLMIKINQDPLGIQGRRIHKEKSLIEVYMRPLSNKASALVFFSCRTDMPYRYHSSLGQLNFTGSVIYEAQDVYSGDIISGLRDETNFTVIINPSGVVMWYLYPIKNLEMSQQHHHHHH","Homo sapiens","NAGA","Alpha-N-acetylgalactosaminidase","1","4DO4"
"4DO5",,"X-RAY DIFFRACTION",3.31,62.8,"VAPOR DIFFUSION, HANGING DROP",3.4,"8-16% PEG3350, 70mM citric acid, 30mM Bis-Tris propane, pH 3.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1203924109","DGJ","4DO5",96.28,"1.51","1.51","Pharmacological chaperones for human alpha-N-acetylgalactosaminidase","LDNGLLQTPPMGWLAWERFRCNINCDEDPKNCISEQLFMEMADRMAQDGWRDMGYTYLNIDDCWIGGRDASGRLMPDPKRFPHGIPFLADYVHSLGLKLGIYADMGNFTCMGYPGTTLDKVVQDAQTFAEWKVDMLKLDGCFSTPEERAQGYPKMAAALNATGRPIAFSCSWPAYEGGLPPRVQYSLLADICNLWRNYDDIQDSWWSVLSILNWFVEHQDILQPVAGPGHWNDPDMLLIGNFGLSLEQSRAQMALWTVLAAPLLMSTDLRTISAQNMDILQNPLMIKINQDPLGIQGRRIHKEKSLIEVYMRPLSNKASALVFFSCRTDMPYRYHSSLGQLNFTGSVIYEAQDVYSGDIISGLRDETNFTVIINPSGVVMWYLYPIKNLEMSQQHHHHHH","Homo sapiens","NAGA","Alpha-N-acetylgalactosaminidase","1","4DO5"
"4DO6",,"X-RAY DIFFRACTION",3.27,62.44,"VAPOR DIFFUSION, HANGING DROP",3.4,"8-16% PEG3350, 70mM citric acid, 30mM Bis-Tris propane, pH 3.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1203924109",,"4DO6",96.33,"1.6","1.6","Pharmacological chaperones for human alpha-N-acetylgalactosaminidase","LDNGLLQTPPMGWLAWERFRCNINCDEDPKNCISEQLFMEMADRMAQDGWRDMGYTYLNIDDCWIGGRDASGRLMPDPKRFPHGIPFLADYVHSLGLKLGIYADMGNFTCMGYPGTTLDKVVQDAQTFAEWKVDMLKLDGCFSTPEERAQGYPKMAAALNATGRPIAFSCSWPAYEGGLPPRVQYSLLADICNLWRNYDDIQDSWWSVLSILNWFVEHQDILQPVAGPGHWNDPDMLLIGNFGLSLEQSRAQMALWTVLAAPLLMSTDLRTISAQNMDILQNPLMIKINQDPLGIQGRRIHKEKSLIEVYMRPLSNKASALVFFSCRTDMPYRYHSSLGQLNFTGSVIYEAQDVYSGDIISGLRDETNFTVIINPSGVVMWYLYPIKNLEMSQQHHHHHH","Homo sapiens","NAGA","Alpha-N-acetylgalactosaminidase","1","4DO6"
"4DO9",,"X-RAY DIFFRACTION",2.25,45.39,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5 
350 mM Sodium Acetate 
18% PEG3350 
, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ja300218x",,"4DO9",48.45,"2.05","2.05","Ternary complex of dna polymerase beta with a dideoxy terminated primer and 2'-deoxyguanosine 5'-beta, gamma-monofluoromethylene triphosphate: stereoselective binding of r-isomer","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4DO9"
,,,,,,,,,,,,,,,,"CCGACCGCGCATCAGC",,,"C C G A C C G C G C A T C A G C","2","4DO9"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"G C T G A T G C G (DOC)","3","4DO9"
,,,,,,,,,,,,,,,,"GTCGG",,,"G T C G G","4","4DO9"
"4DOA",,"X-RAY DIFFRACTION",2.25,45.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5 
350 mM Sodium Acetate 
18% PEG3350 
, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ja300218x",,"4DOA",48.45,"2.051","2.051","Ternary complex of dna polymerase beta with a dideoxy terminated primer and 2'-deoxyguanosine 5'-beta, gamma-monofluoromethylene triphosphate: non-interactive binding of s-isomer","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4DOA"
,,,,,,,,,,,,,,,,"CCGACCGCGCATCAGC",,,"C C G A C C G C G C A T C A G C","2","4DOA"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"G C T G A T G C G (DOC)","3","4DOA"
,,,,,,,,,,,,,,,,"GTCGG",,,"G T C G G","4","4DOA"
"4DOB",,"X-RAY DIFFRACTION",2.26,45.63,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5 
350 mM Sodium Acetate 
18 % PEG3350 
, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ja300218x",,"4DOB",48.46,"2.05","2.05","Ternary complex of DNA polymerase beta with a dideoxy terminated primer and 2'-deoxyguanosine 5'-beta, gamma-monochlororomethylene triphosphate: Stereoselective binding of R-isomer","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4DOB"
,,,,,,,,,,,,,,,,"CCGACCGCGCATCAGC",,,"C C G A C C G C G C A T C A G C","2","4DOB"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"G C T G A T G C G (DOC)","3","4DOB"
,,,,,,,,,,,,,,,,"GTCGG",,,"G T C G G","4","4DOB"
"4DOC",,"X-RAY DIFFRACTION",2.26,45.56,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5 
350 mM Sodium Acetate 
18 % PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ja300218x",,"4DOC",48.46,"1.949","1.949","Ternary complex of dna polymerase beta with a dideoxy terminated primer and 2'-deoxyguanosine 5'-beta, gamma-monochlororomethylene triphosphate:binding of S-isomer","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4DOC"
,,,,,,,,,,,,,,,,"CCGACCGCGCATCAGC",,,"C C G A C C G C G C A T C A G C","2","4DOC"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"G C T G A T G C G (DOC)","3","4DOC"
,,,,,,,,,,,,,,,,"GTCGG",,,"G T C G G","4","4DOC"
"4DOM",,"X-RAY DIFFRACTION",1.81,32.08,"VAPOR DIFFUSION, HANGING DROP",8,"30% PEG 8000, 0.1M Immidazole pH 8.0, 0.2M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.1215770110",,"4DOM",16.72,"1.798","1.798","Crystal Structure of the TIR-domain of Human Myeloid Differentiation Primary Response protein (MyD88)","DMPERFDAFICYCPSDIQFVQEMIRQLEQTNYRLKLCVSDRDVLPGTCVWSIASELIEKRCRRMVVVVSDDYLQSKECDFQTKFALSLSPGAHQKRLIPIKYKAMKKEFPSILRFITVCDYTNPCTKSWFWTRLAKALSLP","Homo sapiens","MYD88","Myeloid differentiation primary response protein MyD88","1","4DOM"
"4DON",,"X-RAY DIFFRACTION",1.76,30.26,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Naformate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,,"3PF","4DON",17.39,"1.52","1.52","Brd4 Bromodomain 1 complex with a fragment 3,4-Dihydro-3-methyl-2(1H)-quinazolinon","MHHHHHHSSGVDLGTENLYFQMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4DON"
"4DOT",,"X-RAY DIFFRACTION",2.62,53,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M BIS-TRIS, 28% PEG MME 2000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1074/jbc.M112.361550",,"4DOT",15.9,"1.96","1.96","Crystal structure of human HRASLS3.","MRAPIPEPKPGDLIEIFRPFYRHWAIYVGDGYVVHLAPPSEVAGAGAASVMSALTDKAIVKKELLYDVAGSDKYQVNNKHDDKYSPLPCSKIIQRAEELVGQEVLYKLTSENCEHFVNELRYGVARSDQVRDLEHHHHHH","Homo sapiens","PLA2G16, HRASLS3, HREV107, PLAAT3","Group XVI phospholipase A2","1","4DOT"
"4DPE",,"X-RAY DIFFRACTION",2.02,39.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"25-30% PEG 8000, 10 mM CaCl2, 100 mM TRIS 
, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1039/c3cc41278d","NGH","4DPE",40.89,"1.96","1.96","Structure of MMP3 complexed with a platinum-based inhibitor.","FRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGPPPDSPET","Homo sapiens","MMP3, STMY1","Stromelysin-1","1","4DPE"
"4DPF",,"X-RAY DIFFRACTION",2.18,43.63,"VAPOR DIFFUSION",4.5,"18% PEG 1000, 0.1 Na-Acetate pH4.5, 5% Glycerol, vapor diffusion, temperature 291K",291,"10.1016/j.bmc.2012.05.039","0LG","4DPF",44.25,"1.8","1.8","BACE-1 in complex with a HEA-macrocyclic type inhibitor","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4DPF"
"4DPI",,"X-RAY DIFFRACTION",2.18,43.63,"VAPOR DIFFUSION",4.5,"18% PEG 1000, 0.1 Na-Acetate pH4.5, 5% Glycerol, vapor diffusion, temperature 291K",291,"10.1016/j.bmc.2012.05.039","0N1","4DPI",44.16,"1.9","1.9","BACE-1 in complex with HEA-macrocyclic inhibitor, MV078512","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4DPI"
"4DPR",,"X-RAY DIFFRACTION",2.43,49.44,"LIQUID DIFFUSION",6.7,"26% PEG 8000, 0.1 mM Na-acetate, 0.1 mM Imidazole, 5 mM YbCL3, pH 6.7, LIQUID DIFFUSION, temperature 277K",277,"10.1073/pnas.1710850114","X8Z","4DPR",70.76,"2.02","2.02","Structure of human Leukotriene A4 hydrolase in complex with inhibitor captopril","MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","4DPR"
"4DPZ",,"X-RAY DIFFRACTION",2.11,41.78,"VAPOR DIFFUSION, SITTING DROP",7,"1.1 ammonium tartrate dibasic, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1074/jbc.M112.361550",,"4DPZ",15.27,"1.25","1.25","Crystal structure of human HRASLS2","MALARPRPRLGDLIEISRFGYAHWAIYVGDGYVVHLAPASEIAGAGAASVLSALTNKAIVKKELLSVVAGGDNYRVNNKHDDRYTPLPSNKIVKRAEELVGQELPYSLTSDNCEHFVNHLRYGVSRSDQLEHHHHHH","Homo sapiens","HRASLS2, PLAAT2","HRAS-like suppressor 2","1","4DPZ"
"4DQY",,"X-RAY DIFFRACTION",2.8,56.13,"VAPOR DIFFUSION, SITTING DROP",7.5,"7% Peg 3350, 10% ethylene glycol, 100 mM Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1126/science.1216338",,"4DQY",193.57,"3.25","3.25","Structure of Human PARP-1 bound to a DNA double strand break","MGSSHHHHHHSSGLVPRGSHMAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPHWYHFSCFWKVGHSIRHPDVEVDGFSELRWDDQQKVKKTAEAGGVTG","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","4DQY"
,,,,,,,,,,,,,,,,"MVDEVAKKKSKKEKDKDSKLEKALKAQNDLIWNIKDELKKVCSTNDLKELLIFNKQQVPSGESAILDRVADGMVFGALLPCEECSGQLVFKSDAYYCTGDVTAWTKCMVKTQTPNRKEWVTPKEFREISYLKKLKVKKQDRIFPPETSASVALEHHHHHH","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","2","4DQY"
,,,,,,,,,,,,,,,,"MKSEKRMKLTLKGGAAVDPDSGLEHSAHVLEKGGKVFSATLGLVDIVKGTNSYYKLQLLEDDKENRYWIFRSWGRVGTVIGSNKLEQMPSKEDAIEHFMKLYEEKTGNAWHSKNFTKYPKKFYPLEIDYGQDEEAVKKLTVNPGTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTSLWLEHHHHHH","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","3","4DQY"
,,,,,,,,,,,,,,,,"GCCTACCGGTTCGCGAACCGGTAGGC",,,"DNA (26-MER)","4","4DQY"
"4DRK",,"X-RAY DIFFRACTION",2.17,43.38,"VAPOR DIFFUSION",7.5,"37.5 % PEG3350, 0.1 M NH4OAc, 0.1 M HEPES pH 7.5, 10 % DMSO, vapor diffusion, temperature 293K",293,"10.1021/jm201746x","I63","4DRK",29.22,"1.5","1.5","EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[(1R)-3-(3,4-dimethoxyphenyl)-1-({[(2S)-1-(3,3-dimethyl-2-oxopentanoyl)piperidin-2-yl]carbonyl}oxy)propyl]phenoxy}acetic acid","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4DRK"
"4DRM",,"X-RAY DIFFRACTION",2.36,47.89,"VAPOR DIFFUSION",7.5,"37.5 % PEG3350, 0.1 M NH4OAc, 0.1 M HEPES pH 7.5, 10 % DMSO, vapor diffusion, temperature 293K",293,"10.1021/jm201746x","0MC","4DRM",14.67,"1.48","1.48","EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[(1R)-3-(3,4-dimethoxyphenyl)-1-({[(2S)-1-{[(1S,2R)-2-ethyl-1-hydroxycyclohexyl](oxo)acetyl}piperidin-2-yl]carbonyl}oxy)propyl]phenoxy}acetic acid","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4DRM"
"4DRN",,"X-RAY DIFFRACTION",2.63,53.24,"VAPOR DIFFUSION",7.5,"37.5 % PEG3350, 0.1 M NH4OAc, 0.1 M HEPES pH 7.5, 10 % DMSO, vapor diffusion, temperature 293K",293,"10.1021/jm201746x","0MC","4DRN",14.67,"1.069","1.069","EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[(1R)-3-(3,4-dimethoxyphenyl)-1-({[(2S)-1-{[(1S,2R)-2-ethyl-1-hydroxycyclohexyl](oxo)acetyl}piperidin-2-yl]carbonyl}oxy)propyl]phenoxy}acetic acid","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4DRN"
"4DRO",,"X-RAY DIFFRACTION",2.34,47.38,"VAPOR DIFFUSION",7.5,"37.5 % PEG3350, 0.1 M NH4OAc, 0.1 M HEPES pH 7.5, 10 % DMSO, vapor diffusion, temperature 293K",293,"10.1021/jm201746x","0MD","4DRO",14.67,"1.1","1.1","EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH (1R)-3-(3,4-dimethoxyphenyl)-1-phenylpropyl (2S)-1-{[(1R,2S)-2-ethyl-1-hydroxycyclohexyl](oxo)acetyl}piperidine-2-carboxylate","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4DRO"
"4DRP",,"X-RAY DIFFRACTION",2.9,57.56,"VAPOR DIFFUSION",7.5,"37.5 % PEG3350, 0.1 M NH4OAc, 0.1 M HEPES pH 7.5, 10 % DMSO, vapor diffusion, temperature 293K",293,"10.1021/jm201746x","0MD","4DRP",14.67,"1.8","1.8","Evaluation of Synthetic FK506 Analogs as Ligands for the FK506-Binding Proteins 51 and 52: Complex of FKBP51 with 2-(3-((R)-3-(3,4-dimethoxyphenyl)-1-((S)-1-(2-((1R,2S)-2-ethyl-1-hydroxy-cyclohexyl)-2-oxoacetyl)piperidine-2-carbonyloxy)propyl)phenoxy)acetic acid from cocrystallization","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4DRP"
"4DRQ",,"X-RAY DIFFRACTION",2.31,46.83,"VAPOR DIFFUSION",7.5,"37.5 % PEG3350, 0.1 M NH4OAc, 0.1 M HEPES pH 7.5, 10 % DMSO, vapor diffusion, temperature 293K",293,"10.1021/jm201747c","0OS","4DRQ",14.69,"1","1","Exploration of Pipecolate Sulfonamides as Binders of the FK506-Binding Proteins 51 and 52: Complex of FKBP51 with 2-(3-((R)-1-((S)-1-(3,5-dichlorophenylsulfonyl)piperidine-2-carbonyloxy)-3-(3,4-dimethoxy -phenyl)propyl)phenoxy)acetic acid","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4DRQ"
"4DRZ",,"X-RAY DIFFRACTION",1.73,28.71,"VAPOR DIFFUSION, HANGING DROP",7.2,"20% PEG-3350, 0.2M CALCIUM ACETATE, pH 7.2, vapor diffusion, hanging drop",,,,"4DRZ",22.5,"2.3","2.3","Crystal structure of human RAB14","MGSSHHHHHHSSGLVPRGSMATAPYNYSYIFKYIIIGDMGVGKSCLLHQFTEKKFMADCPHTIGVEFGTRIIEVSGQKIKLQIWDTAGQGRFRAVTRSYYRGAAGALMVYDITRRSTYNHLSSWLTDARNLTNPNTVIILIGNKADLEAQRDVTYEEAKQFAEENGLLFLEASAKTGENVEDAFLEAAKKIYQNIQ","Homo sapiens","RAB14","Ras-related protein Rab-14","1","4DRZ"
"4DSA",,"X-RAY DIFFRACTION",3.07,59.88,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M MES, 30%(w/v) PEG 1500, 0.01M Betaine hydrochloride, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4DSA",169.38,"3.25","3.25","Crystal Structure of DPP-IV with Compound C1","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","4DSA"
"4DSN",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 uL + 0.2 uL drops containing 40 mg/mL KRas, 0.1 M TrisCl, 25% polyethylene glycol 4000, 0.2 M NaOAc, 2% benzamidine-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1116510109",,"4DSN",22.22,"2.03","2.03","Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity","GSTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEKMSKDGKKKKKKSKTKCVIM","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas, isoform 2B","1","4DSN"
"4DSO",,"X-RAY DIFFRACTION",2.19,43.81,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 uL + 0.2 uL drops containing 40 mg/mL KRas, 0.1 M TrisCl, 25% polyethylene glycol 4000, 0.2 M NaOAc, 2% benzamidine-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1116510109",,"4DSO",22.31,"1.85","1.85","Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity","GSTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEKMSKDGKKKKKKSKTKCVIM","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas, isoform 2B","1","4DSO"
"4DST",,"X-RAY DIFFRACTION",2.19,43.81,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 uL + 0.2 uL drops containing 40 mg/mL KRas, 0.1 M TrisCl, 25% polyethylene glycol 4000, 0.2 M NaOAc, 2% benzamidine-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1116510109","9LI","4DST",22.63,"2.3","2.3","Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity","GSTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEKMSKDGKKKKKKSKTKCVIM","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas, isoform 2B","1","4DST"
"4DSU",,"X-RAY DIFFRACTION",2.21,44.29,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 uL + 0.2 uL drops containing 40 mg/mL KRas, 0.1 M TrisCl, 25% polyethylene glycol 4000, 0.2 M NaOAc, 2% benzamidine-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1116510109","BZI","4DSU",22.12,"1.7","1.7","Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity","GSTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEKMSKDGKKKKKKSKTKCVIM","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas, isoform 2B","1","4DSU"
"4DSZ",,"X-RAY DIFFRACTION",3.14,60.83,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M MES, 30%(w/v) PEG 1500, 0.01M Betaine hydrochloride, pH 5.5, vapor diffusion, hanging drop, temperature 291K",291,,,"4DSZ",169.65,"3.2","3.2","Crystal Structure of DPP-IV with Compound C2","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","4DSZ"
"4DT6",,"X-RAY DIFFRACTION",2.55,51.73,"VAPOR DIFFUSION, SITTING DROP",,"The purified protein which contained 100 uM m7-GTP was concentrated to about 7 mg/mL in 20 mM Hepes, pH 7.6, 100 mM KCl, 1mM DTT, and 0.1 mM EDTA for crystallization. The m7-GTP-bound eIF4e protein was crystallized with 1:1 ratio of protein solution to reservoir solution of 17-20% PEG-3350 and 0.1-0.4M Na formate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm300037x","6LI","4DT6",28.9,"2.6","2.6","Co-crystal structure of eIF4E with inhibitor","MDYKDDDDKHHHHHHTENLYFQGMATVEPETTPTPNPPTTEEEKTESNQEVANPEHYIKHPLQNRWALWFFKNDKSKTWQANLRLISKFDTVEDFWALYNHIQLSSNLMPGCDYSLFKDGIEPMWEDEKNKRGGRWLITLNKQQRRSDLDRFWLETLLCLIGESFDDYSDDVCGAVVNVRAKGDKIAIWTTECENREAVTHIGRVYKERLGLPPKIVIGYQSHADTATKSGSTTKNRFVV","Homo sapiens","EIF4E, EIF4EL1, EIF4F","Eukaryotic translation initiation factor 4E","1","4DT6"
"4DTC",,"X-RAY DIFFRACTION",3.22,61.79,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M MES, 30%(w/v) PEG 1500, 0.01M Betaine hydrochloride, pH 5.5, vapor diffusion, hanging drop, temperature 291K",291,,,"4DTC",169.86,"3","3","Crystal Structure of DPP-IV with Compound C5","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","4DTC"
"4DTK",,"X-RAY DIFFRACTION",3.5,64.81,"VAPOR DIFFUSION, HANGING DROP",7.3,"18% PEG 3350, 0.2 M Na2SO4, 6% ethylene glycol, 0.1 M Tris, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.05.098","7LI","4DTK",32.89,"1.86","1.86","Novel and selective pan-PIM kinase inhibitor","EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4DTK"
"4DTT",,"X-RAY DIFFRACTION",3.95,68.9,,7,"10-13% PEG MME 5000, 100 MM HEPES PH 7.0, 4-14% TACSIMATE, 10% DIOXANE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1016/j.ejmech.2014.04.009",,"4DTT",230.75,"3.22","3.22","Crystal structure of human insulin degrading enzyme (ide) in complex with compund 41367","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLEHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4DTT"
"4DU0",,"X-RAY DIFFRACTION",2.74,55.1,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 Magnesium Chloride, 0.1M HEPES, pH7.5, 30% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.355255",,"4DU0",14.3,"1.9","1.9","Crystal structure of human alpha-defensin 1, HNP1 (G17A mutant)","ACYCRIPACIAGERRYATCIYQGRLWAFCC","Homo sapiens","DEFA1, DEF1, DEFA2, MRS, DEFA1B","Neutrophil defensin 1","1","4DU0"
"4DUM",,"X-RAY DIFFRACTION",2.51,51.04,"VAPOR DIFFUSION, SITTING DROP",,"The purified protein which contained 100 uM m7-GTP was then concentrated to about 7 mg/mL in 20 mM Hepes, pH7.6, 100 mM KCl, 1mM DTT, 0.1 mM EDTA for crystallization. The m7-GTP-bound eIF4e protein was crystallized with 1:1 ratio of protein solution to reservoir solution of 17-20% PEG-3350 and 0.1-0.4M Na formate, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1021/jm300037x","HLI","4DUM",28.64,"2.95","2.95","Co-crystal structure of eIF4E with inhibitor","MDYKDDDDKHHHHHHTENLYFQGMATVEPETTPTPNPPTTEEEKTESNQEVANPEHYIKHPLQNRWALWFFKNDKSKTWQANLRLISKFDTVEDFWALYNHIQLSSNLMPGCDYSLFKDGIEPMWEDEKNKRGGRWLITLNKQQRRSDLDRFWLETLLCLIGESFDDYSDDVCGAVVNVRAKGDKIAIWTTECENREAVTHIGRVYKERLGLPPKIVIGYQSHADTATKSGSTTKNRFVV","Homo sapiens","EIF4E, EIF4EL1, EIF4F","Eukaryotic translation initiation factor 4E","1","4DUM"
"4DUQ",,"X-RAY DIFFRACTION",2.72,54.82,"VAPOR DIFFUSION, HANGING DROP",4,"0.1 mM Na+ acetate, 40% PEG 400, pH 4.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1111/j.1742-4658.2012.08556.x",,"4DUQ",25.38,"1.3","1.3","The Structure of Ca2+-loaded S100A2 at 1.3A resolution","MMSSSLEQALAVLVTTFHKYSSQEGDKFKLSKGEMKELLHKELPSFVGEKVDEEGLKKLMGSLDENSDQQVDFQEYAVFLALITVMSNDFFQGCPDRP","Homo sapiens","S100A2, S100L","Protein S100-A2","1","4DUQ"
"4DUR",,"X-RAY DIFFRACTION",3.98,69.12,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M sodium citrate, 0.2M sodium acetate, polyethylene glycol 1000, polyethylene glycol 8000, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.celrep.2012.02.012",,"4DUR",178.95,"2.45","2.45","The X-ray Crystal Structure of Full-Length type II Human Plasminogen","EPLDDYVNTQGASLFSVTKKQLGAGSIEECAAKCEEDEEFTCRAFQYHSKEQQCVIMAENRKSSIIIRMRDVVLFEKKVYLSECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILECEEECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDRELRPWCFTTDPNKRWELCDIPRCTTPPPSSGPTYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHNRTPENFPCKNLDENYCRNPDGKRAPWCHTTNSQVRWEYCKIPSCDSSPVSTEQLAPTAPPELTPVVQDCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENYPNAGLTMNYCRNPDADKGPWCFTTDPSVRWEYCNLKKCSGTEASVVAPPPVVLLPDVETPSEEDCMFGNGKGYRGKRATTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQCAAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN","Homo sapiens","PLG","Plasminogen","1","4DUR"
"4DUS",,"X-RAY DIFFRACTION",2.8,56.05,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% (w/v) PEG 5000 monomethylethyl ether (MME), 200mM sodium citrate, 200mM sodium iodide, , pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ml3000148","0MP, OMP","4DUS",47.38,"2.5","2.5","Structure of Bace-1 (Beta-Secretase) in complex with N-((2S,3R)-1-(4-fluorophenyl)-3-hydroxy-4-((6'-neopentyl-3',4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridin]-4'-yl)amino)butan-2-yl)acetamide","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4DUS"
"4DUU",,"X-RAY DIFFRACTION",4.02,69.4,"VAPOR DIFFUSION, HANGING DROP",7.4,"2M sodium formate, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.celrep.2012.02.012",,"4DUU",88.54,"5.2","5.2","The X-ray Crystal Structure of Full-Length type I Human Plasminogen","EPLDDYVNTQGASLFSVTKKQLGAGSIEECAAKCEEDEEFTCRAFQYHSKEQQCVIMAENRKSSIIIRMRDVVLFEKKVYLSECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILECEEECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDRELRPWCFTTDPNKRWELCDIPRCTTPPPSSGPTYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHNRTPENFPCKNLDENYCRNPDGKRAPWCHTTNSQVRWEYCKIPSCDSSPVSTEQLAPTAPPELTPVVQDCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENYPNAGLTMNYCRNPDADKGPWCFTTDPSVRWEYCNLKKCSGTEASVVAPPPVVLLPDVETPSEEDCMFGNGKGYRGKRATTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQCAAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN","Homo sapiens","PLG","Plasminogen","1","4DUU"
"4DVA",,"X-RAY DIFFRACTION",2.19,43.73,"VAPOR DIFFUSION, SITTING DROP",4.6,"2.0M ammonium sulfate, 50mM sodium citrate, 5% PEG400, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1042/BJ20121132",,"4DVA",28.47,"1.94","1.94","The crystal structure of human urokinase-type plasminogen activator catalytic domain","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4DVA"
"4DVI",,"X-RAY DIFFRACTION",2.36,47.98,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES pH 6.0, 0.2 or 0.4 M Di-Ammonium Tartrate, 12.5-25% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1371/journal.pone.0033740","2IW","4DVI",51.06,"1.9","1.9","Crystal structure of Tankyrase 1 with IWR2","QGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEHHHHHH","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4DVI"
"4DVQ",,"X-RAY DIFFRACTION",2.8,56.2,,8.5,"6% PEG 4000, 0.1M Tris, pH 8.5, 0.2M Lithium sulfate, vapor diffusion, hanging drop, temperature 298K",298,"10.1210/me.2012-1287",,"4DVQ",680.02,"2.49","2.49","Structure of human aldosterone synthase, CYP11B2, in complex with deoxycorticosterone","MAKKTSSTVLPFEAMPQHPGNRWLRLLQIWREQGYEHLHLEMHQTFQELGPIFRYNLGGPRMVCVMLPEDVEKLQQVDSLHPCRMILEPWVAYRQHRGHKCGVFLLNGPEWRFNRLRLNPDVLSPKAVQRFLPMVDAVARDFSQALKKKVLQNARGSLTLDVQPSIFHYTIEASNLALFGERLGLVGHSPSSASLNFLHALEVMFKSTVQLMFMPRSLSRWISPKVWKEHFEAWDCIFQYGDNCIQKIYQELAFNRPQHYTGIVAELLLKAELSLEAIKANSMELTAGSVDTTAFPLLMTLFELARNPDVQQILRQESLAAAASISEHPQKATTELPLLRAALKETLRLYPVGLFLERVVSSDLVLQNYHIPAGTLVQVFLYSLGRNAALFPRPERYNPQRWLDIRGSGRNFHHVPFGFGMRQCLGRRLAEAEMLLLLHHVLKHFLVETLTQEDIKMVYSFILRPGTSPLLTFRAINHHHHHH","Homo sapiens","Aldosterone synthase, CYP11B2","Cytochrome P450 11B2, mitochondrial","1","4DVQ"
"4DWF",,"X-RAY DIFFRACTION",2.46,49.98,"VAPOR DIFFUSION, SITTING DROP",5.6,"2.0M (NH4)2SO4, 0.2M K/Na Tartrate, 0.1M Citrate pH 5.6, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4DWF",20.3,"1.8","1.8","Crystal structure of a HLA-B associated transcript 3 (BAT3) from Homo sapiens at 1.80 A resolution","GEPDSLEVLVKTLDSQTRTFIVGAQMNVKEFKEHIAASVSIPSEKQRLIYQGRVLQDDKKLQEYNVGGKVIHLVERAPPQTHLPSGASSG","Homo sapiens","BAG6, BAT3, BC003133, G3","HLA-B-associated transcript 3","1","4DWF"
"4DWK",,"X-RAY DIFFRACTION",3.95,68.87,"VAPOR DIFFUSION, HANGING DROP",7,"10-13% PEG MME 5000, 100 MM HEPES PH 7.0, 4-14% TACSIMATE, 10% DIOXANE, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,"10.1016/j.ejmech.2014.04.009",,"4DWK",230.06,"3","3","Structure of cystein free insulin degrading enzyme with compound bdm41671 ((s)-2-{2-[carboxymethyl-(3-phenyl-propyl)-amino]-acetylamino}-3-(1h-imidazol-4-yl)-propionic acid methyl ester)","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4DWK"
"4DWN",,"X-RAY DIFFRACTION",1.89,35,"VAPOR DIFFUSION, HANGING DROP",7,"HEPES pH 7.0, ammonium sulfate, DMSO, PEG 8000, L-glutathione reduced/oxidized, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444913001558",,"4DWN",24.03,"1.581","1.581","Crystal Structure of Human BinCARD CARD","SNADQTYCDRLVQDTPFLTGHGRLSEQQVDRIILQLNRYYPQILTNKEAEKFRNPKASLRVRLCDLLSHLQRSGERDCQEFYRALYIHAQPLHSRLPSRH","Homo sapiens","C9orf89, CARD19","Bcl10-interacting CARD protein","1","4DWN"
"4DX1",,"X-RAY DIFFRACTION",3.08,60.01,"VAPOR DIFFUSION, HANGING DROP",7.8,"0.35M sodium potassium phosphate, 0.1M HEPES, 10% glycerol, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi300279b",,"4DX1",59.48,"2.85","2.85","Crystal structure of the human TRPV4 ankyrin repeat domain","MFNRPILFDIVSRGSTADLDGLLPFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSNGRNDTIPVLLDIAERTGNMREFINSPFRDIYYRGQTALHIAIERRCKHYVELLVAQGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVNYLTENPHKKADMRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLLKCARLFPDSNLEAVLNNDGLSPLMMAAKTGKIGIFQHIIRREVTDEAAAHHHHHH","Homo sapiens","TRPV4, VRL2, VROAC","Transient receptor potential cation channel subfamily V member 4","1","4DX1"
"4DX2",,"X-RAY DIFFRACTION",5.03,75.55,"VAPOR DIFFUSION, HANGING DROP",7.8,"3.5% PEG4000, 0.1M HEPES, 10% glycerol, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi300279b",,"4DX2",59.69,"2.95","2.95","Crystal structure of the human TRPV4 ankyrin repeat domain","MFNRPILFDIVSRGSTADLDGLLPFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSNGRNDTIPVLLDIAERTGNMREFINSPFRDIYYRGQTALHIAIERRCKHYVELLVAQGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVNYLTENPHKKADMRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLLKCARLFPDSNLEAVLNNDGLSPLMMAAKTGKIGIFQHIIRREVTDEAAAHHHHHH","Homo sapiens","TRPV4, VRL2, VROAC","Transient receptor potential cation channel subfamily V member 4","1","4DX2"
"4DXT",,"X-RAY DIFFRACTION",2.74,55.11,"VAPOR DIFFUSION, HANGING DROP",8,"16% PEG3350, 0.2 M potassium thiocyanate, VAPOR DIFFUSION, HANGING DROP, temperature 291K, pH 8.0",291,"10.1016/j.cell.2012.03.046",,"4DXT",22.18,"2.22","2.22","Human SUN2 (AA 522-717)","GPGVTEEQVHHIVKQALQRYSEDRIGLADYALESGGASVISTRCSETYETKTALLSLFGIPLWYHSQSPRVILQPDVHPGNCWAFQGPQGFAVVRLSARIRPTAVTLEHVPKALSPNSTISSAPKDFAIFGFDEDLQQEGTLLGKFTYDQDGEPIQTFHFQAPTMATYQVVELRILTNWGHPEYTCIYRFRVHGEPAH","Homo sapiens","SUN2, FRIGG, KIAA0668, RAB5IP, UNC84B","SUN domain-containing protein 2","1","4DXT"
"4DY0",,"X-RAY DIFFRACTION",2.76,55.43,"VAPOR DIFFUSION, HANGING DROP",7.4,"25mM NaAc, 12% PEG3350, 0.2M (NH4)2SO4, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1182/blood-2012-03-415869",,"4DY0",84.99,"2.35","2.35","Crystal structure of native protease nexin-1 with heparin","SHFNPLSLEELGSNTGIQVFNQIVKSRPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRYGVNGVGKILKKINKAIVSKKNKDIVTVANAVFVKNASEIEVPFVTRNKDVFQCEVRNVNFEDPASACDSINAWVKNETRDMIDNLLSPDLIDGVLTRLVLVNAVYFKGLWKSRFQPENTKKRTFVAADGKSYQVPMLAQLSVFRCGSTSAPNDLWYNFIELPYHGESISMLIALPTESSTPLSAIIPHISTKTIDSWMSIMVPKRVQVILPKFTAVAQTDLKEPLKVLGITDMFDSSKANFAKITTGSENLHVSHILQKAKIEVSEDGTKASAATTAILIARSSPPWFIVDRPFLFFIRHNPTGAVLFMGQINKP","Homo sapiens","SERPINE2, PI7, PN1","Glia-derived nexin","1","4DY0"
"4DYL",,"X-RAY DIFFRACTION",2.18,43.57,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.20M Na(malonate), 0.1M BTProp pH 6.5, 20.0% PEG 3350, 10.0% Ethylene Glycol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4DYL",46.48,"2.18","2.18","F-BAR domain of human FES tyrosine kinase","SMGFSSELCSPQGHGVLQQMQEAELRLLEGMRKWMAQRVKSDREYAGLLHHMSLQDSGGQSRAISPDSPISQSWAEITSQTEGLSRLLRQHAEDLNSGPLSKLSLLIRERQQLRKTYSEQWQQLQQELTKTHSQDIEKLKSQYRALARDSAQAKRKYQEASKDKDRDKAKDKYVRSLWKLFAHHNRYVLGVRAAQLHHQHHHQLLLPGLLRSLQDLHEEMACILKEILQEYLEISSLVQDEVVAIHREMAAAAARIQPEAEYQGFLRQYGSAPDVPPCVTFDESLLEEGEPLEPGELQLNELTVESVQHTLTSVTDELAVATEMVFRRQEMVTQLQQELRNEEENTHPRERVQLLGKRQVLQEALQGLQVALCSQAKLQAQQELLQTKLEHLGPGEPPPVLLLQDD","Homo sapiens","FES, FPS","Tyrosine-protein kinase Fes/Fps","1","4DYL"
"4DYM",,"X-RAY DIFFRACTION",2.4,48.85,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.60M MgSO4;  0.1M MES pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,,,"4DYM",35.4,"2.42","2.42","Crystal structure of the ACVR1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor K00135","SMQRTVAHQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","4DYM"
"4DYO",,"X-RAY DIFFRACTION",2.85,56.78,"VAPOR DIFFUSION, SITTING DROP",8,"15% PEG3350, 0.25 M magnesium chloride, 0.1 M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1186/1472-6807-12-14",,"4DYO",54.42,"2.2","2.2","Crystal Structure of Human Aspartyl Aminopeptidase (DNPEP) in complex with Aspartic acid Hydroxamate","MSGHSPTRGAMQVAMNGKARKEAVQTAAKELLKFVNRSPSPFHAVAECRNRLLQAGFSELKETEKWNIKPESKYFMTRNSSTIIAFAVGGQYVPGNGFSLIGAHTDSPCLRVKRRSRRSQVGFQQVGVETYGGGIWSTWFDRDLTLAGRVIVKCPTSGRLEQQLVHVERPILRIPHLAIHLQRNINENFGPNTEMHLVPILATAIQEELEKGTPEPGPLNAVDERHHSVLMSLLCAHLGLSPKDIVEMELCLADTQPAVLGGAYDEFIFAPRLDNLHSCFCALQALIDSCAGPGSLATEPHVRMVTLYDNEEVGSESAQGAQSLLTELVLRRISASCQHPTAFEEAIPKSFMISADMAHAVHPNYLDKHEENHRPLFHKGPVIKVNSKQRYASNAVSEALIREVANKVKVPLQDLMVRNDTPCGTTIGPILASRLGLRVLDLGSPQLAMHSIREMACTTGVLQTLTLFKGFFELFPSLAENLYFQ","Homo sapiens","ASPEP, DAP, DNPEP","Aspartyl aminopeptidase","1","4DYO"
"4DYX",,"X-RAY DIFFRACTION",2.99,58.82,"VAPOR DIFFUSION, SITTING DROP",8,"50 mM Tris, 5 mM calcium chloride, 200 microM cupric chloride , pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/nchembio.1163",,"4DYX",20.47,"1.85","1.85","Crystal Structure of the Cu-adduct of Human H-Ferritin variant 4His-delta C-star","TSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFHHQSHEEHEHAHKLMKLQNQRGGRIFLQDIQKPDEDDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLG","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","4DYX"
"4DYY",,"X-RAY DIFFRACTION",3.01,59.13,"VAPOR DIFFUSION, SITTING DROP",8,"50 mM Tris, 5 mM calcium chloride, 8% PEG 1900 MME, 700 micro M cupric chloride, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/nchembio.1163",,"4DYY",20.5,"1.9","1.9","Crystal Structure of the Cu-adduct of Human H-Ferritin variant MIC1","TSQVRQNYHQDSEAAINRQINLELYASYVYLSMSEYFDRDDVALKNFAKYFHHQSHEEHEHAHKLMKLQEQRGGRIFLQDIQKADEDDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLG","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","4DYY"
"4DYZ",,"X-RAY DIFFRACTION",3.08,60.12,"VAPOR DIFFUSION, SITTING DROP",8,"50 mM Tris, 10 mM calcium chloride, 4% PEG 400, soaked in 20 mM EDTA, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/nchembio.1163",,"4DYZ",20.27,"2.3","2.3","Crystal Structure of the apo form of Human H-Ferritin variant MIC1","TSQVRQNYHQDSEAAINRQINLELYASYVYLSMSEYFDRDDVALKNFAKYFHHQSHEEHEHAHKLMKLQEQRGGRIFLQDIQKADEDDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLG","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","4DYZ"
"4DZ0",,"X-RAY DIFFRACTION",3.06,59.75,"VAPOR DIFFUSION, SITTING DROP",8,"50 mM Tris, 5 mM calcium chloride, 50 mM sodium chloride, 10% PEG 3350, 350   M cupric chloride, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/nchembio.1163",,"4DZ0",20.64,"2.5","2.5","Crystal structure of the Cu-adduct of human H-Ferritin variant MIC1 labeled with a dansyl fluorophore","TSQVRQNYHQDSEAAINRQINLELYASYVYLSMSEYFDRDDVALKNFACYFHHQSHEEHEHAHKLMKLQEQRGGRIFLQDIQKADEDDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLG","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","4DZ0"
"4DZ5",,"X-RAY DIFFRACTION",2.39,48.47,"VAPOR DIFFUSION, HANGING DROP",7.55,"0.2 M sodium acetate, 20% PEG 3350, pH 7.55, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4DZ5",39.06,"1.7","1.7","W227F active site mutant of AKR1C3","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRFVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4DZ5"
"4DZ7",,"X-RAY DIFFRACTION",2.08,40.93,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Na-Citrate and 50 mM Tris-Cl at pH 7.8 used as precipitant solution. DMSO was used to dissolve the inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"D02","4DZ7",29.79,"1.491","1.491","hCA II in complex with novel sulfonamide inhibitors Set D","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4DZ7"
"4DZ8",,"X-RAY DIFFRACTION",2.74,55.19,"VAPOR DIFFUSION, SITTING DROP",7,"50 mM Hepes, pH 7.0, 1% Tryptone, and 20% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.jmb.2012.04.020",,"4DZ8",53.26,"1.91","1.91","human IgG1 Fc fragment Heterodimer","TCPRCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4DZ8"
,,,,,,,,,,,,,,,,"TCPECPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCEVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Ig gamma-1 chain C region","2","4DZ8"
"4DZ9",,"X-RAY DIFFRACTION",2.08,40.88,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Na-Citrate and 50 mM Tris-Cl at pH 7.8 used as precipitant solution. DMSO was used to dissolve the inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4DZ9",29.82,"1.491","1.491","hCA II in complex with novel sulfonamide inhibitors Set D","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4DZ9"
"4DZB",,"X-RAY DIFFRACTION",2.09,41.04,"VAPOR DIFFUSION, HANGING DROP",5,"25% PEG 1500, 0.1M MIB buffer (sodium malonate, imidazole, boric acid), VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1084/jem.20112095",,"4DZB",50.32,"1.7","1.7","Mucosal-associated invariant T cell receptor, Valpha7.2Jalpha33-Vbeta2","GQNIDQPTEMTATEGAIVQINCTYQTSGFNGLFWYQQHAGEAPTFLSYNVLDGLEEKGRFSSFLSRSKGYSYLLLKELQMKDSASYLCAFMDSNYQLIWGAGTKLIIKPDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"Valpha7.2-Jalpha33 (MAIT T cell receptor)","1","4DZB"
,,,,,,,,,,,,,,,,"GAVVSQHPSWVISKSGTSVKIECRSLDFQATTMFWYRQFPKQSLMLMATSNEGSKATYEQGVEKDKFLINHASLTLSTLTVTSAHPEDSSFYICSARTSGDFGEQFFGPGTRLTVLEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Vbeta2 (MAIT T cell receptor)","2","4DZB"
"4DZO",,"X-RAY DIFFRACTION",2.17,43.32,"hanging-drop vapor diffusion",6.2,"20 mM Tris, 100 mM KCl, 1 mM TCEP, 26% (w/v) PEG1500, 0.1 M Na Cacodylate, pH 6.2, 1mM reduced L-Glutathione;, hanging-drop vapor diffusion, temperature 293K",293,"10.1073/pnas.1118210109",,"4DZO",28.13,"1.76","1.76","Structure of Human Mad1 C-terminal Domain Reveals Its Involvement in Kinetochore Targeting","GSSKEVAELKKQVESAELKNQRLKEVFQTKIQEFRKACYTLTGYQIDITTENQYRLTSLYAEHPGDCLIFKATSPSGSKMQLLETEFSHTVGELIEVHLRRQDSIPAFLSSLTLELFSRQTVA","Homo sapiens","MAD1, MAD1L1, TXBP181","Mitotic spindle assembly checkpoint protein MAD1","1","4DZO"
"4E1H",,"X-RAY DIFFRACTION",1.88,34.56,"VAPOR DIFFUSION, HANGING DROP",3.5,"100mM Citrate pH 3.5, 10mM iron (II) chloride, and 25% PEG 3350, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/ja403001q",,"4E1H",9.48,"1.4","1.4","Fragment of human prion protein","HDCVNI","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","Major prion protein","1","4E1H"
,,,,,,,,,,,,,,,,"EQMCIT","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","Major prion protein","2","4E1H"
"4E1I",,"X-RAY DIFFRACTION",1.99,38.04,"VAPOR DIFFUSION, HANGING DROP",5.5,"100mM Bis Tris pH 5.5, 25% PEG 3350, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/ja403001q",,"4E1I",8.55,"2.03","2.03","Fragment of human prion protein","HDCVNI","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","Major prion protein","1","4E1I"
,,,,,,,,,,,,,,,,"EQMCIT","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","Major prion protein","2","4E1I"
"4E1O",,"X-RAY DIFFRACTION",2.99,58.87,,,,,"10.1074/jbc.M112.381897",,"4E1O",328.39,"1.8","1.8","Human histidine decarboxylase complex with Histidine methyl ester (HME)","GPLGSMEPEEYRERGREMVDYICQYLSTVRERRVTPDVQPGYLRAQLPESAPEDPDSWDSIFGDIERIIMPGVVHWQSPHMHAYYPALTSWPSLLGDMLADAINCLGFTWASSPACTELEMNVMDWLAKMLGLPEHFLHHHPSSQGGGVLQSTVSESTLIALLAARKNKILEMKTSEPDADESSLNARLVAYASDQAHSSVEKAGLISLVKMKFLPVDDNFSLRGEALQKAIEEDKQRGLVPVFVCATLGTTGVCAFDCLSELGPICAREGLWLHIDAAYAGTAFLCPEFRGFLKGIEYADSFTFNPSKWMMVHFDCTGFWVKDKYKLQQTFSVNPIYLRHANSGVATDFMHWQIPLSRRFRSVKLWFVIRSFGVKNLQAHVRHGTEMAKYFESLVRNDPSFEIPAKRHLGLVVFRLKGPNSLTENVLKEIAKAGRLFLIPATIQDKLIIRFTVTSQFTTRDDILRDWNLIRDAATLILSQ","Homo sapiens","HDC","Histidine decarboxylase","1","4E1O"
"4E26",,"X-RAY DIFFRACTION",2.69,54.36,"MICROBATCH",6.5,"200 MM Magnesium acetate tetrahydrate, 100 mm sodium cacodylate trihydrate (pH 6.5), and 20% polyethylene glycol 8000, MICROBATCH, temperature 298K",298,"10.1021/jm3004416","734","4E26",71.14,"2.55","2.55","BRAF in complex with an organic inhibitor 7898734","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4E26"
"4E28",,"X-RAY DIFFRACTION",2.92,57.9,"VAPOR DIFFUSION, HANGING DROP",7,"1.4 M ammonium sulfate, 20 uM BME, 0.1 M Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1021/jm300850v","0MZ","4E28",38.39,"2.302","2.302","Structure of human thymidylate synthase in inactive conformation with a novel non-peptidic inhibitor","MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","4E28"
"4E2E",,"X-RAY DIFFRACTION",2.55,51.67,"VAPOR DIFFUSION, SITTING DROP",7,"1.00M LiCl, 20.00% PEG-6000, 0.1M HEPES pH 7.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4E2E",28.78,"2.25","2.25","Crystal structure of a tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide (YWHAG) from Homo sapiens at 2.25 A resolution","GMVDREQLVQKARLAEQAERYDDMAAAMKNVTELNEPLSNEERNLLSVAYKNVVGARRSSWRVISSIEQKTSADGNEKKIEMVRAYREKIEKELEAVCQDVLSLLDNYLIKNCSETQYESKVFYLKMKGDYYRYLAEVATGEKRATVVESSEKAYSEAHEISKEHMQPTHPIRLGLALNYSVFYYEIQNAPEQACHLAKTAFDDAIAELDTLNEDSYKDSTLIMQLLRDNLTLWTSDQQDDDGGEGNN","Homo sapiens","BC020963, YWHAG","14-3-3 protein gamma","1","4E2E"
"4E34",,"X-RAY DIFFRACTION",1.98,37.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% w/v PEG8000, 0.3 M potassium bromide, 0.1 M Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M112.401588",,"4E34",21.27,"1.395","1.395","Crystal structure of CFTR Associated Ligand (CAL) PDZ domain bound to iCAL36 (ANSRWPTSII) peptide","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4E34"
,,,,,,,,,,,,,,,,"ANSRWPTSII",,,"decameric peptide, iCAL36","2","4E34"
"4E35",,"X-RAY DIFFRACTION",2,38.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% w/v PEG8000, 0.15 M sodium chloride, 0.1 M Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M112.401588",,"4E35",21.46,"1.4","1.4","Crystal structure of CFTR Associated Ligand (CAL) PDZ domain bound to iCAL36-L (ANSRWPTSIL) peptide","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4E35"
,,,,,,,,,,,,,,,,"ANSRWPTSIL",,,"iCAL50 peptide","2","4E35"
"4E36",,"X-RAY DIFFRACTION",2.85,56.86,"VAPOR DIFFUSION, HANGING DROP",6.5,"10% PEG 8000, 20% ethylene glycol, 20 mM glycine, 20 mM DL-lysine, 20 mM DL-serine, 20 mM DL-alanine, 20 mM sodium L-glutamate, 31 mM imidazole, 69 mM MES. Protein mixed 1:4 with LPL peptide, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.4049/jimmunol.1200918",,"4E36",226.78,"3.22","3.22","Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 variant N392K","MVHSSAMVNSHRKPMFNIHRGFYCLTAILPQICICSQFSVPSSYHFTEDPGAFPVATNGERFPWQELRLPSVVIPLHYDLFVHPNLTSLDFVASEKIEVLVSNATQFIILHSKDLEITNATLQSEEDSRYMKPGKELKVLSYPAHEQIALLVPEKLTPHLKYYVAMDFQAKLGDGFEGFYKSTYRTLGGETRILAVTDFEPTQARMAFPCFDEPLFKANFSIKIRRESRHIALSNMPKVKTIELEGGLLEDHFETTVKMSTYLVAYIVCDFHSLSGFTSSGVKVSIYASPDKRNQTHYALQASLKLLDFYEKYFDIYYPLSKLDLIAIPDFAPGAMENWGLITYRETSLLFDPKTSSASDKLWVTRVIAHELAHQWFGNLVTMEWWNDIWLKEGFAKYMELIAVNATYPELQFDDYFLNVCFEVITKDSLNSSRPISKPAETPTQIQEMFDEVSYNKGACILNMLKDFLGEEKFQKGIIQYLKKFSYRNAKNDDLWSSLSNSCLESDFTSGGVCHSDPKMTSNMLAFLGENAEVKEMMTTWTLQKGIPLLVVKQDGCSLRLQQERFLQGVFQEDPEWRALQERYLWHIPLTYSTSSSNVIHRHILKSKTDTLDLPEKTSWVKFNVDSNGYYIVHYEGHGWDQLITQLNQNHTLLRPKDRVGLIHDVFQLVGAGRLTLDKALDMTYYLQHETSSPALLEGLSYLESFYHMMDRRNISDISENLKRYLLQYFKPVIDRQSWSDKGSVWDRMLRSALLKLACDLNHAPCIQKAAELFSQWMESSGKLNIPTDVLKIVYSVGAQTTAGWNYLLEQYELSMSSAEQNKILYALSTSKHQEKLLKLIELGMEGKVIKTQNLAALLHAIARRPKGQQLAWDFVRENWTHLLKKFDLGSYDIRMIISGTTAHFSSKDKLQEVKLFFESLEAQGSHLDIFQTVLETITKNIKWLEKNLPTLRTWLMVNTRHHHHHH","Homo sapiens","ERAP2, Irap, LRAP","Endoplasmic reticulum aminopeptidase 2","1","4E36"
"4E3B",,"X-RAY DIFFRACTION",2.39,48.53,"VAPOR DIFFUSION, HANGING DROP",6,"25% w/v PEG, 0.25 M potassium thiocyanate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M112.401588",,"4E3B",25.04,"1.5","1.5","Crystal structure of Tax-Interacting Protein-1 (TIP-1) PDZ domain bound to iCAL36-L (ANSRWPTSIL) peptide","AVVQRVEIHKLRQGENLILGFSIGGGIDQDPSQNPFSEDKTDKGIYVTRVSEGGPAEIAGLQIGDKIMQVNGWDMTMVTHDQARKRLTKRSEEVVRLLVTRQ","Homo sapiens","TAX1BP3, TIP1","Tax1-binding protein 3","1","4E3B"
,,,,,,,,,,,,,,,,"ANSRWPTSIL",,,"iCAL50 peptide","2","4E3B"
"4E3C",,"X-RAY DIFFRACTION",4.01,69.36,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.2M sodium malonate, 250mM ammonium acetate, 10mM DTT, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4E3C",462.98,"3.98","3.98","X-ray crystal structure of human IKK2 in an active conformation","NLYFQGAMGSTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPV","Homo sapiens","IKBKB, IKKB","Inhibitor of nuclear factor kappa-B kinase subunit beta","1","4E3C"
"4E3D",,"X-RAY DIFFRACTION",2.09,41.1,"VAPOR DIFFUSION, SITTING DROP",8,"3M Ammonium Sulfate, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1039/c2cc32013d","GTQ","4E3D",30.08,"1.6","1.6","Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4E3D"
"4E3F",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION, SITTING DROP",8,"3M ammonium sulfate, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1039/c2cc32013d","GRE","4E3F",30.14,"1.5","1.5","Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4E3F"
"4E3G",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, SITTING DROP",8,"3M ammonium sulfate, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1039/c2cc32013d","PHB, SO4","4E3G",30,"1.55","1.55","Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4E3G"
"4E3H",,"X-RAY DIFFRACTION",2.09,41.06,"VAPOR DIFFUSION, SITTING DROP",8,"3M ammonium sulfate, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1039/c2cc32013d","HQE","4E3H",29.79,"1.5","1.5","Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4E3H"
"4E42",,"X-RAY DIFFRACTION",3.47,64.54,"VAPOR DIFFUSION",5,"1.5 M sodium nitrate  
0.1 M sodium citrate, pH 5.0, VAPOR DIFFUSION, temperature 298K",298,,,"4E42",100.14,"2.7","2.7","Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor G4","IQVEQSPPDLILQEGANSTLRCNFSDSVNNLQWFHQNPWGQLINLFYIPSGTKQNGRLSATTVATERYSLLYISSSQTTDSGVYFCAVDRGSTLGRLYFGRGTQLTVWPDIQKPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"T cell receptor G4 alpha chain","1","4E42"
,,,,,,,,,,,,,,,,"GVTQSPTHLIKTRGQQATLRCSPISGHTSVYWYQQALGLGLQFLLWYDEGEERNRGNFPPRFSGRQFPNYSSELNVNALELEDSALYLCASSQIRETQYFGPGTRLLVLEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"T cell receptor G4 beta chain","2","4E42"
"4E47",,"X-RAY DIFFRACTION",2.26,45.63,"VAPOR DIFFUSION, HANGING DROP",8,"40% PEG3350, 0.1 M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4E47",122.26,"2","2","SET7/9 in complex with inhibitor (R)-(3-(3-cyanophenyl)-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl)-1,2,3,4-tetrahydroisoquinoline-6- sulfonamide and S-adenosylmethionine","QYKDNIRHGVCWIYYPDGGSLVGEVNEDGEMTGEKIAYVYPDERTALYGKFIDGEMIEGKLATLMSTEEGRPHFELMPGNSVYHFDKSTSSCISTNALLPDPYESERVYVAESLISSAGEGLFSKVAVGPNTVMSFYNGVRITHQEVDSRDWALNGNTLSLDEETVIDVPEPYNHVSKYCASLGHKANHSFTPNCIYDMFVHPRFGPIKCIRTLRAVEADEELTVAYGYDHSPPGKSGPEAPEWYQVELKAFQATQQKHHHHHH","Homo sapiens","SETD7, KIAA1717, KMT7, SET7, SET9","Histone-lysine N-methyltransferase SETD7","1","4E47"
"4E49",,"X-RAY DIFFRACTION",2.08,40.93,"VAPOR DIFFUSION, SITTING DROP",8,"3M ammonium sulfate, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1039/c2cc32013d","SO4, RCO","4E49",30.21,"1.45","1.45","Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4E49"
"4E4A",,"X-RAY DIFFRACTION",2.08,40.84,"VAPOR DIFFUSION, SITTING DROP",8,"3M ammonium sulfate, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1039/c2cc32013d","SO4, JKE","4E4A",29.93,"1.45","1.45","Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4E4A"
"4E4H",,"X-RAY DIFFRACTION",3.34,63.13,"VAPOR DIFFUSION, SITTING DROP",7,"200mM (NH4)2SO4, 100mM Tris-HCl, 10% PEG 8000, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"4E4H",211.11,"2.28","2.28","Crystal structure of Histone Demethylase NO66","HMGSSPLRRVLAELNRIPSSRRRAARLFEWLIAPMPPDHFYRRLWEREAVLVRRQDHTYYQGLFSTADLDSMLRNEEVQFGQHLDAARYINGRRETLNPPGRALPAAAWSLYQAGCSLRLLCPQAFSTTVWQFLAVLQEQFGSMAGSNVYLTPPNSQGFAPHYDDIEAFVLQLEGRKLWRVYRPRAPTEELALTSSPNFSQDDLGEPVLQTVLEPGDLLYFPRGFIHQAECQDGVHSLHLTLSTYQRNTWGDFLEAILPLAVQAAMEENVEFRRGLPRDFMDYMGAQHSDSKDPRRTAFMEKVRVLVARLGHFAPVDAVADQRAKDFIHDSLPPVLTDRERALSVYGLPIRWEAGEPVNVGAQLTTETEVHMLQDGIARLVGEGGHLFLYYTVENSRVYHLEEPKCLEIYPQQADAMELLLGSYPEFVRVGDLPCDSVEDQLSLATTLYDKGLLLTKMPLALN","Homo sapiens","C14orf169, NO66, RIOX1, MAPJD","Lysine-specific demethylase NO66","1","4E4H"
"4E4K",,"X-RAY DIFFRACTION",2.57,52.08,,8,"0.8M NACITRATE, 0.15M TRIS, PH8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293 KK",293,"10.1021/jm301018z","RRG","4E4K",66.11,"2.5","2.5","Crystal Structure of PPARgamma with the ligand JO21","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4E4K"
"4E4L",,"X-RAY DIFFRACTION",2.32,47.05,"VAPOR DIFFUSION, SITTING DROP",5.5,"MES pH 5.5 30% PEG6000, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1021/jm300438j","0NH","4E4L",140.32,"2","2","JAK1 kinase (JH1 domain) in complex with compound 30","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4E4L"
"4E4M",,"X-RAY DIFFRACTION",2.65,53.58,"VAPOR DIFFUSION, SITTING DROP",6,"ammonium acetate, sodium citrate, PEG 8000, pH 6, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1021/jm300438j","0NH","4E4M",143.28,"2.25","2.25","JAK2 kinase (JH1 domain) in complex with compound 30","GSSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4E4M"
"4E4N",,"X-RAY DIFFRACTION",2.37,48.2,"VAPOR DIFFUSION, SITTING DROP",5.5,"PEG 6000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1021/jm300438j","0NL","4E4N",70.18,"1.9","1.9","JAK1 kinase (JH1 domain) in complex with compound 49","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4E4N"
"4E4Q",,"X-RAY DIFFRACTION",2.51,51.05,"VAPOR DIFFUSION, SITTING DROP",8,"0.8M NaCitrate, 0.15M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293 KK",293,"10.1021/jm301018z",,"4E4Q",65.75,"2.5","2.5","Crystal structure of PPARgamma with the ligand FS214","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4E4Q"
"4E4V",,"X-RAY DIFFRACTION",3.35,63.26,"VAPOR DIFFUSION, SITTING DROP",5.4,"0.5 CITRATE PH 5.4 10 MM DTT, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4E4V",106.84,"2.5283","2.5283","The crystal structure of the dimeric human importin alpha 1 at 2.5 angstrom resolution.","MGSSHHHHHSSGENLYFQGHMLDALNQGTVNWSVDDIVKGINSSNVENQLQATQAARKLLSREKQPPIDNIIRAGLIPKFVSFLGRTDCSPIQFESAWALTNIASGTSEQTKAVVDGGAIPAFISLLASPHAHISEQAVWALGNIAGDGSVFRDLVIKYGAVDPLLALLAVPDMSSLACGYLRNLTWTLSNLCRNKNPAPPIDAVEQILPTLVRLLHHDDPEVLADTCWAISYLTDGPNERIGMVVKTGVVPQLVKLLGASELPIVTPALRAIGNIVTGTDEQTQVVIDAGALAVFPSLLTNPKTNIQKEATWTMSNITAGRQDQIQQVVNHGLVPFLVSVLSKADFKTQKEAVWAVTNYTSGGTVEQIVYLVHCGIIEPLMNLLTAKDTKIILVILDAISNIFQAAEKLGETEKLSIMIEECGGLDKIEALQNHENESVYRASLSLIEKYFSVEEEEDQNVVPETTSEGYTFQVQDGAPGTFNF","Homo sapiens","IP0A1, KPNA2, RCH1, SRP1","Importin subunit alpha-2","1","4E4V"
"4E4X",,"X-RAY DIFFRACTION",3.27,62.41,"VAPOR DIFFUSION, HANGING DROP",9,"PEG 8000, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.04.015","T1Q","4E4X",71.37,"3.6","3.6","Crystal Structure of B-Raf Kinase Domain in Complex with a Dihydropyrido[2,3-d]pyrimidinone-based Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4E4X"
"4E52",,"X-RAY DIFFRACTION",2.94,58.18,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 4000, Tris, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1128/IAI.01239-15",,"4E52",57.69,"1.7","1.7","Crystal structure of Haemophilus Eagan 4A polysaccharide bound human lung surfactant protein D","GSPGLKGDKGIPGDKGAKGESGLPDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNGKWNDRACGEKRLVVCEF","Homo sapiens","SFTPD, COLEC7, PSPD, SFTP4","Pulmonary surfactant-associated protein D","1","4E52"
"4E58",,"X-RAY DIFFRACTION",2.38,48.22,"VAPOR DIFFUSION, SITTING DROP",5.6,"MES, MgCl2 and Li2SO4, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 292.0K",292,"10.1093/nar/gks557",,"4E58",7.78,"1.952","1.952","Crystal structure of GCC(LCG)CCGC duplex containing LNA residue","GCCGCCGC","Homo sapiens",,"RNA duplex containing CCG repeats","1","4E58"
"4E59",,"X-RAY DIFFRACTION",1.77,30.41,"VAPOR DIFFUSION, HANGING DROP",5.6,"magnesium acetate, MES and  ammonium sulphate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 303K",303,"10.1093/nar/gks557",,"4E59",5.03,"1.54","1.54","Crystal structure of GCCGCCGC duplex","GCCGCCGC","Homo sapiens",,"RNA duplex containing CCG repeats","1","4E59"
"4E5A",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION, SITTING DROP",7,"3%-17% (w/v) PEG 3350, 0.1M Hepes pH 6.5-7.25, 0.2M KF, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.jmb.2012.10.007",,"4E5A",41.23,"1.87","1.87","The W197A mutant of p38a MAP kinase","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4E5A"
"4E5B",,"X-RAY DIFFRACTION",2.23,44.87,"VAPOR DIFFUSION, SITTING DROP",7,"3%-17% (w/v) PEG 3350, 0.1M Hepes pH 6.5-7.25, 0.2M KF, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.jmb.2012.10.007",,"4E5B",41.34,"2","2","Structure of p38a MAP kinase without BOG","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4E5B"
"4E5Q",,"X-RAY DIFFRACTION",2.05,39.87,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM TRIS Chloride, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S2053230X14018135","0NM","4E5Q",29.4,"1.7024","1.7024","Human Carbonic Anhydrase II in complex with cyanate","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4E5Q"
"4E5W",,"X-RAY DIFFRACTION",2.44,49.66,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES 
25% PEG 6K, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm300438j","0NT","4E5W",70.36,"1.86","1.86","JAK1 kinase (JH1 domain) in complex with compound 26","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4E5W"
"4E5Y",,"X-RAY DIFFRACTION",2.85,56.79,"VAPOR DIFFUSION, SITTING DROP",8,"100mM Tris pH 8.0, 30% PEG 2000, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4E5Y",146.72,"2.37","2.37","Structure of human FX protein, the key enzyme in the biosynthesis of GDP-L-fucose","MGEPQGSMRILVTGGSGLVGKAIQKVVADGAGLPGEDWVFVSSKDADLTDTAQTRALFEKVQPTHVIHLAAMVGGLFRNIKYNLDFWRKNVHMNDNVLHSAFEVGARKVVSCLSTCIFPDKTTYPIDETMIHNGPPHNSNFGYSYAKRMIDVQNRAYFQQYGCTFTAVIPTNVFGPHDNFNIEDGHVLPGLIHKVHLAKSSGSALTVWGTGNPRRQFIYSLDLAQLFIWVLREYNEVEPIILSVGEEDEVSIKEAAEAVVEAMDFHGEVTFDTTKSDGQFKKTASNSKLRTYLPDFRFTPFKQAVKETCAWFTDNYEQARK","Homo sapiens","TSTA3, SDR4E1, GFUS","GDP-L-fucose synthase","1","4E5Y"
"4E67",,"X-RAY DIFFRACTION",1.86,33.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES (pH 7.5), 0.1 M sodium azide and 22% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/anie.201205676",,"4E67",27.59,"2.1","2.1","The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with hydrocinnamoyl-derivatized PLHSpTA peptide","XPLHSTAX",,,"hydrocinnamoyl-derivatized PLHSpTA peptide","2","4E67"
,,,,,,,,,,,,,,,,"GPLGSPEFDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSR","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4E67"
"4E6A",,"X-RAY DIFFRACTION",2.3,46.41,"VAPOR DIFFUSION, SITTING DROP",7,"13%-17% (w/v) PEG 3350, 0.1M Hepes pH 6.5-7.25, 0.2M KF, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.jmb.2012.10.007",,"4E6A",41.98,"2.09","2.09","p38a-PIA23 complex","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4E6A"
"4E6C",,"X-RAY DIFFRACTION",2.27,45.74,"VAPOR DIFFUSION, SITTING DROP",7,"13%-17% (w/v) PEG 3350, 0.1M Hepes pH 6.5-7.25, 0.2M KF, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.jmb.2012.10.007","0O8","4E6C",41.81,"2.39","2.39","p38a-perifosine Complex","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4E6C"
"4E6D",,"X-RAY DIFFRACTION",3.09,60.16,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.025 M Bicine pH 8.5, 0.25 M NaCl, 20% glycerol, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/jm300438j","0NU","4E6D",71.16,"2.22","2.22","JAK2 kinase (JH1 domain) triple mutant in complex with compound 7","AFEDRDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4E6D"
"4E6Q",,"X-RAY DIFFRACTION",2.61,52.79,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.025 M Bicine pH 8.5, 0.25 M NaCl, 20% glycerol, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/jm300438j","0NV","4E6Q",71.11,"1.948","1.948","JAK2 kinase (JH1 domain) triple mutant in complex with compound 12","AFEDRDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4E6Q"
"4E6R",,"X-RAY DIFFRACTION",4.27,71.16,"VAPOR DIFFUSION, SITTING DROP",8,"40.00% polyethylene glycol 300, 0.20M zinc acetate, 0.1M Imidazole pH 8.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4E6R",14.02,"2.2","2.2","Crystal structure of a Cytoplasmic protein NCK2 (NCK2) from Homo sapiens at 2.20 A resolution","XIPAFVKFAYVAEREDELSLVKGSRVTVMEKCSDGWWRGSYNGQIGWFPSNYVLEEVD","Homo sapiens","BC007195, GRB4, NCK2","Cytoplasmic protein NCK2","1","4E6R"
"4E71",,"X-RAY DIFFRACTION",2.15,42.85,"VAPOR DIFFUSION, SITTING DROP",9.6,"2.5M sodium formate, 0.1M glycine, pH 9.6, vapor diffusion, sitting drop, temperature 291K",291,,,"4E71",12.37,"2.26","2.26","Crystal structure of the RHO GTPASE binding domain of Plexin B2","GLLGDDVEYAPLTVSVIVQDEGVDAIPVKVLNCDTISQVKEKIIDQVYRGQPCSCWPRPDSVVLEWRPGSTAQILSDLDLTSQREGRWKRVNTLMHYNVRDGATLILSKVG","Homo sapiens","PLXNB2, KIAA0315","Plexin-B2","1","4E71"
"4E74",,"X-RAY DIFFRACTION",2.93,57.99,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG3350, 0.2M ammonium acetate, 0.1M HEPES, pH 7.5, vapor diffusion, sitting drop, temperature 291K",291,,,"4E74",13.15,"1.58","1.58","Crystal structure of the RHO GTPASE BINDING DOMAIN of Plexin A4A","GDKLIRQQIDYKTLVLSCVSPDNANSPEVPVKILNCDTITQVKEKILDAIFKNVPCSHRPKAADMDLEWRQGSGARMILQDEDITTKIENDWKRLNTLAHYQVPDGSVVALVSKQVT","Homo sapiens","PLXNA4, KIAA1550, PLXNA4A, PLXNA4B, UNQ2820/PRO34003","Plexin-A4","1","4E74"
"4E82",,"X-RAY DIFFRACTION",1.75,29.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M sodium citrate tribasic dehydrate, 0.1 M HEPES sodium, 20% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.367995",,"4E82",7.22,"1.7","1.7","Crystal structure of monomeric variant of human alpha-defensin 5, HD5 (Glu21EMe mutant)","ATCYCRTGRCATRESLSGVCXISGRLYRLCCR","Homo sapiens","DEFA5, DEF5","Defensin-5","1","4E82"
"4E83",,"X-RAY DIFFRACTION",1.69,27.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.0 M HEPES sodium, pH 7.5, 0.2 M magnesium chloride hexahydrate, 30% 2-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.367995",,"4E83",7.22,"1.9","1.9","Crystal structure of human alpha-defensin 5, HD5 (Leu29NLe mutant)","ATCYCRTGRCATRESLSGVCEISGRLYRLCCR","Homo sapiens","DEFA5, DEF5","Defensin-5","1","4E83"
"4E86",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES sodium, pH 7.5, 0.8 M sodium phosphate monobasic monohydrate, 0.8 M potassium phosphate monobasic, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.367995",,"4E86",32.2,"2.75","2.75","Crystal structure of human alpha-defensin 5, HD5 (Leu29Aba mutant)","ATCYCRTGRCATRESLSGVCEISGRLYRACCR","Homo sapiens","DEFA5, DEF5","Defensin-5","1","4E86"
"4E8A",,"X-RAY DIFFRACTION",2.13,42.13,,7,"13%-17% (w/v) PEG 3350, 0.1M Hepes pH 6.5-7.25, 0.2M KF, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.jmb.2012.10.007",,"4E8A",42.02,"2.7","2.7","The crystal structure of p38a MAP kinase in complex with PIA24","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4E8A"
"4E90",,"X-RAY DIFFRACTION",4.66,73.62,,,,,"10.1021/jm3009635","7RG","4E90",78.7,"2.5","2.5","Human phosphodiesterase 9 in complex with inhibitors","GSHMTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","4E90"
"4E93",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M SPG, 30.0% PEG 1K, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.chembiol.2012.01.020","GUI","4E93",43.37,"1.84","1.84","Crystal structure of human Feline Sarcoma Viral Oncogene Homologue (v-FES)in complex with TAE684","SMIPEVQKPLHEQLWYHGAIPRAEVAELLVHSGDFLVRESQGKQEYVLSVLWDGLPRHFIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR","Homo sapiens","FES, FPS","Tyrosine-protein kinase Fes/Fps","1","4E93"
"4E96",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M Na(malonate) 
0.1M BTProp pH 8.5 
20% PEG3350 
10% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3010515","0NS","4E96",15.61,"1.92","1.92","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor PFi-1","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4E96"
"4E99",,"X-RAY DIFFRACTION",1.87,34.08,"EVAPORATION, RECRYSTALLIZATION",7.5,"30-36% PEG3350, 50mM potassium phosphate, pH 7.5, EVAPORATION, RECRYSTALLIZATION, temperature 298K",298,"10.1021/tx300112p",,"4E99",67.57,"2.3","2.3","Human Serum Albumin Complex with Perfluorooctane Sulfonate Potassium","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","4E99"
"4E9C",,"X-RAY DIFFRACTION",2.01,38.95,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES pH 6.5, 30% PEG 300, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/anie.201202660",,"4E9C",28.14,"1.7","1.7","The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with LDPPLHSpTA phosphopeptide","GPLGSPEFDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSR","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4E9C"
,,,,,,,,,,,,,,,,"XLDPPLHSTAX",,,"LDPPLHSpTA phosphopeptide","2","4E9C"
"4E9D",,"X-RAY DIFFRACTION",2.01,38.82,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M sodium acetate, 1.0 M LiCl, 30% PEG 6000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/anie.201202660",,"4E9D",27.95,"2.75","2.75","The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with 3-(1-benzothiophen-2-yl)propanoyl-derivatized DPPLHSpTA peptide","GPLGSPEFDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSR","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4E9D"
,,,,,,,,,,,,,,,,"XDPPLHSTAX",,,"3-(1-benzothiophen-2-yl)propanoyl-derivatized DPPLHSpTA peptide","2","4E9D"
"4E9E",,"X-RAY DIFFRACTION",2.42,49.23,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG 4000, 100 mM Tris-HCl and 0.2 M MgCl2, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gks714",,"4E9E",19.42,"1.9","1.9","Structure of the glycosylase domain of MBD4","MLSPPRRKAFKKWTPPRSPFNLVQETLFHDPWKLLIATIFLNRTSGKMAIPVLWKFLEKYPSAEVARTADWRDVSELLKPLGLYDLRAKTIVKFSDEYLTKQWKYPIELHGIGKYGNDSYRIFCVNEWKQVHPEDHKLNKYHDWLWENHEKLSLSHHHHHH","Homo sapiens","MBD4, MED1","Methyl-CpG-binding domain protein 4","1","4E9E"
"4E9F",,"X-RAY DIFFRACTION",2.08,40.88,"VAPOR DIFFUSION, HANGING DROP",8,"25% ethylene glycol, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gks714",,"4E9F",26.7,"1.79","1.79","Structure of the glycosylase domain of MBD4 bound to AP site containing DNA","MLSPPRRKAFKKWTPPRSPFNLVQETLFHDPWKLLIATIFLNRTSGKMAIPVLWKFLEKYPSAEVARTADWRDVSELLKPLGLYDLRAKTIVKFSDEYLTKQWKYPIELHGIGKYGNDSYRIFCVNEWKQVHPEDHKLNKYHDWLWENHEKLSLSHHHHHH","Homo sapiens","MBD4, MED1","Methyl-CpG-binding domain protein 4","1","4E9F"
,,,,,,,,,,,,,,,,"CCAGCGNGCAGC",,,"DNA (5'-D(*CP*CP*AP*GP*CP*GP*(3DR)P*GP*CP*AP*GP*C)-3')","2","4E9F"
,,,,,,,,,,,,,,,,"GCTGCGCGCTGG",,,"DNA (5'-D(*GP*CP*TP*GP*CP*GP*CP*GP*CP*TP*GP*G)-3')","3","4E9F"
"4E9G",,"X-RAY DIFFRACTION",2.23,44.75,"VAPOR DIFFUSION, HANGING DROP",6.5,"15% PEG MME 2000, 100 mM MES, 0.2 M NaAcetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gks714",,"4E9G",26.72,"2.35","2.35","structure of the glycosylase domain of MBD4 bound to thymine containing DNA","MLSPPRRKAFKKWTPPRSPFNLVQETLFHDPWKLLIATIFLNRTSGKMAIPVLWKFLEKYPSAEVARTADWRDVSELLKPLGLYDLRAKTIVKFSDEYLTKQWKYPIELHGIGKYGNDSYRIFCVNEWKQVHPEAHKLNKYHDWLWENHEKLSLSHHHHHH","Homo sapiens","MBD4, MED1","Methyl-CpG-binding domain protein 4","1","4E9G"
,,,,,,,,,,,,,,,,"CCAGCGTGCAGC",,,"DNA (5'-D(*CP*CP*AP*GP*CP*GP*TP*GP*CP*AP*GP*C)-3')","2","4E9G"
,,,,,,,,,,,,,,,,"GCTGCGCGCTGG",,,"DNA (5'-D(*GP*CP*TP*GP*CP*GP*CP*GP*CP*TP*GP*G)-3')","3","4E9G"
"4E9M",,"X-RAY DIFFRACTION",2.01,38.7,"VAPOR DIFFUSION, HANGING DROP",5.2,"2.07 M AMMONIUM CITRATE (DIBASIC), 6.7% (W/V) PEG3350, 10 mM TRIS-HCL FINAL PH ~5.2, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,,,"4E9M",100.32,"2.15","2.15","NOD1 card domain with three disulfide-clinched, domain-swapped dimers in the asymmetric unit","MHHHHHHEEQGHSEMEIIPSESHPHIQLLKSNRELLVTHIRNTQCLVDNLLKNDYFSAEDAEIVCACPTQPDKVRKILDLVQSKGEEVSEFFLYLLQQLADAYVDLRPWLLEIGFSPSLLTQSKVVVNTDPVSRYTQQLRHHLG","Homo sapiens","CARD4, NOD1","Nucleotide-binding oligomerization domain-containing protein 1","1","4E9M"
"4EA4",,"X-RAY DIFFRACTION",2.45,49.76,"VAPOR DIFFUSION, HANGING DROP",5.6,"20% PEG 4000, 0.1 M Nacitrate, 20% isopropanol, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gks714",,"4EA4",26.07,"2","2","Structure of the glycosylase domain of MBD4 bound to 5hmU-containing DNA","MLSPPRRKAFKKWTPPRSPFNLVQETLFHDPWKLLIATIFLNRTSGKMAIPVLWKFLEKYPSAEVARTADWRDVSELLKPLGLYDLRAKTIVKFSDEYLTKQWKYPIELHGIGKYGNDSYRIFCVNEWKQVHPEAHKLNKYHDWLWENHHHHHHH","Homo sapiens","MBD4, MED1","Methyl-CpG-binding domain protein 4","1","4EA4"
,,,,,,,,,,,,,,,,"CCAGCGUGCAGC",,,"DNA (5'-D(*CP*CP*AP*GP*CP*GP*(5HU)P*GP*CP*AP*GP*C)-3')","2","4EA4"
,,,,,,,,,,,,,,,,"GCTGCGCGCTGG",,,"DNA (5'-D(*GP*CP*TP*GP*CP*GP*CP*GP*CP*TP*GP*G)-3')","3","4EA4"
"4EA5",,"X-RAY DIFFRACTION",1.98,37.94,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% Jeffamine M2070, 20% dimethylsulfoxite, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gks714",,"4EA5",26.59,"2.14","2.14","Structure of the glycoslyase domain of MBD4 bound to a 5hmU containing DNA","MLSPPRRKAFKKWTPPRSPFNLVQETLFHDPWKLLIATIFLNRTSGKMAIPVLWKFLEKYPSAEVARTADWRDVSELLKPLGLYDLRAKTIVKFSDEYLTKQWKYPIELHGIGKYGNDSYRIFCVNEWKQVHPEAHKLNKYHDWLWENHEKLSLSHHHHH","Homo sapiens","MBD4, MED1","Methyl-CpG-binding domain protein 4","1","4EA5"
,,,,,,,,,,,,,,,,"CCAGCGUGCAGC",,,"DNA (5'-D(*CP*CP*AP*GP*CP*GP*(5HU)*GP*CP*AP*GP*C)-3')","2","4EA5"
,,,,,,,,,,,,,,,,"GCTGCGCGCTGG",,,"DNA (5'-D(*GP*CP*TP*GP*CP*GP*CP*GP*CP*TP*GP*G)-3')","3","4EA5"
"4EAR",,"X-RAY DIFFRACTION",2.33,47.14,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG 1000, 0.1M Tris, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.chembiol.2013.01.009","IM5","4EAR",109.56,"1.7","1.7","Crystal structure of purine nucleoside phosphorylase (W16Y, W94Y, W178Y, H257W) mutant from human complexed with DADMe-ImmG and phosphate","MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPTLMENGYTYEDYKNTAEYLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLYKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTYKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANWEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","NP, PNP, X00737.1","Purine nucleoside phosphorylase","1","4EAR"
"4EB8",,"X-RAY DIFFRACTION",2.32,46.92,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 5000 monomethyl ether, 0.1M Bis-Tris, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.chembiol.2013.01.009","IM5","4EB8",109.63,"2.3","2.3","Crystal structure of purine nucleoside phosphorylase (W16Y, W94Y, W178Y, H257W) mutant from human complexed with DADMe-ImmG and phosphate","MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPTLMENGYTYEDYKNTAEYLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLYKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTYKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANWEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","NP, PNP, X00737.1","Purine nucleoside phosphorylase","1","4EB8"
"4EB9",,"X-RAY DIFFRACTION",2.69,54.33,"VAPOR DIFFUSION, SITTING DROP",5.5,"6% PEG3350, 0.1 M Bis-Tris, pH 5.2, 0.2 M magnesium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0049527","0O6","4EB9",60.19,"2.6","2.6","cIAP1-BIR3 in complex with a divalent Smac mimetic","MENSLETLRFSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRYPHLLEQLLSTSLEHHHHHH","Homo sapiens","BIRC2, API1, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","4EB9"
"4EBB",,"X-RAY DIFFRACTION",2.68,54.07,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1M sodium acetate, 0.05M zinc acetate, 5% PEG3350, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1371/journal.pone.0043019",,"4EBB",106.54,"2","2","Structure of DPP2","PDPGFQERFFQQRLDHFNFERFGNKTFPQRFLVSDRFWVRGEGPIFFYTGNEGDVWAFANNSAFVAELAAERGALLVFAEHRYYGKSLPFGAQSTQRGHTELLTVEQALADFAELLRALRRDLGAQDAPAIAFGGSYGGMLSAYLRMKYPHLVAGALAASAPVLAVAGLGDSNQFFRDVTADFEGQSPKCTQGVREAFRQIKDLFLQGAYDTVRWEFGTCQPLSDEKDLTQLFMFARNAFTVLAMMDYPYPTDFLGPLPANPVKVGCDRLLSEAQRITGLRALAGLVYNASGSEHCYDIYRLYHSCADPTGCGTGPDARAWDYQACTEINLTFASNNVTDMFPDLPFTDELRQRYCLDTWGVWPRPDWLLTSFWGGDLRAASNIIFSNGNLDPWAGGGIRRNLSASVIAVTIQGGAHHLDLRASHPEDPASVVEARKLEATIIGEWVKAARREQQPALRGGPRLSLENLYFQ","Homo sapiens","DPP7, DPP2, QPP","Dipeptidyl peptidase 2","1","4EBB"
"4EBC",,"X-RAY DIFFRACTION",2.71,54.63,"VAPOR DIFFUSION, SITTING DROP",7.9,"20 mM Tris-HCl, pH 7.9, 5% glycerol, 10 mM 2-mercaptoethanol, 150 mM calcium chloride, 12% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/ja304176q",,"4EBC",52.56,"2.901","2.901","Conformationally Restrained North-methanocarba-2'-deoxyadenosine Corrects the Error-Prone Nature of Human DNA Polymerase Iota","MELADVGAAASSQGVHDQVLPTPNASSRVIVHVDLDCFYAQVEMISNPELKDKPLGVQQKYLVVTCNYEARKLGVKKLMNVRDAKEKCPQLVLVNGEDLTRYREMSYKVTELLEEFSPVVERLGFDENFVDLTEMVEKRLQQLQSDELSAVTVSGHVYNNQSINLLDVLHIRLLVGSQIAAEMREAMYNQLGLTGCAGVASNKLLAKLVSGVFKPNQQTVLLPESCQHLIHSLNHIKEIPGIGYKTAKCLEALGINSVRDLQTFSPKILEKELGISVAQRIQKLSFGEDNSPVILSGPPQSFSEEDSFKKCSSEVEAKNKIEELLASLLNRVCQDGRKPHTVRLIIRRYSSEKHYGRESRQCPIPSHVIQKLGTGNYDVMTPMVDILMKLFRNMVNVKMPFHLTLLSVCFCNLKALNTAK","Homo sapiens","POLI, RAD30B","DNA polymerase iota","1","4EBC"
,,,,,,,,,,,,,,,,"AGGACCC",,,"5'-D(P*AP*GP*GP*AP*CP*CP*(DOC))-3'","2","4EBC"
,,,,,,,,,,,,,,,,"CTGGGTCCT",,,"5'-D(P*CP*TP*GP*GP*GP*TP*CP*CP*T)-3'","3","4EBC"
"4EBD",,"X-RAY DIFFRACTION",2.7,54.41,"VAPOR DIFFUSION, SITTING DROP",7.9,"20 mM Tris-HCl, pH 7.9, 5% glycerol, 10 mM 2-mercaptoethanol, 150 mM calcium chloride, 12% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/ja304176q",,"4EBD",52.65,"2.571","2.571","Conformationally Restrained North-methanocarba-2'-deoxyadenosine Corrects the Error-Prone Nature of Human DNA Polymerase Iota","MELADVGAAASSQGVHDQVLPTPNASSRVIVHVDLDCFYAQVEMISNPELKDKPLGVQQKYLVVTCNYEARKLGVKKLMNVRDAKEKCPQLVLVNGEDLTRYREMSYKVTELLEEFSPVVERLGFDENFVDLTEMVEKRLQQLQSDELSAVTVSGHVYNNQSINLLDVLHIRLLVGSQIAAEMREAMYNQLGLTGCAGVASNKLLAKLVSGVFKPNQQTVLLPESCQHLIHSLNHIKEIPGIGYKTAKCLEALGINSVRDLQTFSPKILEKELGISVAQRIQKLSFGEDNSPVILSGPPQSFSEEDSFKKCSSEVEAKNKIEELLASLLNRVCQDGRKPHTVRLIIRRYSSEKHYGRESRQCPIPSHVIQKLGTGNYDVMTPMVDILMKLFRNMVNVKMPFHLTLLSVCFCNLKALNTAK","Homo sapiens","POLI, RAD30B","DNA polymerase iota","1","4EBD"
,,,,,,,,,,,,,,,,"AGGACCC",,,"5'-D(P*AP*GP*GP*AP*CP*CP*(DOC))-3'","2","4EBD"
,,,,,,,,,,,,,,,,"CTGGGTCCT",,,"5'-D(P*CP*TP*GP*GP*GP*TP*CP*CP*T)-3'","3","4EBD"
"4EBE",,"X-RAY DIFFRACTION",2.71,54.69,"VAPOR DIFFUSION, SITTING DROP",7.9,"20 mM Tris-HCl, pH 7.9, 5% glycerol, 10 mM 2-mercaptoethanol, 150 mM calcium chloride, 10% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/ja304176q",,"4EBE",52.64,"2.1","2.1","Conformationally Restrained North-methanocarba-2'-deoxyadenosine Corrects the Error-Prone Nature of Human DNA Polymerase Iota","MELADVGAAASSQGVHDQVLPTPNASSRVIVHVDLDCFYAQVEMISNPELKDKPLGVQQKYLVVTCNYEARKLGVKKLMNVRDAKEKCPQLVLVNGEDLTRYREMSYKVTELLEEFSPVVERLGFDENFVDLTEMVEKRLQQLQSDELSAVTVSGHVYNNQSINLLDVLHIRLLVGSQIAAEMREAMYNQLGLTGCAGVASNKLLAKLVSGVFKPNQQTVLLPESCQHLIHSLNHIKEIPGIGYKTAKCLEALGINSVRDLQTFSPKILEKELGISVAQRIQKLSFGEDNSPVILSGPPQSFSEEDSFKKCSSEVEAKNKIEELLASLLNRVCQDGRKPHTVRLIIRRYSSEKHYGRESRQCPIPSHVIQKLGTGNYDVMTPMVDILMKLFRNMVNVKMPFHLTLLSVCFCNLKALNTAK","Homo sapiens","POLI, RAD30B","DNA polymerase iota","1","4EBE"
,,,,,,,,,,,,,,,,"AGGACCC",,,"5'-D(P*AP*GP*GP*AP*CP*CP*(DOC))-3'","2","4EBE"
,,,,,,,,,,,,,,,,"CTGGGTCCT",,,"5'-D(P*CP*TP*GP*GP*GP*TP*CP*CP*T)-3'","3","4EBE"
"4EBV",,"X-RAY DIFFRACTION",1.95,36.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG4000, 8% 2-Propanol, 12% Glycerol, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.ejmech.2012.06.035","0O7","4EBV",35.55,"1.67","1.67","Structure of Focal Adhesion Kinase catalytic domain in complex with novel allosteric inhibitor","MSYYHHHHHHDYDIPTTENLYFQGAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","4EBV"
"4EBW",,"X-RAY DIFFRACTION",2.04,39.71,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG4000, 8% 2-Propanol, 12% Glycerol, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.ejmech.2012.06.035","0PF","4EBW",35.46,"2.65","2.65","Structure of Focal Adhesion Kinase catalytic domain in complex with novel allosteric inhibitor","MSYYHHHHHHDYDIPTTENLYFQGAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","4EBW"
"4EC0",,"X-RAY DIFFRACTION",2.11,41.75,"VAPOR DIFFUSION",,"vapor diffusion",,"10.1016/j.bmcl.2012.04.004","7PQ","4EC0",48.05,"1.85","1.85","Crystal structure of hH-PGDS with water displacing inhibitor","HMPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","GSTS, HPGDS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","4EC0"
"4EC4",,"X-RAY DIFFRACTION",3.26,62.27,"VAPOR DIFFUSION, SITTING DROP",7.5,"30% PEG400, 0.2 M sodium citrate, 0.1 M Tris, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0049527","0O6","4EC4",149.6,"3.3","3.3","XIAP-BIR3 in complex with a potent divalent Smac mimetic","SDAVSSDRNFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVRTTHHHHHH","Homo sapiens","XIAP, API3, BIRC4, IAP3","Baculoviral IAP repeat-containing protein 4","1","4EC4"
"4ECE",,"X-RAY DIFFRACTION",2.33,47.32,"VAPOR DIFFUSION, SITTING DROP",6.5,"16% PEG 8000, 20% glycerol, 0.16M magnesium acetate, 0.08M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.chembiol.2013.01.009",,"4ECE",217.67,"2.6","2.6","Crystal structure of purine nucleoside phosphorylase (W16Y, W94Y, W178Y, H257W) mutant from human complexed with guanine","MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPTLMENGYTYEDYKNTAEYLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLYKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTYKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANWEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","NP, PNP, X00737.1","Purine nucleoside phosphorylase","1","4ECE"
"4ECQ",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ECQ",55.8,"1.5","1.5","Human DNA polymerase eta- DNA ternary complex: AT crystal at pH6.8(K+ MES) with 1 Ca2+ ion","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ECQ"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ECQ"
,,,,,,,,,,,,,,,,"AGCGTCATA",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*TP*A)-3')","3","4ECQ"
"4ECR",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ECR",55.45,"1.892","1.892","Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 40 sec","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ECR"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ECR"
,,,,,,,,,,,,,,,,"AGCGTCAT",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","4ECR"
"4ECS",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ECS",55.93,"1.951","1.951","Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 80 sec","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ECS"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ECS"
,,,,,,,,,,,,,,,,"AGCGTCATA",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*TP*A)-3')","3","4ECS"
"4ECT",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ECT",56.05,"1.795","1.795","Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 140 sec","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ECT"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ECT"
,,,,,,,,,,,,,,,,"AGCGTCATA",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*TP*A)-3')","3","4ECT"
"4ECU",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ECU",55.96,"1.949","1.949","Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 200 sec","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ECU"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ECU"
,,,,,,,,,,,,,,,,"AGCGTCATA",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*TP*A)-3')","3","4ECU"
"4ECV",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ECV",56.05,"1.521","1.521","Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 230 sec","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ECV"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ECV"
,,,,,,,,,,,,,,,,"AGCGTCATA",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*TP*A)-3')","3","4ECV"
"4ECW",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ECW",56.05,"1.896","1.896","Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 250 sec","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ECW"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ECW"
,,,,,,,,,,,,,,,,"AGCGTCATA",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*TP*A)-3')","3","4ECW"
"4ECX",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ECX",55.96,"1.744","1.744","Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 300 sec","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ECX"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ECX"
,,,,,,,,,,,,,,,,"AGCGTCATA",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*TP*A)-3')","3","4ECX"
"4ECY",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ECY",55.49,"1.943","1.943","Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 6.0 (Na+ MES) with 1 Ca2+ ion","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ECY"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ECY"
,,,,,,,,,,,,,,,,"AGCGTCAT",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","4ECY"
"4ECZ",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, VAPOR DIFFUSION, HANGING DROP, temperature 293K, pH 6.0",293,"10.1038/nature11181",,"4ECZ",55.51,"1.834","1.834","Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 6.5 (Na+ MES) with 1 Ca2+ ion","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ECZ"
,,,,,,,,,,,,,,,,"AGCGTCAT",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","4ECZ"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ECZ"
"4ED0",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ED0",55.51,"1.653","1.653","Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 6.8 (Na+ MES) with 1 Ca2+ ion","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ED0"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ED0"
,,,,,,,,,,,,,,,,"AGCGTCAT",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","4ED0"
"4ED1",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ED1",55.51,"1.806","1.806","Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 7.0 (Na+ MES) with 1 Ca2+ ion","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ED1"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ED1"
,,,,,,,,,,,,,,,,"AGCGTCAT",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","4ED1"
"4ED2",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ED2",55.51,"1.711","1.711","Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 7.2 (Na+ HEPES) with 1 Ca2+ ion","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ED2"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ED2"
,,,,,,,,,,,,,,,,"AGCGTCAT",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","4ED2"
"4ED3",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ED3",55.51,"1.791","1.791","Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 7.5 (Na+ HEPES) with 1 Ca2+ ion","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ED3"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ED3"
,,,,,,,,,,,,,,,,"AGCGTCAT",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","4ED3"
"4ED5",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 5000, 0.1M HEPES, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,"10.1107/S0907444912047828",,"4ED5",47.27,"2","2","Crystal structure of the two N-terminal RRM domains of HuR complexed with RNA","GRTNLIVNYLPQNMTQDELRSLFSSIGEVESAKLIRDKVAGHSLGYGFVNYVTAKDAERAINTLNGLRLQSKTIKVSYARPSSEVIKDANLYISGLPRTMTQKDVEDMFSRFGRIINSRVLVDQTTGLSRGVAFIRFDKRSEAEEAITSFNGHKPPGSSEPITVKFAANLEHHHHHH","Homo sapiens","ELAVL1, HUR","ELAV-like protein 1","1","4ED5"
,,,,,,,,,,,,,,,,"AUUUUUAUUUU",,,"5'-R(*A*UP*UP*UP*UP*UP*AP*UP*UP*UP*U)-3'","2","4ED5"
"4ED6",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11181",,"4ED6",55.18,"2.211","2.211","Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 6.7 for 15 hr, Sideway translocation","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ED6"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4ED6"
,,,,,,,,,,,,,,,,"AGCGTCATA",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*TP*A)-3')","3","4ED6"
"4ED7",,"X-RAY DIFFRACTION",2.12,42.05,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 283K",283,"10.1038/nature11181",,"4ED7",55.41,"1.717","1.717","Human DNA polymerase eta - DNA ternary complex: TG crystal at pH 7.0 (K+ MES) with 1 Ca2+ ion","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ED7"
,,,,,,,,,,,,,,,,"CATTATGACGCG",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*G)-3')","2","4ED7"
,,,,,,,,,,,,,,,,"TGCGTCAT",,,"DNA (5'-D(*TP*GP*CP*GP*TP*CP*AP*T)-3')","3","4ED7"
"4ED8",,"X-RAY DIFFRACTION",2.11,41.72,"VAPOR DIFFUSION",6,"0.1M MES, 6-17%(W/V) PEG 2K-MME, VAPOR DIFFUSION, temperature 293K, pH 6.0",293,"10.1038/nature11181",,"4ED8",55.77,"1.521","1.521","Human DNA polymerase eta - DNA ternary complex: Reaction in the TG crystal at pH 7.0, Normal translocation","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4ED8"
,,,,,,,,,,,,,,,,"CATTATGACGCG",,,"DNA (5'-D(*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*G)-3')","2","4ED8"
,,,,,,,,,,,,,,,,"TGCGTCATA",,,"DNA (5'-D(*TP*GP*CP*GP*TP*CP*AP*TP*A)-3')","3","4ED8"
"4EDE",,"X-RAY DIFFRACTION",2.08,40.84,"EVAPORATION, RECRYSTALLIZATION",4.6,"40% PEG4000, 0.1 M sodium acetate trihydrate, pH 4.6, 0.1 M ammonium acetate, EVAPORATION, RECRYSTALLIZATION, temperature 298K",298,"10.1126/science.1226135","RET","4EDE",32.21,"1.4","1.4","Crystal Structure of the Q108K:K40L:T51V:T53C:Y19W:R58W:T29L:A33W Mutant of Cellular Retinol Binding Protein Type II in Complex with All-trans-Retinal at 1.4 Angstrom Resolution","TRDQNGTWEMESNENFEGWMKALDIDFALRKIWVRLTQTLVIDQDGDNFKVKCTSTFWNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","4EDE"
"4EDF",,"X-RAY DIFFRACTION",2.58,52.3,"VAPOR DIFFUSION, SITTING DROP",5,"5 mM UDP-glucose, 200 mM magnesium chloride, 100 mM citrate tribasic dihydrate, pH 5.0, 10% PEG20000, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi301067w","UPG","4EDF",222.64,"2.08","2.08","Dimeric hUGDH, K94E","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTETYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","Gene ID. 7358, UGDH","UDP-glucose 6-dehydrogenase","1","4EDF"
"4EDJ",,"X-RAY DIFFRACTION",2.46,49.97,"VAPOR DIFFUSION, SITTING DROP",9,"0.2M ammonium acetate, 0.1M Tris pH 9.0, 0.1M immidazole, 30% PEG 4000, 10% PEG 20,000, 10% glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M111.326256",,"4EDJ",45.8,"1.901","1.901","Crystal structure of the GRASP55 GRASP Domain with a phosphomimetic mutation (S189D)","GMGSSQSVEIPGGGTEGYHVLRVQENSPGHRAGLEPFFDFIVSINGSRLNKDNDTLKDLLKANVEKPVKMLIYSSKTLELRETSVTPSNLWGGQGLLGVSIRFCSFDGANENVWHVLEVESNSPAALAGLRPHSDYIIGADTVMNESEDLFSLIETHEAKPLKLYVYNTDTDNCREVIITPNSAWGGEGDLGCGIGYGYLHRIPTRPFE","Homo sapiens","GORASP2, GOLPH6","Golgi reassembly-stacking protein 2","1","4EDJ"
"4EDL",,"X-RAY DIFFRACTION",1.86,33.89,"VAPOR DIFFUSION, HANGING DROP",,"18% PEG 4000, 0.1M sodium citrate, 3% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.367342",,"4EDL",93.28,"2.1","2.1","Crystal structure of beta-parvin CH2 domain","GNSGRFERDAFDTLFDHAPDKLSVVKKSLITFVNKHLNKLNLEVTELETQFADGVYLVLLMGLLEDYFVPLHHFYLTPESFDQKVHNVSFAFELMLDGGLKKPKARPEDVVNLDLKSTLRVLYNLFTKYKNVE","Homo sapiens","PARVB, CGI-56","Beta-parvin","1","4EDL"
"4EDM",,"X-RAY DIFFRACTION",2.86,57.02,"MICROBATCH",7.5,"12% PEG 550 MME, 0.1M Tris, pH 7.5, Microbatch, temperature 298K",298,"10.1074/jbc.M112.367342",,"4EDM",31.18,"2","2","Crystal structure of beta-parvin CH2 domain","GNSGRFERDAFDTLFDHAPDKLSVVKKSLITFVNKHLNKLNLEVTELETQFADGVYLVLLMGLLEDYFVPLHHFYLTPESFDQKVHNVSFAFELMLDGGLKKPKARPEDVVNLDLKSTLRVLYNLFTKYKNVE","Homo sapiens","PARVB, CGI-56","Beta-parvin","1","4EDM"
"4EDY",,"X-RAY DIFFRACTION",2.14,42.45,"VAPOR DIFFUSION",,"vapor diffusion",,"10.1016/j.bmcl.2012.04.004","9PQ","4EDY",47.86,"1.72","1.72","Crystal structure of hH-PGDS with water displacing inhibitor","HPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","GSTS, HPGDS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","4EDY"
"4EDZ",,"X-RAY DIFFRACTION",2.2,44.09,"VAPOR DIFFUSION",,"vapor diffusion",,"10.1016/j.bmcl.2012.04.004","0O5","4EDZ",96.02,"2","2","Crystal structure of hH-PGDS with water displacing inhibitor","APNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","GSTS, HPGDS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","4EDZ"
"4EE0",,"X-RAY DIFFRACTION",2.13,42.18,"VAPOR DIFFUSION",,"vapor diffusion",,"10.1016/j.bmcl.2012.04.004","0O4","4EE0",48.18,"1.75","1.75","Crystal structure of hH-PGDS with water displacing inhibitor","HPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","GSTS, HPGDS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","4EE0"
"4EE3",,"X-RAY DIFFRACTION",3.84,67.94,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM Mes buffer, 1.6 M ammonium sulfate, 2% Dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.373514",,"4EE3",104.73,"2.3","2.3","Crystal structure of human M340H-beta-1,4-galactosyltransferase-1 (M340H-B4GAL-T1) in complex with pentasaccharide","ASMTGGQQMGRGSASLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAIIIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYDYTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTINGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGTTRHIRHSRDKKNEPNPQRFDRIAHTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS","Homo sapiens","B4GALT1, beta4Gal-T1, GGTB2","Beta-1,4-galactosyltransferase 1","1","4EE3"
"4EE4",,"X-RAY DIFFRACTION",3.85,68.02,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM mes buffer, 1.6 ammonium sulfate, 2% dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.373514",,"4EE4",104.42,"1.95","1.95","Crystal structure of human M340H-beta-1,4-galactosyltransferase-1 (M340H-B4GAL-T1) in complex with tetrasaccharide from Lacto-N-neohexose","ASMTGGQQMGRGSASLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAIIIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYDYTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTINGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGTTRHIRHSRDKKNEPNPQRFDRIAHTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS","Homo sapiens","B4GALT1, GGTB2","Beta-1,4-galactosyltransferase 1","1","4EE4"
"4EE5",,"X-RAY DIFFRACTION",3.83,67.93,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM mes buffer, 1.6 M ammonium sulfate, 2% dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.373514",,"4EE5",102.76,"2.2","2.2","Crystal structure of human M340H-beta-1,4-galactosyltransferase-1 (M340H-B4GAL-T1) in complex with trisaccharide from Lacto-N-neotetraose","ASMTGGQQMGRGSASLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAIIIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYDYTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTINGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGTTRHIRHSRDKKNEPNPQRFDRIAHTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS","Homo sapiens","B4GALT1, GGTB2","Beta-1,4-galactosyltransferase 1","1","4EE5"
"4EEA",,"X-RAY DIFFRACTION",3.84,68,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 MM Mes buffer, 1.6 M ammonium sulfate, 2% dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.373514",,"4EEA",103.62,"2","2","Crystal structure of human M340H-beta-1,4-galactosyltransferase-1 (M340H-B4GAL-T1) in complex with GLCNAC-BETA1,6-Gal-Beta1,4-Glc-BETA","ASMTGGQQMGRGSASLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAIIIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYDYTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTINGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGTTRHIRHSRDKKNEPNPQRFDRIAHTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS","Homo sapiens","B4GALT1, GGTB2","Beta-1,4-galactosyltransferase 1","1","4EEA"
"4EEG",,"X-RAY DIFFRACTION",3.83,67.92,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM Mes buffer, 1.6 M Ammonium sulfate, 2% Dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.373514",,"4EEG",102.18,"2.2","2.2","Crystal structure of human M340H-beta-1,4-galactosyltransferase-1 (M340H-B4GAL-T1) in complex with GLCNAC-BETA1,6-Gal-Beta","ASMTGGQQMGRGSASLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAIIIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYDYTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTINGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGTTRHIRHSRDKKNEPNPQRFDRIAHTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS","Homo sapiens","B4GALT1, GGTB2","Beta-1,4-galactosyltransferase 1","1","4EEG"
"4EEH",,"X-RAY DIFFRACTION",2.84,56.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"Na-Cacodylate, 30% PEG8000, 0.2M Ammonium Sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.04.121","HH6","4EEH",26.04,"1.6","1.6","Hsp90 Alpha N-terminal Domain in Complex with an Inhibitor 3-(4-Hydroxy-phenyl)-1H-indazol-6-ol","GDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4EEH"
"4EEJ",,"X-RAY DIFFRACTION",2.05,40.02,"EVAPORATION, RECRYSTALLIZATION",4.6,"40% PEG4000, 0.1 M sodium acetate trihydrate, pH 4.6, 0.1 M ammonium acetate, EVAPORATION, RECRYSTALLIZATION, temperature 298K",298,"10.1126/science.1226135","RET","4EEJ",32.04,"1.501","1.501","Crystal Structure of the Q108K:K40L:T51V:T53C:Y19W:R58W:T29L:Q4R Mutant of Cellular Retinol Binding Protein Type II in Complex with All-trans-Retinal at 1.5 Angstrom Resolution","TRDRNGTWEMESNENFEGWMKALDIDFALRKIAVRLTQTLVIDQDGDNFKVKCTSTFWNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","4EEJ"
"4EEM",,"X-RAY DIFFRACTION",3.85,68.08,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM Mes buffer, 1.6 M ammonium sulfate, 2% Dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.373514",,"4EEM",102.6,"2.2","2.2","Crystal structure of human M340H-beta-1,4-galactosyltransferase-1 (M340H-B4GAL-T1) in complex with GLCNAC-BETA1,6-MAN-ALPHA-methyl","ASMTGGQQMGRGSASLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAIIIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYDYTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTINGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGTTRHIRHSRDKKNEPNPQRFDRIAHTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS","Homo sapiens","B4GALT1, GGTB2","Beta-1,4-galactosyltransferase 1","1","4EEM"
"4EEO",,"X-RAY DIFFRACTION",3.9,68.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM mes buffer, 1.6 M ammonium sulfate, 2% dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.373514",,"4EEO",102.57,"2.3","2.3","Crystal structure of human M340H-beta-1,4-galactosyltransferase-1 (M340H-B4GAL-T1) in complex with GLCNAC-BETA1,6-GlcNAc-ALPHA-benzyl","ASMTGGQQMGRGSASLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAIIIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYDYTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTINGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGTTRHIRHSRDKKNEPNPQRFDRIAHTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS","Homo sapiens","B4GALT1, GGTB2","Beta-1,4-galactosyltransferase 1","1","4EEO"
"4EEV",,"X-RAY DIFFRACTION",2.01,38.8,"VAPOR DIFFUSION, HANGING DROP",7,"16% PEG 10.000, 0.1 M HEPES, and 5% ethylene glycol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1007/s10637-012-9912-9","L1X","4EEV",36.49,"1.8","1.8","Crystal structure of c-Met in complex with LY2801653","MHHHHHHMGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","4EEV"
"4EEW",,"X-RAY DIFFRACTION",1.67,26.53,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M trimethylamine N-oxide, 0.1 M Tris, pH 8.5, 20% w/v PEG2000 MME, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,,,"4EEW",19.77,"1.3","1.3","Crystal structure of the Ubl domain of BAG6","GMEPNDSTSTAVEEPDSLEVLVKTLDSQTRTFIVGAQMNVKEFKEHIAASVSIPSEKQRLIYQGRVLQDDKKLQEYNVGGKVIHLVER","Homo sapiens","BAG6, BAT3, G3","Large proline-rich protein BAG6","1","4EEW"
"4EEY",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION, HANGING DROP",5.5,"15-35% PEG1500, 0.1 M Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nsmb.2295",,"4EEY",56.15,"2.32","2.32","Crystal structure of human DNA polymerase eta in ternary complex with a cisplatin DNA adduct","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNMNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4EEY"
,,,,,,,,,,,,,,,,"CTTGGTCTCCTCC",,,"5'-D(*CP*TP*TP*GP*GP*TP*CP*TP*CP*CP*TP*CP*C)-3'","2","4EEY"
,,,,,,,,,,,,,,,,"TGGAGGAGA",,,"5'-D(*TP*GP*GP*AP*GP*GP*AP*GP*A)-3'","3","4EEY"
"4EF0",,"X-RAY DIFFRACTION",2.66,53.73,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M succinic acid, 15%(w/v) PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"4EF0",27.6,"1.5","1.5","Crystal Structure of the first catalytic domain of protein disulfide isomerase P5","MVIELTPSNFNREVIQSDSLWLVEFYAPWCGHCQRLTPEWKKAATALKDVVKVGAVDADKHHSLGGQYGVQGFPTIKIFGSNKNRPEDYQGGRTGEAIVDAALSALRQLVKDRLGLEHHHHHH","Homo sapiens","PDIA6, ERP5, P5, TXNDC7","Protein disulfide-isomerase A6","1","4EF0"
"4EF4",,"X-RAY DIFFRACTION",2.32,46.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"14.4%(w/v) PEG8000, 0.08M Cacodylate, 0.16M calcium acetate, 20%(v/v) glycerol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.immuni.2012.03.019","C2E","4EF4",60.47,"2.147","2.147","Crystal structure of STING CTD complex with c-di-GMP","MHHHHHHSSGVDLGTENLYFQSNALAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS","Homo sapiens","STING/MITA/ERIS/MPYS/TMEM173, STING1, ERIS, MITA, STING, TMEM173","Transmembrane protein 173","1","4EF4"
"4EF5",,"X-RAY DIFFRACTION",2.25,45.29,"VAPOR DIFFUSION, HANGING DROP",6.5,"14.4%(w/v) PEG8000, 0.08M Cacodylate, 0.16M calcium acetate, 20%(v/v) glycerol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.immuni.2012.03.019",,"4EF5",29.85,"2.45","2.45","Crystal structure of STING CTD","MHHHHHHSSGVDLGTENLYFQSNALAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS","Homo sapiens","STING/MITA/ERIS/MPYS/TMEM173, STING1, ERIS, MITA, STING, TMEM173","Transmembrane protein 173","1","4EF5"
"4EFG",,"X-RAY DIFFRACTION",2.04,39.69,"EVAPORATION, RECRYSTALLIZATION",4.6,"40% PEG4000, 0.1 M sodium acetate trihydrate, pH 4.6, 0.1 M ammonium acetate, EVAPORATION, RECRYSTALLIZATION, temperature 298K",298,"10.1126/science.1226135","RET","4EFG",31.98,"1.58","1.58","Crystal Structure of the Q108K:K40L:T51V:T53C:Y19W:R58W:T29L Mutant of Cellular Retinol Binding Protein Type II in Complex with All-trans-Retinal at 1.58 Angstrom Resolution","TRDQNGTWEMESNENFEGWMKALDIDFALRKIAVRLTQTLVIDQDGDNFKVKCTSTFWNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","4EFG"
"4EFL",,"X-RAY DIFFRACTION",2.24,45.01,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES, 0.2M ammonium sulfate, 30% (w/v) PEG 5000 MME, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.febslet.2012.04.058",,"4EFL",19.83,"1.9","1.9","Crystal structure of H-Ras WT in complex with GppNHp (state 1)","GPLGSMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4EFL"
"4EFM",,"X-RAY DIFFRACTION",2.23,44.89,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES, 0.2M ammonium sulfate, 30% (w/v) PEG 5000 MME, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.febslet.2012.04.058",,"4EFM",19.88,"1.9","1.9","Crystal structure of H-Ras G12V in complex with GppNHp (state 1)","GPLGSMTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4EFM"
"4EFN",,"X-RAY DIFFRACTION",2.24,45.17,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES, 0.2M ammonium sulfate, 30% (w/v) PEG 5000 MME, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.febslet.2012.04.058",,"4EFN",19.82,"2.3","2.3","Crystal structure of H-Ras Q61L in complex with GppNHp (state 1)","GPLGSMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGLEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4EFN"
"4EFO",,"X-RAY DIFFRACTION",2.31,46.86,"VAPOR DIFFUSION, HANGING DROP",5.3,"0.1M BIS-TRIS,0.2M NaCl,21% PEG 3350, pH 5.3, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1007/s13238-012-2929-1",,"4EFO",21.88,"1.769","1.769","Crystal structure of the ubiquitin-like domain of human TBK1","GPLGSTSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSLERPHRD","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","4EFO"
"4EFS",,"X-RAY DIFFRACTION",2.32,46.98,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein solution - 0.53 mM F67D mutant of human MMP12 residues 106-263 in 0.1 M acetohydroxamic acid 0.003 M CaCl2, 0.200 M NaCl 0.02 M Tris-HCl, pH 7.5. Reservoir solution -27% PEG 10K,0.2 M imidazole malate cryoconditions - CryoProtX-Cryomix 7, 25% MPEG 5K, 0.1 M AAB 10/90, VAPOR DIFFUSION, SITTING DROP, temperature 293.0K",293,"10.1074/jbc.M112.380782","E37","4EFS",18.86,"1.63","1.63","Human MMP12 in complex with L-glutamate motif inhibitor","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","4EFS"
"4EFT",,"X-RAY DIFFRACTION",2.91,57.69,"VAPOR DIFFUSION, HANGING DROP",6.5,"Na-Cacodylate, 30% PEG8000, 0.2M Ammonium Sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.04.121","EFT","4EFT",25.98,"2.12","2.12","Hsp90 Alpha N-terminal Domain in Complex with an Inhibitor 3-Cyclohexyl-2-(6-hydroxy-1H-indazol-3-yl)-propionitrile","GDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4EFT"
"4EFU",,"X-RAY DIFFRACTION",2.94,58.18,"VAPOR DIFFUSION, HANGING DROP",6.5,"Na-Cacodylate, 30% PEG8000, 0.2M Ammonium Sulfate   , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.04.121","EFU","4EFU",26.2,"2","2","Hsp90 Alpha N-terminal Domain in Complex with an Inhibitor 6-Hydroxy-3-(3-methyl-benzyl)-1H-indazole-5-carboxylic acid benzyl-methyl-amide","GDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4EFU"
"4EFX",,"X-RAY DIFFRACTION",1.87,34.16,"VAPOR DIFFUSION, SITTING DROP",7,"0.15M DL-Malic Acid, 20% w/v PEG3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/pro.2211",,"4EFX",11.24,"1.98","1.98","Highly biologically active insulin with additional disulfide bond","GIVEQCCTSCCSLYQLENYCN","Homo sapiens","INS","Insulin","1","4EFX"
,,,,,,,,,,,,,,,,"FVNCHLCGSHLVEALYLVCGERGFFYTP","Homo sapiens","INS","Insulin","2","4EFX"
"4EGH",,"X-RAY DIFFRACTION",2.84,56.62,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.2M MgCl2, 0.1M HEPES, 20%w/v PEG2000, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1177/1087057112445785","0OY","4EGH",26.3,"1.6","1.6","Hsp90-alpha ATPase domain in complex with (4-Hydroxyphenyl)morpholin-4-yl methanone","GSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4EGH"
"4EGI",,"X-RAY DIFFRACTION",2.17,43.35,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.2M MgCl2, 0.1M HEPE, 20%w/v PEG2000, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1177/1087057112445785","B2J","4EGI",26.24,"1.79","1.79","Hsp90-alpha ATPase domain in complex with 2-Amino-4-ethylthio-6-methyl-1,3,5-triazine","GSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4EGI"
"4EGK",,"X-RAY DIFFRACTION",2.17,43.21,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.2M MgCl2, 0.1M HEPES, 20%w/v PEG2000, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1177/1087057112445785","RDC","4EGK",26.44,"1.69","1.69","Human Hsp90-alpha ATPase domain bound to Radicicol","GSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4EGK"
"4EGL",,"X-RAY DIFFRACTION",2.14,42.58,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.5M Lithium sulfate monohydrate, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,,,"4EGL",20.21,"2.9","2.9","Crystal structure of two tandem RNA recognition motifs of Human antigen R","GRTNLIVNYLPQNMTQDELRSLFSSIGEVESAKLIRDKVAGHSLGYGFVNYVTAKDAERAINTLNGLRLQSKTIKVSYARPSSEVIKDANLYISGLPRTMTQKDVEDMFSRFGRIINSRVLVDQTTGLSRGVAFIRFDKRSEAEEAITSFNGHKPPGSSEPITVKFAANLEHHHHHH","Homo sapiens","ELAVL1, HUR","ELAV-like protein 1","1","4EGL"
"4EGX",,"X-RAY DIFFRACTION",2.24,44.99,"VAPOR DIFFUSION, HANGING DROP",5.8,"18% (w/v) PEG 5000 MME, 8% (v/v) Tacsimate (pH 6.0), 0.1 M Bis-Tris, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.str.2012.07.002",,"4EGX",84.25,"2.51","2.51","Crystal structure of KIF1A CC1-FHA tandem","GPGSEFSEEAIERLKETEKIIAELNETWEEKLRRTEAIRMEREALLAEMGVAMREDGGTLGVFSPKKTPHLVNLNEDPLMSECLLYYIKDGITRVGREDGERRQDIVLSGHFIKEEHCVFRSDSRGGSEAVVTLEPCEGADTYVNGKKVTEPSILRSGNRIIMGKSHVFRFNHPEQARQERERT","Homo sapiens","KIF1A, ATSV, C2orf20","Kinesin-like protein KIF1A","1","4EGX"
"4EH2",,"X-RAY DIFFRACTION",2.3,46.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 19-24% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchem.1506",,"4EH2",41.77,"2","2","Human p38 MAP kinase in complex with NP-F1 and RL87","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4EH2"
"4EH3",,"X-RAY DIFFRACTION",2.31,46.77,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 19-24% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchem.1506",,"4EH3",41.82,"2.4","2.4","Human p38 MAP kinase in complex with NP-F2 and RL87","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4EH3"
"4EH4",,"X-RAY DIFFRACTION",2.28,46.04,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, pH 6.5, 19-24% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchem.1506",,"4EH4",41.73,"2.5","2.5","Human p38 MAP kinase in complex with NP-F3 and RL87","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4EH4"
"4EH5",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 19-24% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchem.1506",,"4EH5",41.76,"2","2","Human p38 MAP kinase in complex with NP-F4 and RL87","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4EH5"
"4EH6",,"X-RAY DIFFRACTION",2.28,45.97,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 19-24% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchem.1506",,"4EH6",41.74,"2.1","2.1","Human p38 MAP kinase in complex with NP-F5 and RL87","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4EH6"
"4EH7",,"X-RAY DIFFRACTION",2.28,46.04,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 19-24% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchem.1506",,"4EH7",41.75,"2.1","2.1","Human p38 MAP kinase in complex with NP-F6 and RL87","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4EH7"
"4EH8",,"X-RAY DIFFRACTION",2.24,45.12,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 19-24% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchem.1506",,"4EH8",41.97,"2.2","2.2","Human p38 MAP kinase in complex with NP-F7 and RL87","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4EH8"
"4EH9",,"X-RAY DIFFRACTION",2.33,47.18,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 19-24% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchem.1506",,"4EH9",41.91,"2.1","2.1","Human p38 MAP kinase in complex with NP-F11 and RL87","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4EH9"
"4EHA",,"X-RAY DIFFRACTION",2.29,46.37,"VAPOR DIFFUSION, HANGING DROP",8.5,"Protein solution: 8 mg/ml protein in 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Reservoir solution: 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% -16% PEG 6000. Drop: 4ul protein Solution: 4 ul reservoir solution, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1042/BSR20120037",,"4EHA",64.45,"1.696","1.696","Allosteric Modulation of Caspase-3 through Mutagenesis","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIHSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4EHA"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4EHA"
"4EHE",,"X-RAY DIFFRACTION",3.18,61.33,"VAPOR DIFFUSION, HANGING DROP",9,"PEG 8000, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm300016v","RI8","4EHE",71.29,"3.3","3.3","B-Raf Kinase Domain in Complex with an Aminothienopyrimidine-based Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4EHE"
"4EHG",,"X-RAY DIFFRACTION",2.89,57.42,"VAPOR DIFFUSION, HANGING DROP",8.5,"12% PEG 8000, 400 mM Ammonium sulfate, 100 mM MES/Malic Acid/ Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm300016v","RI9","4EHG",71.36,"3.5","3.5","B-Raf Kinase Domain in Complex with an Aminopyridimine-based Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4EHG"
"4EHR",,"X-RAY DIFFRACTION",2.33,47.18,,,,,"10.1016/j.bmcl.2012.04.106","0Q5","4EHR",20.34,"2.09","2.09","Crystal structure of Bcl-Xl complex with 4-(5-butyl-3-(hydroxymethyl)-1-phenyl-1h-pyrazol-4-yl)-3-(3,4-dihydro-2(1h)-isoquinolinylcarbonyl)-n-((2-(trimethylsilyl)ethyl)sulfonyl)benzamide","GSHMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","4EHR"
"4EHV",,"X-RAY DIFFRACTION",2.25,45.4,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 19-24% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchem.1506",,"4EHV",42.53,"1.6","1.6","Human p38 MAP kinase in complex with NP-F10 and RL87","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4EHV"
"4EHZ",,"X-RAY DIFFRACTION",2.33,47.15,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M MES pH 5-6 and 25-35% PEG 6000, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/jm300628c","JAK","4EHZ",140.75,"2.174","2.174","The Jak1 kinase domain in complex with inhibitor","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4EHZ"
"4EI4",,"X-RAY DIFFRACTION",2.37,48.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"PEG 6000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1021/jm300628c","0Q2","4EI4",70.03,"2.22","2.22","JAK1 kinase (JH1 domain) in complex with compound 20","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4EI4"
"4EIH",,"X-RAY DIFFRACTION",1.7,27.67,"VAPOR DIFFUSION, HANGING DROP",8.5,"pH8.5 100mM Tris,  15-17% PEG4000  0.2M Na Acetate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M114.556480",,"4EIH",12.8,"1.2","1.2","Crystal structure of Arg SH2 domain","GPLGSVNSLEKHSWYHGPVSRSAAEYLLSSLINGSFLVRESESSPGQLSISLRYEGRVYHYRINTTADGKVYVTAESRFSTLAELVHHHSTVADGLVTTLHYPAPKCNKPTVYGIL","Homo sapiens","ABL2, ABLL, ARG","Abelson tyrosine-protein kinase 2","1","4EIH"
"4EJG",,"X-RAY DIFFRACTION",2.89,57.46,,8.5,"30% PEG 3350, 0.175 M Tris, and 0.2 M ammonium sulfate, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.372813","NCT","4EJG",444.11,"2.5","2.5","Human Cytochrome P450 2A13 in complex with Nicotine","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVKEALVDQAEEFSGRGEQATFDWLFKGYGVAFSNGERAKQLRRFSIATLRGFGVGKRGIEERIQEEAGFLIDALRGTHGANIDPTFFLSRTVSNVISSIVFGDRFDYEDKEFLSLLRMMLGSFQFTATSTGQLYEMFSSVMKHLPGPQQQAFKELQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFFAGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYTEAVIHEIQRFGDMLPMGLAHRVNKDTKFRDFFLPKGTEVFPMLGSVLRDPRFFSNPRDFNPQHFLDKKGQFKKSDAFVPFSIGKRYCFGEGLARMELFLFFTTIMQNFRFKSPQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A13","Cytochrome P450 2A13","1","4EJG"
"4EJH",,"X-RAY DIFFRACTION",2.87,57.09,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG 3350, 0.175 M Tris, and 0.2 M ammonium sulfate, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.372813","0QA","4EJH",444.8,"2.35","2.35","Human Cytochrome P450 2A13 in complex with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVKEALVDQAEEFSGRGEQATFDWLFKGYGVAFSNGERAKQLRRFSIATLRGFGVGKRGIEERIQEEAGFLIDALRGTHGANIDPTFFLSRTVSNVISSIVFGDRFDYEDKEFLSLLRMMLGSFQFTATSTGQLYEMFSSVMKHLPGPQQQAFKELQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFFAGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYTEAVIHEIQRFGDMLPMGLAHRVNKDTKFRDFFLPKGTEVFPMLGSVLRDPRFFSNPRDFNPQHFLDKKGQFKKSDAFVPFSIGKRYCFGEGLARMELFLFFTTIMQNFRFKSPQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A13","Cytochrome P450 2A13","1","4EJH"
"4EJI",,"X-RAY DIFFRACTION",3.34,63.18,,7.8,"4.0 M sodium formate, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.372813","0QA","4EJI",55.84,"2.1","2.1","Human Cytochrome P450 2A13 in complex with two molecules of 4-(methylnitrosamino)-1-(3-puridyl)-1-butanone","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVKEALVDQAEEFSGRGEQATFDWLFKGYGVAFSNGERAKQLRRFSIATLRGFGVGKRGIEERIQEEAGFLIDALRGTHGANIDPTFFLSRTVSNVISSIVFGDRFDYEDKEFLSLLRMMLGSFQFTATSTGQLYEMFSSVMKHLPGPQQQAFKELQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFFAGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYTEAVIHEIQRFGDMLPMGLAHRVNKDTKFRDFFLPKGTEVFPMLGSVLRDPRFFSNPRDFNPQHFLDKKGQFKKSDAFVPFSIGKRYCFGEGLARMELFLFFTTIMQNFRFKSPQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A13","Cytochrome P450 2A13","1","4EJI"
"4EJJ",,"X-RAY DIFFRACTION",2.78,55.79,,8.5,"30% PEG 3350, 0.175 M Tris, and 0.2 M ammonium sulfate, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.372813","NCT","4EJJ",221.8,"2.3","2.3","Human Cytochrome P450 2A6 in complex with nicotine","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVREALVDQAEEFSGRGEQATFDWVFKGYGVVFSNGERAKQLRRFSIATLRDFGVGKRGIEERIQEEAGFLIDALRGTGGANIDPTFFLSRTVSNVISSIVFGDRFDYKDKEFLSLLRMMLGIFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQLLQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFIGGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQRFGDVIPMSLARRVKKDTKFRDFFLPKGTEVYPMLGSVLRDPSFFSNPQDFNPQHFLNEKGQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A3, CYP2A6","Cytochrome P450 2A6","1","4EJJ"
"4EJN",,"X-RAY DIFFRACTION",2.41,48.92,"EVAPORATION",7.5,"16% butanol, 10mM ammonium sulfate, 0.1% 2-mercaptoethanol, 15% ethylene glycol, 50mM Tris , pH 7.5, EVAPORATION, temperature 277K",277,"10.1021/jm300276x","0R4","4EJN",52.45,"2.19","2.19","Crystal structure of autoinhibited form of AKT1 in complex with N-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide","GSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQM","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","4EJN"
"4EJQ",,"X-RAY DIFFRACTION",1.97,37.64,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.2 M calcium acetate hydrate, 18% (w/v) PEG 3000, 0.1 M Bis-Tris, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.str.2012.07.002",,"4EJQ",139.03,"1.893","1.893","Crystal structure of KIF1A C-CC1-FHA","GSEFTEAIRMEREALLAEMGVAMREDGGTLGVFSPKKTPHLVNLNEDPLMSECLLYYIKDGITRVGREDGERRQDIVLSGHFIKEEHCVFRSDSRGGSEAVVTLEPCEGADTYVNGKKVTEPSILRSGNRIIMGKSHVFRFNHPEQARQERERT","Homo sapiens","KIF1A, ATSV, C2orf20","Kinesin-like protein KIF1A","1","4EJQ"
"4EK3",,"X-RAY DIFFRACTION",2.03,39.36,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,,,"4EK3",34,"1.34","1.34","Crystal structure of apo CDK2","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4EK3"
"4EK4",,"X-RAY DIFFRACTION",2.04,39.78,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, pH 7.8, VAPOR DIFFUSION, SITTING DROP",,,"1CK","4EK4",34.4,"1.26","1.26","Crystal structure of the cdk2 in complex with aminopyrazole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4EK4"
"4EK5",,"X-RAY DIFFRACTION",2.05,39.9,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, pH 7.8, VAPOR DIFFUSION, SITTING DROP",,,"03K","4EK5",34.27,"1.6","1.6","Crystal structure of the cdk2 in complex with aminopyrazole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4EK5"
"4EK6",,"X-RAY DIFFRACTION",2.03,39.47,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, pH 7.8, VAPOR DIFFUSION, SITTING DROP",,,"10K","4EK6",34.33,"1.52","1.52","Crystal structure of the cdk2 in complex with aminopyrazole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4EK6"
"4EK8",,"X-RAY DIFFRACTION",2.05,39.86,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, pH 7.8, VAPOR DIFFUSION, SITTING DROP",,,"16K","4EK8",34.33,"1.7","1.7","Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4EK8"
"4EK9",,"X-RAY DIFFRACTION",3.56,65.5,"VAPOR DIFFUSION, HANGING DROP",5.5,"100 mM Sodium Acetate, 1.8-2.0 M Ammonium Sulfate, 5 mM TCEP, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/cbdd.12050","EP4","4EK9",49.14,"2.5","2.5","Crystal structure of DOT1L in complex with EPZ000004","HHHHHHSSGMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRGRPKK","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","4EK9"
"4EKG",,"X-RAY DIFFRACTION",3.63,66.1,"VAPOR DIFFUSION, HANGING DROP",5.2,"100 mM Sodium Acetate, 1.8-2.0 M Ammonium Sulfate, 5 mM TCEP, pH 5.2, soaking the compound into cross-linked DOT1L-SAM crystal, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/cbdd.12050","0QJ","4EKG",49.08,"2.8","2.8","Crystal Structure of DOT1L in Complex with EPZ003696","HHHHHHSSGMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRGRPKK","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","4EKG"
"4EKI",,"X-RAY DIFFRACTION",3.46,64.47,"VAPOR DIFFUSION, HANGING DROP",5.2,"100 mM Sodium Acetate, 1.8-2.0 M Ammonium Sulfate, 5 mM TCEP, pH 5.2, compound soaked into cross-linked DOT1L-SAM crystal, temperature 293K, VAPOR DIFFUSION, HANGING DROP",293,"10.1111/cbdd.12050","0QK","4EKI",49.39,"2.85","2.85","Crystal Structure of DOT1L in complex with EPZ004777","HHHHHHSSGMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRGRPKK","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","4EKI"
"4EKL",,"X-RAY DIFFRACTION",2.62,53.01,"Under Oil",7.5,"20% PEG4K  
100mM Tris-pH7.5, Under Oil, temperature 293K",293,"10.1126/scisignal.2002618","0RF","4EKL",39.92,"2","2","Akt1 with GDC0068","GAMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFDYSASSTA","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","4EKL"
"4EKU",,"X-RAY DIFFRACTION",4.19,70.67,"VAPOR DIFFUSION, SITTING DROP",7,"1 M AMMONIUM CITRATE TRIBASIC, pH 7.0, 0.1 M BIS-TRIS PROPANE pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"4EKU",45.38,"3.25","3.25","Crystal Structure of FERM Domain of Proline-rich Tyrosine Kinase 2","MELGPAEPMVVVPVDVEKEDVRILKVCFYSNSFNPGKNFKLVKCTVQTEIREIITSILLSGRIGPNIRLAECYGLRLKHMKSDEIHWLHPQMTVGEVQDKYECLHVEAEWRYDLQIRYLPEDFMESLKEDRTTLLYFYQQLRNDYMQRYASKVSEGMALQLGCLELRRFFKDMPHNALDKKSNFELLEKEVGLDLFFPKQMQENLKPKQFRKMIQQTFQQYASLREEECVMKFFNTLAGFANIDQETYRCELIQGWNITVDLVIGPKGIRQLTSQDAKPTCLAEFKQIRSIRCLPLEEGQAVLQLGIEGAPQALSIKTSSLAEAENMADLIDGYCRLQGEHQGSLIIHPRKDGEKRNSLPQIPMLNLEARRSHLSESCSIESDIYAEIPDET","Homo sapiens","FAK2, NM4103, PTK2B, PYK2, RAFTK","Protein-tyrosine kinase 2-beta","1","4EKU"
"4EKZ",,"X-RAY DIFFRACTION",2.21,44.29,"EVAPORATION",9.8,"25% PEG 3350, 0.1M Bis-Tris, 0.2M ammonium acetate, pH 9.8, EVAPORATION, temperature 294K",294,"10.1089/ars.2012.4630",,"4EKZ",54.2,"2.51","2.51","Crystal structure of reduced hPDI (abb'xa')","MHHHHHHSSGLEVLFQGPGSDAPEEEDHVLVLRKSNFAEALAAHKYLLVEFYAPWCGHCKALAPEYAKAAGKLKAEGSEIRLAKVDATEESDLAQQYGVRGYPTIKFFRNGDTASPKEYTAGREADDIVNWLKKRTGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAKQFLQAAEAIDDIPFGITSNSDVFSKYQLDKDGVVLFKKFDEGRNNFEGEVTKENLLDFIKHNQLPLVIEFTEQTAPKIFGGEIKTHILLFLPKSVSDYDGKLSNFKTAAESFKGKILFIFIDSDHTDNQRILEFFGLKKEECPAVRLITLEEEMTKYKPESEELTAERITEFCHRFLEGKIKPHLMSQELPEDWDKQPVKVLVGKNFEDVAFDEKKNVFVEFYAPWCGHCKQLAPIWDKLGETYKDHENIVIAKMDSTANEVEAVKVHSFPTLKFFPASADRTVIDYNGERTLDGFKKFLESGGQDGAG","Homo sapiens","P4HB, ERBA2L, PDI, PDIA1, PO4DB","Protein disulfide-isomerase","1","4EKZ"
"4EL1",,"X-RAY DIFFRACTION",1.91,35.69,"EVAPORATION",9.8,"25% PEG 3350, 0.1M Bis-Tris, 0.2M ammonium acetate, pH 9.8, EVAPORATION, temperature 294K",294,"10.1089/ars.2012.4630",,"4EL1",108.41,"2.883","2.883","Crystal structure of oxidized hPDI (abb'xa')","MHHHHHHSSGLEVLFQGPGSDAPEEEDHVLVLRKSNFAEALAAHKYLLVEFYAPWCGHCKALAPEYAKAAGKLKAEGSEIRLAKVDATEESDLAQQYGVRGYPTIKFFRNGDTASPKEYTAGREADDIVNWLKKRTGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAKQFLQAAEAIDDIPFGITSNSDVFSKYQLDKDGVVLFKKFDEGRNNFEGEVTKENLLDFIKHNQLPLVIEFTEQTAPKIFGGEIKTHILLFLPKSVSDYDGKLSNFKTAAESFKGKILFIFIDSDHTDNQRILEFFGLKKEECPAVRLITLEEEMTKYKPESEELTAERITEFCHRFLEGKIKPHLMSQELPEDWDKQPVKVLVGKNFEDVAFDEKKNVFVEFYAPWCGHCKQLAPIWDKLGETYKDHENIVIAKMDSTANEVEAVKVHSFPTLKFFPASADRTVIDYNGERTLDGFKKFLESGGQDGAG","Homo sapiens","P4HB, ERBA2L, PDI, PDIA1, PO4DB","Protein disulfide-isomerase","1","4EL1"
"4ELJ",,"X-RAY DIFFRACTION",2.96,58.38,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM HEPES, 100mM Ammonium Fluoride, 16% PEG4K, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1101/gad.189837.112",,"4ELJ",76.37,"2.7","2.7","Crystal structure of the inactive retinoblastoma protein phosphorylated at T373","GEFEEPDFTALCQKLKIPDHVRERAWLTWEKVSSVDGVLGGYIQKKKELWGICIFIAAVDLDEMSFTFTELQKNIEISVHKFFNLLKEIDTSTKVDNAMSRLLKKYDVLFALFSKLERTCELIYLTQPSSSISTEINSALVLKVSWITFLLAKGEVLQMEDDLVISFQLMLCVLDYFIKLSPPMLLKEPYKTAVIENDTRIIEVLCKEHECNIDEVANVAFKNFIPFMNSLGLVTSNGLPEVENLSKRYEEIYLKNKDLDARLFLDHDKTLQTDSIDSFETQRTPRKSNLDEEVNVIPPHTPVRTVMNTIQQLMMILNSASDQPSENLISYFNNCTVNPKESILKRVKDIGYIFKEKFAKAVGQGCVEIGSQRYKLGVRLYYRVMESMLKSEEERLSIQNFSKLLNDNIFHMSLLACALEVVMATYSRSTSQNLDSGTDLSFPWILNVLNLKAFDFYKVIESFIKAEGNLTREMIKHLERCEHRIMESLAWLSDSPLFDLIKQSKDREGPLKSTSLSLFYKKVYRLAYLRLNTLCERLLSEHPELEHIIWTLFQHTLQNEYELMRDRHLDQIMMCSMYGICKVKNIDLKFKIIVTAYKDLPHAVQETFKRVLIKEEEYDSIIVFYNSVFMQRLKTNILQYASTRPPTLAPIPHIPR","Homo sapiens","RB1","Retinoblastoma-associated protein","1","4ELJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","RB1"
,,,,,,,,,,,,,,,,,"Homo sapiens","RB1"
"4ELL",,"X-RAY DIFFRACTION",2.21,44.3,"VAPOR DIFFUSION, SITTING DROP",5.5,"100mM sodium citrate, 1mM LiCl, 18% PEG 8K., pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1101/gad.189837.112",,"4ELL",95.35,"1.98","1.98","Structure of the inactive retinoblastoma protein pocket domain","GEFNTIQQLMMILNSASDQPSENLISYFNNCTVNPKESILKRVKDIGYIFKEKFAKAVGQGCVEIGSQRYKLGVRLYYRVMESMLKSEEERLSIQNFSKLLNDNIFHMSLLACALEVVMATYSRSTSQNLDSGTDLSFPWILNVLNLKAFDFYKVIESFIKAEGNLTREMIKHLERCEHRIMESFAWLSDSPLFDLIKQSKDREGPTDHLESACPLNLPLQNNHTAADMYLEPVRAPKKKGSTTRVNSTANAETQATSAFQTQKPLKSTSLSLFYKKVYRLAYLRLNTLCERLLSEHPELEHIIWTLFQHTLQNEYELMRDRHLDQIMMCSMYGICKVKNIDLKFKIIVTAYKDLPHAVQETFKRVLIKEEEYDSIIVFYNSVFMQRLKTNILQYASTRPPTLAPIPHIPR","Homo sapiens","RB1","Retinoblastoma-associated protein","1","4ELL"
"4EM9",,"X-RAY DIFFRACTION",2.67,53.88,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M tris-HCl, 0.9M sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0036297",,"4EM9",63.98,"2.1","2.1","Human PPAR gamma in complex with nonanoic acids","GSHMESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4EM9"
"4EMA",,"X-RAY DIFFRACTION",2.58,52.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M tris-HCl, 0.9M sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0036297","BRL","4EMA",63.18,"2.545","2.545","Human peroxisome proliferator-activated receptor gamma in complex with rosiglitazone","GSHMESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4EMA"
"4EMO",,"X-RAY DIFFRACTION",1.98,37.72,"VAPOR DIFFUSION, SITTING DROP",7.4,"4M sodium formate, pH 7.4, vapor diffusion, sitting drop, temperature 291K",291,"10.1074/jbc.M112.359547",,"4EMO",53.42,"2","2","Crystal structure of the PH domain of SHARPIN","GSMAPPAGGAAAAASDLGSAAVLMAVHAAVRPLGAGPDAEAQLRRLQLSADPERPGRFRLELLGAGPGAVNLEWPLESVSYTIRGPTQHELQPPPGGPGTLSMHFLNPQEAQRWAVLVRGATVEGQNGS","Homo sapiens","PSEC0216, SHARPIN, SIPL1","Sharpin","1","4EMO"
"4EMT",,"X-RAY DIFFRACTION",2.02,39.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"28% PEG400, 0.2M CaCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2331","C2E","4EMT",43.97,"1.5","1.5","Crystal Structure of human STING bound to c-di-GMP","SVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Transmembrane protein 173","1","4EMT"
"4EMU",,"X-RAY DIFFRACTION",2.03,39.3,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M HEPES, pH 8.5, 28% PEG400, 0.2M CaCl2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2331",,"4EMU",43.09,"1.9","1.9","Crystal structure of ligand free human STING","SVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Transmembrane protein 173","1","4EMU"
"4EMX",,"X-RAY DIFFRACTION",2.33,47.17,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 microL 100 mg/mL protein in 50 mM disodium/monosodium phosphate buffer and 100 mM NaCl were mixed with 2 uL 25% PEG 3350, 50 mM disodium/monosodium phosphate buffer, 100 mM NaCl, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,,,"4EMX",133.36,"2.3","2.3","Crystal structure analysis of Human Serum Albumin in complex with chloride anions at cryogenic temperature","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","4EMX"
"4EN0",,"X-RAY DIFFRACTION",2.66,53.79,"VAPOR DIFFUSION, SITTING DROP",5.6,"1.26M NAH2PO4, 0.14M K2HPO4 AND 0.2M NDSB-211, PH 5.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 290.0K",290,"10.1016/j.str.2014.06.013",,"4EN0",55.71,"2.59","2.59","Crystal structure of light","RSHHHHHHGLIQERRSHEVNPAAHLTGANSSLTGSGGPLLWETQLGLAFLRGLSYHDGALVVTKAGYYYIYSKVQLGGVGCPLGLASTITHGLYKRTPRYPEELELLVSQQSPCGRATSSSRVWWDSSFLGGVVHLEAGEEVVVRVLDERLVRLRDGTRSYFGAFMV","Homo sapiens","HVEML, LIGHT, TNFSF14, UNQ391/PRO726","Tumor necrosis factor ligand superfamily member 14","1","4EN0"
"4EN4",,"X-RAY DIFFRACTION",3.22,61.83,"VAPOR DIFFUSION, HANGING DROP",7.2,"ginkgotoxin, MgATP, 48-50% MPD, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0040954","GT0","4EN4",73.62,"2.15","2.15","Crystal Structure of the Ternary Human PL Kinase-Ginkgotoxin-MgATP Complex","MEEECRVLSIQSHVIRGYVGNRAATFPLQVLGFEIDAVNSVQFSNHTGYAHWKGQVLNSDELQELYEGLRLNNMNKYDYVLTGYTRDKSFLAMVVDIVQELKQQNPRLVYVCDPVLGDKWDGEGSMYVPEDLLPVYKEKVVPLADIITPNQFEAELLSGRKIHSQEEALRVMDMLHSMGPDTVVITSSDLPSPQGSNYLIVLGSQRRRNPAGSVVMERIRMDIRKVDAVFVGTGDLFAAMLLAWTHKHPNNLKVACEKTVSTLHHVLQRTIQCAKAQAGEGVRPSPMQLELRMVQSKRDIEDPEIVVQATVL","Homo sapiens","PDXK, C21orf124, C21orf97, PKH, PNK, PRED79","Pyridoxal kinase","1","4EN4"
"4ENH",,"X-RAY DIFFRACTION",2.5,50.73,"VAPOR DIFFUSION, SITTING DROP",5.8,"Crystals were grown after mixing 1 ul of an ~40 mg/ml P450 solution with 1 ul of precipitant solution (15% PEG 8000, 50   M FLX, 50 mM potassium phosphate, 20% glycerol), pH 5.8, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1124/mol.112.080424","FVX","4ENH",53.06,"2.5","2.5","Crystal Structure of Human Cytochrome P450 CYP46A1 with Fluvoxamine Bound","MAKKDEVGGRVLQDVFLDWAKKYGPVVRVNVFHKTSVIVTSPESVKKFLMSTKYNKDSKMYRALQTVFGERLFGQGLVSECNYERWHKQRRVIDLAFSRSSLVSLMETFNEKAEQLVEILEAKADGQTPVSMQDMLTYTAMDILAKAAFGMETSMLLGAQKPLSQAVKLMLEGITASRNTLAKFLPGKRKQLREVRESIRFLRQVGRDWVQRRREALKRGEEVPADILTQILKAEEGAQDDEGLLDNFVTFFIAGHETSANHLAFTVMELSRQPEIVARLQAEVDEVIGSKRYLDFEDLGRLQYLSQVLKESLRLYPPAWGTFRLLEEETLIDGVRVPGNTPLLFSTYVMGRMDTYFEDPLTFNPDRFGPGAPKPRFTYFPFSLGHRSCIGQQFAQMEVKVVMAKLLQRLEFRLVPGQRFGLQEQATLKPLDPVLCTLRPRGWQPAPPPPPCHHHH","Homo sapiens","CYP46A1, CYP46","Cholesterol 24-hydroxylase","1","4ENH"
"4ENO",,"X-RAY DIFFRACTION",2.95,58.35,"VAPOR DIFFUSION, HANGING DROP",6.4,"2.0M sodium potassium phosphate pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1107/S0907444913001194",,"4ENO",34.53,"2.8","2.8","Crystal structure of oxidized human nm23-H1","MANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKEHYVDLKDRPFFAGLVKYMHSGPVVAMVWEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIQVGRNIIHGSDSVESAEKEIGLWFHPEELVDYTSCAQNWIYE","Homo sapiens","NME1, NDPKA, NM23","Nucleoside diphosphate kinase A","1","4ENO"
"4ENX",,"X-RAY DIFFRACTION",3.22,61.8,"VAPOR DIFFUSION, HANGING DROP",5.5,"100mM Citrate buffer, pH 5.5, 200mM NaCl, 1M NH4HPO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1744309112027108","Z20","4ENX",34.66,"2.8","2.8","Crystal Structure of Pim-1 Kinase in complex with inhibitor (2E,5Z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-nitrobenzylidene)thiazolidin-4-one","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPSSGENLYFQ","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4ENX"
"4ENY",,"X-RAY DIFFRACTION",3.2,61.57,"VAPOR DIFFUSION, HANGING DROP",5.5,"100mM Citrate buffer, pH 5.5, 200mM NaCl, 1M NH4HPO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1744309112027108","J19","4ENY",34.81,"2.801","2.801","Crystal Structure of Pim-1 kinase in complex with (2E,5Z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-methoxybenzylidene)thiazolidin-4-one","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPSSGENLYFQ","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4ENY"
"4ENZ",,"X-RAY DIFFRACTION",4.43,72.23,"VAPOR DIFFUSION, SITTING DROP",4.6,"40% MPD, 100 mM sodium chloride, 10 mM calcium chloride, 0.1 M sodium acetate, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 280K",280,"10.1371/journal.pone.0067145",,"4ENZ",123.38,"2.6","2.6","Structure of human ceruloplasmin at 2.6 A resolution","MKILILGIFLFLCSTPAWAKEKHYYIGIIETTWDYASDHGEKKLISVDTEHSNIYLQNGPDRIGRLYKKALYLQYTDETFRTTIEKPVWLGFLGPIIKAETGDKVYVHLKNLASRPYTFHSHGITYYKEHEGAIYPDNTTDFQRADDKVYPGEQYTYMLLATEEQSPGEGDGNCVTRIYHSHIDAPKDIASGLIGPLIICKKDSLDKEKEKHIDREFVVMFSVVDENFSWYLEDNIKTYCSEPEKVDKDNEDFQESNRMYSVNGYTFGSLPGLSMCAEDRVKWYLFGMGNEVDVHAAFFHGQALTNKNYRIDTINLFPATLFDAYMVAQNPGEWMLSCQNLNHLKAGLQAFFQVQECNKSSSKDNIRGKHVRHYYIAAEEIIWNYAPSGIDIFTKENLTAPGSDSAVFFEQGTTRIGGSYKKLVYREYTDASFTNRKERGPEEEHLGILGPVIWAEVGDTIRVTFHNKGAYPLSIEPIGVRFNKNNEGTYYSPNYNPQSRSVPPSASHVAPTETFTYEWTVPKEVGPTNADPVCLAKMYYSAVDPTKDIFTGLIGPMKICKKGSLHANGRQKDVDKEFYLFPTVFDENESLLLEDNIRMFTTAPDQVDKEDEDFQESNKMHSMNGFMYGNQPGLTMCKGDSVVWYLFSAGNEADVHGIYFSGNTYLWRGERRDTANLFPQTSLTLHMWPDTEGTFNVECLTTDHYTGGMKQKYTVNQCRRQSEDSTFYLGERTYYIAAVEVEWDYSPQREWEKELHHLQEQNVSNAFLDKGEFYIGSKYKKVVYRQYTDSTFRVPVERKAEEEHLGILGPQLHADVGDKVKIIFKNMATRPYSIHAHGVQTESSTVTPTLPGETLTYVWKIPERSGAGTEDSACIPWAYYSTVDQVKDLYSGLIGPLIVCRRPYLKVFNPRRKLEFALLFLVFDENESWYLDDNIKTYSDHPEKVNKDDEEFIESNKMHAINGRMFGNLQGLTMHVGDEVNWYLMGMGNEIDLHTVHFHGHSFQYKHRGVYSSDVFDIFPGTYQTLEMFPRTPGIWLLHCHVTDHIHAGMETTYTVLQNEDTKSG","Homo sapiens","CP","Ceruloplasmin","1","4ENZ"
"4EO7",,"X-RAY DIFFRACTION",1.97,37.49,"VAPOR DIFFUSION",6.5,"25% PEG 3350, 0.1M BIS-TRIS pH 6.5,0.2M NaCl, VAPOR DIFFUSION, temperature 277K",277,"10.1073/pnas.1215770110",,"4EO7",16.8,"1.449","1.449","Crystal structure of the TIR domain of human myeloid differentiation primary response protein 88.","GGVDMPERFDAFICYCPSDIQFVQEMIRQLEQTNYRLKLCVSDRDVLPGTCVWSIASELIEKRCRRMVVVVSDDYLQSKECDFQTKFALSLSPGAHQKRLIPIKYKAMKKEFPSILRFITVCDYTNPCTKSWFWTRLAKALSLP","Homo sapiens","MYD88","Myeloid differentiation primary response protein MyD88","1","4EO7"
"4EOH",,"X-RAY DIFFRACTION",3.27,62.37,"VAPOR DIFFUSION, HANGING DROP",7.2,"48-50% MPD, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0040954","TEP","4EOH",73.02,"2.1","2.1","Crystal Structure of Human PL Kinase with bound Theophylline","MEEECRVLSIQSHVIRGYVGNRAATFPLQVLGFEIDAVNSVQFSNHTGYAHWKGQVLNSDELQELYEGLRLNNMNKYDYVLTGYTRDKSFLAMVVDIVQELKQQNPRLVYVCDPVLGDKWDGEGSMYVPEDLLPVYKEKVVPLADIITPNQFEAELLSGRKIHSQEEALRVMDMLHSMGPDTVVITSSDLPSPQGSNYLIVLGSQRRRNPAGSVVMERIRMDIRKVDAVFVGTGDLFAAMLLAWTHKHPNNLKVACEKTVSTLHHVLQRTIQCAKAQAGEGVRPSPMQLELRMVQSKRDIEDPEIVVQATVL","Homo sapiens","PDXK, C21orf124, C21orf97, PKH, PNK, PRED79","Pyridoxal Kinase","1","4EOH"
"4EOT",,"X-RAY DIFFRACTION",4.8,74.35,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.2 M ammonium sulfate, 100 mM sodium acetate, pH 4.5, one week of growth, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/bi301248j",,"4EOT",34.81,"2.855","2.855","Crystal structure of the MafA homodimer bound to the consensus MARE","CCGGTGCTGAGTCAGCAGG",,,"5'-D(*CP*CP*GP*GP*TP*GP*CP*TP*GP*AP*GP*TP*CP*AP*GP*CP*AP*GP*G)-3'","2","4EOT"
,,,,,,,,,,,,,,,,"CCCTGCTGACTCAGCACCG",,,"5'-D(*CP*CP*CP*TP*GP*CP*TP*GP*AP*CP*TP*CP*AP*GP*CP*AP*CP*CP*G)-3'","3","4EOT"
,,,,,,,,,,,,,,,,"GSRFSDDQLVSMSVRELNRQLRGFSKEEVIRLKQKRRTLKNRGYAQSCRFKRVQQRHILESEKCQLQSQVEQLKLEVGRLAKERDLYKEKYEKLA","Homo sapiens","MAFA","Transcription factor MafA","1","4EOT"
"4EPR",,"X-RAY DIFFRACTION",2.71,54.54,,7.5,"30% PEG4000, 0.1 M sodium phosphate, 0.2 M Li2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/anie.201201358",,"4EPR",19.84,"2","2","Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation.","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4EPR"
"4EPT",,"X-RAY DIFFRACTION",2.41,48.91,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG8000, 0.1 M MES, 0.2 M sodium acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/anie.201201358",,"4EPT",19.99,"2","2","Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activation","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4EPT"
"4EPU",,"X-RAY DIFFRACTION",3.48,64.62,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M PIPES pH 6.5, 0.2M NaCl, 2M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4EPU",50.65,"2.098","2.098","Ang1 fibrinogen-related domain (FReD)","ADPFRDCADVYQAGFNKSGIYTIYINNMPEPKKVFCNMDVNGGGWTVIQHREDGSLDFQRGWKEYKMGFGNPSGEYWLGNEFIFAITSQRQYMLRIELMDWEGNRAYSQYDRFHIGNEKQNYRLYLKGHTGTAGKQSSLILHGADFSTKDADNDNCMCKCALMLTGGWWFDACGPSNLNGMFYTAGQNHGKLNGIKWHYFKGPSYSLRSTTMMIRPLDGGR","Homo sapiens","ANGPT1, KIAA0003","Angiopoietin-1","1","4EPU"
"4EPV",,"X-RAY DIFFRACTION",1.91,35.71,"VAPOR DIFFUSION, HANGING DROP",4,"25% PEG1500, 0.1 M MMT, pH 4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/anie.201201358",,"4EPV",20.03,"1.35","1.35","Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activation","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4EPV"
"4EPW",,"X-RAY DIFFRACTION",1.95,36.81,"VAPOR DIFFUSION, SITTING DROP",,"32% PEG1500, 0.7% 1-Butanol, pH 6.1-8.7, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/anie.201201358","0QV","4EPW",20.04,"1.7","1.7","Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activation","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4EPW"
"4EPX",,"X-RAY DIFFRACTION",1.92,36.03,"VAPOR DIFFUSION, SITTING DROP",4.5,"28% PEG8000, 0.1 M sodium acetate, 5% DMSO, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/anie.201201358",,"4EPX",20.09,"1.76","1.76","Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activation","GMTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4EPX"
"4EPY",,"X-RAY DIFFRACTION",1.91,35.75,"VAPOR DIFFUSION, SITTING DROP",4,"28% PEG4000, 0.1 M MMT, 0.2 M ammonium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/anie.201201358","0QY","4EPY",20.18,"1.801","1.801","Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activation","GMTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4EPY"
"4EQ1",,"X-RAY DIFFRACTION",2.56,51.92,"VAPOR DIFFUSION, HANGING DROP",7.5,"2M Ammonium Sulfate, 3% PEG400, 1% PEI, 50mM Tris pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/cb300604u",,"4EQ1",26.1,"1.6","1.6","Crystal Structure of the ARNT PAS-B homodimer","GVCQPTEFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFRSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNV","Homo sapiens","ARNT, BHLHE2","Aryl hydrocarbon receptor nuclear translocator","1","4EQ1"
"4EQC",,"X-RAY DIFFRACTION",2.4,48.72,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 1 M NaCl, 25% PEG 3350, 10 mM DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M113.510933","XR1","4EQC",34.46,"2.01","2.01","Crystal structure of PAK1 kinase domain in complex with FRAX597 inhibitor","DPFTSDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH","Homo sapiens","PAK1","Serine/threonine-protein kinase PAK 1","1","4EQC"
"4EQE",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION, SITTING DROP",7.5,"25-28% PEG3350, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jp212457w",,"4EQE",28.76,"1.52","1.52","Crystal structure of histidine triad nucleotide-binding protein 1 (HINT1) from human complexed with Lys-AMS","SLMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","4EQE"
"4EQG",,"X-RAY DIFFRACTION",2.07,40.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"25-28% PEG3350, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jp212457w",,"4EQG",28.7,"1.52","1.52","Crystal structure of histidine triad nucleotide-binding protein 1 (HINT1) from human complexed with Ala-AMS","SLMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","4EQG"
"4EQH",,"X-RAY DIFFRACTION",2.08,40.86,"VAPOR DIFFUSION, SITTING DROP",7.5,"25-28% PEG3350, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jp212457w",,"4EQH",28.82,"1.668","1.668","Crystal structure of histidine triad nucleotide-binding protein 1 (HINT1) from human complexed with Trp-AMS","SLMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","4EQH"
"4EQU",,"X-RAY DIFFRACTION",2.9,57.54,"VAPOR DIFFUSION, SITTING DROP",6.25,"0.1 M NaCacodylate pH 6.25, 0.24 M CaAcetate, 50% PEG 300, vapor diffusion, sitting drop, temperature 277K",277,"10.1021/ja306035v",,"4EQU",70.18,"2","2","Human STK-10 (LOK) kinase domain in DFG-out conformation with inhibitor DSA-7","SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE","Homo sapiens","STK10, LOK","Serine/threonine-protein kinase 10","1","4EQU"
"4EQZ",,"X-RAY DIFFRACTION",3.6,65.87,"VAPOR DIFFUSION, HANGING DROP",4.5,"3.5 M NaFormate, 0.1 M NaAcet, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/ncomms2304",,"4EQZ",48.48,"2.15","2.15","Crystal structure of human DOT1L in complex with inhibitor FED2","GMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRGRPKKMNTA","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","4EQZ"
"4ER0",,"X-RAY DIFFRACTION",3.61,65.9,"VAPOR DIFFUSION, HANGING DROP",4.5,"3.5 M NaFormate, 0.1 M NaAcet, 0.5 mM inhibitor in H2O, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/ncomms2304","AW1","4ER0",48.52,"2.5","2.5","Crystal Structure of human DOT1L in complex with inhibitor FED1","GMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRGRPKKMNTA","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","4ER0"
"4ER3",,"X-RAY DIFFRACTION",4.16,70.42,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.6M (NH4)2SO4, 0.01M MgCl2, 0.1M NaCaCo, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/ncomms2304","0QK","4ER3",41.95,"2.4","2.4","Crystal Structure of Human DOT1L in complex with inhibitor EPZ004777","GMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKS","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","4ER3"
"4ER5",,"X-RAY DIFFRACTION",3.7,66.76,"VAPOR DIFFUSION, HANGING DROP",4.5,"3.5 M NaFormate, 0.1 M NaAcet, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/ncomms2304","0QK","4ER5",48.13,"2.57","2.57","Crystal structure of human DOT1L in complex with 2 molecules of EPZ004777","GMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRG","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","4ER5"
"4ER6",,"X-RAY DIFFRACTION",3.64,66.23,"VAPOR DIFFUSION, HANGING DROP",4.5,"3.5 M NaFormate, 0.1 M NaAcet, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/ncomms2304","AW2","4ER6",47.77,"2.3","2.3","Crystal structure of human DOT1L in complex with inhibitor SGC0946","GMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRG","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","4ER6"
"4ER7",,"X-RAY DIFFRACTION",3.6,65.86,"VAPOR DIFFUSION, HANGING DROP",4.5,"3.5 M NaFormate, 0.1 M NaAcet, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/ncomms2304",,"4ER7",48.65,"2.2","2.2","Crystal Structure of human DOT1L in complex with inhibitor SGC0947","GMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRGRPKKMNTA","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","4ER7"
"4ERC",,"X-RAY DIFFRACTION",1.98,37.88,,7.5,"VHZ 20 mg/mL in the crystallization buffer was mixed with 50 mM solution of sodium vanadate (final vanadate concentration 10mM One uL of protein-vanadate complex was mixed with an equal volume of well solution containing 150 mM L-Malate, pH 7.0 and PEG3350 (15-20 % v/w), VAPOR DIFFUSION, temperature 298K",298,"10.1021/bi300908y",,"4ERC",33.42,"1.15","1.15","Structure of VHZ bound to metavanadate","MGVQPPNFSWVLPGRLAGLALPRLPAHYQFLLDLGVRHLVSLTERGPPHSDSCPGLTLHRLRIPDFCPPAPDQIDRFVQIVDEANARGEAVGVHCALGFGRTGTMLACYLVKERGLAAGDAIAEIRRLRPGSIETYEQEKAVFQFYQRTK","Homo sapiens","DUSP23, LDP3, VHZ","Dual specificity protein phosphatase 23","1","4ERC"
"4ERE",,"X-RAY DIFFRACTION",1.98,37.98,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, 2.7-3.2 M Ammonium Sulfate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm300354j","0R2","4ERE",23.45,"1.8","1.8","crystal structure of MDM2 (17-111) in complex with compound 23","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4ERE"
"4ERF",,"X-RAY DIFFRACTION",2.19,43.88,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate, 1.9-2.4 M Ammonium Sulfate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm300354j","0R3","4ERF",34.9,"2","2","crystal structure of MDM2 (17-111) in complex with compound 29 (AM-8553)","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4ERF"
"4ERN",,"X-RAY DIFFRACTION",1.78,30.78,"VAPOR DIFFUSION, SITTING DROP",5.55,"0.1 M sodium acetate, pH 5.55, 0.2 M ammonium acetate, 27% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S0907444912045040",,"4ERN",33.42,"1.8","1.8","Crystal structure of the C-terminal domain of human XPB/ERCC-3 excision repair protein at 1.80 A","MELQNNGYIAKVQCAEVWCPMSPEFYREYVAIKTKKRILLYTMNPNKFRACQFLIKFHERRNDKIIVFADNVFALKEYAIRLNKPYIYGPTSQGERMQILQNFKHNPKINTIFISKVGDTSFDLPEANVLIQISSHGGSRRQEAQRLGRVLRAKKGMVAEEYNAFFYSLVSQDTQEMAYSTKRQRFLVDQGYSFKVITKLAGMEEEDLAFSTKEEQQQLLQKVLAATDLDAEEEVVAGEFGSRSSQASRRFGTMSSMSGADDTVYMEYHSSRSKAPSKHVHPLFKRFRK","Homo sapiens","ERCC3, XPB, XPBC","TFIIH basal transcription factor complex helicase XPB subunit","1","4ERN"
"4ERO",,"X-RAY DIFFRACTION",2.3,46.58,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 200000, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1073/pnas.1221743110",,"4ERO",32.47,"2.65","2.65","Study on structure and function relationships in human Pirin with Cobalt ion","MGSSKKVTLSVLSREQSEGVGARVRRSIGRPELKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTWKSKIGN","Homo sapiens","human, PIR","Pirin","1","4ERO"
"4ERV",,"X-RAY DIFFRACTION",2.72,54.71,"VAPOR DIFFUSION, HANGING DROP",9.5,"1.4M Ammonium sulfate, 0.1M Bicine, pH 9.5, vapor diffusion, hanging drop, temperature 295K",295,"10.1016/j.str.2012.04.015",,"4ERV",24.31,"1.75","1.75","Crystal structure of human ryanodine receptor 3 (2597-2800)","SNANFDPKPINTMNFSLPEKLEYIVTKYAEHSHDKWACDKSQSGWKYGISLDENVKTHPLIRPFKTLTEKEKEIYRWPARESLKTMLAVGWTVERTKEGEALVQQRENEKLRSVSQANQGNSYSPAPLDLSNVVLSRELQGMVEVVAENYHNIWAKKKKLELESKGGGSHPLLVPYDTLTAAEKFKDREKAQDLFKFLQVNGIIVSR","Homo sapiens","RYR3, HBRR","Ryanodine receptor 3","1","4ERV"
"4ERW",,"X-RAY DIFFRACTION",1.99,38.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 50 mM sodium/potassium phosphate, 50 mM HEPES, pH 7.5, 5% v/v PEG3350, soaked overnight in 1 mM staurosporine in 50 mM phosphate, 50 mM HEPES, 15% v/v PEG3350, 25% v/v glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cbic.201200316","STU","4ERW",36.27,"2","2","CDK2 in complex with staurosporine","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4ERW"
"4ES7",,"X-RAY DIFFRACTION",1.95,36.3,"VAPOR DIFFUSION, SITTING DROP",6.9,"0.2M ammonium citrate, 20% PEG 3350, 0.1M HEPES pH 6.9, 40% 1,1,1,3,3,3-Hexafluoro-z-propanol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4ES7",22.95,"2.001","2.001","crystal structure of protein HC from Homo sapiens at 2 angstrom","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSDNIQVQENFNISRIYGKWYNLAIGSTCPWLKKIMDRMTVSTLVLGEGATEAEISMTSTRWRKGVCEETSGAYEKTDTDGKFLYHKSKWNITMESYVVHTNYDEYAIFLTKKFSRHHGPTITAKLYGRAPQLRETLLQDFRVVAQGVGIPEDSIFTMADRGECVPGEQ","Homo sapiens","AMBP, HCP, ITIL","Protein AMBP","1","4ES7"
"4ESR",,"X-RAY DIFFRACTION",3.59,65.77,"VAPOR DIFFUSION, HANGING DROP",3,"0.2M ammonium sulphate, 10mM sodium bromide, 0.1M sodium acetate and 7% PEG200 MME, pH 3.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/pmic.201100553",,"4ESR",16.23,"1.53","1.53","Molecular and Structural Characterization of the SH3 Domain of AHI-1 in Regulation of Cellular Resistance of BCR-ABL+ Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitors","HQVDTAPTVVALYDYTANRSDELTIHRGDIIRVFFKDNEDWWYGSIGKGQEGYFPANHVASETLYQELP","Homo sapiens","AHI1","Jouberin","1","4ESR"
"4ET0",,"X-RAY DIFFRACTION",3.57,65.52,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 0.15M Tri-Potassium Citrate, Microseeding, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/cb300232n",,"4ET0",67.58,"3.3","3.3","Crystal structure of circularly permuted human asparaginase-like protein 1","GNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGHHHHHHMTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLPGAGSGAGSGAGG","Homo sapiens","ASRGL1, ALP, CRASH","L-asparaginase","1","4ET0"
"4ET7",,"X-RAY DIFFRACTION",2.27,45.89,"VAPOR DIFFUSION, HANGING DROP",7.5,"2M ammonium sulfate, 0.1M Tris-HCl pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4ET7",20.32,"2.6","2.6","Crystal structure of Eph receptor 5","GSNEVNLLDSRTVMGDLGWIAFPKNGWEEIGEVDENYAPIHTYQVCKVMEQNQNNWLLTSWISNEGASRIFIELKFTLRDCNSLPGGLGTCKETFNMYYFESDDQNGRNIKENQYIKIDTIAADESFTELDLGDRVMKLNTEVRDVGPLSKKGFYLAFQDVGACIALVSVRVYYKEAPS","Homo sapiens","BSK, EHK1, EPHA5, HEK7, TYRO4","Ephrin type-A receptor 5","1","4ET7"
"4ETG",,"X-RAY DIFFRACTION",2.8,56.06,"VAPOR DIFFUSION",7.5,"1.8M Ammonium sulfate in 0.1M Tris and 3% isopropanol, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,"10.1371/journal.pone.0045024",,"4ETG",37.19,"1.61","1.61","Crystal Structure of MIF L46G mutant","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQGMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4ETG"
"4EUI",,"X-RAY DIFFRACTION",2.77,55.56,"VAPOR DIFFUSION",7.5,"1.8M Ammonium sulfate in 0.1M Tris and 3% isopropanol, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,"10.1371/journal.pone.0045024",,"4EUI",37.55,"1.7","1.7","Crystal Structure of MIF L46F mutant","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQFMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4EUI"
"4EUT",,"X-RAY DIFFRACTION",3.49,64.75,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M lithium sulfate, 0.1 M TRIS pH 8.5, 
25% (w/v) PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1121552109",,"4EUT",91.96,"2.6","2.6","Structure of BX-795 Complexed with Unphosphorylated Human TBK1 Kinase-ULD Domain","MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREGNSHHHHHH","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","4EUT"
"4EUU",,"X-RAY DIFFRACTION",3.02,59.34,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M BIS-TRIS pH 5.5 (5.5-7.5), 2.0 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1121552109",,"4EUU",74.73,"1.8","1.8","Structure of BX-795 Complexed with Human TBK1 Kinase Domain Phosphorylated on Ser172","MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNSHHHHHH","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","4EUU"
"4EVG",,"X-RAY DIFFRACTION",2.83,56.54,"VAPOR DIFFUSION",7.5,"1.8M Ammonium sulfate in 0.1M Tris (pH 7.5) and 3% isopropanol, VAPOR DIFFUSION, temperature 291K",291,"10.1371/journal.pone.0045024",,"4EVG",37.32,"1.7","1.7","Crystal Structure of MIF L46A mutant","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQAMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4EVG"
"4EVN",,"X-RAY DIFFRACTION",2.53,51.39,"VAPOR DIFFUSION",6.5,"100 mM imidazole pH 6.5, 17.5% polyethylene glycol 8,000, and 3% 2-methyl-2,4-pentanediol, VAPOR DIFFUSION, temperature 293K",293,"10.1038/nature11371",,"4EVN",389.35,"2.851","2.851","Crystal Structure of Fab CR6261 (somatic heavy chain with germline-reverted light chain)","QVQLVESGAEVKKPGSSVKVSCKASGGPFRSYAISWVRQAPGQGPEWMGGIIPIFGTTKYAPKFQGRVTITADDFAGTVYMELSSLRSEDTAMYYCAKHMGYQVRETMDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKSGRLVPRGSGHHHHHH","Homo sapiens",,"Fab Heavy Chain","1","4EVN"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAYVVFGGGTKLTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab Lambda Light Chain","2","4EVN"
"4EW1",,"X-RAY DIFFRACTION",4.47,72.5,"VAPOR DIFFUSION, SITTING DROP",4.2,"0.1 M phosphate/citrate buffer, 1.5-2.0 M ammonium sulfate at p.H 4.2. 25% Glycerol added as cryoprotectant, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi4005182",,"4EW1",23.06,"1.522","1.522","High resolution structure of human glycinamide ribonucleotide transformylase in apo form.","ARVAVLISGTGSNLQALIDSTREPNSSAQIDIVISNKAAVAGLDKAERAGIPTRVINHKLYKNRVEFDSAIDLVLEEFSIDIVCLAGFMRILSGPFVQKWNGKMLNIHPSLLPSFKGSNAHEQALETGVTVTGCTVHFVAEDVDAGQIILQEAVPVKRGDTVATLSERVKLAEHKIFPAALQLVASGTVQLGENGKICWVKEEHHHHHH","Homo sapiens","GART, PGFT, PRGS","Trifunctional purine biosynthetic protein adenosine-3","1","4EW1"
"4EW2",,"X-RAY DIFFRACTION",4.46,72.42,"VAPOR DIFFUSION, SITTING DROP",4.2,"0.1 M phosphate/citrate buffer, 1.5-2.0 M ammonium sulfate at p.H 4.2. 25% Glycerol added as cryoprotectant, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi4005182","DXY","4EW2",23.44,"1.602","1.602","The structure of human glycinamide ribonucleotide transformylase in complex with 10S-methylthio-DDATHF.","ARVAVLISGTGSNLQALIDSTREPNSSAQIDIVISNKAAVAGLDKAERAGIPTRVINHKLYKNRVEFDSAIDLVLEEFSIDIVCLAGFMRILSGPFVQKWNGKMLNIHPSLLPSFKGSNAHEQALETGVTVTGCTVHFVAEDVDAGQIILQEAVPVKRGDTVATLSERVKLAEHKIFPAALQLVASGTVQLGENGKICWVKEEHHHHHH","Homo sapiens","GART, PGFT, PRGS","Trifunctional purine biosynthetic protein adenosine-3","1","4EW2"
"4EW3",,"X-RAY DIFFRACTION",4.47,72.47,"VAPOR DIFFUSION, SITTING DROP",4.2,"0.1 M phosphate/citrate buffer, 1.5-2.0 M ammonium sulfate at p.H 4.2. 25% Glycerol added as , VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi4005182","DXZ","4EW3",23.44,"1.702","1.702","The structure of human glycinamide ribonucleotide transformylase in complex with 10R-methylthio-DDATHF.","ARVAVLISGTGSNLQALIDSTREPNSSAQIDIVISNKAAVAGLDKAERAGIPTRVINHKLYKNRVEFDSAIDLVLEEFSIDIVCLAGFMRILSGPFVQKWNGKMLNIHPSLLPSFKGSNAHEQALETGVTVTGCTVHFVAEDVDAGQIILQEAVPVKRGDTVATLSERVKLAEHKIFPAALQLVASGTVQLGENGKICWVKEEHHHHHH","Homo sapiens","GART, PGFT, PRGS","Trifunctional purine biosynthetic protein adenosine-3","1","4EW3"
"4EWA",,"X-RAY DIFFRACTION",2.32,47.03,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 20000, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1073/pnas.1221743110",,"4EWA",32.22,"2.47","2.47","Study on structure and function relationships in human Pirin with Fe ion","MGSSKKVTLSVLSREQSEGVGARVRRSIGRPELKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTWKSKIGN","Homo sapiens","human, PIR","Pirin","1","4EWA"
"4EWD",,"X-RAY DIFFRACTION",2.38,48.28,"VAPOR DIFFUSION, HANGING DROP",6.5,"15% PEG 20000, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1073/pnas.1221743110",,"4EWD",32.21,"2.15","2.15","Study on structure and function relationships in human Pirin with Mn ion","MGSSKKVTLSVLSREQSEGVGARVRRSIGRPELKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTWKSKIGN","Homo sapiens","human, PIR","Pirin","1","4EWD"
"4EWE",,"X-RAY DIFFRACTION",2.35,47.76,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 20000, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1073/pnas.1221743110",,"4EWE",32.46,"1.56","1.56","Study on structure and function relationships in human Pirin with Manganese ion","MGSSKKVTLSVLSREQSEGVGARVRRSIGRPELKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTWKSKIGN","Homo sapiens","human, PIR","Pirin","1","4EWE"
"4EWH",,"X-RAY DIFFRACTION",2.4,48.72,"VAPOR DIFFUSION",,"vapor diffusion, temperature 298K",298,"10.1016/j.bmcl.2012.08.020","T77","4EWH",63.99,"2.5","2.5","Co-crystal structure of ACK1 with inhibitor","LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT","Homo sapiens","TNK2, ACK1","Activated CDC42 kinase 1","1","4EWH"
"4EWI",,"X-RAY DIFFRACTION",2.52,51.16,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2 M Disodium tartrate, 2.2 M Ammonium sulfate, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi3007059",,"4EWI",27.79,"2.28","2.28","Crystal structure of the NLRP4 Pyrin domain","GSMAASFFSDFGLMWYLEELKKEEFRKFKEHLKQMTLQLELKQIPWTEVKKASREELANLLIKHYEEQQAWNITLRIFQKMDRKDLCMKVMRERTGYTKTYQAHAKQKFSRLE","Homo sapiens","NLRP4, NALP4, PAN2, PYPAF4, RNH2","NACHT, LRR and PYD domains-containing protein 4","1","4EWI"
"4EWO",,"X-RAY DIFFRACTION",2.28,46.03,"VAPOR DIFFUSION",5,"16%PEG1000, 0.1 M NAacetate, 5 % Glycerol, pH 5.0, VAPOR DIFFUSION, temperature 299K",299,"10.1016/j.bmcl.2012.08.097","996","4EWO",43.46,"1.8","1.8","Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitors","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4EWO"
"4EWQ",,"X-RAY DIFFRACTION",2.11,41.81,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Ammonium Acetate, 0.1< BisTris (pH 5.5), 17% PEG 10,000, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/acs.jmedchem.9b00058","GG5","4EWQ",45.5,"2.1","2.1","Human p38 alpha MAPK in complex with a pyridazine based inhibitor","MHHHHHHSSGVDLGTENLYFQSNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4EWQ"
"4EWS",,"X-RAY DIFFRACTION",4.28,71.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"10mg/ml protein 1:1 mixing with 0.1M HEPES, pH=7.5, 0.2 M MgCl2 and 27-35% (W/v) PEG400, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.380063","0RP","4EWS",56.85,"2.59","2.59","Crystal structure of cholesteryl ester transfer protein in complex with inhibitors","ASKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQDVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTADSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKDVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVDSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESIQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS","Homo sapiens","CETP","CETP","1","4EWS"
"4EWW",,"X-RAY DIFFRACTION",1.8,31.65,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000, cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4EWW",11.84,"2.3","2.3","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4EWW"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4EWW"
"4EWX",,"X-RAY DIFFRACTION",1.87,34.4,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000, cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4EWX",11.84,"2.201","2.201","Human Insulin","FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4EWX"
,,,,,,,,,,,,,,,,"GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4EWX"
"4EWZ",,"X-RAY DIFFRACTION",1.79,31.21,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Betalin H, lot # 310996-1), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4EWZ",11.84,"1.791","1.791","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4EWZ"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4EWZ"
"4EX0",,"X-RAY DIFFRACTION",1.8,31.54,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Betalin H, lot # 310996-1), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4EX0",11.84,"1.86","1.86","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4EX0"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4EX0"
"4EX1",,"X-RAY DIFFRACTION",1.79,31.18,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Betalin H, lot # 310996-1), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4EX1",11.84,"1.657","1.657","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4EX1"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4EX1"
"4EXG",,"X-RAY DIFFRACTION",2.23,44.94,"VAPOR DIFFUSION",5,"16%PEG1000,0.1 M NAacetate,5 % Glycerol, pH 5.0, VAPOR DIFFUSION, temperature 299K",299,"10.1016/j.bmcl.2012.08.097","916","4EXG",43.48,"1.8","1.8","Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitors","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4EXG"
"4EXX",,"X-RAY DIFFRACTION",1.79,31.28,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Insunorm R, lot # I 550005), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4EXX",11.84,"1.55","1.55","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4EXX"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4EXX"
"4EXZ",,"X-RAY DIFFRACTION",2.02,39.06,,,,,"10.1126/science.1226135","RET","4EXZ",31.85,"1.608","1.608","Crystal Structure of the Q108K:K40L Mutant of Cellular Retinol Binding Protein Type II in Complex with All-trans-Retinal at 1.7 Angstrom Resolution","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTLVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGNKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","4EXZ"
"4EY0",,"X-RAY DIFFRACTION",2.25,45.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 8000, 0.1M HEPES.Na, 0.2M Calcium Acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.str.2012.09.005",,"4EY0",114.5,"2.8","2.8","Structure of tandem SH2 domains from PLCgamma1","HSNEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDFGALFEGRNPGFYVEANPMP","Homo sapiens","PLC1, PLCG1","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1","1","4EY0"
"4EY1",,"X-RAY DIFFRACTION",1.79,31.42,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Insunorm R, lot # I 550005), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4EY1",11.84,"1.471","1.471","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4EY1"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4EY1"
"4EY4",,"X-RAY DIFFRACTION",4.44,72.3,"VAPOR DIFFUSION, SITTING DROP",7,"12 to 18% PEG 3350, 0.2M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/jm300871x",,"4EY4",120.94,"2.156","2.156","Crystal Structure of Recombinant Human Acetylcholinesterase in the Apo state","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","4EY4"
"4EY5",,"X-RAY DIFFRACTION",4.35,71.69,"VAPOR DIFFUSION, SITTING DROP",7,"12 to 18% PEG 3350, 0.2M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/jm300871x","HUP","4EY5",121.21,"2.3012","2.3012","Crystal Structure of Recombinant Human Acetylcholinesterase in Complex with (-)-huperzine A","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","4EY5"
"4EY6",,"X-RAY DIFFRACTION",4.33,71.57,"VAPOR DIFFUSION, SITTING DROP",7,"12 to 18% PEG 3350, 0.2M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/jm300871x","GNT","4EY6",121.51,"2.3983","2.3983","Crystal Structure of Recombinant Human Acetylcholinesterase in Complex with (-)-galantamine","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","4EY6"
"4EY7",,"X-RAY DIFFRACTION",4.33,71.63,"VAPOR DIFFUSION, SITTING DROP",7,"12 to 18% PEG 3350, 0.2M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/jm300871x","E20","4EY7",121.33,"2.3509","2.3509","Crystal Structure of Recombinant Human Acetylcholinesterase in Complex with Donepezil","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","4EY7"
"4EY9",,"X-RAY DIFFRACTION",1.79,31.29,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Insunorm R, lot # I 550005), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4EY9",11.84,"1.471","1.471","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4EY9"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4EY9"
"4EYC",,"X-RAY DIFFRACTION",2.18,43.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 m SODIUM HEPES, 0.2 m SODIUM CITRATE, 20% ISOPROPANOL, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi301008r",,"4EYC",23.94,"1.9","1.9","Crystal structure of the cathelin-like domain of human cathelicidin LL-37 (hCLD)","GSHMQVLSYKEAVLRAIDGINQRSSDANLYRLLDLDPRPTMDGDPDTPKPVSFTVKETVCPRTTQQSPEDCDFKKDGLVKRCMGTVTLNQARGSFDISCDKDNKRFA","Homo sapiens","CAMP, CAP18, FALL39, HSD26","Cathelicidin antimicrobial peptide","1","4EYC"
"4EYD",,"X-RAY DIFFRACTION",1.79,31.35,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Insunorm R, lot # I 550005), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4EYD",11.84,"1.471","1.471","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4EYD"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4EYD"
"4EYH",,"X-RAY DIFFRACTION",2.62,53.09,"VAPOR DIFFUSION, HANGING DROP",6.5,"15% PEG 5000MME, 0.2 M MH4SO4, 0.1 M MES pH 6.5, 2.5% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.1093/nar/gks1296",,"4EYH",52.35,"2.9","2.9","Human DNA polymerase iota incorporating dCTP opposite N-(deoxyguanosin-8-yl)-1-aminopyrene lesion","MELADVGAAASSQGVHDQVLPTPNASSRVIVHVDLDCFYAQVEMISNPELKDKPLGVQQKYLVVTCNYEARKLGVKKLMNVRDAKEKCPQLVLVNGEDLTRYREMSYKVTELLEEFSPVVERLGFDENFVDLTEMVEKRLQQLQSDELSAVTVSGHVYNNQSINLLDVLHIRLLVGSQIAAEMREAMYNQLGLTGCAGVASNKLLAKLVSGVFKPNQQTVLLPESCQHLIHSLNHIKEIPGIGYKTAKCLEALGINSVRDLQTFSPKILEKELGISVAQRIQKLSFGEDNSPVILSGPPQSFSEEDSFKKCSSEVEAKNKIEELLASLLNRVCQDGRKPHTVRLIIRRYSSEKHYGRESRQCPIPSHVIQKLGTGNYDVMTPMVDILMKLFRNMVNVKMPFHLTLLSVCFCNLKALNTAK","Homo sapiens","POLI, RAD30B","DNA polymerase iota","1","4EYH"
,,,,,,,,,,,,,,,,"XGGGTCCT",,,"DNA template","2","4EYH"
,,,,,,,,,,,,,,,,"AGGACCC",,,"DNA primer","3","4EYH"
"4EYI",,"X-RAY DIFFRACTION",2.66,53.75,"VAPOR DIFFUSION, HANGING DROP",6.5,"15% PEG 5000MME, 0.2 M NH4SO4, 0.1M MES pH 6.5, 2.5% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.1093/nar/gks1296",,"4EYI",52.37,"2.9","2.9","Human DNA polymerase iota incorporating dATP opposite N-(deoxyguanosin-8-yl)-1-aminopyrene lesion","MELADVGAAASSQGVHDQVLPTPNASSRVIVHVDLDCFYAQVEMISNPELKDKPLGVQQKYLVVTCNYEARKLGVKKLMNVRDAKEKCPQLVLVNGEDLTRYREMSYKVTELLEEFSPVVERLGFDENFVDLTEMVEKRLQQLQSDELSAVTVSGHVYNNQSINLLDVLHIRLLVGSQIAAEMREAMYNQLGLTGCAGVASNKLLAKLVSGVFKPNQQTVLLPESCQHLIHSLNHIKEIPGIGYKTAKCLEALGINSVRDLQTFSPKILEKELGISVAQRIQKLSFGEDNSPVILSGPPQSFSEEDSFKKCSSEVEAKNKIEELLASLLNRVCQDGRKPHTVRLIIRRYSSEKHYGRESRQCPIPSHVIQKLGTGNYDVMTPMVDILMKLFRNMVNVKMPFHLTLLSVCFCNLKALNTAK","Homo sapiens","POLI, RAD30B","DNA polymerase iota","1","4EYI"
,,,,,,,,,,,,,,,,"XGGGTCCT",,,"DNA template","2","4EYI"
,,,,,,,,,,,,,,,,"AGGACCC",,,"DNA primer","3","4EYI"
"4EYJ",,"X-RAY DIFFRACTION",2.32,46.91,"VAPOR DIFFUSION, HANGING DROP",6.5,"50 mM ammonium tartrate, 18% PEG 3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1172/JCI64896","N61","4EYJ",43,"2.102","2.102","MAPK13 Complex with inhibitor","MGSSHHHHHHSSGLVPRGSMSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSPI","Homo sapiens","MAPK13, PRKM13, SAPK4","Mitogen-activated protein kinase 13","1","4EYJ"
"4EYM",,"X-RAY DIFFRACTION",2.32,47.03,"VAPOR DIFFUSION, HANGING DROP",6.5,"50 mM ammonium tartrate, 18% PEG 3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1172/JCI64896","0RX","4EYM",43.01,"2.353","2.353","MAPK13 complex with inhibitor","MGSSHHHHHHSSGLVPRGSMSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSPI","Homo sapiens","MAPK13, PRKM13, SAPK4","Mitogen-activated protein kinase 13","1","4EYM"
"4EYN",,"X-RAY DIFFRACTION",1.8,31.59,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Insunorm R, lot # I 550005), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejpb.2013.05.005",,"4EYN",11.84,"1.532","1.532","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4EYN"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4EYN"
"4EYP",,"X-RAY DIFFRACTION",1.88,34.57,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Insunorm R, lot # I 550005), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejpb.2013.05.005",,"4EYP",11.84,"1.591","1.591","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4EYP"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4EYP"
"4EZ3",,"X-RAY DIFFRACTION",1.93,36.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 5% v/v PEG3350, 50 mM HEPES/NaOH, pH 7.5, 50 mM sodium/potassium phosphate, pH 7.5, 10 mM NSC134199 soak, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cbic.201200316","0S0","4EZ3",35.12,"2","2","CDK2 in complex with NSC 134199","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4EZ3"
"4EZ5",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES pH 6.0, 12% PEG-3350, 0.1M NH4NO3, EVAPORATION, temperature 298K, VAPOR DIFFUSION, HANGING DROP",298,"10.1021/ml200241a","ORS","4EZ5",35.5,"2.7","2.7","CDK6 (monomeric) in complex with inhibitor","MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQHHHHHH","Homo sapiens","CDK6, CDKN6","Cyclin-dependent kinase 6","1","4EZ5"
"4EZ7",,"X-RAY DIFFRACTION",1.93,36.23,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 50 mM sodium/potassium phosphate, pH 7.5, 50 mM HEPES, pH 7.5, 5% v/v PEG3350, 1 mM staurosporine overnight soak followed by 20 mM ANS soak (50 mM HEPES, 50 mM phosphate, 15% v/v PEG3350, 25% v/v glycerol), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cbic.201200316","2AN","4EZ7",36.07,"2.49","2.49","CDK2 in complex with staurosporine and 2 molecules of 8-anilino-1-naphthalene sulfonic acid","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4EZ7"
"4EZA",,"X-RAY DIFFRACTION",1.87,34.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% PEG-MME, 0.2M ammonium sulfate, 0.1M MES, 1:100 (w/w) chymotrypsin, pH 6.5, vapor diffusion, sitting drop, temperature 291K",291,"10.1074/jbc.M112.352773",,"4EZA",26.46,"1.5","1.5","Crystal structure of the atypical phosphoinositide (aPI) binding domain of IQGAP2","MHHHHHHSSGRENLYFQGAKPVKYTAAKLHEKGVLLDIDDLQTNQFKNVTFDIIATEDVGIFDVRSKFLGVEMEKVQLNIQDLLQMQYEGVAVMKMFDKVKVNVNLLIYLLNKK","Homo sapiens","IQGAP2","Ras GTPase-activating-like protein IQGAP2","1","4EZA"
"4EZF",,"X-RAY DIFFRACTION",1.79,31.33,,,,,"10.1073/pnas.1208286110",,"4EZF",18.39,"1.19","1.19","The Crystal Structure of a Human MitoNEET mutant with an Ala inserted between Asp 67 and Lys 68","RFYVKDHRNKAMINLHIQKDNPKIVHAFDMEDLGDAKAVYCRCWRSKKFPFCDGAHTKHNEETGDNVGPLIIKKKET","Homo sapiens","C10orf70, CISD1, MDS029, mitoNEET, ZCD1","CDGSH iron-sulfur domain-containing protein 1","1","4EZF"
"4EZJ",,"X-RAY DIFFRACTION",2.23,44.73,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3350, 0.2M NH4SO4, 0.1M Tris-HCl 8.5, vapor diffusion, hanging drop, temperature 289K",289,"10.1016/j.bmcl.2012.05.027","0SC","4EZJ",111.2,"2.67","2.67","Potent and Selective Inhibitors of PI3K-delta: Obtaining Isoform Selectivity from the Affinity Pocket and Tryptophan Shelf","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCTVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4EZJ"
"4EZK",,"X-RAY DIFFRACTION",2.25,45.28,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3350, 0.2M NH4SO4, 0.1M Tris-HCl 8.5, vapor diffusion, hanging drop, temperature 289K",289,"10.1016/j.bmcl.2012.05.027","0SD","4EZK",111.19,"2.803","2.803","Potent and Selective Inhibitors of PI3K-delta: Obtaining Isoform Selectivity from the Affinity Pocket and Tryptophan Shelf","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCTVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4EZK"
"4EZL",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3350, 0.2M NH4SO4, 0.1M Tris-HCl 8.5, vapor diffusion, hanging drop, temperature 289K",289,"10.1016/j.bmcl.2012.05.027","0SE","4EZL",111.16,"2.94","2.94","Potent and Selective Inhibitors of PI3K-delta: Obtaining Isoform Selectivity from the Affinity Pocket and Tryptophan Shelf","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCTVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4EZL"
"4F08",,"X-RAY DIFFRACTION",3.17,61.26,"VAPOR DIFFUSION, HANGING DROP",6,"0.2 M ammonium acetate,  
0.1M sodium citrate pH6,  
25% PEG 8000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm300628c","JAK, 1RS","4F08",71.46,"2.82","2.82","Discovery and Optimization of C-2 Methyl Imidazo-pyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2","GSSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2, JAK2 kinase domain","Tyrosine-protein kinase JAK2","1","4F08"
"4F09",,"X-RAY DIFFRACTION",2.22,44.61,,6,"0.2 M ammonium acetate,  
0.1M sodium citrate pH6,  
20 % PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm300628c","JAK","4F09",35.74,"2.4","2.4","Discovery and Optimization of C-2 Methyl Imidazo-pyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2","GSSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2 kinase domain, JAK2","Tyrosine-protein kinase JAK2","1","4F09"
"4F0D",,"X-RAY DIFFRACTION",2.79,55.97,"VAPOR DIFFUSION",6.6,"22% PEG 3350, 200 mM di-ammonium tartrate, 0.2 M NaCl, 20% glycerol, pH 6.6, VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M112.379289",,"4F0D",62.36,"2.7","2.7","Human ARTD15/PARP16 IN COMPLEX WITH 3-AMINOBENZAMIDE","SMGWAAAREAAGRDMLAADLRCSLFASALQSYKRDSVLRPFPASYARGDCKDFEALLADASKLPNLKELLQSSGDNHKRAWDLVSWILSSKVLTIHSAGKAEFEKIQKLTGAPHTPVPAPDFLFEIEYFDPANAKFYETKGERDLIYAFHGSRLENFHSIIHNGLHCHLNKTSLFGEGTYLTSDLSLALIYSPHGHGWQHSLLGPILSCVAVCEVIDHPDVKCQTKKKDSKEIDRRRARIKHSEGGDIPPKYFVVTNNQLLRVKYLLVYSQKPPKRA","Homo sapiens","C15orf30, PARP16, ARTD15","Poly [ADP-ribose] polymerase 16","1","4F0D"
"4F0E",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION",10.5,"40% 2-methyl-1,3-propanediol, 0.1 M CAPS, 2mM STO1102, pH 10.5, VAPOR DIFFUSION, temperature 293K",293,"10.1021/jm300746d",,"4F0E",92.72,"2.4","2.4","Human ADP-RIBOSYLTRANSFERASE 7 (ARTD7/PARP15), CATALYTIC DOMAIN IN COMPLEX WITH STO1102","SMNLPEHWTDMNHQLFCMVQLEPGQSEYNTIKDKFTRTCSSYAIEKIERIQNAFLWQSYQVKKRQMDIKNDHKNNERLLFHGTDADSVPYVNQHGFNRSCAGKNAVSYGKGTYFAVDASYSAKDTYSKPDSNGRKHMYVVRVLTGVFTKGRAGLVTPPPKNPHNPTDLFDSVTNNTRSPKLFVVFFDNQAYPEYLITFTA","Homo sapiens","BAL3, PARP15","Poly [ADP-ribose] polymerase 15","1","4F0E"
"4F0I",,"X-RAY DIFFRACTION",2.86,57.04,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1 M Na citrate, pH 5.6, 14% PEG 3350, 5% 2-Propanol , VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.jmb.2012.08.002",,"4F0I",67.93,"2.302","2.302","Crystal structure of apo TrkA","GSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","4F0I"
"4F0N",,"X-RAY DIFFRACTION",1.88,34.69,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Novolin R, lot # XS60393), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4F0N",11.84,"1.679","1.679","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F0N"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F0N"
"4F0O",,"X-RAY DIFFRACTION",1.85,33.67,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium citrate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Novolin R, lot # XS60393), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4F0O",11.84,"1.672","1.672","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F0O"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F0O"
"4F0X",,"X-RAY DIFFRACTION",2.7,54.42,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG 2000 MME    
0.1M AcNa    
10mM CitNa, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.443846",,"4F0X",411.77,"3.29","3.29","Crystal structure of human Malonyl-CoA Decarboxylase (Peroxisomal Isoform)","GSGAMDELLRRAVPPTPAYELREKTPAPAEGQCADFVSFYGGLAETAQRAELLGRLARGFGVDHGQVAEQSAGVLHLRQQQREAAVLLQAEDRLRYALVPRYRGLFHHISKLDGGVRFLVQLRADLLEAQALKLVEGPDVREMNGVLKGMLSEWFSSGFLNLERVTWHSPCEVLQKISEAEAVHPVKNWMDMKRRVGPYRRCYFFSHCSTPGEPLVVLHVALTGDISSNIQAIVKEHPPSETEEKNKITAAIFYSISLTQQGLQGVELGTFLIKRVVKELQREFPHLGVFSSLSPIPGFTKWLLGLLNSQTKEHGRNELFTDSECKEISEITGGPINETLKLLLSSSEWVQSEKLVRALQTPLMRLCAWYLYGEKHRGYALNPVANFHLQNGAVLWRINWMADVSLRGITGSCGLMANYRYFLEETGPNSTSYLGSKIIKASEQVLSLVAQFQKNSKL","Homo sapiens","DCYLM, MLYCD","Malonyl-CoA decarboxylase, mitochondrial","1","4F0X"
"4F11",,"X-RAY DIFFRACTION",3.42,64.07,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG MME 550, 20% glycerol, 2mM zinc sulfate, 0.1M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nn.3133",,"4F11",49.13,"2.38","2.38","Crystal structure of the extracellular domain of human GABA(B) receptor GBR2","WARGAPRPPPSSPPLSIMGLMPLTKEVAKGSIGRGVLPAVELAIEQIRNESLLRPYFLDLRLYDTECDNAKGLKAFYDAIKYGPNHLMVFGGVCPSVTSIIAESLQGWNLVQLSFAATTPVLADKKKYPYFFRTVPSDNAVNPAILKLLKHYQWKRVGTLTQDVQRFSEVRNDLTGVLYGEDIEISDTESFSNDPCTSVKKLKGNDVRIILGQFDQNMAAKVFCCAYEENMYGSKYQWIIPGWYEPSWWEQVHTEANSSRCLRKNLLAAMEGYIGVDFEPLSSKQIKTISGKTPQQYEREYNNKRSGVGPSKFHGYAYDGIWVIAKTLQRAMETLHASSRHQRIQDFNYTDHTLGRIILNAMNETNFFGVTGQVVFRNGERMGTIKFTQFQDSREVKVGEYNAVADTLEIINDTIRFQGSEPPKDDYKDDDDK","Homo sapiens","GABBR2, GPR51, GPRC3B","Gamma-aminobutyric acid type B receptor subunit 2","1","4F11"
"4F12",,"X-RAY DIFFRACTION",2.38,48.24,"VAPOR DIFFUSION, HANGING DROP",7,"30% Jeffamine ED-2001, 0.1M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nn.3133",,"4F12",50.36,"3.02","3.02","Crystal structure of the extracellular domain of human GABA(B) receptor GBR2","WARGAPRPPPSSPPLSIMGLMPLTKEVAKGSIGRGVLPAVELAIEQIRNESLLRPYFLDLRLYDTECDNAKGLKAFYDAIKYGPNHLMVFGGVCPSVTSIIAESLQGWNLVQLSFAATTPVLADKKKYPYFFRTVPSDNAVNPAILKLLKHYQWKRVGTLTQDVQRFSEVRNDLTGVLYGEDIEISDTESFSNDPCTSVKKLKGNDVRIILGQFDQNMAAKVFCCAYEENMYGSKYQWIIPGWYEPSWWEQVHTEANSSRCLRKNLLAAMEGYIGVDFEPLSSKQIKTISGKTPQQYEREYNNKRSGVGPSKFHGYAYDGIWVIAKTLQRAMETLHASSRHQRIQDFNYTDHTLGRIILNAMNETNFFGVTGQVVFRNGERMGTIKFTQFQDSREVKVGEYNAVADTLEIINDTIRFQGSEPPKDDYKDDDDK","Homo sapiens","GABBR2, GPR51, GPRC3B","Gamma-aminobutyric acid type B receptor subunit 2","1","4F12"
"4F1A",,"X-RAY DIFFRACTION",1.85,33.67,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Novolin R, lot # XS60393), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4F1A",11.84,"1.8","1.8","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F1A"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F1A"
"4F1B",,"X-RAY DIFFRACTION",1.88,34.45,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Novolin R, lot # TS 62987), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejpb.2013.05.005",,"4F1B",11.84,"1.591","1.591","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F1B"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F1B"
"4F1C",,"X-RAY DIFFRACTION",1.8,31.69,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Novolin R, lot # TS 62987), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejpb.2013.05.005",,"4F1C",11.84,"1.7","1.7","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F1C"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F1C"
"4F1D",,"X-RAY DIFFRACTION",1.88,34.59,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Humulin R, lot # A 505073), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejpb.2013.05.005",,"4F1D",11.84,"1.637","1.637","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F1D"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F1D"
"4F1E",,"X-RAY DIFFRACTION",2.02,39.25,,,,,"10.1073/pnas.1208286110",,"4F1E",163.19,"2.4","2.4","The Crystal Structure of a Human MitoNEET mutant with Asp 67 replaced by a Gly","RFYVKDHRNKAMINLHIQKDNPKIVHAFDMEDLGGKAVYCRCWRSKKFPFCDGAHTKHNEETGDNVGPLIIKKKET","Homo sapiens","C10orf70, CISD1, MDS029, ZCD1","CDGSH iron-sulfur domain-containing protein 1","1","4F1E"
"4F1F",,"X-RAY DIFFRACTION",1.86,33.92,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Humulin R, lot # A 560347), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejpb.2013.05.005",,"4F1F",11.84,"1.684","1.684","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F1F"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F1F"
"4F1G",,"X-RAY DIFFRACTION",1.88,34.72,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Humulin R, lot # A 560347), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejpb.2013.05.005",,"4F1G",11.84,"1.637","1.637","Human insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F1G"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F1G"
"4F1L",,"X-RAY DIFFRACTION",2.58,52.4,"VAPOR DIFFUSION, SITTING DROP",5.9,"20% (w/v) polyethylene glycol (PEG) 3350, 0.2 M sodium nitrate, 0.1 M Bis-Tris, 1.3mM A16, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm300746d","0RY","4F1L",89.54,"1.9","1.9","Human Artd8 (Parp14, Bal2) - catalytic domain in complex with inhibitor A16(Z)","SMDMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","BAL2, KIAA1268, PARP14","Poly [ADP-ribose] polymerase 14","1","4F1L"
"4F1P",,"X-RAY DIFFRACTION",2.31,46.74,"VAPOR DIFFUSION, HANGING DROP",5.1,"0.2M ammonium sulfate, 12-14% PEG 3350, 0.1M Sodium Citrate, pH 5.1, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1074/jbc.M112.378810",,"4F1P",78.7,"2.3","2.3","Crystal Structure of mutant S554D for ArfGAP and ANK repeat domain of ACAP1","GPLGSGSGHLAIGSAATLGSGGMARGREPGGVGHVVAQVQSVDGNAQCCDCREPAPEWASINLGVTLCIQCSGIHRSLGVHFSKVRSLTLDSWEPELVKLMCELGNVIINQIYEARVEAMAVKKPGPSCSRQEKEAWIHAKYVEKKFLTKLPEIRGRRGGRGRPRGQPPVPPKPSIRPRPGDLRSKPEPPSEDLGSLHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLRLAKMREAEAAQGQAGDETYLDIFRDFSLMASDDPEKLSRRSHDLHTL","Homo sapiens","ACAP1, CENTB1, KIAA0050","Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1","1","4F1P"
"4F1Q",,"X-RAY DIFFRACTION",2.82,56.42,"VAPOR DIFFUSION, SITTING DROP",5.8,"19% PEG 3350, 0.19M NaNO3, 0.1M Bis-tris, pH 5.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm300746d","0RZ","4F1Q",44.77,"2.8","2.8","Human Artd8 (Parp14, Bal2) - catalytic domain in complex with A16(E)","SMDMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","BAL2, KIAA1268, PARP14","Poly [ADP-ribose] polymerase 14","1","4F1Q"
"4F1S",,"X-RAY DIFFRACTION",2.47,50.28,"VAPOR DIFFUSION, HANGING DROP",7.3,"20% PEG 3350, 100 mM Tris, 250 mM ammonium sulfate, 2 mM dithiothreitol, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.06.078","F1S","4F1S",110.89,"3","3","Crystal structure of human PI3K-gamma in complex with a pyridyl-triazine-sulfonamide inhibitor","GSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4F1S"
"4F25",,"X-RAY DIFFRACTION",1.85,33.62,"VAPOR DIFFUSION, HANGING DROP",6,"25% PEG 1500 and 0.1 M MIB buffer, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.molcel.2012.09.001",,"4F25",12.68,"1.9","1.9","Crystal structure of the second RRM domain of human PABPC1 at pH 6.0","GPLGSGNIFIKNLDKSIDNKALYDTFSAFGNILSCKVVCDENGSKGYGFVHFETQEAAERAIEKMNGMLLNDRKVFVGRFKSRKEREAELGARAKEFTNVYIKNFGPGSTRAAAS","Homo sapiens","PABPC1, PAB1, PABP1, PABPC2, PABP","Polyadenylate-binding protein 1","1","4F25"
"4F26",,"X-RAY DIFFRACTION",1.52,18.85,"VAPOR DIFFUSION, HANGING DROP",9,"25% PEG 1500 and 0.1 M MMT buffer , pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.molcel.2012.09.001",,"4F26",12.68,"2","2","Crystal structure of the second RRM domain of human PABPC1 a pH 9.0","GPLGSGNIFIKNLDKSIDNKALYDTFSAFGNILSCKVVCDENGSKGYGFVHFETQEAAERAIEKMNGMLLNDRKVFVGRFKSRKEREAELGARAKEFTNVYIKNFGPGSTRAAAS","Homo sapiens","PABPC1, PAB1, PABP1, PABPC2, PABP","Polyadenylate-binding protein 1","1","4F26"
"4F28",,"X-RAY DIFFRACTION",1.95,36.85,,,,,"10.1073/pnas.1208286110",,"4F28",18.1,"1.55","1.55","The Crystal Structure of a Human MitoNEET mutant with Met 62 Replaced by a Gly","RFYVKDHRNKAMINLHIQKDNPKIVHAFDGEDLGDKAVYCRCWRSKKFPFCDGAHTKHNEETGDNVGPLIIKKKET","Homo sapiens","C10orf70, CISD1, MDS029, ZCD1","CDGSH iron-sulfur domain-containing protein 1","1","4F28"
"4F2A",,"X-RAY DIFFRACTION",4.24,70.97,,,,,"10.1074/jbc.M112.380063",,"4F2A",56.67,"3.11","3.11","Crystal structure of cholestryl esters transfer protein in complex with inhibitors","ASKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQDVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTADSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKDVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVDSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESIQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS","Homo sapiens","CETP","Cholesteryl ester transfer protein","1","4F2A"
"4F2C",,"X-RAY DIFFRACTION",1.96,37.33,,,,,"10.1073/pnas.1208286110",,"4F2C",18.19,"1.35","1.35","The Crystal Structure of a Human MitoNEET double mutant in which Gly 66 are Asp 67 are both Replaced with Ala Residues","RFYVKDHRNKAMINLHIQKDNPKIVHAFDMEDLAAKAVYCRCWRSKKFPFCDGAHTKHNEETGDNVGPLIIKKKET","Homo sapiens","C10orf70, CISD1, MDS029, ZCD1","CDGSH iron-sulfur domain-containing protein 1","1","4F2C"
"4F2J",,"X-RAY DIFFRACTION",4.37,71.87,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 0.2M Sodium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M112.441451",,"4F2J",13.1,"2.64","2.64","Crystal structure of ZNF217 bound to DNA, P6522 crystal form","TTTGCAGAATCGATTCTGCA",,,"5'-D(*TP*TP*TP*GP*CP*AP*GP*AP*AP*TP*CP*GP*AP*TP*TP*CP*TP*GP*CP*A)-3'","1","4F2J"
,,,,,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 0.2M Sodium sulfate, 10mM Trimethyllead acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,,,,,,"GSSSRECSYCGKFFRSNYYLNIHLRTHTGEKPYKCEFCEYAAAQKTSLRYHLERHHK","Homo sapiens","ZNF217, ZABC1","Zinc finger protein 217","2","4F2J"
"4F2K",,"X-RAY DIFFRACTION",2.77,55.53,"VAPOR DIFFUSION, HANGING DROP",8,"1.9M (NH4)2SO4, 100mM Tris pH 8.0, 200mM NaCl, 4% v/v isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1744309112030552",,"4F2K",38.19,"1.53","1.53","Macrophage Migration Inhibitory Factor covalently complexed with phenethylisothiocyanate","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","4F2K"
"4F3I",,"X-RAY DIFFRACTION",2.13,42.29,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% PEG3350, 0.2 M lithium sulfate, 0.1 M Tris-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M112.359505","0S6","4F3I",15.64,"1.4","1.4","Crystal structure of the first bromodomain of human BRD4 in complex with MS417 inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4F3I"
"4F3J",,"X-RAY DIFFRACTION",1.77,30.42,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M Sodium Acetate pH 5.0, 2 M NaCl, 10% Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2012.07.011",,"4F3J",16.42,"1.337","1.337","Crystal Structure of Trimeric gC1q Domain of Human C1QTNF5 associated with Late-onset Retinal Macular Degeneration","ARSAFSAKRSESRVPPPSDAPLPFDRVLVNEQGHYDAVTGKFTCQVPGVYYFAVHATVYRASLQFDLVKNGESIASFFQFFGGWPKPASLSGGAMVRLEPEDQVWVQVGVGDYIGIYASIKTDSTFSGFLVYSDWHSSPVFAHHHHHH","Homo sapiens","C1QTNF5, CTRP5, UNQ303/PRO344","Complement C1q tumor necrosis factor-related protein 5","1","4F3J"
"4F45",,"X-RAY DIFFRACTION",2.27,45.86,"VAPOR DIFFUSION, HANGING DROP",4,"0.1M sodium acetate pH 4.0, 12% PEG 20K, vapor diffusion, hanging drop, temperature 298K",298,,,"4F45",61.11,"2.1","2.1","Crystal structure of human CD38 E226Q mutant in complex with NAADP","EFWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVQVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","4F45"
"4F46",,"X-RAY DIFFRACTION",2.23,44.8,"VAPOR DIFFUSION, HANGING DROP",4,"0.1M sodium acetate pH 4.0, 15% PEG 10K, 0.2M ammonium acetate, 3% isopropanol, vapor diffusion, hanging drop, temperature 298K",298,,,"4F46",61.01,"1.69","1.69","Crystal structure of wild type human CD38 in complex with NAADP and ADPRP","EFWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","4F46"
"4F4D",,"X-RAY DIFFRACTION",2.8,56.1,,6.5,"0.1 M BIS-TRIS, 0.05 M AMMONIUM ACETATE, 20% PENTAERYTHRITOL ETHOXYLATE (15/4 EO/OH) , PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",,,,"4F4D",85.34,"1.8","1.8","F337R variant of human ferrochelatase","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIARTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase, mitochondrial","1","4F4D"
"4F4P",,"X-RAY DIFFRACTION",2.43,49.47,,,,,"10.1016/j.bmcl.2012.07.045","0SB","4F4P",32.09,"2.37","2.37","SYK in COMPLEX WITH LIGAND LASW836","LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4F4P"
"4F4T",,"X-RAY DIFFRACTION",1.87,34.24,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Humulin R, lot # A 505073), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4F4T",11.84,"1.637","1.637","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F4T"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F4T"
"4F4V",,"X-RAY DIFFRACTION",1.87,34.3,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Humulin R, lot # A 505073), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4F4V",11.84,"1.637","1.637","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F4V"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F4V"
"4F51",,"X-RAY DIFFRACTION",1.88,34.45,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Humulin R, lot # A 505073), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4F51",11.84,"1.637","1.637","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F51"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F51"
"4F57",,"X-RAY DIFFRACTION",2.58,52.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.17 M (NH4)2SO4, 0.085 M cacodylate pH 6.5, 25.5% (w/v) polyethylene glycol (PEG) 8000, and 15% (v/v) glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1371/journal.ppat.1003173",,"4F57",47.02,"1.7","1.7","Fab structure of a neutralizing antibody L1 from an early subtype A HIV-1 infected patient","QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYRQHPGEAPKAIIFDVTNRPSGISNRFSGSKFGNTASLTISGLQAEDEADYYCAAYTVASTLLFGGGTKVTVLRQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPT","Homo sapiens",,"Light chain of Fab of a neutralizing antibody L1","1","4F57"
,,,,,,,,,,,,,,,,"EVQLVESGGGVVQPGGSLRLSCVASGFSFSDFGMNWVRQAPGKGLEWVAFVPFDRRINYYAESVRGRFTISRDDSKNTVFLQMDSLRPEDTAIYYCAKHRSQWNFWPREGGLDHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Heavy chain of Fab of a neutralizing antibody L1","2","4F57"
"4F58",,"X-RAY DIFFRACTION",2.97,58.54,"VAPOR DIFFUSION, HANGING DROP",8.5,"28% PEG 4K, 0.17 M Li2SO4, 0.085 M Tris pH 8.5, and 15% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1371/journal.ppat.1003173",,"4F58",189.22,"2.488","2.488","Fab structure of a neutralizing antibody L3 from an early subtype A HIV-1 infected patient","QSALTQPASVSGSPGQSITISCTGTTSDVGTYNFVSWYQQHPGKAPKAIIFDVTNRPSGISNRFSGSKFGNTASLTISGLQAEDEADYYCAAYTVASTLLFGGGTKVTVLRQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPT","Homo sapiens",,"Light chain of Fab of a neutralizing antibody L3","1","4F58"
,,,,,,,,,,,,,,,,"EVQLVESGGGVVQPGGSLRLSCVASGFSFSDFGMNWVRQAPGKGLEWVAFVPFDRRINYYAESVRGRFTISRDDSKNTVFLQMDSLRPEDTAIYYCAKHRSQWNFWPREGGLDHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Heavy chain of Fab of a neutralizing antibody L3","2","4F58"
"4F59",,"X-RAY DIFFRACTION",2.4,48.72,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.1 M Tris-HCl, 18% PEG6000, 0.2 M lithium chloride, pH 7.6, vapor diffusion, sitting drop, temperature 277K",277,"10.1126/scisignal.2003021",,"4F59",12.7,"1.71","1.71","Triple mutant Src SH2 domain","GAMDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETVKGAYALSVSDFDNAKGLNVKHYLIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK","Homo sapiens","SRC, SRC1","Proto-oncogene tyrosine-protein kinase Src","1","4F59"
"4F5A",,"X-RAY DIFFRACTION",2.38,48.41,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.1 M Tris-HCl, 18% PEG6000, 0.2 M lithium chloride, pH 7.6, vapor diffusion, sitting drop, temperature 277K",277,"10.1126/scisignal.2003021",,"4F5A",12.79,"1.8","1.8","Triple mutant Src SH2 domain bound to phosphate ion","GAMDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETVKGAYALSVSDFDNAKGLNVKHYLIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK","Homo sapiens","SRC, SRC1","Proto-oncogene tyrosine-protein kinase Src","1","4F5A"
"4F5B",,"X-RAY DIFFRACTION",2.43,49.4,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.1 M Tris-HCl, 18% PEG6000, 0.2 M lithium chloride, pH 7.6, vapor diffusion, sitting drop, temperature 277K",277,"10.1126/scisignal.2003021","PTR","4F5B",12.96,"1.57","1.57","Triple mutant Src SH2 domain bound to phosphotyrosine","GAMDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETVKGAYALSVSDFDNAKGLNVKHYLIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK","Homo sapiens","SRC, SRC1","Proto-oncogene tyrosine-protein kinase Src","1","4F5B"
"4F5D",,"X-RAY DIFFRACTION",1.91,35.71,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.025M MgSO4, 0.05M Tris-HCl pH 8.5, 1.8M AmSO4, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1038/nsmb.2333",,"4F5D",57.99,"3","3","ERIS/STING in complex with ligand","GSHMASMTGGMGRGSMMPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTADRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Transmembrane protein 173","1","4F5D"
"4F5E",,"X-RAY DIFFRACTION",1.94,36.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"25.0% PEG 3350, 0.1M Bis-tris pH 6.5, 0.2M NH4-acetate, 5% Glycerol, 0.025% Dichloromethane, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/nsmb.2333",,"4F5E",28.86,"2.601","2.601","Crystal structure of ERIS/STING","GSHMASMTGGMGRGSMMPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTADRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Transmembrane protein 173","1","4F5E"
"4F5W",,"X-RAY DIFFRACTION",2.49,50.53,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.08M Sodium cacodylate pH 6.5, 0.16M Calcium acetate, 15% PEG 8000, 20% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nsmb.2332",,"4F5W",27.28,"2.201","2.201","Crystal structure of ligand free human STING CTD","EKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFSLEHHHHHH","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Transmembrane protein 173","1","4F5W"
"4F5Y",,"X-RAY DIFFRACTION",2.5,50.74,"VAPOR DIFFUSION, HANGING DROP",6.5,"15% PEG 8000, 0.08M sodium cacodylate pH6.5, 0.16M calcium acetate and 20% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nsmb.2332","C2E","4F5Y",55.25,"2.396","2.396","Crystal structure of human STING CTD complex with C-di-GMP","EKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFSLEHHHHHH","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Transmembrane protein 173","1","4F5Y"
"4F63",,"X-RAY DIFFRACTION",2.66,53.76,"VAPOR DIFFUSION, HANGING DROP",,"16-20% PEG8000, 100 mM PCTP, 100-300 mM ammonium sulfate, 25% ethylene glycol, pH 6.25-7.25, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm3004043","0S7","4F63",71.27,"2.55","2.55","Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compound 1","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","4F63"
"4F64",,"X-RAY DIFFRACTION",2.65,53.66,"VAPOR DIFFUSION, HANGING DROP",,"16-20% PEG8000, 100 mM PCTP, 100-300 mM ammonium sulfate, 25% ethylene glycol, pH 6.25-7.25, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm3004043","0S8","4F64",71.46,"2.05","2.05","Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compound 6","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","4F64"
"4F65",,"X-RAY DIFFRACTION",2.37,48.19,"VAPOR DIFFUSION, HANGING DROP",,"16-20% PEG8000, 100 mM PCTP, 100-300 mM ammonium sulfate, 25% ethylene glycol, pH 6.25-7.25, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm3004043","0S9","4F65",72.18,"2.26","2.26","Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compound 8","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","4F65"
"4F7B",,"X-RAY DIFFRACTION",2.91,57.77,"VAPOR DIFFUSION, HANGING DROP",5.5,"28% PEG 1500, 0.2M Sodium Chloride and Sodium Cacodylate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/nature12684",,"4F7B",312.71,"3","3","Structure of the lysosomal domain of limp-2","AAPEHHHHHHDYDIPTTENLYFQGAMDQSIEKKIVLRNGTEAFDSWEKPPLPVYTQFYFFNVTNPEEILRGETPRVEEVGPYTYRELRNKANIQFGDNGTTISAVSNKAYVFERDQSVGDPKIDLIRTLNIPVLTVIEWSQVHFLREIIEAMLKAYQQKLFVTHTVDELLWGYKDEILSLIHVFRPDISPYFGLFYEKNGTNDGDYVFLTGEDSYLNFTKIVEWNGKTSLDWWITDKCNMINGTDGDSFHPLITKDEVLYVFPSDFCRSVYITFSDYESVQGLPAFRYKVPAEILANTSDNAGFCIPEGNCLGSGVLNVSICKNGAPIIMSFPHFYQADERFVSAIEGMHPNQEDHETFVDINPLTGIILKAAKRFQINIYVKKLDDFVETGDIRTMVFPVMYLNESVHIDKETASRLKSMIN","Homo sapiens","CD36L2, LIMPII, SCARB2, LIMP2","Lysosome membrane protein 2","1","4F7B"
"4F7H",,"X-RAY DIFFRACTION",2.03,39.37,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.4 M ammonium tartrate dibasic, 0.1 M tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1007/s13238-012-2046-1",,"4F7H",19.73,"1.9","1.9","The crystal structure of kindlin-2 pleckstrin homology domain in free form","SSIMTSENHLNNSDKEVDEVDAALSDLEITLEGGKTSTILGDITSIPELADYIKVFKPKKLTLKGYKQYWCTFKDTSISCYKSKEESSGTPAHQMNLRGCEVTPDVNISGQKFNIKLLIPVAEGMNEIWLRCDNEKQYAHWMAACRLASKGKTMADSSYNLEVQNILSFLKMQ","Homo sapiens","FERMT2, KIND2, MIG2, PLEKHC1","Fermitin family homolog 2","1","4F7H"
"4F7O",,"X-RAY DIFFRACTION",2.23,44.88,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG3350, KSCN, Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1209345110",,"4F7O",59.39,"2.6","2.6","Crystal structure of CSN5","MAASGSGMAQKTWELANNMQEAQSIDEIYKYDKKQQQEILAAKPWTKDHHYFKYCKISALALLKMVMHARSGGNLEVMGLMLGKVDGETMIIMDSFALPVEGTETRVNAQAAAYEYMAAYIENAKQVGRLENAIGWYHSHPGYGCWLSGIDVSTQMLNQQFQEPFVAVVIDPTRTISAGKVNLGAFRTYPKGYKPPDEGPSEYQTIPLNKIEDFGVHCKQYYALEVSYFKSSLDRKLLELLWNKYWVNTLSSSSLLT","Homo sapiens","COPS5, CSN5, JAB1","COP9 signalosome complex subunit 5","1","4F7O"
"4F80",,"X-RAY DIFFRACTION",3.15,60.95,"VAPOR DIFFUSION, SITTING DROP",4,"0.1M Citric acid pH4.0, 1.6M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M112.384354",,"4F80",24.47,"1.944","1.944","Crystal Structure of the human BTN3A1 ectodomain","ADLQFSVLGPSGPILAMVGEDADLPCHLFPTMSAETMELKWVSSSLRQVVNVYADGKEVEDRQSAPYRGRTSILRDGITAGKAALRIHNVTASDSGKYLCYFQDGDFYEKALVELKVAALGSDLHVDVKGYKDGGIHLECRSTGWYPQPQIQWSNNKGENIPTVEAPVVADGVGLYAVAASVIMRGSSGEGVSCTIRSSLLGLEKTASISIADPFFRSAQHHHHHH","Homo sapiens","BTF5, BTN3A1","Butyrophilin subfamily 3 member A1","1","4F80"
"4F8E",,"X-RAY DIFFRACTION",2.4,48.65,"VAPOR DIFFUSION",4.1,"pH 4.1, VAPOR DIFFUSION, temperature 295K",295,"10.1002/iub.1154",,"4F8E",72.57,"2.27","2.27","Crystal structure of human PRS1 D52H mutant","MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEHVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPLLEHHHHHH","Homo sapiens","PRPS1","Ribose-phosphate pyrophosphokinase 1","1","4F8E"
"4F8F",,"X-RAY DIFFRACTION",1.89,34.75,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 uL 0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000 + 2 uL 100 U/mL human insulin (Humulin R, lot # A 405936), cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejpb.2013.05.005",,"4F8F",11.84,"1.676","1.676","Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4F8F"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4F8F"
"4F8Q",,"X-RAY DIFFRACTION",2.73,55,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1M Sodium Citrate pH5.6, 0.5M Ammonium Sulfate, 1M Lithium Sulfate, vapor diffusion, sitting drop, temperature 298K",298,"10.1074/jbc.M112.384354",,"4F8Q",23.64,"2.3789","2.3789","Crystal Structure of the Human BTN3A2 Ectodomain","ADLQFSVLGPSGPILAMVGEDADLPCHLFPTMSAETMELKWVSSSLRQVVNVYADGKEVEDRQSAPYRGRTSILRDGITAGKAALRIHNVTASDSGKYLCYFQDGDFYEKALVELKVAALGSNLHVEVKGYEDGGIHLECRSTGWYPQPQIQWSNAKGENIPAVEAPVVADGVGLYEVAASVIMRGGSGEGVSCIIRNSLLGLEKTASISIADHHHHHH","Homo sapiens","BT3.2, BTF3, BTF4, BTN3A2","Butyrophilin subfamily 3 member A2","1","4F8Q"
"4F8T",,"X-RAY DIFFRACTION",3.14,60.88,"Sitting drop",4,"0.1M Citric acid pH4.0, 0.8M ammonium sulfate, 0.15M Sodium Fluoride, Sitting drop, temperature 298K",298,"10.1074/jbc.M112.384354",,"4F8T",24.45,"2.382","2.382","Crystal Structure of the Human BTN3A3 Ectodomain","ADLQFSVLGPSGPILAMVGEDADLPCHLFPTMSAETMELRWVSSSLRQVVNVYADGKEVEDRQSAPYRGRTSILRDGITAGKAALRIHNVTASDSGKYLCYFQDGDFYEKALVELKVAALGSDLHIEVKGYEDGGIHLECRSTGWYPQPQIKWSDTKGENIPAVEAPVVADGVGLYAVAASVIMRGSSGGGVSCIIRNSLLGLEKTASISIADPFFRSAQHHHHHH","Homo sapiens","BTF3, BTN3A3","Butyrophilin subfamily 3 member A3","1","4F8T"
"4F91",,"X-RAY DIFFRACTION",3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M sodium citrate, 1.2 M sodium Malonate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1208098109",,"4F91",197.24,"2.697","2.697","Brr2 Helicase Region","ALAPRQVLDLEDLVFTQGSHFMANKRCQLPDGSFRRQRKGYEEVHVPALKPKPFGSEEQLLPVEKLPKYAQAGFEGFKTLNRIQSKLYRAALETDENLLLCAPTGAGKTNVALMCMLREIGKHINMDGTINVDDFKIIYIAPMRSLVQEMVGSFGKRLATYGITVAELTGDHQLCKEEISATQIIVCTPEKWDIITRKGGERTYTQLVRLIILDEIHLLHDDRGPVLEALVARAIRNIEMTQEDVRLIGLSATLPNYEDVATFLRVDPAKGLFYFDNSFRPVPLEQTYVGITEKKAIKRFQIMNEIVYEKIMEHAGKNQVLVFVHSRKETGKTARAIRDMCLEKDTLGLFLREGSASTEVLRTEAEQCKNLELKDLLPYGFAIHHAGMTRVDRTLVEDLFADKHIQVLVSTATLAWGVNLPAHTVIIKGTQVYSPEKGRWTELGALDILQMLGRAGRPQYDTKGEGILITSHGELQYYLSLLNQQLPIESQMVSKLPDMLNAEIVLGNVQNAKDAVNWLGYAYLYIRMLRSPTLYGISHDDLKGDPLLDQRRLDLVHTAALMLDKNNLVKYDKKTGNFQVTELGRIASHYYITNDTVQTYNQLLKPTLSEIELFRVFSLSSEFKNITVREEEKLELQKLLERVPIPVKESIEEPSAKINVLLQAFISQLKLEGFALMADMVYVTQSAGRLMRAIFEIVLNRGWAQLTDKTLNLCKMIDKRMWQSMCPLRQFRKLPEEVVKKIEKKNFPFERLYDLNHNEIGELIRMPKMGKTIHKYVHLFPKLELSVHLQPITRSTLKVELTITPDFQWDEKVHGSSEAFWILVEDVDSEVILHHEYFLLKAKYAQDEHLITFFVPVFEPLPPQYFIRVVSDRWLSCETQLPVSFRHLILPEKYPPPTELLDLQPLPVSALRNSAFESLYQDKFPFFNPIQTQVFNTVYNSDDNVFVGAPTGSGKTICAEFAILRMLLQSSEGRCVYITPMEALAEQVYMDWYEKFQDRLNKKVVLLTGETSTDLKLLGKGNIIISTPEKWDILSRRWKQRKNVQNINLFVVDEVHLIGGENGPVLEVICSRMRYISSQIERPIRIVALSSSLSNAKDVAHWLGCSATSTFNFHPNVRPVPLELHIQGFNISHTQTRLLSMAKPVYHAITKHSPKKPVIVFVPSRKQTRLTAIDILTTCAADIQRQRFLHCTEKDLIPYLEKLSDSTLKETLLNGVGYLHEGLSPMERRLVEQLFSSGAIQVVVASRSLCWGMNVAAHLVIIMDTQYYNGKIHAYVDYPIYDVLQMVGHANRPLQDDEGRCVIMCQGSKKDFFKKFLYEPLPVESHLDHCMHDHFNAEIVTKTIENKQDAVDYLTWTFLYRRMTQNPNYYNLQGISHRHLSDHLSELVEQTLSDLEQSKCISIEDEMDVAPLNLGMIAAYYYINYTTIELFSMSLNAKTKVRGLIEIISNAAEYENIPIRHHEDNLLRQLAQKVPHKLNNPKFNDPHVKTNLLLQAHLSRMQLSAELQSDTEEILSKAIRLIQACVDVLSSNGWLSPALAAMELAQMVTQAMWSKDSYLKQLPHFTSEHIKRCTDKGVESVFDIMEMEDEERNALLQLTDSQIADVARFCNRYPNIELSYEVVDKDSIRSGGPVVVLVQLEREEEVTGPVIAPLFPQKREEGWWVVIGDAKSNSLISIKRLTLQQKAKVKLDFVAPATGAHNYTLYFMSDAYMGCDQEYKFSVD","Homo sapiens","SNRNP200, ASCC3L1, HELIC2, KIAA0788","U5 small nuclear ribonucleoprotein 200 kDa helicase","1","4F91"
"4F92",,"X-RAY DIFFRACTION",3.38,63.59,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M sodium citrate, 1.2 M sodium Malonate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1208098109",,"4F92",197.44,"2.662","2.662","Brr2 Helicase Region S1087L","ALAPRQVLDLEDLVFTQGSHFMANKRCQLPDGSFRRQRKGYEEVHVPALKPKPFGSEEQLLPVEKLPKYAQAGFEGFKTLNRIQSKLYRAALETDENLLLCAPTGAGKTNVALMCMLREIGKHINMDGTINVDDFKIIYIAPMRSLVQEMVGSFGKRLATYGITVAELTGDHQLCKEEISATQIIVCTPEKWDIITRKGGERTYTQLVRLIILDEIHLLHDDRGPVLEALVARAIRNIEMTQEDVRLIGLSATLPNYEDVATFLRVDPAKGLFYFDNSFRPVPLEQTYVGITEKKAIKRFQIMNEIVYEKIMEHAGKNQVLVFVHSRKETGKTARAIRDMCLEKDTLGLFLREGSASTEVLRTEAEQCKNLELKDLLPYGFAIHHAGMTRVDRTLVEDLFADKHIQVLVSTATLAWGVNLPAHTVIIKGTQVYSPEKGRWTELGALDILQMLGRAGRPQYDTKGEGILITSHGELQYYLSLLNQQLPIESQMVSKLPDMLNAEIVLGNVQNAKDAVNWLGYAYLYIRMLRSPTLYGISHDDLKGDPLLDQRRLDLVHTAALMLDKNNLVKYDKKTGNFQVTELGRIASHYYITNDTVQTYNQLLKPTLSEIELFRVFSLSSEFKNITVREEEKLELQKLLERVPIPVKESIEEPSAKINVLLQAFISQLKLEGFALMADMVYVTQLAGRLMRAIFEIVLNRGWAQLTDKTLNLCKMIDKRMWQSMCPLRQFRKLPEEVVKKIEKKNFPFERLYDLNHNEIGELIRMPKMGKTIHKYVHLFPKLELSVHLQPITRSTLKVELTITPDFQWDEKVHGSSEAFWILVEDVDSEVILHHEYFLLKAKYAQDEHLITFFVPVFEPLPPQYFIRVVSDRWLSCETQLPVSFRHLILPEKYPPPTELLDLQPLPVSALRNSAFESLYQDKFPFFNPIQTQVFNTVYNSDDNVFVGAPTGSGKTICAEFAILRMLLQSSEGRCVYITPMEALAEQVYMDWYEKFQDRLNKKVVLLTGETSTDLKLLGKGNIIISTPEKWDILSRRWKQRKNVQNINLFVVDEVHLIGGENGPVLEVICSRMRYISSQIERPIRIVALSSSLSNAKDVAHWLGCSATSTFNFHPNVRPVPLELHIQGFNISHTQTRLLSMAKPVYHAITKHSPKKPVIVFVPSRKQTRLTAIDILTTCAADIQRQRFLHCTEKDLIPYLEKLSDSTLKETLLNGVGYLHEGLSPMERRLVEQLFSSGAIQVVVASRSLCWGMNVAAHLVIIMDTQYYNGKIHAYVDYPIYDVLQMVGHANRPLQDDEGRCVIMCQGSKKDFFKKFLYEPLPVESHLDHCMHDHFNAEIVTKTIENKQDAVDYLTWTFLYRRMTQNPNYYNLQGISHRHLSDHLSELVEQTLSDLEQSKCISIEDEMDVAPLNLGMIAAYYYINYTTIELFSMSLNAKTKVRGLIEIISNAAEYENIPIRHHEDNLLRQLAQKVPHKLNNPKFNDPHVKTNLLLQAHLSRMQLSAELQSDTEEILSKAIRLIQACVDVLSSNGWLSPALAAMELAQMVTQAMWSKDSYLKQLPHFTSEHIKRCTDKGVESVFDIMEMEDEERNALLQLTDSQIADVARFCNRYPNIELSYEVVDKDSIRSGGPVVVLVQLEREEEVTGPVIAPLFPQKREEGWWVVIGDAKSNSLISIKRLTLQQKAKVKLDFVAPATGAHNYTLYFMSDAYMGCDQEYKFSVD","Homo sapiens","SNRNP200, ASCC3L1, HELIC2, KIAA0788","U5 small nuclear ribonucleoprotein 200 kDa helicase","1","4F92"
"4F93",,"X-RAY DIFFRACTION",3.55,65.39,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M sodium citrate, 1.2 M sodium Malonate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1208098109",,"4F93",198.4,"2.92","2.92","Brr2 Helicase Region S1087L, Mg-ATP","ALAPRQVLDLEDLVFTQGSHFMANKRCQLPDGSFRRQRKGYEEVHVPALKPKPFGSEEQLLPVEKLPKYAQAGFEGFKTLNRIQSKLYRAALETDENLLLCAPTGAGKTNVALMCMLREIGKHINMDGTINVDDFKIIYIAPMRSLVQEMVGSFGKRLATYGITVAELTGDHQLCKEEISATQIIVCTPEKWDIITRKGGERTYTQLVRLIILDEIHLLHDDRGPVLEALVARAIRNIEMTQEDVRLIGLSATLPNYEDVATFLRVDPAKGLFYFDNSFRPVPLEQTYVGITEKKAIKRFQIMNEIVYEKIMEHAGKNQVLVFVHSRKETGKTARAIRDMCLEKDTLGLFLREGSASTEVLRTEAEQCKNLELKDLLPYGFAIHHAGMTRVDRTLVEDLFADKHIQVLVSTATLAWGVNLPAHTVIIKGTQVYSPEKGRWTELGALDILQMLGRAGRPQYDTKGEGILITSHGELQYYLSLLNQQLPIESQMVSKLPDMLNAEIVLGNVQNAKDAVNWLGYAYLYIRMLRSPTLYGISHDDLKGDPLLDQRRLDLVHTAALMLDKNNLVKYDKKTGNFQVTELGRIASHYYITNDTVQTYNQLLKPTLSEIELFRVFSLSSEFKNITVREEEKLELQKLLERVPIPVKESIEEPSAKINVLLQAFISQLKLEGFALMADMVYVTQLAGRLMRAIFEIVLNRGWAQLTDKTLNLCKMIDKRMWQSMCPLRQFRKLPEEVVKKIEKKNFPFERLYDLNHNEIGELIRMPKMGKTIHKYVHLFPKLELSVHLQPITRSTLKVELTITPDFQWDEKVHGSSEAFWILVEDVDSEVILHHEYFLLKAKYAQDEHLITFFVPVFEPLPPQYFIRVVSDRWLSCETQLPVSFRHLILPEKYPPPTELLDLQPLPVSALRNSAFESLYQDKFPFFNPIQTQVFNTVYNSDDNVFVGAPTGSGKTICAEFAILRMLLQSSEGRCVYITPMEALAEQVYMDWYEKFQDRLNKKVVLLTGETSTDLKLLGKGNIIISTPEKWDILSRRWKQRKNVQNINLFVVDEVHLIGGENGPVLEVICSRMRYISSQIERPIRIVALSSSLSNAKDVAHWLGCSATSTFNFHPNVRPVPLELHIQGFNISHTQTRLLSMAKPVYHAITKHSPKKPVIVFVPSRKQTRLTAIDILTTCAADIQRQRFLHCTEKDLIPYLEKLSDSTLKETLLNGVGYLHEGLSPMERRLVEQLFSSGAIQVVVASRSLCWGMNVAAHLVIIMDTQYYNGKIHAYVDYPIYDVLQMVGHANRPLQDDEGRCVIMCQGSKKDFFKKFLYEPLPVESHLDHCMHDHFNAEIVTKTIENKQDAVDYLTWTFLYRRMTQNPNYYNLQGISHRHLSDHLSELVEQTLSDLEQSKCISIEDEMDVAPLNLGMIAAYYYINYTTIELFSMSLNAKTKVRGLIEIISNAAEYENIPIRHHEDNLLRQLAQKVPHKLNNPKFNDPHVKTNLLLQAHLSRMQLSAELQSDTEEILSKAIRLIQACVDVLSSNGWLSPALAAMELAQMVTQAMWSKDSYLKQLPHFTSEHIKRCTDKGVESVFDIMEMEDEERNALLQLTDSQIADVARFCNRYPNIELSYEVVDKDSIRSGGPVVVLVQLEREEEVTGPVIAPLFPQKREEGWWVVIGDAKSNSLISIKRLTLQQKAKVKLDFVAPATGAHNYTLYFMSDAYMGCDQEYKFSVD","Homo sapiens","SNRNP200, ASCC3L1, HELIC2, KIAA0788","U5 small nuclear ribonucleoprotein 200 kDa helicase","1","4F93"
"4F95",,"X-RAY DIFFRACTION",1.87,34.38,"VAPOR DIFFUSION, HANGING DROP",6.667,"24.4% PEG 3350, 0.1 M BIS-TRIS, 10 MM BETA-MERCAPTOETHANOL, pH 6.667, VAPOR DIFFUSION, HANGING DROP, temperature 295.15K",295.15,"10.1016/j.jsb.2013.03.007",,"4F95",21.75,"2.07","2.07","Crystal structure of human inosine triphosphate pyrophosphatase P32T variant","GSHMAASLVGKKIVFVTGNAKKLEEVVQILGDKFTCTLVAQKIDLPEYQGEPDEISIQKCQEAVRQVQGPVLVEDTCLCFNALGGLPGPYIKWFLEKLKPEGLHQLLAGFEDKSAYALCTFALSTGDPSQPVRLFRGRTSGRIVAPRGCQDFGWDPCFQPDGYEQTYAEMPKAEKNAVSHRFRALLELQEYFGSLAA","Homo sapiens","C20orf37, ITPA, ITPA (P32T MUTANT), My049, OK/SW-cl.9","Inosine triphosphate pyrophosphatase","1","4F95"
"4F9E",,"X-RAY DIFFRACTION",2.05,34.15,,,,,"10.1016/j.molcel.2012.05.029",,"4F9E",29.85,"2.75","2.75","Cyclic di-GMP Sensing via the Innate Immune Signaling Protein STING","MHHHHHHSSGVDLGTENLYFQSNALAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Transmembrane protein 173","1","4F9E"
"4F9G",,"X-RAY DIFFRACTION",2.23,44.72,"VAPOR DIFFUSION, HANGING DROP",6.5,"12-15% PEG8000, 0.08 M sodium cacodylate pH 6.3-6.5, 0.16 M calcium acetate and 20% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.molcel.2012.05.029","C2E","4F9G",60.39,"2.95","2.95","Crystal structure of STING complex with Cyclic di-GMP.","MHHHHHHSSGVDLGTENLYFQSNALAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Transmembrane protein 173","1","4F9G"
"4F9K",,"X-RAY DIFFRACTION",1.67,26.32,"microbatch under oil",6.5,"Protein solution: 100mM NaCl, 5mM DTT, 0.02% NaN3, 10mM Tris-HCl (pH 7.5) . Reservoir solution:0.2M (NH4)2SO4, 0.1M Na-c, microbatch under oil, temperature 291K",291,,,"4F9K",46.64,"2.8","2.8","Crystal Structure of human cAMP-dependent protein kinase type I-beta regulatory subunit (fragment 11-73), Northeast Structural Genomics Consortium (NESG) Target HR8613A","MSGLNDIFEAQKIEWHEHHHHHHENLYFQSHMEDESLKGCELYVQLHGIQQVLKDCIVHLCISKPERPMKFLREHFEKLEKEENRQILARQKSNS","Homo sapiens","PRKAR1B","cAMP-dependent protein kinase type I-beta regulatory subunit","1","4F9K"
"4F9O",,"X-RAY DIFFRACTION",2.97,58.63,"hanging drop",6,"PEG 4000, PEG 8000, sodium acetate, sodium citrate, pH 6.0, hanging drop, temperature 277K",277,,,"4F9O",206.74,"2.65","2.65","Crystal Structure of recombinant human Hexokinase type I with 2-deoxy-Glucose 6-Phosphate","MIAAQLLAYYFTELKDDQVKKIDKYLYAMRLSDETLIDIMTRFRKEMKNGLSRDFNPTATVKMLPTFVRSIPDGSEKGDFIALDLGGSSFRILRVQVNHEKNQNVHMESEVYDTPENIVHGSGSQLFDHVAECLGDFMEKRKIKDKKLPVGFTFSFPCQQSKIDEAILITWTKRFKASGVEGADVVKLLNKAIKKRGDYDANIVAVVNDTVGTMMTCGYDDQHCEVGLIIGTGTNACYMEELRHIDLVEGDEGRMCINTEWGAFGDDGSLEDIRTEFDREIDRGSLNPGKQLFEKMVSGMYLGELVRLILVKMAKEGLLFEGRITPELLTRGKFNTSDVSAIEKNKEGLHNAKEILTRLGVEPSDDDCVSVQHVCTIVSFRSANLVAATLGAILNRLRDNKGTPRLRTTVGVDGSLYKTHPQYSRRFHKTLRRLVPDSDVRFLLSESGSGKGAAMVTAVAYRLAEQHRQIEETLAHFHLTKDMLLEVKKRMRAEMELGLRKQTHNNAVVKMLPSFVRRTPDGTENGDFLALDLGGTNFRVLLVKIRSGKKRTVEMHNKIYAIPIEIMQGTGEELFDHIVSCISDFLDYMGIKGPRMPLGFTFSFPCQQTSLDAGILITWTKGFKATDCVGHDVVTLLRDAIKRREEFDLDVVAVVNDTVGTMMTCAYEEPTCEVGLIVGTGSNACYMEEMKNVEMVEGDQGQMCINMEWGAFGDNGCLDDIRTHYDRLVDEYSLNAGKQRYEKMISGMYLGEIVRNILIDFTKKGFLFRGQISETLKTRGIFETKFLSQIESDRLALLQVRAILQQLGLNSTCDDSILVKTVCGVVSRRAAQLCGAGMAAVVDKIRENRGLDRLNVTVGVDGTLYKLHPHFSRIMHQTVKELSPKCNVSFLLSEDGSGKGAALITAVGVRLRTE","Homo sapiens","HK1","Hexokinase-1","1","4F9O"
"4F9W",,"X-RAY DIFFRACTION",2.14,42.65,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Ammonium Acetate, 0.1 M BIS-TRIS pH 5.5, 17% PEG 10000, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1371/journal.pone.0066226","LM4, GG5","4F9W",45.06,"2","2","Human P38alpha MAPK in Complex with a Novel and Selective Small Molecule Inhibitor","MHHHHHHSSGVDLGTENLYFQSNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4F9W"
"4F9Y",,"X-RAY DIFFRACTION",2.22,44.5,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Ammonium Acetate, 0.1 M BIS-TRIS pH 5.5, 17% PEG 10000, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1371/journal.pone.0066226","GG5, LM3","4F9Y",45.02,"1.85","1.85","Human P38 alpha MAPK In Complex With a Novel and Selective Small Molecule Inhibitor","MHHHHHHSSGVDLGTENLYFQSNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4F9Y"
"4F9Z",,"X-RAY DIFFRACTION",2.29,46.36,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG 4000, 150mM sodium acetate, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M112.410522",,"4F9Z",128.43,"2.2","2.2","Crystal Structure of human ERp27","SSDGPGAAQEPTWLTDVPAAMEFIAATEVAVIGFFQDLEIPAVPILHSMVQKFPGVSFGISTDSEVLTHYNITGNTICLFRLVDNEQLNLEDEDIESIDATKLSRFIEINSLHMVTEYNPVTVIGLFNSVIQIHLLLIMNKASPEYEENMHRYQKAAKLFQGKILFILVDSGMKENGKVISFFKLKESQLPALAIYQTLDDEWDTLPTAEVSVEHVQNFCDGFLSGK","Homo sapiens","C12orf46, ERP27, UNQ781/PRO1575","Endoplasmic reticulum resident protein 27","1","4F9Z"
,,,,,"VAPOR DIFFUSION, HANGING DROP",8.5,"26% PEG 4000, 125mM sodium acetate, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293
"4FA0",,"X-RAY DIFFRACTION",2.51,51.01,"VAPOR DIFFUSION",5,"25% PEG 1500, 100mM MIB buffer, pH 5.0, vapor diffusion, temperature 293K",293,"10.1074/jbc.M112.398859",,"4FA0",15.31,"2.65","2.65","Crystal structure of human AdPLA to 2.65 A resolution","SNAMRAPIPEPKPGDLIEIFRPFYRHWAIYVGDGYVVHLAPPSEVAGAGAASVMSALTDKAIVKKELLYDVAGSDKYQVNNKHDDKYSPLPCSKIIQRAEELVGQEVLYKLTSENCEHFVNELRYGVARSDQVRDVI","Homo sapiens","PLA2G16, HRASLS3, HREV107, PLAAT3","Group XVI phospholipase A1/A2","1","4FA0"
"4FA2",,"X-RAY DIFFRACTION",2.14,42.39,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Ammonium Acetate, 0.1 M BIS-TRIS pH 5.5, 17% PEG 10000, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1371/journal.pone.0066226","SB0, GG5","4FA2",44.7,"2","2","Human P38 alpha Mitogen-Activated Kinase In Complex With SB239063","MHHHHHHSSGVDLGTENLYFQSNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4FA2"
"4FA3",,"X-RAY DIFFRACTION",2.3,46.57,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2 M sodium acetate, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1021/jm3007867","0SL","4FA3",39.16,"2.2","2.2","Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (R)-1-(naphthalen-2-ylsulfonyl)piperidine-3-carboxylic acid (86)","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4FA3"
"4FA6",,"X-RAY DIFFRACTION",2.34,47.39,"VAPOR DIFFUSION",8.2,"0.1M BIS-TRIS PROPANE, 0.2M (NH4)2SO4, 16-18% (W/V) PEG3350, 10% (V/V) ETHYLENE GLYCOL AND 10MM TCEP , pH 8.2, VAPOR DIFFUSION, temperature 286K",286,"10.1016/j.bmcl.2012.05.100",,"4FA6",111.04,"2.7","2.7","Design and Synthesis of a Novel Pyrrolidinyl Pyrido Pyrimidinone Derivative as a Potent Inhibitor of PI3Ka and mTOR","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4FA6"
"4FAD",,"X-RAY DIFFRACTION",2.35,47.67,"VAPOR DIFFUSION",8.2,"0.1M BIS-TRIS PROPANE, 0.2M (NH4)2SO4, 16-18% (W/V) PEG3350, 10% (V/V) ETHYLENE GLYCOL AND 10MM TCEP , pH 8.2, VAPOR DIFFUSION, temperature 286K",286,"10.1016/j.bmcl.2012.05.100",,"4FAD",111.1,"2.7","2.7","Design and Synthesis of a Novel Pyrrolidinyl Pyrido Pyrimidinone Derivative as a Potent Inhibitor of PI3Ka and mTOR","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4FAD"
"4FAL",,"X-RAY DIFFRACTION",2.42,49.09,"VAPOR DIFFUSION, SITTING DROP",8,"25 % (w/v) PEG1500, 0.1M PCTP buffer, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1021/jm3007867","0T0","4FAL",39.24,"2","2","Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)-N-methylbenzamide (80)","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4FAL"
"4FAM",,"X-RAY DIFFRACTION",2.5,50.74,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M potassium thiocyanate, 20 % (w/v) PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1021/jm3007867","0SZ","4FAM",78.63,"2","2","Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)benzoic acid (17)","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4FAM"
"4FBN",,"X-RAY DIFFRACTION",2.16,42.95,"VAPOR DIFFUSION, SITTING DROP",7,"22% PEG 5K MME,  
0.1M Na Malonate 
20mM CaCl2, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1016/j.str.2012.09.005",,"4FBN",28.58,"2.4","2.4","Insights into structural integration of the PLCgamma regulatory region and mechanism of autoinhibition and activation based on key roles of SH2 domains","HSNEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNPGFYVEANPMP","Homo sapiens","PLC1, PLCG1","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1","1","4FBN"
"4FBX",,"X-RAY DIFFRACTION",2.16,42.98,"VAPOR DIFFUSION, SITTING DROP",,"The concentrated enzyme solution contained 6.2 mg/ml protein dissolved in 500 mM NaCl, 25 mM Tris/HCl, pH 8.5. Nine volume parts of this protein stock solution were mixed with one part 12 mM ARC-1154 dissolved in 100% dimethyl sulfoxide. The CK2alpha1-335/ARC-1154 mixture was incubated for 30 min at room temperature. The best crystals grew with a reservoir solution composed of 4.4 M NaCl, 100 mM citric acid, pH 5.25 and mixing 2 microliter of this reservoir solution with microliter CK2alpha1-335/ARC-1154 mixture, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1039/c2ob26022k","0TJ","4FBX",41.47,"2.33","2.33","Complex structure of human protein kinase CK2 catalytic subunit crystallized in the presence of a bisubstrate inhibitor","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","4FBX"
,,,,,,,,,,,,,,,,"XGDDDDD",,,"bisubstrate inhibitor","2","4FBX"
"4FC0",,"X-RAY DIFFRACTION",3.41,63.96,"VAPOR DIFFUSION, SITTING DROP",8.3,"7.8% PEG 8000, 0.8M LiCl, 100 mM Tris, pH 8.3, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmc.2012.07.032","0T2","4FC0",65.8,"2.95","2.95","Crystal Structure of Human Kinase Domain of B-raf with a DFG-out Inhibitor","GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, P94, RAFB1, V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1","Serine/threonine-protein kinase B-raf","1","4FC0"
"4FC6",,"X-RAY DIFFRACTION",2.39,48.53,"VAPOR DIFFUSION",6,"0.1M MES (pH 6.0) and 8% PEG6000, VAPOR DIFFUSION, temperature 295K",295,"10.1074/jbc.M112.385351",,"4FC6",123.31,"2.1","2.1","Studies on DCR shed new light on peroxisomal beta-oxidation: Crystal structure of the ternary complex of pDCR","AQPPPDVEGDDCLPAYRHLFCPDLLRDKVAFITGGGSGIGFRIAEIFMRHGCHTVIASRSLPRVLTAARKLAGATGRRCLPLSMDVRAPPAVMAAVDQALKEFGRIDILINCAAGNFLCPAGALSFNAFKTVMDIDTSGTFNVSRVLYEKFFRDHGGVIVNITATLGNRGQALQVHAGSAKAAVDAMTRHLAVEWGPQNIRVNSLAPGPISGTEGLRRLGGPQASLSTKVTASPLQRLGNKTEIAHSVLYLASPLASYVTGAVLVADGGAWLTFPNG","Homo sapiens","DECR2, PDCR, SDR17C1","Peroxisomal 2,4-dienoyl-CoA reductase","1","4FC6"
"4FC7",,"X-RAY DIFFRACTION",2.32,46.94,"VAPOR DIFFUSION",6,"0.1M MES (pH 6.0) and 8% PEG6000, VAPOR DIFFUSION, temperature 295K",295,"10.1074/jbc.M112.385351",,"4FC7",122.92,"1.84","1.84","Studies on DCR shed new light on peroxisomal beta-oxidation: Crystal structure of the ternary complex of pDCR","AQPPPDVEGDDCLPAYRHLFCPDLLRDKVAFITGGGSGIGFRIAEIFMRHGCHTVIASRSLPRVLTAARKLAGATGRRCLPLSMDVRAPPAVMAAVDQALKEFGRIDILINCAAGNFLCPAGALSFNAFKTVMDIDTSGTFNVSRVLYEKFFRDHGGVIVNITATLGNRGQALQVHAGSAKAAVDAMTRHLAVEWGPQNIRVNSLAPGPISGTEGLRRLGGPQASLSTKVTASPLQRLGNKTEIAHSVLYLASPLASYVTGAVLVADGGAWLTFPNG","Homo sapiens","DECR2, PDCR, SDR17C1","Peroxisomal 2,4-dienoyl-CoA reductase","1","4FC7"
"4FCB",,"X-RAY DIFFRACTION",2.02,39.11,"VAPOR DIFFUSION, HANGING DROP",7.1,"12-18% PEG 3350, 100 mM MES, 3-6% Methanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2012.07.076","0T7","4FCB",80.19,"2.1","2.1","Potent and Selective Phosphodiesterase 10A Inhibitors","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4FCB"
"4FCD",,"X-RAY DIFFRACTION",2.09,41.1,"VAPOR DIFFUSION, HANGING DROP",7.1,"12-18% PEG 3350, 100 mM MES, 3-6% methanol, pH 7.1, VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2012.07.076","0T6","4FCD",80.1,"2.02","2.02","Potent and Selective Phosphodiesterase 10A Inhibitors","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4FCD"
"4FCI",,"X-RAY DIFFRACTION",2.39,48.53,"VAPOR DIFFUSION, HANGING DROP",8.5,"An unliganded Mn2+2-HAI crystal was soaked in 50 mM AGPA, 5 mM MnCl2, 100 mM bicine (pH 8.5), 32% (v/v) Jeffamine ED-2001 for 21 hours, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1744309112027820","GPA","4FCI",69.93,"1.82","1.82","Crystal Structure of the Mn2+2-Human Arginase I-AGPA Complex","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","4FCI"
"4FCJ",,"X-RAY DIFFRACTION",2.07,40.54,"VAPOR DIFFUSION, HANGING DROP",5.5,"20% PEG3350, 0.1 M Bis-tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K",279,"10.1371/journal.pone.0080947",,"4FCJ",32.45,"1.62","1.62","Crystal structure of the NTF2-like domain of human G3BP1","GSHMVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKEIHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSVANKFYVHNDIFRYQDEVFG","Homo sapiens","G3BP1, G3BP","Ras GTPase-activating protein-binding protein 1","1","4FCJ"
"4FCK",,"X-RAY DIFFRACTION",2.36,47.77,"VAPOR DIFFUSION, HANGING DROP",8.5,"An unliganded Co2+2-HAI crystal was soaked in 20 mM AGPA, 5 mM CoCl2, 100 mM bicine (pH 8.5), 32% (v/v) Jeffamine ED-2001 for 18 hours, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1744309112027820","GPA","4FCK",70.09,"1.9","1.9","Crystal Structure of the Co2+2-Human Arginase I-AGPA Complex","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","4FCK"
"4FCM",,"X-RAY DIFFRACTION",2,38.48,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG3350, 0.1 M Bis-tris, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 279K",279,"10.1371/journal.pone.0080947",,"4FCM",34.32,"2.69","2.69","Crystal structure of the NTF2-like domain of human G3BP1 in complex with a peptide","GSHMVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKEIHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSVANKFYVHNDIFRYQDEVFG","Homo sapiens","G3BP1, G3BP","Ras GTPase-activating protein-binding protein 1","1","4FCM"
,,,,,,,,,,,,,,,,"DSGFSFGSK",,,"Nucleoporin repeat peptide","2","4FCM"
"4FCO",,"X-RAY DIFFRACTION",2.65,53.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.7 M Li2SO4/100 mM HEPES, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,,"0U4","4FCO",49.37,"1.76","1.76","Crystal structure of bace1 with its inhibitor","MGSSHHHHHHSAGENLYFQGTLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4FCO"
"4FCP",,"X-RAY DIFFRACTION",2.64,53.36,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG MME 2000, 0.1M NA CACODYLATE 6.5, 0.2M MGCL2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2012.08.050",,"4FCP",53.53,"2","2","Targetting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo [2,3-d] pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4FCP"
"4FCQ",,"X-RAY DIFFRACTION",2.66,53.83,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG MME 2000, 0.1M Na Cacodylate, PH6.5, 0.2M MGCl2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2012.08.050","2N6","4FCQ",26.9,"2.151","2.151","Targeting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4FCQ"
"4FCR",,"X-RAY DIFFRACTION",2.68,54.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG MME 2000, 0.1M Na Cacodylate, PH6.5, 0.2M MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2012.08.050","0TM","4FCR",27.03,"1.698","1.698","Targeting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4FCR"
"4FDC",,"X-RAY DIFFRACTION",2.56,52.01,"microbatch under oil",8.5,"30% PEG 1500, 0.1 M TrisHCl pH 8.5, 4% acetone, microbatch under oil, temperature 298K",298,"10.1016/j.ajhg.2012.10.008",,"4FDC",56.84,"2.4","2.4","Crystal structure of the E493V mutant of human apoptosis inducing factor (AIF)","GLTPEQKQKKAALSASEGEEVPQDKAPSHVPFLLIGGGTAAFAAARSIRARDPGARVLIVSEDPELPYMRPPLSKELWFSDDPNVTKTLRFKQWNGKERSIYFQPPSFYVSAQDLPHIENGGVAVLTGKKVVQLDVRDNMVKLNDGSQITYEKCLIATGGTPRSLSAIDRAGAEVKSRTTLFRKIGDFRSLEKISREVKSITIIGGGFLGSELACALGRKARALGTEVIQLFPEKGNMGKILPEYLSNWTMEKVRREGVKVMPNAIVQSVGVSSGKLLIKLKDGRKVETDHIVAAVGLEPNVELAKTGGLEIDSDFGGFRVNAELQARSNIWVAGDAACFYDIKLGRRRVEHHDHAVVSGRLAGENMTGAAKPYWHQSMFWSDLGPDVGYVAIGLVDSSLPTVGVFAKATAQDNPKSATEQSGTGIRSESETESEASEITIPPSTPAVPQAPVQGEDYGKGVIFYLRDKVVVGIVLWNIFNRMPIARKIIKDGEQHEDLNEVAKLFNIHEDLVP","Homo sapiens","AIF, AIFM1, PDCD8","Apoptosis-inducing factor 1, mitochondrial","1","4FDC"
"4FDH",,"X-RAY DIFFRACTION",2.69,54.25,"VAPOR DIFFUSION, HANGING DROP",8.5,"12% PEG 4000, 0.1M Tris, pH 8.5, 0.2M Lithium sulfate, vapor diffusion, hanging drop, temperature 298K",298,"10.1210/me.2012-1287","0T3","4FDH",677.87,"2.71","2.71","Structure of human aldosterone synthase, CYP11B2, in complex with fadrozole","MAKKTSSTVLPFEAMPQHPGNRWLRLLQIWREQGYEHLHLEMHQTFQELGPIFRYNLGGPRMVCVMLPEDVEKLQQVDSLHPCRMILEPWVAYRQHRGHKCGVFLLNGPEWRFNRLRLNPDVLSPKAVQRFLPMVDAVARDFSQALKKKVLQNARGSLTLDVQPSIFHYTIEASNLALFGERLGLVGHSPSSASLNFLHALEVMFKSTVQLMFMPRSLSRWISPKVWKEHFEAWDCIFQYGDNCIQKIYQELAFNRPQHYTGIVAELLLKAELSLEAIKANSMELTAGSVDTTAFPLLMTLFELARNPDVQQILRQESLAAAASISEHPQKATTELPLLRAALKETLRLYPVGLFLERVVSSDLVLQNYHIPAGTLVQVFLYSLGRNAALFPRPERYNPQRWLDIRGSGRNFHHVPFGFGMRQCLGRRLAEAEMLLLLHHVLKHFLVETLTQEDIKMVYSFILRPGTSPLLTFRAINHHHHHH","Homo sapiens","Aldosterone synthase, CYP11B2","Cytochrome P450 11B2, mitochondrial","1","4FDH"
"4FDI",,"X-RAY DIFFRACTION",2.43,49.43,"VAPOR DIFFUSION, HANGING DROP",5,"10-15% PEG6000, 0.1 M citric acid, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2012.08.020",,"4FDI",114.14,"2.2","2.2","The molecular basis of mucopolysaccharidosis IV A","APQPPNILLLLMDDMGWGDLGVYGEPSRETPNLDRMAAEGLLFPNFYSANPLASPSRAALLTGRLPIRNGFYTTNAHARNAYTPQEIVGGIPDSEQLLPELLKKAGYVSKIVGKWHLGHRPQFHPLKHGFDEWFGSPNCHFGPYDNKARPNIPVYRDWEMVGRYYEEFPINLKTGEANLTQIYLQEALDFIKRQARHHPFFLYWAVDATHAPVYASKPFLGTSQRGRYGDAVREIDDSIGKILELLQDLHVADNTFVFFTSDNGAALISAPEQGGSNGPFLCGKQTTFEGGMREPALAWWPGHVTAGQVSHQLGSIMDLFTTSLALAGLTPPSDRAIDGLNLLPTLLQGRLMDRPIFYYRGDTLMAATLGQHKAHFWTWTNSWENFRQGIDFCPGQNVSGVTTHNLEDHTKLPLIFHLGRDPGERFPLSFASAEYQEALSRITSVVQQHQEALVPAQPQLNVCNWAVMNWAPPGCEKLGKCLTPPESIPKKCLWSHHHHHHH","Homo sapiens","GALNS","N-acetylgalactosamine-6-sulfatase","1","4FDI"
"4FDJ",,"X-RAY DIFFRACTION",2.39,48.49,"VAPOR DIFFUSION, HANGING DROP",5,"10-15% PEG6000, 0.1 M citric acid, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2012.08.020",,"4FDJ",114.01,"2.81","2.81","The molecular basis of mucopolysaccharidosis IV A, complex with GalNAc","APQPPNILLLLMDDMGWGDLGVYGEPSRETPNLDRMAAEGLLFPNFYSANPLASPSRAALLTGRLPIRNGFYTTNAHARNAYTPQEIVGGIPDSEQLLPELLKKAGYVSKIVGKWHLGHRPQFHPLKHGFDEWFGSPNCHFGPYDNKARPNIPVYRDWEMVGRYYEEFPINLKTGEANLTQIYLQEALDFIKRQARHHPFFLYWAVDATHAPVYASKPFLGTSQRGRYGDAVREIDDSIGKILELLQDLHVADNTFVFFTSDNGAALISAPEQGGSNGPFLCGKQTTFEGGMREPALAWWPGHVTAGQVSHQLGSIMDLFTTSLALAGLTPPSDRAIDGLNLLPTLLQGRLMDRPIFYYRGDTLMAATLGQHKAHFWTWTNSWENFRQGIDFCPGQNVSGVTTHNLEDHTKLPLIFHLGRDPGERFPLSFASAEYQEALSRITSVVQQHQEALVPAQPQLNVCNWAVMNWAPPGCEKLGKCLTPPESIPKKCLWSHHHHHHH","Homo sapiens","GALNS","N-acetylgalactosamine-6-sulfatase","1","4FDJ"
"4FDL",,"X-RAY DIFFRACTION",3.03,59.39,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M sodium citrate, pH 5.0-5.7, 1.9 M sodium formate, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2012.06.007",,"4FDL",69.13,"2.801","2.801","Crystal structure of Caspase-7","MLEADDQGCIEEQGVEDSANEDSVDAKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQADSGPINDTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Caspase-7","1","4FDL"
"4FEA",,"X-RAY DIFFRACTION",3.75,67.24,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M sodium citrate, pH 5.0-5.7, 1.9 M sodium formate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.molcel.2012.06.007","0TE","4FEA",56.95,"3.79","3.79","Crystal structure of CASPASE-7 in Complex with allosteric inhibitor","TYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQADSGPINDTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Caspase-7","1","4FEA"
"4FF9",,"X-RAY DIFFRACTION",4.11,70.1,"VAPOR DIFFUSION, HANGING DROP",6.25,"0.1M MES, pH 6.25, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi400613h",,"4FF9",32.03,"2.5003","2.5003","Crystal Structure of cysteinylated WT SOD1.","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","4FF9"
"4FFX",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris pH 8.0, and 20% PEG 6000, 12.5 mM MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi300796y",,"4FFX",221.09,"2.7","2.7","Structural and Biochemical Characterization of Human Adenylosuccinate Lyase (ADSL) and the R303C ADSL Deficiency Associated Mutation","GSHMAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIREMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL","Homo sapiens","ADSL, AMPS","Adenylosuccinate lyase","1","4FFX"
"4FG3",,"X-RAY DIFFRACTION",1.84,33.33,"VAPOR DIFFUSION, HANGING DROP",5.5,"Hanging drop: 2 uL 0.1 M sodium phosphate, 10% w/v PEG 6K + 2 uL Human Insulin 100 U/mL (Humulin R, lot #A 405936). Cryo = mother liquor + 10% glycerol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejpb.2013.05.005",,"4FG3",11.93,"2.001","2.001","Crystal Structure Analysis of the Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","4FG3"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","4FG3"
"4FG7",,"X-RAY DIFFRACTION",2.27,45.86,"VAPOR DIFFUSION, HANGING DROP",6,"200mM NH4Ac, 100mM (CH3)2AsO2Na, 25% PEG 8000, pH 6.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1371/journal.pone.0044828",,"4FG7",33.71,"2.7","2.7","Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-293 in complex with ATP","MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ","Homo sapiens","CAMK1","Calcium/calmodulin-dependent protein kinase type 1","1","4FG7"
"4FG8",,"X-RAY DIFFRACTION",2.15,42.88,"VAPOR DIFFUSION, HANGING DROP",6,"3% dioxane, 100mM MES, 1.5M (NH4)2SO4, pH 6.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1371/journal.pone.0044828",,"4FG8",72.55,"2.2","2.2","Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-315 in complex with ATP","MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVVRH","Homo sapiens","CAMK1","Calcium/calmodulin-dependent protein kinase type 1","1","4FG8"
"4FG9",,"X-RAY DIFFRACTION",2.09,41.24,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.5M (NH4)2SO4, 100mM tri-sodium citrate, 0.8M Li2SO4, pH 5.6, vapor diffusion, hanging drop, temperature 291K",291,"10.1371/journal.pone.0044828",,"4FG9",73.86,"2.4","2.4","Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP","MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVVRHMRKLQ","Homo sapiens","CAMK1","Calcium/calmodulin-dependent protein kinase type 1","1","4FG9"
"4FGB",,"X-RAY DIFFRACTION",2.34,47.45,"VAPOR DIFFUSION, HANGING DROP",8,"2.0 M (NH4)2SO4, 100 mM bicine, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0044828",,"4FGB",36.42,"2.6","2.6","Crystal structure of human calcium/calmodulin-dependent protein kinase I apo form","MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVVRHMRKLQ","Homo sapiens","CAMK1","Calcium/calmodulin-dependent protein kinase type 1","1","4FGB"
"4FGF",,"X-RAY DIFFRACTION",1.83,32.96,,,,,"10.1002/pro.5560020810",,"4FGF",16.69,"1.6","1.6","REFINEMENT OF THE STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION AND ANALYSIS OF PRESUMED HEPARIN BINDING SITES BY SELENATE SUBSTITUTION","PALPEDGGSGAFPPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS","Homo sapiens","FGF2, FGFB","BASIC FIBROBLAST GROWTH FACTOR","1","4FGF"
"4FGJ",,"X-RAY DIFFRACTION",2.39,48.55,"VAPOR DIFFUSION, HANGING DROP",7,"1.7M Ammonium sulfate, 0.1M Hepes pH 7.0, vapor diffusion, hanging drop, temperature 298K",298,,,"4FGJ",54.62,"1.346","1.346","Oxidized quinone reductase 2 in complex with primaquine","GAMAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NMOR2, NQO2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4FGJ"
"4FGK",,"X-RAY DIFFRACTION",2.39,48.55,"VAPOR DIFFUSION, HANGING DROP",7,"1.7M Ammonium sulfate, 0.1M Hepes pH 7.0, vapor diffusion, hanging drop, temperature 298K",298,,"0TX","4FGK",54.56,"1.401","1.401","Oxidized quinone reductase 2 in complex with chloroquine","GAMAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NMOR2, NQO2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4FGK"
"4FGL",,"X-RAY DIFFRACTION",2.25,45.43,"VAPOR DIFFUSION, HANGING DROP",7,"1.7M Ammonium sulfate, 0.1M Hepes , pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4FGL",109.44,"1.2","1.2","Reduced quinone reductase 2 in complex with chloroquine","GAMAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NMOR2, NQO2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4FGL"
"4FGU",,"X-RAY DIFFRACTION",2.9,57.57,"VAPOR DIFFUSION, SITTING DROP",6.5,"35 % 2-ethoxyethanol, 0.1 M cacodylate pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1300686110",,"4FGU",99.7,"3.9","3.9","Crystal structure of prolegumain","GASLEIPIDDPEDGGKHWVVIVAGSNGWYNYRHQADACHAYQIIHRNGIPDEQIVVMMYDDIAYSEDNPTPGIVINRPNGTDVYQGVPKDYTGEDVTPQNFLAVLRGDAEAVKGIGSGKVLKSGPQDHVFIYFTDHGSTGILVFPNEDLHVKDLNETIHYMYKHKMYRKMVFYIEACESGSMMNHLPDNINVYATTAANPRESSYACYYDEKRSTYLGDWYSVNWMEDSDVEDLTKETLHKQYHLVKSHTNTSHVMQYGQKTISTMKVMQFQGMKRKASSPVPLPPVTHLDLTPSPDVPLTIMKRKLMNTNDLEESRQLTEEIQRHLDARHLIEKSVRKIVSLLAASEAEVEQLLSERAPLTGHSCYPEALLHFRTHCFNWHSPTYEYALRHLYVLVNLCEKPYPLHRIKLSMDHVCLGHYGTHHHHHH","Homo sapiens","LGMN, PRSC1","Legumain","1","4FGU"
"4FGX",,"X-RAY DIFFRACTION",2.66,53.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.7 M Li2SO4/100 mM HEPES, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm301630s",,"4FGX",49.55,"1.59","1.59","Crystal structure of bace1 with novel inhibitor","MGSSHHHHHHSAGENLYFQGTLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4FGX"
,,,,,,,,,,,,,,,,"XVXFLAX",,,"Inhibitor (2R,5S,8S,12S,13S,16S,19S,22S)-16-(3-amino-3-oxopropyl)-2,13-dibenzyl-12,22-dihydroxy-8-isobutyl-19-isopropyl-3,5,17-trimethyl-4,7,10,15,18,21-hexaoxo-3,6,9,14,17,20-hexaazatricosan-1-oic acid","2","4FGX"
"4FH0",,"X-RAY DIFFRACTION",1.94,36.21,"VAPOR DIFFUSION",6.5,"Bis-Tris pH 6.5, ammonium sulfate, PEG 3350, VAPOR DIFFUSION, temperature 298K",298,"10.1107/S0907444913001558",,"4FH0",24.56,"1.4","1.4","Crystal Structure of Human BinCARD CARD, double mutant F16M/L66M SeMet form","SNADQTYCDRLVQDTPMLTGHGRLSEQQVDRIILQLNRYYPQILTNKEAEKFRNPKASLRVRLCDLMSHLQRSGERDCQEFYRALYIHAQPLHSRLPSRHAL","Homo sapiens","C9orf89, CARD19","Bcl10-interacting CARD protein","1","4FH0"
"4FHJ",,"X-RAY DIFFRACTION",2.32,46.96,"VAPOR DIFFUSION, HANGING DROP",7.8,"19.6% PEG 3350, 0.1M Tris, 0.1M ammonium sulfate, 10 mM DTT, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2012.06.033",,"4FHJ",110.52,"2.6","2.6","Crystal Structure of PI3K-gamma in Complex with Imidazopyridine 2","GSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4FHJ"
"4FHK",,"X-RAY DIFFRACTION",2.37,48.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"21% PEG 3350, 0.1M Tris, 0.2M ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2012.06.033",,"4FHK",110.59,"3","3","Crystal Structure of PI3K-gamma in Complex with Imidazopyridazine 19e","GSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4FHK"
"4FHQ",,"X-RAY DIFFRACTION",3,58.99,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M SODIUM ACETATE TRIHYDRATE, PH 8.5, TRIS-HCL, 30% W/V PEG4000, VAPOR DIFFUSION, SITTING DROP, temperature 294.0K",294,"10.1007/s12033-015-9881-2",,"4FHQ",14.33,"2.251","2.251","Crystal Structure of HVEM","RSLPSCKEDEYPVGSECCPKCSPGYRVKEACGELTGTVCEPCPPGTYIAHLNGLSKCLQCQMCDPAMGLRASRNCSRTENAVCGCSPGHFCIVQDGDHCAACRAYATSSPGQRVQKGGTESQDTLCTGHHHHHH","Homo sapiens","HVEA, HVEM, TNFRSF14, UNQ329/PRO509","Tumor necrosis factor receptor superfamily member 14","1","4FHQ"
"4FI6",,"X-RAY DIFFRACTION",2.12,41.89,"VAPOR DIFFUSION, SITTING DROP",5.5,"The wt-TTR was concentrated to 4 mg/ml in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature with inhibitors using the vapor-diffusion sitting drop method, crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at ph 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 m sodium citrate, ph 5.5, containing 10% v/v glycerol, vapor diffusion, sitting drop, temperature 298.0, VAPOR DIFFUSION, SITTING DROP",298,"10.1021/ja311729d",,"4FI6",28.3,"1.46","1.46","Kinetic Stabilization of transthyretin through covalent modification of K15 by 3-(5-(3,5-dichlorophenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4FI6"
"4FI7",,"X-RAY DIFFRACTION",2.11,41.78,"VAPOR DIFFUSION, SITTING DROP",5.5,"The wt-TTR was concentrated to 4 mg/ml in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature with inhibitors using the vapor-diffusion sitting drop method, crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at ph 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 m sodium citrate, ph 5.5, containing 10% v/v glycerol, vapor diffusion, sitting drop, temperature 298.0, VAPOR DIFFUSION, SITTING DROP",298,"10.1021/ja311729d",,"4FI7",28.33,"1.402","1.402","Kinetic Stabilization of transthyretin through covalent modification of K15 by 3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4FI7"
"4FI8",,"X-RAY DIFFRACTION",2.15,42.78,"VAPOR DIFFUSION, SITTING DROP",5.5,"The wt-TTR was concentrated to 4 mg/ml in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature with inhibitors using the vapor-diffusion sitting drop method, crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at ph 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 m sodium citrate, ph 5.5, containing 10% v/v glycerol, vapor diffusion, sitting drop, temperature 298.0, VAPOR DIFFUSION, SITTING DROP",298,"10.1021/ja311729d",,"4FI8",28.49,"1.22","1.22","Kinetic Stabilization of transthyretin through covalent modification of K15 by 4-bromo-3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4FI8"
"4FIA",,"X-RAY DIFFRACTION",2.5,50.82,,,,,"10.1074/jbc.M112.438754","0U9, 198","4FIA",53.69,"2.1","2.1","Crystal Structure of Human CYP46A1 P450 with bicalutamide Bound","MAKKDEVGGRVLQDVFLDWAKKYGPVVRVNVFHKTSVIVTSPESVKKFLMSTKYNKDSKMYRALQTVFGERLFGQGLVSECNYERWHKQRRVIDLAFSRSSLVSLMETFNEKAEQLVEILEAKADGQTPVSMQDMLTYTAMDILAKAAFGMETSMLLGAQKPLSQAVKLMLEGITASRNTLAKFLPGKRKQLREVRESIRFLRQVGRDWVQRRREALKRGEEVPADILTQILKAEEGAQDDEGLLDNFVTFFIAGHETSANHLAFTVMELSRQPEIVARLQAEVDEVIGSKRYLDFEDLGRLQYLSQVLKESLRLYPPAWGTFRLLEEETLIDGVRVPGNTPLLFSTYVMGRMDTYFEDPLTFNPDRFGPGAPKPRFTYFPFSLGHRSCIGQQFAQMEVKVVMAKLLQRLEFRLVPGQRFGLQEQATLKPLDPVLCTLRPRGWQPAPPPPPCHHHH","Homo sapiens","CYP46, CYP46A1","Cholesterol 24-hydroxylase","1","4FIA"
"4FIE",,"X-RAY DIFFRACTION",3.75,67.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 500 mM K/Na tartrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1073/pnas.1214447109",,"4FIE",96.35,"3.11","3.11","Full-length human PAK4","GRKKRVEISAPSNFEHRVHTGFDQHEQKFTGLPRQWQSLIEESARRPKPLVDPACITSIQPGAPKTIVRGSKGAKDGALTLLLDEFENMSVTRSNSLRRDSPPPPARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","KIAA1142, PAK4","Serine/threonine-protein kinase PAK 4","1","4FIE"
"4FIG",,"X-RAY DIFFRACTION",4.6,73.25,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 700 mM K/Na tartrate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1073/pnas.1214447109",,"4FIG",79.31,"3.01","3.01","Catalytic domain of human PAK4","MGSSHHHHHHSSGLVPRGSHMENLYFQGARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","KIAA1142, PAK4","Serine/threonine-protein kinase PAK 4","1","4FIG"
"4FIH",,"X-RAY DIFFRACTION",2.21,44.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris-HCl, 1.5M Na acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1073/pnas.1214447109",,"4FIH",39.12,"1.97","1.97","Catalytic domain of human PAK4 with QKFTGLPRQW peptide","MGSSHHHHHHSSGLVPRGSHMENLYFQGARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","KIAA1142, PAK4","Serine/threonine-protein kinase PAK 4","1","4FIH"
"4FIJ",,"X-RAY DIFFRACTION",2.14,42.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris-HCl, 1.5M Na acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1073/pnas.1214447109",,"4FIJ",39.12,"2.3","2.3","Catalytic domain of human PAK4","MGSSHHHHHHSSGLVPRGSHMENLYFQGARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","KIAA1142, PAK4","Serine/threonine-protein kinase PAK 4","1","4FIJ"
"4FIK",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION, HANGING DROP",8,"50MM TRIS-HCL, 2.6M AMMONIUM SULFATE, 2UL OF 100UM THIOXOLONE ADDED TO DROP 24HRS PRIOR TO FREEZING, PH 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1021/jz100954h","SO4","4FIK",30.2,"1.2","1.2","Human carbonic anhydrase II H64A complexed with thioxolone hydrolysis products","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGAAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4FIK"
"4FIT",,"X-RAY DIFFRACTION",2.93,58.01,,6.5,"GROWN FROM AMMONIUM SULFATE, PH 6.5",,"10.1126/science.278.5336.286",,"4FIT",16.89,"2.5","2.5","FHIT-APO","MSFRFGQHLIKPSVVFLKTELSFALVNRKPVVPGHVLVCPLRPVERFHDLRPDEVADLFQTTQRVGTVVEKHFHGTSLTFSMQDGPEAGQTVKHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ","Homo sapiens","FHIT","FRAGILE HISTIDINE TRIAD PROTEIN","1","4FIT"
"4FJY",,"X-RAY DIFFRACTION",2.36,47.97,"VAPOR DIFFUSION, HANGING DROP",7.3,"22% PEG 3350, 250 mM ammonium sulfate, 10 mM EDTA, 100 mM Tris, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm300679u",,"4FJY",110.58,"2.9","2.9","Crystal structure of PI3K-gamma in complex with quinoline-indoline inhibitor 24f","GSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4FJY"
"4FJZ",,"X-RAY DIFFRACTION",2.36,47.91,"VAPOR DIFFUSION, HANGING DROP",7.3,"21% PEG 3350, 250 mM ammonium sulfate, 2 mM DTT, 100 mM Tris, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm300679u","4FJ","4FJZ",110.72,"3","3","Crystal structure of PI3K-gamma in complex with pyrrolo-pyridine inhibitor 63","GSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4FJZ"
"4FK3",,"X-RAY DIFFRACTION",2.24,45.05,,6,"100MM BISTRIS AT PH 6.0, 12.5% 2,5-HEXANEDIOL, AND 12% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.0711741105",,"4FK3",67.09,"2.65","2.65","B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203","MKKGHHHHHHGSRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4FK3"
"4FK6",,"X-RAY DIFFRACTION",2.32,46.91,"VAPOR DIFFUSION, SITTING DROP",5.5,"MES/PEG6000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1016/j.bmcl.2012.10.008","0UJ","4FK6",70.21,"2.2","2.2","JAK1 kinase (JH1 domain) in complex with compound 72","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4FK6"
"4FKA",,"X-RAY DIFFRACTION",1.86,33.94,"VAPOR DIFFUSION, HANGING DROP",6.4,"The protein solution consisted of 7.5 mg mL-1 of zinc-free insulin in 0.02 mol L-1 hydrochloric acid.  
The reservoir solution was at pH 6.4 containing 1mM sodium citrate, volume fraction of aceton 10 % ,9 mmol L-1 manganese(II) sulphate monohydrate and redistilled water, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4FKA",11.77,"1.08","1.08","High resolution structure of the manganese derivative of insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4FKA"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4FKA"
"4FKG",,"X-RAY DIFFRACTION",2.03,39.49,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K, VAPOR DIFFUSION, SITTING DROP, pH 7.8",293.15,,,"4FKG",34.27,"1.51","1.51","Crystal structure of the cdk2 in complex with aminopyrazole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKG"
"4FKI",,"X-RAY DIFFRACTION",2.03,39.49,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K, PH 7.8, VAPOR DIFFUSION, SITTING DROP",293.15,,"09K","4FKI",34.33,"1.6","1.6","Crystal Structure of the Cdk2 in Complex with Aminopyrazole Inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKI"
"4FKJ",,"X-RAY DIFFRACTION",2.03,39.45,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K, VAPOR DIFFUSION, SITTING DROP, pH 7.8",293.15,,,"4FKJ",34.42,"1.63","1.63","Crystal structure of the cdk2 in complex with aminopyrazole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKJ"
"4FKL",,"X-RAY DIFFRACTION",2.03,39.5,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K, pH 7.8",293.15,,"CK2","4FKL",34.21,"1.26","1.26","Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKL"
"4FKO",,"X-RAY DIFFRACTION",2.03,39.36,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K, pH 7.8",293.15,,"20K","4FKO",34.42,"1.55","1.55","Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKO"
"4FKP",,"X-RAY DIFFRACTION",2.01,38.81,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K, VAPOR DIFFUSION, SITTING DROP, pH 7.8",293.15,,"LS5","4FKP",34.38,"1.6","1.6","Crystal structure of the cdk2 in complex with oxindole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKP"
"4FKQ",,"X-RAY DIFFRACTION",2.05,39.95,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K, PH 7.8, VAPOR DIFFUSION, SITTING DROP",293.15,,"42K","4FKQ",34.45,"1.75","1.75","Crystal structure of the cdk2 in complex with oxindole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKQ"
"4FKR",,"X-RAY DIFFRACTION",2.05,39.94,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, PH 7.8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K",293.15,,"45K","4FKR",34.48,"1.9","1.9","Crystal structure of the cdk2 in complex with oxindole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKR"
"4FKS",,"X-RAY DIFFRACTION",2.02,39.02,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K, pH 7.8",293.15,,,"4FKS",34.42,"1.55","1.55","Crystal structure of the cdk2 in complex with oxindole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKS"
"4FKT",,"X-RAY DIFFRACTION",2.04,39.62,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K, pH 7.8",293.15,,,"4FKT",34.39,"1.6","1.6","Crystal structure of the cdk2 in complex with oxindole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKT"
"4FKU",,"X-RAY DIFFRACTION",2.03,39.36,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES PH 7.8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K",293.15,,"60K","4FKU",34.82,"1.47","1.47","Crystal structure of the cdk2 in complex with oxindole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKU"
"4FKV",,"X-RAY DIFFRACTION",2.05,39.86,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K, pH 7.8",293.15,,"61K","4FKV",34.55,"1.7","1.7","Crystal structure of the cdk2 in complex with oxindole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKV"
"4FKW",,"X-RAY DIFFRACTION",2.05,40.05,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K, pH 7.8",293.15,,"62K","4FKW",34.51,"1.8","1.8","Crystal structure of the cdk2 in complex with oxindole inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4FKW"
"4FL1",,"X-RAY DIFFRACTION",2.34,47.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 28% PEG 3350, 0.2 M ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2012.11.007","ANP","4FL1",34.41,"1.79","1.79","Structural and Biophysical Characterization of the Syk Activation Switch","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4FL1"
"4FL2",,"X-RAY DIFFRACTION",2.27,45.85,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG 3350, 100 mM Hepes, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2012.11.007","ANP","4FL2",72.75,"2.19","2.19","Structural and Biophysical Characterization of the Syk Activation Switch","GMASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4FL2"
"4FL3",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, HANGING DROP",7,"8% PEG 3350, 100 mM Hepes, 200 mM proline, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2012.11.007","ANP","4FL3",72.66,"1.9","1.9","Structural and Biophysical Characterization of the Syk Activation Switch","MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4FL3"
"4FL6",,"X-RAY DIFFRACTION",2.8,56.1,"VAPOR DIFFUSION",5.5,"25% PEG-3350, 0.2M ammonium acetate, 0.1M Bis-Tris, pH 5.5, vapor diffusion, temperature 291K",291,"10.1038/nchembio.1157","UWN","4FL6",78.08,"2.55","2.55","Crystal structure of the complex of the 3-MBT repeat domain of L3MBTL3 and UNC1215","MKKAWCWASYLEEEKAVAVPAKLFKEHQSFPYNKNGFKVGMKLEGVDPEHQSVYCVLTVAEVCGYRIKLHFDGYSDCYDFWVNADALDIHPVGWCEKTGHKLHPPKGYKEEEFNWQTYLKTCKAQAAPKSLFENQNITVIPSGFRVGMKLEAVDKKNPSFICVATVTDMVDNRFLVHFDNWDESYDYWCEASSPHIHPVGWCKEHRRTLITPPGYPNVKHFSWDKYLEETNSLPAPARAFKVKPPHGFQKKMKLEVVDKRNPMFIRVATVADTDDHRVKVHFDGWNNCYDYWIDADSPDIHPVGWCSKTGHPLQPPLSPLELMEASHHHHHH","Homo sapiens","KIAA1798, L3MBTL3, MBT1","Lethal(3)malignant brain tumor-like protein 3","1","4FL6"
"4FL7",,"X-RAY DIFFRACTION",2.09,41.21,"VAPOR DIFFUSION, HANGING DROP",8.6,"2.4 M ammonium sulfate, 0.3 M sodium chloride, 0.1 M Tris-HCl, pH 8.6, 5 mM 4-(hydroxymercurybenzoate), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1039/c2cc34275h","BHO","4FL7",29.87,"1.85","1.85","The crystal structure of human carbonic anhydrase II in complex with N-(Hydroxy)-benzamide","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4FL7"
"4FLA",,"X-RAY DIFFRACTION",3.1,60.3,"VAPOR DIFFUSION",7.5,"25% PEG-3350, 0.2M ammonium acetate, 0.1M HEPES, pH 7.5, vapor diffusion, temperature 291K",291,"10.1038/nsmb.2853",,"4FLA",69.46,"2.2","2.2","Crystal structure of human RPRD1B, carboxy-terminal domain","MHHHHHHSSGRENLYFQGAGPLLTEELIKALQDLENAASGDATVRQKIASLPQEVQDVSLLEKITDKEAAERLSKTVDEACLLLAEYNGRLAAELEDRRQLARMLVEYTQNQKDVLSEKEKKLEEYKQKLARVTQVRKELKSHIQSLPDLSL","Homo sapiens","RPRD1B, C20orf77, CREPT","Regulation of nuclear pre-mRNA domain-containing protein 1B","1","4FLA"
"4FLB",,"X-RAY DIFFRACTION",2,37,"VAPOR DIFFUSION",5.5,"25% PEG-3350, 0.2M ammounium sulfate, 0.1M sodium cacodylate, praseodymium(III) acetate, pH 5.5, vapor diffusion, temperature 291K",291,"10.1038/nsmb.2853",,"4FLB",17.23,"1.802","1.802","CID of human RPRD2","GSAGALESSLDRKFQSVTNTMESIQGLSSWCIENKKHHSTIVYHWMKWLRRSAYPHRLNLFYLANDVIQNCKRKNAIIFRESFADVLPEAAALVKDPSVSKSVERIFKIWEDRNVYPEEMIVALREALSTTFKTQKQLKENLNK","Homo sapiens","RPRD2, KIAA0460, HSPC099","Regulation of nuclear pre-mRNA domain-containing protein 2","1","4FLB"
"4FLC",,"X-RAY DIFFRACTION",2.23,44.76,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris pH 8.5, 20% PEG 8000, 12.5 mM spermine tetrahydrochloride, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi300796y",,"4FLC",220.88,"2.6","2.6","Structural and Biochemical Characterization of Human Adenylosuccinate Lyase (ADSL) and the R303C ADSL Deficiency Associated Mutation","GSHMAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIREMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSECCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAELCL","Homo sapiens","ADSL, AMPS","Adenylosuccinate lyase","1","4FLC"
"4FLH",,"X-RAY DIFFRACTION",2.4,48.69,"VAPOR DIFFUSION, HANGING DROP",7.3,"21% PEG 3350, 200 mM ammonium sulfate, 2 mM DTT, 100 mM Tris, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm300846z","14K","4FLH",110.73,"2.6","2.6","Crystal structure of human PI3K-gamma in complex with AMG511","GSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4FLH"
"4FLI",,"X-RAY DIFFRACTION",2.45,49.88,"microbatch under oil",8,"200 mM sodium acetate, 20% PEG 3350, pH 8.0, microbatch under oil",,"10.1021/jm3008695","Y16","4FLI",37.3,"1.55","1.55","Human MetAP1 with bengamide analog Y16, in Mn form","MYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQFEFELVDKLAAALEHHHHHH","Homo sapiens","KIAA0094, map1, METAP1","Methionine aminopeptidase 1","1","4FLI"
"4FLJ",,"X-RAY DIFFRACTION",2.44,49.64,"microbatch under oil",8,"200 mM sodium acetate, 20% PEG 3350, pH 8.0, microbatch under oil",,"10.1021/jm3008695","Y08","4FLJ",37.4,"1.74","1.74","Human MetAP1 with bengamide analog Y08, in Mn form","MYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQFEFELVDKLAAALEHHHHHH","Homo sapiens","KIAA0094, map1, METAP1","Methionine aminopeptidase 1","1","4FLJ"
"4FLK",,"X-RAY DIFFRACTION",2.44,49.65,"microbatch under oil",7.2,"200 mM sodium formate, 20% PEG 3350, pH 7.2, microbatch under oil",,"10.1021/jm3008695","Y10","4FLK",37.36,"1.47","1.47","Human MetAP1 with bengamide analog Y10, in Mn form","MYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQFEFELVDKLAAALEHHHHHH","Homo sapiens","KIAA0094, map1, METAP1","Methionine aminopeptidase 1","1","4FLK"
"4FLL",,"X-RAY DIFFRACTION",2.43,49.38,"microbatch under oil",8,"200 mM sodium acetate, 20% PEG 3350, pH 8.0, microbatch under oil",,"10.1021/jm3008695","YZ6","4FLL",37.42,"1.5","1.5","Human MetAP1 with bengamide analog YZ6, in Mn form","MYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQFEFELVDKLAAALEHHHHHH","Homo sapiens","KIAA0094, map1, METAP1","Methionine aminopeptidase 1","1","4FLL"
"4FLP",,"X-RAY DIFFRACTION",2.44,49.59,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M BisTris propane pH 8.0, 0.15M KSCN, 25% PEG3350, 10% EtGly , VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.06.045","JQ1","4FLP",29.29,"2.23","2.23","Crystal Structure of the first bromodomain of human BRDT in complex with the inhibitor JQ1","SMNTKKNGRLTNQLQYLQKVVLKDLWKHSFSWPFQRPVDAVKLQLPDYYTIIKNPMDLNTIKKRLENKYYAKASECIEDFNTMFSNCYLYNKPGDDIVLMAQALEKLFMQKLSQMPQEE","Homo sapiens","BRDT","Bromodomain testis-specific protein","1","4FLP"
"4FM7",,"X-RAY DIFFRACTION",2.16,42.96,"VAPOR DIFFUSION",,"30% PEG 200, 0.1 M sodium acetate, pH 5.2-5.4; protein buffer is NaBorate, pH 8.5, vapor diffusion, temperature 298K",298,"10.1021/jm3009426","0UP","4FM7",45.77,"1.56","1.56","Crystal Structure of BACE with Compound 14g","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4FM7"
"4FM8",,"X-RAY DIFFRACTION",2.11,41.6,"VAPOR DIFFUSION",,"30% PEG 200, 0.1 M sodium acetate, pH 5.2-5.4, protein buffer is NaBorate, pH 8.5, vapor diffusion, temperature 298K",298,"10.1021/jm3009426","0UQ","4FM8",45.75,"1.9","1.9","Crystal Structure of BACE with Compound 12a","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4FM8"
"4FMF",,"X-RAY DIFFRACTION",3.88,68.27,"VAPOR DIFFUSION, HANGING DROP",5.4,"1.8 M sodium formate, 0.1 M sodium citrate, pH 5.4, cryoprotectant: 15% 2R,3R-butane-di-ol, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1038/nsmb.2366",,"4FMF",142.64,"3.2","3.2","Crystal structure of human nectin-1 full ectodomain (D1-D3)","QVVQVNDSMYGFIGTDVVLHCSFANPLPSVKITQVTWQKSTNGSKQNVAIYNPSMGVSVLAPYRERVEFLRPSFTDGTIRLSRLELEDEGVYICEFATFPTGNRESQLNLTVMAKPTNWIEGTQAVLRAKKGQDDKVLVATCTSANGKPPSVVSWETRLKGEAEYQEIRNPNGTVTVISRYRLVPSREAHQQSLACIVNYHMDRFKESLTLNVQYEPEVTIEGFDGNWYLQRMDVKLTCKADANPPATEYHWTTLNGSLPKGVEAQNRTLFFKGPINYSLAGTYICEATNPIGTRSGQVEVNITEFPHHHHHH","Homo sapiens","PVRL1, HVEC, PRR1, NECTIN1","Poliovirus receptor-related protein 1","1","4FMF"
"4FMQ",,"X-RAY DIFFRACTION",2,38.38,"VAPOR DIFFUSION",8.5,"20-24% PEG6000, 100mM TRIS, pH 8.5, VAPOR DIFFUSION, temperature 298K",298,"10.1126/scisignal.2003004",,"4FMQ",43.91,"2.098","2.098","Crystal structure of human ERK2 complexed with a MAPK docking peptide","GSMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FMQ"
,,,,,,,,,,,,,,,,"LSLSSLAASSLAKRRQQ",,,"MAPK DOCKING PEPTIDE","2","4FMQ"
"4FMU",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG4000, 10% isoprpanol, 0.1M HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ja307060p","0UM","4FMU",32.58,"2.1","2.1","Crystal structure of Methyltransferase domain of human SET domain-containing protein 2 Compound: Pr-SNF","GETSVPPGSALVGPSCVMDDFRDPQRWKECAKQGKMPCYFDLIEENVYLTERKKNKSHRDIKRMQCECTPLSKDERAQGEIACGEDCLNRLLMIECSSRCPNGDYCSNRRFQRKQHADVEVILTEKKGWGLRAAKDLPSNTFVLEYCGEVLDHKEFKARVKEYARNKNIHYYFMALKNDEIIDATQKGNCSRFMNHSCEPNCETQKWTVNGQLRVGFFTTKLVPSGSELTFDYQFQRYGKEAQKCFCGSANCRGYLGGENRVSIRAAGGKMKKERSRK","Homo sapiens","SETD2, HIF1, HYPB, KIAA1732, KMT3A, SET2, HSPC069","Histone-lysine N-methyltransferase SETD2","1","4FMU"
"4FMW",,"X-RAY DIFFRACTION",2.05,39.95,"VAPOR DIFFUSION, HANGING DROP",8.5,"2.22 M NH4SO4, 0.1 M Tris-HCl, 10% Glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,,,"4FMW",47.49,"2","2","Crystal structure of methyltransferase domain of human RNA (guanine-9-) methyltransferase domain containing protein 2","GPNSDGHDRKRVRRDVVHSTLRLIIDCSFDHLMVLKDIKKLHKQIQRCYAENRRALHPVQFYLTSHGGQLKKNMDENDKGWVNWKDIHIKPEHYSELIKKEDLIYLTSDSPNILKELDESKAYVIGGLVDHNHHKGLTYKQASDYGINHAQLPLGNFVKMNSRKVLAVNHVFEIILEYLETRDWQEAFFTILPQRKG","Homo sapiens","RG9MTD2, TRMT10A","RNA (guanine-9-)-methyltransferase domain-containing protein 2","1","4FMW"
"4FNC",,"X-RAY DIFFRACTION",2.44,49.69,"VAPOR DIFFUSION, SITTING DROP",4.6,"30% polyethylene glycol (PEG) 4000, 0.2 M ammonium acetate, 0.1 M sodium acetate, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1093/nar/gks845",,"4FNC",40.64,"2.493","2.493","Human TDG in a post-reactive complex with 5-hydroxymethyluracil (5hmU)","GSHMASFNGVSEAELLTKTLPDILTFNLDIVIIGINPGLMAAYKGHHYPGPGNHFWKCLFMSGLSEVQLNHMDDHTLPGKYGIGFTNMVERTTPGSKDLSSKEFREGGRILVQKLQKYQPRIAVFNGKCIYEIFSKEVFGVKVKNLEFGLQPHKIPDTETLCYVMPSSSARCAQFPRAQDKVHYYIKLKDLRDQLKGIERNMDV","Homo sapiens","TDG","G/T mismatch-specific thymine DNA glycosylase","1","4FNC"
,,,,,,,,,,,,,,,,"CAGCTCTGTACGTGAGCAGTGGACAGCT",,,"DNA (28-MER)","2","4FNC"
,,,,,,,,,,,,,,,,"AGCTGTCCACTGCTCAXGTACAGAGCTGT",,,"DNA (29-MER)","3","4FNC"
"4FNL",,"X-RAY DIFFRACTION",4.37,71.87,"VAPOR DIFFUSION, SITTING DROP",5.4,"1.8 M ammonium sulfate, 100 mM sodium acetate, pH 5.4, 50 mM sodium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nature11414",,"4FNL",99.46,"2.297","2.297","Crystal structure of broadly neutralizing antibody C05","QVQLQESGGGLVQPGESLRLSCVGSGSSFGESTLSYYAVSWVRQAPGKGLEWLSIINAGGGDIDYADSVEGRFTISRDNSKETLYLQMTNLRVEDTGVYYCAKHMSMQQVVSAGWERADLVGDAFDVWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCHHHHHH","Homo sapiens",,"Antibody C05, Heavy Chain","1","4FNL"
,,,,,,,,,,,,,,,,"DIQLTQSPSSLSASVGDRVTLTCQASQDIRKFLNWYQQKPGKGPKLLIYDASNLQRGVPSRFSGGGSGTDFTLIISSLQPEDVGTYYCQQYDGLPFTFGGGTKVVIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Antibody C05, Light Chain","2","4FNL"
"4FNW",,"X-RAY DIFFRACTION",2.14,42.4,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 5000 monomethyl ether, 200 mM ammonium sulfate, 5 mM dithiothreitol, 100 mM MES (pH 6.5), VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.391425",,"4FNW",36.98,"1.75","1.75","Crystal structure of the apo F1174L anaplastic lymphoma kinase catalytic domain","RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","4FNW"
"4FNX",,"X-RAY DIFFRACTION",2.14,42.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG 5000 monomethyl ether, 100 mM ammonium sulfate, 5 mM dithiothreitol, 100 mM MES (pH 6.5), VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.391425",,"4FNX",36.9,"1.7","1.7","Crystal structure of the apo R1275Q anaplastic lymphoma kinase catalytic domain","RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","4FNX"
"4FNY",,"X-RAY DIFFRACTION",2.05,40.13,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 0.2 M di-ammonium citrate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.391425","I3K","4FNY",37.25,"2.45","2.45","Crystal structure of the R1275Q anaplastic lymphoma kinase catalytic domain in complex with a benzoxazole inhibitor","RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","4FNY"
"4FNZ",,"X-RAY DIFFRACTION",2.13,42.35,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG 5000 monomethyl ether, 200 mM ammonium sulfate, 5 mM dithiothreitol, 100 mM MES (pH 6.5), VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M112.391425","NZF","4FNZ",37.39,"2.6","2.6","Crystal structure of human anaplastic lymphoma kinase in complex with piperidine-carboxamide inhibitor 2","RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","4FNZ"
"4FO0",,"X-RAY DIFFRACTION",3.95,68.86,"VAPOR DIFFUSION, HANGING DROP",6.1,"3.9 M NaCl, 0.5 % (v/v) methanol, 50 mM Mes pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1093/nar/gks842",,"4FO0",68.42,"2.6","2.6","Human actin-related protein Arp8 in its ATP-bound state","GPLVPESLQEQIQSNFIIVIHPGSTTLRIGRATDTLPASIPHVIARRHKQQGQPLYKDSWLLREGLNKPESNEQRQNGLKMVDQAIWSKKMSNGTRRIPVSPEQARSYNKQMRPAILDHCSGNKWTNTSHHPEYLVGEEALYVNPLDCYNIHWPIRRGQLNIHPGPGGSLTAVLADIEVIWSHAIQKYLEIPLKDLKYYRCILLIPDIYNKQHVKELVNMILMKMGFSGIVVHQESVCATYGSGLSSTCIVDVGDQKTSVCCVEDGVSHRNTRLCLAYGGSDVSRCFYWLMQRAGFPYRECQLTNKMDCLLLQHLKETFCHLDQDISGLQDHEFQIRHPDSPALLYQFRLGDEKLQAPMALFYPATFGIVGQKMTTLQHRSQGDPEDPHDEHYLLATQSKQEQSAKATADRKSASKPIGFEGDLRGQSSDLPERLHSQEVDLGSAQGDGLMAGNDSEEALTALMSRKTAISLFEGKALGLDKAILHSIDCCSSDDTKKKMYSSILVVGGGLMFHKAQEFLQHRILNKMPPSFRRIIENVDVITRPKDMDPRLIAWKGGAVLACLDTTQELWIYQREWQRFGVRMLRERAAFVW","Homo sapiens","ACTR8, ACTR8: ARP8 actin-related protein 8 homolog (yeast), ARP8, INO80N","Actin-related protein 8","1","4FO0"
"4FO6",,"X-RAY DIFFRACTION",2.73,54.88,"VAPOR DIFFUSION, HANGING DROP",6.5,"50mM MES pH 6.5, 9%(v/v) PEG400, 100mM KCL, 10mM MGCL2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/nar/gks413",,"4FO6",46.72,"2.007","2.007","Crystal structure of the pre-catalytic ternary complex of polymerase lambda with a dATP analog opposite a templating T and an rCMP at the primer terminus.","AQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVKGETKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGAKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","1","4FO6"
,,,,,,,,,,,,,,,,"CGGCTGTACTG",,,"5'-D(*CP*GP*GP*CP*TP*GP*TP*AP*CP*TP*G)-3'","2","4FO6"
,,,,,,,,,,,,,,,,"CAGTAC",,,"5'-D(*CP*AP*GP*TP*AP)-R(P*C)-3'","3","4FO6"
,,,,,,,,,,,,,,,,"GCCG",,,"5'-D(P*GP*CP*CP*G)-3'","4","4FO6"
,,,,,,,,,,,,,,,,"TACTG",,,"5'-D(P*TP*AP*CP*TP*G)-3'","5","4FO6"
,,,,,,,,,,,,,,,,"CAGTA",,,"5'-D(P*CP*AP*GP*TP*A)-3'","6","4FO6"
"4FO9",,"X-RAY DIFFRACTION",2.7,54.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.7 M KH2PO4/NaH2PO4, pH6.5, vapor diffusion hanging drop, temperature 291K",291,,,"4FO9",40.7,"2.39","2.39","Crystal structure of the E3 SUMO Ligase PIAS2","MHHHHHHSSGRENLYFQGQLKNLPFYDVLDVLIKPTSLVQSSIQRFQEKFFIFALTPQQVREICISRDFLPGGRRDYTVQVQLRLCLAETSCPQEDNYPNSLCIKVNGKLFPLPGYAPPPKNGIEQKRPGRPLNITSLVRLSSAVPNQISISWASEIGKNYSMSVYLVRQLTSAMLLQRLKMKGIRNPDHSRALIKEKLTADPDSEIATTSLRVSLMCPLGKMRLTIPCRAVTCTHLQCFDAALYLQMNEKKPTWICPVCDKKAAYESLILDGLFMEILNDCSDVDEIKFQEDGSWCPMRPKKEAMKVSSQPCTKIESSSVLSKPCSVTVASEASKKKVDVIDLTIESSSDEEEDPPAKR","Homo sapiens","PIAS2, PIASX","E3 SUMO-protein ligase PIAS2","1","4FO9"
"4FOB",,"X-RAY DIFFRACTION",1.96,37.11,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG 5000 monomethyl ether, 200 mM ammonium sulfate, 2 mM dithiothreitol, 100 mM MES (pH 6.5) - 1:200 (w/w) chymotrypsin:ALK, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm3005866","0US","4FOB",40.62,"1.9","1.9","Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 1","VYRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","4FOB"
"4FOC",,"X-RAY DIFFRACTION",1.96,37.11,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG 5000 monomethyl ether, 200 mM ammonium sulfate, 2 mM dithiothreitol, 100 mM MES (pH 6.5) - 1:200 (w/w) chymotrypsin:ALK, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm3005866","0UU","4FOC",40.53,"1.7","1.7","Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 2","VYRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","4FOC"
"4FOD",,"X-RAY DIFFRACTION",2.1,41.53,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG 5000 monomethyl ether, 200 mM ammonium sulfate, 2 mM dithiothreitol, 100 mM sodium cacodylate (pH 6.5), VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm3005866","0UV","4FOD",38.24,"2","2","Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 36","YKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","4FOD"
"4FOE",,"X-RAY DIFFRACTION",2.91,57.78,"hanging drop",6,"PEG 4000, PEG 8000, sodium acetate, sodium citrate, pH 6.0, hanging drop, temperature 277K",277,,,"4FOE",207.49,"2.7","2.7","Crystal Structure of recombinant human Hexokinase type I with Mannose 6-Phosphate","MIAAQLLAYYFTELKDDQVKKIDKYLYAMRLSDETLIDIMTRFRKEMKNGLSRDFNPTATVKMLPTFVRSIPDGSEKGDFIALDLGGSSFRILRVQVNHEKNQNVHMESEVYDTPENIVHGSGSQLFDHVAECLGDFMEKRKIKDKKLPVGFTFSFPCQQSKIDEAILITWTKRFKASGVEGADVVKLLNKAIKKRGDYDANIVAVVNDTVGTMMTCGYDDQHCEVGLIIGTGTNACYMEELRHIDLVEGDEGRMCINTEWGAFGDDGSLEDIRTEFDREIDRGSLNPGKQLFEKMVSGMYLGELVRLILVKMAKEGLLFEGRITPELLTRGKFNTSDVSAIEKNKEGLHNAKEILTRLGVEPSDDDCVSVQHVCTIVSFRSANLVAATLGAILNRLRDNKGTPRLRTTVGVDGSLYKTHPQYSRRFHKTLRRLVPDSDVRFLLSESGSGKGAAMVTAVAYRLAEQHRQIEETLAHFHLTKDMLLEVKKRMRAEMELGLRKQTHNNAVVKMLPSFVRRTPDGTENGDFLALDLGGTNFRVLLVKIRSGKKRTVEMHNKIYAIPIEIMQGTGEELFDHIVSCISDFLDYMGIKGPRMPLGFTFSFPCQQTSLDAGILITWTKGFKATDCVGHDVVTLLRDAIKRREEFDLDVVAVVNDTVGTMMTCAYEEPTCEVGLIVGTGSNACYMEEMKNVEMVEGDQGQMCINMEWGAFGDNGCLDDIRTHYDRLVDEYSLNAGKQRYEKMISGMYLGEIVRNILIDFTKKGFLFRGQISETLKTRGIFETKFLSQIESDRLALLQVRAILQQLGLNSTCDDSILVKTVCGVVSRRAAQLCGAGMAAVVDKIRENRGLDRLNVTVGVDGTLYKLHPHFSRIMHQTVKELSPKCNVSFLLSEDGSGKGAALITAVGVRLRTEASS","Homo sapiens","HK1","Hexokinase-1","1","4FOE"
"4FOI",,"X-RAY DIFFRACTION",2.92,57.87,"hanging drop",6,"PEG 4000, PEG 8000, sodium acetate, sodium citrate, pH 6.0, hanging drop, temperature 277K",277,,,"4FOI",207.8,"2.4","2.4","Crystal Structure of recombinant human Hexokinase type I mutant D413N with Glucose 1,6-bisphosphate","MIAAQLLAYYFTELKDDQVKKIDKYLYAMRLSDETLIDIMTRFRKEMKNGLSRDFNPTATVKMLPTFVRSIPDGSEKGDFIALDLGGSSFRILRVQVNHEKNQNVHMESEVYDTPENIVHGSGSQLFDHVAECLGDFMEKRKIKDKKLPVGFTFSFPCQQSKIDEAILITWTKRFKASGVEGADVVKLLNKAIKKRGDYDANIVAVVNDTVGTMMTCGYDDQHCEVGLIIGTGTNACYMEELRHIDLVEGDEGRMCINTEWGAFGDDGSLEDIRTEFDREIDRGSLNPGKQLFEKMVSGMYLGELVRLILVKMAKEGLLFEGRITPELLTRGKFNTSDVSAIEKNKEGLHNAKEILTRLGVEPSDDDCVSVQHVCTIVSFRSANLVAATLGAILNRLRDNKGTPRLRTTVGVNGSLYKTHPQYSRRFHKTLRRLVPDSDVRFLLSESGSGKGAAMVTAVAYRLAEQHRQIEETLAHFHLTKDMLLEVKKRMRAEMELGLRKQTHNNAVVKMLPSFVRRTPDGTENGDFLALDLGGTNFRVLLVKIRSGKKRTVEMHNKIYAIPIEIMQGTGEELFDHIVSCISDFLDYMGIKGPRMPLGFTFSFPCQQTSLDAGILITWTKGFKATDCVGHDVVTLLRDAIKRREEFDLDVVAVVNDTVGTMMTCAYEEPTCEVGLIVGTGSNACYMEEMKNVEMVEGDQGQMCINMEWGAFGDNGCLDDIRTHYDRLVDEYSLNAGKQRYEKMISGMYLGEIVRNILIDFTKKGFLFRGQISETLKTRGIFETKFLSQIESDRLALLQVRAILQQLGLNSTCDDSILVKTVCGVVSRRAAQLCGAGMAAVVDKIRENRGLDRLNVTVGVDGTLYKLHPHFSRIMHQTVKELSPKCNVSFLLSEDGSGKGAALITAVGVRLRTEASS","Homo sapiens","HK1","Hexokinase-1","1","4FOI"
"4FOM",,"X-RAY DIFFRACTION",9.13,86.52,"VAPOR DIFFUSION, HANGING DROP",4.6,"4.6 M ammonium acetate, 0.1 M sodium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1038/nsmb.2366",,"4FOM",37.73,"3.93","3.93","Crystal structure of human nectin-3 full ectodomain (D1-D3)","GPIIVEPHVTAVWGKNVSLKCLIEVNETITQISWEKIHGKSSQTVAVHHPQYGFSVQGEYQGRVLFKNYSLNDATITLHNIGFSDSGKYICKAVTFPLGNAQSSTTVTVLVEPTVSLIKGPDSLIDGGNETVAAICIAATGKPVAHIDWEGDLGEMESTTTSFPNETATIISQYKLFPTRFARGRRITCVVKHPALEKDIRYSFILDIQYAPEVSVTGYDGNWFVGRKGVNLKCNADANPPPFKSVWSRLDGQWPDGLLASDNTLHFVHPLTFNYSGVYICKVTNSLGQRSDQKVIYISDPPHHHHHH","Homo sapiens","PVRL3, PRR3, NECTIN3","Poliovirus receptor-related protein 3","1","4FOM"
"4FPA",,"X-RAY DIFFRACTION",2.92,57.87,"hanging drop",6,"PEG 4000, PEG 8000, sodium acetate, sodium citrate, pH 6.0, hanging drop, temperature 277K",277,,,"4FPA",207.49,"2.48","2.48","Crystal Structure of recombinant human Hexokinase type I mutant D413N Glucose 6-Phosphate","MIAAQLLAYYFTELKDDQVKKIDKYLYAMRLSDETLIDIMTRFRKEMKNGLSRDFNPTATVKMLPTFVRSIPDGSEKGDFIALDLGGSSFRILRVQVNHEKNQNVHMESEVYDTPENIVHGSGSQLFDHVAECLGDFMEKRKIKDKKLPVGFTFSFPCQQSKIDEAILITWTKRFKASGVEGADVVKLLNKAIKKRGDYDANIVAVVNDTVGTMMTCGYDDQHCEVGLIIGTGTNACYMEELRHIDLVEGDEGRMCINTEWGAFGDDGSLEDIRTEFDREIDRGSLNPGKQLFEKMVSGMYLGELVRLILVKMAKEGLLFEGRITPELLTRGKFNTSDVSAIEKNKEGLHNAKEILTRLGVEPSDDDCVSVQHVCTIVSFRSANLVAATLGAILNRLRDNKGTPRLRTTVGVNGSLYKTHPQYSRRFHKTLRRLVPDSDVRFLLSESGSGKGAAMVTAVAYRLAEQHRQIEETLAHFHLTKDMLLEVKKRMRAEMELGLRKQTHNNAVVKMLPSFVRRTPDGTENGDFLALDLGGTNFRVLLVKIRSGKKRTVEMHNKIYAIPIEIMQGTGEELFDHIVSCISDFLDYMGIKGPRMPLGFTFSFPCQQTSLDAGILITWTKGFKATDCVGHDVVTLLRDAIKRREEFDLDVVAVVNDTVGTMMTCAYEEPTCEVGLIVGTGSNACYMEEMKNVEMVEGDQGQMCINMEWGAFGDNGCLDDIRTHYDRLVDEYSLNAGKQRYEKMISGMYLGEIVRNILIDFTKKGFLFRGQISETLKTRGIFETKFLSQIESDRLALLQVRAILQQLGLNSTCDDSILVKTVCGVVSRRAAQLCGAGMAAVVDKIRENRGLDRLNVTVGVDGTLYKLHPHFSRIMHQTVKELSPKCNVSFLLSEDGSGKGAALITAVGVRLRTEASS","Homo sapiens","HK1","Hexokinase-1","1","4FPA"
"4FPB",,"X-RAY DIFFRACTION",2.95,58.25,"hanging drop",6,"PEG 4000, PEG 8000, sodium acetate, sodium citrate, pH 6.0, hanging drop, temperature 277K",277,,,"4FPB",207.42,"3","3","Crystal Structure of Recombinant Human Hexokinase Type I with 1,5-Anhydroglucitol 6-Phosphate","MIAAQLLAYYFTELKDDQVKKIDKYLYAMRLSDETLIDIMTRFRKEMKNGLSRDFNPTATVKMLPTFVRSIPDGSEKGDFIALDLGGSSFRILRVQVNHEKNQNVHMESEVYDTPENIVHGSGSQLFDHVAECLGDFMEKRKIKDKKLPVGFTFSFPCQQSKIDEAILITWTKRFKASGVEGADVVKLLNKAIKKRGDYDANIVAVVNDTVGTMMTCGYDDQHCEVGLIIGTGTNACYMEELRHIDLVEGDEGRMCINTEWGAFGDDGSLEDIRTEFDREIDRGSLNPGKQLFEKMVSGMYLGELVRLILVKMAKEGLLFEGRITPELLTRGKFNTSDVSAIEKNKEGLHNAKEILTRLGVEPSDDDCVSVQHVCTIVSFRSANLVAATLGAILNRLRDNKGTPRLRTTVGVDGSLYKTHPQYSRRFHKTLRRLVPDSDVRFLLSESGSGKGAAMVTAVAYRLAEQHRQIEETLAHFHLTKDMLLEVKKRMRAEMELGLRKQTHNNAVVKMLPSFVRRTPDGTENGDFLALDLGGTNFRVLLVKIRSGKKRTVEMHNKIYAIPIEIMQGTGEELFDHIVSCISDFLDYMGIKGPRMPLGFTFSFPCQQTSLDAGILITWTKGFKATDCVGHDVVTLLRDAIKRREEFDLDVVAVVNDTVGTMMTCAYEEPTCEVGLIVGTGSNACYMEEMKNVEMVEGDQGQMCINMEWGAFGDNGCLDDIRTHYDRLVDEYSLNAGKQRYEKMISGMYLGEIVRNILIDFTKKGFLFRGQISETLKTRGIFETKFLSQIESDRLALLQVRAILQQLGLNSTCDDSILVKTVCGVVSRRAAQLCGAGMAAVVDKIRENRGLDRLNVTVGVDGTLYKLHPHFSRIMHQTVKELSPKCNVSFLLSEDGSGKGAALITAVGVRLRTEASS","Homo sapiens","HK1","Hexokinase-1","1","4FPB"
"4FPT",,"X-RAY DIFFRACTION",2.1,41.41,"VAPOR DIFFUSION, SITTING DROP",7.8,"2.75 M (NH4)2SO4, 0.3 M NaCl, 0.15 mM p-chloromercurybenzoic acid 0.1 M Tris-HCl, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4FPT",30.18,"0.98","0.98","Carbonic Anhydrase II in complex with ethyl (2Z,4R)-2-(sulfamoylimino)-1,3-thiazolidine-4-carboxylate","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4FPT"
"4FQ1",,"X-RAY DIFFRACTION",2.49,50.55,,8.5,"PEG 4000, Tris HCl, CuCl2, pH 8.5, vapor diffusion, temperature 298K",298,"10.1073/pnas.1217207109",,"4FQ1",49.17,"3","3","Crystal Structure of PGT121 Fab","QMQLQESGPGLVKPSETLSLTCSVSGASISDSYWSWIRRSPGKGLEWIGYVHKSGDTNYSPSLKSRVNLSLDTSKNQVSLSLVAATAADSGKYYCARTLHGRRIYGIVAFNEWFTYFYMDVWGNGTQVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHHHHHH","Homo sapiens",,"Fab heavy chain","1","4FQ1"
,,,,,,,,,,,,,,,,"SDISVAPGETARISCGEKSLGSRAVQWYQHRAGQAPSLIIYNNQDRPSGIPERFSGSPDSPFGTTATLTITSVEAGDEADYYCHIWDSRVPTKWVFGGGTTLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab light chain","2","4FQ1"
"4FQ2",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION",5.5,"PEG 3350, Bis-Tris HCl, NaCl, pH 5.5, vapor diffusion, temperature 298K",298,"10.1073/pnas.1217207109",,"4FQ2",49.98,"1.9","1.9","Crystal Structure of 10-1074 Fab","QVQLQESGPGLVKPSETLSVTCSVSGDSMNNYYWTWIRQSPGKGLEWIGYISDRESATYNPSLNSRVVISRDTSKNQLSLKLNSVTPADTAVYYCATARRGQRIYGVVSFGEFFYYYSMDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHHHHHH","Homo sapiens",,"Fab heavy chain","1","4FQ2"
,,,,,,,,,,,,,,,,"SYVRPLSVALGETARISCGRQALGSRAVQWYQHRPGQAPILLIYNNQDRPSGIPERFSGTPDINFGTRATLTISGVEAGDEADYYCHMWDSRSGFSWSFGGATRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab light chain","2","4FQ2"
"4FQC",,"X-RAY DIFFRACTION",2.21,44.32,,5.5,"PEG 10000, Bis Tris HCl, CH3COOHNH4, pH 5.5, vapor diffusion, temperature 298K",298,"10.1073/pnas.1217207109",,"4FQC",51.03,"2.4","2.4","Crystal Structure of PGT121 Fab Bound to a complex-type sialylated N-glycan","QMQLQESGPGLVKPSETLSLTCSVSGASISDSYWSWIRRSPGKGLEWIGYVHKSGDTNYSPSLKSRVNLSLDTSKNQVSLSLVAATAADSGKYYCARTLHGRRIYGIVAFNEWFTYFYMDVWGNGTQVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHHHHHH","Homo sapiens",,"Fab heavy chain","1","4FQC"
,,,,,,,,,,,,,,,,"SDISVAPGETARISCGEKSLGSRAVQWYQHRAGQAPSLIIYNNQDRPSGIPERFSGSPDSPFGTTATLTITSVEAGDEADYYCHIWDSRVPTKWVFGGGTTLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab light chain","2","4FQC"
"4FQF",,"X-RAY DIFFRACTION",2.05,40,"VAPOR DIFFUSION, SITTING DROP",6.4,"100 mM bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane (Bis-TRIS), 25% PEG 3350, 60 mM urea;      
13.3 mM magnesium chloride, 8.9 mM tris(2-carboxyethyl)phosphine (TCEP), 4.4 mM NAD+, 45.8 mM glucose, crystals have been soaked with glyceryl trinitrate (GTN), pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M112.371716",,"4FQF",221.39,"2.281","2.281","Crystal structure of a thionitrate intermediate of human aldehyde dehydrogenase-2","SAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLAALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADMDWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGPQVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYKMSGSGRELGEYGLQAYTEVKTVTVKVPQKNS","Homo sapiens","ALDH2, ALDM","Aldehyde dehydrogenase, mitochondrial","1","4FQF"
"4FQG",,"X-RAY DIFFRACTION",2.21,44.24,"VAPOR DIFFUSION, HANGING DROP",9,"0.016 M NiCl2, 0.1 M Tris-HCl, 16% polyethylene glycol monomethyl ether 2000, and 0.13 M glycine, pH 9, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M113.460238",,"4FQG",46.33,"2","2","Crystal structure of the TCERG1 FF4-6 tandem repeat domain","SHMKREEAIQNFKALLSDMVRSSDVSWSDTRRTLRKDHRWESGSLLEREEKEKLFNEHIEALTKKKREHFRQLLDETSAITLTSTWKEVKKIIKEDPRCIKFSSSDRKKQREFEEYIRDKYITAKADFRTLLKETKFITYRSKKLIQESDQHLKDVEKILQNDKRYLVLDCVPEERRKLIVAYVDDLDRR","Homo sapiens","TCERG1, CA150, TAF2S","Transcription elongation regulator 1","1","4FQG"
"4FQH",,"X-RAY DIFFRACTION",2.25,45.23,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M lithium nitrate, 20% PEG3350, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1126/science.1222908",,"4FQH",95.09,"2.05","2.05","Crystal Structure of Fab CR9114","QVQLVQSGAEVKKPGSSVKVSCKSSGGTSNNYAISWVRQAPGQGLDWMGGISPIFGSTAYAQKFQGRVTISADIFSNTAYMELNSLTSEDTAVYFCARHGNYYYYSGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCHHHHHH","Homo sapiens",,"antibody CR9114 heavy chain","1","4FQH"
,,,,,,,,,,,,,,,,"QSALTQPPAVSGTPGQRVTISCSGSDSNIGRRSVNWYQQFPGTAPKLLIYSNDQRPSVVPDRFSGSKSGTSASLAISGLQSEDEAEYYCAAWDDSLKGAVFGGGTQLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"antibody CR9114 light chain","2","4FQH"
"4FQL",,"X-RAY DIFFRACTION",2.65,53.66,"VAPOR DIFFUSION, SITTING DROP",6,"200 mM zinc acetate, 10% PEG8000, 100 mM MES, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1126/science.1222908",,"4FQL",48.76,"1.898","1.898","Influenza B HA Antibody (Fab) CR8033","EVQLVESGGGLVQPGRSLRLSCAASGFSFDEYTMHWVRQAPGKGLEWVAGINWKGNFMGYADSVQGRFTISRDNGKNSLYLQMNSLRAEDTALYYCAKDRLESSAMDILEGGTFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCHHHHHH","Homo sapiens",,"monoclonal antibody CR8033 heavy chain","1","4FQL"
,,,,,,,,,,,,,,,,"EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTDFTLTISRLEPEDLAVYYCQQYGSSPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"monoclonal antibody CR8033 light chain","2","4FQL"
"4FQN",,"X-RAY DIFFRACTION",2,38.47,"VAPOR DIFFUSION, SITTING DROP",6.5,"2.072M ammonium sulfate, 0.2M potassium formate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.febslet.2012.12.011",,"4FQN",44.65,"1.9","1.9","Crystal structure of the CCM2 C-terminal Harmonin Homology Domain (HHD)","GSKTISESELSASATELLQDYMLTLRTKLSSQEIQQFAALLHEYRNGASIHEFCINLRQLYGDSRKFLLLGLRPFIPEKDSQHFENFLETIGVKDGRG","Homo sapiens","C7orf22, CCM2, PP10187","Malcavernin","1","4FQN"
"4FQP",,"X-RAY DIFFRACTION",11.12,88.94,"VAPOR DIFFUSION, HANGING DROP",9,"55% v/v tacsimate, 0.1 M Bicine, pH 9.0, with additional 10% tacsimate as cryoprotectant, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1038/nsmb.2366",,"4FQP",38.14,"3.6","3.6","Crystal structure of human Nectin-like 5 full ectodomain (D1-D3)","DVVVQAPTQVPGFLGDSVTLPCYLQVPNMEVTHVSQLTWARHGESGSMAVFHQTQGPSYSESKRLEFVAARLGAELRNASLRMFGLRVEDEGNYTCLFVTFPQGSRSVDIWLRVLAKPQNTAEVQKVQLTGEPVPMARCVSTGGRPPAQITWHSDLGGMPNTSQVPGFLSGTVTVTSLWILVPSSQVDGKNVTCKVEHESFEKPQLLTVNLTVYYPPEVSISGYDNNWYLGQNEATLTCDARSNPEPTGYNWSTTMGPLPPFAVAQGAQLLIRPVDKPINTTLICNVTNALGARQAELTVQVKEGPPHHHHHH","Homo sapiens","PVR, PVS","Poliovirus receptor","1","4FQP"
"4FQW",,"X-RAY DIFFRACTION",2.27,45.7,"VAPOR DIFFUSION, HANGING DROP",5,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride,50 mM ADA, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4FQW",34.95,"2.02","2.02","Crystal Structure of AAAA+UDP+Gal at pH 5.0 with MPD as the cryoprotectant","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYLGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4FQW"
"4FQZ",,"X-RAY DIFFRACTION",3.08,60.05,"VAPOR DIFFUSION, HANGING DROP",9,"10% PEG 20000, 0.1M Bicine, 2% Dioxane, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/j.1742-4658.2012.08753.x",,"4FQZ",34.07,"2.8","2.8","Crystal structure of a protease-resistant mutant form of human galectin-8","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSSHMRLPFAARLNTPMGPGRTVVVKGEVNANAKSFNVDLLAGKSKDIALHLNPRLNIKAFVRNSFLQESWGEEERNITSFPFSPGMYFEMIIYCDVREFKVAVNGVHSLEYKHRFKELSSIDTLEINGDIHLLEVRSW","Homo sapiens","LGALS8","Galectin-8","1","4FQZ"
,,,,,,,,,,,,,,,,,"Homo sapiens","LGALS8"
"4FR4",,"X-RAY DIFFRACTION",2.84,56.63,"VAPOR DIFFUSION, SITTING DROP",7.8,"20% PEG 3350, 0.2M sodium acetate, 10% ethylene glycol, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4FR4",274.28,"2.29","2.29","Crystal structure of human serine/threonine-protein kinase 32A (YANK1)","SMPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFELEEMILESKPLHKKKKRLAKKEKDMRKCDSSQTCLLQEHLDSVQKEFIIFNREKVNRDFNKRQPNLALEQTKDPQGED","Homo sapiens","STK32A, YANK1","Serine/threonine-protein kinase 32A","1","4FR4"
"4FR8",,"X-RAY DIFFRACTION",2.09,41.18,"VAPOR DIFFUSION, SITTING DROP",6.4,"100 mM bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane (Bis-TRIS), 25% PEG 3350, 60 mM urea; 6.9 mM magnesium chloride, 4.6 mM tris(2-carboxyethyl)phosphine (TCEP), 2.3 mM NAD+, 47.6 mM glucose, crystals have been soaked with glyceryl trinitrate (GTN), pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M112.371716",,"4FR8",441.27,"2.2","2.2","Crystal structure of human aldehyde dehydrogenase-2 in complex with nitroglycerin","SAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLAALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLQLGGKSPNIIMSDADMDWAVEQAHFALFFNQGQSCSAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGPQVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYKMSGSGRELGEYGLQAYTEVKTVTVKVPQKNS","Homo sapiens","ALDH2, ALDM","Aldehyde dehydrogenase, mitochondrial","1","4FR8"
"4FRA",,"X-RAY DIFFRACTION",2.27,45.8,"VAPOR DIFFUSION, HANGING DROP",5,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride,50 mM ADA, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4FRA",35.06,"1.43","1.43","Crystal Structure of ABBA+UDP+Gal at pH 5.0 with MPD as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4FRA"
"4FRB",,"X-RAY DIFFRACTION",2.27,45.8,"VAPOR DIFFUSION, HANGING DROP",8,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4FRB",35.01,"1.54","1.54","Crystal Structure of ABBA+UDP+Gal at pH 8.0 with MPD as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4FRB"
"4FRC",,"X-RAY DIFFRACTION",2.1,41.39,"VAPOR DIFFUSION, SITTING DROP",7.8,"2.75 M (NH4)2SO4, 0.3 M NaCl, 0.15 mM p-chloromercurybenzoic acid 0.1 M Tris-HCl , pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4FRC",29.95,"0.98","0.98","Carbonic Anhydrase II in complex with N'-sulfamoylpyrrolidine-1-carboximidamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4FRC"
"4FRD",,"X-RAY DIFFRACTION",2.27,45.91,"VAPOR DIFFUSION, HANGING DROP",8,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4FRD",35.01,"1.55","1.55","Crystal Structure of ABBA+UDP+Gal at pH 9.0 with MPD as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4FRD"
"4FRE",,"X-RAY DIFFRACTION",2.3,46.59,"VAPOR DIFFUSION, HANGING DROP",6.5,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4FRE",34.74,"1.85","1.85","Crystal Structure of BBBB+UDP+Gal at pH 6.5 with MPD as the cryoprotectant","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDGCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4FRE"
"4FRH",,"X-RAY DIFFRACTION",2.28,46.11,"VAPOR DIFFUSION, HANGING DROP",7.5,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM Tris-HCl, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4FRH",34.79,"1.8","1.8","Crystal Structure of BBBB+UDP+Gal at pH 7.5 with MPD as the cryoprotectant","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDGCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4FRH"
"4FRI",,"X-RAY DIFFRACTION",2.76,55.5,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% PEG 5000 monomethyl ether, 200 mM ammonium iodide, 180 mM sodium citrate (pH 6.6), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm300598e","DWA","4FRI",46.64,"2.3","2.3","Crystal structure of BACE1 in complex with biarylspiro aminooxazoline 6","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4FRI"
"4FRJ",,"X-RAY DIFFRACTION",2.73,54.98,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% PEG 5000 monomethyl ether, 200 mM ammonium iodide, 180 mM sodium citrate (pH 6.6), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm300598e","DWB","4FRJ",46.66,"1.95","1.95","Crystal structure of BACE1 in complex with aminooxazoline xanthene 9l","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4FRJ"
"4FRK",,"X-RAY DIFFRACTION",2.82,56.37,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% PEG 5000 monomethyl ether, 200 mM ammonium iodide, 180 mM sodium citrate (pH 6.6), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm300598e","DWD","4FRK",46.92,"2.1","2.1","Crystal structure of BACE1 in complex with aminooxazoline xanthene 11a","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4FRK"
"4FRL",,"X-RAY DIFFRACTION",2.29,46.33,"VAPOR DIFFUSION, HANGING DROP",8,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM Tris-HCl, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4FRL",34.78,"1.9","1.9","Crystal Structure of BBBB+UDP+Gal at pH 8.0 with MPD as the cryoprotectant","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4FRL"
"4FRM",,"X-RAY DIFFRACTION",2.29,46.29,"VAPOR DIFFUSION, HANGING DROP",7,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM Tris-HCl, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4FRM",34.63,"1.9","1.9","Crystal Structure of BBBB+UDP+Gal at pH 7.0 with MPD as the cryoprotectant","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDGCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4FRM"
"4FRO",,"X-RAY DIFFRACTION",2.28,46.05,"VAPOR DIFFUSION, HANGING DROP",9,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM glycine, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4FRO",34.85,"1.75","1.75","Crystal Structure of BBBB+UDP+Gal at pH 9.0 with MPD as the cryoprotectant","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4FRO"
"4FRP",,"X-RAY DIFFRACTION",2.28,46.04,"VAPOR DIFFUSION, HANGING DROP",8.5,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM Tris-HCl, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4FRP",34.78,"2","2","Crystal Structure of BBBB+UDP+Gal at pH 8.5 with MPD as the cryoprotectant","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4FRP"
"4FRQ",,"X-RAY DIFFRACTION",2.31,46.69,"VAPOR DIFFUSION, HANGING DROP",9.5,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM glycine, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 9.5, temperature 298K, VAPOR DIFFUSION, HANGING DROP",298,"10.1093/glycob/cwt098",,"4FRQ",34.81,"2.35","2.35","Crystal Structure of BBBB+UDP+Gal at pH 9.5 with MPD as the cryoprotectant","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDACERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4FRQ"
"4FRS",,"X-RAY DIFFRACTION",2.89,57.41,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ml3001165","0V6","4FRS",88.79,"1.7","1.7","Structure of BACE in complex with (S)-4-(3-chloro-5-(5-(prop-1-yn-1-yl)pyridin-3-yl)thiophen-2-yl)-1,4-dimethyl-6-oxotetrahydropyrimidin-2(1H)-iminium","EPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4FRS"
"4FRW",,"X-RAY DIFFRACTION",3.73,66.99,"VAPOR DIFFUSION, HANGING DROP",5.5,"3 M sodium chloride, 0.1 M Bis-Tris, pH 5.5, cryoprotectant: 30% w/v D-Trehalose, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1038/nsmb.2366",,"4FRW",140.8,"3.5","3.5","Crystal structure of human nectin-4 extracellular fragment D1-D2","GELETSDVVTVVLGQDAKLPCFYRGDSGEQVGQVAWARVDAGEGAQELALLHSKYGLHVSPAYEGRVEQPPPPRNPLDGSVLLRNAVQADEGEYECRVSTFPAGSFQARLRLRVLVPPLPSLNPGPALEEGQGLTLAASCTAEGSPAPSVTWDTEVKGTTSSRSFKHSRSAAVTSEFHLVPSRSMNGQPLTCVVSHPGLLQDQRITHILHVSHHHHHH","Homo sapiens","PVRL4, LNIR, PRR4, NECTIN4","Poliovirus receptor-related protein 4","1","4FRW"
"4FS4",,"X-RAY DIFFRACTION",2.95,58.31,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ml3000148","H24","4FS4",87.8,"1.74","1.74","Structure of BACE Bound to (S)-4-(3'-methoxy-[1,1'-biphenyl]-3-yl)-1,4-dimethyl-6-oxotetrahydropyrimidin-2(1H)-iminium","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4FS4"
"4FSE",,"X-RAY DIFFRACTION",2.49,50.52,"VAPOR DIFFUSION, HANGING DROP",6.2,"35% PEG8K, 0.2 M ammonium sulfate, pH 6.2, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/jm300931y","0VA","4FSE",203.88,"2.65","2.65","crystal structure of beta-site app-cleaving enzyme 1 (bace-wt) complex with N-(N-(4-amino-3,5- dichlorobenzyl)carbamimidoyl)-3-(4-methoxyphenyl)-5- methyl-4-isothiazolecarboxamide","MASMTGGQQMGRGSAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4FSE"
"4FSL",,"X-RAY DIFFRACTION",2.77,55.53,"VAPOR DIFFUSION, HANGING DROP",6.2,"35% PEG8K, 0.2 M ammonium sulfate, pH 6.2, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/jm300931y","0VB","4FSL",187.16,"2.5","2.5","Crystal structure of beta-site app-cleaving enzyme 1 (BACE-DB-MUT) complex with N-(N-(4- acetamido-3-chloro-5-methylbenzyl)carbamimidoyl)-3-(4- methoxyphenyl)-5-methyl-4-isothiazolecarboxamide","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4FSL"
"4FSM",,"X-RAY DIFFRACTION",2.69,54.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"HK1","4FSM",32.71,"2.3","2.3","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FSM"
"4FSN",,"X-RAY DIFFRACTION",2.65,53.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"A58","4FSN",32.61,"2.1","2.1","Crystal Structure of the CHK1","APFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FSN"
"4FSQ",,"X-RAY DIFFRACTION",2.71,54.63,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,,"4FSQ",32.63,"2.4","2.4","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FSQ"
"4FSR",,"X-RAY DIFFRACTION",2.67,53.92,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"HKC","4FSR",32.61,"2.5","2.5","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FSR"
"4FSS",,"X-RAY DIFFRACTION",3.47,64.58,"VAPOR DIFFUSION, SITTING DROP",8.5,"20.00% Glycerol, 1.600M NH4H2PO4, 0.1M TRIS pH 8.5, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4FSS",22.38,"2.25","2.25","Crystal structure of a RAS p21 protein activator (RASA1) from Homo sapiens at 2.25 A resolution","GRRRVRAILPYTKVPDTDEISFLKGDMFIVHNELEDGWMWVTNLRTDEQGLIVEDLVEEVGR","Homo sapiens","BC033015, RASA, RASA1, GAP","Ras GTPase-activating protein 1","1","4FSS"
"4FST",,"X-RAY DIFFRACTION",2.77,55.63,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"HK4","4FST",31.85,"1.9","1.9","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FST"
"4FSU",,"X-RAY DIFFRACTION",2.79,55.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,,"4FSU",32.68,"2.1","2.1","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FSU"
"4FSV",,"X-RAY DIFFRACTION",2.27,45.93,"VAPOR DIFFUSION, SITTING DROP",6,"20.00% 2-methyl-2,4-pentanediol, 0.1M MES pH 6.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4FSV",42.55,"1.8","1.8","Crystal structure of a heat shock 70kDa protein 2 (HSPA2) from Homo sapiens at 1.80 A resolution","GSARGPAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTIFDAKRLIGRKFEDATVQSDMKHWPFRVVSEGGKPKVQVEYKGETKTFFPEEISSMVLTKMKEIAEAYLGGKVHSAVITVPAYFNDSQRQATKDAGTITGLNVLRIINEPTAAAIAYGLDKKGCAGGEKNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVSHLAEEFKRKHKKDIGPNKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGVDFYTSITRARFEELNADLFRGTLEPVEKALRDAKLDKGQIQEIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILIGDK","Homo sapiens","BC001752, HSPA2","Heat shock-related 70 kDa protein 2","1","4FSV"
"4FSW",,"X-RAY DIFFRACTION",2.69,54.19,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"HK6","4FSW",32.57,"2.3","2.3","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FSW"
"4FSY",,"X-RAY DIFFRACTION",2.68,54.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"HK7","4FSY",32.75,"2.3","2.3","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FSY"
"4FSZ",,"X-RAY DIFFRACTION",2.69,54.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"HK8","4FSZ",32.71,"2.3","2.3","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FSZ"
"4FT0",,"X-RAY DIFFRACTION",2.69,54.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"HK9","4FT0",32.67,"2.3","2.3","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FT0"
"4FT3",,"X-RAY DIFFRACTION",2.65,53.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"H1K","4FT3",32.92,"2.5","2.5","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FT3"
"4FT5",,"X-RAY DIFFRACTION",2.65,53.52,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"H2K","4FT5",32.7,"2.4","2.4","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FT5"
"4FT7",,"X-RAY DIFFRACTION",2.7,54.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"H3K","4FT7",32.88,"2.2","2.2","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FT7"
"4FT9",,"X-RAY DIFFRACTION",2.67,53.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"H4K","4FT9",32.54,"2.2","2.2","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FT9"
"4FTA",,"X-RAY DIFFRACTION",2.67,53.85,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"H5K","4FTA",32.81,"2.4","2.4","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTA"
"4FTC",,"X-RAY DIFFRACTION",2.69,54.27,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"H6K","4FTC",32.78,"2","2","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTC"
"4FTI",,"X-RAY DIFFRACTION",2.69,54.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"H7K","4FTI",32.81,"2.2","2.2","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTI"
"4FTJ",,"X-RAY DIFFRACTION",2.7,54.48,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"H8K","4FTJ",32.72,"2.2","2.2","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTJ"
"4FTK",,"X-RAY DIFFRACTION",2.67,54.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"H9K","4FTK",32.65,"2.3","2.3","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTK"
"4FTL",,"X-RAY DIFFRACTION",2.7,54.47,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"H0K","4FTL",32.66,"2.5","2.5","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTL"
"4FTM",,"X-RAY DIFFRACTION",2.68,54.03,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,,"4FTM",32.86,"1.9","1.9","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTM"
"4FTN",,"X-RAY DIFFRACTION",2.75,55.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,,"4FTN",32.99,"2.02","2.02","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTN"
"4FTO",,"X-RAY DIFFRACTION",2.74,55.03,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"3HK","4FTO",32.92,"2.1","2.1","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTO"
"4FTQ",,"X-RAY DIFFRACTION",2.76,55.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,,"4FTQ",32.79,"2","2","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTQ"
"4FTR",,"X-RAY DIFFRACTION",2.74,55.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"5HK","4FTR",32.85,"2.25","2.25","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTR"
"4FTT",,"X-RAY DIFFRACTION",2.7,54.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES        , pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"6HK","4FTT",32.79,"2.3","2.3","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTT"
"4FTU",,"X-RAY DIFFRACTION",2.65,53.59,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES , pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,"7HK","4FTU",32.87,"2.1","2.1","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4FTU"
"4FU3",,"X-RAY DIFFRACTION",2.1,41.7,"VAPOR DIFFUSION",8.5,"30% PEG-4000, 0.2M magnesium chloride, 0.1M TRIS hydrochloride, pH 8.5, vapor diffusion, temperature 291K",291,,,"4FU3",31.3,"1.9","1.9","CID of human RPRD1B","GSSFSESALEKKLSELSNSQQSVQTLSLWLIHHRKHAGPIVSVWHRELRKAKSNRKLTFLYLANDVIQNSKRKGPEFTREFESVLVDAFSHVAREADEGCKKPLERLLNIWQERSVYGGEFIQQLKLSMEDSKSP","Homo sapiens","RPRD1B, C20orf77, CREPT","Regulation of nuclear pre-mRNA domain-containing protein 1B","1","4FU3"
"4FU4",,"X-RAY DIFFRACTION",2.91,57.7,"SLOW COOLING",7.5,"PROPEPTIDE IMPURITY INDUCES CRYSTALLIZATION ON COLD STORAGE CRYOPROTECTANT: 20% MPEG2K, 10% MPEG550, 10% ethylene glycol, 90mM imidazole malate, pH 6.0, SLOW COOLING, temperature 277.0K",277,"10.1096/fj.13-233601",,"4FU4",93.13,"2.849","2.849","Human collagenase 3 (MMP-13) with peptide from pro-domain","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHAFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPNPKHPKTPDKCDPSLSLDAITSLRGETMIFKDRFFWRLHPQQVDAELFLTKSFWPELPNRIDAAYEHPSHDLIFIFRGRKFWALNGYDILEGYPKKISELGLPKEVKKISAAVHFEDTGKTLLFSGNQVWRYDDTNHIMDKDYPRLIEEDFPGIGDKVDAVYEKNGYIYFFNGPIQFEYSIWSNRIVRVMPANSILWC","Homo sapiens","MMP13","Collagenase 3","1","4FU4"
,,,,,,,,,,,,,,,,"GGDEDDLSEEDLQFAERYLRSYYHPT","Homo sapiens","MMP13","Collagenase 3, pro-domain peptide","2","4FU4"
"4FU5",,"X-RAY DIFFRACTION",2.09,41.21,"VAPOR DIFFUSION, SITTING DROP",7.8,"2.75 M AMMONIUMSULFATE, 0.15 mM P-CHLOROMERCURIBENZOIC ACID, 0.1 M TRIS, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4FU5",30,"0.98","0.98","Carbonic Anhydrase II in complex with N-[(2Z)-1,3-oxazolidin-2-ylidene]sulfuric diamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4FU5"
"4FU6",,"X-RAY DIFFRACTION",2.35,47.77,"VAPOR DIFFUSION",8.5,"The protein sample was treated with V8 protease. 2.5M ammonium sulfate, 0.1M TRIS, pH 8.5, vapor diffusion, temperature 291K",291,"10.1016/j.tibs.2014.09.001",,"4FU6",17.9,"2.1","2.1","Crystal structure of the PSIP1 PWWP domain","MHHHHHHSSGRENLYFQGMTRDFKPGDLIFAKMKGYPHWPARVDEVPDGAVKPPTNKLPIFFFGTHETAFLGPKDIFPYSENKEKYGKPNKRKGFNEGLWEIDNNPKVKFSSQQAATKQSNASSDVEVEEKETSVSKEDTDHEEKASNEDVTK","Homo sapiens","PSIP1, DFS70, LEDGF, PSIP2","PC4 and SFRS1-interacting protein","1","4FU6"
"4FU7",,"X-RAY DIFFRACTION",2.09,41.15,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"1UP","4FU7",28.34,"2","2","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FU7"
"4FU8",,"X-RAY DIFFRACTION",2.1,41.45,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,"2UP","4FU8",28.51,"2.2","2.2","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FU8"
"4FU9",,"X-RAY DIFFRACTION",2.09,41.15,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291 - 298.0K",298,,"675","4FU9",29.08,"1.6","1.6","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FU9"
"4FUB",,"X-RAY DIFFRACTION",2.09,41.15,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,"4UP","4FUB",30.6,"1.9","1.9","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FUB"
"4FUC",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,"239","4FUC",29.33,"1.72","1.72","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FUC"
"4FUD",,"X-RAY DIFFRACTION",2.09,41.08,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,"6UP","4FUD",28.66,"2","2","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FUD"
"4FUE",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,"7UP","4FUE",28.75,"2","2","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FUE"
"4FUF",,"X-RAY DIFFRACTION",2.09,41.15,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,"8UP","4FUF",29,"2","2","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FUF"
"4FUG",,"X-RAY DIFFRACTION",2.09,41.15,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,"9UP","4FUG",28.65,"1.8","1.8","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FUG"
"4FUH",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,"1U2","4FUH",29.11,"1.6","1.6","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FUH"
"4FUI",,"X-RAY DIFFRACTION",2.13,42.25,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,"UI3","4FUI",28.86,"2","2","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FUI"
"4FUJ",,"X-RAY DIFFRACTION",2.07,40.54,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M Li2SO4, 20% polyethylene glycol MW 4000 in succinate buffer, pH 4.8-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291 - 298.0K",298,,"1U9","4FUJ",28.74,"2.05","2.05","Crystal Structure of the Urokinase","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4FUJ"
"4FUL",,"X-RAY DIFFRACTION",2.16,42.93,"VAPOR DIFFUSION, HANGING DROP",8.3,"100 mM tris HCl pH8.3, 100 mM Ammonium Sulfate, 18% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2012.08.107",,"4FUL",111.19,"2.47","2.47","PI3 Kinase Gamma bound to a pyrmidine inhibitor","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4FUL"
"4FUX",,"X-RAY DIFFRACTION",2.35,47.7,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,"E75","4FUX",42.13,"2.2","2.2","Crystal Structure of the ERK2 complexed with E75","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FUX"
"4FUY",,"X-RAY DIFFRACTION",2.35,47.66,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,"EK2","4FUY",42.32,"2","2","Crystal Structure of the ERK2 complexed with EK2","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FUY"
"4FV0",,"X-RAY DIFFRACTION",2.32,47.1,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,"EK3","4FV0",42.69,"2.1","2.1","Crystal Structure of the ERK2 complexed with EK3","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FV0"
"4FV1",,"X-RAY DIFFRACTION",2.33,47.27,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,"EK4","4FV1",42.4,"1.99","1.99","Crystal Structure of the ERK2 complexed with EK4","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FV1"
"4FV2",,"X-RAY DIFFRACTION",2.34,47.39,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,"EK5","4FV2",42.72,"2","2","Crystal Structure of the ERK2 complexed with EK5","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FV2"
"4FV3",,"X-RAY DIFFRACTION",2.37,48.18,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,,"4FV3",42.57,"2.2","2.2","Crystal Structure of the ERK2 complexed with EK6","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FV3"
"4FV4",,"X-RAY DIFFRACTION",2.25,45.36,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,"EK7","4FV4",42.26,"2.5","2.5","Crystal Structure of the ERK2 complexed with EK7","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FV4"
"4FV5",,"X-RAY DIFFRACTION",2.23,44.87,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,"EK9","4FV5",42.46,"2.4","2.4","Crystal Structure of the ERK2 complexed with EK9","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FV5"
"4FV6",,"X-RAY DIFFRACTION",2.27,45.89,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,"E57","4FV6",42.24,"2.5","2.5","Crystal Structure of the ERK2 complexed with E57","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FV6"
"4FV7",,"X-RAY DIFFRACTION",2.34,47.39,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,,"4FV7",42.69,"1.9","1.9","Crystal Structure of the ERK2 complexed with E94","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FV7"
"4FV8",,"X-RAY DIFFRACTION",2.23,44.82,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,"E63","4FV8",42.41,"2","2","Crystal Structure of the ERK2 complexed with E63","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FV8"
"4FV9",,"X-RAY DIFFRACTION",2.24,45.19,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,"E71","4FV9",42.44,"2.11","2.11","Crystal Structure of the ERK2 complexed with E71","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4FV9"
"4FVL",,"X-RAY DIFFRACTION",2.91,57.77,"SLOW COOLING",7.5,"propeptide impurity induces crystallization on cold storage cryoprotectant: 10% Di-ethylene glycol, 10% 1.2-propanediol, 10% glycerol, 10% PEG 10K, 10% PCTP 80/20, 0.2 M NaCl, pH 7.5, SLOW COOLING, temperature 277.0K",277,"10.1096/fj.13-233601",,"4FVL",94.39,"2.436","2.436","Human collagenase 3 (MMP-13) full form with peptides from pro-domain","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHAFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPNPKHPKTPDKCDPSLSLDAITSLRGETMIFKDRFFWRLHPQQVDAELFLTKSFWPELPNRIDAAYEHPSHDLIFIFRGRKFWALNGYDILEGYPKKISELGLPKEVKKISAAVHFEDTGKTLLFSGNQVWRYDDTNHIMDKDYPRLIEEDFPGIGDKVDAVYEKNGYIYFFNGPIQFEYSIWSNRIVRVMPANSILWC","Homo sapiens","MMP13","Collagenase 3","1","4FVL"
,,,,,,,,,,,,,,,,"LSEEDLQFAERYLRSYYHPT","Homo sapiens","MMP13","Collagenase 3, pro-domain peptide","2","4FVL"
"4FVN",,"X-RAY DIFFRACTION",2.08,41,"VAPOR DIFFUSION, SITTING DROP",7.8,"2.75 M AMMONIUMSULFATE, 0.15 mM P-CHLOROMERCURIBENZOIC ACID, 0.1 M TRIS-HCl, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4FVN",30.01,"1.05","1.05","Carbonic Anhydrase II in complex with N-(tetrahydropyrimidin-2(1H)-ylidene)sulfuric diamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4FVN"
"4FVO",,"X-RAY DIFFRACTION",2.09,41.05,"VAPOR DIFFUSION, SITTING DROP",7.8,"2.75 M AMMONIUMSULFATE, 0.15 mM P-CHLOROMERCURIBENZOIC ACID, 0.1 M TRIS-HCl, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4FVO",30.3,"1.05","1.05","Carbonic Anhydrase II in complex with N-[(2E)-3,4-dihydroquinazolin-2(1H)-ylidene]sulfuric diamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4FVO"
"4FVP",,"X-RAY DIFFRACTION",2.17,43.38,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris/HCl, PEG 4000, pH 8.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1038/nsmb.2348",,"4FVP",33.31,"2.01","2.01","Crystal structure of the Jak2 pseudokinase domain (apo form)","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4FVP"
"4FVQ",,"X-RAY DIFFRACTION",2.21,44.32,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris/HCl, PEG 4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2348","ATP","4FVQ",33.77,"1.75","1.75","Crystal structure of the Jak2 pseudokinase domain (Mg-ATP-bound form)","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4FVQ"
"4FVR",,"X-RAY DIFFRACTION",2.21,44.32,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris/HCl, PEG 4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2348","ATP","4FVR",33.82,"2","2","Crystal structure of the Jak2 pseudokinase domain mutant V617F (Mg-ATP-bound form)","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4FVR"
"4FVT",,"X-RAY DIFFRACTION",3.15,60.99,"VAPOR DIFFUSION, HANGING DROP",5.3,"0.2M lithium sulfate monohydrate, 15% (w/v) poly-ethylene glycol (PEG) 12000, and 0.1 M Bis-Tris, pH 5.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jo301067e",,"4FVT",32.21,"2.47","2.47","Human SIRT3 bound to Ac-ACS peptide and Carba-NAD","KLSLQDVAELIRARACQRVVVMVGAGISTPSGIPDFRSPGSGLYSNLQQYDLPYPEAIFELPFFFHNPKPFFTLAKELYPGNYKPNVTHYFLRLLHDKGLLLRLYTQNIDGLERVSGIPASKLVEAHGTFASATCTVCQRPFPGEDIRADVMADRVPRCPVCTGVVKPDIVFFGEPLPQRFLLHVVDFPMADLLLILGTSLEVEPFASLTEAVRSSVPRLLINRDLVGPLAWHPRSRDVAQLGDVVHGVESLVELLGWTEEMRDLVQRETGKLD","Homo sapiens","SIRT3, SIR2L3","NAD-dependent protein deacetylase sirtuin-3, mitochondrial","1","4FVT"
,,,,,,,,,,,,,,,,"SGKVL",,,"Acetylated ACS2 peptide","2","4FVT"
"4FWE",,"X-RAY DIFFRACTION",2.31,46.68,"EVAPORATION",7,"21% PEG3350, 200mM diammonium citrate, pH 7, EVAPORATION, temperature 289K",289,"10.1038/cr.2012.177",,"4FWE",90.51,"2.13","2.13","Native structure of LSD2 /AOF1/KDM1b in spacegroup of C2221 at 2.13A","GHMAKKKATETTDEDEDGGSEKKYRKCEKAGCTATCPVCFASASERCAKNGYTSRWYHLSCGEHFCNECFDHYYRSHKDGYDKYTTWKKIWTSNGKTEPSPKAFMADQQLPYWVQCTKPECRKWRQLTKEIQLTPQIAKTYRCGMKPNTAIKPETSDHCSLPEDLRVLEVSNHWWYSMLILPPLLKDSVAAPLLSAYYPDCVGMSPSCTSTNRAAATGNASPGKLEHSKAALSVHVPGMNRYFQPFYQPNECGKALCVRPDVMELDELYEFPEYSRDPTMYLALRNLILALWYTNCKEALTPQKCIPHIIVRGLVRIRCVQEVERILYFMTRKGLINTGVLSVGADQYLLPKDYHNKSVIIIGAGPAGLAAARQLHNFGIKVTVLEAKDRIGGRVWDDKSFKGVTVGRGAQIVNGCINNPVALMCEQLGISMHKFGERCDLIQEGGRITDPTIDKRMDFHFNALLDVVSEWRKDKTQLQDVPLGEKIEEIYKAFIKESGIQFSELEGQVLQFHLSNLEYACGSNLHQVSARSWDHNEFFAQFAGDHTLLTPGYSVIIEKLAEGLDIQLKSPVQCIDYSGDEVQVTTTDGTGYSAQKVLVTVPLALLQKGAIQFNPPLSEKKMKAINSLGAGIIEKIALQFPYRFWDSKVQGADFFGHVPPSASKRGLFAVFYDMDPQKKHSVLMSVIAGEAVASVRTLDDKQVLQQCMATLRELFKEQEVPDPTKYFVTRWSTDPWIQMAYSFVKTGGSGEAYDIIAEDIQGTVFFAGEATNRHFPQTVTGAYLSGVREASKIAAF","Homo sapiens","LSD2, KDM1B, AOF1, C6orf193","Lysine-specific histone demethylase 1B","1","4FWE"
"4FWJ",,"X-RAY DIFFRACTION",3.5,64.82,,,,,"10.1038/cr.2012.177",,"4FWJ",180.78,"2.9","2.9","Native structure of LSD2/AOF1/KDM1b in spacegroup of I222 at 2.9A","GHMAKKKATETTDEDEDGGSEKKYRKCEKAGCTATCPVCFASASERCAKNGYTSRWYHLSCGEHFCNECFDHYYRSHKDGYDKYTTWKKIWTSNGKTEPSPKAFMADQQLPYWVQCTKPECRKWRQLTKEIQLTPQIAKTYRCGMKPNTAIKPETSDHCSLPEDLRVLEVSNHWWYSMLILPPLLKDSVAAPLLSAYYPDCVGMSPSCTSTNRAAATGNASPGKLEHSKAALSVHVPGMNRYFQPFYQPNECGKALCVRPDVMELDELYEFPEYSRDPTMYLALRNLILALWYTNCKEALTPQKCIPHIIVRGLVRIRCVQEVERILYFMTRKGLINTGVLSVGADQYLLPKDYHNKSVIIIGAGPAGLAAARQLHNFGIKVTVLEAKDRIGGRVWDDKSFKGVTVGRGAQIVNGCINNPVALMCEQLGISMHKFGERCDLIQEGGRITDPTIDKRMDFHFNALLDVVSEWRKDKTQLQDVPLGEKIEEIYKAFIKESGIQFSELEGQVLQFHLSNLEYACGSNLHQVSARSWDHNEFFAQFAGDHTLLTPGYSVIIEKLAEGLDIQLKSPVQCIDYSGDEVQVTTTDGTGYSAQKVLVTVPLALLQKGAIQFNPPLSEKKMKAINSLGAGIIEKIALQFPYRFWDSKVQGADFFGHVPPSASKRGLFAVFYDMDPQKKHSVLMSVIAGEAVASVRTLDDKQVLQQCMATLRELFKEQEVPDPTKYFVTRWSTDPWIQMAYSFVKTGGSGEAYDIIAEDIQGTVFFAGEATNRHFPQTVTGAYLSGVREASKIAAF","Homo sapiens","LSD2, KDM1B, AOF1, C6orf193","Lysine-specific histone demethylase 1B","1","4FWJ"
"4FWW",,"X-RAY DIFFRACTION",3.03,59.38,"VAPOR DIFFUSION, HANGING DROP",4.6,"19% PEG 4000, 0.1 M Sodium Acetate, pH 4.6, 0.2 M Ammonium Sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0041912",,"4FWW",58.09,"1.85","1.85","Crystal structure of the Sema-PSI extracellular domains of human RON receptor tyrosine kinase","VKYVVPSFSAGGLVQAMVTYEGDRNESAVFVAIRNRLHVLGPDLKSVQSLATGPAGDPGCQTCAACGPGPHGPPGDTDTKVLVLDPALPALVSCGSSLQGRCFLHDLEPQGTAVHLAAPACLFSAHHNRPDDCPDCVASPLGTRVTVVEQGQASYFYVASSLDAAVAASFSPRSVSIRRLKADASGFAPGFVALSVLPKHLVSYSIEYVHSFHTGAFVYFLTVQPASVTDDPSALHTRLARLSATEPELGDYRELVLDCRFAPKLVPRGSPEGGQPYPVLQVAHSAPVGAQLATELSIAEGQEVLFGVFVTGKDGGPGVGPNSVVCAFPIDLLDTLIDEGVERCCESPVHPGLRRGLDFFQSPSFCPNPPGLEALSPNTSCRHFPLLVSSSFSRVDLFNGLLGPVQVTALYVTRLDNVTVAHMGTMDGRILQVELVRSLNYLLYVSNFSLGDSGQPVQRDVSRLGDHLLFASGDQVFQVPIQGPGCRHFLTCGRCLRAWHFMGCGWCGNMCGQQKECPGSWQQDHCP","Homo sapiens","MST1R, PTK8, RON","Macrophage-stimulating protein receptor","1","4FWW"
"4FXF",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, HANGING DROP",7,"10-16% PEG 8000, 100 mM sodium Cacodylate, 50 mM MgCl2, 100 mM KCl, VAPOR DIFFUSION, HANGING DROP, temperature 290K, pH 7",290,"10.1073/pnas.1217157110","FBP","4FXF",243.69,"2.55","2.55","Structure of M2 pyruvate kinase in complex with phenylalanine","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQNLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","OIP3, PK2, PK3, PKM, PKM2, pyruvate Kinase M2","Pyruvate kinase isozymes M1/M2","1","4FXF"
"4FXJ",,"X-RAY DIFFRACTION",2.3,46.56,"VAPOR DIFFUSION, HANGING DROP",7,"10-16% PEG 3350, 100 mM sodium Cacodylate, 50 mM MgCl2, 100 mM KCl, VAPOR DIFFUSION, HANGING DROP, temperature 290K, pH 7",290,"10.1073/pnas.1217157110","PHE","4FXJ",241.79,"2.9","2.9","Structure of M2 pyruvate kinase in complex with phenylalanine","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQNLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","OIP3, PK2, PK3, PKM, PKM2, pyruvate Kinase M2","Pyruvate kinase isozymes M1/M2","1","4FXJ"
"4FXK",,"X-RAY DIFFRACTION",2.99,58.83,,6.4,"0.9 M sodium citrate pH 6.4, 0.25 M potassium chloride, 1% v/v ethanol, 3 % v/v acetonitrile, 6 % v/v 
ethylene glycol and 10 mM spermidine, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1208031109",,"4FXK",190.8,"3.6","3.6","Human complement C4","KPRLLLFSPSVVHLGVPLSVGVQLQDVPRGQVVKGSVFLRNPSRNNVPCSPKVDFTLSSERDFALLSLQVPLKDAKSCGLHQLLRGPEVQLVAHSPWLKDSLSRTTNIQGINLLFSSRRGHLFLQTDQPIYNPGQRVRYRVFALDQKMRPSTDTITVMVENSHGLRVRKKEVYMPSSIFQDDFVIPDISEPGTWKISARFSDGLESNSSTQFEVKKYVLPNFEVKITPGKPYILTVPGHLDEMQLDIQARYIYGKPVQGVAYVRFGLLDEDGKKTFFRGLESQTKLVNGQSHISLSKAEFQDALEKLNMGITDLQGLRLYVAAAIIESPGGEMEEAELTSWYFVSSPFSLDLSKTKRHLVPGAPFLLQALVREMSGSPASGIPVKVSATVSSPGSVPEVQDIQQNTDGSGQVSIPIIIPQTISELQLSVSAGSPHPAIARLTVAAPPSGGPGFLSIERPDSRPPRVGDTLNLNLRAVGSGATFSHYYYMILSRGQIVFMNREPKRTLTSVSVFVDHHLAPSFYFVAFYYHGDHPVANSLRVDVQAGACEGKLELSVDGAKQYRNGESVKLHLETDSLALVALGALDTALYAAGSKSHKPLNMGKVFEAMNSYDLGCGPGGGDSALQVFQAAGLAFSDGDQWTLSRKRLSCPKEKTT","Homo sapiens","C4A, CO4, CPAMD2","Complement C4 Beta chain","1","4FXK"
,,,,,,,,,,,,,,,,"NVNFQKAINEKLGQYASPTAKRCCQDGVTRLPMMRSCEQRAARVQQPDCREPFLSCCQFAESLRKKSRDKGQAGLQRALEILQEEDLIDEDDIPVRSFFPENWLWRVETVDRFQILTLWLPDSLTTWEIHGLSLSKTKGLCVATPVQLRVFREFHLHLRLPMSVRRFEQLELRPVLYNYLDKNLTVSVHVSPVEGLCLAGGGGLAQQVLVPAGSARPVAFSVVPTAAAAVSLKVVARGSFEFPVGDAVSKVLQIEKEGAIHREELVYELNPLDHRGRTLEIPGNSDPNMIPDGDFNSYVRVTASDPLDTLGSEGALSPGGVASLLRLPRGCGEQTMIYLAPTLAASRYLDKTEQWSTLPPETKDHAVDLIQKGYMRIQQFRKADGSYAAWLSRDSSTWLTAFVLKVLSLAQEQVGGSPEKLQETSNWLLSQQQADGSFQDPCPVLDRSMQGGLVGNDETVALTAFVTIALHHGLAVFQDEGAEPLKQRVEASISKANSFLGEKASAGLLGAHAAAITAYALSLTKAPVDLLGVAHNNLMAMAQETGDNLYWGSVTGSQSNAVSPTPAPRNPSDPMPQAPALWIETTAYALLHLLLHEGKAEMADQASAWLTRQGSFQGGFRSTQDTVIALDALSAYWIASHTTEERGLNVTLSSTGRNGFKSHALQLNNRQIRGLEEELQFSLGSKINVKVGGNSKGTLKVLRTYNVLDMKNTTCQDLQIEVTVKGHVEYTMEANEDYEDYEYDELPAKDDPDAPLQPVTPLQLFEG","Homo sapiens","C4A, CO4, CPAMD2","Complement C4-A Alpha chain","2","4FXK"
,,,,,,,,,,,,,,,,"EAPKVVEEQESRVHYTVCIWRNGKVGLSGMAIADVTLLSGFHALRADLEKLTSLSDRYVSHFETEGPHVLLYFDSVPTSRECVGFEAVQEVPVGLVQPASATLYDYYNPERRCSVFYGAPSKSRLLATLCSAEVCQCAEGKCPRQRRALERGLQDEDGYRMKFACYYPRVEYGFQVKVLREDSRAAFRLFETKITQVLHFTKDVKAAANQMRNFLVRASCRLRLEPGKEYLIMGLDGATYDLEGHPQYLLDSNSWIEEMPSERLCRSTRQRAACAQLNDFLQEYGTQGCQV","Homo sapiens","C4A, CO4, CPAMD2","Complement C4 gamma chain","3","4FXK"
"4FXL",,"X-RAY DIFFRACTION",1.91,35.74,"VAPOR DIFFUSION, HANGING DROP",5.5,"18-20% PEG 4000, 20% glycerol, 0.2M ammonium acetate, 0.1 M MES, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1056/NEJMoa1201356",,"4FXL",12.07,"1.4","1.4","Crystal structure of the D76N Beta-2 Microglobulin mutant","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKNEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","4FXL"
"4FXM",,"X-RAY DIFFRACTION",3.23,61.95,"VAPOR DIFFUSION, HANGING DROP",7.2,"15% PEG 400, 0.4M ammonium sulfate, 0.05M lithium cacodylate, 0.05M potassium chloride, 0.01M calcium chloride, , pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ja3088746",,"4FXM",7.68,"1.651","1.651","Crystal structure of the complex of a human telomeric repeat G-quadruplex and N-methyl mesoporphyrin IX (P21212)","AGGGTTAGGGTTAGGGTTAGGG","Homo sapiens",,"DNA (5'-D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*G)-3')","1","4FXM"
"4FXO",,"X-RAY DIFFRACTION",1.8,31.14,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1 M Sodium Acetate pH 4.6, 2M NaCl, 3% EtOH, VAPOR DIFFUSION, SITTING DROP, temperature 100K, temperature 298K",298,"10.1074/jbc.M112.397752",,"4FXO",137.01,"2.85","2.85","Zinc-mediated allosteric inhibiton of caspase-6","MSSASGLRRGHPAGGEENMTETDAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNHHHHHH","Homo sapiens","CASP6, MCH2","Caspase-6","1","4FXO"
"4FXV",,"X-RAY DIFFRACTION",2.35,47.71,"VAPOR DIFFUSION, SITTING DROP",6.3,"0.200M NH4Cl, 20.00% PEG-3350, No Buffer pH 6.3, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4FXV",45.17,"1.9","1.9","Crystal structure of an ELAV-like protein 1 (ELAVL1) from Homo sapiens at 1.90 A resolution","MGSDKIHHHHHHENLYFQGTNLIVNYLPQNMTQDELRSLFSSIGEVESAKLIRDKVAGHSLGYGFVNYVTAKDAERAINTLNGLRLQSKTIKVSYARPS","Homo sapiens","BC003376, ELAVL1, HUR","ELAV-like protein 1","1","4FXV"
"4FXX",,"X-RAY DIFFRACTION",2.47,50.11,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.34 M sodium malonate pH 6.0, 0.1 M imidazole maleate pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2012.10.020",,"4FXX",51.81,"2.4801","2.4801","Structure of SF1 coiled-coil domain","GPLGSTMEQKTVIPGMPTVIPPGLTREQERAYIVQLQIEDLTRKLRTGDLGIPPNPEDRSPSPEPIYNSEGKRLNTREFRTRKKLEEERHNLITEMVALNPDFKPPADYKPP","Homo sapiens","SF1, ZFM1, ZNF162","Splicing factor 1","1","4FXX"
"4FYN",,"X-RAY DIFFRACTION",2.28,45.99,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG 4000, 0.2M ammonium sulfate, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm301367c",,"4FYN",34.27,"2.318","2.318","Crystal structure of spleen tyrosine kinase complexed with 3-(8-{4-[Ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,2-a]pyrazin-5-yl)-phenol","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4FYN"
"4FYO",,"X-RAY DIFFRACTION",2.27,45.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG 4000, 0.2M ammonium sulfate, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm301367c","0VF","4FYO",34.4,"1.4","1.4","Crystal structure of spleen tyrosine kinase complexed with N-{(S)-1-[7-(3,4-Dimethoxy-phenylamino)-thiazolo[5,4-d]pyrimidin-5-yl]-pyrrolidin-3-yl}-terephthalamic acid","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4FYO"
"4FYQ",,"X-RAY DIFFRACTION",4.01,69.33,"hanging drop vapor diffusion",5,"2M ammonium sulfate, 0.1M sodium acetate, 10% glycerol, pH 5.0, hanging drop vapor diffusion, temperature 295K",295,"10.1074/jbc.M112.398842",,"4FYQ",106.77,"1.9","1.9","Human aminopeptidase N (CD13)","PDQSKAWNRYRLPNTLKPDSYRVTLRPYLTPNDRGLYVFKGSSTVRFTCKEATDVIIIHSKKLNYTLSQGHRVVLRGVGGSQPPDIDKTELVEPTEYLVVHLKGSLVKDSQYEMDSEFEGELADDLAGFYRSEYMEGNVRKVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPKDLTALSNMLPKGPSTPLPEDPNWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLIRIWARPSAIAAGHGDYALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLSTPASEINTPAQISELFDAISYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNNRSIQLPTTVRDIMNRWTLQMGFPVITVDTSTGTLSQEHFLLDPDSNVTRPSEFNYVWIVPITSIRDGRQQQDYWLIDVRAQNDLFSTSGNEWVLLNLNVTGYYRVNYDEENWRKIQTQLQRDHSAIPVINRAQIINDAFNLASAHKVPVTLALNNTLFLIEERQYMPWEAALSSLSYFKLMFDRSEVYGPMKNYLKKQVTPLFIHFRNNTNNWREIPENLMDQYSEVNAISTACSNGVPECEEMVSGLFKQWMENPNNNPIHPNLRSTVYCNAIAQGGEEEWDFAWEQFRNATLVNEADKLRAALACSKELWILNRYLSYTLNPDLIRKQDATSTIISITNNVIGQGLVWDFVQSNWKKLFNDYGGGSFSFSNLIQAVTRRFSTEYELQQLEQFKKDNEETGFGSGTRALEQALEKTKANIKWVKENKEVVLQWFTENSK","Homo sapiens","ANPEP, APN, CD13, PEPN","Aminopeptidase N","1","4FYQ"
"4FYR",,"X-RAY DIFFRACTION",4.01,69.33,"hanging drop vapor diffusion",5,"2M ammonium sulfate, 0.1M sodium acetate, 10% glycerol, pH 5.0, hanging drop vapor diffusion, temperature 295K",295,"10.1074/jbc.M112.398842","BES","4FYR",107.2,"1.91","1.91","Human aminopeptidase N (CD13) in complex with bestatin","PDQSKAWNRYRLPNTLKPDSYRVTLRPYLTPNDRGLYVFKGSSTVRFTCKEATDVIIIHSKKLNYTLSQGHRVVLRGVGGSQPPDIDKTELVEPTEYLVVHLKGSLVKDSQYEMDSEFEGELADDLAGFYRSEYMEGNVRKVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPKDLTALSNMLPKGPSTPLPEDPNWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLIRIWARPSAIAAGHGDYALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLSTPASEINTPAQISELFDAISYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNNRSIQLPTTVRDIMNRWTLQMGFPVITVDTSTGTLSQEHFLLDPDSNVTRPSEFNYVWIVPITSIRDGRQQQDYWLIDVRAQNDLFSTSGNEWVLLNLNVTGYYRVNYDEENWRKIQTQLQRDHSAIPVINRAQIINDAFNLASAHKVPVTLALNNTLFLIEERQYMPWEAALSSLSYFKLMFDRSEVYGPMKNYLKKQVTPLFIHFRNNTNNWREIPENLMDQYSEVNAISTACSNGVPECEEMVSGLFKQWMENPNNNPIHPNLRSTVYCNAIAQGGEEEWDFAWEQFRNATLVNEADKLRAALACSKELWILNRYLSYTLNPDLIRKQDATSTIISITNNVIGQGLVWDFVQSNWKKLFNDYGGGSFSFSNLIQAVTRRFSTEYELQQLEQFKKDNEETGFGSGTRALEQALEKTKANIKWVKENKEVVLQWFTENSK","Homo sapiens","ANPEP, APN, CD13, PEPN","Aminopeptidase N","1","4FYR"
"4FYT",,"X-RAY DIFFRACTION",3.97,69.04,"hanging drop vapor diffusion",5,"2M ammonium sulfate, 0.1M sodium acetate, 10% glycerol, pH 5.0, hanging drop vapor diffusion, temperature 295K",295,"10.1074/jbc.M112.398842",,"4FYT",107.32,"1.85","1.85","Human aminopeptidase N (CD13) in complex with amastatin","PDQSKAWNRYRLPNTLKPDSYRVTLRPYLTPNDRGLYVFKGSSTVRFTCKEATDVIIIHSKKLNYTLSQGHRVVLRGVGGSQPPDIDKTELVEPTEYLVVHLKGSLVKDSQYEMDSEFEGELADDLAGFYRSEYMEGNVRKVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPKDLTALSNMLPKGPSTPLPEDPNWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLIRIWARPSAIAAGHGDYALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLSTPASEINTPAQISELFDAISYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNNRSIQLPTTVRDIMNRWTLQMGFPVITVDTSTGTLSQEHFLLDPDSNVTRPSEFNYVWIVPITSIRDGRQQQDYWLIDVRAQNDLFSTSGNEWVLLNLNVTGYYRVNYDEENWRKIQTQLQRDHSAIPVINRAQIINDAFNLASAHKVPVTLALNNTLFLIEERQYMPWEAALSSLSYFKLMFDRSEVYGPMKNYLKKQVTPLFIHFRNNTNNWREIPENLMDQYSEVNAISTACSNGVPECEEMVSGLFKQWMENPNNNPIHPNLRSTVYCNAIAQGGEEEWDFAWEQFRNATLVNEADKLRAALACSKELWILNRYLSYTLNPDLIRKQDATSTIISITNNVIGQGLVWDFVQSNWKKLFNDYGGGSFSFSNLIQAVTRRFSTEYELQQLEQFKKDNEETGFGSGTRALEQALEKTKANIKWVKENKEVVLQWFTENSK","Homo sapiens","ANPEP, APN, CD13, PEPN","Aminopeptidase N","1","4FYT"
,,,,,,,,,,,,,,,,"XVVD",,,"AMASTATIN","2","4FYT"
"4FZ5",,"X-RAY DIFFRACTION",2.95,58.26,"EVAPORATION",8.5,"5%(v/v) PEG200, 0.1M TRIS, pH8.5, EVAPORATION, temperature 298K",298,,,"4FZ5",33.66,"3.6","3.6","Crystal Structure of Human TIRAP TIR-domain","GSHMTHASDSGSSRWSKDYDVCVCHSEEDLVAAQDLVSYLEGSTASLRCFLQLRDATPGGAIVSELCQALSSSHCRVLLITPGFLQDPWCKYQMLQALTEAPGAEGCTIPLLSGLSRAAYPPELRFMYYVDGRGPDGGFRQVKEAVMRYLQTLS","Homo sapiens","TIRAP, MAL","Toll/interleukin-1 receptor domain-containing adapter protein","1","4FZ5"
"4FZ6",,"X-RAY DIFFRACTION",2.26,45.52,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG 4000, 0.2M ammonium sulfate, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm301367c","0VG","4FZ6",34.25,"1.85","1.85","Crystal structure of spleen tyrosine kinase complexed with [6-((S)-2-Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-imidazo[1,2-b]pyridazin-8-yl)-amine","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4FZ6"
"4FZ7",,"X-RAY DIFFRACTION",2.2,44.13,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG 4000, 0.2M ammonium sulfate, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm401982j","0VH","4FZ7",34.24,"1.75","1.75","Crystal structure of spleen tyrosine kinase complexed with 6-((1R,2S)-2-Amino-cyclohexylamino)-4-(6-ethyl-pyridin-2-ylamino)-pyridazine-3-carboxylic acid amide","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4FZ7"
"4FZ8",,"X-RAY DIFFRACTION",2.6,52.61,,7.5,"0.14 M sodium citrate, 0.07 M HEPES sodium pH 7.5, 14% isopropanol, and 30% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1128/mBio.00208-20",,"4FZ8",49.4,"2.66","2.66","Crystal structure of C11 Fab, an ADCC mediating anti-HIV-1 antibody.","EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGRGLEWVSSISNTSTYIYYADSVEGRFTLSRDNAKNSLYLQMNSLRAEDTAVYYCARANQHFDWLLSLLGGYHYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKT","Homo sapiens",,"FAB heavy chain of human ANTI-HIV-1 ENV ANTIBODY C11","1","4FZ8"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFIGSGSGTDFTLKISRVEAEDVGVFYCMQALQAVGFGPGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"FAB light chain of human ANTI-HIV-1 ENV ANTIBODY C11","2","4FZ8"
"4FZE",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M ammonium sulfate, 0.1 M sodium cacodylate pH 6.5, and 30% PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,,,"4FZE",47.07,"1.999","1.999","Crystal structure of N26_i1 Fab, an ADCC mediating anti-HIV-1 antibody.","QSVLTQPPSVSVSPGQTASITCSGDNLRDGYASWYQQKPGQSPVLVIYRDDKRPSGIPERFSGSSSGNTAILTLSGAQAMDEADYYCQAWASTTVIFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"N26_i1 Fab light chain","1","4FZE"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGSSAKVSCKASRGTLSSYFISWVRQAPGQGLEWLGGITPLLGTANYAQKFQGRVTITADKSTNTAFMQLSSLTSDDTAVYYCAGTVYYDILTGLYTNFHYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"N26_i1 Fab heavy chain","2","4FZE"
"4FZS",,"X-RAY DIFFRACTION",3.06,59.83,"VAPOR DIFFUSION, SITTING DROP",8.1,"1-3% PEG 20K, 0.1 M Tris pH 8.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4FZS",53.05,"2.8","2.8","Structure of human SNX1 BAR domain","GAKMNESDIWFEEKLQEVECEEQRLRKLHAVVETLVNHRKELALNTAQFAKSLAMLGSSEDNTALSRALSQLAEVEEKIEQLHQEQANNDFFLLAELLSDYIRLLAIVRAAFDQRMKTWQRWQDAQATLQKKREAEARLLWANKPDKLQQAKDEILEWESRVTQYERDFERISTVVRKEVIRFEKEKSKDFKNHVIKYLETLLYSQQQLAKYWEAFLPEAKAIS","Homo sapiens","SNX1","Sorting nexin-1","1","4FZS"
"4G03",,"X-RAY DIFFRACTION",2.29,46.39,"VAPOR DIFFUSION",7,"28-30% (w/v) PEG 3350, Sigma-Aldrich, 50mM potassium phosphate, pH 7.0, VAPOR DIFFUSION, temperature 291K",291,,,"4G03",133.14,"2.216","2.216","High-resolution Crystal Structural Variance Analysis between Recombinant and Wild-type Human Serum Albumin","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","4G03"
"4G04",,"X-RAY DIFFRACTION",2.3,46.58,"VAPOR DIFFUSION",7,"28-30% (w/v), PEG3350, Sigma-Aldrich), 50mM potassium phosphate, pH 7.0, VAPOR DIFFUSION, temperature 291K",291,,,"4G04",133.14,"2.301","2.301","High-resolution Crystal Structural Variance Analysis between Recombinant and Wild-type Human Serum Albumin","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","4G04"
"4G0C",,"NEUTRON DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",9,"1.3 M sodium citrate, 100 mM Tris, 1mM acetazolamide dissolved in DMSO (final), pH 9, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/ja3068098","AZM","4G0C",29.22,"2","2","Neutron structure of acetazolamide-bound human carbonic anhydrase II reveal molecular details of drug binding.","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4G0C"
"4G0D",,"X-RAY DIFFRACTION",2.92,57.89,"SLOW COOLING",7.5,"propeptide impurity induces crystallization on cold storage Cryoprotectant: 10% PEG 10K, 5% di-ethylene glycol, 20% 1.2-propanediol, 5% glycerol, .2 M NaCl, 10% PCTP buffer 8:2 ratio, pH 7.5, SLOW COOLING, temperature 277.0K",277,"10.1096/fj.13-233601",,"4G0D",187.08,"2.54","2.54","Human collagenase 3 (MMP-13) full form with peptides from pro-domain","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHAFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPNPKHPKTPDKCDPSLSLDAITSLRGETMIFKDRFFWRLHPQQVDAELFLTKSFWPELPNRIDAAYEHPSHDLIFIFRGRKFWALNGYDILEGYPKKISELGLPKEVKKISAAVHFEDTGKTLLFSGNQVWRYDDTNHIMDKDYPRLIEEDFPGIGDKVDAVYEKNGYIYFFNGPIQFEYSIWSNRIVRVMPANSILWC","Homo sapiens","MMP13","Collagenase 3","1","4G0D"
,,,,,,,,,,,,,,,,"GGDEDDLSEEDLQFAERYLRSYYHPT","Homo sapiens","MMP13","Collagenase 3, pro-domain peptide","2","4G0D"
"4G0F",,"X-RAY DIFFRACTION",3.61,65.91,"VAPOR DIFFUSION, HANGING DROP",7.2,"50mM lithium cacodylate, 0.625M ammonium acetate, 200mM KCl, 15% PEG400, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ja3088746",,"4G0F",7.68,"2.15","2.15","Crystal structure of the complex of a human telomeric repeat G-quadruplex and N-methyl mesoporphyrin IX (P6)","AGGGTTAGGGTTAGGGTTAGGG","Homo sapiens",,"DNA (5'-D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*G)-3')","1","4G0F"
"4G0U",,"X-RAY DIFFRACTION",3.1,60.27,"VAPOR DIFFUSION, HANGING DROP",5.8,"100mM magnesium acetate, 50mM 2-(N-morpholino)ethanesulfonic acid pH 5.8, 22% 2-methyl-2,4-pentanediol (MPD), VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkt828","ASW","4G0U",196.97,"2.7","2.7","Human topoisomerase IIbeta in complex with DNA and amsacrine","MASWSHPQFEKGADDDDKVPDPTSVDSVKYSKIKGIPKLDDANDAGGKHSLECTLILTEGDSAKSLAVSGLGVIGRDRYGVFPLRGKILNVREASHKQIMENAEINNIIKIVGLQYKKSYDDAESLKTLRYGKIMIMTDQDQDGSHIKGLLINFIHHNWPSLLKHGFLEEFITPIVKASKNKQELSFYSIPEFDEWKKHIENQKAWKIKYYKGLGTSTAKEAKEYFADMERHRILFRYAGPEDDAAITLAFSKKKIDDRKEWLTNFMEDRRQRRLHGLPEQFLYGTATKHLTYNDFINKELILFSNSDNERSIPSLVDGFKPGQRKVLFTCFKRNDKREVKVAQLAGSVAEMSAYHHGEQALMMTIVNLAQNFVGSNNINLLQPIGQFGTRLHGGKDAASPRYIFTMLSTLARLLFPAVDDNLLKFLYDDNQRVEPEWYIPIIPMVLINGAEGIGTGWACKLPNYDAREIVNNVRRMLDGLDPHPMLPNYKNFKGTIQELGQNQYAVSGEIFVVDRNTVEITELPVRTWTQVYKEQVLEPMLNGTDKTPALISDYKEYHTDTTVKFVVKMTEEKLAQAEAAGLHKVFKLQTTLTCNSMVLFDHMGCLKKYETVQDILKEFFDLRLSYYGLRKEWLVGMLGAESTKLNNQARFILEKIQGKITIENRSKKDLIQMLVQRGYESDPVKAWKEAQEKAAEEDETQNQHDDSSSDSGTPSGPDFNYILNMSLWSLTKEKVEELIKQRDAKGREVNDLKRKSPSDLWKEDLAAFVEELDKVESQEREDGAPGFSSISAHHHHHHHHHH","Homo sapiens","TOP2B","DNA topoisomerase 2-beta","1","4G0U"
,,,,,,,,,,,,,,,,"AGCCGAGC",,,"DNA (5'-D(P*AP*GP*CP*CP*GP*AP*GP*C)-3')","2","4G0U"
,,,,,,,,,,,,,,,,"TGCAGCTCGGCT",,,"DNA (5'-D(P*TP*GP*CP*AP*GP*CP*TP*CP*GP*GP*CP*T)-3')","3","4G0U"
"4G0V",,"X-RAY DIFFRACTION",3.16,61.13,"VAPOR DIFFUSION, HANGING DROP",5.8,"100mM magnesium acetate, 50mM 2-(N-morpholino)ethanesulfonic acid pH 5.8, 22% 2-methyl-2,4-pentanediol (MPD), VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkt828",,"4G0V",197.07,"2.548","2.548","Human topoisomerase iibeta in complex with DNA and mitoxantrone","MASWSHPQFEKGADDDDKVPDPTSVDSVKYSKIKGIPKLDDANDAGGKHSLECTLILTEGDSAKSLAVSGLGVIGRDRYGVFPLRGKILNVREASHKQIMENAEINNIIKIVGLQYKKSYDDAESLKTLRYGKIMIMTDQDQDGSHIKGLLINFIHHNWPSLLKHGFLEEFITPIVKASKNKQELSFYSIPEFDEWKKHIENQKAWKIKYYKGLGTSTAKEAKEYFADMERHRILFRYAGPEDDAAITLAFSKKKIDDRKEWLTNFMEDRRQRRLHGLPEQFLYGTATKHLTYNDFINKELILFSNSDNERSIPSLVDGFKPGQRKVLFTCFKRNDKREVKVAQLAGSVAEMSAYHHGEQALMMTIVNLAQNFVGSNNINLLQPIGQFGTRLHGGKDAASPRYIFTMLSTLARLLFPAVDDNLLKFLYDDNQRVEPEWYIPIIPMVLINGAEGIGTGWACKLPNYDAREIVNNVRRMLDGLDPHPMLPNYKNFKGTIQELGQNQYAVSGEIFVVDRNTVEITELPVRTWTQVYKEQVLEPMLNGTDKTPALISDYKEYHTDTTVKFVVKMTEEKLAQAEAAGLHKVFKLQTTLTCNSMVLFDHMGCLKKYETVQDILKEFFDLRLSYYGLRKEWLVGMLGAESTKLNNQARFILEKIQGKITIENRSKKDLIQMLVQRGYESDPVKAWKEAQEKAAEEDETQNQHDDSSSDSGTPSGPDFNYILNMSLWSLTKEKVEELIKQRDAKGREVNDLKRKSPSDLWKEDLAAFVEELDKVESQEREDGAPGFSSISAHHHHHHHHHH","Homo sapiens","TOP2B","DNA topoisomerase 2-beta","1","4G0V"
,,,,,,,,,,,,,,,,"AGCCGAGC",,,"DNA (5'-D(P*AP*GP*CP*CP*GP*AP*GP*C)-3')","2","4G0V"
,,,,,,,,,,,,,,,,"TGCAGCTCGGCT",,,"DNA (5'-D(P*TP*GP*CP*AP*GP*CP*TP*CP*GP*GP*CP*T)-3')","3","4G0V"
"4G0W",,"X-RAY DIFFRACTION",3.15,60.95,"VAPOR DIFFUSION, HANGING DROP",5.8,"100mM magnesium acetate, 50mM 2-(N-morpholino)ethanesulfonic acid pH 5.8, 22% 2-methyl-2,4-pentanediol (MPD) , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkt828",,"4G0W",197.01,"2.696","2.696","Human topoisomerase iibeta in complex with DNA and ametantrone","MASWSHPQFEKGADDDDKVPDPTSVDSVKYSKIKGIPKLDDANDAGGKHSLECTLILTEGDSAKSLAVSGLGVIGRDRYGVFPLRGKILNVREASHKQIMENAEINNIIKIVGLQYKKSYDDAESLKTLRYGKIMIMTDQDQDGSHIKGLLINFIHHNWPSLLKHGFLEEFITPIVKASKNKQELSFYSIPEFDEWKKHIENQKAWKIKYYKGLGTSTAKEAKEYFADMERHRILFRYAGPEDDAAITLAFSKKKIDDRKEWLTNFMEDRRQRRLHGLPEQFLYGTATKHLTYNDFINKELILFSNSDNERSIPSLVDGFKPGQRKVLFTCFKRNDKREVKVAQLAGSVAEMSAYHHGEQALMMTIVNLAQNFVGSNNINLLQPIGQFGTRLHGGKDAASPRYIFTMLSTLARLLFPAVDDNLLKFLYDDNQRVEPEWYIPIIPMVLINGAEGIGTGWACKLPNYDAREIVNNVRRMLDGLDPHPMLPNYKNFKGTIQELGQNQYAVSGEIFVVDRNTVEITELPVRTWTQVYKEQVLEPMLNGTDKTPALISDYKEYHTDTTVKFVVKMTEEKLAQAEAAGLHKVFKLQTTLTCNSMVLFDHMGCLKKYETVQDILKEFFDLRLSYYGLRKEWLVGMLGAESTKLNNQARFILEKIQGKITIENRSKKDLIQMLVQRGYESDPVKAWKEAQEKAAEEDETQNQHDDSSSDSGTPSGPDFNYILNMSLWSLTKEKVEELIKQRDAKGREVNDLKRKSPSDLWKEDLAAFVEELDKVESQEREDGAPGFSSISAHHHHHHHHHH","Homo sapiens","TOP2B","DNA topoisomerase 2-beta","1","4G0W"
,,,,,,,,,,,,,,,,"AGCCGAGC",,,"DNA (5'-D(P*AP*GP*CP*CP*GP*AP*GP*C)-3')","2","4G0W"
,,,,,,,,,,,,,,,,"TGCAGCTCGGCT",,,"DNA (5'-D(P*TP*GP*CP*AP*GP*CP*TP*CP*GP*GP*CP*T)-3')","3","4G0W"
"4G11",,"X-RAY DIFFRACTION",2.25,45.38,"VAPOR DIFFUSION, HANGING DROP",,"22% PEG3350, 0.2M Na Malonate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2012.08.072","0W7","4G11",111.04,"3.4","3.4","X-ray structure of PI3K-gamma bound to a 4-(morpholin-4-yl)- (6-oxo-1,6-dihydropyrimidin-2-yl)amide inhibitor","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4G11"
"4G16",,"X-RAY DIFFRACTION",2.74,55.08,"VAPOR DIFFUSION, HANGING DROP",9,"100 mM Tris, 0.2 M MgCl2, 2.5-15% PEG10K, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.07.046","0VM","4G16",38.86,"2.3","2.3","Crystal structure of ck1g3 with 2-[(4-{[3-(TRIFLUOROMETHYL)PYRIDIN2-YL]OXY}PHENYL)AMINO]-1H-BENZIMIDAZOLE-6-CARBONITRILE","GSGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGAVQQDPALSSNREAHQHRDKMQQSKNQ","Homo sapiens","CSNK1G3","Casein kinase I isoform gamma-3","1","4G16"
"4G17",,"X-RAY DIFFRACTION",2.78,55.74,"VAPOR DIFFUSION, HANGING DROP",9,"100 mM Tris, 0.2 M MgCl2, 2.5-15% PEG10K, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.07.046","0VN","4G17",38.76,"2.1","2.1","Crystal structure of ck1g3 with 2-[(4-TERT-BUTYLPHENYL)AMINO]-1H-BENZIMIDAZOLE-6-CARBONITRILE","GSGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGAVQQDPALSSNREAHQHRDKMQQSKNQ","Homo sapiens","CSNK1G3","Casein kinase I isoform gamma-3","1","4G17"
"4G1C",,"X-RAY DIFFRACTION",2.29,46.28,"VAPOR DIFFUSION, HANGING DROP",7.6,"0.15 M magnesium formate, and 20% (w/v) PEG 3350, pH 7.6, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jo301067e",,"4G1C",60.13,"1.944","1.944","Human SIRT5 bound to Succ-IDH2 and Carba-NAD","PSSSMADFRKFFAKAKHIVIISGAGVSAESGVPTFRGAGGYWRKWQAQDLATPLAFAHNPSRVWEFYHYRREVMGSKEPNAGHRAIAECETRLGKQGRRVVVITQNIDELHRKAGTKNLLEIHGSLFKTRCTSCGVVAENYKSPICPALSGKGAPEPGTQDASIPVEKLPRCEEAGCGGLLRPHVVWFGENLDPAILEEVDRELAHCDLCLVVGTSSVVYPAAMFAPQVAARGVPVAEFNTETTPATNRFRFHFQGPCGTTLPEALA","Homo sapiens","SIRT5, SIR2L5","NAD-dependent protein deacylase sirtuin-5, mitochondrial","1","4G1C"
,,,,,,,,,,,,,,,,"XAVXCAX",,,"Succinylated IDH2 peptide","2","4G1C"
"4G1F",,"X-RAY DIFFRACTION",2.8,56.09,"VAPOR DIFFUSION, SITTING DROP",7.8,"22.5% PEG 200mme, 0.1M Bicine pH 7.8  , VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.08.110","0WG","4G1F",349.44,"2.9","2.9","Crystal Structure of human Dipeptidyl Peptidase IV in complex with a pyridopyrimidinedione analogue","ADPGGSHHHHHHSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","ADCP2, CD26, DPP4","Dipeptidyl peptidase 4","1","4G1F"
"4G1N",,"X-RAY DIFFRACTION",2.52,51.14,"EVAPORATION",7.8,"0.1 M Imidazole pH 7.8, 20 %(w/v) PEG 6000, 15 mg/ml PKM2, EVAPORATION, temperature 291K",291,"10.1016/j.chembiol.2012.07.021",,"4G1N",228.03,"2.3","2.3","PKM2 in complex with an activator","QTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM2, OIP3, PK2, PK3, PKM","Pyruvate kinase isozymes M1/M2","1","4G1N"
"4G1T",,"X-RAY DIFFRACTION",2.71,54.66,"VAPOR DIFFUSION, HANGING DROP",7.4,"PEG, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/cr.2012.111",,"4G1T",109.46,"2.8","2.8","Crystal structure of interferon-stimulated gene 54","MSENNKNSLESSLRQLKCHFTWNLMEGENSLDDFEDKVFYRTEFQNREFKATMCNLLAYLKHLKGQNEAALECLRKAEELIQQEHADQAEIRSLVTWGNYAWVYYHMGRLSDVQIYVDKVKHVCEKFSSPYRIESPELDCEEGWTRLKCGGNQNERAKVCFEKALEKKPKNPEFTSGLAIASYRLDNWPPSQNAIDPLRQAIRLNPDNQYLKVLLALKLHKMREEGEEEGEGEKLVEEALEKAPGVTDVLRSAAKFYRRKDEPDKAIELLKKALEYIPNNAYLHCQIGCCYRAKVFQVMNLRENGMYGKRKLLELIGHAVAHLKKADEANDNLFRVCSILASLHALADQYEEAEYYFQKEFSKELTPVAKQLLHLRYGNFQLYQMKCEDKAIHHFIEGVKINQKSREKEKMKDKLQKIAKMRLSKNGADSEALHVLAFLQELNEKMQQADEDSERGLESGSLIPSASSWNGE","Homo sapiens","IFIT2, G10P2, IFI54, CIG-42, ISG54","Interferon-induced protein with tetratricopeptide repeats 2","1","4G1T"
"4G2F",,"X-RAY DIFFRACTION",1.86,33.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate pH 6.5, 0.15M ammonium sulfate, 22.5% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ml3001984","C07","4G2F",40.78,"1.699","1.699","Human EphA3 kinase domain in complex with compound 7","MGSSHHHHHHSSGLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","EPH receptor A3","1","4G2F"
"4G2I",,"X-RAY DIFFRACTION",2.59,52.56,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M Mes and 1.4 M ammonium sulphate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm300858s",,"4G2I",29.88,"1.8","1.8","Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor","DSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","4G2I"
"4G2J",,"X-RAY DIFFRACTION",4.67,73.66,,,,,"10.1021/jm3009635","0WF","4G2J",78.66,"2.4","2.4","Human pde9 in complex with selective compound","GSHMTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","4G2J"
"4G2L",,"X-RAY DIFFRACTION",4.73,73.97,,,,,"10.1021/jm3009635","0WL","4G2L",78.64,"3","3","Human PDE9 in complex with selective compound","GSHMTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","4G2L"
"4G2O",,"X-RAY DIFFRACTION",3,58.97,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris pH 7.5-8.5, 20 mM BME, 25-42% Ammonium Sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"4G2O",36.28,"2.25","2.25","Human Thymidylate Synthase M190K with bound Purpurogallin","MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLKALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","OK/SW-cl.29, TS, TYMS","Thymidylate synthase","1","4G2O"
"4G2W",,"X-RAY DIFFRACTION",2.62,53.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M MgSO4, 100mM Tris HCl, 20% PEG 3350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301159y","NI0","4G2W",40.74,"2.28","2.28","Crystal structure of PDE5A in complex with its inhibitor","MGSSHHHHHHSSGLVPRGSHMEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5, PDE5A","cGMP-specific 3',5'-cyclic phosphodiesterase","1","4G2W"
"4G2Y",,"X-RAY DIFFRACTION",2.68,54.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M MgSO4, 100mM Tris-HCl, 20% PEG 3350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301159y","NI5","4G2Y",40.72,"2.4","2.4","Crystal structure of PDE5A complexed with its inhibitor","MGSSHHHHHHSSGLVPRGSHMEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5, PDE5A","cGMP-specific 3',5'-cyclic phosphodiesterase","1","4G2Y"
"4G31",,"X-RAY DIFFRACTION",3.37,63.48,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM BTP, pH 7.0, 3.5-4.9 M linear gradient of ammonium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm300713s","0WH","4G31",35.34,"2.28","2.28","Crystal Structure of GSK6414 Bound to PERK (R587-R1092, delete A660-T867) at 2.28 A Resolution","GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR","Homo sapiens","EIF2AK3, PEK, PERK","Eukaryotic translation initiation factor 2-alpha kinase 3","1","4G31"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK3, PEK, PERK"
"4G34",,"X-RAY DIFFRACTION",3.38,63.61,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM BTP, pH 7.0, 3.5 - 4.9 M linear gradient of ammonium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm300713s","924","4G34",35.18,"2.7","2.7","Crystal Structure of GSK6924 Bound to PERK (R587-R1092, delete A660-T867) at 2.70 A Resolution","GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR","Homo sapiens","EIF2AK3, PEK, PERK","Eukaryotic translation initiation factor 2-alpha kinase 3","1","4G34"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK3, PEK, PERK"
"4G3D",,"X-RAY DIFFRACTION",2.36,47.97,"VAPOR DIFFUSION, HANGING DROP",6.5,"1:1 protein and well solution of 100 mM imidazole (pH 6.5), 1 M sodium acetate tri-hydrate, 7.5% 1,6-hexanediol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2012.07.013",,"4G3D",162.92,"2.9","2.9","Crystal structure of human NF-kappaB inducing kinase (NIK)","GSDSPKPLPGPHLEPSCLSRGAHEKFSVEEYLVHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRGNS","Homo sapiens","MAP3K14, NF-kappaB inducing kinase (NIK), NIK","NF-kappa-beta-inducing kinase","1","4G3D"
"4G3O",,"X-RAY DIFFRACTION",2.06,40.35,"VAPOR DIFFUSION, HANGING DROP",8,"0.056 M sodium phosphate, 1.344 M potassium phosphate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,,,"4G3O",6.66,"1.6","1.6","Crystal structure of the CUE domain of the E3 ubiquitin ligase AMFR (gp78)","GSMGYRGSENLYFQGQLNAMAHQIQEMFPQVPYHLVLQDLQLTRSVEITTDNILEGRI","Homo sapiens","AMFR, RNF45","E3 ubiquitin-protein ligase AMFR","1","4G3O"
"4G55",,"X-RAY DIFFRACTION",2.62,53.12,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG 3350, 150 MM POTASSIUM ACETATE, 0.1 M TRIS, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.cell.2011.06.025","VH2","4G55",42.73,"1.69","1.69","Clathrin terminal domain complexed with pitstop 2","GSPEFMAQILPIRFQEHLQLQNLGINPANIGFSTLTMESDKFICIREKVGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASKVIALKAGKTLQIFNIEMKSKMKAHTMTDDVTFWKWISLNTVALVTDNAVYHWSMEGESQPVKMFDRHSSLAGCQIINYRTDAKQKWLLLTGISAQQNRVVGAMQLYSVDRKVSQPIEGHAASFAQFKMEGNAEESTLFCFAVRGQAGGKLHIIEVGTPPTGNQPFPKKAVDVFFPPEAQNDFPVAMQISEKHDVVFLITKYGYIHLYDLETGTCIYMNRISGETIFVTAPHEATAGIIGVNRKGQVLSVCVEEENIIPYITNVLQNPDLALRMAVRNNLAGAEELF","Homo sapiens","CLH17, CLTC, CLTCL2, KIAA0034","Clathrin heavy chain 1","1","4G55"
"4G5J",,"X-RAY DIFFRACTION",3.48,64.67,,,,,"10.1124/jpet.112.197756","0WM","4G5J",39.04,"2.8","2.8","Crystal structure of EGFR kinase in complex with BIBW2992","GSMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4G5J"
"4G5P",,"X-RAY DIFFRACTION",2.61,52.93,,,,,"10.1124/jpet.112.197756",,"4G5P",75.71,"3.17","3.17","Crystal structure of EGFR kinase T790M in complex with BIBW2992","GSMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4G5P"
"4G5Z",,"X-RAY DIFFRACTION",2.24,45.15,"VAPOR DIFFUSION, SITTING DROP",8.5,"crystal grown in 11% w/v PEG 3350 and 0.14M Tris-HCL equilibrated against a reservoir solution of 24% w/v PEG 3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2012.09.021",,"4G5Z",46.5,"1.83","1.83","Crystal structure of the therapeutical antibody fragment of canakinumab in its unbound state","QVQLVESGGGVVQPGRSLRLSCAASGFTFSVYGMNWVRQAPAKGLEWVAIIWYDGDNQYYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTAVYYCARDLRTGPFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVAP","Homo sapiens",,"canakinumab antibody fragment heavy chain","1","4G5Z"
,,,,,,,,,,,,,,,,"EIVLTQSPDFQSVTPKEKVTITCRASQSIGSSLHWYQQKPDQSPKLLIKYASQSFSGVPSRFSGSGSGTDFTLTINSLEAEDAAAYYCHQSSSLPFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG","Homo sapiens",,"canakinumab antibody fragment light chain","2","4G5Z"
"4G6N",,"X-RAY DIFFRACTION",2.32,46.96,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,"EK0","4G6N",41.95,"2","2","Crystal Structure of the ERK2","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4G6N"
"4G6O",,"X-RAY DIFFRACTION",2.33,47.25,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,,,"4G6O",42.42,"2.2","2.2","Crystal Structure of the ERK2","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4G6O"
"4G6W",,"X-RAY DIFFRACTION",3.01,59.13,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris pH 7.5-8.5, 20 mM BME, 25-42% Ammonium Sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"4G6W",36.27,"2.3","2.3","Human Thymidylate Synthase M190K with bound 4-Bromobenzene-1,2,3-triol","MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLKALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","4G6W"
"4G82",,"X-RAY DIFFRACTION",2.84,56.74,,9,"0.1M TRIS, 20% PEG3350 , pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"4G82",53.77,"3.1","3.1","Crystal Structure of p73 DNA-Binding Domain Tetramer bound to a Full Response-Element","MGHHHHHHHHEFIPSNTDYPGPHHFEVTFQQSSTAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDFNEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRICACPGRDRKADEDHYREQ","Homo sapiens","human, P73, TP73","Tumor protein p73","1","4G82"
,,,,,,,,,,,,,,,,"GAACATGTTC",,,"DNA (5'-D(P*GP*AP*AP*CP*AP*TP*GP*TP*TP*C)-3')","2","4G82"
"4G83",,"X-RAY DIFFRACTION",1.96,37.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M BTP, 20% PEG3350 , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"4G83",59.95,"4","4","Crystal Structure of p73 DNA-Binding Domain Tetramer bound to a Full Response-Element","GAACCGGTTCGAACCGGTTC",,,"dna","1","4G83"
,,,,,,,,,,,,,,,,"MGHHHHHHHHEFIPSNTDYPGPHHFEVTFQQSSTAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDFNEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRICACPGRDRKADEDHYREQ","Homo sapiens","HUMAN, P73, TP73","Tumor protein p73","2","4G83"
"4G84",,"X-RAY DIFFRACTION",2.65,53.58,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M imidazole 
20% v/v PEGMME550, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.str.2012.08.001",,"4G84",105.26,"2.4","2.4","Crystal structure of human HisRS","GPGSEFELRRQFVLKTPKGTRDYSPRQMAVREKVFDVIIRCFKRHGAEVIDTPVFELKETLMGKYGEDSKLIYDLKDQGGELLSLRYDLTVPFARYLAMNKLTNIKRYHIAKVYRRDNPAMTRGRYREFYQCDFDIAGNFDPMIPDAECLKIMCEILSSLQIGDFLVKVNDRRILDGMFAICGVSDSKFRTICSSVDKLDKVSWEEVKNEMVGEKGLAPEVADRIGDYVQQHGGVSLVEQLLQDPKLSQNKQALEGLGDLKLLFEYLTLFGIDDKISFDLSLARGLDYYTGVIYEAVLLQTPAQAGEEPLGVGSVAAGGRYDGLVGMFDPKGRKVPCVGLSIGVERIFSIVEQRLEALEEKIRTTETQVLVASAQKKLLEERLKLVSELWDAGIKAELLYKKNPKLLNQLQYCEEAGIPLVAIIGEQELKDGVIKLRSVTSREEVDVRREDLVEEIKRRTGQPL","Homo sapiens","HARS, HRS, HARS1","Histidine--tRNA ligase, cytoplasmic","1","4G84"
"4G85",,"X-RAY DIFFRACTION",2.78,55.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M ammonium citrate 
20% PEGMME 2000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.str.2012.08.001",,"4G85",116.86,"3.11","3.11","Crystal structure of human HisRS","GPGSEFELRRQMAERAALEELVKLQGERVRGLKQQKASAELIEEEVAKLLKLKAQLGPDESKQKFVLKTPKGTRDYSPRQMAVREKVFDVIIRCFKRHGAEVIDTPVFELKETLMGKYGEDSKLIYDLKDQGGELLSLRYDLTVPFARYLAMNKLTNIKRYHIAKVYRRDNPAMTRGRYREFYQCDFDIAGNFDPMIPDAECLKIMCEILSSLQIGDFLVKVNDRRILDGMFAICGVSDSKFRTICSSVDKLDKVSWEEVKNEMVGEKGLAPEVADRIGDYVQQHGGVSLVEQLLQDPKLSQNKQALEGLGDLKLLFEYLTLFGIDDKISFDLSLARGLDYYTGVIYEAVLLQTPAQAGEEPLGVGSVAAGGRYDGLVGMFDPKGRKVPCVGLSIGVERIFSIVEQRLEALEEKIRTTETQVLVASAQKKLLEERLKLVSELWDAGIKAELLYKKNPKLLNQLQYCEEAGIPLVAIIGEQELKDGVIKLRSVTSREEVDVRREDLVEEIKRRTGQPL","Homo sapiens","HARS, HRS, HARS1","Histidine-tRNA ligase, cytoplasmic","1","4G85"
"4G8K",,"X-RAY DIFFRACTION",3.22,61.75,"VAPOR DIFFUSION",7,"50 mM potassium acetate, 20% PEG3350, pH 7.0, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.celrep.2012.09.004",,"4G8K",74.29,"2.4","2.4","Intact sensor domain of human RNase L in the inactive signaling state","MESRDHNNPQEGPTSSSGRRAAVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFILAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDLVMTARRNYDHSLVKVLLSHGAKEDFHPPAEDWK","Homo sapiens","RNASEL, RNS4","2-5A-dependent ribonuclease","1","4G8K"
"4G8L",,"X-RAY DIFFRACTION",2.95,58.33,"VAPOR DIFFUSION",7,"200 mM sodium acetate, 18% PEG 3350, 1.3M sodium citrate, pH 7.0, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.celrep.2012.09.004","25A","4G8L",152.6,"2.8","2.8","Active state of intact sensor domain of human RNase L with 2-5A bound","MESRDHNNPQEGPTSSSGRRAAVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFILAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDLVMTARRNYDHSLVKVLLSHGAKEDFHPPAEDWK","Homo sapiens","RNASEL, RNS4","2-5A-dependent ribonuclease","1","4G8L"
"4G8O",,"X-RAY DIFFRACTION",2.74,55.08,,,"0.99 - 1.54 M ammonium sulfate, 200 mM NaCl and 100 mM Na Cacodylate pH 6.5 - 6.8., VAPOR DIFFUSION, temperature 298.0K",298,"10.1073/pnas.1216499110","96P","4G8O",170.74,"2.71","2.71","Crystal Structure of a novel small molecule inactivator bound to plasminogen activator inhibitor-1","APSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISHLLGTGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVVRHNPTGTVLFMGQVMEP","Homo sapiens","PAI-1, PAI1, PLANH1, SERPINE1","Plasminogen activator inhibitor 1","1","4G8O"
"4G8R",,"X-RAY DIFFRACTION",2.49,50.52,"VAPOR DIFFUSION",,"0.99 - 1.54 M ammonium sulfate, 200 mM NaCl and 100 mM Na Cacodylate pH 6.5 - 6.8., VAPOR DIFFUSION, temperature 298.0K",298,"10.1073/pnas.1216499110","96P","4G8R",86.02,"2.19","2.19","Crystal Structure of a novel small molecule inactivator bound to plasminogen activator inhibitor-1","APSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISHLLGTGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVVRHNPTGTVLFMGQVMEP","Homo sapiens","PAI-1, PAI1, PLANH1, SERPINE1","Plasminogen activator inhibitor-1","1","4G8R"
"4G95",,"X-RAY DIFFRACTION",2.48,50.44,"VAPOR DIFFUSION, HANGING DROP",6.9,"100 mM K2PO4, 60-64% AS, 3% ethanol, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,"10.1128/AAC.00172-13","OAG","4G95",21.88,"1.35","1.35","hDHFR-OAG binary complex","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","4G95"
"4G96",,"X-RAY DIFFRACTION",2.54,51.59,"VAPOR DIFFUSION, SITTING DROP",4.7,"18.5% PEG 6000, 2% 1,6-hexanediol, 0.05M ammonium sulphate, 0.1M sodium acetate pH 4.7, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1074/jbc.M113.480657",,"4G96",64.91,"2.25","2.25","Crystal structure of calcium2+-free wild-type CD23 lectin domain","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","FCER2, CD23A, CLEC4J, FCE2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4G96"
"4G9A",,"X-RAY DIFFRACTION",2.1,41.46,"VAPOR DIFFUSION, SITTING DROP",4.7,"18.5% PEG 6000, 2% 1,6-hexanediol, 0.05M ammonium sulphate, 0.1M sodium acetate pH 4.7, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1074/jbc.M113.480657",,"4G9A",65.1,"2.001","2.001","Crystal structure of calcium2+-bound wild-type CD23 lectin domain","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","CD23A, CLEC4J, FCE2, FCER2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4G9A"
"4G9C",,"X-RAY DIFFRACTION",3.29,62.63,"VAPOR DIFFUSION, HANGING DROP",9,"100 mM Tris pH 9.0, PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.08.007","0WP","4G9C",71.42,"3.5","3.5","Human B-Raf Kinase Domain bound to a Type II Pyrazolopyridine Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4G9C"
"4G9J",,"X-RAY DIFFRACTION",3.35,63.26,"SITTING DROP",8,"20% PEG6000, 1 M lithium chloride, pH 8.0, SITTING DROP, temperature 293K",293,"10.1002/anie.201204308",,"4G9J",80.95,"3.1","3.1","Protein Ser/Thr phosphatase-1 in complex with cell-permeable peptide","GMSDSEKLNLDSIIGRLLEVQGSRPGKNVQLTENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVQGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPADKNKGKYGQFSGLNPGGRPITPPRNSAKAKK","Homo sapiens","PPP1A, PPP1CA","Serine/threonine-protein phosphatase PP1-alpha catalytic subunit","1","4G9J"
,,,,,,,,,,,,,,,,"RRKRPKRKRKNARVTFAEAAEII",,,"synthetic peptide","2","4G9J"
"4G9L",,"X-RAY DIFFRACTION",2.06,40.23,,7.5,"25-30% PEG 8000, 10 mM CaCl2, 100 mM TRIS, pH 7.5, VAPOR DIFFUSION, temperature 293K",293,"10.1039/c3cc41278d","NGH","4G9L",39.65,"1.88","1.88","Structure of MMP3 complexed with NNGH inhibitor.","FRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGPPPDSPET","Homo sapiens","MMP3, STMY1","Stromelysin-1","1","4G9L"
"4G9R",,"X-RAY DIFFRACTION",2.8,56.14,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris, 16% PEG 8000, 100 mM NDSB-256, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.08.007","B1E","4G9R",71.4,"3.2","3.2","B-Raf V600E Kinase Domain Bound to a Type II Dihydroquinazoline Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4G9R"
"4GA0",,"X-RAY DIFFRACTION",2.09,41.03,"VAPOR DIFFUSION, HANGING DROP",,"18 % (w/v) PEG 3350  
200 mM lithium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2012.08.026",,"4GA0",17.35,"1.15","1.15","Structure of the N-terminal domain of Nup358","GPLGSMRRSKADVERYIASVQGSTPSPRQKSMKGFYFAKLYYEAKEYDLAKKYICTYINVQERDPKAHRFLGLLYELEENTDKAVECYRRSVELNPTQKDLVLKIAELLCKNDVTDGRAKYWLERAAKLFPGSPAIYKLKEQLLDCEGED","Homo sapiens","RANBP2, NUP358","E3 SUMO-protein ligase RanBP2","1","4GA0"
"4GA3",,"X-RAY DIFFRACTION",2.7,54.43,"VAPOR DIFFUSION, HANGING DROP",5.2,"1.2M Na/K phosphate, 25% glycerol, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ml4000436","4GA","4GA3",40.62,"2.39","2.39","Crystal Structure of Human Farnesyl Diphosphate Synthase in Complex with BPH-1260","NSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4GA3"
"4GA7",,"X-RAY DIFFRACTION",2.33,47.11,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.18M Lithium citrate tribasic tetrahydrate, 18% w/v Polyethylene glycol 3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.4049/jimmunol.1202542",,"4GA7",87.88,"2.9","2.9","Crystal structure of human serpinB1 mutant","MGHHHHHHSGMEQLSSANTRFALDLFLALSENNPAGNIFISPFSISSAMAMVFLGTRGNTAAQLSKTFHFNTVEEVHSRFQSLNADINKRGASYILKLANRLYGEKTYNFLPEFLVSTQKTYGADLASVDFQHASEDARKTINQWVKGQTEGKIPELLASGMVDNMTKLVLVNAIYFKGNWKDKFMKEATTNAPFRLNKKDRKTVKMMYQKKKFAYGYIEDLKCRVLELPYQGEELSMVILLPDDIEDESTGLKKIEEQLTLEKLHEWTKPENLDFIEVNVSLPRFKLEESYTLNSDLARLGVQDLFNSSKADLSGMSGARDIFISKIVHKSFVEVNEEGTEAAAATAGIATFCMDDPEENFTADHPFLFFIRHNSSGSILFLGRFSSP","Homo sapiens","SERPINB1, ELANH2, MNEI, PI2","Leukocyte elastase inhibitor","1","4GA7"
"4GA8",,"X-RAY DIFFRACTION",2.49,50.66,"VAPOR DIFFUSION, HANGING DROP",9,"30% PEG 6000, 100 mM SODIUM CACODYLATE, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"SBI","4GA8",37.07,"1.942","1.942","Human AKR1B10 mutant V301L complexed with NADP+ and sorbinil","MATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPKDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNLLQSSHLEDYPFNAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4GA8"
"4GAB",,"X-RAY DIFFRACTION",2.48,50.39,"VAPOR DIFFUSION, HANGING DROP",9,"30% PEG 6000, 100 mM SODIUM CACODYLATE , pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.cbi.2012.12.013","FID","4GAB",37.14,"1.5971","1.5971","Human AKR1B10 mutant V301L complexed with NADP+ and fidarestat","MATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPKDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNLLQSSHLEDYPFNAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4GAB"
"4GAH",,"X-RAY DIFFRACTION",2.35,47.67,"VAPOR DIFFUSION",,"1:1 protein and reservoir solution. Reservoir: 11 % w/v PEG 3350 and 0.1 M ammonium phosphate monobasic. Proteins: 8 mg/mL in kept in 0.2 M NaCl and 50 mM HEPES (pH 7.5), 4 mM  undecan-2-one-CoA., VAPOR DIFFUSION, temperature 298K",298,"10.1021/bi300968n","0ET","4GAH",50.74,"2.3","2.3","Human acyl-CoA thioesterases 4 in complex with undecan-2-one-CoA inhibitor","EVILKDCSVPNPSWNKDLRLLFDQFMKKCEDGSWKRLPSYKRTPTEWIQDFKTHFLDPKLMKEEQMSQAQLFTRSFDDGLGFEYVMFYNDIEKRMVCLFQGGPYLEGPPGFIHGGAIATMIDATVGMCAMMAGGIVMTANLNINYKRPIPLCSVVMINSQLDKVEGRKFFVSCNVQSVDEKTLYSEATSLFIKLNPAKSLTLEHHHHHH","Homo sapiens","CTMP, THEM4","Thioesterase superfamily member 4","1","4GAH"
"4GAI",,"X-RAY DIFFRACTION",2.21,44.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% PEG 3350, 200 mM MgCl2, 100 mM HEPES, pH 7.5, 0.5% w/v n-Dodecy-  -D-maltoside (DDM), VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1217996110",,"4GAI",35.44,"1.49","1.49","Crystal structure of EBI-005, a chimera of human IL-1beta and IL-1Ra","APVRSLNCRIWDVNQKTFYLRNNQLVAGYLQGPNVNLEEKFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWFLCTAMEADQPVSLTNMPDEGVMVTKFYMQFVSS","Homo sapiens","IL1B, IL1F2","EBI-005","1","4GAI"
"4GAL",,"X-RAY DIFFRACTION",2.2,43,"VAPOR DIFFUSION, HANGING DROP",8.1,"CRYSTALS WERE GROWN USING THE HANGING DROP METHOD FROM DROPS CONTAINING 9 MG/ML PROTEIN AT PH 8.1 IN 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 8.5% PEG 3350. DROPS WERE EQUILIBRATED AGAINST RESERVOIRS CONTAINING 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 17% PEG 3350. GALECTIN-7 CRYSTALS WERE THEN SOAKED WITH 5 MM LACTOSE FOR 2 HRS., vapor diffusion - hanging drop",,"10.1021/bi981056x",,"4GAL",30.27,"1.95","1.95","CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH LACTOSE","SNVPHKSSLPEGIRPGTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","GALECTIN-7","1","4GAL"
"4GAW",,"X-RAY DIFFRACTION",3.16,61.07,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Li2SO4, 0.1M Bicine (pH8.5), 25% (w/v) PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.4049/jimmunol.1202542",,"4GAW",304.1,"3","3","Crystal structure of active human granzyme H","IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSSINVTLGAHNIKEQERTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRLPSSKAQVKPGQLCSVAGWGYVSMSTLATTLQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQTGFKGDSGGPLVCKDVAQGILSYGNKKGTPPGVYIKVSHFLPWIKRTMKRL","Homo sapiens","GZMH, CGL2, CTSGL2","Granzyme H","1","4GAW"
"4GAZ",,"X-RAY DIFFRACTION",3.2,61.6,,7.5,"100mM HEPES, 9% PEG 3350 (w/v), pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,,,"4GAZ",59.08,"2.81","2.81","Crystal Structure of a Jumonji Domain-containing Protein JMJD5","MGSPDVKLEKTVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWSLEHHHHHH","Homo sapiens","JMJD5, KDM8","Lysine-specific demethylase 8","1","4GAZ"
"4GB0",,"X-RAY DIFFRACTION",2.57,52.21,"VAPOR DIFFUSION, SITTING DROP",7,"1.6M sodium malonate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.4161/cc.23104",,"4GB0",14.15,"2.6","2.6","Crystal Structure of the RING domain of RNF168","MGHHHHHHGSMALPKDAIPSLSECQCGICMEILVEPVTLPCNHTLCKPCFQSTVEKASLCCPFCRRRVSSWTRYHTRRNSLVNVELWTIIQKHYPRECKLRASGQESEEVADDYQPVRLLS","Homo sapiens","RNF168","E3 ubiquitin-protein ligase RNF168","1","4GB0"
"4GB9",,"X-RAY DIFFRACTION",2.1,41.53,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3350, 0.2M NH4SO4, 0.1M Tris-HCl, pH 8.5, vapor diffusion, hanging drop, temperature 289K",289,"10.1021/jm300717c","0WR","4GB9",111.26,"2.438","2.438","Potent and Highly Selective Benzimidazole Inhibitors of PI3K-delta","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4GB9"
"4GBC",,"X-RAY DIFFRACTION",1.86,33.71,"VAPOR DIFFUSION, HANGING DROP",6.5,"2 uL mother liquor (0.1 M MES monohydrate, pH 6.5, 1.6 M magnesium sulfate heptahydrate) + 2 uL protein (aspart insulin, 100 U/mL), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bpc.2013.01.003",,"4GBC",12.09,"1.778","1.778","Crystal structure of aspart insulin at pH 6.5","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4GBC"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTDKT","Homo sapiens","INS","Insulin B chain","2","4GBC"
"4GBI",,"X-RAY DIFFRACTION",1.87,34.06,"VAPOR DIFFUSION, HANGING DROP",6.5,"2 uL mother liquor (0.1 M MES, pH 6.5, 1.6 M magnesium sulfate heptahydrate) + 2 uL protein (aspart insulin, 100 U/mL), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bpc.2013.01.003",,"4GBI",12.09,"2.502","2.502","Crystal structure of aspart insulin at pH 6.5","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4GBI"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTDKT","Homo sapiens","INS","Insulin B chain","2","4GBI"
"4GBK",,"X-RAY DIFFRACTION",1.86,33.94,"VAPOR DIFFUSION, HANGING DROP",8.5,"2 uL mother liquor (0.1 M Tris, pH 8.5, 1.5 M ammonium sulfate, 12% v/v glycerol) + 2 uL protein (aspart insulin 100 U/mL), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bpc.2013.01.003",,"4GBK",12.09,"2.4","2.4","Crystal structure of aspart insulin at pH 8.5","FVNQHLCGSHLVEALYLVCGERGFFYTDKT","Homo sapiens","INS","Insulin B chain","2","4GBK"
,,,,,,,,,,,,,,,,"GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4GBK"
"4GBL",,"X-RAY DIFFRACTION",1.92,35.95,"VAPOR DIFFUSION, HANGING DROP",8.5,"2 uL mother liquor (0.1 M Tris, pH 8.5, 1.5 M ammonium sulfate, 12% v/v glycerol) + 2 uL protein (aspart insulin 100 U/mL), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bpc.2013.01.003",,"4GBL",12.09,"2.5","2.5","Crystal structure of aspart insulin at pH 8.5","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4GBL"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTDKT","Homo sapiens","INS","Insulin B chain","2","4GBL"
"4GBN",,"X-RAY DIFFRACTION",1.89,34.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"2 uL mother liquor (0.1 M MES monohydrate, pH 6.5, 1.6 M magnesium sulfate heptahydrate) + 2 uL protein (aspart insulin, 100 U/mL), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bpc.2013.01.003",,"4GBN",12.09,"1.872","1.872","Crystal structure of aspart insulin at pH 6.5","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4GBN"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTDKT","Homo sapiens","INS","Insulin B chain","2","4GBN"
"4GBP",,"X-RAY DIFFRACTION",2.29,46.23,"HANGING DROP",10,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM glycine, 30 mM sodium acetate with 20% MPD as cryoprotectant, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4GBP",34.96,"2.15","2.15","Crystal Structure of BBBB+UDP+Gal at pH 10 with MPD as the cryoprotectant","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4GBP"
"4GCA",,"X-RAY DIFFRACTION",2.21,44.3,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 6000 IN 120 MM AMMONIUM CITRATE, PH 5.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 
, temperature 277K",277,,,"4GCA",36.88,"0.9","0.9","Complex of Aldose Reductase with inhibitor IDD 1219","ASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4GCA"
"4GCJ",,"X-RAY DIFFRACTION",1.94,36.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM sodium/potassium phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X64","4GCJ",35.43,"1.42","1.42","CDK2 in complex with inhibitor RC-3-89","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4GCJ"
"4GD4",,"X-RAY DIFFRACTION",2.45,49.81,"VAPOR DIFFUSION",7.5,"0.2 M NaF, 20% w/v PEG 3350, 0.1 M Bis Tris Propane, pH 7.5, VAPOR DIFFUSION, temperature 277K",277,,,"4GD4",89.42,"2.33","2.33","Crystal Structure of JMJD2A Complexed with Inhibitor","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","4GD4"
"4GD7",,"X-RAY DIFFRACTION",3.01,59.12,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris pH 7.5-8.5, 20 mM BME, 25-42% Ammonium Sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"4GD7",36.52,"2.29","2.29","Wild-Type Human Thymidylate Synthase with bound Purpurogallin","MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","tys, TS, OK/SW-cl.29, TYMS","Thymidylate Synthase","1","4GD7"
"4GDO",,"X-RAY DIFFRACTION",2.1,41.29,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1M sodium acetate, 2.2M sodium chloride, 0.2M lithium sulfate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/nmeth.2644",,"4GDO",29.28,"1.7","1.7","Structure of a fragment of the rod domain of plectin","GSHMRAEERERLAEVEAALEKQRQLAEAHAQAKAQAEREAKEL","Homo sapiens","PLEC, PLEC1","Plectin","1","4GDO"
"4GDX",,"X-RAY DIFFRACTION",2.81,56.22,"VAPOR DIFFUSION, HANGING DROP",7,"17.5% PEG3350, 100 mM Ammonium chloride, 0.5 mM L-glutamate, and 100 mM Na:Cacodylate pH 6.0 , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M113.498139",,"4GDX",63,"1.67","1.67","Crystal Structure of Human Gamma-Glutamyl Transpeptidase--Glutamate complex","VKKKLVVLGLLAVVLVLVIVGLCLWLPSASKEPDNHVYTRAAVAADAKQCSKIGRDALRDGGSAVDAAIAALLCVGLMNAHSMGIGGGLFLTIYNSTTRKAEVINAREVAPRLAFATMFNSSEQSQKGGLSVAVPGEIRGYELAHQRHGRLPWARLFQPSIQLARQGFPVGKGLAAALENKRTVIEQQPVLCEVFCRDRKVLREGERLTLPQLADTYETLAIEGAQAFYNGSLTAQIVKDIQAAGGIVTAEDLNNYRAELIEHPLNISLGDAVLYMPSAPLSGPVLALILNILKGYNFSRESVESPEQKGLTYHRIVEAFRFAYAKRTLLGDPKFVDVTEVVRNMTSEFFAAQLRAQISDDTTHPISYYKPEFY","Homo sapiens","GGT, GGT1","Gamma-glutamyltranspeptidase 1 heavy chain","1","4GDX"
,,,,,,,,,,,,,,,,"TPDDGGTAHLSVVAEDGSAVSATSTINLYFGSKVRSPVSGILFNNEMDDFSSPSITNEFGVPPSPANFIQPGKQPLSSMCPTIMVGQDGQVRMVVGAAGGTQITTATALAIIYNLWFGYDVKRAVEEPRLHNQLLPNVTTVERNIDQAVTAALETRHHHTQIASTFIAVVQAIVRTAGGWAAASDSRKGGEPAGY","Homo sapiens","GGT, GGT1","Gamma-glutamyltranspeptidase 1 light chain","2","4GDX"
"4GDY",,"X-RAY DIFFRACTION",2.3,46.61,,,,,,"0X1","4GDY",98.95,"2.89","2.89","Kynurenine Aminotransferase II inhibitors","MNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNSGRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESLLVPRGSLEHHHHHH","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial","1","4GDY"
"4GE2",,"X-RAY DIFFRACTION",2.01,38.76,"VAPOR DIFFUSION, HANGING DROP",6.7,"25% PEG3350, 0.2 M potassium thiocyanate, 10% ethylene glycol, 0.1 M Bis-Tris propane, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja308212y","75A","4GE2",73.14,"1.8","1.8","Crystal structure of human protein tyrosine phosphatase PTPN9 (MEG2) complex with compound 3","MSVHVPGPHAMTIQELVDYVNARQKQGIYEEYEDIRRENPVGTFHCSMSPGNLEKNRYGDVPCLDQTRVKLTKRSGHTQTDYINASFMDGYKQKNAYIGTQGPLENTYRDFWLMVWEQKVLVIVMTTRFEEGGRRKCGQYWPLEKDSRIRFGFLTVTNLGVENMNHYKKTTLEIHNTEERQKRQVTHFQFLSWPDYGVPSSAASLIDFLRVVRNQQSLAVSNMGARSKGQCPEPPIVVHCSAGIGRTGTFCSLDICLAQLEELGTLNVFQTVSRMRTQRAFSIQTPEQYYFCYKAILEFAEKEGMVSAHHHHHH","Homo sapiens","PTPN9","Tyrosine-protein phosphatase non-receptor type 9","1","4GE2"
"4GE4",,"X-RAY DIFFRACTION",2.54,51.58,,,,,"10.1021/ml300237v","0KE","4GE4",98.77,"2.41","2.41","Kynurenine Aminotransferase II Inhibitors","MNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNSGRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESLLVPRGSLEHHHHHH","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial","1","4GE4"
"4GE5",,"X-RAY DIFFRACTION",2,38.44,"VAPOR DIFFUSION, HANGING DROP",6.7,"25% PEG3350, 0.2 M potassium thiocyanate, 10% ethylene glycol, 0.1 M Bis-Tris propane, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja308212y","A89","4GE5",73.29,"2","2","Crystal structure of human protein tyrosine phosphatase PTPN9 (MEG2) complex with compound 5","MSVHVPGPHAMTIQELVDYVNARQKQGIYEEYEDIRRENPVGTFHCSMSPGNLEKNRYGDVPCLDQTRVKLTKRSGHTQTDYINASFMDGYKQKNAYIGTQGPLENTYRDFWLMVWEQKVLVIVMTTRFEEGGRRKCGQYWPLEKDSRIRFGFLTVTNLGVENMNHYKKTTLEIHNTEERQKRQVTHFQFLSWPDYGVPSSAASLIDFLRVVRNQQSLAVSNMGARSKGQCPEPPIVVHCSAGIGRTGTFCSLDICLAQLEELGTLNVFQTVSRMRTQRAFSIQTPEQYYFCYKAILEFAEKEGMVSAHHHHHH","Homo sapiens","PTPN9","Tyrosine-protein phosphatase non-receptor type 9","1","4GE5"
"4GE6",,"X-RAY DIFFRACTION",2.02,39.05,"VAPOR DIFFUSION, HANGING DROP",6.15,"25% PEG3350, 0.2 M potassium thiocyanate, 10% ethylene glycol, 0.1 M Bis-Tris propane, pH 6.15, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja308212y","B26","4GE6",73.54,"1.4","1.4","Crystal structure of human protein tyrosine phosphatase PTPN9 (MEG2) complex with compound 7","MSVHVPGPHAMTIQELVDYVNARQKQGIYEEYEDIRRENPVGTFHCSMSPGNLEKNRYGDVPCLDQTRVKLTKRSGHTQTDYINASFMDGYKQKNAYIGTQGPLENTYRDFWLMVWEQKVLVIVMTTRFEEGGRRKCGQYWPLEKDSRIRFGFLTVTNLGVENMNHYKKTTLEIHNTEERQKRQVTHFQFLSWPDYGVPSSAASLIDFLRVVRNQQSLAVSNMGARSKGQCPEPPIVVHCSAGIGRTGTFCSLDICLAQLEELGTLNVFQTVSRMRTQRAFSIQTPEQYYFCYKAILEFAEKEGMVSAHHHHHH","Homo sapiens","PTPN9","Tyrosine-protein phosphatase non-receptor type 9","1","4GE6"
"4GE7",,"X-RAY DIFFRACTION",2.93,58.06,,,,,"10.1021/ml300237v","0K5","4GE7",98.93,"2.1","2.1","Kynurenine Aminotransferase II Inhibitors","MNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNSGRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESLLVPRGSLEHHHHHH","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial","1","4GE7"
"4GE9",,"X-RAY DIFFRACTION",2.2,44.02,,,,,"10.1021/ml300237v","0L0","4GE9",197.91,"2.43","2.43","Kynurenine Aminotransferase II Inhibitors","MNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNSGRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESLLVPRGSLEHHHHHH","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial","1","4GE9"
"4GEB",,"X-RAY DIFFRACTION",2.92,57.9,,,,,"10.1016/j.bmcl.2013.02.039",,"4GEB",99.23,"2.15","2.15","Kynurenine Aminotransferase II Inhibitors","MNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNSGRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESLLVPRGSLEHHHHHH","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial","1","4GEB"
"4GEI",,"X-RAY DIFFRACTION",3.41,63.89,"batch",7.15,"25mM Hepes, 1 mM DTT, pH 7.15, batch, temperature 277K",277,"10.1107/S0907444912047099",,"4GEI",17.05,"1.5","1.5","N-terminal domain of VDUP-1","SNVMFKKIKSFEVVFNDPEKVYGSGERVAGRVIVEVSEVTRVKAVRILASGVAKVLWMQGSQQCAQTSEYLRYEDTLLLEDQPTGENEMVIMRPGNKYEYKFGFELPQGPLGTSFKGKYGSVDYWVKAFLDRPSQPTQETKKNFEVVDLV","Homo sapiens","TXNIP, VDUP1","Thioredoxin-interacting protein","1","4GEI"
"4GEJ",,"X-RAY DIFFRACTION",3.13,60.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Hepes, 0.2 M Calcium Acetate, 10-12% PEG monomethyl ether 5000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1107/S0907444912047099",,"4GEJ",171.27,"2.9","2.9","N-terminal domain of VDUP-1","SNVMFKKIKSFEVVFNDPEKVYGSGERVAGRVIVEVSEVTRVKAVRILASGVAKVLWMQGSQQCKQTSEYLRYEDTLLLEDQPTGENEMVIMRPGNKYEYKFGFELPQGPLGTSFKGKYGSVDYWVKAFLDRPSQPTQETKKNFEVVDLV","Homo sapiens","TXNIP, VDUP1","Thioredoxin-interacting protein","1","4GEJ"
"4GEO",,"X-RAY DIFFRACTION",2.23,44.8,"VAPOR DIFFUSION, SITTING DROP",7.25,"15% w/v PEG3350, 0.1 M HEPES, pH 7.25, 0.2 M potassium fluoride, 25 mM beta-octyl glucoside, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4GEO",42.52,"1.66","1.66","P38a MAP kinase DEF-pocket penta mutant (M194A, L195A, H228A, I229A, Y258A)","MHHHHHHASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIAANWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDAADQLKLILRLVGTPGAELLKKISSESARNAIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4GEO"
"4GFG",,"X-RAY DIFFRACTION",2.3,46.57,"VAPOR DIFFUSION, SITTING DROP",4,"12% PEG 3350, 0.1M sodium malonate, pH 4.0, VAPOR DIFFUSION, SITTING DROP, temperature 278K",278,,"0XF","4GFG",34.24,"2.35","2.35","Crystal structure of spleen tyrosine kinase complexed with r9021","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4GFG"
"4GFM",,"X-RAY DIFFRACTION",2.27,45.77,"VAPOR DIFFUSION, SITTING DROP",6,"ammonium acetate, sodium citrate, PEG8000, pH 6, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1016/j.ejmech.2013.03.070","0X2","4GFM",35.77,"2.3","2.3","JAK2 kinase (JH1 domain) with 2,6-DICHLORO-N-(2-OXO-2,5-DIHYDROPYRIDIN-4-YL)BENZAMIDE","GSSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4GFM"
"4GFO",,"X-RAY DIFFRACTION",2.11,41.8,"VAPOR DIFFUSION, SITTING DROP",5,"2 M ammonium sulfate, pH 5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1016/j.ejmech.2013.03.070","0X2","4GFO",35.69,"2.3","2.3","TYK2 kinase (JH1 domain) with 2,6-DICHLORO-N-(2-OXO-2,5-DIHYDROPYRIDIN-4-YL)BENZAMIDE","MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRHHHHHH","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","4GFO"
"4GFX",,"X-RAY DIFFRACTION",2.1,41.47,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.75 M sodium/potassium phosphate, 0.1 M HEPES sodium, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1038/ncomms3958",,"4GFX",17.15,"1.6","1.6","Crystal structure of the N-terminal domain of TXNIP","VAAIKSFEVVFNDPEKVYGSGEKVAGRVIVEVCEVTRVKAVRILACGVAKVLWMQGSQQCKQTSEYLRYEDTLLLEDQPTGENEMVIMRPGNKYEYKFGFELPQGPLGTSFKGKYGCVDYWVKAFLDRPSQPTQETKKNFEVVDLVDVNTP","Homo sapiens","TXNIP, VDUP1","Thioredoxin-interacting protein","1","4GFX"
"4GG2",,"X-RAY DIFFRACTION",2.85,56.84,"VAPOR DIFFUSION, HANGING DROP",6,"15-25% PEG3350, 100 mM Ammonium chloride, 0.5 mM L-glutamate,  100 mM Na:Cacodylate pH 6.0 , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M113.498139",,"4GG2",61.23,"2.21","2.21","The crystal structure of glutamate-bound human gamma-glutamyltranspeptidase 1","SASKEPDNHVYTRAAVAADAKQCSKIGRDALRDGGSAVDAAIAALLCVGLMNAHSMGIGGGLFLTIYNSTTRKAEVINAREVAPRLAFATMFNSSEQSQKGGLSVAVPGEIRGYELAHQRHGRLPWARLFQPSIQLARQGFPVGKGLAAALENKRTVIEQQPVLCEVFCRDRKVLREGERLTLPQLADTYETLAIEGAQAFYNGSLTAQIVKDIQAAGGIVTAEDLNNYRAELIEHPLNISLGDVVLYMPSAPLSGPVLALILNILKGYNFSRESVESPEQKGLTYHRIVEAFRFAYAKRTLLGDPKFVDVTEVVRNMTSEFFAAQLRAQISDDTTHPISYYKPEFYTPDDGG","Homo sapiens","GGT, GGT1, hGGT1","Gamma-glutamyltranspeptidase 1 heavy chain","1","4GG2"
,,,,,,,,,,,,,,,,"TAHLSVVAEDGSAVSATSTINLYFGSKVRSPVSGILFNNEMDDFSSPSITNEFGVPPSPANFIQPGKQPLSSMCPTIMVGQDGQVRMVVGAAGGTQITTATALAIIYNLWFGYDVKRAVEEPRLHNQLLPNVTTVERNIDQAVTAALETRHHHTQIASTFIAVVQAIVRTAGGWAAASDSRKGGEPAGY","Homo sapiens","GGT, GGT1, hGGT1","Gamma-glutamyltranspeptidase 1 light chain","2","4GG2"
"4GG5",,"X-RAY DIFFRACTION",2.78,55.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 8% isopropanol, 3mM TECP, 16% PEG4000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.08.075","0J3","4GG5",36.48,"2.423","2.423","Crystal structure of CMET in complex with novel inhibitor","MGSSHHHHHHGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","c-MET, MET","Hepatocyte growth factor receptor","1","4GG5"
"4GG7",,"X-RAY DIFFRACTION",2.82,56.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris-HCl, 15% glycerol, 12% MPD, 5% isopropanol, 14% PEG5000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.08.075","0J8","4GG7",36.53,"2.27","2.27","Crystal structure of cMET in complex with novel inhibitor","MGSSHHHHHHGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","CMET, MET","Hepatocyte growth factor receptor","1","4GG7"
"4GGA",,"X-RAY DIFFRACTION",2.13,42.36,"VAPOR DIFFUSION, SITTING DROP",5.6,"100 mM Na citrate, 15 % (w/v) PEG 6000, and 4% MPD, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1213438109",,"4GGA",46.35,"2.044","2.044","Structural Analysis of Human Cdc20 Supports Multi-site Degron Recognition by APC/C","GPHRSAAQMEVASFLLSKENQPENSQTPTKKEHQKAWALNLNGFDVEEAKILRLSGKPQNAPEGYQNRLKVLYSQKATPGSSRKTCRYIPSLPDRILDAPEIRNDYYLNLVDWSSGNVLAVALDNSVYLWSASSGDILQLLQMEQPGEYISSVAWIKEGNYLAVGTSSAEVQLWDVQQQKRLRNMTSHSARVGSLSWNSYILSSGSRSGHIHHHDVRVAEHHVATLSGHSQEVCGLRWAPDGRHLASGGNDNLVNVWPSAPGEGGWVPLQTFTQHQGAVKAVAWCPWQSNVLATGGGTSDRHIRIWNVCSGACLSAVDAHSQVCSILWSPHYKELISGHGFAQNQLVIWKYPTMAKVAELKGHTSRVLSLTMSPDGATVASAAADETLRLWRCFELDPARRREREKASAAKSSLIHQGIR","Homo sapiens","CDC20","Cell division cycle protein 20 homolog","1","4GGA"
"4GGC",,"X-RAY DIFFRACTION",2.29,46.23,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM MES, 15% (w/v) PEG 6000, and 5% MPD, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1213438109",,"4GGC",35.38,"1.35","1.35","Structural Analysis of Human Cdc20 Supports Multi-site Degron Recognition by APC/C","GSRKTCRYIPSLPDRILDAPEIRNDYYLNLVDWSSGNVLAVALDNSVYLWSASSGDILQLLQMEQPGEYISSVAWIKEGNYLAVGTSSAEVQLWDVQQQKRLRNMTSHSARVGSLSWNSYILSSGSRSGHIHHHDVRVAEHHVATLSGHSQEVCGLRWAPDGRHLASGGNDNLVNVWPSAPGEGGWVPLQTFTQHQGAVKAVAWCPWQSNVLATGGGTSDRHIRIWNVCSGACLSAVDAHSQVCSILWSPHYKELISGHGFAQNQLVIWKYPTMAKVAELKGHTSRVLSLTMSPDGATVASAAADETLRLWRCFELDP","Homo sapiens","CDC20","Cell division cycle protein 20 homolog","1","4GGC"
"4GH0",,"X-RAY DIFFRACTION",1.95,37.05,"VAPOR DIFFUSION, HANGING DROP",5,"15% PEG 3350, 0.1M MES pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444913000024",,"4GH0",24.8,"1.35","1.35","Crystal structure of D48V mutant of human GLTP bound with 12:0 monosulfatide","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKAVISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","4GH0"
"4GH2",,"X-RAY DIFFRACTION",2.67,53.88,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 8000, Isopropanol, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,,"4GH2",33.11,"2.03","2.03","Crystal Structure of the CHK1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4GH2"
"4GH6",,"X-RAY DIFFRACTION",4.76,74.17,"VAPOR DIFFUSION, HANGING DROP",7.5,"PDE9A2 (15 mg/mL) in a buffer of 50 mM NaCl, 20 mM Tris.HCl pH 7.5, 1 mM beta-mercaptoethanol and 1 mM EDTA was mixed with 2 mM IBMX for 2h before setting-up of crystallization against the well buffer of 2.0 M Na formate, 0.1 M HEPES pH 7.5, 5% xylitol at 4C. The PDE9A-IBMX complex crystals were formed after 1d and reached the maximum size in 2 weeks. Crystals of the PDE9A-28 complex were prepared by soaking PDE9-IBMX co-crystals in the crystallization buffer plus 5 mM 28 at 25C for 3 days, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm301189c","LUO","4GH6",78.53,"2.7","2.7","Crystal structure of the PDE9A catalytic domain in complex with inhibitor 28","PTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","4GH6"
"4GHP",,"X-RAY DIFFRACTION",2.23,44.72,"VAPOR DIFFUSION, HANGING DROP",6.5,"10-20% PEG 3350, pH 5.5-7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444913000024",,"4GHP",24.63,"1.9","1.9","Crystal Structure of D48V||A47D mutant of Human GLTP bound with 12:0 monosulfatide","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKDVISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","4GHP"
"4GHS",,"X-RAY DIFFRACTION",3.31,62.8,"VAPOR DIFFUSION, HANGING DROP",7,"10-20% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444913000024",,"4GHS",49.36,"3.2","3.2","Crystal structure of human GLTP bound with 12:0 disulfatide (orthorombic form; two subunits in asymmetric unit)","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKADISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","4GHS"
"4GI0",,"X-RAY DIFFRACTION",2.71,54.64,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M potassium thiocyanate, 0.1M bis tris propane pH 8.5, 20% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1074/jbc.M113.480657",,"4GI0",48.41,"2.27","2.27","Crystal structure of CD23 lectin domain mutant E249A","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGAPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","FCER2, CD23A, CLEC4J, FCE2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4GI0"
"4GID",,"X-RAY DIFFRACTION",2.85,56.89,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG 8000, NA CACODYLATE BUFFER, 15MG/ML PROTEIN CONCENTRATION, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/jm3008823","0GH","4GID",176.14,"2","2","Structure of beta-secretase complexed with inhibitor","SFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4GID"
"4GIF",,"X-RAY DIFFRACTION",3.49,64.8,"EVAPORATION",7.5,"18-20% PEG 8000, 100 mM HEPES, pH 7.5, 3.9 mM HEGA-9, EVAPORATION, temperature 293.0K",293,"10.1038/ncomms2257",,"4GIF",5.1,"2.8","2.8","C-terminal coiled-coil domain of transient receptor potential channel TRPP3 (PKD2L1, Polycystin-L)","GGWVSGEEFYMLTRRVLQLETVLEGVVSQIDAVGSKLKMLERKGW","Homo sapiens","PKD2L1, PKD2L, PKDL, TRPP3","Polycystic kidney disease 2-like 1 protein","1","4GIF"
"4GIH",,"X-RAY DIFFRACTION",2.05,39.96,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25%(w/v) PEG3350 and 0.2M Mg sulfate, 0.1M MES pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejmech.2013.03.070","0X5","4GIH",35.1,"2","2","Tyk2 (JH1) in complex with 2,6-DICHLORO-N-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE","MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRHHHHHH","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","4GIH"
"4GII",,"X-RAY DIFFRACTION",2.03,39.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25%(w/v) PEG3350 and 0.2M Mg sulfate, 0.1M MES pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm400266t","0X6","4GII",35.12,"2.31","2.31","Tyk2 (JH1) in complex with 2,6-dichloro-4-cyano-N-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}benzamide","MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRHHHHHH","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","4GII"
"4GIW",,"X-RAY DIFFRACTION",1.86,33.73,"VAPOR DIFFUSION, SITTING DROP",,"20%(w/v) PEG3350, 0.2M K2HPO4, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1007/s13238-012-2052-3",,"4GIW",43.66,"2","2","Crystal structure of the RUN domain of human NESCA","TGQLQEQKKGLLIAVSVSVDKIISHFGAARNLVQKAQLGDSRLSPDVGHLVLTTLCPALHALVADGLKPFRKDLITGQRRSSPWSVVEASVKPGSSTRSLGTLYSQVSRLAPLSSSRSRFHAFILGLLNTKQLELWFSSLQEDAGLLSLMYMPTGFFSLARGGCPSLSTELLLLLQPLSVLTFHLDLLFELEHHHHHH","Homo sapiens","NESCA, RUSC1","RUN and SH3 domain-containing protein 1","1","4GIW"
"4GIX",,"X-RAY DIFFRACTION",2.27,45.71,"VAPOR DIFFUSION, HANGING DROP",6.5,"15%PEG 3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444913000024",,"4GIX",24.68,"1.8","1.8","Crystal structure of human GLTP bound with 12:0 disulfatide","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKADISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","4GIX"
"4GJ0",,"X-RAY DIFFRACTION",2.57,52.1,"VAPOR DIFFUSION, SITTING DROP",4.7,"18.5% PEG 6000, 2% 1,6-hexanediol, 0.05M ammonium sulphate, 0.1M sodium acetate pH 4.7, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1074/jbc.M113.480657",,"4GJ0",65.35,"1.953","1.953","Crystal structure of CD23 lectin domain mutant S252A","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTARSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","FCER2, CD23A, CLEC4J, FCE2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4GJ0"
"4GJ2",,"X-RAY DIFFRACTION",2.04,39.77,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25%(w/v) PEG3350 and 0.2M Mg sulfate, 0.1M MES pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm400266t","0XH","4GJ2",35.12,"2.4","2.4","Tyk2 (JH1) in complex with 2,6-dichloro-N-[2-({[(1R,2R)-2-fluorocyclopropyl]carbonyl}amino)pyridin-4-yl]benzamide","MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRHHHHHH","Homo sapiens","Tyk2 gene, TYK2","Non-receptor tyrosine-protein kinase TYK2","1","4GJ2"
"4GJ3",,"X-RAY DIFFRACTION",2.05,39.94,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25%(w/v) PEG3350 and 0.2M Mg sulfate, 0.1M MES pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm400266t","0XP","4GJ3",35.14,"2.5","2.5","Tyk2 (JH1) in complex with 2,6-dichloro-4-cyano-N-[2-({[(1R,2R)-2-fluorocyclopropyl]carbonyl}amino)pyridin-4-yl]benzamide","MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRHHHHHH","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","4GJ3"
"4GJ5",,"X-RAY DIFFRACTION",3.15,60.95,"VAPOR DIFFUSION, HANGING DROP",,"reservoir: 18-21% PEG4000, 0.4-0.6 M sodium chloride, 50 mM sodium citrate, pH 4-5, protein solution: 10-15 mg/mL protein, 25 mM sodium chloride, 12.5 mM Tris, pH 8, drop: 1 uL protein solution + 1 uL reservoir, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm3017078",,"4GJ5",75.61,"2.4","2.4","Crystal structure of renin in complex with NVP-AMQ838 (compound 5)","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4GJ5"
"4GJ6",,"X-RAY DIFFRACTION",3.25,62.16,"VAPOR DIFFUSION, HANGING DROP",,"reservoir: 18-21% PEG4000, 0.4-0.6 M sodium chloride, 50 mM sodium citrate, pH 4-5, protein solution: 10-15 mg/mL protein, 25 mM sodium chloride, 12.5 mM Tris, pH 8, drop: 1 uL protein solution + 1 uL reservoir, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm3017078","0LS","4GJ6",76.77,"2.58","2.58","Crystal structure of renin in complex with NVP-AYZ832 (compound 6a)","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4GJ6"
"4GJ7",,"X-RAY DIFFRACTION",3.17,61.15,"VAPOR DIFFUSION, HANGING DROP",,"reservoir: 18-21% PEG4000, 0.4-0.6 M sodium chloride, 50 mM sodium citrate, pH 4-5, protein solution: 10-15 mg/mL protein, 25 mM sodium chloride, 12.5 mM Tris, pH 8, drop: 1 uL protein solution + 1 uL reservoir, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm3017078","0LT","4GJ7",75.98,"2.8","2.8","Crystal structure of renin in complex with NVP-BCA079 (compound 12a)","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4GJ7"
"4GJ8",,"X-RAY DIFFRACTION",3.17,61.18,"VAPOR DIFFUSION, HANGING DROP",,"reservoir: 18-21% PEG4000, 0.4-0.6 M sodium chloride, 50 mM sodium citrate, pH 4-5, protein solution: 10-15 mg/mL protein, 25 mM sodium chloride, 12.5 mM Tris, pH 8, drop: 1 uL protein solution + 1 uL reservoir, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301706j","0LU","4GJ8",76.14,"2.5","2.5","Crystal structure of renin in complex with PKF909-724 (compound 3)","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4GJ8"
"4GJ9",,"X-RAY DIFFRACTION",3.38,63.64,"VAPOR DIFFUSION, HANGING DROP",,"reservoir: 18-21% PEG4000, 0.4-0.6 M sodium chloride, 50 mM sodium citrate, pH 4-5, protein solution: 10-15 mg/mL protein, 25 mM sodium chloride, 12.5 mM Tris, pH 8, drop: 1 uL protein solution + 1 uL reservoir, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301706j","0M2","4GJ9",75.56,"2.6","2.6","Crystal structure of renin in complex with GP055321 (compound 4)","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4GJ9"
"4GJA",,"X-RAY DIFFRACTION",3.17,61.22,"VAPOR DIFFUSION, HANGING DROP",,"reservoir: 18-21% PEG4000, 0.4-0.6 M sodium chloride, 50 mM sodium citrate, pH 4-5, protein solution: 10-15 mg/mL protein, 25 mM sodium chloride, 12.5 mM Tris, pH 8, drop: 1 uL protein solution + 1 uL reservoir, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301706j","0M3","4GJA",76.22,"2.6","2.6","Crystal structure of renin in complex with NVP-AYL747 (compound 5)","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4GJA"
"4GJB",,"X-RAY DIFFRACTION",3.21,61.64,"VAPOR DIFFUSION, HANGING DROP",,"reservoir: 18-21% PEG4000, 0.4-0.6 M sodium chloride, 50 mM sodium citrate, pH 4-5, protein solution: 10-15 mg/mL protein, 25 mM sodium chloride, 12.5 mM Tris, pH 8, drop: 1 uL protein solution + 1 uL reservoir, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301706j","0ME","4GJB",75.81,"2.75","2.75","Crystal structure of renin in complex with NVP-BBV031 (compound 6)","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4GJB"
"4GJC",,"X-RAY DIFFRACTION",3.18,61.36,"VAPOR DIFFUSION, HANGING DROP",,"reservoir: 18-21% PEG4000, 0.4-0.6 M sodium chloride, 50 mM sodium citrate, pH 4-5, protein solution: 10-15 mg/mL protein, 25 mM sodium chloride, 12.5 mM Tris, pH 8, drop: 1 uL protein solution + 1 uL reservoir, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301706j","0MJ","4GJC",76.25,"2.4","2.4","Crystal structure of renin in complex with NVP-BCH965 (compound 9)","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4GJC"
"4GJD",,"X-RAY DIFFRACTION",3.2,61.51,"VAPOR DIFFUSION, HANGING DROP",,"reservoir: 18-21% PEG4000, 0.4-0.6 M sodium chloride, 50 mM sodium citrate, pH 4-5, protein solution: 10-15 mg/mL protein, 25 mM sodium chloride, 12.5 mM Tris, pH 8, drop: 1 uL protein solution + 1 uL reservoir, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301706j","0N0","4GJD",76.01,"2.65","2.65","Crystal structure of renin in complex with NVP-BGQ311 (compound 12)","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4GJD"
"4GJE",,"X-RAY DIFFRACTION",2.05,40.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"cadmium sulphate 0.05M, sodium acetate 1.0M, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S0907444913001182",,"4GJE",11.11,"1.6","1.6","Crystal structure of the refolded amino-terminal domain of human cardiac troponin C in complex with cadmium","MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGCISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRCMKDDS","Homo sapiens","TNNC, TNNC1","Troponin C, slow skeletal and cardiac muscles","1","4GJE"
"4GJF",,"X-RAY DIFFRACTION",1.97,37.5,"VAPOR DIFFUSION, SITTING DROP",8,"cadmium sulphate octahydrate 0.02M, sodium acetate 0.6M, 0.1M Tris-HCl, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S0907444913001182",,"4GJF",11.18,"1.9","1.9","Crystal structure of the amino-terminal domain of human cardiac troponin C mutant L29Q in complex with cadmium","MDDIYKAAVEQLTEEQKNEFKAAFDIFVQGAEDGCISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRCMKDDS","Homo sapiens","TNNC, TNNC1","Troponin C, slow skeletal and cardiac muscles","1","4GJF"
"4GJG",,"X-RAY DIFFRACTION",2.01,38.85,"VAPOR DIFFUSION, SITTING DROP",8,"cadmium sulphate octahydrate 0.02M, sodium acetate 0.6M, 0.1M Tris-HCl, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S0907444913001182",,"4GJG",11.21,"2","2","Crystal structure of the amino-terminal domain of human cardiac troponin C mutant D2N/V28I/L29Q/G30D (NIQD) in complex with cadmium.","MNDIYKAAVEQLTEEQKNEFKAAFDIFIQDAEDGCISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRCMKDDS","Homo sapiens","TNNC, TNNC1","Troponin C, slow skeletal and cardiac muscles","1","4GJG"
"4GJQ",,"X-RAY DIFFRACTION",3.37,63.52,"VAPOR DIFFUSION, HANGING DROP",7,"10 % PEG 3350, 0.1M MES pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444913000024",,"4GJQ",49.62,"2","2","Crystal structure of human GLTP bound with 12:0 monosulfatide (orthorhombic form;two subunits in asymmetric unit)","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKADISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","4GJQ"
"4GJX",,"X-RAY DIFFRACTION",3.26,62.24,"VAPOR DIFFUSION, SITTING DROP",5,"18% ethanol, 4% PEG 400, 0.1 M sodium acetate pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1074/jbc.M113.480657",,"4GJX",129.15,"2.8","2.8","Crystal structure of CD23 lectin domain mutant D258A","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEACVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","FCER2, CD23A, CLEC4J, FCE2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4GJX"
"4GJY",,"X-RAY DIFFRACTION",2.24,45.13,"VAPOR DIFFUSION, HANGING DROP",5.5,"4.5% PEG 3000, 0.1 M Bis-Tris pH 5.5, 0.05 M MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1128/MCB.00513-12",,"4GJY",27.61,"1.2492","1.2492","JMJD5 in complex with N-Oxalylglycine","STVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","JMJD5, KDM8","JmjC domain-containing protein 5","1","4GJY"
"4GJZ",,"X-RAY DIFFRACTION",2.24,45.14,"VAPOR DIFFUSION, HANGING DROP",6.2,"9.5% PEG 3000, 0.1 M Bis-Tris pH 6.2, 0.05 M MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1128/MCB.00513-12",,"4GJZ",27.55,"1.0481","1.0481","JMJD5 in complex with 2-oxoglutarate","STVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","JMJD5, JMJD5 (Amino Acids 183 - 416), KDM8","JmjC domain-containing protein 5","1","4GJZ"
"4GK1",,"X-RAY DIFFRACTION",2.48,50.38,"VAPOR DIFFUSION, SITTING DROP",5.5,"30% PEG 4000, 0.3M ammonium sulphate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1074/jbc.M113.480657",,"4GK1",116.35,"2.236","2.236","Crystal structure of CD23 lectin domain mutant D270A","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNAAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","FCER2, CD23A, CLEC4J, FCE2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4GK1"
"4GK2",,"X-RAY DIFFRACTION",1.84,33.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate pH 6.5, 0.15M ammonium sulf ate, 22.5% PEG 3350 
, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301187e","L66","4GK2",40.88,"2.195","2.195","Human EphA3 Kinase domain in complex with ligand 66","MGSSHHHHHHSSGLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","EPH receptor A3","1","4GK2"
"4GK3",,"X-RAY DIFFRACTION",1.88,34.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate pH 6.5, 0.15M ammonium sulf ate, 22.5% PEG 3350 
, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301187e","L87","4GK3",40.81,"1.898","1.898","Human EphA3 Kinase domain in complex with ligand 87","MGSSHHHHHHSSGLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","EPH receptor A3","1","4GK3"
"4GK4",,"X-RAY DIFFRACTION",1.86,33.91,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate pH 6.5, 0.15M ammonium sulf ate, 22.5% PEG 3350 
, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301187e","L90","4GK4",40.85,"2.1","2.1","Human EphA3 Kinase domain in complex with ligand 90","MGSSHHHHHHSSGLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","EPH receptor A3","1","4GK4"
"4GKA",,"X-RAY DIFFRACTION",2.02,39.07,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M zinc acetate, 10% (v/v) 2-propanol, 0.1M sodium cacodylate , pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.chembiol.2013.01.009",,"4GKA",217.52,"2.2","2.2","Crystal structure of purine nucleoside phosphorylase (W16Y, W94Y, W178Y, H257W) mutant from human complexed with phosphate","MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPTLMENGYTYEDYKNTAEYLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLYKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTYKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANWEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","NP, PNP, X00737.1","Purine nucleoside phosphorylase","1","4GKA"
"4GKC",,"X-RAY DIFFRACTION",2.07,40.69,"EVAPORATION",4.6,"40% PEG 4000, 0.1M CH3COONa.3H2O, 0.1 M CH3COONH4, EVAPORATION, temperature 298K, pH 4.6",298,"10.1126/science.1226135","RET","4GKC",31.75,"1.3","1.3","Crystal structure of Q108K:K40L:T51V:T53C:R58W:T29L:Y19W:Q4A mutant of cellular retinol binding protein II complex with all-trans-retinal at 1.33","TRDANGTWEMESNENFEGWMKALDIDFALRKIAVRLTQTLVIDQDGDNFKVKCTSTFWNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","4GKC"
"4GKX",,"X-RAY DIFFRACTION",2.45,49.84,"VAPOR DIFFUSION, HANGING DROP",6.2,"17% PEG 8000, 0.002M calcium chloride, 0.01M alpha-1,2-dimannose, 0.05M sodium cacodylate, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.461434",,"4GKX",175.22,"2.7","2.7","Crystal structure of a carbohydrate-binding domain","MGSSHHHHHHSSGLVPRGSHMDGVGGDPAVALPHRRFEYKYSFKGPHLVQSDGTVPFWAHAGNAIPSSDQIRVAPSLKSQRGSVWTKTKAAFENWEVEVTFRVTGRGRIGADGLAIWYAENQGLEGPVFGSADLWNGVGIFFDSFDNDGKKNNPAIVIIGNNGQIHYDHQNDGASQALASCQRDFRNKPYPVRAKITYYQNTLTVMINNGFTPDKNDYEFCAKVENMIIPAQGHFGISAATGGLADDHDVLSFLTFQLTEP","Homo sapiens","ERGIC53, F5F8D, LMAN1","Protein ERGIC-53","1","4GKX"
"4GKY",,"X-RAY DIFFRACTION",2.35,47.57,"VAPOR DIFFUSION, HANGING DROP",6.2,"17% PEG 8000, 0.002M calcium chloride, 0.01M alpha-1,2-dimannose, 0.05M sodium cacodylate, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.461434",,"4GKY",29.12,"2.4201","2.4201","Crystal structure of a carbohydrate-binding domain","MGSSHHHHHHSSGLVPRGSHMDGVGGDPAVALPHRRFEYKYSFKGPHLVQSDGTVPFWAHAGNAIPSSDQIRVAPSLKSQRGSVWTKTKAAFENWEVEVTFRVTGRGRIGADGLAIWYAENQGLEGPVFGSADLWNGVGIFFDSFDNDGKKNNPAIVIIGNNGQIHYDHQNDGASQALASCQRDFRNKPYPVRAKITYYQNTLTVMINNGFTPDKNDYEFCAKVENMIIPAQGHFGISAATGGLADDHDVLSFLTFQLTEP","Homo sapiens","ERGIC53, F5F8D, LMAN1","Protein ERGIC-53","1","4GKY"
"4GKZ",,"X-RAY DIFFRACTION",2.49,50.69,"VAPOR DIFFUSION, SITTING DROP",8.5,"100 mM Bis-Tris Propane, 200mM Sodium Bromide, 20% PEG 3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/srep00629",,"4GKZ",50.63,"2.39","2.39","HA1.7, a MHC class II restricted TCR specific for haemagglutinin","MQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSESPFGNEKLTFGTGTRLTIIPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTF","Homo sapiens",,"Alpha chain of Class II TCR","1","4GKZ"
,,,,,,,,,,,,,,,,"VKVTQSSRYLVKRTGEKVFLECVQDMDHENMFWYRQDPGLGLRLIYFSYDVKMKEKGDIPEGYSVSREKKERFSLILESASTNQTSMYLCASSSTGLPYGYTFGSGTRLTVVEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFFPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRA","Homo sapiens",,"Beta Chain of Class II TCR","2","4GKZ"
"4GL1",,"X-RAY DIFFRACTION",2.06,40.27,"VAPOR DIFFUSION, HANGING DROP",8,"1.0 to 1.3 Sodium Citrate and 50 to 100 mM Tris Buffer pH 7-9, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4GL1",29.29,"1.5","1.5","Structure of H64A/N62L/N67L Human Carbonic Anhydrase II triple mutant","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNLGAAFLVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4GL1"
"4GL2",,"X-RAY DIFFRACTION",2.89,57.4,"VAPOR DIFFUSION, HANGING DROP",7,"pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.cell.2012.11.048",,"4GL2",177.42,"3.557","3.557","Structural Basis for dsRNA duplex backbone recognition by MDA5","GPGAMLQLRPYQMEVAQPALEGKNIIICLPTGCGKTRVAVYIAKDHLDKKKKASEPGKVIVLVNKVLLVEQLFRKEFQPFLKKWYRVIGLSGDTQLKISFPEVVKSCDIIISTAQILENSLLNLENGEDAGVQLSDFSLIIIDECHHTNKEAVYNNIMRHYLMQKLKNNRLKKENKPVIPLPQILGLTASPGVGGATKQAKAEEHILKLCANLDAFTIKTVKENLDQLKNQIQEPCKKFAIADATREDPFKEKLLEIMTRIQTYCQMSPMSDFGTQPYEQWAIQMEKKAAKEGNRKERVCAEHLRKYNEALQINDTIRMIDAYTHLETFYNEEKDKKFAVIEDDLKKPLKLDETDRFLMTLFFENNKMLKRLAENPEYENEKLTKLRNTIMEQYTRTEESARGIIFTKTRQSAYALSQWITENEKFAEVGVKAHHLIGAGHSSEFKPMTQNEQKEVISKFRTGKINLLIATTVAEEGLDIKECNIVIRYGLVTNEIAMVQARGRARADESTYVLVAHSGSGVIERETVNDFREKMMYKAIHCVQNMKPEEYAHKILELQMQSIMEKKMKTKRNIAKHYKNNPSLITFLCKNCSVLACSGEDIHVIEKMHHVNMTPEFKELYIVRENKTLQKKCADYQINGEIICKCGQAWGTMMVHKGLDLPCLKIRNFVVVFKNNSTKKQYKKWVELPITFPNLDYSE","Homo sapiens","IFIH1, MDA5, RH116","Interferon-induced helicase C domain-containing protein 1","1","4GL2"
,,,,,,,,,,,,,,,,"AUCCGCGGCCCU",,,"RNA (5'-R(*AP*UP*CP*CP*GP*CP*GP*GP*CP*CP*CP*U)-3')","2","4GL2"
,,,,,,,,,,,,,,,,"AGGGCCGCGGAU",,,"RNA (5'-R(P*AP*GP*GP*GP*CP*CP*GP*CP*GP*GP*AP*U)-3')","3","4GL2"
"4GL5",,"X-RAY DIFFRACTION",5.82,78.88,"VAPOR DIFFUSION",7.4,"The enzyme-inhibitor complexes were prepared by the addition from 20mM stock solutions of compound 4 in PEG550 to 18  M (~1mg/ml) of aromatase, to give a final inhibitor concentration of 300 uM.  The mixture was incubated overnight at 4 C in 100mM potassium phosphate buffer pH 7.4 containing 20% glycerol, 20mM dithiothreitol, 0.5  M ASD and 1mM BDM.  The complex was then concentrated to 25-30mg/ml using ultrafiltration. Protein was setup for crystallization using protein to cocktail ratios 2:1 and 3:1. The protein was mixed with reservoir cocktails of 24-30% polyethylene glycol 4000 in 50mM NaCl, 50mM Tris, pH 8.5 and vapor diffused in sealed 24-well sitting drop plates against corresponding reservoir solution., VAPOR DIFFUSION, temperature 277K",277,"10.1021/jm300930n","G29","4GL5",58.92,"3.48","3.48","Structure of human placental aromatase complexed with designed inhibitor HDDG029 (compound 4)","MVLEMLNPIHYNITSIVPEAMPAATMPVLLLTGLFLLVWNYEGTSSIPGPGYCMGIGPLISHGRFLWMGIGSACNYYNRVYGEFMRVWISGEETLIISKSSSMFHIMKHNHYSSRFGSKLGLQCIGMHEKGIIFNNNPELWKTTRPFFMKALSGPGLVRMVTVCAESLKTHLDRLEEVTNESGYVDVLTLLRRVMLDTSNTLFLRIPLDESAIVVKIQGYFDAWQALLIKPDIFFKISWLYKKYEKSVKDLKDAIEVLIAEKRRRISTEEKLEECMDFATELILAEKRGDLTRENVNQCILEMLIAAPDTMSVSLFFMLFLIAKHPNVEEAIIKEIQTVIGERDIKIDDIQKLKVMENFIYESMRYQPVVDLVMRKALEDDVIDGYPVKKGTNIILNIGRMHRLEFFPKPNEFTLENFAKNVPYRYFQPFGFGPRGCAGKYIAMVMMKAILVTLLRRFHVKTLQGQCVESIQKIHDLSLHPDETKNMLEMIFTPRNSDRCLEH","Homo sapiens","CYP19A1, ARO1, CYAR, CYP19","Cytochrome P450 19A1","1","4GL5"
"4GL7",,"X-RAY DIFFRACTION",5.92,79.23,"VAPOR DIFFUSION, SITTING DROP",7.4,"The enzyme-inhibitor complexes were prepared by the addition from 20mM stock solutions of compound 5 in PEG550 to 18 M (~1mg/ml) of aromatase, to give a final inhibitor concentration of 300 microM. The mixture was incubated overnight at 4 C in 100mM potassium phosphate buffer pH 7.4 containing 20% glycerol, 20mM dithiothreitol, 0.5 microM ASD and 1mM BDM. The complex was then concentrated to 25-30mg/ml using ultrafiltration. Protein was setup for crystallization using protein to cocktail ratios 2:1 and 3:1. The protein was mixed with reservoir cocktails of 24-30% polyethylene glycol 4000 in 50mM NaCl, 50mM Tris, pH 8.5 and vapor diffused in sealed 24-well sitting drop plates against corresponding reservoir solution, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm300930n","0XJ","4GL7",58.94,"3.9","3.9","Structure of human placental aromatase complexed with designed inhibitor HDDG046 (compound 5)","MVLEMLNPIHYNITSIVPEAMPAATMPVLLLTGLFLLVWNYEGTSSIPGPGYCMGIGPLISHGRFLWMGIGSACNYYNRVYGEFMRVWISGEETLIISKSSSMFHIMKHNHYSSRFGSKLGLQCIGMHEKGIIFNNNPELWKTTRPFFMKALSGPGLVRMVTVCAESLKTHLDRLEEVTNESGYVDVLTLLRRVMLDTSNTLFLRIPLDESAIVVKIQGYFDAWQALLIKPDIFFKISWLYKKYEKSVKDLKDAIEVLIAEKRRRISTEEKLEECMDFATELILAEKRGDLTRENVNQCILEMLIAAPDTMSVSLFFMLFLIAKHPNVEEAIIKEIQTVIGERDIKIDDIQKLKVMENFIYESMRYQPVVDLVMRKALEDDVIDGYPVKKGTNIILNIGRMHRLEFFPKPNEFTLENFAKNVPYRYFQPFGFGPRGCAGKYIAMVMMKAILVTLLRRFHVKTLQGQCVESIQKIHDLSLHPDETKNMLEMIFTPRNSDRCLEH","Homo sapiens","CYP19A1, ARO1, CYAR, CYP19","Cytochrome P450 19A1","1","4GL7"
"4GLL",,"X-RAY DIFFRACTION",2.96,58.44,"VAPOR DIFFUSION, HANGING DROP",8,"1.3 M AMMONIUM SULFATE, 0.1 M MAGNESIUM FORMATE AND 0.15% 1.5K PEG, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi301135b",,"4GLL",77.75,"2.5","2.5","Crystal structure of human UDP-xylose synthase.","MEKDRKRILITGGAGFVGSHLTDKLMMDGHEVTVVDNFFTGRKRNVEHWIGHENFELINHDVVEPLYIEVDQIYHLASPASPPNYMYNPIKTLKTNTIGTLNMLGLAKRVGARLLLASTSEVYGDPEVHPQSEDYWGHVNPIGPRACYDEGKRVAETMCYAYMKQEGVEVRVARIFNTFGPRMHMNDGRVVSNFILQALQGEPLTVYGSGSQTRAFQYVSDLVNGLVALMNSNVSSPVNLGNPEEHTILEFAQLIKNLVGSGSEIQFLSEAQDDPQKRKPDIKKAKLMLGWEPVVPLEEGLNKAIHYFRKELEYQANNQYIPKPKPARIKKGRTRHS","Homo sapiens","UNQ2538/PRO6079, UXS, UXS1","UDP-glucuronic acid decarboxylase 1","1","4GLL"
"4GLM",,"X-RAY DIFFRACTION",2.15,42.84,,8.5,"5% PEG 8000, 0.2 M NaCl, and 0.1 M Tris 8.5, vapor diffusion hanging drop, temperature 291K",291,,,"4GLM",31.01,"1.9","1.9","Crystal structure of the SH3 Domain of DNMBP protein [Homo sapiens]","GGAAQPAMAQGALTYGVALYRFQALEPNELDFEVGDKIRILATLEDGWLEGSLKGRTGIFPYRFVKLCPAAA","Homo sapiens","DNMBP, KIAA1010, ARHGEF36, TUBA","Dynamin-binding protein","1","4GLM"
"4GLP",,"X-RAY DIFFRACTION",4.13,70.23,"VAPOR DIFFUSION, HANGING DROP",6,"30% PEG 6000, 0.1 M 2-(N-morpholino)ethanesulfonic acid, 0.2 M calcium acetate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.4049/jimmunol.1202446",,"4GLP",33.51,"4.002","4.002","The crystal structure of soluble human CD14 reveals a bent solenoid with a hydrophobic amino-terminal pocket.","ELDDEDFRCVCNFSEPQPDWSEAFQCVSAVEVEIHAGGLNLEPFLKRVDADADPRQYADTVKALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLPAKLRVLDLSSNRLNRAPQPDELPEVDNLTLDGNPFLVPG","Homo sapiens","CD14","Monocyte differentiation antigen CD14","1","4GLP"
"4GLS",,"X-RAY DIFFRACTION",2.64,53.43,"VAPOR DIFFUSION, HANGING DROP",8.4,"Proteins were dissolved in 0.01 M HEPES, 50 mM NaCl at pH 8.4 and crystallized against reservoir containing 0.1 M MgCl2, 0.1 M HEPES, 12.5% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1073/pnas.1210483109",,"4GLS",73.49,"1.6","1.6","Crystal Structure of Chemically Synthesized Heterochiral {D-Protein Antagonist plus VEGF-A} Protein Complex in space group P21","GQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKD",,,"D- Vascular endothelial growth factor-A","1","4GLS"
,,,,,,,,,,,,,,,,"TYKLILNGKTLKGETTTEAVDVFDAFDVFFVYAASNFSDFDDWTYDDATKTFTVTE",,,"L- RFX001","2","4GLS"
,,,,,,,,,,,,,,,,"GQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKD","Homo sapiens","VEGFA, VEGF","Vascular endothelial growth factor A","4","4GLS"
,,,,,,,,,,,,,,,,"TYKLILNGKTLKGETTTEAVDVFDAFDVFFVYAASNFSDFDDWTYDDATKTFTVTE",,,"D- RFX001","3","4GLS"
"4GM3",,"X-RAY DIFFRACTION",2.24,45.05,"VAPOR DIFFUSION, HANGING DROP",4.6,"25% PEG4000, 0.2 M ammonium sulfate, 0.1 M sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ja306028q",,"4GM3",280.21,"3.393","3.393","Crystal structure of human WD repeat domain 5 with compound MM-101","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","4GM3"
,,,,,,,,,,,,,,,,"XXRXX",,,"MM-101","2","4GM3"
"4GM8",,"X-RAY DIFFRACTION",2.24,45.07,"VAPOR DIFFUSION, HANGING DROP",8,"30% PEG8000, 0.2 M ammonium sulfate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ja306028q",,"4GM8",140.25,"2.601","2.601","Crystal structure of human WD repeat domain 5 with compound MM-102","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","4GM8"
,,,,,,,,,,,,,,,,"XXRXX",,,"MM-102","2","4GM8"
"4GM9",,"X-RAY DIFFRACTION",2.1,41.47,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG4000, 0.2 M magnesium chloride, 0.1 M Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.00K",293,,,"4GM9",69.99,"2.1","2.1","Crystal structure of human WD repeat domain 5 with compound MM-401","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","4GM9"
,,,,,,,,,,,,,,,,"XXRAG",,,"MM-401","2","4GM9"
"4GMB",,"X-RAY DIFFRACTION",2.37,48.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% tert-butanol, 0.1 M Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acs.jmedchem.6b01796",,"4GMB",35.02,"2.781","2.781","Crystal structure of human WD repeat domain 5 with compound MM-402","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","4GMB"
,,,,,,,,,,,,,,,,"XXRAG",,,"MM-402","2","4GMB"
"4GMI",,"X-RAY DIFFRACTION",2.21,44.26,"VAPOR DIFFUSION, HANGING DROP",4.5,"18% PEG 1000, 0.1 Na-Acetate, 5% Glycerol  , pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4GMI",44.26,"1.8","1.8","BACE-1 in complex with HEA-type macrocyclic inhibitor, MV078571","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4GMI"
"4GML",,"X-RAY DIFFRACTION",2.99,58.93,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.1M BTP, 1.6M AmSO4, 0.2M LiCl , pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/nar/gks883",,"4GML",163.62,"2.9","2.9","Crystal structure of human NOT1 MIF4G domain","VLFQGPHMLEENIQEKIAFIFNNLSQSNMTQKVEELKETVKEEFMPWVSQYLVMKRVSIEPNFHSLYSNFLDTLKNPEFNKMVLNETYRNIKVLLTSDKAAANFSDRSLLKNLGHWLGMITLAKNKPILHTDLDVKSLLLEAYVKGQQELLYVVPFVAKVLESSIRSVVFRPPNPWTMAIMNVLAELHQEHDLKLNLKFEIEVLCKNLALDINELKPGNLLKDKDRLKNLDEQLS","Homo sapiens","AD-005, CDC39, CNOT1, KIAA1007, NOT1","CCR4-NOT transcription complex subunit 1","1","4GML"
"4GMV",,"X-RAY DIFFRACTION",2.63,53.27,"VAPOR DIFFUSION, HANGING DROP",7,"50 mM sodium formate, 20% (w/v) polyethylene glycol 3350, 30% (v/v) ethylene glycol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1007/s13238-013-2082-5",,"4GMV",66.47,"2.403","2.403","Crystal Structure of the coiled-coil, RA and PH domains of Lamellipodin","QPITEEEQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMSDDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVETVSELQMERIFEDHENLVENLLNWTRDSQNKLIFMERIEKYALFKNPQNYLLGKKETAEMADRNKEVLLEECFCGSSVTVPEIEGVLWLKDDGKKSWKKRYFLLRASGIYYVPKGKAKVSRDLVCFLQLDHVNVYYGQDYRNKYKAPTDYCLVLKHPQIQKKSQYIKYLCCDDVRTLHQWVNGIRIAKYGKQLYMNYQEALKRT","Homo sapiens","RAPH1, ALS2CR18, ALS2CR9, KIAA1681, LPD, PREL2, RMO1","Ras-associated and pleckstrin homology domains-containing protein 1","1","4GMV"
"4GMY",,"X-RAY DIFFRACTION",2.62,53.04,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M Na Citrate pH 6, 0.2 M NH4OAc, PEG 8K, vapor diffusion, hanging drop, temperature 300K",300,"10.1016/j.ejmech.2013.03.070","0X5","4GMY",35.84,"2.403","2.403","JAK2 kinase (JH1 domain) in complex with 2,6-DICHLORO-N-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE","GSSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4GMY"
"4GN1",,"X-RAY DIFFRACTION",2.27,45.8,"VAPOR DIFFUSION, HANGING DROP",7,"200 mM sodium malonate pH 5.0, 20% (w/v) polyethylene glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1007/s13238-013-2082-5",,"4GN1",121.42,"2.4","2.4","Crystal Structure of the RA and PH domains of Lamellipodin","AQVKKLVIRVHMSDDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVETVSELQMERIFEDHENLVENLLNWTRDSQNKLIFMERIEKYALFKNPQNYLLGKKETAEMADRNKEVLLEECFCGSSVTVPEIEGVLWLKDDGKKSWKKRYFLLRASGIYYVPKGKAKVSRDLVCFLQLDHVNVYYGQDYRNKYKAPTDYCLVLKHPQIQKKSQYIKYLCCDDVRTLHQWVNGIRIAKYGKQLYMNYQEALKRT","Homo sapiens","RAPH1, ALS2CR18, ALS2CR9, KIAA1681, LPD, PREL2, RMO1","Ras-associated and pleckstrin homology domains-containing protein 1","1","4GN1"
"4GNB",,"X-RAY DIFFRACTION",2.1,41.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG6000, 100mM Tris-HCl, 5mM CaCl2, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0053706",,"4GNB",66.7,"1.5","1.5","human SMP30/GNL","MSSIKIECVLPENCRCGESPVWEEVSNSLLFVDIPAKKVCRWDSFTKQVQRVTMDAPVSSVALRQSGGYVATIGTKFCALNWKEQSAVVLATVDNDKKNNRFNDGKVDPAGRYFAGTMAEETAPAVLERHQGALYSLFPDHHVKKYFDQVDISNGLDWSLDHKIFYYIDSLSYSVDAFDYDLQTGQISNRRSVYKLEKEEQIPDGMCIDAEGKLWVACYNGGRVIRLDPVTGKRLQTVKLPVDKTTSCCFGGKNYSEMYVTCARDGMDPEGLLRQPEAGGIFKITGLGVKGIAPYSYAG","Homo sapiens","SMP30, RGN","Regucalcin","1","4GNB"
"4GNC",,"X-RAY DIFFRACTION",2.07,40.64,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG6000, 100mM Tris-HCl, 5mM CaCl2, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0053706",,"4GNC",67.48,"1.749","1.749","human SMP30/GNL-1,5-AG complex","MSSIKIECVLPENCRCGESPVWEEVSNSLLFVDIPAKKVCRWDSFTKQVQRVTMDAPVSSVALRQSGGYVATIGTKFCALNWKEQSAVVLATVDNDKKNNRFNDGKVDPAGRYFAGTMAEETAPAVLERHQGALYSLFPDHHVKKYFDQVDISNGLDWSLDHKIFYYIDSLSYSVDAFDYDLQTGQISNRRSVYKLEKEEQIPDGMCIDAEGKLWVACYNGGRVIRLDPVTGKRLQTVKLPVDKTTSCCFGGKNYSEMYVTCARDGMDPEGLLRQPEAGGIFKITGLGVKGIAPYSYAG","Homo sapiens","SMP30, RGN","Regucalcin","1","4GNC"
"4GND",,"X-RAY DIFFRACTION",2.22,44.71,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes, 1.1M Sodium Malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 283K",283,"10.1074/jbc.M112.426148",,"4GND",24.64,"2.27","2.27","Crystal Structure of NSD3 tandem PHD5-C5HCH domains","SNARKIKTEPKQMHEDYCFQCGDGGELVMCDKKDCPKAYHLLCLNLTQPPYGKWECPWHQCDECSSAAVSFCEFCPHSFCKDHEKGALVPSALEGRLCCSEHDPMAP","Homo sapiens","WHSC1L1, NSD3, DC28","Histone-lysine N-methyltransferase NSD3","1","4GND"
"4GOD",,"X-RAY DIFFRACTION",1.9,35.43,"VAPOR DIFFUSION, SITTING DROP",8.5,"45% 2-methyl-2,4-pentanediol, 0.2 M ammonium acetate, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.celrep.2012.10.010",,"4GOD",11.71,"1.4","1.4","Crystal structure of the SGTA homodimerization domain","MKKRLAYAIIQFLHDQLRHGGLSSDAQESLEVAIQCLETAFGVTVEDSDLAL","Homo sapiens","SGT, SGT1, SGTA","Small glutamine-rich tetratricopeptide repeat-containing protein alpha","1","4GOD"
"4GOE",,"X-RAY DIFFRACTION",1.83,32.72,"VAPOR DIFFUSION, SITTING DROP",5,"10% 2-propanol, 0.1 M sodium citrate, 26% PEG 400, 10 mM 2-mercaptoethanol, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.celrep.2012.10.010",,"4GOE",11.59,"1.45","1.45","Crystal structure of the SGTA homodimerization domain with a covalent modification of a single C38","MKKRLAYAIIQFLHDQLRHGGLSSDAQESLEVAIQCLETAFGVTVEDSDLAL","Homo sapiens","SGT, SGT1, SGTA","Small glutamine-rich tetratricopeptide repeat-containing protein alpha","1","4GOE"
"4GOF",,"X-RAY DIFFRACTION",1.78,31.09,"VAPOR DIFFUSION, SITTING DROP",5,"10% 2-propanol, 0.1 M sodium citrate, 26% PEG 400, 10 mM 2-mercaptoethanol, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.celrep.2012.10.010",,"4GOF",11.67,"1.35","1.35","Crystal structure of the SGTA homodimerization domain with covalent modifications to both C38","MKKRLAYAIIQFLHDQLRHGGLSSDAQESLEVAIQCLETAFGVTVEDSDLAL","Homo sapiens","SGT, SGT1, SGTA","Small glutamine-rich tetratricopeptide repeat-containing protein alpha","1","4GOF"
"4GOS",,"X-RAY DIFFRACTION",2.28,46.06,"VAPOR DIFFUSION",7,"200 mM tri-Potassium citrate, 2.2 M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.celrep.2014.09.053",,"4GOS",14.63,"1.59","1.59","Crystal structure of human B7-H4 IgV-like domain","GISGRHSITVTTVASAGNIGEDGILSCTFEPDIKLSDIVIQWLKEGVLGLVHEFKEGKDELSEQDEMFRGRTAVFADQVIVGNASLRLKNVQLTDAGTYKCYIITSKGKGNANLEYKTGHHHHHH","Homo sapiens","B7-H4, B7H4, B7S1, B7x, UNQ659/PRO1291, VTCN1","V-set domain-containing T-cell activation inhibitor 1","1","4GOS"
,,,,,"VAPOR DIFFUSION",7,"200 mM tri-Potassium citrate, 2.2 M ammonium sulfate, I3C (magic triangle) soak, pH 7.0, VAPOR DIFFUSION, temperature 291K",291
"4GOV",,"X-RAY DIFFRACTION",2.2,44.03,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Hepes, 16% PEG 4000, 1% isopropanol , pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M112.427971",,"4GOV",111.28,"2.2","2.2","The crystal structure of human fascin 1 S39D mutant","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASDLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FAN1, FSCN1, HSN, SNL","Fascin","1","4GOV"
"4GOY",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION, HANGING DROP",8,"100mM Hepes, 16% PEG 4000, 1% isopropanol , pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M112.427971",,"4GOY",110.79,"2.3","2.3","The crystal structure of human fascin 1 K41A mutant","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLAKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FAN1, FSCN1, HSN, SNL","Fascin","1","4GOY"
"4GP0",,"X-RAY DIFFRACTION",2.19,43.88,"VAPOR DIFFUSION, HANGING DROP",8,"100mM Hepes, 16% PEG 4000, 1% isopropanol , pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M112.427971",,"4GP0",111.95,"2.5","2.5","The crystal structure of human fascin 1 R149A K150A R151A mutant","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTAAAYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FAN1, FSCN1, HSN, SNL","Fascin","1","4GP0"
"4GP3",,"X-RAY DIFFRACTION",2.19,43.76,"VAPOR DIFFUSION, HANGING DROP",8,"100mM Hepes, 16% PEG 4000, 1% isopropanol , pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M112.427971",,"4GP3",110.93,"2.25","2.25","The crystal structure of human fascin 1 K358A mutant","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSAKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FAN1, FSCN1, HSN, SNL","Fascin","1","4GP3"
"4GPI",,"X-RAY DIFFRACTION",2.44,49.69,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 8% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/ncomms2759",,"4GPI",59.87,"2.0817","2.0817","Crystal structure of human B type phosphoglycerate mutase","MAAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVRKAMEAVAAQGKAKKLEHHHHHH","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","1","4GPI"
"4GPJ",,"X-RAY DIFFRACTION",2.17,43.26,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.20M Na2SO4, 0.1M BTProp, 20.0% PEG 3350, 10.0% EtGly, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1039/C2MD20189E","0Q1","4GPJ",15.55,"1.6","1.6","Crystal Structure of the first bromodomain of human BRD4 in complex with a isoxazolylbenzimidazole ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4GPJ"
"4GPL",,"X-RAY DIFFRACTION",3.34,63.13,"VAPOR DIFFUSION, HANGING DROP",,"0.25M potassium sodium tartrate tetrahydrate, 20% w/v PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/srep01639",,"4GPL",36.55,"3","3","Structure of Cbl(TKB) bound to a phosphorylated pentapeptide","XYTPEPX",,,"ACE-PTR-THR-PRO-GLU-PRO, PEPTIDE INHIBITOR","1","4GPL"
,,,,,,,,,,,,,,,,"GSHMPPGTVDKKMVEKCWKLMDKVVRLCQNPKLALKNSPPYILDLLPDTYQHLRTILSRYEGKMETLGENEYFRVFMENLMKKTKQTISLFKEGKERMYEENSQPRRNLTKLSLIFSHMLAELKGIFPSGLFQGDTFRITKADAAEFWRKAFGEKTIVPWKSFRQALHEVHPISSGLEAMALKSTIDLTCNDYISVFEFDIFTRLFQPWSSLLRNWNSLAVTHPGYMAFLTYDEVKARLQKFIHKPGSYIFRLSCTRLGQWAIGYVTADGNILQTIPHNKPLFQALIDGFREGFYLFPDGRNQNPDLTG","Homo sapiens","CBL, CBL2, RNF55","E3 ubiquitin-protein ligase CBL","2","4GPL"
"4GPQ",,"X-RAY DIFFRACTION",2.24,44.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M ammonium acetate, 0.1 M HEPES pH 7.5 and 25% w/v PEG 
3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM 
Tris-HCl (pH 8.0), 50mM NaCl, and 1mM TCEP. Prior to data collection, 
crystals were transferred into a cryo-solution containing 20% PEG550 
MME and flash-frozen in liquid nitrogen, VAPOR DIFFUSION, SITTING DROP",,"10.1182/blood-2012-05-429274",,"4GPQ",55.21,"1.46","1.46","Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPAASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","4GPQ"
"4GPZ",,"X-RAY DIFFRACTION",2.38,48.29,"VAPOR DIFFUSION, HANGING DROP",6,"PEG3350, MES, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/ncomms2759",,"4GPZ",60.42,"1.65","1.65","Crystal structure of human B type phosphoglycerate mutase H11 phosphorylated form","MAAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVRKAMEAVAAQGKAKKLEHHHHHH","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","1","4GPZ"
"4GQ0",,"X-RAY DIFFRACTION",2.56,51.91,"VAPOR DIFFUSION, HANGING DROP",9,"100mM Tris, 30-35% PEG6000, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,"QAP","4GQ0",37.33,"2.1","2.1","Crystal structure of AKR1B10 complexed with NADP+ and Caffeic acid phenethyl ester","SHMATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPKDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNVLQSSHLEDYPFDAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4GQ0"
"4GQ3",,"X-RAY DIFFRACTION",2.23,44.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M ammonium acetate, 0.1 M HEPES pH 7.5 and 25% w/v PEG   
3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM   
Tris-HCl (pH 8.0), 50mM NaCl, and 1mM TCEP. Prior to data collection,   
crystals were transferred into a cryo-solution containing 20% PEG550   
MME and flash-frozen in liquid nitrogen, 200 mM 0RO, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1182/blood-2012-05-429274","0RO","4GQ3",55.53,"1.56","1.56","Human menin with bound inhibitor MI-2","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPAASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","4GQ3"
"4GQ4",,"X-RAY DIFFRACTION",2.25,45.28,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium acetate, 0.1 M HEPES pH 7.5 and 25% w/v PEG     
3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM     
Tris-HCl (pH 8.0), NBm1 peptide, 50mM NaCl, and 1mM TCEP. Prior to data collection,     
crystals were transferred into a cryo-solution containing 20% PEG550     
MME and flash-frozen in liquid nitrogen, 200 mM 0RT, VAPOR DIFFUSION, SITTING DROP",,"10.1182/blood-2012-05-429274","0RT","4GQ4",56.4,"1.27","1.27","Human menin with bound inhibitor MI-2-2","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPAASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","4GQ4"
"4GQG",,"X-RAY DIFFRACTION",2.48,50.49,"VAPOR DIFFUSION, HANGING DROP",9,"100mM Tris, 30-35% PEG6000, 3-5% 1,6-Hexanediol, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.febslet.2013.09.031",,"4GQG",37.04,"1.92","1.92","Crystal structure of AKR1B10 complexed with NADP+","SHMATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPKDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNVLQSSHLEDYPFDAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4GQG"
"4GQI",,"X-RAY DIFFRACTION",2.38,48.29,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2012.10.005","M49","4GQI",54.04,"1.948","1.948","Synthesis of novel MT3 receptor ligands via unusual Knoevenagel condensation","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4GQI"
"4GQL",,"X-RAY DIFFRACTION",2.31,46.75,"VAPOR DIFFUSION, SITTING DROP",8.5,"Reservoir: 25% PEG 10000, 0.2M imidazole malate. Cryoprotectant: 27% PEG 8000, 15% MPEG 550, 10% glycerol, .01M hydroxamic acid, 90mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm301574d","R47","4GQL",18.68,"1.15","1.15","Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhibitor RXP470.1","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","4GQL"
"4GQQ",,"X-RAY DIFFRACTION",2,38.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM sodium cacodylate, 60% MPD, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/jm301273u","0XR","4GQQ",56.85,"1.35","1.35","Human pancreatic alpha-amylase with bound ethyl caffeate","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","4GQQ"
"4GQR",,"X-RAY DIFFRACTION",2.04,39.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"60% MPD, 100 mM sodium cacodylate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/jm301273u","MYC","4GQR",56.55,"1.2","1.2","Human Pancreatic alpha-amylase in complex with myricetin","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","4GQR"
"4GQS",,"X-RAY DIFFRACTION",2.51,51.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 2000, 10% isopropanol, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1074/jbc.M112.424895",,"4GQS",222.19,"2.87","2.87","Structure of Human Microsomal Cytochrome P450 (CYP) 2C19","MAKKTSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKIYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFMESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVVGRNRSPCMQDRGHMPYTDAVVHEVQRYIDLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFKKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVPPFYQLCFIPIHHHH","Homo sapiens","CYP2C19","Cytochrome P450 2C19","1","4GQS"
"4GR0",,"X-RAY DIFFRACTION",2.35,47.69,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein complex: hMMP12 F171D 855 microM, inhibitor 0.788 milliM. Reservoir: 35% PEG 4,000  
0.2M imidazole malate pH 8.5. Drops: 1 microL protein complex + 1 microL reservoir. Cryoprotectant: 40% MPEG 5K, 10% 1,2-propanediol, (10% (Na acetate, ADA, Bicine) 90% at pH 4/ 10% at pH 9.0). Flash freezing in Liquid N2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm301574d","R4B","4GR0",18.57,"1.497","1.497","Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhibitor RXP470B","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","4GR0"
"4GR1",,"X-RAY DIFFRACTION",2.65,53.51,,,,,"10.2210/pdb4gr1/pdb",,"4GR1",53.13,"2.4","2.4","THE BINDING OF THE RETRO-ANALOGUE OF GLUTATHIONE DISULFIDE TO GLUTATHIONE REDUCTASE","ACRQEPQPQGPPPAAGAVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHSEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDPKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR","Homo sapiens","GSR, GLUR, GRD1","GLUTATHIONE REDUCTASE","1","4GR1"
"4GR3",,"X-RAY DIFFRACTION",2.31,46.64,"VAPOR DIFFUSION, SITTING DROP",8,"Protein: hMMP12(F171D) 643 microM. Reservoir: 18% PEG 10000, 0.2 M imidazole malate pH 8.0. Cryoprotectant: 27% PEG 8000, 15% monomethylPEG 550, 10% glycerol, 0.09 M Tris-HCl, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm301574d","R45","4GR3",18.57,"1.494","1.494","Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhibitor RXP470A","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","4GR3"
"4GR7",,"X-RAY DIFFRACTION",2.2,44.06,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.18 M Li2SO4, 0.1 M Tris-HCl, 22% (w/v) PEG 4000, 15% (v/v) glycerol , pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.416354",,"4GR7",41.31,"1.7","1.7","The human W42R Gamma D-Crystallin Mutant Structure at 1.7A Resolution","GKITLYEDRGFQGRHYECSSDHPNLQPYLSRCNSARVDSGCRMLYEQPNYSGLQYFLRRGDYADHQQWMGLSDSVRSCRLIPHSGSHRIRLYEREDYRGQMIEFTEDCSCLQDRFRFNEIHSLNVLEGSWVLYELSNYRGRQYLLMPGDYRRYQDWGATNARVGSLRRVIDFS","Homo sapiens","CRYGD, CRYG4","Gamma-crystallin D","1","4GR7"
"4GR8",,"X-RAY DIFFRACTION",2.07,40.64,"VAPOR DIFFUSION, SITTING DROP",8.5,"protein: hMMP12 F171D 848 microM. reservoir: 24% PEG 10000, 0.2 M imidazole malate pH 8.5. CRYOPROTECTANT: 27% PEG 8000, 15% monomethyl-PEG 550, 10% glycerol, 0.09 M Tris-HCl, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm301574d","R4C","4GR8",17.74,"1.299","1.299","Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhibitor RXP470C","KHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLY","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","4GR8"
"4GR9",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2012.10.005","372","4GR9",53.98,"2.291","2.291","Synthesis of novel MT3 receptor ligands via unusual Knoevenagel condensation","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4GR9"
"4GRA",,"X-RAY DIFFRACTION",2.35,47.57,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris PH 8.0,  
20% PEG, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/bi301492j",,"4GRA",70.14,"2.56","2.56","Crystal structure of SULT1A1 bound with PAP","GPLHMELIQDTSRPPLEYVKGVPLIKYFAEALGPLQSFQARPDDLLISTYPKSGTTWVSQILDMIYQGGDLEKCHRAPIFMRVPFLEFKAPGIPSGMETLKDTPAPRLLKTHLPLALLPQTLLDQKVKVVYVARNAKDVAVSYYHFYHMAKVHPEPGTWDSFLEKFMVGEVSYGSWYQHVQEWWELSRTHPVLYLFYEDMKENPKREIQKILEFVGRSLPEETVDFMVQHTSFKEMKKNPMTNYTTVPQEFMDHSISPFMRKGMAGDWKTTFTVAQNERFDADYAEKMAGCSLSFRSEL","Homo sapiens","SULT1A1, STP, STP1, OK/SW-cl.88","Sulfotransferase 1A1","1","4GRA"
"4GRB",,"X-RAY DIFFRACTION",2.23,44.83,"VAPOR DIFFUSION, HANGING DROP",6.5,"22-26% PEG 6K, 200 mM ammonium sulfate, 100 mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1021/ml400197u","0XG","4GRB",40.31,"2.15","2.15","Casein kinase 2 (CK2) bound to inhibitor","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQAR","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","4GRB"
"4GRM",,"X-RAY DIFFRACTION",2.21,44.45,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG, 0.1 M TRIS, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,"10.3389/fimmu.2013.00168",,"4GRM",97.7,"2","2","The crystal structure of the high affinity TCR A6","KEVEQNSGPLSVPEGAIASLNCTYSDRGSQSFFWYRQYSGKSPELIMSIYSNGDKEDGRFTAQLNKASQYVSLLIRDSQPSDSATYLCAVTTDSWGKLQFGAGTQVVVTPDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPE","Homo sapiens",,"A6 alpha chain","1","4GRM"
,,,,,,,,,,,,,,,,"NAGVTQTPKFQVLKTGQSMTLQCAQDMNHEYMSWYRQDPGMGLRLIHYSVGAGITDQGEVPNGYNVSRSTTEDFPLRLLSAAPSQTSVYFCASRPGLMSAQPEQYFGPGTRLTVTEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQDPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"A6 beta chain","2","4GRM"
"4GRN",,"X-RAY DIFFRACTION",3.65,66.3,"VAPOR DIFFUSION, HANGING DROP",6.5,"2M NH42SO4, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4GRN",38.32,"1.25","1.25","crystal structure of PAAM mutant of human MIF","PAAMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, human, MIF, MMIF","Macrophage migration inhibitory factor","1","4GRN"
"4GRO",,"X-RAY DIFFRACTION",2.27,45.73,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.0 ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4GRO",100.9,"2","2","Crystallographic and biological characterization of N- and C- terminus mutants of human MIF","PAAAMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","4GRO"
"4GRP",,"X-RAY DIFFRACTION",2.06,40.42,,5.6,"1.6M ammonium sulfate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4GRP",38.47,"1.27","1.27","Crystallographic and biological characterization of N- and C- terminus mutants of human MIF","PAAAAMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","4GRP"
"4GRQ",,"X-RAY DIFFRACTION",3.64,66.17,,6.5,"1.6M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 310K",310,,,"4GRQ",38.03,"1.65","1.65","Characterization of N- and C- terminus mutants of human MIF","PAAMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","4GRQ"
"4GRR",,"X-RAY DIFFRACTION",3.65,66.31,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M ammmonium sualfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 310K",310,,,"4GRR",38.59,"1.47","1.47","characterization of N- and C- terminus mutants of human MIF","PAAMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","4GRR"
"4GRT",,"X-RAY DIFFRACTION",2.73,54.99,"VAPOR DIFFUSION, HANGING DROP",8,"0.57-0.90 M AMMONIUM SULFATE,100 MM POTASSIUM PHOSPHATE, PH 8.0, AND 0.5% 1-N-BETA-OCTYL-D-GLUCOPYRANOSIDE HANGING DROP VAPOR DIFFUSION. CRYSTALS WERE SOAKED IN ARTIFICIAL MOTHER LIQUOR AT PH 6.5 CONTAINING 420 MM OXIDIZED GLUTATHIONE, vapor diffusion - hanging drop",,"10.1021/bi963074p",,"4GRT",51.57,"2.8","2.8","HUMAN GLUTATHIONE REDUCTASE A34E, R37W MUTANT, MIXED DISULFIDE BETWEEN TRYPANOTHIONE AND THE ENZYME","VASYDYLVIGGGSGGLESAWRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHSEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDPKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR","Homo sapiens","GSR, GLUR, GRD1","GLUTATHIONE REDUCTASE","1","4GRT"
"4GRU",,"X-RAY DIFFRACTION",3.69,66.67,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.0M ammonium sulfate, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4GRU",37.95,"1.92","1.92","crystallographic and biological characterization of N- and C- terminus mutants of human MIF","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","4GRU"
"4GRY",,"X-RAY DIFFRACTION",2.2,44.13,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES pH 6.5, 1.5 M ammonium sulfate, 3% PEG400, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jsb.2012.12.009",,"4GRY",33.11,"1.6998","1.6998","Crystal structure of SHP1 catalytic domain with SO4","GSGFWEEFESLQKQEVKNLHQRLEGQRPENKGKNRYKNILPFDHSRVILQGRDSNIPGSDYINANYIKNQLLGPDENAKTYIASQGCLEATVNDFWQMAWQENSRVIVMTTREVEKGRNKCVPYWPEVGMQRAYGPYSVTNCGEHDTTEYKLRTLQVSPLDNGDLIREIWHYQYLSWPDHGVPSEPGGVLSFLDQINQRQESLPHAGPIIVHSSAGIGRTGTIIVIDMLMENISTKGLDCDIDIQKTIQMVRAQRSGMVQTEAQYKFIYVAIAQFIETTKKKLEVLQS","Homo sapiens","HCP, PTP1C, PTPN6, SHP-1","Tyrosine-protein phosphatase non-receptor type 6","1","4GRY"
"4GRZ",,"X-RAY DIFFRACTION",2.53,51.35,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M ammonium phosphate, 12% PEG2000 , pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jsb.2012.12.009",,"4GRZ",33.01,"1.3732","1.3732","Crystal structure of SHP1 catalytic domain with PO4","GSGFWEEFESLQKQEVKNLHQRLEGQRPENKGKNRYKNILPFDHSRVILQGRDSNIPGSDYINANYIKNQLLGPDENAKTYIASQGCLEATVNDFWQMAWQENSRVIVMTTREVEKGRNKCVPYWPEVGMQRAYGPYSVTNCGEHDTTEYKLRTLQVSPLDNGDLIREIWHYQYLSWPDHGVPSEPGGVLSFLDQINQRQESLPHAGPIIVHSSAGIGRTGTIIVIDMLMENISTKGLDCDIDIQKTIQMVRAQRSGMVQTEAQYKFIYVAIAQFIETTKKKLEVLQS","Homo sapiens","HCP, PTP1C, PTPN6, SHP-1","Tyrosine-protein phosphatase non-receptor type 6","1","4GRZ"
"4GS4",,"X-RAY DIFFRACTION",2.24,44.98,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris pH 7.5, 2.7M Sodium Formate, VAPOR DIFFUSION, HANGING DROP, temperature 298.5K",298.5,"10.1073/pnas.1209357109",,"4GS4",28,"2.112","2.112","Structure of the alpha-tubulin acetyltransferase, alpha-TAT1","GPLGSEFPFDVDALFPERITVLDQHLRPPARRPGTTTPARVDLQQQIMTIIDELGKASAKAQNLSAPITSASRMQSNRHVVYILKDSSARPAGKGAIIGFIKVGYKKLFVLDDREAHNEVEPLCILDFYIHESVQRHGHGRELFQYMLQKERVEPHQLAIDRPSQKLLKFLNKHYNLETTVPQVNNFVIFEGFFAHQHRPPAPSLRATRHSRAAAVDPTPAAPARKLPPKRAEGDIKPYS","Homo sapiens","ATAT1, C6orf134, MEC17, Nbla00487","Alpha-tubulin N-acetyltransferase","1","4GS4"
"4GS6",,"X-RAY DIFFRACTION",3.89,68.4,"VAPOR DIFFUSION, HANGING DROP",7,"0.55-0.75 M sodium citrate, 0.2 M NaCl, 0.1 M Tris, and 5mM adenosine. Adenosine bound crystals are backsoaked with inhibitor, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/cb3005897","1FM","4GS6",36.5,"2.2","2.2","Irreversible Inhibition of TAK1 Kinase by 5Z-7-Oxozeaenol","GSLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDHGEQSVVTAP","Homo sapiens","MAP3K7, TAK1, TAB1, MAP3K7IP1","Tak1-Tab1 fusion protein","1","4GS6"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP3K7, TAK1, TAB1, MAP3K7IP1"
"4GS8",,"X-RAY DIFFRACTION",3.99,69.14,"VAPOR DIFFUSION, HANGING DROP",7,"10-13% PEG MME 5000, 100 MM HEPES PH 7.0, 4-14% TACSIMATE, 10% DIOXANE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K",,"10.1016/j.ejmech.2014.04.009","MGJ","4GS8",230.05,"2.99","2.99","Structure analysis of cysteine free insulin degrading enzyme (ide) with compound bdm43079 [{[(s)-2-(1h-imidazol-4-yl)-1-methylcarbamoyl-ethylcarbamoyl]-methyl}-(3-phenyl-propyl)-amino]-acetic acid","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4GS8"
"4GSC",,"X-RAY DIFFRACTION",4,69.25,"VAPOR DIFFUSION, HANGING DROP",7,"10-13% PEG MME 5000, 100 MM HEPES PH 7.0, 4-14% TACSIMATE, 10% DIOXANE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 287K",,"10.1016/j.ejmech.2014.04.009",,"4GSC",230.03,"2.81","2.81","Structure analysis of insulin degrading enzyme with compound bdm41559 ((s)-2-[2-(carboxymethyl-phenethyl-amino)-acetylamino]-3-(1h-imidazol-4-yl)-propionic acid methyl ester)","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4GSC"
"4GSD",,"X-RAY DIFFRACTION",4.94,75.09,"VAPOR DIFFUSION",7.5,"24% PEG 1500 and 20% glycerol, 21 mg/mL protein, pH 7.5, VAPOR DIFFUSION, temperature 298K",298,"10.1172/JCI69377",,"4GSD",46.64,"2.251","2.251","H5.3 Fab Structure","SYELTQPPSVSVSPGQTVNITCSGDTLGDKYVCWYQQKPGQSPVLVIYQDTKRPSGIPERFSGSNSGDTATLTVSGTQAMDEADYYCQAWDSSSFVFGTGTKVTVLRQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"H5.3 Fab Light Chain","1","4GSD"
,,,,,,,,,,,,,,,,"EVQLQESGPGLVKPSGTVSLTCAVSGGSISSSYWWSWVRQPPGKGLEWIGEIYHSGNTNYNPSLKSRVTISVDKSKNLFSLKLSSVTAADTAVYYCARVALFDILTGGWFDPWGQGTLVTVSSAGTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"H5.3 Fab Heavy Chain","2","4GSD"
"4GSF",,"X-RAY DIFFRACTION",3.95,68.87,"VAPOR DIFFUSION, HANGING DROP",7,"10-13% PEG MME 5000, 100 MM HEPES PH 7.0, 4-14% TACSIMATE, 10% DIOXANE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 287K",,"10.1016/j.ejmech.2014.12.005",,"4GSF",230.08,"2.7","2.7","The structure analysis of cysteine free insulin degrading enzyme (ide) with (s)-2-{2-[carboxymethyl-(3-phenyl-propionyl)-amino]-acetylamino}-3-(3h-imidazol-4-yl)-propionic acid methyl ester","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4GSF"
"4GSM",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, SITTING DROP",7,"A metal-free HAI crystal was soaked in 5 mM NiCl2, 100 mM HEPES (pH 7.0), 30% (v/v) Jeffamine ED-2001 for 26 hours., VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi301145n",,"4GSM",69.79,"1.7","1.7","Crystal Structure of Ni2+2-Human Arginase I","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","4GSM"
"4GSS",,"X-RAY DIFFRACTION",2.61,52.83,,6,"pH 6.0",,"10.1021/bi962813z",,"4GSS",47.64,"2.5","2.5","HUMAN GLUTATHIONE S-TRANSFERASE P1-1 Y108F MUTANT","PPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIFTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GTP_HUMAN, GSTP1, FAEES3, GST3","GLUTATHIONE S-TRANSFERASE","1","4GSS"
"4GSV",,"X-RAY DIFFRACTION",2.38,48.29,"VAPOR DIFFUSION, SITTING DROP",7,"A metal-free HAI crystal was soaked in 5 mM NiCl2, 5 mM ABH, 100 mM HEPES (pH 7.0), 32% (w/v) Jeffamine ED-2001 for 26 hours., VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi301145n",,"4GSV",70.18,"1.48","1.48","Crystal Structure of the Ni2+2-Human Arginase I-ABH complex","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","4GSV"
"4GSZ",,"X-RAY DIFFRACTION",2.4,48.84,"VAPOR DIFFUSION, SITTING DROP",7,"A metal-free HAI crystal was soaked in 5 mM ZnCl2, 5 mM ABH, 100 mM HEPES (pH 7.0), 30% (v/v) Jeffamine ED-2001 for 18 hours., VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi301145n",,"4GSZ",70.53,"2.2","2.2","Crystal Structure of the Zn2+5-Human Arginase I-ABH Complex","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","4GSZ"
"4GT4",,"X-RAY DIFFRACTION",2.35,47.62,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG3350, 0.2 M magnesium nitrate hexahydrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1042/BJ20121365",,"4GT4",71.18,"2.406","2.406","Structure of unliganded, inactive Ror2 kinase domain","HHHHHHMEMPLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNLS","Homo sapiens","NTRKR2, ROR2","Tyrosine-protein kinase transmembrane receptor ROR2","1","4GT4"
"4GT5",,"X-RAY DIFFRACTION",3.1,60.26,"VAPOR DIFFUSION, HANGING DROP",6,"1.5 M sodium chloride, 0.1 M MES, pH 6.5, 0.2 M sodium/potassium phosphate, VAPOR DIFFUSION, HANGING DROP, temperature 294.15K",294.15,"10.1042/BJ20121365",,"4GT5",34.87,"2.398","2.398","Crystal structure of the inactive TrkA kinase domain","MHHHHHHSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","MTC, NTRK1, TRK, TRKA","High affinity nerve growth factor receptor","1","4GT5"
"4GT7",,"X-RAY DIFFRACTION",2.59,52.49,"VAPOR DIFFUSION",4.5,"20 mM sodium acetate, pH 4.6, 28.8% (w/v) PEG 4000, 2% (w/v) Anapoe  -X-405, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M112.407502",,"4GT7",102.36,"2.61","2.61","An engineered disulfide bond reversibly traps the IgE-Fc3-4 in a closed, non-receptor binding conformation","ADPAADSNPRCVSAYLSRPSPFDLFIRKSPTITCLVVDLAPSKGTVNLTWSRASGKPVNHSTRKEEKQRNGTLTVTSTLPVGTRDWIEGETYQCRVTHPHLPRALMRSTTKTSGPRAAPEVYAFATPEWPGSRDKRTLACLIQNFMPEDISVQWLHNEVQLPDARHSTTQPRKTKGSGFFVFSRLEVTRAEWEQKDEFICRAVHEAASPSQTVQRAVSVNP","Homo sapiens","IGHE","Ig epsilon chain C region","1","4GT7"
"4GTU",,"X-RAY DIFFRACTION",2.54,50,,5.6,"22% PEG4000, 0.1M NA CITRATE,0.2M AMMONIUM ACETATE, PH5.6",,"10.1021/bi991714t",,"4GTU",203.7,"3.3","3.3","LIGAND-FREE HOMODIMERIC HUMAN GLUTATHIONE S-TRANSFERASE M4-4","SMTLGYWDIRGLAHAIRLLLEYTDSSYEEKKYTMGDAPDYDRSQWLNEKFKLGLDFPNLPYLIDGAHKITQSNAILCYIARKHNLCGETEEEKIRVDILENQAMDVSNQLARVCYSPDFEKLKPEYLEELPTMMQHFSQFLGKRPWFVGDKITFVDFLAYDVLDLHRIFEPNCLDAFPNLKDFISRFEGLEKISAYMKSSRFLPKPLYTRVAVWGNK","Homo sapiens","GSTM4","GLUTATHIONE S-TRANSFERASE","1","4GTU"
"4GU1",,"X-RAY DIFFRACTION",3.87,68.18,"VAPOR DIFFUSION, HANGING DROP",6,"0.2M Sodium chloride, 0.1M Na/K phosphate, 7% PEG 8000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.molcel.2012.11.019",,"4GU1",178.35,"2.939","2.939","Crystal structure of LSD2","PLGSEFKGLRRRRKCEKAGCTATCPVCFASASERCAKNGYTSRWYHLSCGEHFCNECFDHYYRSHKDGYDKYTTWKKIWTSNGKTEPSPKAFMADQQLPYWVQCTKPECRKWRQLTKEIQLTPQIAKTYRCGMKPNTAIKPETSDHCSLPEDLRVLEVSNHWWYSMLILPPLLKDSVAAPLLSAYYPDCVGMSPSCTSTNRAAATGNASPGKLEHSKAALSVHVPGMNRYFQPFYQPNECGKALCVRPDVMELDELYEFPEYSRDPTMYLALRNLILALWYTNCKEALTPQKCIPHIIVRGLVRIRCVQEVERILYFMTRKGLINTGVLSVGADQYLLPKDYHNKSVIIIGAGPAGLAAARQLHNFGIKVTVLEAKDRIGGRVWDDKSFKGVTVGRGAQIVNGCINNPVALMCEQLGISMHKFGERCDLIQEGGRITDPTIDKRMDFHFNALLDVVSEWRKDKTQLQDVPLGEKIEEIYKAFIKESGIQFSELEGQVLQFHLSNLEYACGSNLHQVSARSWDHNEFFAQFAGDHTLLTPGYSVIIEKLAEGLDIQLKSPVQCIDYSGDEVQVTTTDGTGYSAQKVLVTVPLALLQKGAIQFNPPLSEKKMKAINSLGAGIIEKIALQFPYRFWDSKVQGADFFGHVPPSASKRGLFAVFYDMDPQKKHSVLMSVIAGEAVASVRTLDDKQVLQQCMATLRELFKEQEVPDPTKYFVTRWSTDPWIQMAYSFVKTGGSGEAYDIIAEDIQGTVFFAGEATNRHFPQTVTGAYLSGVREASKIAAF","Homo sapiens","LSD2, KDM1B, AOF1, C6orf193","Lysine-specific histone demethylase 1B","1","4GU1"
"4GU6",,"X-RAY DIFFRACTION",2.22,44.57,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.1 M tris, 16% PEG 3350, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm3016014","10N","4GU6",65.47,"1.95","1.95","FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-{3-[(5-Cyano-2-phenyl-1H-pyrrolo[2,3-b]pyridin-4-ylamino)- methyl]-pyridin-2-yl}-N-methyl-methanesulfonamide","GSGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","4GU6"
"4GU9",,"X-RAY DIFFRACTION",2.2,44.04,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.1 M tris, 16% PEG3350, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm3016014","4GU","4GU9",64.37,"2.4","2.4","Focal adhesion kinase catalytic domain in complex with (2-Fluoro-phenyl)-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine","GSPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","4GU9"
"4GUB",,"X-RAY DIFFRACTION",3.39,63.69,"VAPOR DIFFUSION, HANGING DROP",6.5,"22-26% PEG 6K, 200 mM ammonium sulfate, 100 mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,,,"4GUB",40.32,"2.2","2.2","Casein Kinase II bound to Inhibitor","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQAR","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","4GUB"
"4GUK",,"X-RAY DIFFRACTION",2.13,42.29,"VAPOR DIFFUSION, HANGING DROP",6.5,"pH6.5, 0.2M NaAC, 30%PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4GUK",91.69,"1.75","1.75","New crystal form structure of human NCS1","MGKSNSKLKPEVVEELTRKTYFTEKEVQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSKADPSIVQALSLYDGLV","Homo sapiens","FLUP, FREQ, NCS1","Neuronal calcium sensor 1","1","4GUK"
"4GUL",,"X-RAY DIFFRACTION",2.37,48.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 20000, 0.1 MES 
, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1073/pnas.1221743110",,"4GUL",32.03,"1.8","1.8","Study on structure and function relationships in human ferric Pirin","SSKKVTLSVLSREQSEGVGARVRRSIGRPELKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTWKSKIGN","Homo sapiens","human, PIR","Pirin","1","4GUL"
"4GUM",,"X-RAY DIFFRACTION",2.27,45.75,,8,"0.2M LiSO4, 3% DMSO, pH8.0, 33% PEG4000  , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1221817110",,"4GUM",111.38,"2.33","2.33","Cystal structure of locked-trimer of human MIF","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNCSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4GUM"
"4GUO",,"X-RAY DIFFRACTION",2.4,48.65,"VAPOR DIFFUSION",6,"0.1M MES, 0.1M NA ACETATE, 15-17% PEG 20K, pH 6.0, VAPOR DIFFUSION, temperature 298K",298,,,"4GUO",220.05,"3.19","3.19","structure of p73 DNA binding domain complex with 12 bp DNA","MGHHHHHHHHEFIPSNTDYPGPHHFEVTFQQSSTAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDFNEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRICACPGRDRKADEDHYREQ","Homo sapiens","human p73, P73, TP73","Tumor protein p73","1","4GUO"
,,,,,,,,,,,,,,,,"CGGGCAAGCCCG",,,"DNA (5'-D(*CP*GP*GP*GP*CP*AP*AP*GP*CP*CP*CP*G)-3')","2","4GUO"
,,,,,,,,,,,,,,,,"CGGGCTTGCCCG",,,"DNA (5'-D(*CP*GP*GP*GP*CP*TP*TP*GP*CP*CP*CP*G)-3')","3","4GUO"
"4GUQ",,"X-RAY DIFFRACTION",2.72,54.84,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris, 50-125 mM sodium acetate and 20-24% (w/v) PEG 3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gkt657",,"4GUQ",53.89,"3.7","3.7","Structure of mutS139F p73 DNA binding domain complexed with 20BP DNA response element","GAACATGTTC",,,"DNA (5'-D(P*GP*AP*AP*CP*AP*TP*GP*TP*TP*C)-3')","1","4GUQ"
,,,,,,,,,,,,,,,,"MGHHHHHHHHEFIPSNTDYPGPHHFEVTFQQSSTAKFATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDFNEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRICACPGRDRKADEDHYREQ","Homo sapiens","human p73, P73, TP73","Tumor protein p73","2","4GUQ"
"4GUY",,"X-RAY DIFFRACTION",2.2,44.03,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M TRIS-HCL, 30% PEG 6000, 1M LICL, PH 8.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K",298,,"KLJ","4GUY",18.02,"2","2","Human MMP12 catalytic domain in complex with*N*-Hydroxy-2-(2-(4-methoxyphenyl)ethylsulfonamido)acetamide","GPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","4GUY"
"4GV0",,"X-RAY DIFFRACTION",2.05,40,"VAPOR DIFFUSION, SITTING DROP",7,"2.1M DL-Malic Acid, 0.05M Bis-tris-propane, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/cb4002014","8ME","4GV0",40.15,"1.9","1.9","Human ARTD3 (PARP3) - Catalytic domain in complex with inhibitor ME0355","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","PARP3, ADPRT3, ADPRTL3","Poly [ADP-ribose] polymerase 3","1","4GV0"
"4GV1",,"X-RAY DIFFRACTION",2.62,53.05,"VAPOR DIFFUSION, SITTING DROP",6.9,"alcohol, pH 6.9, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm301762v","0XZ","4GV1",40.19,"1.49","1.49","PKB alpha in complex with AZD5363","LGSRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFDYSASSTA","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","4GV1"
"4GV2",,"X-RAY DIFFRACTION",2.06,40.27,"VAPOR DIFFUSION, SITTING DROP",7,"1.7M DL-Malic Acid, 0.1M Bis-tris-propane, VAPOR DIFFUSION, SITTING DROP, temperature 293K, pH 7.0",293,"10.1021/cb4002014","5ME","4GV2",40.15,"1.8","1.8","Human ARTD3 (PARP3) - Catalytic domain in complex with inhibitor ME0354","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","PARP3, ADPRT3, ADPRTL3","Poly [ADP-ribose] polymerase 3","1","4GV2"
"4GV4",,"X-RAY DIFFRACTION",2.05,40,"VAPOR DIFFUSION, SITTING DROP",7,"1.8M DL-Malic Acid, 0.1M Bis-tris-propane, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/cb4002014","MEJ","4GV4",40.15,"1.8","1.8","Human ARTD3 (PARP3) - Catalytic domain in complex with inhibitor ME0328","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","PARP3, ADPRT3, ADPRTL3","Poly [ADP-ribose] polymerase 3","1","4GV4"
"4GV7",,"X-RAY DIFFRACTION",2.4,48.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2M KSCN, 0.1M Bis-tris-propane, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/cb4002014","MEW","4GV7",161.44,"2.89","2.89","Human ARTD1 (PARP1) - Catalytic domain in complex with inhibitor ME0328","MKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTAHHHHHH","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","4GV7"
"4GVJ",,"X-RAY DIFFRACTION",2.04,39.65,,6.5,"20-30% w/v PEG 3350, 0.2M Mg sulfate, 0.1M MES , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejmech.2013.03.070",,"4GVJ",35.23,"2.03","2.03","Tyk2 (JH1) in complex with adenosine di-phosphate","MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRHHHHHH","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","4GVJ"
"4GVT",,"X-RAY DIFFRACTION",2.8,56.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"10-20% PEG 3350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444913000024",,"4GVT",24.67,"2.9","2.9","Crystal structure of D48V mutant of human GLTP bound with 12:0 disulfatide (hexagonal form)","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKAVISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","4GVT"
"4GW4",,"X-RAY DIFFRACTION",3.64,66.24,"VAPOR DIFFUSION, SITTING DROP",3.9,"16% polyethylene glycol 6,000, 0.1 M citric acid pH 3.9, 0.15 M lithium sulfate monohydrate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2013.03.018",,"4GW4",96.33,"2.65","2.65","Crystal structure of 3BNC60 Fab with P61A mutation","DIQMTQSPSSLSARVGDTVTITCQANGYLNWYQQRRGKAPKLLIYDGSKLERGVPARFSGRRWGQEYNLTINNLQPEDVATYFCQVYEFIVPGTRLDLKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"3BNC60 Fab Light-chain","1","4GW4"
,,,,,,,,,,,,,,,,"QVHLSQSGAAVTKPGASVRVSCEASGYKISDHFIHWWRQAPGQGLQWVGWINPKTGQPNNARQFQGRVSLTRQASWDFDTYSFYMDLKAVRSDDTAIYFCARQRSDFWDFDVWGSGTQVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKT","Homo sapiens",,"3BNC60 Fab Heavy-chain","2","4GW4"
"4GW8",,"X-RAY DIFFRACTION",3,59.02,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.16M Na(OAc), 0.08M BTProp pH 8.5 , 16% PEG3350, 8% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm301034u","3RA","4GW8",37.55,"2","2","Human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and Leucettine L41","SMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4GW8"
,,,,,,,,,,,,,,,,"ARKRRRHPSGPPTA",,,"Consensus peptide (Pimtide)","2","4GW8"
"4GWC",,"X-RAY DIFFRACTION",2.4,48.73,"VAPOR DIFFUSION, SITTING DROP",7,"An unliganded Mn2+2-HAI crystal was soaked in 5 mM ZnCl2, 50 mM boric acid, 100 mM HEPES (pH 7.0), and 30% (v/v) Jeffamine ED-2001 for 26 hours., VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi301145n",,"4GWC",69.91,"1.9","1.9","Crystal Structure of Mn2+2,Zn2+-Human Arginase I","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","4GWC"
"4GWD",,"X-RAY DIFFRACTION",2.41,48.89,"VAPOR DIFFUSION, SITTING DROP",7,"An unliganded Mn2+2-HAI crystal was soaked in 5 mM ZnCl2, 5 mM ABH, 100 mM HEPES (pH 7.0), and 32% (w/v) Jeffamine ED-2001 for 26 hours., VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi301145n",,"4GWD",70.29,"1.53","1.53","Crystal Structure of the Mn2+2,Zn2+-Human Arginase I-ABH Complex","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","4GWD"
"4GWF",,"X-RAY DIFFRACTION",2.09,41.24,"VAPOR DIFFUSION",8,"0.1M Tris buffer pH8.0, 15% PEG4000, 0.02M DDT, VAPOR DIFFUSION, temperature 293K",293,,,"4GWF",130.14,"2.1","2.1","Crystal structure of the tyrosine phosphatase SHP-2 with Y279C mutation","MGSSHHHHHHSSGRENLYFQGMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRCKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRIEEEQKSKRKG","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4GWF"
"4GWG",,"X-RAY DIFFRACTION",2.34,47.43,"VAPOR DIFFUSION, HANGING DROP",6,"14% PEG3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.ccr.2012.09.020",,"4GWG",53.67,"1.3907","1.3907","Crystal Structure Analysis of 6-phosphogluconate dehydrogenase apo-form","SNAQADIALIGLAVMGQNLILNMNDHGFVVCAFNRTVSKVDDFLANEAKGTKVVGAQSLKEMVSKLKKPRRIILLVKAGQAVDDFIEKLVPLLDTGDIIIDGGNSEYRDTTRRCRDLKAKGILFVGSGVSGGEEGARYGPSLMPGGNKEAWPHIKTIFQGIAAKVGTGEPCCDWVGDEGAGHFVKMVHNGIEYGDMQLICEAYHLMKDVLGMAQDEMAQAFEDWNKTELDSFLIEITANILKFQDTDGKHLLPKIRDSAGQKGTGKWTAISALEYGVPVTLIGEAVFARCLSSLKDERIQASKKLKGPQKFQFDGDKKSFLEDIRKALYASKIISYAQGFMLLRQAATEFGWTLNYGGIALMWRGGCIIRSVFLGKIKDAFDRNPELQNLLLDDFFKSAVENCQDSWRRAVSTGVQAGIPMPCFTTALSFYDGYRHEMLPASLIQAQRDYFGAHTYELLAKPGQFIHTNWTGHGGTVSSSSYNA","Homo sapiens","PGD, PGDH","6-phosphogluconate dehydrogenase, decarboxylating","1","4GWG"
"4GWK",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, HANGING DROP",6,"14% PEG3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.ccr.2012.09.020","3PG","4GWK",54.04,"1.534","1.534","Crystal structure of 6-phosphogluconate dehydrogenase complexed with 3-phosphoglyceric acid","SNAQADIALIGLAVMGQNLILNMNDHGFVVCAFNRTVSKVDDFLANEAKGTKVVGAQSLKEMVSKLKKPRRIILLVKAGQAVDDFIEKLVPLLDTGDIIIDGGNSEYRDTTRRCRDLKAKGILFVGSGVSGGEEGARYGPSLMPGGNKEAWPHIKTIFQGIAAKVGTGEPCCDWVGDEGAGHFVKMVHNGIEYGDMQLICEAYHLMKDVLGMAQDEMAQAFEDWNKTELDSFLIEITANILKFQDTDGKHLLPKIRDSAGQKGTGKWTAISALEYGVPVTLIGEAVFARCLSSLKDERIQASKKLKGPQKFQFDGDKKSFLEDIRKALYASKIISYAQGFMLLRQAATEFGWTLNYGGIALMWRGGCIIRSVFLGKIKDAFDRNPELQNLLLDDFFKSAVENCQDSWRRAVSTGVQAGIPMPCFTTALSFYDGYRHEMLPASLIQAQRDYFGAHTYELLAKPGQFIHTNWTGHGGTVSSSSYNA","Homo sapiens","PGD, PGDH","6-phosphogluconate dehydrogenase, decarboxylating","1","4GWK"
"4GWM",,"X-RAY DIFFRACTION",2.83,56.55,"VAPOR DIFFUSION, SITTING DROP",9,"18.2%(wt/vol) PEG8000, 1M LiCl, 0.1M bicine, pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1211076109",,"4GWM",143.87,"1.85","1.85","Crystal structure of human promeprin beta","PWENFDVDGGMDQDIFDINEGLGLDLFEGDIRLDRAQIRNSIIGEKYRWPHTIPYVLEDSLEMNAKGVILNAFERYRLKTCIDFKPWAGETNYISVFKGSGCWSSVGNRRVGKQELSIGANCDRIATVQHEFLHALGFWHEQSRSDRDDYVRIMWDRILSGREHNFNTYSDDISDSLNVPYDYTSVMHYSKTAFQNGTEPTIVTRISDFEDVIGQRMDFSDSDLLKLNQLYNCSSSLSFMDSCSFELENVCGMIQSSGDNADWQRVSQVPRGPESDHSNMGQCQGSGFFMHFDSSSVNVGATAVLESRTLYPKRGFQCLQFYLYNSGSESDQLNIYIREYSADNVDGNLTLVEEIKEIPTGSWQLYHVTLKVTKKFRVVFEGRKGSGASLGGLSIDDINLSETRCPHHIWHIRNFTQFIGSPNGTLYSPPFYSSKGYAFQIYLNLAHVTNAGIYFHLISGANDDQLQWPCPWQQATMTLLDQNPDIRQRMSNQRSITTDPFMTTDNGNYFWDRPSKVGTVALFSNGTQFRRGGGYGTSAFITHERLKSRDFIKGDDVYILLTVEDISHLNSTQIQLTPAPSVQDLCSKTTCK","Homo sapiens","MEP1B","Meprin A subunit beta","1","4GWM"
"4GWN",,"X-RAY DIFFRACTION",3.36,63.4,"VAPOR DIFFUSION, SITTING DROP",8.5,"20%(wt/vol) PEG 3350, 0.2M sodium malonate, 0.1M bis-Tris propane, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1211076109",,"4GWN",67.82,"3","3","Crystal structure of human mature meprin beta","NSIIGEKYRWPHTIPYVLEDSLEMNAKGVILNAFERYRLKTCIDFKPWAGETNYISVFKGSGCWSSVGNRRVGKQELSIGANCDRIATVQHEFLHALGFWHEQSRSDRDDYVRIMWDRILSGREHNFNTYSDDISDSLNVPYDYTSVMHYSKTAFQNGTEPTIVTRISDFEDVIGQRMDFSDSDLLKLNQLYNCSSSLSFMDSCSFELENVCGMIQSSGDNADWQRVSQVPRGPESDHSNMGQCQGSGFFMHFDSSSVNVGATAVLESRTLYPKRGFQCLQFYLYNSGSESDQLNIYIREYSADNVDGNLTLVEEIKEIPTGSWQLYHVTLKVTKKFRVVFEGRKGSGASLGGLSIDDINLSETRCPHHIWHIRNFTQFIGSPNGTLYSPPFYSSKGYAFQIYLNLAHVTNAGIYFHLISGANDDQLQWPCPWQQATMTLLDQNPDIRQRMSNQRSITTDPFMTTDNGNYFWDRPSKVGTVALFSNGTQFRRGGGYGTSAFITHERLKSRDFIKGDDVYILLTVEDISHLNSTQIQLTPAPSVQDLCSKTTCK","Homo sapiens","MEP1B","Meprin A subunit beta","1","4GWN"
"4GWR",,"X-RAY DIFFRACTION",1.89,34.81,"VAPOR DIFFUSION, HANGING DROP",3.5,"0.1M citric acid, 25% PEG3350, pH 3.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,,,"4GWR",27.78,"1.81","1.81","Crystal Structure of the second catalytic domain of protein disulfide isomerase P5","MHHHHHHMKDVIELTDDSFDKNVLDSEDVWMVEFYAPWCGHCKNLEPEWAAAASEVKEQTKGKVKLAAVDATVNQVLASRYGIRGFPTIKIFQKGESPVDYDGGRTRSDIVSRALDLFSDNAP","Homo sapiens","PDIA6, ERP5, P5, TXNDC7","Protein disulfide-isomerase A6","1","4GWR"
"4GWT",,"X-RAY DIFFRACTION",2.52,51.14,"VAPOR DIFFUSION, HANGING DROP",7,"Peptide stock at 5 mg/mL (2.5 mg/mL L-peptide + 2.5 mg/L D-peptide), crystallized from 2.1 M DL-malic acid pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S090744491302444X",,"4GWT",4.31,"2.25","2.25","Structure of racemic Pin1 WW domain cocrystallized with DL-malic acid","GSKLPPGWEKRMSRSSGRVYYFNHITNASQWERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","4GWT"
"4GWV",,"X-RAY DIFFRACTION",2.52,51.27,"VAPOR DIFFUSION, HANGING DROP",7,"Peptide stock at 5 mg/mL (2.5 mg/mL L-peptide + 2.5 mg/L D-peptide), crystallized from 1.8 M tri-ammonium citrate pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S090744491302444X",,"4GWV",4.36,"3.05","3.05","Structure of racemic Pin1 WW domain cocrystallized with tri-ammonium citrate","GSKLPPGWEKRMSRSSGRVYYFNHITNASQWERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","4GWV"
"4GXD",,"X-RAY DIFFRACTION",2,38.6,"VAPOR DIFFUSION, HANGING DROP",7,"15% PEG 3350, 0.1M MES pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444913000024",,"4GXD",24.67,"2.1","2.1","Crystal structure of D48V mutant of human GLTP bound with 12:0 disulfatide","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKAVISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","4GXD"
"4GXG",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION, HANGING DROP",7,"10-20% PEG3350, pH7.0-7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444913000024",,"4GXG",98.41,"2.4","2.4","Crystal structure of human GLTP bound with 12:0 monosulfatide (orthorhombic form; four subunits in asymmetric unit)","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKADISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","4GXG"
"4GXV",,"X-RAY DIFFRACTION",2.36,47.95,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG4000, 200 mM sodium phosphate dibasic, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.ppat.1003067",,"4GXV",95.41,"1.449","1.449","Crystal structure of anti-influenza virus antibody 1F1","QVQLVQSGGGVVQPRRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGRNKYYADSVKGRFTVSRDNSKNTLYLQMNSLRAEDTSVYYCARELLMDYYDHIGYSPGPTWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDK","Homo sapiens",,"Antibody 1F1, heavy chain","1","4GXV"
,,,,,,,,,,,,,,,,"QPVLTQPPSASGSPGQRVTISCSGSSSNIGSYTVNWYQQLPGTAPKLLIYSLNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEAVYYCAAWDDSLSAHVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Antibody 1F1, light chain","2","4GXV"
"4GYH",,"X-RAY DIFFRACTION",3.05,59.69,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS, 1.8M Ammonium Sulfate, 20mM 2-mercaptoethanol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BSR20140137",,"4GYH",36.65,"3.005","3.005","Structure of human thymidylate synthase at high salt conditions","MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAVHHHHH","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","4GYH"
"4GYX",,"X-RAY DIFFRACTION",1.91,35.64,"VAPOR DIFFUSION, HANGING DROP",5.5,"28% PEG 3350, 0.1M sodium acetate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M112.417543",,"4GYX",8.63,"1.49","1.49","The von Willebrand Factor A3 domain binding region of type III collagen stabilized by the cysteine knot","GPPGPPGPRGQPGVMGFPGPPGPPGPCCGGV","Homo sapiens","COL3A1","Type III collagen fragment in a host peptide stabilized by the cysteine knot","1","4GYX"
"4GZ5",,"X-RAY DIFFRACTION",4.69,73.75,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.9M Ammonium Sulfate, 0.1M Tris pH 8.5, 1% Xylitol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio.1109",,"4GZ5",327.86,"3.075","3.075","Crystal structure of human O-GlcNAc Transferase with UDP-GlcNAc","GPGSCPTHADSLNNLANIKREQGNIEEAVRLYRKALEVFPEFAAAHSNLASVLQQQGKLQEALMHYKEAIRISPTFADAYSNMGNTLKEMQDVQGALQCYTRAIQINPAFADAHSNLASIHKDSGNIPEAIASYRTALKLKPDFPDAYCNLAHCLQIVCDWTDYDERMKKLVSIVADQLEKNRLPSVHPHHSMLYPLSHGFRKAIAERHGNLCLDKINVLHKPPYEHPKDLKLSDGRLRVGYVSSDFGNHPTSHLMQSIPGMHNPDKFEVFCYALSPDDGTNFRVKVMAEANHFIDLSQIPCNGKAADRIHQDGIHILVNMNGYTKGARNELFALRPAPIQAMWLGYPGTSGALFMDYIITDQETSPAEVAEQYSEKLAYMPHTFFIGDHANMFPHLKKKAVIDFKSNGHIYDNRIVLNGIDLKAFLDSLPDVKIVKMKCPDGGDNADSSNTALNMPVIPMNTIAEAVIEMINRGQIQITINGFSISNGLATTQINNKAATGEEVPRTIIVTTRSQYGLPEDAIVYCNFNQLYKIDPSTLQMWANILKRVPNSVLWLLRFPAVGEPNIQQYAQNMGLPQNRIIFSPVAPKEEHVRRGQLADVCLDTPLCNGHTTGMDVLWAGTPMVTMPGETLASRVAASQLTCLGCLELIAKNRQEYEDIAVKLGTDLEYLKKVRGKVWKQRISSPLFNTKQYTMELERLYLQMWEHYAAGNKPDHMIKPVE","Homo sapiens","OGT","UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit","1","4GZ5"
"4GZ6",,"X-RAY DIFFRACTION",4.74,74.06,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.9M Ammonium Sulfate, 0.1M Tris pH 8.5, 1% Xylitol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio.1109",,"4GZ6",328.02,"2.98","2.98","Crystal structure of human O-GlcNAc Transferase with UDP-5SGlcNAc","GPGSCPTHADSLNNLANIKREQGNIEEAVRLYRKALEVFPEFAAAHSNLASVLQQQGKLQEALMHYKEAIRISPTFADAYSNMGNTLKEMQDVQGALQCYTRAIQINPAFADAHSNLASIHKDSGNIPEAIASYRTALKLKPDFPDAYCNLAHCLQIVCDWTDYDERMKKLVSIVADQLEKNRLPSVHPHHSMLYPLSHGFRKAIAERHGNLCLDKINVLHKPPYEHPKDLKLSDGRLRVGYVSSDFGNHPTSHLMQSIPGMHNPDKFEVFCYALSPDDGTNFRVKVMAEANHFIDLSQIPCNGKAADRIHQDGIHILVNMNGYTKGARNELFALRPAPIQAMWLGYPGTSGALFMDYIITDQETSPAEVAEQYSEKLAYMPHTFFIGDHANMFPHLKKKAVIDFKSNGHIYDNRIVLNGIDLKAFLDSLPDVKIVKMKCPDGGDNADSSNTALNMPVIPMNTIAEAVIEMINRGQIQITINGFSISNGLATTQINNKAATGEEVPRTIIVTTRSQYGLPEDAIVYCNFNQLYKIDPSTLQMWANILKRVPNSVLWLLRFPAVGEPNIQQYAQNMGLPQNRIIFSPVAPKEEHVRRGQLADVCLDTPLCNGHTTGMDVLWAGTPMVTMPGETLASRVAASQLTCLGCLELIAKNRQEYEDIAVKLGTDLEYLKKVRGKVWKQRISSPLFNTKQYTMELERLYLQMWEHYAAGNKPDHMIKPVE","Homo sapiens","OGT","UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit","1","4GZ6"
"4GZL",,"X-RAY DIFFRACTION",1.83,32.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"16-18% PEG4000, 6% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1073/pnas.1220895110",,"4GZL",46.59,"2","2","Crystal structure of RAC1 Q61L mutant","MGSSHHHHHHSSGLVPRGSHMENLYFQGQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGLEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVL","Homo sapiens","RAC1, TC25, MIG5","Ras-related C3 botulinum toxin substrate 1","1","4GZL"
"4GZM",,"X-RAY DIFFRACTION",2.27,45.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"16-18% PEG4000, 8% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1073/pnas.1220895110",,"4GZM",46.53,"2.8","2.8","Crystal structure of RAC1 F28L mutant","MGSSHHHHHHSSGLVPRGSHMENLYFQGQAIKCVVVGDGAVGKTCLLISYTTNALPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVL","Homo sapiens","RAC1, TC25, MIG5","Ras-related C3 botulinum toxin substrate 1","1","4GZM"
"4H0W",,"X-RAY DIFFRACTION",2.46,49.93,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.01M HEPES, 15% PEG3000, PH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 271K",271,"10.1038/srep00999",,"4H0W",76.1,"2.4","2.4","Bismuth bound human serum transferrin","VPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Serotransferrin","1","4H0W"
"4H12",,"X-RAY DIFFRACTION",2.45,49.78,"VAPOR DIFFUSION, HANGING DROP",,"1 uL protein (1:10 molar ratio of SETD2:AdoMet) + 1 uL reservoir solution (30% PEG2000 MME, 0.1 M potassium thiocyanate), VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja307060p",,"4H12",32.57,"2.06","2.06","The crystal structure of methyltransferase domain of human SET domain-containing protein 2 in complex with S-adenosyl-L-homocysteine","GETSVPPGSALVGPSCVMDDFRDPQRWKECAKQGKMPCYFDLIEENVYLTERKKNKSHRDIKRMQCECTPLSKDERAQGEIACGEDCLNRLLMIECSSRCPNGDYCSNRRFQRKQHADVEVILTEKKGWGLRAAKDLPSNTFVLEYCGEVLDHKEFKARVKEYARNKNIHYYFMALKNDEIIDATQKGNCSRFMNHSCEPNCETQKWTVNGQLRVGFFTTKLVPSGSELTFDYQFQRYGKEAQKCFCGSANCRGYLGGENRVSIRAAGGKMKKERSRK","Homo sapiens","SETD2, HIF1, HYPB, KIAA1732, KMT3A, SET2, HSPC069","Histone-lysine N-methyltransferase SETD2","1","4H12"
"4H1E",,"X-RAY DIFFRACTION",2.75,55.3,"VAPOR DIFFUSION, HANGING DROP",7,"15% PEG 3350, 200mM Na/K tartrate, 100mM Hepes pH7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm301039c","10J","4H1E",93.41,"1.9","1.9","Structure of BACE-1 Bound to (7aR)-6-benzoyl-7a-(4-(3-cyanophenyl)thiophen-2-yl)-3-methyl-4-oxohexahydro-1H-pyrrolo[3,4-d]pyrimidin-2(3H)-iminium","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4H1E"
"4H1I",,"X-RAY DIFFRACTION",2.84,61.71,"VAPOR DIFFUSION, HANGING DROP",8,"Protein at 5mg/ml, 30% PEG 1500, 15mM ammonium sulfate, 20mM 2-mercaptoethanol, 3% w/v 1,5-Diaminopentane dihydrochloride, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BSR20140137",,"4H1I",146.2,"3.095","3.095","Structure of human thymidylate synthase at low salt conditions","MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAVHHHHH","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","4H1I"
"4H1J",,"X-RAY DIFFRACTION",1.98,38,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris, 0.2 M magnesium chloride, 20-27% PEG3350, 1 mM TCEP, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bmcl.2012.10.039","0YH","4H1J",34.45,"2","2","Crystal structure of PYK2 with the pyrazole 13a","MHHHHHHSSGLVPRGSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME","Homo sapiens","PTK2B, FAK2, PYK2, RAFTK","Protein-tyrosine kinase 2-beta","1","4H1J"
"4H1M",,"X-RAY DIFFRACTION",1.93,36.43,"VAPOR DIFFUSION",6.5,"0.1 M Bis-Tris, 0.2 M magnesium chloride, 20-27% PEG3350, 1 mM TCEP, pH 6.5, VAPOR DIFFUSION, temperature 295K",295,"10.1016/j.bmcl.2012.10.039","0YJ","4H1M",34.46,"1.99","1.99","Crystal structure of PYK2 with the indole 10c","MHHHHHHSSGLVPRGSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME","Homo sapiens","PTK2B, FAK2, PYK2, RAFTK","Protein-tyrosine kinase 2-beta","1","4H1M"
"4H1O",,"X-RAY DIFFRACTION",1.96,37.2,"VAPOR DIFFUSION",7.9,"0.02M DDT, 0.1M Tris pH7.9, 13% PEG4000, 0.1M LiCl , VAPOR DIFFUSION, temperature 293K",293,,,"4H1O",64.69,"2.2","2.2","Crystal structure of the tyrosine phosphatase SHP-2 with D61G mutation","MGSSHHHHHHSSGRENLYFQGMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGGYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRIEEEQKSKRKG","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4H1O"
"4H1Q",,"X-RAY DIFFRACTION",1.99,38.04,,8,"Protein: MMP9h Nter=GFQT E402Q  V391Q at 130.3 micro-M with 5 milli-M AHA Reservoir: 40% MPEG 5K, 100mM HEPES. Cryoprotectant: 35% MPEG 5K, 15% PEG 400, 15% AAB (90/10), pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.015",,"4H1Q",38.64,"1.59","1.59","Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor.","FEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGQGYSLFLVAAHQFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG","Homo sapiens","CLG4B, MMP9","Matrix metalloproteinase-9","1","4H1Q"
,,,,,,,,,,,,,,,,,"Homo sapiens","CLG4B, MMP9"
"4H1S",,"X-RAY DIFFRACTION",2.54,51.64,"VAPOR DIFFUSION, SITTING DROP",7,"SPG buffer 0.1M pH4.0, 15% Peg 1500, drop volumes 200nl plus 200nl, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/cbic.201200426",,"4H1S",118.98,"2.2","2.2","Crystal Structure of a Truncated Soluble form of Human CD73 with Ecto-5'-Nucleotidase activity","MWELTILHTNDVHSRLEQTSEDSSKCVNASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLNSSIPEDPSIKADINKWRIKLDNYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHTDEMFWNHVSMCILNGGGIRSPIDERNNGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","4H1S"
"4H1U",,"X-RAY DIFFRACTION",2.11,41.8,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M sodium citrate, 27.5% PEG 3000, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0071835",,"4H1U",41.17,"2.3","2.3","Nucleotide-free human dynamin-1-like protein GTPase-GED fusion","MEALIPVINKLQDVFNTVGADIIQLPQIVVVGTQSSGKSSVLESLVGRDLLPRGTGIVTRRPLILQLVHVSQEDKRKTTGEENGVEAEEWGKFLHTKNKLYTDFDEIRQEIENETERISGNNKGVSPEPIHLKIFSPNVVNLTLVDLPGMTKVPVGDQPKDIELQIRELILRFISNPNSIILAVTAANTDMATSEALKISREVDPDGRRTLAVITKLDLMDAGTDAMDVLMGRVIPVKLGIIGVVNRSQLDINNKKSVTDSIRDEYAFLQKKYPSLANRNGTKYLARTLNRLLMHHIRDCLPELKTRINVLAAQYQSLLNSYGEPVDGSGSGSGSKEAADMLKALQGASQIIAEIRETHLWLEHHHHHH","Homo sapiens","DNM1L, DLP1, DRP1","Dynamin-1-like protein","1","4H1U"
,,,,,,,,,,,,,,,,,"Homo sapiens","DNM1L, DLP1, DRP1"
"4H1V",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M sodium citrate, 27.5 % PEG 3000 , pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0071835",,"4H1V",41.5,"2.3","2.3","GMP-PNP bound dynamin-1-like protein GTPase-GED fusion","MEALIPVINKLQDVFNTVGADIIQLPQIVVVGTQSSGKSSVLESLVGRDLLPRGTGIVTRRPLILQLVHVSQEDKRKTTGEENGVEAEEWGKFLHTKNKLYTDFDEIRQEIENETERISGNNKGVSPEPIHLKIFSPNVVNLTLVDLPGMTKVPVGDQPKDIELQIRELILRFISNPNSIILAVTAANTDMATSEALKISREVDPDGRRTLAVITKLDLMDAGTDAMDVLMGRVIPVKLGIIGVVNRSQLDINNKKSVTDSIRDEYAFLQKKYPSLANRNGTKYLARTLNRLLMHHIRDCLPELKTRINVLAAQYQSLLNSYGEPVDGSGSGSGSKEAADMLKALQGASQIIAEIRETHLWLEHHHHHH","Homo sapiens","DNM1L, DLP1, DRP1","Dynamin-1-like protein","1","4H1V"
,,,,,,,,,,,,,,,,,"Homo sapiens","DNM1L, DLP1, DRP1"
"4H1Y",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION, HANGING DROP",7.8,"8% PEG 6,000, 0.1 M Tris-HCl, 1  M Zinc, 10 mM (2,2'-(2-(2-((2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-carboxamido)ethylamino)-2-oxoethylazanediyl) diacetic acid), pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.str.2012.10.001",,"4H1Y",61.24,"1.58","1.58","Human ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with PSB11552","MAHHHHHHVGTGSNDDDDKSPDPWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANISASGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTSCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFS","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","4H1Y"
"4H22",,"X-RAY DIFFRACTION",3.51,64.91,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 8000, MES pH 6.5, sodium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.jsb.2012.10.006",,"4H22",49.6,"2.89","2.89","Crystal structure of the dimeric coiled-coil domain of the cytosolic nucleic acid sensor LRRFIP1","MDSLAEVEEKYKKAMVSNAQLDNEKTNFMYQVDTLKDMLLELEEQLAESRRQYEEKNKEFEREKHAHSILQFQFAEVKEALKQREEMLEPKLAAALEHHHHHH","Homo sapiens","LRRFIP1, GCF2, TRIP","Leucine-rich repeat flightless-interacting protein 1","1","4H22"
"4H27",,"X-RAY DIFFRACTION",2.41,49,"VAPOR DIFFUSION, SITTING DROP",7,"0.8 M ammonium sulfate, 0.1 M Tris-HCl, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/protein/gzs078",,"4H27",39,"1.3","1.3","Modulating the function of human serine racemase and human serine dehydratase by protein engineering","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSEFMMSGEPLHVKTPIRDSMALSKMAGTSVYLKMDSAQPSGSFKIRGIGHFCKRWAKQGCAHFVCSSSGNAGMAAAYAARQLGVPATIVVPGTTPALTIERLKNEGATVKVVGELLDEAFELAKALAKNNPGWVYIPPFDDPLIWEGHASIVKELKETLWEKPGAIALSVGGGGLLCGVVQGLQEVGWGDVPVIAMETFGAHSFHAATTAGKLVSLPKITSVAKALGVKTVGAQALKLFQEHPIFSEVISDQEAVAAIEKFVDDEKILVEPACGAALAAVYSHVIQKLQLEGNLRTPLPSLVVIVCGGSNISLAQLRALKEQLGMTNRLPK","Homo sapiens","SDS, SDH","L-serine dehydratase/L-threonine deaminase","1","4H27"
"4H29",,"X-RAY DIFFRACTION",2.13,42.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"10% MPD, 10 mM magnesium chloride, 100 mM sodium chloride, 50 mM sodium cacodylate at pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ja4101358",,"4H29",13.1,"1.991","1.991","B-raf dimer DNA quadruplex","GGGCGGGGAGGGGGAAGGGA","Homo sapiens",,"DNA (5'-D(*GP*GP*GP*CP*GP*GP*GP*GP*AP*GP*GP*GP*GP*GP*AP*AP*GP*GP*GP*A)-3')","1","4H29"
"4H2B",,"X-RAY DIFFRACTION",2.41,48.97,"VAPOR DIFFUSION, HANGING DROP",8,"6% PEG 6,000, 0.1 M Tris-HCl, 1M ZnCl2, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1016/j.str.2012.10.001",,"4H2B",61.21,"1.7","1.7","Human ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with Baicalin","MAHHHHHHVGTGSNDDDDKSPDPPWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANISASGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTSCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFS","Homo sapiens","NT5, NT5E, NTE","5'-nucleotidase","1","4H2B"
"4H2D",,"X-RAY DIFFRACTION",2.24,45.03,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M ammonium sulfate, 0.1 M MES, 30% PEG5000 MME, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.1302378110",,"4H2D",37.6,"1.8","1.8","Crystal structure of NDOR1","GSFTMPSPQLLVLFGSQTGTAQDVSERLGREARRRRLGCRVQALDSYPVVNLINEPLVIFVCATTGQGDPPDNMKNFWRFIFRKNLPSTALCQMDFAVLGLGDSSYAKFNFVAKKLHRRLLQLGGSALLPVCLGDDQHELGPDAAVDPWLRDLWDRVLGLYPPPP","Homo sapiens","NDOR1, NR1","NADPH-dependent diflavin oxidoreductase 1","1","4H2D"
"4H2E",,"X-RAY DIFFRACTION",2.26,45.58,"VAPOR DIFFUSION, SITTING DROP",8.5,"protein: hMMP-9-WT at 2 mg/mL with 120 milli-M acetohydroxamic acid. Reservoir: 40% monomethyl PEG 5,000, 0.1 M glycine. Cryoprotectant: 35% MPEG 5K, 15% PEG 400, 15% AAB buffer at pH 8.0 
, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.015","0Y3","4H2E",39.93,"2.902","2.902","Crystal structure of an MMP twin inhibitor complexing two MMP-9 catalytic domains","GFQTFEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVGYSLFLVAAHEFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9","1","4H2E"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"4H2F",,"X-RAY DIFFRACTION",3.38,63.59,"VAPOR DIFFUSION",7,"1.0 M lithium chloride, 0.1 M Hepes  , pH 7.0, VAPOR DIFFUSION, temperature 292K",292,"10.1016/j.str.2012.10.001",,"4H2F",60.85,"1.85","1.85","Human ecto-5'-nucleotidase (CD73): crystal form I (open) in complex with adenosine","MAHHHHHHVGTGSNDDDDKSPDPWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTACAVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFS","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","4H2F"
"4H2G",,"X-RAY DIFFRACTION",2.5,50.86,"VAPOR DIFFUSION",8.5,"1.8 M magnesium sulfate, 0.1 M Tris-HCl , pH 8.5, VAPOR DIFFUSION, temperature 292K",292,"10.1016/j.str.2012.10.001",,"4H2G",60.92,"1.55","1.55","Human ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with adenosine","MAHHHHHHVGTGSNDDDDKSPDPWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTACAVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFS","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","4H2G"
"4H2I",,"X-RAY DIFFRACTION",2.54,51.58,"VAPOR DIFFUSION",5,"5% PEG 6000, 0.1 M citric acid  , pH 5.0, VAPOR DIFFUSION, temperature 292K",292,"10.1016/j.str.2012.10.001",,"4H2I",59.89,"2","2","Human ecto-5'-nucleotidase (CD73): crystal form III (closed) in complex with AMPCP","MWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSLEHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","4H2I"
"4H2Z",,"X-RAY DIFFRACTION",2.24,45.19,"VAPOR DIFFUSION, HANGING DROP",7,"15-20% pEG 3350, 0.1M MES pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444913000024",,"4H2Z",25.05,"1.45","1.45","Crystal structure of human GLTP bound with 12:0 monosulfatide","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKADISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","4H2Z"
"4H30",,"X-RAY DIFFRACTION",2.31,46.84,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein: hMMP12 F171D at 0.36 milli-M + 0.001 M AHA. Reservoir: 13% PEG 20,000  
0.2 M imidazole malate   
0.05 M NaCl Cryoprotectant: 27% PEG 8,000 15% MPEG 550, 10% glycerol, 0.09 M Tris-HCl , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.015",,"4H30",37.46,"1.43","1.43","Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor.","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","4H30"
"4H34",,"X-RAY DIFFRACTION",1.91,35.71,"VAPOR DIFFUSION",8,"0.02M DDT, 0.1M Tris pH8.0, 19% PEG4000, 10% Glycerol, VAPOR DIFFUSION, temperature 293K",293,,,"4H34",64.97,"2.7","2.7","Crystal structure of the tyrosine phosphatase SHP-2 with Q506P mutation","MGSSHHHHHHSSGRENLYFQGMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVPTEAQYRFIYMAVQHYIETLQRRIEEEQKSKRKG","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4H34"
"4H3F",,"X-RAY DIFFRACTION",2.73,54.97,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm301039c","10O","4H3F",93.87,"1.7","1.7","Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(6-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H-pyrrolo[3,4-d]pyrimidin-7a-yl)thiophen-3-yl)benzonitrile","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4H3F"
"4H3G",,"X-RAY DIFFRACTION",2.77,55.52,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm301039c","10Q","4H3G",93.86,"1.85","1.85","Structure of BACE Bound to 2-((7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-2-imino-3-methyl-4-oxohexahydro-1H-pyrrolo[3,4-d]pyrimidin-6(2H)-yl)nicotinonitrile","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4H3G"
"4H3I",,"X-RAY DIFFRACTION",2.75,55.22,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm301039c","10V","4H3I",93.87,"1.96","1.96","Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(3-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H-pyrrolo[3,4-d]pyrimidin-7a-yl)thiophen-3-yl)benzonitrile","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4H3I"
"4H3J",,"X-RAY DIFFRACTION",2.74,55.17,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm301039c","10W","4H3J",93.84,"1.6","1.6","Structure of BACE Bound to 2-fluoro-5-(5-(2-imino-3-methyl-4-oxo-6-phenyloctahydro-1H-pyrrolo[3,4-d]pyrimidin-7a-yl)thiophen-2-yl)benzonitrile","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4H3J"
"4H3X",,"X-RAY DIFFRACTION",2.29,46.34,"VAPOR DIFFUSION, SITTING DROP",7,"protein: hMMP-9-WT 5.5 mg/mL 120 milli-M acetohydroxamic acid. Reservoir: 10% PEG 20,000, 60mM MES pH 5.5 + 18% MPEG 5,000, 0.08 M imidazole piperidine; pH 8.5, 0.05 M NaCl. Cryoprotectant: 10% Di-ethylene glycol, 10% 1.2-propanediol, 10% glycerol, 10% PEG 10K, 10% PCTP 50/50, 200mM NaCl , VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.015","10B","4H3X",38.84,"1.764","1.764","Crystal structure of an MMP broad spectrum hydroxamate based inhibitor CC27 in complex with the MMP-9 catalytic domain","GFQTFEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVGYSLFLVAAHEFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9","1","4H3X"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"4H42",,"X-RAY DIFFRACTION",2.16,42.96,"VAPOR DIFFUSION, SITTING DROP",4.6,"2.0 M ammonium sulfate, 50 mM sodium citrate pH 4.6 and 5% PEG400, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,"11E","4H42",28.49,"2.01","2.01","Synthesis of a Weak Basic uPA Inhibitor and Crystal Structure of Complex with uPA","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEE","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4H42"
"4H49",,"X-RAY DIFFRACTION",2.35,47.72,"VAPOR DIFFUSION, SITTING DROP",6,"Protein: hMMP12 F171D 0.78 milli-M + 0.010 M AHA. Reservoir: 17% PEG 20.000, 0.2 M imidazole malate, pH 6.0, 0.25 M NaCl.  
Cryoprotectant: 10% di-ethylene glycol + 10% glycerol + 10% 1,2-propanediol, 25% M PEG 5.000, 0.1 M BES pH 5.5., VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.015",,"4H49",74.04,"2.16","2.16","Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor.","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","4H49"
"4H4B",,"X-RAY DIFFRACTION",2.89,57.5,"VAPOR DIFFUSION, HANGING DROP",8.5,"magnesium sulphate and Tris buffer, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bcp.2012.11.024","11H","4H4B",65.05,"2.9","2.9","Human cytosolic 5'-nucleotidase II in complex with Anthraquinone-2,6- disulfonic acid","MGSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFDMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","4H4B"
"4H58",,"X-RAY DIFFRACTION",4.26,71.13,"VAPOR DIFFUSION, SITTING DROP",6.5,"salt, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm301658d","10Z","4H58",94.47,"3.1","3.1","BRAF in complex with compound 3","DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4H58"
"4H5C",,"X-RAY DIFFRACTION",2.38,48.39,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG 300, 0.1M sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 295.0K",295,"10.1186/1472-6807-12-32","YS4","4H5C",43.72,"2.02","2.02","Crystal structure of human FPPS in ternary complex with YS0470 and inorganic phosphate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4H5C"
"4H5D",,"X-RAY DIFFRACTION",2.39,48.47,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG 300, 0.1M sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 295.0K",295,"10.1186/1472-6807-12-32","POP, YS4","4H5D",43.8,"2.02","2.02","Crystal structure of human FPPS in ternary complex with YS0470 and inorganic pyrophosphate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4H5D"
"4H5E",,"X-RAY DIFFRACTION",2.35,47.73,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG 300, 0.1M sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 295.0K",295,"10.1186/1472-6807-12-32","YS4","4H5E",43.87,"2.04","2.04","Crystal structure of human FPPS in ternary complex with YS0470 and isopentenyl pyrophosphate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4H5E"
"4H5N",,"X-RAY DIFFRACTION",2.72,54.84,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M KCl in Tris, 30%PEG 400, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.biochi.2014.11.012",,"4H5N",85.86,"1.86","1.86","HSC70 NBD with PO4, Na, Cl","SKGPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILSGDK","Homo sapiens","HSC70, HSP73, HSPA10, HSPA8","Heat shock cognate 71 kDa protein","1","4H5N"
"4H5R",,"X-RAY DIFFRACTION",2.84,56.72,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M KCl in Tris, 30%PEG 400, pH 8.5, VAPOR DIFFUSION, SITTING DROP",,"10.1016/j.biochi.2014.11.012",,"4H5R",85.77,"1.64","1.64","HSC70 NBD with Na, Cl and glycerol","SKGPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILSGDK","Homo sapiens","HSC70, HSP73, HSPA10, HSPA8","Heat shock cognate 71 kDa protein","1","4H5R"
"4H5T",,"X-RAY DIFFRACTION",2.53,51.46,"VAPOR DIFFUSION, SITTING DROP",9.5,"0.1 M TRIS buffer, 1.5M NaCl, pH 9.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.biochi.2014.11.012","ADP","4H5T",42.74,"1.9","1.9","HSC70 NBD with ADP and Mg","SKGPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILSGDK","Homo sapiens","HSC70, HSP73, HSPA10, HSPA8","Heat shock cognate 71 kDa protein","1","4H5T"
"4H5V",,"X-RAY DIFFRACTION",2.53,51.47,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1 M ammonium sulfate (AS) in 0.1 M MES buffer, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.biochi.2014.11.012",,"4H5V",42.94,"1.75","1.75","HSC70 NBD with Mg","SKGPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILSGDK","Homo sapiens","HSC70, HSP73, HSPA10, HSPA8","Heat shock cognate 71 kDa protein","1","4H5V"
"4H5W",,"X-RAY DIFFRACTION",2.53,51.35,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Ammonium Acetate, 0.1 M Tris, 25% PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.biochi.2014.11.012",,"4H5W",85.11,"1.94","1.94","HSC70 NBD with betaine","SKGPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILSGDK","Homo sapiens","HSC70, HSP73, HSPA10, HSPA8","Heat shock cognate 71 kDa protein","1","4H5W"
"4H5X",,"X-RAY DIFFRACTION",2.09,41.12,"VAPOR DIFFUSION, HANGING DROP",6,"1.4M Sodium Potassium Tartrate, 50mM MES (pH 6.5), 100mM Hepes pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb3004379",,"4H5X",55.18,"1.95","1.95","human Plk1-PBD with a glycerol bound at the phophopeptide binding site","SNAGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4H5X"
"4H6S",,"X-RAY DIFFRACTION",1.91,35.57,"VAPOR DIFFUSION, HANGING DROP",6.3,"0.2M NH4Cl and 20% PEG 3350, pH 6.3, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.451542",,"4H6S",33.27,"2.19","2.19","Crystal structure of thrombin mutant E14eA/D14lA/E18A/S195A","EADCGLRPLFEKKSLEDKTERALLESYIAGR","Homo sapiens","F2","Prothrombin","1","4H6S"
,,,,,,,,,,,,,,,,"IVAGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","2","4H6S"
"4H6T",,"X-RAY DIFFRACTION",2.78,55.74,"VAPOR DIFFUSION, HANGING DROP",4.7,"0.2M KH2PO4 and 20% PEG 3350, pH 4.7, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.451542",,"4H6T",35.72,"2.4","2.4","Crystal structure of prethrombin-2 mutant E14eA/D14lA/E18A/S195A","TSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERALLESYIAGRIVAGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","1","4H6T"
"4H6Y",,"X-RAY DIFFRACTION",5.3,76.8,"VAPOR DIFFUSION, HANGING DROP",6.4,"100 mM MES, 0.2 M Mg formate, 14% PEG3350, pH 6.4, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.str.2013.01.001",,"4H6Y",115.84,"4.09","4.09","Crystal structure of the DH-PH-PH domain of FARP1","GPHMDKAYFIAKEVSTTERTYLKDLEVITSWFQSTVSKEDAMPEALKSLIFPNFEPLHKFHTNFLKEIEQRLALWEGRSNAQIRDYQRIGDVMLKNIQGMKHLAAHLWKHSEALEALENGIKSSRRLENFCRDFELQKVCYLPLNTFLLRPLHRLMHYKQVLERLCKHHPPSHADFRDCRAALAEITEMVAQLHGTMIKMENFQKLHELKKDLIGIDNLVVPGREFIRLGSLSKLSGKGLQQRMFFLFNDVLLYTSRGLTASNQFKVHGQLPLYGMTIEESEDEWGVPHCLTLRGQRQSIIVAASSRSEMEKWVEDIQMAIDLAEKSSSPAPEFLASSPPDNKSPDEATAADQESEDDLSASRTSLERQAPHRGNTMVHVCWHRNTSVSMVDFSIAVENQLSGNLLRKFKNSNGWQKLWVVFTNFCLFFYKSHQDNHPLASLPLLGYSLTIPSESENIQKDYVFKLHFKSHVYYFRAESEYTFERWMEVIRSATSSASRPH","Homo sapiens","CDEP, FARP1, PLEKHC2","FERM, RhoGEF and pleckstrin domain-containing protein 1","1","4H6Y"
"4H71",,"X-RAY DIFFRACTION",2.12,41.97,"VAPOR DIFFUSION, HANGING DROP",6,"1.4M Sodium Potassium Tartrate, 50mM MES (pH 6.5), 100mM Hepes pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb3004379","PXE","4H71",55.36,"1.93","1.93","Human Plk1-PBD in complex with Poloxime ((E)-4-(hydroxyimino)-2-isopropyl-5-methylcyclohexa-2,5-dienone)","SNAGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4H71"
"4H76",,"X-RAY DIFFRACTION",2.35,47.72,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein:(hMMP12 F171D at  927 micro-M + acetohydroxamic acid at 11.6 milli-M 
Reservoir: 45% PEG 4,000 
0.2 M imidazole piperidine 
Cryoprotection: 10% Di-ethylene glycol, 10% 1.2-propanediol, 10% glycerol, 10% PEG 10,000, 10% (AAB buffer 10% acid/90% basic) 0.2 M NaCl. Flash cooling in LN2. 
, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.015",,"4H76",18.87,"1.5","1.5","Crystal structure of the catalytic domain of Human MMP12 in complex with a broad spectrum hydroxamate inhibitor","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","4H76"
"4H7C",,"X-RAY DIFFRACTION",2.32,46.91,"VAPOR DIFFUSION",,"20% PEG3350, 0.2 M sodium acetate, VAPOR DIFFUSION, temperature 289K",289,"10.1016/j.ejmech.2013.01.047","10H","4H7C",39.04,"1.97","1.97","Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 1-{4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl}-2-pyrrolidinone","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4H7C"
"4H7W",,"X-RAY DIFFRACTION",2.24,45.15,"VAPOR DIFFUSION, SITTING DROP",5.6,"25% PEG 4000, 0.2 M ammonium sulphate, 0.1 M Na citrate pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1182/blood-2012-10-461491",,"4H7W",22.69,"1.1","1.1","Crystal Structure of Human C16orf57","TFPHERGNWATHVYVPYEAKEEFLDLLDVLLPHAQTYVPRLVRMKVFHLSLSQSVVLRHHWILPFVQALKARMTSFHRFFFTANQVKIYTNQEKTRTFIGLEVTSGHAQFLDLVSEVDRVMEEFNLTTFYQDPSFHLSLAWCVGDARLQLEGQCLQELQAIVDGFEDAEVLLRVHTEQVRCKSGNKFFSMPLK","Homo sapiens","C16orf57, USB1, Mpn1","UPF0406 protein C16orf57","1","4H7W"
"4H7X",,"X-RAY DIFFRACTION",2.99,58.86,"VAPOR DIFFUSION",6,"20% PEG 3350, 100 mM MES, 250 mM KCl, pH 6.0, VAPOR DIFFUSION, temperature 291K",291,"10.1042/BJ20121448",,"4H7X",36.58,"2.6","2.6","Crystal structure of the tetratricopeptide repeat (TPR) motif of human dual specificity protein kinase Mps1","GPLGSIMMMANNPEDWLSLLLKLEKNSVPLSDALLNKLIGRYSQAIEALPPDKYGQNESFARIQVRFAELKAIQEPDDARDYFQMARANCKKFAFVHISFAQFELSQGNVKKSKQLLQKAVERGAVPLEMLEIALRNLNLQKKQLLSEEEKKNLSASTVLT","Homo sapiens","MPS1, MPS1L1, NCBI Reference Sequence NM_003318.4, TTK","Dual specificity protein kinase TTK","1","4H7X"
"4H7Y",,"X-RAY DIFFRACTION",3.1,60.29,"VAPOR DIFFUSION",6,"20% PEG 3350, 100 mM MES, 250 mM KCl, pH 6.0, VAPOR DIFFUSION, temperature 291K",291,"10.1042/BJ20121448",,"4H7Y",72.75,"1.8","1.8","Crystal structure of the tetratricopeptide repeat (TPR) motif of human dual specificity protein kinase Mps1","GPLGSIMMMANNPEDWLSLLLKLEKNSVPLSDALLNKLIGRYSQAIEALPPDKYGQNESFARIQVRFAELKAIQEPDDARDYFQMARANCKKFAFVHISFAQFELSQGNVKKSKQLLQKAVERGAVPLEMLEIALRNLNLQKKQLLSEEEKKNLSASTVLT","Homo sapiens","MPS1, MPS1L1, NCBI Reference Sequence NM_003318.4, TTK","Dual specificity protein kinase TTK","1","4H7Y"
"4H80",,"X-RAY DIFFRACTION",2.2,44.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M Potassium acetate, 20 % PEG 3350, (3 microliters of 3 mg/mL of ALDH3A1 + 3 microlitres of mother liquor), pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.15K",298.15,,"04T","4H80",420.76,"2.5","2.5","Crystal structure of human ALDH3A1 with its isozyme selective inhibitor - N-[4-(4-methylsulfonyl-2-nitroanilino)phenyl]acetamide","HHHHHHSSGLVPRGSHMSKISEAVKRARAAFSSGRTRPLQFRIQQLEALQRLIQEQEQELVGALAADLHKNEWNAYYEEVVYVLEEIEYMIQKLPEWAADEPVEKTPQTQQDELYIHSEPLGVVLVIGTWNYPFNLTIQPMVGAIAAGNAVVLKPSELSENMASLLATIIPQYLDKDLYPVINGGVPETTELLKERFDHILYTGSTGVGKIIMTAAAKHLTPVTLELGGKSPCYVDKNCDLDVACRRIAWGKFMNSGQTCVAPDYILCDPSIQNQIVEKLKKSLKEFYGEDAKKSRDYGRIISARHFQRVMGLIEGQKVAYGGTGDAATRYIAPTILTDVDPQSPVMQEEIFGPVLPIVCVRSLEEAIQFINQREKPLALYMFSSNDKVIKKMIAETSSGGVAANDVIVHITLHSLPFGGVGNSGMGSYHGKKSFETFSHRRSCLVRPLMNDEGLKVRYPPSPAKMTQH","Homo sapiens","ALDH3, ALDH3A1","Aldehyde dehydrogenase, dimeric NADP-preferring","1","4H80"
"4H82",,"X-RAY DIFFRACTION",2.4,48.83,,8,"Protein: MMP9h Nter=GFQT E402Q V391Q at 384.3 micro-M with 120 milli-M AHA Reservoir: 10% MPEG 20K, 100mM PCTP 75/25, 1.5 NaCl. Cryoprotectant: 12.5% di-ethylene glycol, 12.5% DMSO, 12.5% MPD, 12.5% 1,2-propnaediol, 25% glycerol, 9% PEG 10K, 100 milli-M PCTP 80/20, 1.5 NaCl , pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.015","L29","4H82",75.7,"1.9","1.9","Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor.","FEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGQGYSLFLVAAHQFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG","Homo sapiens","CLG4B, MMP9","Matrix metalloproteinase-9","1","4H82"
,,,,,,,,,,,,,,,,,"Homo sapiens","CLG4B, MMP9"
"4H84",,"X-RAY DIFFRACTION",2.12,42.1,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein: hMMP12 F171D at4 784 mico-M + 10 milli-M AHA   
Reservoir: 12% PEG 20K, 0.14 M imidazole malate, .0175 M NaCl   
Cryoprotectant: 40% C7 (C7 = 12.5 % di-ethylene glycol + 12.5 % ethylene glycol + 25 % 1,2-propanediol + 12.5 % DMSO + 12.5 % glycerol), 1M NaCl, 0.1 M (MMT buffer 75% acid/25% basic), 9% PEG 10.000, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.015",,"4H84",38.27,"1.592","1.592","Crystal structure of the catalytic domain of Human MMP12 in complex with a selective carboxylate based inhibitor.","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","4H84"
"4H87",,"X-RAY DIFFRACTION",2.09,41.08,"VAPOR DIFFUSION, SITTING DROP",5,"1.60M ammonium sulfate, 0.1M citric acid pH 5.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4H87",29.24,"1.55","1.55","Crystal structure of a FHA domain of kanadaptin (SLC4A1AP) from Homo sapiens at 1.55 A resolution","SMARAPPYQEPPWGGPATAPYSLETLKGGTILGTRSLKGTSYCLFGRLSGCDVCLEHPSVSRYHAVLQHRASGPDGECDSNGPGFYLYDLGSTHGTFLNKTRIPPRTYCRVHVGHVVRFGGSTRLFILQG","Homo sapiens","HLC3, NM_018158, SLC4A1AP","Kanadaptin","1","4H87"
"4H8S",,"X-RAY DIFFRACTION",6.01,79.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.9% w/v PEG8000, 40 mM hexamine cobalt(III) chloride, 20% glycerol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.349803",,"4H8S",184.48,"3.5","3.5","Crystal structure of human APPL2BARPH domain","MHHHHHHSSGVDLGTENLYFQSNAPAVDKLLLEEALQDSPQTRSLLSVFEEDAGTLTDYTNQLLQAMQRVYGAQNEMCLATQQLSKQLLAYEKQNFALGKGDEEVISTLHYFSKVVDELNLLHTELAKQLADTMVLPIIQFREKDLTEVSTLKDLFGLASNEHDLSMAKYSRLPKKKENEKVKTEVGKEVAAARRKQHLSSLQYYCALNALQYRKQMAMMEPMIGFAHGQINFFKKGAEMFSKRMDSFLSSVADMVQSIQVELEAEAEKMRVSQQELLSVDESVYTPDSDVAAPQINRNLIQKAGYLNLRNKTGLVTTTWERLYFFTQGGNLMCQPRGAVAGGLIQDLDNCSVMAVDCEDRRYCFQITTPNGKSGIILQAESRKENEEWICAINNISRQIYLTDNPE","Homo sapiens","APPL2, DIP13B","DCC-interacting protein 13-beta","1","4H8S"
"4HA5",,"X-RAY DIFFRACTION",2.74,55.19,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm301039c","13W","4HA5",93.6,"1.83","1.83","Structure of BACE Bound to (S)-3-(5-(2-imino-1,4-dimethyl-6-oxohexahydropyrimidin-4-yl)thiophen-3-yl)benzonitrile","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4HA5"
"4HAE",,"X-RAY DIFFRACTION",2.4,48.8,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% PEG3350, 0.2M magnesium chloride, 0.1M TRIS, pH 8.5, vapor diffusion, sitting drop, temperature 291K",291,,,"4HAE",9.93,"2","2","Crystal structure of the CDYL2-chromodomain","MHHHHHHSSGRENLYFQGASGDLYEVERIVDKRKNKKGKWEYLIRWKGYGSTEDTWEPEHHLLHCEEFIDEFNGLHMSKDK","Homo sapiens","CDYL2","Chromodomain Y-like protein 2","1","4HAE"
"4HAF",,"X-RAY DIFFRACTION",2.7,54.52,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES, 9% PEG 4000, 0.2 M AMMONIUM CHLORIDE, 5% MPD CRYO CONDITIONS: 0.1 M MES, 12% PEG 4000, 0.2 M AMMONIUM CHLORIDE, 20% PEG 400, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.molimm.2013.03.018",,"4HAF",51.69,"2.04","2.04","Crystal structure of fc-fragment of human IgG2 antibody (primitive crystal form)","VECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG2","Ig gamma-2 chain C region","1","4HAF"
"4HAG",,"X-RAY DIFFRACTION",2.83,56.56,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG 3350, 0.1 M HEPES. CRYO CONDITIONS: 23% PEG 3350, 0.1 M HEPES, 22% GLYCEROL, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.molimm.2013.03.018",,"4HAG",26.43,"3.4","3.4","Crystal structure of fc-fragment of human IgG2 antibody (centered crystal form)","VECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG2","Ig gamma-2 chain C region","1","4HAG"
"4HAI",,"X-RAY DIFFRACTION",2.39,48.62,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 3350, 0-10% sucrose , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.11.084","I23","4HAI",63.21,"2.55","2.55","Crystal structure of human soluble epoxide hydrolase complexed with N-cycloheptyl-1-(mesitylsulfonyl)piperidine-4-carboxamide.","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4HAI"
"4HAS",,"X-RAY DIFFRACTION",1.74,29.34,"VAPOR DIFFUSION, SITTING DROP",5.5,"18% PEG 3.3k, 0.1M citrate pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4HAS",31.8,"1.74","1.74","Crystal structure of PX domain of human sorting nexin SNX27","MHHHHHHSSGVDLGTENLYFQSMDYTEKQAVPISVPRYKHVEQNGEKFVVYNVYMAGRQLCSKRYREFAILHQNLKREFANFTFPRLPGKWPFSLSEQQLDARRRGLEEYLEKVCSIRVIGESDIMQEFLSES","Homo sapiens","SNX27, KIAA0488, My014","Sorting nexin-27","1","4HAS"
"4HBA",,"X-RAY DIFFRACTION",2.06,40.36,"VAPOR DIFFUSION, HANGING DROP",9,"1.3M sodium citrate, 50mM Tris-HCl, pH 9.0, VAPOR DIFFUSION, HANGING DROP",,"10.1107/S0907444913008743",,"4HBA",29.54,"1.762","1.762","Structural and Catalytic Characterization of a Thermal and Acid Stable Variant of Human Carbonic Anhydrase II Containing an Engineered Disulfide Bond","MSHHWGYGKHNGPEHWHKDFPICKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPCLESVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4HBA"
"4HBD",,"X-RAY DIFFRACTION",2.7,53.4,"VAPOR DIFFUSION",,"20% PEG 3350, 0.2 M ammonium nitrate, VAPOR DIFFUSION, temperature 291K",291,,,"4HBD",30.16,"1.72","1.72","Crystal structure of KANK2 ankyrin repeats","MGSSHHHHHHSSGRENLYFQGSGSNTEEEIRMELSPDLISACLALEKYLDNPNALTERELKVAYTTVLQEWLRLACRSDAHPELVRRHLVTFRAMSARLLDYVVNIADSNGNTALHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGSTALMVALDAGQSEIASMLYSRMNIK","Homo sapiens","KANK2, ANKRD25, KIAA1518, MXRA3, SIP","KN motif and ankyrin repeat domain-containing protein 2","1","4HBD"
,,,,,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2 M ammonium iodide, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291
"4HBM",,"X-RAY DIFFRACTION",3.3,62.76,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate, pH 5.0  
1.5-2.0 M (NH4)2SO4 , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ja305839b","0Y7","4HBM",112.37,"1.9","1.9","Ordering of the N Terminus of Human MDM2 by Small Molecule Inhibitors","MSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4HBM"
"4HBN",,"X-RAY DIFFRACTION",2.73,54.93,"VAPOR DIFFUSION, HANGING DROP",4.2,"1.6 M KH2PO4/Na2HPO4 and 0.1 M Phosphate-Citrate, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2012.09.017","CMP","4HBN",24.64,"2.6","2.6","Crystal structure of the human HCN4 channel C-terminus carrying the S672R mutation","SDSSRRQYQEKYKQVEQYMSFHKLPPDTRQRIHDYYEHRYQGKMFDEESILGELSEPLREEIINFNCRKLVASMPLFANADPNFVTSMLTKLRFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKGNKETKLADGSYFGEICLLTRGRRTARVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVALDRLDRIGKKNSILLHK","Homo sapiens","HCN4","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4","1","4HBN"
"4HBQ",,"X-RAY DIFFRACTION",2.37,48.09,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris pH 8.5, 0.2 M (NH4)2SO4, 12% polyethylene glycol (PEG) 8000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4HBQ",43.91,"1.4","1.4","Crystal structure of a loop deleted mutant of Human MAdCAM-1 D1D2","VKPLQVEPPEPVVAVALGASRQLTCRLACADRGASVQWRGLDTSLGAVQSDTGRSVLTVRNASLSAAGTRVCVGSCGGRTFQHTVQLLVYAFPNQLTVSPAALVPGDPEVACTAHKVTPVDPNALSFSLLVGGQELEGAQALGPEVQQEPIGGDVLFRVTERWRLPPLGTPVPPALYCQATMRLPGLELSHRQAIPVLGGENLYFQ","Homo sapiens","MADCAM1","Mucosal addressin cell adhesion molecule 1","1","4HBQ"
"4HBV",,"X-RAY DIFFRACTION",2.11,41.64,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M NaNO3, 0.1M BTProp pH 6.5, 20% PEG3350, 10% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3010515","15E","4HBV",15.46,"1.63","1.63","Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolin ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HBV"
"4HBW",,"X-RAY DIFFRACTION",2.16,43.02,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.20M K3(cit), 0.1M BTProp pH 8.5, 20.0% PEG 3350, 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3010515","14Z","4HBW",15.47,"1.69","1.69","Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazoline ligand","SMNPPPPETSNPNKPKRETNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HBW"
"4HBX",,"X-RAY DIFFRACTION",2.13,42.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M KSCN, 0.1M BTProp pH 7.5, 20% PEG3350, 10% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3010515","14X","4HBX",15.39,"1.62","1.62","Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolin ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HBX"
"4HBY",,"X-RAY DIFFRACTION",2.15,42.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M KSCN, 20% PEG3350, 10% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3010515","13F","4HBY",15.48,"1.59","1.59","Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolin ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HBY"
"4HC4",,"X-RAY DIFFRACTION",2.86,56.95,"VAPOR DIFFUSION, HANGING DROP",7,"Purified HRMT1L6 was complexed with SAH at 1:5 molar ratio of protein:SAH and crystallized by mixing 1 ul of the protein solution with 1 ul of the reservoir solution containing 15% PEG3350, 0.1 M succinate acid, pH 7.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1042/BCJ20160537",,"4HC4",42.61,"1.97","1.97","Human HMT1 hnRNP methyltransferase-like protein 6 (S. cerevisiae)","GMSQPKKRKLESGGGGEGGEGTEEEDGAEREAALERPRRTKRERDQLYYECYSDVSVHEEMIADRVRTDAYRLGILRNWAALRGKTVLDVGAGTGILSIFCAQAGARRVYAVEASAIWQQAREVVRFNGLEDRVHVLPGPVETVELPEQVDAIVSEWMGYGLLHESMLSSVLHARTKWLKEGGLLLPASAELFIVPISDQMLEWRLGFWSQVKQHYGVDMSCLEGFATRCLMGHSEIVVQGLSGEDVLARPQRFAQLELSRAGLEQELEAGVGGRFRCSCYGSAPMHGFAIWFQVTFPGGESEKPLVLSTSPFHPATHWKQALLYLNEPVQVEQDTDVSGEITLLPSRDNPRRLRVLLRYKVGDQEEKTKDFAMED","Homo sapiens","PRMT6, HRMT1L6","Protein arginine N-methyltransferase 6","1","4HC4"
"4HC7",,"X-RAY DIFFRACTION",3.13,60.74,,,,,"10.1016/j.celrep.2012.10.012",,"4HC7",50.58,"2.65","2.65","Crystal structure of the full DNA binding domain of GATA3-complex 2","GSHMGRECVNCGATSTPLWRRDGTGHYLCNACGLYHKMNGQNRPLIKPKRRLSAARRAGTSCANCQTTTTTLWRRNANGDPVCNACGLYYKLHNINRPLTMKKEGIQTRNRKMSS","Homo sapiens","GATA3","Trans-acting T-cell-specific transcription factor GATA-3","1","4HC7"
,,,,,,,,,,,,,,,,"TTCCTAAATCAGAGATAACC",,,"DNA (5'-D(*TP*TP*CP*CP*TP*AP*AP*AP*TP*CP*AP*GP*AP*GP*AP*TP*AP*AP*CP*C)-3')","2","4HC7"
,,,,,,,,,,,,,,,,"AAGGTTATCTCTGATTTAGG",,,"DNA (5'-D(*AP*AP*GP*GP*TP*TP*AP*TP*CP*TP*CP*TP*GP*AP*TP*TP*TP*AP*GP*G)-3')","3","4HC7"
"4HC9",,"X-RAY DIFFRACTION",2.76,55.45,"hanging drop",,"hanging drop",,"10.1016/j.celrep.2012.10.012",,"4HC9",25.29,"1.6","1.6","DNA binding by GATA transcription factor-complex 3","GSHMGRECVNCGATSTPLWRRDGTGHYLCNACGLYHKMNGQNRPLIKPKRRLSAARRAGTSCANCQTTTTTLWRRNANGDPVCNACGLYYKLHNINRPLTMKKEGIQTRNRKMSS","Homo sapiens","GATA3","Trans-acting T-cell-specific transcription factor GATA-3","1","4HC9"
,,,,,,,,,,,,,,,,"TTCCTAAATCAGAGATAACC",,,"DNA (5'-D(*TP*TP*CP*CP*TP*AP*AP*AP*TP*CP*AP*GP*AP*GP*AP*TP*AP*AP*CP*C)-3')","2","4HC9"
,,,,,,,,,,,,,,,,"AAGGTTATCTCTGATTTAGG",,,"DNA (5'-D(*AP*AP*GP*GP*TP*TP*AP*TP*CP*TP*CP*TP*GP*AP*TP*TP*TP*AP*GP*G)-3')","3","4HC9"
"4HCA",,"X-RAY DIFFRACTION",2.57,52.23,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.celrep.2012.10.012",,"4HCA",25.29,"2.8","2.8","DNA binding by GATA transcription factor-complex 1","GSHMGRECVNCGATSTPLWRRDGTGHYLCNACGLYHKMNGQNRPLIKPKRRLSAARRAGTSCANCQTTTTTLWRRNANGDPVCNACGLYYKLHNINRPLTMKKEGIQTRNRKMSS","Homo sapiens","GATA3","Trans-acting T-cell-specific transcription factor GATA-3","1","4HCA"
,,,,,,,,,,,,,,,,"AATGTCCATCTGATAAGACG",,,"DNA (5'-D(*AP*AP*TP*GP*TP*CP*CP*AP*TP*CP*TP*GP*AP*TP*AP*AP*GP*AP*CP*G)-3')","2","4HCA"
,,,,,,,,,,,,,,,,"TTCGTCTTATCAGATGGACA",,,"DNA (5'-D(*TP*TP*CP*GP*TP*CP*TP*TP*AP*TP*CP*AP*GP*AP*TP*GP*GP*AP*CP*A)-3')","3","4HCA"
"4HCK",,"SOLUTION NMR",,,,,,,"10.1006/jmbi.1998.1690",,"4HCK",8.24,,,"HUMAN HCK SH3 DOMAIN, NMR, 25 STRUCTURES","GIREAGSEDIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEE","Homo sapiens","RESIDUES G72-E143 OF HUMAN HCK, HCK","HEMATOPOIETIC CELL KINASE","1","4HCK"
"4HCO",,"X-RAY DIFFRACTION",2.08,40.98,"VAPOR DIFFUSION, HANGING DROP",6,"1.4M Sodium Potassium Tartrate, 50mM MES pH 6.5, 100mM Hepes pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb3004379","IMW","4HCO",55.35,"2.75","2.75","Human Plk1-PBD in complex with Thymoquinone at the phophopeptide binding site","SNAGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4HCO"
"4HCT",,"X-RAY DIFFRACTION",2.11,41.58,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.1M Hepes, 0.1M Mg acetate, 12% PEG 3350 , pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm301190s","18R","4HCT",31.17,"1.48","1.48","Crystal structure of ITK in complex with compound 52","GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4HCT"
"4HCU",,"X-RAY DIFFRACTION",2.11,41.79,"VAPOR DIFFUSION, HANGING DROP",7.2,"12% PEG 3350, 0.1M Mg acetate, 0.1M HEPES , pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm301190s","13L","4HCU",31.16,"1.43","1.43","Crystal structure of ITK in complext with compound 40","GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4HCU"
"4HCV",,"X-RAY DIFFRACTION",1.95,37.08,"VAPOR DIFFUSION, HANGING DROP",7.2,"12% PEG3350, 0.1M Mg acetate, 0.1M Hepes , pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm301190s","13J","4HCV",31.16,"1.48","1.48","Crystal structure of ITK in complex with compound 53","GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4HCV"
"4HD8",,"X-RAY DIFFRACTION",2.42,49.24,"VAPOR DIFFUSION, HANGING DROP",7,"200 mM NaCl, 100 mM HEPES pH 7, 10% (v/v) isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0049761",,"4HD8",32.62,"2.3","2.3","Crystal structure of human Sirt3 in complex with Fluor-de-Lys peptide and piceatannol","GSSDKGKLSLQDVAELIRARACQRVVVMVGAGISTPSGIPDFRSPGSGLYSNLQQYDLPYPEAIFELPFFFHNPKPFFTLAKELYPGNYKPNVTHYFLRLLHDKGLLLRLYTQNIDGLERVSGIPASKLVEAHGTFASATCTVCQRPFPGEDIRADVMADRVPRCPVCTGVVKPDIVFFGEPLPQRFLLHVVDFPMADLLLILGTSLEVEPFASLTEAVRSSVPRLLINRDLVGPLAWHPRSRDVAQLGDVVHGVESLVELLGWTEEMRDLVQRETGKLDGPDK","Homo sapiens","SIR2L3, SIRT3","NAD-dependent protein deacetylase sirtuin-3, mitochondrial","1","4HD8"
,,,,,,,,,,,,,,,,"RHKX",,,"Fluor-de-Lys peptide","2","4HD8"
"4HD9",,"X-RAY DIFFRACTION",2.51,51.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG4K, 0.5M Li2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4HD9",22.57,"1.7","1.7","Crystal structure of native human MAdCAM-1 D1D2 domain","VKPLQVEPPEPVVAVALGASRQLTCRLACADRGASVQWRGLDTSLGAVQSDTGRSVLTVRNASLSAAGTRVCVGSCGGRTFQHTVQLLVYAFPNQLTVSPAALVPGDPEVACTAHKVTPVDPNALSFSLLVGGQELEGAQALGPEVQEEEEEPQGDEDVLFRVTERWRLPPLGTPVPPALYCQATMRLPGLELSHRQAIPVLHHHHHHH","Homo sapiens","MADCAM1","Mucosal addressin cell adhesion molecule 1","1","4HD9"
"4HDA",,"X-RAY DIFFRACTION",2.15,42.69,"VAPOR DIFFUSION, HANGING DROP",,"150 mM NH4Cl, 15% (w/v) PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0049761",,"4HDA",60.96,"2.601","2.601","Crystal structure of human Sirt5 in complex with Fluor-de-Lys peptide and resveratrol","GIDPFTARPSSSMADFRKFFAKAKHIVIISGAGVSAESGVPTFRGAGGYWRKWQAQDLATPLAFAHNPSRVWEFYHYRREVMGSKEPNAGHRAIAECETRLGKQGRRVVVITQNIDELHRKAGTKNLLEIHGSLFKTRCTSCGVVAENYKSPICPALSGKGAPEPGTQDASIPVEKLPRCEEAGCGGLLRPHVVWFGENLDPAILEEVDRELAHCDLCLVVGTSSVVYPAAMFAPQVAARGVPVAEFNTETTPATNRFRFHFQGPCGTTLPEALA","Homo sapiens","SIR2L5, SIRT5","NAD-dependent protein deacylase sirtuin-5, mitochondrial","1","4HDA"
,,,,,,,,,,,,,,,,"RHKX",,,"Fluor-de-Lys peptide","2","4HDA"
"4HE0",,"X-RAY DIFFRACTION",2.73,54.92,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MgCl2, 15% PEG 4000,  0.1M Hepes pH 7.5, vapor diffusion, hanging drop, temperature 295K",295,"10.1371/journal.pone.0071242",,"4HE0",36.87,"2.69","2.69","Crystal structure of human muscle fructose-1,6-bisphosphatase","TDRSPFETDMLTLTRYVMEKGRQAKGTGELTQLLNSMLTAIKAISSAVRKAGLAHLYGIAGSVNVTGDEVKKLDVLSNSLVINMLQSSYSTCVLVSEENKDAIITAKEKRGKYVVCFDPLDGSSNIDCLASIGTIFAIYRKTSEDEPSEKDALQCGRNIVAAGYALYGSATLVALSTGQGVDLFMLDPALGEFVLVEKDVKIKKKGKIYSLNEGYAKYFDAATTEYVQKKKFPEDGSAPYGARYVGSMVADVHRTLVYGGIFLYPANQKSPKGKLRLLYECNPVAYIIEQAGGLATTGTQPVLDVKPEAIHQRVPLILGSPEDVQEYLTCVQKNQAGS","Homo sapiens","FBP2","Fructose-1,6-bisphosphatase isozyme 2","1","4HE0"
"4HE1",,"X-RAY DIFFRACTION",2.72,54.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MgCl2, 15% PEG 4000,  0.1M Hepes pH 7.5, vapor diffusion, hanging drop, temperature 295K",295,"10.1371/journal.pone.0071242",,"4HE1",37.14,"2.23","2.23","Crystal structure of human muscle fructose-1,6-bisphosphatase Q32R mutant complex with fructose-6-phosphate and phosphate","TDRSPFETDMLTLTRYVMEKGRQAKGTGELTRLLNSMLTAIKAISSAVRKAGLAHLYGIAGSVNVTGDEVKKLDVLSNSLVINMLQSSYSTCVLVSEENKDAIITAKEKRGKYVVCFDPLDGSSNIDCLASIGTIFAIYRKTSEDEPSEKDALQCGRNIVAAGYALYGSATLVALSTGQGVDLFMLDPALGEFVLVEKDVKIKKKGKIYSLNEGYAKYFDAATTEYVQKKKFPEDGSAPYGARYVGSMVADVHRTLVYGGIFLYPANQKSPKGKLRLLYECNPVAYIIEQAGGLATTGTQPVLDVKPEAIHQRVPLILGSPEDVQEYLTCVQKNQAGS","Homo sapiens","FBP2","Fructose-1,6-bisphosphatase isozyme 2","1","4HE1"
"4HE2",,"X-RAY DIFFRACTION",2.69,54.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MgCl2, 15% PEG 4000,  0.1M Hepes pH 7.5, vapor diffusion, hanging drop, temperature 295K",295,"10.1371/journal.pone.0071242","AMP","4HE2",37.3,"1.6","1.6","Crystal structure of human muscle fructose-1,6-bisphosphatase Q32R mutant complex with AMP","TDRSPFETDMLTLTRYVMEKGRQAKGTGELTRLLNSMLTAIKAISSAVRKAGLAHLYGIAGSVNVTGDEVKKLDVLSNSLVINMLQSSYSTCVLVSEENKDAIITAKEKRGKYVVCFDPLDGSSNIDCLASIGTIFAIYRKTSEDEPSEKDALQCGRNIVAAGYALYGSATLVALSTGQGVDLFMLDPALGEFVLVEKDVKIKKKGKIYSLNEGYAKYFDAATTEYVQKKKFPEDGSAPYGARYVGSMVADVHRTLVYGGIFLYPANQKSPKGKLRLLYECNPVAYIIEQAGGLATTGTQPVLDVKPEAIHQRVPLILGSPEDVQEYLTCVQKNQAGS","Homo sapiens","FBP2","Fructose-1,6-bisphosphatase isozyme 2","1","4HE2"
"4HEU",,"X-RAY DIFFRACTION",4.57,73.08,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium Sulfate, 0.1M MES monohydrate, 10% v/v 1,4-Dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.10.078","15J","4HEU",75.96,"2","2","Crystal Structure of PDE10A with a biaryl ether inhibitor ((1-(3-(4-((1H-benzo[d]imidazol-2-yl)amino)phenoxy)pyridin-2-yl)piperidin-4-yl)methanol)","TSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGE","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4HEU"
"4HEW",,"X-RAY DIFFRACTION",2.08,40.75,"VAPOR DIFFUSION, HANGING DROP",8,"Drops of 10 uL (0.3 mM protein; 100 mM small imidazole; 0.8 M sodium citrate; 50 mM Tris-HCl; pH 8.0) were equilibrated against the precipitant solution (1.6 M sodium citrate; 50 mM Tris-HCl; pH 8.0), VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S2052252514004096",,"4HEW",29.45,"1.6984","1.6984","Activity Enhancers of H64A Variant of Human Carbonic Anhydrase II Possess Multiple Binding Sites within and around the Enzyme Structure","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGAAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4HEW"
"4HEY",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION, HANGING DROP",8,"Drops of 10 uL (0.3 mM protein; 100 mM small imidazole; 0.8 M sodium citrate; 50 mM Tris-HCl; pH 8.0) were equilibrated against the precipitant solution (1.6 M sodium citrate; 50 mM Tris-HCl; pH 8.0), VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S2052252514004096",,"4HEY",30.03,"1.45","1.45","Activity Enhancers of H64A Variant of Human Carbonic Anhydrase II Possess Multiple Binding Sites within and around the Enzyme Structure","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGAAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4HEY"
"4HEZ",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION, HANGING DROP",8,"Drops of 10 uL (0.3 mM protein; 100 mM small imidazole; 0.8 M sodium citrate; 50 mM Tris-HCl; pH 8.0) were equilibrated against the precipitant solution (1.6 M sodium citrate; 50 mM Tris-HCl; pH 8.0), VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S2052252514004096",,"4HEZ",29.87,"1.3446","1.3446","Activity Enhancers of H64A Variant of Human Carbonic Anhydrase II Possess Multiple Binding Sites within and around the Enzyme Structure","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGAAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4HEZ"
"4HF3",,"X-RAY DIFFRACTION",2.1,41.31,"VAPOR DIFFUSION, HANGING DROP",8,"Drops of 10 uL (0.3 mM protein; 100 mM small imidazole; 0.8 M sodium citrate; 50 mM Tris-HCl; pH 8.0) were equilibrated against the precipitant solution (1.6 M sodium citrate; 50 mM Tris-HCl; pH 8.0), VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S2052252514004096",,"4HF3",29.91,"1.1476","1.1476","Activity Enhancers of H64A Variant of Human Carbonic Anhydrase II Possess Multiple Binding Sites within and around the Enzyme Structure","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGAAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4HF3"
"4HF4",,"X-RAY DIFFRACTION",4.57,73.09,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium Sulfate, 0.1M MES monohydrate, 10% v/v 1,4-Dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2012.10.078","15H","4HF4",76.4,"2","2","Crystal Structure of PDE10A with a biaryl ether inhibitor (1-(1-(3-(4-(benzo[d]thiazol-2-ylamino)phenoxy)pyrazin-2-yl)piperidin-4-yl)ethanol)","TSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGE","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4HF4"
"4HFG",,"X-RAY DIFFRACTION",2.2,43.3,"VAPOR DIFFUSION",6.5,"30% PEG550MME, 0.1M ammounium sulfate, 0.1M sodium cacodylate, pH 6.5, vapor diffusion, temperature 291K",291,,,"4HFG",31.7,"2","2","CID of human RPRD1B","GSSFSESALEKKLSELSNSQHSVQTLSLWLIHHRKHAGPIVSVWHRELRKAKSNRKLTFLYLANDVIQNSKRKGPEFTREFESVLVDAFSHVAREADEGCKKPLERLLNIWQERSVYGGEFIQQLKLSMEDSKSP","Homo sapiens","RPRD1B, C20orf77, CREPT","Regulation of nuclear pre-mRNA domain-containing protein 1B","1","4HFG"
"4HFP",,"X-RAY DIFFRACTION",2.12,41.9,"VAPOR DIFFUSION, HANGING DROP",4.6,"100mM Na acetate pH 4.6 and 25% PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.451542","15U","4HFP",67.89,"2.4","2.4","Structure of thrombin mutant S195a bound to the active site inhibitor argatroban","EADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Prothrombin","1","4HFP"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","2","4HFP"
"4HFR",,"X-RAY DIFFRACTION",3.83,67.85,"VAPOR DIFFUSION",8.5,"42% PEG400, 100 mM Tris-HCl, pH 8.5, VAPOR DIFFUSION",,"10.1021/jm300592r","14M","4HFR",62.08,"2.73","2.73","Human 11beta-Hydroxysteroid Dehydrogenase Type 1 in complex with an orally bioavailable acidic inhibitor AZD4017.","GGGNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPLVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPSRKILEELYSTSYNWDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","4HFR"
"4HFW",,"X-RAY DIFFRACTION",3.15,60.98,"VAPOR DIFFUSION",7.5,"2.0 M Ammonium sulfate, 5% v/v 2-Propanol., pH 7.5, VAPOR DIFFUSION, temperature 291K",291,"10.1371/journal.pone.0061101",,"4HFW",94.5,"2.601","2.601","Anti Rotavirus Antibody","DIRLTQSPSSLSASVGDRVTITCRASQSISNYLNWYQKKPGQAPKLLIYAATSLQSGVPSRFSGSGSGTDFTLTISSVQPEDFATYYCQKTLRTWTFGQGTKVEIKRTAAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"6-26 Fab Light chain","1","4HFW"
,,,,,,,,,,,,,,,,"EFQLVESGAEVKKPGASVKVSCKASGYSFTSYYVHWVREAPGEGLEWMGMINPSDGSTYYAQRFQPRVTMTRDTSTTTVFMEMSGLRSEDTAVYYCARGVVGATNEIDFWGQGTTVTVSSASFKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"6-26 Fab Heavy chain","2","4HFW"
"4HFX",,"X-RAY DIFFRACTION",2.44,49.66,"Microbatch under oil method",9,"1.88M Na2s2o3, 0.1M TAPS PH9, Microbatch under oil method, temperature 277K",277,,,"4HFX",48.87,"2.54","2.54","Crystal structure of a transcription elongation factor B polypeptide 3 from Homo sapiens, Northeast Structural Genomics consortium target id HR4748B.","MGHHHHHHSHMGVPYSVLEPVLERCTPDQLYRIEEYNHVLIEETDQLWKVHCHRDFKEERPEEYESWREMYLRLQDAREQRLRVLTKNIQFAHANKP","Homo sapiens","ELOA, TCEB3, MSTP059","Transcription elongation factor B polypeptide 3","1","4HFX"
"4HG7",,"X-RAY DIFFRACTION",3.46,64.5,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.5 M ammonium sulfate, 0.1 M sodium citrate, 1.0 M lithium sulfate, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1107/S0907444913004459","NUT","4HG7",11.76,"1.6","1.6","Crystal Structure of an MDM2/Nutlin-3a complex","GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4HG7"
"4HGE",,"X-RAY DIFFRACTION",3.13,60.64,"VAPOR DIFFUSION, SITTING DROP",6,"ammonium sulfate, sodium citrate, PEG 8000, pH 6, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1021/jm3012239","15V","4HGE",71.39,"2.3","2.3","JAK2 kinase (JH1 domain) in complex with compound 8","SGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4HGE"
"4HGL",,"X-RAY DIFFRACTION",2.77,50.49,"VAPOR DIFFUSION, HANGING DROP",9,"100 mM Tris, 0.2 M MgCl2, 2.5-15% PEG10K , pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ml300278f","0YO","4HGL",38.94,"2.4","2.4","Crystal structure of ck1g3 with compound 1","GSGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGAVQQDPALSSNREAHQHRDKMQQSKNQ","Homo sapiens","CSNK1G3","Casein kinase I isoform gamma-3","1","4HGL"
"4HGS",,"X-RAY DIFFRACTION",2.73,54.87,"VAPOR DIFFUSION, HANGING DROP",9,"100 mM Tris, 0.2 M MgCl2,  
2.5-15% PEG10K , pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"15G","4HGS",38.85,"2.4","2.4","Crystal structure of ck1gs with compound 13","GSGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGAVQQDPALSSNREAHQHRDKMQQSKNQ","Homo sapiens","CSNK1G3","Casein kinase I isoform gamma-3","1","4HGS"
"4HGT",,"X-RAY DIFFRACTION",2.27,45.74,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate, 1.0 M LiCl,  
30% PEG6000 , pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ml300278f","15G","4HGT",69.47,"1.8","1.8","Crystal structure of ck1d with compound 13","GSMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","4HGT"
"4HH9",,"X-RAY DIFFRACTION",2.38,48.32,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.05M Bis-Tris, pH 5.5, 20% PEG 3350, 0.2M Ammonium citrate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.4049/jimmunol.1402890",,"4HH9",97.74,"1.7","1.7","Anti-Human Cytomegalovirus (HCMV) Fab KE5","EVVLTQSPATLSLSPGERATISCRASQSVGGYLTWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISGLEPEDFAIYYCQQRGNWPPITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab KE5, light chain","1","4HH9"
,,,,,,,,,,,,,,,,"QVQLVESGGGVVQPGRSLRLSCAASGFTFSNHGMHWVRQAPGKRLEWVAVISYDGRHEHYADLVKGRFTISRDNSKNTLYLQMNSLRAEDRALYFCAREGLSRDNSGFTGLIDYWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTGLE","Homo sapiens",,"Fab KE5, heavy chain","2","4HH9"
"4HHV",,"X-RAY DIFFRACTION",2.66,53.84,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M sodium citrate, pH 6.0, 1.0 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0079590",,"4HHV",25.21,"1.75","1.75","Crystal structure of ceramide transfer protein pleckstrin homology domain","GEFSGPPVERCGVLSKWTNYIHGWQDRWVVLKNNALSYYKSEDETEYGCRGSICLSKAVITPHDFDECRFDISVNDSVWYLRAQDPDHRQQWIDAIEQHKTESGY","Homo sapiens","CERT, COL4A3BP, STARD11, CERT1","Collagen type IV alpha-3-binding protein","1","4HHV"
"4HHY",,"X-RAY DIFFRACTION",2.52,51.24,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M TRIS pH 8.0, 1% PEG400, 1.9M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301825t","15R","4HHY",160.94,"2.3637","2.3637","Crystal structure of PARP catalytic domain in complex with novel inhibitors","GPLGSKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","ADPRT, PARP1, PPOL","Poly [ADP-ribose] polymerase 1","1","4HHY"
"4HHZ",,"X-RAY DIFFRACTION",2.48,50.43,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M TRIS pH 8.0, 1% PEG400, 1.9M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301825t","15S","4HHZ",160.52,"2.7199","2.7199","Crystal structure of PARP catalytic domain in complex with novel inhibitors","GPLGSKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","ADPRT, PARP1, PPOL","Poly [ADP-ribose] polymerase 1","1","4HHZ"
"4HIB",,"X-RAY DIFFRACTION",2.09,41.1,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.6M-1.7M Ammonium sulphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301176r",,"4HIB",68.95,"1.8","1.8","Crystal structure of human orotidine 5'-monophosphate decarboxylase complexed with CMP-N4-OH","MGSSHHHHHHSSGLVPRGSHMDAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","4HIB"
"4HIE",,"X-RAY DIFFRACTION",2.3,46.54,"VAPOR DIFFUSION, HANGING DROP",4,"0.05M Na Citrate, pH 3-4, 18% PEG 3350, 0.2M Li Acetate 
, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.4049/jimmunol.1402890",,"4HIE",49.05,"1.9","1.9","Anti-Streptococcus pneumoniae 23F Fab 023.102","QAGQLTQSPATLSLSPGERATLSCRASQSVTNYLAWYQQKPGQAPRLLIYGASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRDNWPPDATFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLRSPVTKSFNRGECAAA","Homo sapiens",,"Fab 023.102","1","4HIE"
,,,,,,,,,,,,,,,,"LINLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVVSSDGRTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVFYCAKEGGDNKFSFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCWARHHHHHH","Homo sapiens",,"Antibody 023.102","2","4HIE"
"4HIH",,"X-RAY DIFFRACTION",2.69,54.24,"VAPOR DIFFUSION, HANGING DROP",4,"0.05M Na Citrate, pH 3-4, 18% PEG 3350, 0.2M Li Acetate 
, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.4049/jimmunol.1402890",,"4HIH",98.42,"2","2","Anti-Streptococcus pneumoniae 23F Fab 023.102 with bound rhamnose.","QAGQLTQSPATLSLSPGERATLSCRASQSVTNYLAWYQQKPGQAPRLLIYGASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRDNWPPDATFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLRSPVTKSFNRGECAAA","Homo sapiens",,"Fab 023.102","1","4HIH"
,,,,,,,,,,,,,,,,"LINLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVVSSDGRTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVFYCAKEGGDNKFSFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCWARHHHHHH","Homo sapiens",,"Antibody 023.102","2","4HIH"
"4HII",,"X-RAY DIFFRACTION",2.73,54.91,"VAPOR DIFFUSION, HANGING DROP",4,"0.05M Na Citrate, pH 3-4, 18% PEG 3350, 0.2M Li Acetate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.4049/jimmunol.1402890",,"4HII",98.49,"2.3","2.3","Anti-Streptococcus pneumoniae 23F Fab 023.102 with bound rhamnose-galactose","AGQLTQSPATLSLSPGERATLSCRASQSVTNYLAWYQQKPGQAPRLLIYGASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRDNWPPDATFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLRSPVTKSFNRGECAAA","Homo sapiens",,"Fab 023.102 light chain","1","4HII"
,,,,,,,,,,,,,,,,"LINLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVVSSDGRTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVFYCAKEGGDNKFSFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCWARHHHHHH","Homo sapiens",,"Fab 023.102 heavy chain","2","4HII"
"4HIJ",,"X-RAY DIFFRACTION",2.69,54.22,"VAPOR DIFFUSION, HANGING DROP",4,"0.05M Na Citrate, pH 3-4, 18% PEG 3350, 0.2M Li Acetate 
, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.4049/jimmunol.1402890",,"4HIJ",98.89,"2.1","2.1","Anti-Streptococcus pneumoniae 23F Fab 023.102 with bound L-rhamnose-(1-2)-alpha-D-galactose-(3-O)-phosphate-2-glycerol","AGQLTQSPATLSLSPGERATLSCRASQSVTNYLAWYQQKPGQAPRLLIYGASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRDNWPPDATFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLRSPVTKSFNRGECAAA","Homo sapiens",,"Fab 023.102 light chain","1","4HIJ"
,,,,,,,,,,,,,,,,"LINLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVVSSDGRTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVFYCAKEGGDNKFSFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCWARHHHHHH","Homo sapiens",,"Fab 023.102 heavy chain","2","4HIJ"
"4HIQ",,"X-RAY DIFFRACTION",2.1,41.42,"VAPOR DIFFUSION, SITTING DROP",5.5,"THE WT-TTR WAS CONCENTRATED TO 4 MG/ML IN 10 MM NAPI, 100 MM KCL, AT PH 7.6 AND CO-CRYSTALLIZED AT ROOM TEMPERATURE WITH INHIBITORS USING THE VAPOR-DIFFUSION SITTING DROP METHOD, CRYSTALS WERE GROWN FROM 1.395 M SODIUM CITRATE, 3.5% V/V GLYCEROL AT PH 5.5. THE CRYSTALS WERE FROZEN USING A CRYO-PROTECTANT SOLUTION OF 1.395 M SODIUM CITRATE, PH 5.5, CONTAINING 10% V/V GLYCEROL, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.1300761110","16V","4HIQ",28.17,"1.18","1.18","The Structure of V122I Mutant Transthyretin in Complex with AG10","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVITNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4HIQ"
"4HIS",,"X-RAY DIFFRACTION",2.1,41.55,"VAPOR DIFFUSION, SITTING DROP",5.5,"THE WT-TTR WAS CONCENTRATED TO 4 MG/ML IN 10 MM NAPI, 100 MM KCL, AT PH 7.6 AND CO-CRYSTALLIZED AT ROOM TEMPERATURE WITH INHIBITORS USING THE VAPOR-DIFFUSION SITTING DROP METHOD, CRYSTALS WERE GROWN FROM 1.395 M SODIUM CITRATE, 3.5% V/V GLYCEROL AT PH 5.5. THE CRYSTALS WERE FROZEN USING A CRYO-PROTECTANT SOLUTION OF 1.395 M SODIUM CITRATE, PH 5.5, CONTAINING 10% V/V GLYCEROL, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.1300761110","3MI","4HIS",27.89,"1.2","1.2","The Structure of V122I Mutant Transthyretin in Complex with Tafamidis","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVITNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4HIS"
"4HJ2",,"X-RAY DIFFRACTION",2.36,47.9,,,,,"10.1371/journal.pone.0056337","LZ6","4HJ2",51.22,"2.1","2.1","Crystal Structure Analysis of GSTA1-1 in complex with chlorambucil","KPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","4HJ2"
"4HJE",,"X-RAY DIFFRACTION",2.17,43.34,,,,,"10.1093/nar/gkt584",,"4HJE",103.26,"1.907","1.907","Crystal structure of p53 core domain in complex with DNA","PLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRK","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","4HJE"
,,,,,,,,,,,,,,,,"TCACAAGTTAGAGACAAGCCT",,,"DNA (5'-D(*TP*CP*AP*CP*AP*AP*GP*TP*TP*AP*GP*AP*GP*AP*CP*AP*AP*GP*CP*CP*T)-3')","2","4HJE"
,,,,,,,,,,,,,,,,"AGGCTTGTCTCTAACTTGTGA",,,"DNA (5'-D(*AP*GP*GP*CP*TP*TP*GP*TP*CP*TP*CP*TP*AP*AP*CP*TP*TP*GP*TP*GP*A)-3')","3","4HJE"
"4HJK",,"X-RAY DIFFRACTION",2.12,41.91,"VAPOR DIFFUSION, HANGING DROP",4,"2.4M AmSO4 and 0.1M Citric acid pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4HJK",8.81,"1.784","1.784","U7Ub7 Disulfide variant","AMQIFVKCLTGKTNTLEVEPSDTIENVKAKIQDKIGYPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHCVRRLRGG","Homo sapiens","DKFZp434K0435, Ubiquitin, UBA52, UBCEP2","Ubiquitin","1","4HJK"
"4HJO",,"X-RAY DIFFRACTION",2.45,49.86,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.25 M sodium thiocyanate, 27% w/v PEG3350, 10 mM taurine, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 294.15K",294.15,"10.1042/BJ20121513","AQ4","4HJO",38.95,"2.75","2.75","Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinib","MKKGHHHHHGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4HJO"
"4HJP",,"X-RAY DIFFRACTION",2.2,43.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.0 M tri-sodium citrate, 2-4% 1-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.2174/09298665113209990041",,"4HJP",32.93,"1.3994","1.3994","SHP-1 catalytic domain WPD loop open","GSGFWEEFESLQKQEVKNLHQRLEGQRPENKGKNRYKNILPFDHSRVILQGRDSNIPGSDYINANYIKNQLLGPDENAKTYIASQGCLEATVNDFWQMAWQENSRVIVMTTREVEKGRNKCVPYWPEVGMQRAYGPYSVTNCGEHDTTEYKLRTLQVSPLDNGDLIREIWHYQYLSWPDHGVPSEPGGVLSFLDQINQRQESLPHAGPIIVHCSAGIGRTGTIIVIDMLMENISTKGLDCDIDIQKTIQMVRAQRSGMVQTEAQYKFIYVAIAQFIETTKKKLEVLQS","Homo sapiens","HCP, PTP1C, PTPN6, SHP-1 (PTPN6)","Tyrosine-protein phosphatase non-receptor type 6","1","4HJP"
"4HJQ",,"X-RAY DIFFRACTION",2.61,52.82,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH7.5, 20 mM MgCl2, 28% sodium polyacrylate 5100 , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.2174/09298665113209990041",,"4HJQ",70.93,"1.8013","1.8013","SHP-1 catalytic domain WPD loop closed","MHHHHHHGSLVPRSENLYFQGSGFWEEFESLQKQEVKNLHQRLEGQRPENKGKNRYKNILPFDHSRVILQGRDSNIPGSDYINANYIKNQLLGPDENAKTYIASQGCLEATVNDFWQMAWQENSRVIVMTTREVEKGRNKCVPYWPEVGMQRAYGPYSVTNCGEHDTTEYKLRTLQVSPLDNGDLIREIWHYQYLSWPDHGVPSEPGGVLSFLDQINQRQESLPHAGPIIVHSSAGIGRTGTIIVIDMLMENISTKGLDCDIDIQKTIQMVRAQRSGMVQTEAQYKFIYVAIAQFIETTKKKLEVLQS","Homo sapiens","HCP, PTP1C, PTPN6, SHP-1 (PTPN6)","Tyrosine-protein phosphatase non-receptor type 6","1","4HJQ"
"4HJS",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, SITTING DROP",5.5,"THE WT-TTR WAS CONCENTRATED TO 4 MG/ML IN 10 MM NAPI, 100 MM KCL, AT PH 7.6 AND CO-CRYSTALLIZED AT ROOM TEMPERATURE WITH INHIBITORS USING THE VAPOR-DIFFUSION SITTING DROP METHOD, CRYSTALS WERE GROWN FROM 1.395 M SODIUM CITRATE, 3.5% V/V GLYCEROL AT PH 5.5. THE CRYSTALS WERE FROZEN USING A CRYO-PROTECTANT SOLUTION OF 1.395 M SODIUM CITRATE, PH 5.5, CONTAINING 10% V/V GLYCEROL, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/ja408230k","18J","4HJS",26.07,"1.22","1.22","Kinetic stabilization of transthyretin through covalent modification of K15 by (E)-N-(4-(4-hydroxy-3,5-dimethylstyryl)ethanesulfonamide","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNP","Homo sapiens","PALB, TTR","Transthyretin","1","4HJS"
"4HJT",,"X-RAY DIFFRACTION",2.13,42.22,"VAPOR DIFFUSION, SITTING DROP",5.5,"THE WT-TTR WAS CONCENTRATED TO 4 MG/ML IN 10 MM NAPI, 100 MM KCL, AT PH 7.6 AND CO-CRYSTALLIZED AT ROOM TEMPERATURE WITH INHIBITORS USING THE VAPOR-DIFFUSION SITTING DROP METHOD, CRYSTALS WERE GROWN FROM 1.395 M SODIUM CITRATE, 3.5% V/V GLYCEROL AT PH 5.5. THE CRYSTALS WERE FROZEN USING A CRYO-PROTECTANT SOLUTION OF 1.395 M SODIUM CITRATE, PH 5.5, CONTAINING 10% V/V GLYCEROL, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/ja408230k",,"4HJT",28.15,"1.45","1.45","Kinetic stabilization of transthyretin through covalent modification of K15 by (E)-N-(4-(4-hydroxy-3,5-dimethylstyryl)phenyl)propionamide","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4HJT"
"4HJU",,"X-RAY DIFFRACTION",2.13,42.19,"VAPOR DIFFUSION, SITTING DROP",5.5,"THE WT-TTR WAS CONCENTRATED TO 4 MG/ML IN 10 MM NAPI, 100 MM KCL, AT PH 7.6 AND CO-CRYSTALLIZED AT ROOM TEMPERATURE WITH INHIBITORS USING THE VAPOR-DIFFUSION SITTING DROP METHOD, CRYSTALS WERE GROWN FROM 1.395 M SODIUM CITRATE, 3.5% V/V GLYCEROL AT PH 5.5. THE CRYSTALS WERE FROZEN USING A CRYO-PROTECTANT SOLUTION OF 1.395 M SODIUM CITRATE, PH 5.5, CONTAINING 10% V/V GLYCEROL, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/ja408230k",,"4HJU",28.14,"1.35","1.35","Transthyretin in complex with (E)-N-(3-(4-hydroxy-3,5-dimethylstyryl)phenyl)acrylamide","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4HJU"
"4HK2",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4,"2.4 M AmSO4 and 0.1M Citric acid pH 4.0, vapor diffusion, hanging drop, temperature 277K",277,,,"4HK2",35.74,"1.4","1.4","U7Ub25.2540","GSMQIFVKFRTGKTYTLEVEPSDTIENVKAKIQDKLGIPPDQQWLIFAGKRLEDGRTLSDYNIQKESTLRGVRRLRGG","Homo sapiens","UBC, Ubiquitin","Ubiquitin","1","4HK2"
"4HKB",,"X-RAY DIFFRACTION",2.75,55.35,"VAPOR DIFFUSION, HANGING DROP",8,"15-20% PEG4000, 10 mM Tris-HCl, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1218256109",,"4HKB",289.91,"3.6","3.6","CH67 Fab (unbound) from the CH65-67 Lineage","QVQLVQSGAEVRKPGASVKVSCKASGYTFTDNYIHWVRQAPGQGLEWMGWIHPNSGATKYAQKFEGWVTMTRDTSISTVYMELSRSRSDDTAVYYCARAGLEPRSVDYYFYGLDVWGQGTAVTVSSASTKGPSVFPLAPSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"CH67 heavy chain","1","4HKB"
,,,,,,,,,,,,,,,,"SALTQPPSVSVAPGQTATITCGGNNIGRKRVDWFQQKPGQAPVLVVYEDSDRPSGIPERFSDSNSGTTATLTISRVEAGDEADYYCQVWDSDSDHVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CH67 light chain","2","4HKB"
"4HKD",,"X-RAY DIFFRACTION",1.88,34.45,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.4M calcium chloride dihydrate, 0.1M sodium acetate trihydrate, 5%(v/v) 2-propanol, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"4HKD",26.24,"1.503","1.503","Crystal structure of human MST2 SARAH domain","GAMDDFDFLKNLSLEELQMRLKALDPMMEREIEELRQRYTAKRQPILDAMDAK","Homo sapiens","STK3, KRS1, MST2","Serine/threonine-protein kinase 3","1","4HKD"
"4HKI",,"X-RAY DIFFRACTION",2.43,49.43,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M LiSO4, 0.1 M Tris HCl 24 % PEG3350, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3018783","FLN","4HKI",55.99,"2.15","2.15","Tankyrase 2 in complex with flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4HKI"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4HKI"
"4HKK",,"X-RAY DIFFRACTION",2.43,49.38,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris HCl 24 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3018783","AGI","4HKK",55.9,"1.95","1.95","Complex structure of human tankyrase 2 with apigenin","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4HKK"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4HKK"
"4HKN",,"X-RAY DIFFRACTION",2.45,49.7,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3018783","LU2","4HKN",27.96,"2.05","2.05","Complex structure of human tankyrase 2 with luteolin","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4HKN"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4HKN"
"4HKP",,"X-RAY DIFFRACTION",2.04,39.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.6M-1.7M Ammonium sulphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301176r","16B","4HKP",69.68,"1.75","1.75","Crystal structure of human orotidine 5'-monophosphate decarboxylase complexed with CMP-N3-oxide","MGSSHHHHHHSSGLVPRGSHMDAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","4HKP"
"4HL4",,"X-RAY DIFFRACTION",2.62,53.03,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.1M sodium acetate pH 4.5, 0.8M di-potassium hydrogen phospate, 0.8M sodium dihydrogen phosphate, 0.025M beryllium fluoride, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K",277,"10.1073/pnas.1214431110",,"4HL4",33.87,"2.2","2.2","Crystal structure of the human TBC1D20 RabGAP domain","GHWDGGAEKADFNAKRKKKVAEIHQALNSDPTDVAALRRMAISEGGLLTDEIRRKVWPKLLNVNANDPPPISGKNLRQMSKDYQQVLLDVRRSLRRFPPGMPEEQREGLQEELIDIILLILERNPQLHYYQGYHDIVVTFLLVVGERLATSLVEKLSTHHLRDFMDPTMDNTKHILNYLMPIIDQVNPELHDFMQSAEVGTIFALSWLITWFGHVLSDFRHVVRLYDFFLACHPLMPIYFAAVIVLYREQEVLDCDCDMASVHHLLSQIPQDLPYETLISRAGDLFVQFPPS","Homo sapiens","TBC1D20, C20orf140","TBC1 domain family member 20","1","4HL4"
"4HL5",,"X-RAY DIFFRACTION",2.41,49.06,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris HCl 24 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3018783","15W","4HL5",27.95,"2.2","2.2","Complex structure of human tankyrase 2 with 7-hydroxy -4'-methoxyflavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4HL5"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4HL5"
"4HLE",,"X-RAY DIFFRACTION",2.35,47.62,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3350, 0.2M NH4SO4, 0.1M Tris-HCl 8.5, vapor diffusion, hanging drop, temperature 289K",289,"10.1016/j.bmcl.2012.10.121","17V","4HLE",111.08,"2.78","2.78","Compound 21 (1-alkyl-substituted 1,2,4-triazoles)","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","p110 gamma, PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4HLE"
"4HLF",,"X-RAY DIFFRACTION",2.43,49.43,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3018783","15Z","4HLF",56.09,"2.15","2.15","Crystal structure of Tankyrase 2 in complex with 7,3',4'-Trihydroxyflavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4HLF"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4HLF"
"4HLG",,"X-RAY DIFFRACTION",2.43,49.38,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3018783","20B","4HLG",55.72,"2","2","Crystal structure of Tankyrase 2 in complex with 3'-hydroxyflavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4HLG"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4HLG"
"4HLH",,"X-RAY DIFFRACTION",2.43,49.29,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3018783","20D","4HLH",55.83,"1.75","1.75","Crystal structure of Tankyrase 2 in complex with 4'-fluoroflavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4HLH"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4HLH"
"4HLI",,"X-RAY DIFFRACTION",2.27,45.73,"VAPOR DIFFUSION, SITTING DROP",7,"0.04m sodium cacodylate buffer, 0.08M NaCCl, 0.12m KCl, 0.02m MgCl2, 0.012m spermine tetra hydrochloride, 35% MPD, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/nar/gkt738",,"4HLI",7.45,"1.99","1.99","DNA dodecamer containing 5-hydroxymethyl-cytosine","CGXGAATTCGCG","Homo sapiens",,"DNA (5'-D(*CP*GP*(5HC)P*GP*AP*AP*TP*TP*CP*GP*CP*G)-3')","1","4HLI"
"4HLJ",,"X-RAY DIFFRACTION",1.94,36.71,"VAPOR DIFFUSION, HANGING DROP",4.5,"35% PEG 400, 0.1M Sodium acetate trihydrate, 5% glycerol, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4HLJ",26.6,"1.8","1.8","Axon Guidance Receptor","STSQGVDHKQVQRELGNAVLHLHNPTVLSSSSIEVHWTVDQQSQYIQGYKILYRPSGANHGESDWLVFEVRTPAKNSVVIPDLRKGVNYEIKARPFFNEFQGADSEIKFAKTLEEAPSAPPQGVTVSKNDGNGTAILVSWQPPPEDTQNGMVQEYKVWCLGNETRYHINKTVDGSTFSVVIPFLVPGIRYSVEVAASTGAGSGVKSEPQFIQLDAHGNPVSPEDRVSLAQQISDVVKQPK","Homo sapiens","DUTT1, ROBO1","Roundabout homolog 1","1","4HLJ"
"4HLK",,"X-RAY DIFFRACTION",2.43,49.38,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3018783","431","4HLK",55.82,"2","2","Crystal structure of Tankyrase 2 in complex with 4'-methylflavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4HLK"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4HLK"
"4HLM",,"X-RAY DIFFRACTION",2.43,49.38,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3018783","16S","4HLM",55.75,"1.95","1.95","Crystal structure of Tankyrase 2 in complex with 3',4'-Dihydroxyflavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4HLM"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4HLM"
"4HLT",,"X-RAY DIFFRACTION",2.37,48.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 20000, 0.1 MES 
, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1073/pnas.1221743110",,"4HLT",32,"1.7","1.7","Crystal structure of ferric E32V Pirin","SSKKVTLSVLSREQSEGVGARVRRSIGRPVLKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTWKSKIGN","Homo sapiens","human, PIR","Pirin","1","4HLT"
"4HLW",,"X-RAY DIFFRACTION",2.24,44.99,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.35MNa2HPO4/K2HPO4, 0.1M (NH4)2HPO4, 7.0% polyethylene glycol 400 (PEG 400), and 50mM Tris-HCl at pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/jm3015712","TES, 17W","4HLW",30.62,"2.5","2.5","Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives.","IEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4HLW"
"4HM9",,"X-RAY DIFFRACTION",2.98,58.74,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 2000, Tris 8.0, KBr, vapor diffusion, hanging drop, temperature 298K",298,"10.1107/S0907444913011360",,"4HM9",65.69,"3.1001","3.1001","Crystal structure of full-length human catenin-beta-like 1","GPSSPMDVGELLSYQPNRGTKRPRDDEEEEQKMRRKQTGTRERGRYREEEMTVVEEADDDKKRLLQIIDRDGEEEEEEEEPLDESSVKKMILTFEKRSYKNQELRIKFPDNPEKFMESELDLNDIIQEMHVVATMPDLYHLLVELNAVQSLLGLLGHDNTDVSIAVVDLLQELTDIDTLHESEEGAEVLIDALVDGQVVALLVQNLERLDESVKEEADGVHNTLAIVENMAEFRPEMCTEGAQQGLLQWLLKRLKAKMPFDANKLYCSEVLAILLQDNDENRELLGELDGIDVLLQQLSVFKRHNPSTAEEQEMMENLFDSLCSCLMLSSNRERFLKGEGLQLMNLMLREKKISRSSALKVLDHAMIGPEGTDNCHKFVDILGLRTIFPLFMKSPRKIKKVGTTEKEHEEHVCSILASLLRNLRGQQRTRLLNKFTENDSEKVDRLMELHFKYLGAMQVADKKIEGEKHDMVRRGEIIDNDTEEEFYLRRLDAGLFVLQHICYIMAEICNANVPQIRQRVHQILNMRGSSIKIVRHIIKEYAENIGDGRSPEFRENEQKRILGLLENF","Homo sapiens","C20orf33, CTNNBL1, PP8304","Beta-catenin-like protein 1","1","4HM9"
"4HMA",,"X-RAY DIFFRACTION",2.4,48.74,"VAPOR DIFFUSION, SITTING DROP",6,"Protein: human MMP9 (E402Q) at 308.7 micro-M twin inhibitor LC20 at 154 micro-M (stoichiometry 2:1) and 120mM acetohydroxamic acid.        
RESERVOIR: 12% Polyethylene glycol 20,000, 1.5M NaCl, 0.1 M PCTP (Na propionate, Na cacodylate, Bis-Tris-propane ratio 2:1:2; 75% pH 4, 25% pH 9.5)      
CRYOPROTECTANT:  40% C2 (25 % di-ethylene glycol + 25 % glycerol + 25 % 1,2-propanediol), 9% PEG 10,000 1.5M NaCl, 0.1M PCTP 80/2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.015","0ZD","4HMA",39.04,"1.94","1.94","Crystal structure of an MMP twin carboxylate based inhibitor LC20 in complex with the MMP-9 catalytic domain","FEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGQGYSLFLVAAHQFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG","Homo sapiens","CLG4B, MMP9","Matrix metalloproteinase-9","1","4HMA"
,,,,,,,,,,,,,,,,,"Homo sapiens","CLG4B, MMP9"
"4HMH",,"X-RAY DIFFRACTION",2.42,49.27,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm3018783","F94","4HMH",28.03,"2.3","2.3","Crystal structure of tankyrase 2 in complex with 7,3-dihydroxyflavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4HMH"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4HMH"
"4HMN",,"X-RAY DIFFRACTION",2.36,47.8,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2 M sodium acetate , VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1016/j.bmc.2013.12.050","16J","4HMN",39.09,"2.4","2.4","Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (4-(4-Chlorophenyl)piperazin-1-yl)(morpholino)methanone (24)","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4HMN"
"4HN2",,"X-RAY DIFFRACTION",2.75,55.19,"VAPOR DIFFUSION, HANGING DROP",,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES pH 7.0, 1 mM AMPPNP, 2 mM CdCl2. Soaking with 2 mM 5-PA-InsP5 under pH 5.2 for 3 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c2cc36044f","0EJ","4HN2",38.87,"1.9","1.9","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with AMPPNP and a substrate analog 5PA-IP5","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","HISPPD1, KIAA0433, PPIP5K2, VIP2","Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2","1","4HN2"
"4HND",,"X-RAY DIFFRACTION",4.18,70.56,,5.8,"0.1 M citric acid, 150 mM sodium chloride, 1 mM dithiothreitol, 20 mM magnesium chloride, 18% PEG400, 20 mM hexaethylene glycol monooctyl ether (C8E6), pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/ncomms4552","ADP","4HND",88.79,"3.2","3.2","Crystal structure of the catalytic domain of Selenomethionine substituted human PI4KIIalpha in complex with ADP","GPLGSPEFAAQAQALAAQAAAAAHAAQAHRERNEFPEDPEFEAVVRQAELAIERCIFPERIYQGSSGSYFVKDPQGRIIAVFKPKNEEPYGHLNPKWTKWLQKLSSPSSFGRDCLVLNQGYLSEAGASLVDQKLELNIVPRTKVVYLASETFNYSAIDRVKSRGKRLALEKVPKVGQRFNRIGLPPKVGSFQLFVEGYKDADYWLRRFEAEPLPENTNRQLLLQFERLVVLDYIIRNTDRGNDNWLIKYDCPMDSSSSRDTDWVVVKEPVIKVAAIDNGLAFPLKHPDSWRAYPFYWAWLPQAKVPFSQEIKDLILPKISDPNFVKDLEEDLYELFKKDPGFDRGQFHKQIAVMRGQILNLTQALKDNKSPLHLVQMPPVIVET","Homo sapiens","PI4K2A, PI4KIIA","Phosphatidylinositol 4-kinase type 2-alpha","1","4HND"
"4HNE",,"X-RAY DIFFRACTION",4.13,70.24,,5.8,"0.1 M citric acid, 150 mM sodium chloride, 1 mM dithiothreitol, 20 mM magnesium chloride, 18% PEG400, 20 mM hexaethylene glycol monooctyl ether (C8E6), pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/ncomms4552","ADP","4HNE",88.5,"2.95","2.95","Crystal structure of the catalytic domain of human type II alpha Phosphatidylinositol 4-kinase (PI4KIIalpha) in complex with ADP","GPLGSPEFAAQAQALAAQAAAAAHAAQAHRERNEFPEDPEFEAVVRQAELAIERCIFPERIYQGSSGSYFVKDPQGRIIAVFKPKNEEPYGHLNPKWTKWLQKLSSPSSFGRDCLVLNQGYLSEAGASLVDQKLELNIVPRTKVVYLASETFNYSAIDRVKSRGKRLALEKVPKVGQRFNRIGLPPKVGSFQLFVEGYKDADYWLRRFEAEPLPENTNRQLLLQFERLVVLDYIIRNTDRGNDNWLIKYDCPMDSSSSRDTDWVVVKEPVIKVAAIDNGLAFPLKHPDSWRAYPFYWAWLPQAKVPFSQEIKDLILPKISDPNFVKDLEEDLYELFKKDPGFDRGQFHKQIAVMRGQILNLTQALKDNKSPLHLVQMPPVIVET","Homo sapiens","PI4K2A, PI4KIIA (AMINO ACIDS 78-453)","Phosphatidylinositol 4-kinase type 2-alpha","1","4HNE"
"4HNF",,"X-RAY DIFFRACTION",2.26,45.49,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate, 1.0 M LiCl, 20-30% PEG6000, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm301336n","16W","4HNF",69.42,"2.07","2.07","Crystal structure of ck1d in complex with pf4800567","GSMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","4HNF"
"4HNI",,"X-RAY DIFFRACTION",3.49,64.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM Hepes, 3% Ethanol, 1.1-1.6 M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm301336n","16W","4HNI",70.22,"2.74","2.74","crystal structure of ck1e in complex with PF4800567","GSMELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1E","Casein kinase I isoform epsilon","1","4HNI"
"4HNM",,"X-RAY DIFFRACTION",3.41,63.91,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 2000, Tris 8.0, KBr, vapor diffusion, hanging drop, temperature 298K",298,"10.1107/S0907444913011360",,"4HNM",57.17,"2.9001","2.9001","Crystal structure of human catenin-beta-like 1 56 kDa fragment","EPLDESSVKKMILTFEKRSYKNQELRIKFPDNPEKFMESELDLNDIIQEMHVVATMPDLYHLLVELNAVQSLLGLLGHDNTDVSIAVVDLLQELTDIDTLHESEEGAEVLIDALVDGQVVALLVQNLERLDESVKEEADGVHNTLAIVENMAEFRPEMCTEGAQQGLLQWLLKRLKAKMPFDANKLYCSEVLAILLQDNDENRELLGELDGIDVLLQQLSVFKRHNPSTAEEQEMMENLFDSLCSCLMLSSNRERFLKGEGLQLMNLMLREKKISRSSALKVLDHAMIGPEGTDNCHKFVDILGLRTIFPLFMKSPRKIKKVGTTEKEHEEHVCSILASLLRNLRGQQRTRLLNKFTENDSEKVDRLMELHFKYLGAMQVADKKIEGEKHDMVRRGEIIDNDTEEEFYLRRLDAGLFVLQHICYIMAEICNANVPQIRQRVHQILNMRGSSIKIVRHIIKEYAENIGDGRSPEFRENEQKRILGLLENF","Homo sapiens","C20orf33, CTNNBL1, PP8304","Beta-catenin-like protein 1","1","4HNM"
"4HOK",,"X-RAY DIFFRACTION",3.44,64.23,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM Hepes,  
1.0-1.5 M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.5",298,"10.1021/jm301336n",,"4HOK",412.94,"2.77","2.77","crystal structure of apo ck1e","GSMELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1E","Casein kinase I isoform epsilon","1","4HOK"
"4HOO",,"X-RAY DIFFRACTION",2.76,55.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M calcium acetate, 0.1M HEPES pH 7.5, 10% PEG 8000, vapor diffusion, hanging drop, temperature 277.15K",277.15,"10.1016/j.str.2012.10.018",,"4HOO",76.41,"2.495","2.495","Crystal structure of human JMJD2D/KDM4D apoenzyme","QNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKAAAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQD","Homo sapiens","JHDM3D, JMJD2D, KDM4D","Lysine-specific demethylase 4D","1","4HOO"
"4HOQ",,"X-RAY DIFFRACTION",2.39,48.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1038/nature11783",,"4HOQ",56.26,"2.07","2.07","Crystal Structure of Full-Length Human IFIT5","MSEIRKDTLKAILLELECHFTWNLLKEDIDLFEVEDTIGQQLEFLTTKSRLALYNLLAYVKHLKGQNKDALECLEQAEEIIQQEHSDKEEVRSLVTWGNYAWVYYHMDQLEEAQKYTGKIGNVCKKLSSPSNYKLECPETDCEKGWALLKFGGKYYQKAKAAFEKALEVEPDNPEFNIGYAITVYRLDDSDREGSVKSFSLGPLRKAVTLNPDNSYIKVFLALKLQDVHAEAEGEKYIEEILDQISSQPYVLRYAAKFYRRKNSWNKALELLKKALEVTPTSSFLHHQMGLCYRAQMIQIKKATHNRPKGKDKLKVDELISSAIFHFKAAMERDSMFAFAYTDLANMYAEGGQYSNAEDIFRKALRLENITDDHKHQIHYHYGRFQEFHRKSENTAIHHYLEALKVKDRSPLRTKLTSALKKLSTKRLCHNALDVQSLSALGFVYKLEGEKRQAAEYYEKAQKIDPENAEFLTALCELRLSI","Homo sapiens","IFIT5, IFIT5/ISG58, ISG58, RI58","Interferon-induced protein with tetratricopeptide repeats 5","1","4HOQ"
"4HOR",,"X-RAY DIFFRACTION",2.37,48.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295.15K",295.15,"10.1038/nature11783",,"4HOR",57.6,"1.861","1.861","Crystal Structure of Full-Length Human IFIT5 with 5`-triphosphate Oligocytidine","MSEIRKDTLKAILLELECHFTWNLLKEDIDLFEVEDTIGQQLEFLTTKSRLALYNLLAYVKHLKGQNKDALECLEQAEEIIQQEHSDKEEVRSLVTWGNYAWVYYHMDQLEEAQKYTGKIGNVCKKLSSPSNYKLECPETDCEKGWALLKFGGKYYQKAKAAFEKALEVEPDNPEFNIGYAITVYRLDDSDREGSVKSFSLGPLRKAVTLNPDNSYIKVFLALKLQDVHAEAEGEKYIEEILDQISSQPYVLRYAAKFYRRKNSWNKALELLKKALEVTPTSSFLHHQMGLCYRAQMIQIKKATHNRPKGKDKLKVDELISSAIFHFKAAMERDSMFAFAYTDLANMYAEGGQYSNAEDIFRKALRLENITDDHKHQIHYHYGRFQEFHRKSENTAIHHYLEALKVKDRSPLRTKLTSALKKLSTKRLCHNALDVQSLSALGFVYKLEGEKRQAAEYYEKAQKIDPENAEFLTALCELRLSI","Homo sapiens","IFIT5, IFIT5/ISG58, ISG58, RI58","Interferon-induced protein with tetratricopeptide repeats 5","1","4HOR"
,,,,,,,,,,,,,,,,"XCCCC",,,"RNA (5'-R(*(CTP)P*CP*CP*CP*C)-3')","2","4HOR"
"4HOS",,"X-RAY DIFFRACTION",2.36,47.81,,7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295.15K",295.15,"10.1038/nature11783",,"4HOS",57.3,"2","2","Crystal Structure of Full-Length Human IFIT5 with 5`-triphosphate Oligouridine","MSEIRKDTLKAILLELECHFTWNLLKEDIDLFEVEDTIGQQLEFLTTKSRLALYNLLAYVKHLKGQNKDALECLEQAEEIIQQEHSDKEEVRSLVTWGNYAWVYYHMDQLEEAQKYTGKIGNVCKKLSSPSNYKLECPETDCEKGWALLKFGGKYYQKAKAAFEKALEVEPDNPEFNIGYAITVYRLDDSDREGSVKSFSLGPLRKAVTLNPDNSYIKVFLALKLQDVHAEAEGEKYIEEILDQISSQPYVLRYAAKFYRRKNSWNKALELLKKALEVTPTSSFLHHQMGLCYRAQMIQIKKATHNRPKGKDKLKVDELISSAIFHFKAAMERDSMFAFAYTDLANMYAEGGQYSNAEDIFRKALRLENITDDHKHQIHYHYGRFQEFHRKSENTAIHHYLEALKVKDRSPLRTKLTSALKKLSTKRLCHNALDVQSLSALGFVYKLEGEKRQAAEYYEKAQKIDPENAEFLTALCELRLSI","Homo sapiens","IFIT5, IFIT5/ISG58, ISG58, RI58","Interferon-induced protein with tetratricopeptide repeats 5","1","4HOS"
,,,,,,,,,,,,,,,,"XUUU",,,"RNA (5'-R(*(UTP)P*UP*UP*U)-3')","2","4HOS"
"4HOT",,"X-RAY DIFFRACTION",2.36,47.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"-, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295.15K",295.15,"10.1038/nature11783",,"4HOT",57.39,"2.501","2.501","Crystal Structure of Full-Length Human IFIT5 with 5`-triphosphate Oligoadenine","MSEIRKDTLKAILLELECHFTWNLLKEDIDLFEVEDTIGQQLEFLTTKSRLALYNLLAYVKHLKGQNKDALECLEQAEEIIQQEHSDKEEVRSLVTWGNYAWVYYHMDQLEEAQKYTGKIGNVCKKLSSPSNYKLECPETDCEKGWALLKFGGKYYQKAKAAFEKALEVEPDNPEFNIGYAITVYRLDDSDREGSVKSFSLGPLRKAVTLNPDNSYIKVFLALKLQDVHAEAEGEKYIEEILDQISSQPYVLRYAAKFYRRKNSWNKALELLKKALEVTPTSSFLHHQMGLCYRAQMIQIKKATHNRPKGKDKLKVDELISSAIFHFKAAMERDSMFAFAYTDLANMYAEGGQYSNAEDIFRKALRLENITDDHKHQIHYHYGRFQEFHRKSENTAIHHYLEALKVKDRSPLRTKLTSALKKLSTKRLCHNALDVQSLSALGFVYKLEGEKRQAAEYYEKAQKIDPENAEFLTALCELRLSI","Homo sapiens","IFIT5, IFIT5/ISG58, ISG58, RI58","Interferon-induced protein with tetratricopeptide repeats 5","1","4HOT"
,,,,,,,,,,,,,,,,"XAAA",,,"RNA (5'-R(*(ATP)P*AP*AP*A)-3')","2","4HOT"
"4HOU",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295.15K",295.15,"10.1038/nature11783",,"4HOU",63.88,"1.95","1.95","Crystal Structure of N-terminal Human IFIT1","DHQVKDSLEQLRCHFTWELSIDDDEMPDLENRVLDQIEFLDTKYSVGIHNLLAYVKHLKGQNEEALKSLKEAENLMQEEHDNQANVRSLVTWGNFAWMYYHMGRLAEAQTYLDKVENICKKLSNPFRYRMECPEIDCEEGWALLKCGGKNYERAKACFEKVLEVDPENPESSAGYAISAYRLDGFKLATKNHKPFSLLPLRQAVRLNPDNGYIKVLLALKLQDEGQEAEGEKYIEEALANMSSQTYVFRYAAKFYRRKGSVDKALELLKKALQ","Homo sapiens","G10P1, IFI56, IFIT1, IFIT1/ISG56, IFNAI1, ISG56","Interferon-induced protein with tetratricopeptide repeats 1","1","4HOU"
"4HP9",,"X-RAY DIFFRACTION",2.07,40.61,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG-MME2000, 0.1M potasiumm thiocyanate, 1.0% benzamidine-HCl, vapor diffusion, sitting drop, temperature 298K",298,"10.1371/journal.pone.0059265",,"4HP9",14.44,"2.12","2.12","Crystal structure of the N-terminal truncated PAS domain from the hERG potassium channel","GSPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK","Homo sapiens","ERG, ERG1, HERG, KCNH2","Potassium voltage-gated channel subfamily H member 2","1","4HP9"
"4HPF",,"X-RAY DIFFRACTION",3.77,67.37,"VAPOR DIFFUSION, HANGING DROP",6.8,"PEG12000, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1215078109",,"4HPF",162.44,"3.4","3.4","Structure of the human SLO3 gating ring","MGKKFIVVCGNITVDSVTAFLRNFLRDKSGEINTEIVFLGETPPSLELETIFKCYLAYTTFISGSAMKWEDLRRVAVESAEACLIIANPLCSDSHAEDISNIMRVLSIKNYDSTTRIIIQILQSHNKVYLPKIPSWNWDTGDNIICFAELKLGFIAQGCLVPGLCTFLTSLFVEQNKKVMPKQTWKKHFLNSMKNKILTQRLSDDFAGMSFPEVARLCFLKMHLLLIAIEYKSLFTDGFCGLILNPPPQVRIRKNTLGFFIAETPKDVRRALFYCSVCHDDVFIPELITNCGCKSRSRQHITVPSVKRMKKCLKGISSRISGQDSPPRVSASTSSISNFTTRTLQHDVEQDSDQLDSSGMFHWCKPTSLDKVTLKRTGKSKYKFRNHIVACVFGDAHSAPMGLRNFVMPLRASNYTRKELKDIVFIGSLDYLQREWRFLWNFPQIYILPGCALYSGDLHAANIEQCSMCAVLSPPPQPSSNQTLVDTEAIMATLTIGSLQIDEKSNCRKVPILTELKNPSNIHFIEQLGGLEGSLQETNLHLSTAFSTGTVFSGSFLDSLLATAFYNYHVLELLQMLVTGGVSSQLEQHLDKDKVYGVADSCTSLLSGRNRCKLGLLSLHETILSDVNPRNTFGQLFCGSLDLFGILCVGLYRIIDEEELNPENKRFVITRPANEFKLLPSDLVFCAIPFSTACYKRNEEFSLQKSYEIVNKASNSLEVLFQ","Homo sapiens","KCNMA3, KCNMC1, KCNU1, SLO3","Potassium channel subfamily U member 1","1","4HPF"
,,,,,,,,,,,,,,,,,"Homo sapiens","KCNMA3, KCNMC1, KCNU1, SLO3"
"4HQ0",,"X-RAY DIFFRACTION",3.42,63.99,"VAPOR DIFFUSION, HANGING DROP",4.6,"sodium acetate pH 4.6, sodium formate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444913010196",,"4HQ0",62.03,"3","3","Crystal Structure of mutant form of Caspase-7","MSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQAASGPINDLVPRGSTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQLEHHHHHH","Homo sapiens","CASP7, MCH3","Caspase-7","1","4HQ0"
"4HQ6",,"X-RAY DIFFRACTION",2.44,49.56,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, 1.8M Ammonium Sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4HQ6",63.86,"2.7","2.7","BC domain in the presence of citrate","MRGSGSMRPSMSGLHLVKRGREHKKIDLHRDFTVASPAEFVTRFGGDRVIEKVLIANNGIAAVKCMRSIRRWAYEMFRNERAIRFVVMVTPEDLKANAEYIKMADHYVPVPGGPNNNNYANVELIVDIAKRIPVQAVWAGWGHASENPKLPELLCKNGVAFLGPPSEAMWALGDKIASTVVAQTLQVPTLPWSGSGLTVEWTEDDLQQGKRISVPEDVYDKGCVKDVDEGLEAAERIGFPLMIKASEGGGGKGIRKAESAEDFPILFRQVQSEIPGSPIFLMKLAQHARHLEVQILADQYGNAVSLFGRDCSIQRRHQKIVEEAPATIAPLAIFEFMEQCAIRLAKTVGYVSAGTVEYLYSQDGSFHFLELNPRLQVEHPCTEMIADVNLPAAQLQIAMGVPLHRLKDIRLLYGESPWGVTPISFETPSNPPLARGHVIAARITSENPDEGFKPSSGTVQELNFRSSKNVWGYFSVAATGGLHEFADSQFGHCFSWGENREEAISNMVVALKELSIRGDFRTTVEYLINLLETESFQNNDIDTGWLDYLIAEKVQAEKPDIMLGVLEHHHHHH","Homo sapiens","ACACB, ACC2, ACCB","Acetyl-CoA carboxylase 2","1","4HQ6"
"4HQA",,"X-RAY DIFFRACTION",2.03,39.4,"VAPOR DIFFUSION, SITTING DROP",7,"1.0M sodium/potassium tartrate, 0.1M Hepes, pH 7.0, vapor diffusion, sitting drop, temperature 298K",298,"10.1371/journal.pone.0059265",,"4HQA",15.44,"1.96","1.96","Crystal structure of PAS domain from the human ERG (hERG) potassium channel","GSMPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK","Homo sapiens","ERG, ERG1, HERG, KCNH2","Potassium voltage-gated channel subfamily H member 2","1","4HQA"
"4HQQ",,"X-RAY DIFFRACTION",3.12,60.63,"VAPOR DIFFUSION, HANGING DROP",4.2,"38% (w/v) PEG 8000, 0.2 M NaCl, 0.1 M sodium phosphate-citrate pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.immuni.2012.11.011",,"4HQQ",48.19,"2.4","2.4","Crystal structure of RV144-elicited antibody CH58","EVQLVQSGAEVKKPGESLKISCKGSGYRFTSYWIVWVRQMPGKGLEWMGIIYPGDFDTKYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARLGGRYYHDSSGYYYLDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDK","Homo sapiens",,"CH58 Fab heavy chain","1","4HQQ"
,,,,,,,,,,,,,,,,"NFMLTQPHSVSESPGKTVTISCTRSSGSVASDYVQWYQQRPGSAPTTVVYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDNSSWVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CH58 Fab light chain","2","4HQQ"
"4HQR",,"X-RAY DIFFRACTION",3.47,64.56,"VAPOR DIFFUSION",4.6,"sodium formate, pH 4.6, VAPOR DIFFUSION, temperature 293K",293,"10.1107/S0907444913010196",,"4HQR",63,"3","3","Crystal Structure of mutant form of Caspase-7","MSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQAASGPINDLVPRGSTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQLEHHHHHH","Homo sapiens","CASP7, MCH3","Caspase-7","1","4HQR"
,,,,,,,,,,,,,,,,"XDEVX",,,"Ac-Asp-Glu-Val-Asp-Aldehyde","2","4HQR"
"4HQU",,"X-RAY DIFFRACTION",3.57,65.5,"VAPOR DIFFUSION, SITTING DROP",6.5,"PROPLEX D8: 0.1 M MAGNESIUM ACETATE, 0.1 M SODIUM CACODYLATE PH 6.5, 15% PEG 6000, VAPOR DIFFUSION, TEMPERATURE 289K, VAPOR DIFFUSION, SITTING DROP",289,"10.1073/pnas.1213933109",,"4HQU",20.92,"2.2","2.2","Crystal structure of human PDGF-BB in complex with a modified nucleotide aptamer (SOMAmer SL5)","SLGSLTIAEPAMIAECKTRTEVFEISRRLIDRTNANFLVWPPCVEVQRCSGCCNNRNVQCRPTQVQLRPVQVRKIEIVRKKPIFKKATVTLEDHLACKCETVAAARPVT","Homo sapiens","PDGFB, PDGF2, SIS","Platelet-derived growth factor subunit B","1","4HQU"
,,,,,,,,,,,,,,,,"XXACXGXXACACGCGXXXAXAGCX",,,"SOMAmer SL5","2","4HQU"
"4HQX",,"X-RAY DIFFRACTION",3.68,66.57,"VAPOR DIFFUSION, SITTING DROP",4.5,"PROPLEX E1: 0.1 M MAGNESIUM ACETATE, 0.1 M SODIUM ACETATE PH 4.5, 8% PEG 8000, VAPOR DIFFUSION, TEMPERATURE 289K, VAPOR DIFFUSION, SITTING DROP",289,"10.1073/pnas.1213933109",,"4HQX",20.22,"2.3","2.3","CRYSTAL STRUCTURE OF HUMAN PDGF-BB IN COMPLEX WITH A Modified nucleotide aptamer (SOMAmer SL4)","SLGSLTIAEPAMIAECKTRTEVFEISRRLIDRTNANFLVWPPCVEVQRCSGCCNNRNVQCRPTQVQLRPVQVRKIEIVRKKPIFKKATVTLEDHLACKCETV","Homo sapiens","PDGFB, PDGF2, SIS","Platelet-derived growth factor subunit B","1","4HQX"
,,,,,,,,,,,,,,,,"XXACXGXXACACGCGXXXAXAGCX",,,"SOMAmer SL4","2","4HQX"
"4HR9",,"X-RAY DIFFRACTION",2.91,57.74,,,,,"10.1038/ncomms2880",,"4HR9",28.24,"2.48","2.48","Human interleukin 17A","PNSEDKNFPRTVMVNLNIHNRNTNTNPKRSSDYYDRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHSPNSFRLEKILVSVGCTCVTPIVHHVA","Homo sapiens","IL17A, CTLA8, IL17","Interleukin-17A","1","4HR9"
"4HRA",,"X-RAY DIFFRACTION",3.37,63.48,"VAPOR DIFFUSION, HANGING DROP",5.2,"100 MM SODIUM ACETATE, 1.8-2.0 M AMMONIUM SULFATE, 5 MM TCEP, SOAKING THE COMPOUND INTO      CROSS-LINKED DOT1L-SAM CRYSTAL, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1182/blood-2013-04-497644","EP6","4HRA",49.32,"3.15","3.15","Crystal Structure of DOT1L in Complex with EPZ-5676","HHHHHHSSGMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRGRPKK","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","4HRA"
"4HRF",,"X-RAY DIFFRACTION",2.09,41.05,"VAPOR DIFFUSION",6.5,"0.15M Calcium Acetate, 0.1M Na Cacodylate pH 6.5, 17% PEG 8,000, VAPOR DIFFUSION, temperature 298K",298,"10.1021/bi301476m",,"4HRF",72.95,"1.68","1.68","Atomic structure of DUSP26","MHADEVWPGLYLGDQDMANNRRELRRLGITHVLNASHSRWRGTPEAYEGLGIRYLGVEAHDSPAFDMSIHFQTAADFIHRALSQPGGKILVHSAVGVSRSATLVLAYLMLYHHLTLVEAIKKVKDHRGIIPNRGFLRQLLALDRRLRQGLEALEHHHHHH","Homo sapiens","DUSP24, DUSP26, LDP4, MKP8, NATA1, SKRP3","Dual specificity protein phosphatase 26","1","4HRF"
"4HS2",,"X-RAY DIFFRACTION",2.07,40.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"26% PEG 1500, 7% isopropanol, 0.1M CaCl2, 0.1M imidazole pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S0907444913012687",,"4HS2",11.94,"1.53","1.53","Crystal Structure of the Human SPOP C-terminal Domain","GPLGSADDDLAAADKYADERKKVMCEDALCSNLSVENAAEILILADLHSADQLKTQAVDFINYHASDVLETSGWKSMVVSHPHLVAEAYRSLASAQCPFLGPPRKRLKQS","Homo sapiens","SPOP","Speckle-type POZ protein","1","4HS2"
"4HSG",,"X-RAY DIFFRACTION",2.82,56.42,,7.5,"25% PEG 3350, 0.2 M Lithium Sulfate, 0.1 M Hepes pH7.5, vapor diffusion hanging drop, temperature 291K",291,"10.1021/jm3018332","KTD","4HSG",38.59,"2.3","2.3","Crystal structure of human PRMT3 in complex with an allosteric inhibitor (PRMT3- KTD)","MGSSHHHHHHSSGLVPRGSDLQEDEDGVYFSSYGHYGIHEEMLKDKIRTESYRDFIYQNPHIFKDKVVLDVGCGTGILSMFAAKAGAKKVLGVDQSEILYQAMDIIRLNKLEDTITLIKGKIEEVHLPVEKVDVIISEWMGYFLLFESMLDSVLYAKNKYLAKGGSVYPDICTISLVAVSDVNKHADRIAFWDDVYGFKMSCMKKAVIPEAVVEVLDPKTLISEPCGIKHIDCHTTSISDLEFSSDFTLKITRTSMCTAIAGYFDIYFEKNCHNRVVFSTGPQSTKTHWKQTVFLLEKPFSVKAGEALKGKVTVHKNKKDPRSLTVTLTLNNSTQTYGLQ","Homo sapiens","PRMT3, HRMT1L3","PRMT3 protein","1","4HSG"
"4HSV",,"X-RAY DIFFRACTION",2.24,44.98,"Vapor batch",8,"0.1M Tris, 0.2M Sodium citrate, 20% PEG 400, 26% Isopropanol, pH 8.0, Vapor batch, temperature 291K",291,"10.1074/jbc.M113.455329",,"4HSV",31.82,"2.083","2.083","Crystal Structure of CXCL4L1","MEAEEDGDLQCLCVKTTSQVRPRHITSLEVIKAGPHCPTAQLIATLKNGRKICLDLQALLYKKIIKEHLES","Homo sapiens","PF4V1, CXCL4V1, SCYB4V1","Platelet factor 4 variant","1","4HSV"
"4HSZ",,"X-RAY DIFFRACTION",1.96,37.17,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.0, Magnesium chloride, 15% PEG 4000, Vapor diffusion, Sitting drop, temperature 298K",298,,,"4HSZ",43.37,"2.25","2.25","Structure of truncated (delta8C) S100A4","MACPLEKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAMMCNEFFEGF","Homo sapiens","CAPL, MTS1, S100A4","Protein S100-A4","1","4HSZ"
"4HT0",,"X-RAY DIFFRACTION",2.1,40,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.bmc.2013.01.008","V50","4HT0",30,"1.6","1.6","Crystal structure of human carbonic anhydrase isozyme II with the inhibitor.","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4HT0"
"4HT2",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M ammonium citrate with pH 5.0 and 16% of PEG4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.bmc.2013.01.008","V50","4HT2",122.46,"1.45","1.45","Crystal structure of human carbonic anhydrase isozyme XII with the inhibitor.","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","4HT2"
"4HTI",,"X-RAY DIFFRACTION",3.01,59.09,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.2 M Ammonium sulfate, 30 % w/v Polyethylene glycol 4000, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1007/s10969-014-9191-0",,"4HTI",10.83,"1.954","1.954","Crystallographic structure of the membrane-proximal ectodomain of the human receptor-type protein-tyrosine phosphatase phogrin","MEVQPSEEEARGYIVTDRDPLRPEEGRRLVEDVARLLQVPSSAFADVEVLGPAVTFKVSANVQNVTTEDVEKATVDNKDKLEETSGLKILQTGVGSKSK","Homo sapiens","PTPRN2, KIAA0387","Receptor-type tyrosine-protein phosphatase N2","1","4HTI"
"4HTJ",,"X-RAY DIFFRACTION",2.98,58.72,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.2 M Ammonium sulfate, 0.1 M Sodium acetate trihydrate pH 4.6, 25 % w/v Polyethylene glycol 4000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1007/s10969-014-9191-0",,"4HTJ",10.83,"2.011","2.011","Crystallographic structure of the membrane-proximal ectodomain of the human receptor-type protein-tyrosine phosphatase phogrin at pH 4.6","MEVQPSEEEARGYIVTDRDPLRPEEGRRLVEDVARLLQVPSSAFADVEVLGPAVTFKVSANVQNVTTEDVEKATVDNKDKLEETSGLKILQTGVGSKSK","Homo sapiens","PTPRN2, KIAA0387","Receptor-type tyrosine-protein phosphatase N2","1","4HTJ"
"4HTM",,"X-RAY DIFFRACTION",1.8,31.68,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, 150 mM zinc acetate, 3 M NaCl and 12% ethanol, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"4HTM",4.15,"2","2","Mechanism of CREB Recognition and Coactivation by the CREB Regulated Transcriptional Coactivator CRTC2","YNPRKFSEKIALQKQRQAEETAAFEEVMMDIGST","Homo sapiens","CRTC2, TORC2","CREB-regulated transcription coactivator 2","1","4HTM"
"4HTO",,"X-RAY DIFFRACTION",2.88,57.27,"VAPOR DIFFUSION, HANGING DROP",7,"16 % PEG 3350, 200 mM (NH4)3PO4, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1016/j.celrep.2012.11.004",,"4HTO",27.54,"2.8068","2.8068","Crystal structure of the DBD domain of human DNA ligase IV Apo form","MAASQTSQTVASHVPFADLCSTLERIQKSKGRAEKIRHFREFLDSWRKFHDALHKNHKDVTDSFYPAMRLILPQLERERMAYGIKETMLAKLYIELLNLPRDGKDALKLLNYRTPTGTHGDAGDFAMIAYFVLKPRCLQKGSLTIQQVNDLLDSIASNNSAKRKDLIKKSLLQLITQSSALEQKWLIRMIIKDLKLGVSQQTIFSVFHNDAAELHNVTTDLEKVCRQLHDPSVGLSDISI","Homo sapiens","LIG4","DNA ligase 4","1","4HTO"
,,,2.88,57.27,"VAPOR DIFFUSION, HANGING DROP",7,"16 % PEG 3350, 200 mM (NH4)3SO4, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15
"4HTX",,"X-RAY DIFFRACTION",2.26,45.6,,,,,"10.1021/ja404449g","19F","4HTX",162.13,"1.9","1.9","Crystal structure of PDE2 catalytic domain in complex with BAY60-7550","SDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","4HTX"
"4HTZ",,"X-RAY DIFFRACTION",2.26,45.63,,,,,"10.1021/ja404449g",,"4HTZ",160.22,"2","2","Crystal structure of PDE2 catalytic domain in space group P1","SDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","4HTZ"
"4HU1",,"X-RAY DIFFRACTION",2.2,43.7,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M sodium citrate pH5.5, 0.1M sodium acetate pH4.5 and 26% of PEG4000  , VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.bmc.2013.01.008","V13","4HU1",60.57,"1.95","1.95","Crystal structure of human carbonic anhydrase isozyme XIII with the inhibitor.","MMSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH","Homo sapiens","CA13","Carbonic anhydrase 13","1","4HU1"
"4HVA",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, HANGING DROP",4,"12% PEG 3350, 0.2M NaMalonate, pH 4.0, vapor diffusion, hanging drop, temperature 289K",289,"10.1371/journal.pone.0050864","4HV","4HVA",63.33,"2.074","2.074","Mechanistic and Structural Understanding of Uncompetitive Inhibitors of Caspase-6","AFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNGNSHHHHHH","Homo sapiens","CASP6, MCH2","Caspase-6","1","4HVA"
,,,,,,,,,,,,,,,,"XVEIX",,,"VEID Inhibitor","2","4HVA"
"4HVB",,"X-RAY DIFFRACTION",2.35,47.67,"VAPOR DIFFUSION, HANGING DROP",8.2,"18.5% (w/v)PEG3350, 0.1M BTP, pH 8.2, 0.2M (NH4)2SO4 ,10% (v/v)Ethylene Glycol, 10mM TCEP, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1021/ml300309h","19P","4HVB",111.2,"2.35","2.35","Catalytic unit of PI3Kg in complex with PI3K/mTOR dual inhibitor PF-04979064","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4HVB"
"4HVC",,"X-RAY DIFFRACTION",2.37,48.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 0.6 M CaCl2, 50 mM HEPES , pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 303K",303,"10.1038/nature11774",,"4HVC",120.15,"2","2","Crystal structure of human prolyl-tRNA synthetase in complex with halofuginone and ATP analogue","MHHHHHHGSGEGQGPKKQTRLGLEAKKEENLADWYSQVITKSEMIEYHDISGCYILRPWAYAIWEAIKDFFDAEIKKLGVENCYFPMFVSQSALEKEKTHVADFAPEVAWVTRSGKTELAEPIAIRPTSETVMYPAYAKWVQSHRDLPIKLNQWCNVVRWEFKHPQPFLRTREFLWQEGHSAFATMEEAAEEVLQILDLYAQVYEELLAIPVVKGRKTEKEKFAGGDYTTTIEAFISASGRAIQGGTSHHLGQNFSKMFEIVFEDPKIPGEKQFAYQNSWGLTTRTIGVMTMVHGDNMGLVLPPRVACVQVVIIPCGITNALSEEDKEALIAKCNDYRRRLLSVNIRVRADLRDNYSPGWKFNHWELKGVPIRLEVGPRDMKSCQFVAVRRDTGEKLTVAENEAETKLQAILEDIQVTLFTRASEDLKTHMVVANTMEDFQKILDSGKIVQIPFCGEIDCEDWIKKTTARDQDLEPGAPSMGAKSLCIPFKPLCELQPGAKCVCGKNPAKYYTLFGRSY","Homo sapiens","EPRS, GLNS, PARS, QARS, QPRS, PIG32, EPRS1","Bifunctional glutamate/proline--tRNA ligase","1","4HVC"
"4HVD",,"X-RAY DIFFRACTION",2.22,44.48,"VAPOR DIFFUSION, HANGING DROP",6,"30% PEG3350, 0.1M MES, 0.2M MgCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301646k","933","4HVD",36.04,"1.85","1.85","JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((S)-1,2,2-trimethyl-propyl)-amide","CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","4HVD"
"4HVG",,"X-RAY DIFFRACTION",2.25,45.4,"VAPOR DIFFUSION, HANGING DROP",6,"30% PEG3350, 0.1M MES, 0.2M MgCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301646k","19Q","4HVG",35.9,"2.75","2.75","JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((S)-2-hydroxy-1,2-dimethyl-propyl)-amide","CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","4HVG"
"4HVH",,"X-RAY DIFFRACTION",2.21,44.39,"VAPOR DIFFUSION, HANGING DROP",6,"30% PEG3350, 0.1M MES, 0.2M MgCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301646k","19R","4HVH",35.9,"2.3","2.3","JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((R)-2-hydroxy-1,2-dimethyl-propyl","CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","4HVH"
"4HVI",,"X-RAY DIFFRACTION",2.25,45.37,"VAPOR DIFFUSION, HANGING DROP",6,"30% PEG3350, 0.1M MES, 0.2M MgCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301646k","19S","4HVI",35.96,"2.4","2.4","JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((R)-1-methyl-2-oxo-2-piperidin-1-yl-ethyl)-amide","CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","4HVI"
"4HVS",,"X-RAY DIFFRACTION",2.84,56.72,"VAPOR DIFFUSION, SITTING DROP",6,"1.6M ammonium sulfate, 2.0M sodium Chloride and 0.1M Bis-Tris, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1219457110","647","4HVS",38.42,"1.9","1.9","Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX647","MGHHHHHHMPMYEVQWKVVEESNGNNYSYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAQGLIKSDAAMTVAVKMLKPSAHSTEREALMSELKVLSYLGNHENIVNLLGACTHGGPTLVITEYCCYGDLLNFLRRKRDSFHSSDTSPASMEDDENALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVDKGNARLPVKWMAPESIFNSVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMSSPEHAPAEMYDIMKTCWDADPDKRPTFKQIVQDIEKQISESTNH","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit","1","4HVS"
"4HVY",,"X-RAY DIFFRACTION",2.08,40.95,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M tri-sodium citrate, 3.2M ammonium sulfate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/ncomms3901",,"4HVY",18.76,"1.46","1.46","A thermostable variant of human NUDT18 NUDIX domain obtained by Hot Colony Filtration","MSAPAGEPPAPVRLRKNVCYMVLAVFLSEQDEVLLIQEAKRECRGSWYLPAGRMEPGETIVEALQRVVKEEAGLHCEPETLLSVEERGPSWVRFVFLARPTGGILKTSKEADAESLQAAWYPRTSLPTPLRAHDILHLVELAAQYRQQARHPLILAHHHHHH","Homo sapiens","NUDT18, MTH3","Nucleoside diphosphate-linked moiety X motif 18","1","4HVY"
"4HW2",,"X-RAY DIFFRACTION",2.42,49.21,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG3350, 0.2M MgCl2, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm301448p","19H","4HW2",107.83,"2.8","2.8","Discovery of potent Mcl-1 inhibitors using fragment-based methods and structure-based design","GDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVED","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","4HW2"
"4HW3",,"X-RAY DIFFRACTION",2.75,55.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG3350, 0.2M MgCl2, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm301448p","19G","4HW3",214.43,"2.4","2.4","Discovery of potent Mcl-1 inhibitors using fragment-based methods and structure-based design","GDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVED","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","4HW3"
"4HW4",,"X-RAY DIFFRACTION",2.09,41.15,"VAPOR DIFFUSION, HANGING DROP",5.5,"25% PEG3350, 0.2M NaCl, 0.1M Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm301448p",,"4HW4",39.4,"1.53","1.53","Discovery of potent Mcl-1 inhibitors using fragment-based methods and structure-based design","GDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","4HW4"
,,,,,,,,,,,,,,,,"XALETLRRVGDGVQRNHX",,,"Mcl-1 BH3 peptide","2","4HW4"
"4HW5",,"X-RAY DIFFRACTION",3.26,62.25,"VAPOR DIFFUSION, SITTING DROP",7,"2-2.2 M ammonium sulfate with the pH ranging from 6 to 9 , VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1002/pro.2200",,"4HW5",19.19,"2.25","2.25","Crystal Structure of the Human C3a anaphylatoxin","GAGAAGSVQLTEKRMDKVGKYPKELRKCCEDGMRENPMRFSCQRRTRFISLGEACKKVFLDCCNYITELRRQHARASHLGLAR","Homo sapiens","C3, CPAMD1","Complement C3","1","4HW5"
"4HW7",,"X-RAY DIFFRACTION",2.35,47.59,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG8K, 0.2M MgCl and 0.1M Tris, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1219457110","64M","4HW7",39.05,"2.9001","2.9001","Crystal structure of FMS kinase domain with a small molecular inhibitor, PLX647-OME","MKKGHHHHHHGQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCTYGDLLNFLRRKAEAMLGPSLSPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDSVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQITSFLQEQAQEDRR","Homo sapiens","CSF1R, FMS","Macrophage colony-stimulating factor 1 receptor","1","4HW7"
"4HWE",,"X-RAY DIFFRACTION",2.95,58.36,"VAPOR DIFFUSION, HANGING DROP",7.2,"1.2 M (NH4)2SO4, 0.5% PEG8000, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20121819",,"4HWE",48.71,"2.43","2.43","Crystal structure of ectodomain 3 of the IL-13 receptor alpha1 in complex with a human neutralizing monoclonal antibody fragment","AEVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGVIYPGDSYTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARMPNWGSFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHL","Homo sapiens",,"Fab heavy chain","1","4HWE"
,,,,,,,,,,,,,,,,"EVVLTQSPGTLSLSPGERATLSCRASQSISSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYETFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab light chain","2","4HWE"
"4HWJ",,"X-RAY DIFFRACTION",3.34,63.19,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Tris pH 7.5-8.5, 25 % w/v PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1002/pro.2200",,"4HWJ",9.44,"2.6","2.6","Crystal Structure of the Human C3a desArg anaphylatoxin","GAGAAGSVQLTEKRMDKVGKYPKELRKCCEDGMRENPMRFSCQRRTRFISLGEACKKVFLDCCNYITELRRQHARASHLGLA","Homo sapiens","C3, CPAMD1","Complement C3","1","4HWJ"
"4HWK",,"X-RAY DIFFRACTION",4.64,73.49,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.75 M ammonium sulphate, 0.1 M HEPES, 2 % w/v PEG 1000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1126/science.1232972","SFY","4HWK",130.85,"2.4","2.4","Crystal structure of human sepiapterin reductase in complex with sulfapyridine","MSYYHHHHHHLESTSLYKKAGLEGVRTMEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK","Homo sapiens","SPR","Sepiapterin reductase","1","4HWK"
"4HWN",,"X-RAY DIFFRACTION",1.71,28.19,"VAPOR DIFFUSION, SITTING DROP",7,"Protein (20 mM Hepes, pH 7.5, 150 mM NaCl, 10% glycerol; Reservoir (0.1M Sodium Cacodylate pH 6.5, 0.2M Sodium Chloride, 2M Ammonium Sulfate); Cryoprotection (Reservoir + 2M Lithium Sulfate), Sitting Drop Vapor Diffusion, temperature 298K, VAPOR DIFFUSION, SITTING DROP",298,,,"4HWN",11.95,"2.006","2.006","Crystal structure of the second Ig-C2 domain of human Fc-receptor like A (FCRLA), Isoform 9 [NYSGRC-005836]","QDYGGFPAPILRAVPSAEPQAGSPMTLSCQTKLPLQRSAARLLFSFYKDGRIVQSRGLSSEFQIPTASEDHSGSYWCEAATEDNQVWKQSPQLEIRVQGASAENLYFQ","Homo sapiens","FCRL, FCRL1, FCRLA, FCRLM1, FCRX, FREB, UNQ291/PRO329","Fc receptor-like A","1","4HWN"
"4HWT",,"X-RAY DIFFRACTION",2.52,51.14,"VAPOR DIFFUSION, HANGING DROP",7.9,"PEG 3350, sodium citrate, pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm301756m","1B2","4HWT",97.83,"2.3","2.3","Crystal structure of human Threonyl-tRNA synthetase bound to a novel inhibitor","MARDHRKIGRDQELYFFHELSPGSCFFLPKGAYIYNALIEFIRSEYRKRGFQEVVTPNIFNSRLWMTSGHWQHYSENMFSFEVEKELFALKPMNCPGHCLMFDHRPRSWRELPLRLADFGVLHRNELSGALTGLTRVRRFQQDDAHIFCAMEQIEDEIKGCLDFLRTVYSVFGFSFKLNLSTRPEKFLGDIEVWDQAEKQLENSLNEFGEKWELNSGDGAFYGPKIDIQIKDAIGRYHQCATIQLDFQLPIRFNLTYVSHDGDDKKRPVIVHRAILGSVERMIAILTENYGGKWPFWLSPRQVMVVPVGPTCDEYAQKVRQQFHDAKFMADIDLDPGCTLNKKIRNAQLAQYNFILVVGEKEKISGTVNIRTRDNKVHGERTISETIERLQQLKEFRSKQAEEEFLEHHHHHH","Homo sapiens","TARS, TARS1","Threonine--tRNA ligase, cytoplasmic","1","4HWT"
"4HWW",,"X-RAY DIFFRACTION",2.4,48.68,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Malonic Acid, Imidazol, Boric system, 25% Polyethylene Glycol (PEG) 1500, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/jm400014c","X7A","4HWW",68.67,"1.298","1.298","Crystal structure of human Arginase-1 complexed with inhibitor 9","SRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYL","Homo sapiens","ARG1","Arginase-1","1","4HWW"
"4HX5",,"X-RAY DIFFRACTION",2.5,50.87,"VAPOR DIFFUSION, HANGING DROP",6.5,"40% PEG300, 0.1M MES, PH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.02.018","19V","4HX5",132.62,"2.19","2.19","Crystal structure of 11 beta-HSD1 in complex with SAR184841","MKHQHQHQHQHQHQQPLNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","4HX5"
"4HXK",,"X-RAY DIFFRACTION",2.02,39.12,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Na formate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm301793a",,"4HXK",15.12,"1.61","1.61","Brd4 Bromodomain 1 complex with 6,7-DIHYDROTHIENO[3,2-C]PYRIDIN-5(4H)-YL(1H-IMIDAZOL-1-YL)METHANONE inhibitor","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HXK"
"4HXL",,"X-RAY DIFFRACTION",2.01,38.74,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Na formate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm301793a","1A9","4HXL",15.37,"1.52","1.52","Brd4 Bromodomain 1 complex with 3-CYCLOHEXYL-N-{3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)-5-[(THIOPHEN-2-YLSULFONYL)AMINO]PHENYL}PROPANAMIDE inhibitor","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HXL"
"4HXM",,"X-RAY DIFFRACTION",2.03,39.33,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Na formate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm301793a","1A8","4HXM",15.18,"1.5","1.5","Brd4 Bromodomain 1 complex with N-{3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)-5-[(THIOPHEN-2-YLSULFONYL)AMINO]PHENYL}BUTANAMIDE inhibitor","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HXM"
"4HXN",,"X-RAY DIFFRACTION",2,38.58,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Na formate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm301793a","1A7","4HXN",15.08,"1.49","1.49","Brd4 Bromodomain 1 complex with 4-(2-FLUOROPHENYL)-1,3-THIAZOL-2(3H)-ONE inhibitor","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HXN"
"4HXO",,"X-RAY DIFFRACTION",2.03,39.35,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Na formate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm301793a",,"4HXO",15.13,"1.76","1.76","Brd4 Bromodomain 1 complex with 3-{[(3-METHYL-1,2-OXAZOL-5-YL)METHYL]SULFANYL}[1,2,4]TRIAZOLO[4,3-A]PYRIDINE inhibitor","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HXO"
"4HXP",,"X-RAY DIFFRACTION",2.05,40,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Na formate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm301793a",,"4HXP",14.96,"1.73","1.73","Brd4 Bromodomain 1 complex with 4-(2-OXO-1,3-OXAZOLIDIN-3-YL)BENZAMIDE inhibitor","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HXP"
"4HXQ",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Malonic Acid, Imidazol, Boric system, 25% Polyethylene Glycol (PEG) 1500, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/jm400014c","X8A","4HXQ",68.7,"1.45","1.45","Crystal structure of human Arginase-1 complexed with inhibitor 14","SRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYL","Homo sapiens","ARG1","Arginase-1","1","4HXQ"
"4HXR",,"X-RAY DIFFRACTION",2.02,39.2,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Na formate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm301793a","1A4","4HXR",15.22,"1.53","1.53","Brd4 Bromodomain 1 complex with N-[3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)PHENYL]THIOPHENE-2-SULFONAMIDE inhibitor","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HXR"
"4HXS",,"X-RAY DIFFRACTION",2.03,39.28,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Na formate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm301793a","1A3","4HXS",15.1,"1.43","1.43","Brd4 Bromodomain 1 complex with N-[3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-4-YL)PHENYL]-1-PHENYLMETHANESULFONAMIDE inhibitor","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4HXS"
"4HXX",,"X-RAY DIFFRACTION",2.58,52.42,"VAPOR DIFFUSION, HANGING DROP",5.6,"14-20 % PEG monomethyl ether 2000, 100 mM MES, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2013.02.023","1AY","4HXX",35.09,"2.09","2.09","Pyridinylpyrimidines selectively inhibit human methionine aminopeptidase-1","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","KIAA0094, METAP1","Methionine aminopeptidase 1","1","4HXX"
"4HY0",,"X-RAY DIFFRACTION",2.39,48.5,"VAPOR DIFFUSION, SITTING DROP",7.6,"18.5% PEG 4000, 0.08M Tris_base, 0.02M Tris Cl, pH 7.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm301674z","1AQ","4HY0",119.42,"2.84","2.84","Crystal structure of XIAP BIR3 with T3256336","GPLGSRSESDAVSSDRNFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVRTTE","Homo sapiens","API3, BIRC4, IAP3, XIAP","E3 ubiquitin-protein ligase XIAP","1","4HY0"
"4HY4",,"X-RAY DIFFRACTION",2.32,47.07,"VAPOR DIFFUSION, SITTING DROP",8.5,"3M NaCl,100mM Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/jm301674z","1BG","4HY4",27.77,"1.249","1.249","Crystal structure of cIAP1 BIR3 bound to T3170284","MGSSHHHHHHSSGENLYFQGGSSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRY","Homo sapiens","API1, BIRC2, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","4HY4"
"4HY5",,"X-RAY DIFFRACTION",2.44,49.56,"VAPOR DIFFUSION, SITTING DROP",8.5,"2.2 M NaCl  100mM tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/jm301674z","1AQ","4HY5",27.93,"1.752","1.752","Crystal structure of cIAP1 BIR3 bound to T3256336","MGSSHHHHHHSSGENLYFQGGSSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRY","Homo sapiens","API1, BIRC2, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","4HY5"
"4HY6",,"X-RAY DIFFRACTION",2.95,58.3,,,,,,,"4HY6",25.89,"1.649","1.649","Crystal Structure of the human Hsp90-alpha N-domain bound to the hsp90 inhibitor FJ1","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4HY6"
"4HYF",,"X-RAY DIFFRACTION",5.69,78.37,"VAPOR DIFFUSION, HANGING DROP",4.5,"100 mM NaOAc pH 4.5 and 16-26% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 310K",310,"10.1021/jm4000566","1AK","4HYF",84.05,"2.8","2.8","Structural basis and SAR for OD 270, a lead stage 1,2,4-triazole based specific Tankyrase1/2 inhibitor","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","PARP5B, TANK2, TNKL, TNKS2","Tankyrase-2","1","4HYF"
"4HYH",,"X-RAY DIFFRACTION",2.39,48.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-Cl pH 7.5 1% v/v n-butanol 2.5% v/v DMSO 25% v/v Glycerol 6 to 12% PEG 3.25K 2.5 mM TCEP-Cl 10 mM Na2-Dithionite, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1016/j.bmcl.2013.02.108","1AM","4HYH",33.49,"1.7","1.7","X-RAY Crystal structure of compound 39 bound to human chk1 kinase domain","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4HYH"
"4HYI",,"X-RAY DIFFRACTION",2.59,52.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-Cl pH 7.5 1% v/v n-butanol 2.5% v/v DMSO 25% v/v Glycerol 6 to 12% PEG 3.25K 2.5 mM TCEP-Cl 10 mM Na2-Dithionite, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1016/j.bmcl.2013.02.108","1AO","4HYI",33.72,"1.399","1.399","X-RAY Crystal structure of compound 40 bound to human chk1 kinase domain","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4HYI"
"4HYY",,"X-RAY DIFFRACTION",2.98,58.73,"VAPOR DIFFUSION, HANGING DROP",7.4,"6% PEG 3350, 0.5 M NaCl, 0.05 M MgCl2, 0.05 M HEPES-NACl, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 294.0K",294,"10.1107/S1744309113005678",,"4HYY",118.27,"2.603","2.603","Filament of octameric rings of DMC1 recombinase from Homo sapiens","GFLTAFEYSEKRKMVFHITTGSQEFDKLLGGGIESMAITEAFGEFRTGKTQLSHTLCVTAQLPGAGGYPGGKIIFIDTENTFRPDRLRDIADRFNVDHDAVLDNVLYARAYTSEHQMELLDYVAAKFHEEAGIFKLLIIDSIMALFRVDFSGRGELAERQQKLAQMLSRLQKISEEYNVAVFVTNQMTADPGATMTFQADPKKPIGGHILAHASTTRISLRKGRGELRIAKIYDSPEMPENEATFAITAGGIGDAKELEHHHHHH","Homo sapiens","DMC1, DMC1H, LIM15","Meiotic recombination protein DMC1/LIM15 homolog","1","4HYY"
"4HZA",,"X-RAY DIFFRACTION",2.12,41.93,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2M NaCl, 0.1M BIS-TRIS pH 5.5, 25% PEG 4K, Vapor diffusion, Sitting drop, temperature 298K",298,,,"4HZA",27.9,"1.7","1.7","Crystal Structure of the Immunoglobulin variable domain of Nectin-2 in monoclinic form","MQDVRVQVLPEVRGQLGGTVELPCHLLPPVPGLYISLVTWQRPDAPANHQNVAAFHPKMGPSFPSPKPGSERLSFVSAKQSTGQDTEAELQDATLALHGLTVEDEGNYTCEFATFPKGSVRGMTWLRV","Homo sapiens","HVEB, PRR2, PVRL2, NECTIN2","Poliovirus receptor-related protein 2","1","4HZA"
"4HZE",,"X-RAY DIFFRACTION",3.26,62.21,"VAPOR DIFFUSION, HANGING DROP",7,"Crystals in condition H3 from Silver Bullet screen (Hampton Research) using Tacsimate in the reservoir, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm400014c","X7A","4HZE",101.76,"1.602","1.602","Crystal structure of human Arginase-2 complexed with inhibitor 9","HSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREG","Homo sapiens","ARG2","Arginase-2, mitochondrial","1","4HZE"
"4HZH",,"X-RAY DIFFRACTION",2.65,53.56,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris-Hcl, pH 8.5 and 25% PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.466946",,"4HZH",121.12,"3.3","3.3","Structure of recombinant Gla-domainless prothrombin mutant S525A","CETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","1","4HZH"
"4HZR",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION, HANGING DROP",9,"0.1 M bicine, pH 9.0, 12-15% PEG400, 25 mM TCEP, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1371/journal.pone.0053994",,"4HZR",63.52,"1.31","1.31","Crystal structure of Ack1 kinase domain","GSQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ","Homo sapiens","TNK2, ACK1","Activated CDC42 kinase 1","1","4HZR"
"4HZS",,"X-RAY DIFFRACTION",3.53,65.16,"VAPOR DIFFUSION, HANGING DROP",6.6,"0.2 M ammonium sulfate, 0.1 M Bis-Tris, pH 6.6, 22-24% PEG3350, 10-20 mM TCEP, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1371/journal.pone.0053994",,"4HZS",155.45,"3.23","3.23","Crystal structure of Ack1 kinase domain with C-terminal SH3 domain","GSQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRALQDFEEPDKLHIQMNDVITVIEGRAENYWWRGQNTRTLCVGPFPRNVVTSVAGLSAQD","Homo sapiens","TNK2, ACK1","Activated CDC42 kinase 1","1","4HZS"
"4HZT",,"X-RAY DIFFRACTION",2.16,43.02,"VAPOR DIFFUSION",5.3,"BACE was concentrated to 10mg/ml in 100 mM borate pH 8.5, 9% PEG 8000, 100mM Sodium Acetate and 10mM ZnCl2, VAPOR DIFFUSION, temperature 277K",277,"10.1016/j.bmcl.2013.01.103","0ZA","4HZT",46.04,"1.8","1.8","Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4HZT"
"4I03",,"X-RAY DIFFRACTION",2.18,43.45,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein solution: 222 microM MMP12 mutant E219A 106 microM bifunctional inhibitor LD884. Reservoir: 27% PEG 10K, 150mM imidazole piperidine, pH 8.5. Cryoprotectant: 5 % di-ethylene glycol + 5 % ethylene glycol + 10 % 1,2-propanediol + 5 % DMSO + 5 % glycerol, 25% MPEG 5K, 100mM (Na acetate, ADA, Bicine 10% pH 4.0/90% pH 9.0), VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.015",,"4I03",19.81,"1.7","1.7","Human MMP12 in complex with a PEG-linked bifunctional L-glutamate motif inhibitor","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHAIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","4I03"
"4I06",,"X-RAY DIFFRACTION",3.26,62.25,"VAPOR DIFFUSION, HANGING DROP",7,"Crystals in condition H3 from Silver Bullet screen (Hampton Research) using Tacsimate in the reservoir, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm400014c","X8A","4I06",101.81,"1.8","1.8","Crystal structure of human Arginase-2 complexed with inhibitor 14","HSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREG","Homo sapiens","ARG2","Arginase-2, mitochondrial","1","4I06"
"4I0D",,"X-RAY DIFFRACTION",2.14,42.59,"VAPOR DIFFUSION, SITTING DROP",5.3,"BACE-1 was concentrated to 10mg/ml in 100 mM borate pH 8.5, 9% PEG 8000, 100mM sodium acetate, 10mM ZnCl2., VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.03.009","1B7","4I0D",46.05,"1.91","1.91","Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4I0D"
"4I0E",,"X-RAY DIFFRACTION",2.14,42.52,"VAPOR DIFFUSION, SITTING DROP",5.3,"BACE was concentrated to 10mg/ml in 100 mM borate pH 8.5, 9% PEG 8000, 100mM sodium acetate and 10mM ZnCl2, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.03.009",,"4I0E",46.15,"1.7","1.7","Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4I0E"
"4I0F",,"X-RAY DIFFRACTION",2.15,42.82,"VAPOR DIFFUSION, SITTING DROP",5.3,"BACE was concentrated to 10mg/ml in 100 mM borate pH 8.5, 9% PEG 8000, 100mM sodium acetate and 10mM ZnCl2 , VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.03.009","1BF","4I0F",46.07,"1.8","1.8","Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4I0F"
"4I0G",,"X-RAY DIFFRACTION",2.11,41.7,"VAPOR DIFFUSION, SITTING DROP",5.3,"BACE was concentrated to 10mg/ml in 100 mM borate pH 8.5, 9% PEG 8000, 100mM sodium acetate  and 10mM ZnCl2  , VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.01.103",,"4I0G",46.08,"1.78","1.78","Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4I0G"
"4I0H",,"X-RAY DIFFRACTION",3.12,60.51,"VAPOR DIFFUSION, SITTING DROP",5.3,"Human BACE protein containing residues 57-453 and a C-terminal 6His-tag was concentrated to 6mg/ml in buffer 0.1M borate pH 8.5. Compound was added to give a final molar access of compound:protein of 8:1. Protein and compound were then incubated on ice for 1 hour. The drops were set up with a 1:1(v/v) ratio of protein to mother liquor in a total volume of 2 ul. Diffraction quality crystals of BACE in complex with compound was obtained by sitting-drop vapor diffusion method at 291K  against a reservoir containing 0.1 M sodium acetate, 2% PEG8000, VAPOR DIFFUSION, SITTING DROP",291,,,"4I0H",138.02,"2.2","2.2","SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors.","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4I0H"
"4I0I",,"X-RAY DIFFRACTION",3.06,59.75,"VAPOR DIFFUSION, SITTING DROP",5.3,"Human BACE protein was concentrated to 6mg/ml in buffer 0.1M borate pH 8.5. Compound was added to give a final molar access of compound:protein of 8:1. Protein and compound were then incubated on ice for 1 hour. The drops were set up with a 1:1(v/v) ratio of protein to mother liquor in a total volume of 2 ul. Diffraction quality crystals of BACE in complex with compound 19 was obtained by sitting-drop vapor diffusion method at 291K against a reservoir containing 0.1 M sodium acetate pH 5.3, 2% PEG8000, VAPOR DIFFUSION, SITTING DROP",291,,"957","4I0I",137.69,"2.2","2.2","SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4I0I"
"4I0J",,"X-RAY DIFFRACTION",2.13,42.32,"VAPOR DIFFUSION, SITTING DROP",5.3,"BACE was concentrated to 10mg/ml in 100 mM borate pH 8.5. Apo crystals were grown at 277K in 1 uL with a 1:1(v/v) ratio of protein to reservoir, a solution of 9% PEG 8000, 100mM sodium acetate and 10mM ZnCl2 , VAPOR DIFFUSION, SITTING DROP",277,,"842","4I0J",46.19,"1.99","1.99","SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4I0J"
"4I0R",,"X-RAY DIFFRACTION",2.25,45.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG4000, 0.2 M ammonium sulfate, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm301720p","1B4","4I0R",34.25,"2.1","2.1","Crystal structure of spleen tyrosine kinase complexed with 2-(3,4,5-Trimethoxy-phenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid isopropylamide","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4I0R"
"4I0S",,"X-RAY DIFFRACTION",2.26,45.59,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG4000, 0.2 M ammonium sulfate, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm301720p","1B5","4I0S",34.25,"1.98","1.98","Crystal structure of spleen tyrosine kinase complexed with 2-(6-Chloro-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid isopropylamide","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4I0S"
"4I0T",,"X-RAY DIFFRACTION",2.28,46.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG4000, 0.2 M ammonium sulfate, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm301720p","1B6","4I0T",34.22,"1.7","1.7","Crystal structure of spleen tyrosine kinase complexed with 2-(5,6,7,8-Tetrahydro-imidazo[1,5-a]pyridin-1-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid tert-butylamide","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4I0T"
"4I0Z",,"X-RAY DIFFRACTION",2.14,42.58,"VAPOR DIFFUSION, SITTING DROP",5.3,"9% PEG 8000, 100mM sodium acetate, 10mM ZnCl2, VAPOR DIFFUSION, SITTING DROP, temperature 277K, pH 5.3",277,"10.1016/j.bmcl.2013.01.103","1BB","4I0Z",46.14,"1.8","1.8","Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","2-{(1S)-1-[(6-CHLORO-3,3-DIMETHYL-3,4-DIHYDROISOQUINOLIN-1-YL)AMINO]-2-PHENYLETHYL}-4-OXO-1,4-DIHYDROPYRIMIDINE-5-CARBONITRILE","1","4I0Z"
"4I10",,"X-RAY DIFFRACTION",2.14,42.52,"VAPOR DIFFUSION, SITTING DROP",5.3,"9% PEG 8000, 100mM sodium acetate, 10mM ZnCl2  , pH 5.3, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.01.103","1BS","4I10",46.1,"2.07","2.07","Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4I10"
"4I11",,"X-RAY DIFFRACTION",2.17,43.31,"EVAPORATION",5.3,"9% PEG 8000, 100mM sodium acetate and 10mM ZnCl2, pH 5.3, EVAPORATION, temperature 277K",277,"10.1016/j.bmcl.2013.01.103","1CH","4I11",45.96,"1.89","1.89","Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4I11"
"4I12",,"X-RAY DIFFRACTION",2.12,41.85,,5.3,"9% PEG 8000, 100mM sodium acetate , 10mM ZnCl2, VAPOR DIFFUSION, SITTING DROP, temperature 277K, pH 5.3",277,"10.1016/j.bmcl.2013.03.009","1BC","4I12",46.21,"1.78","1.78","Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4I12"
"4I1B",,"X-RAY DIFFRACTION",3.35,63.26,,,,,"10.1002/prot.340120103",,"4I1B",17.4,"2","2","FUNCTIONAL IMPLICATIONS OF INTERLEUKIN-1BETA BASED ON THE THREE-DIMENSIONAL STRUCTURE","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","INTERLEUKIN-1 BETA","1","4I1B"
"4I1C",,"X-RAY DIFFRACTION",2.09,41.27,"VAPOR DIFFUSION, SITTING DROP",5.3,"9% PEG 8000, 100mM sodium acetate , 10mM ZnCl2, VAPOR DIFFUSION, SITTING DROP, temperature 277K, pH 5.3",277,"10.1016/j.bmcl.2013.03.009","1BE","4I1C",46.11,"2","2","Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4I1C"
"4I1F",,"X-RAY DIFFRACTION",2.6,52.63,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, pH 7.5, 20% PEG4000, 10% isopropanol, 10 mM barium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1038/ncomms2982",,"4I1F",37.11,"1.58","1.58","Structure of Parkin-S223P E3 ligase","SIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETPVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV","Homo sapiens","PARK2, PRKN","E3 ubiquitin-protein ligase parkin","1","4I1F"
"4I1H",,"X-RAY DIFFRACTION",2.65,53.58,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Tris, pH 6.5, 0.2 M sodium chloride, 25% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 383K",283,"10.1038/ncomms2982",,"4I1H",36.96,"2","2","Structure of Parkin E3 ligase","SIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV","Homo sapiens","PARK2, PRKN","E3 ubiquitin-protein ligase parkin","1","4I1H"
"4I1P",,"X-RAY DIFFRACTION",2.04,39.77,"VAPOR DIFFUSION, HANGING DROP",5.5,"25 mM Mes, 75 mM calcium acetate, 10 % benzamidine hypochloride, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.chembiol.2014.10.021",,"4I1P",90.47,"2.403","2.403","Human MALT1 (caspase-IG3) in complex with activity based-probe","MLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHRHHHHHH","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","4I1P"
,,,,,,,,,,,,,,,,"ALRSX",,,"tetrapeptide","2","4I1P"
"4I1Q",,"X-RAY DIFFRACTION",2.5,50.84,"VAPOR DIFFUSION, HANGING DROP",5.3,"10% MPD, 7% PEG 4000, 0.1M sodium citrate, pH 5.3, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1371/journal.pone.0052401",,"4I1Q",52.13,"2.53","2.53","Crystal Structure of hBRAP1 N-BAR domain","GSKFSRAQEKVLQKLGKAVETKDERFEQSANNFYQQQAEGHKLYKDLKNFLSAVKVMHESSKRVSETLQEIYSSEWDGHEELKAIVWNNDLLWEDYEEKLADQAVRTMEIYVAQFSEIKERIAKRGRKLVDYDSARHHLEAVQNAKKKDEAKTAKAEEEFNKAQTVFEDLNQELLEELPILYNSRIGCYVTIFQNISNLRDVFYREMSKLNHNLYEVMSKL","Homo sapiens","BIN2, BRAP1","Bridging integrator 2","1","4I1Q"
"4I1R",,"X-RAY DIFFRACTION",2.17,43.44,,6.5,"200   M magnesium formate, 13 % PEG3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/anie.201304290","LZU","4I1R",44.56,"2.7","2.7","Human MALT1 (caspase-IG3) in complex with thioridazine","MLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHRHHHHHH","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","4I1R"
"4I1Z",,"X-RAY DIFFRACTION",4.63,73.41,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.5-2.8M K Acetate, 0.1M ADA pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.str.2012.11.014",,"4I1Z",37.58,"3","3","Crystal structure of the monomeric (V948R) form of the gefitinib/erlotinib resistant EGFR kinase domain L858R+T790M","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4I1Z"
"4I20",,"X-RAY DIFFRACTION",4.63,73.41,"VAPOR DIFFUSION, HANGING DROP",,"2.8M Sodium acetate trihydrate, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.str.2012.11.014",,"4I20",37.55,"3.34","3.34","Crystal structure of monomeric (V948R) primary oncogenic mutant L858R EGFR kinase domain","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4I20"
"4I22",,"X-RAY DIFFRACTION",2.59,52.49,"VAPOR DIFFUSION, HANGING DROP",5.5,"25.0% PEG 3350, 0.2 M Li Sulfate, 0.1 M Bis-Tris pH 5.50, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.str.2012.11.014",,"4I22",38.22,"1.71","1.71","Structure of the monomeric (V948R)gefitinib/erlotinib resistant double mutant (L858R+T790M) EGFR kinase domain co-crystallized with gefitinib","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4I22"
"4I23",,"X-RAY DIFFRACTION",3.49,64.73,"VAPOR DIFFUSION, HANGING DROP",,"1.2-1.4 M Na-K Tartrate 0.1 M MES, pH 6.9-7.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.str.2012.11.014","1C9","4I23",37.92,"2.8","2.8","Crystal structure of the wild-type EGFR kinase domain in complex with dacomitinib (soaked)","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4I23"
"4I24",,"X-RAY DIFFRACTION",2.59,52.49,"VAPOR DIFFUSION, HANGING DROP",,"0.12-0.14 M ammonium acetate, 12-14% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2012.11.014","1C9","4I24",75.9,"1.8","1.8","Structure of T790M EGFR kinase domain co-crystallized with dacomitinib","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4I24"
"4I3K",,"X-RAY DIFFRACTION",2.79,55.97,"VAPOR DIFFUSION, HANGING DROP",5.6,"10 mM NADPH and 10 mM CaCl2 in a solution of 1.75 M (NH4)2SO4 and 0.1 M NaAc (pH 5.6), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ml400036z","1BX","4I3K",95.51,"3.3056","3.3056","Crystal structure of a metabolic reductase with 1-hydroxy-6-(4-hydroxybenzyl)-4-methylpyridin-2(1H)-one","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","4I3K"
"4I3L",,"X-RAY DIFFRACTION",2.67,53.88,"VAPOR DIFFUSION, HANGING DROP",5.7,"10 mM NADPH and 10 mM CaCl2 in a solution of 1.75 M (NH4)2SO4 and 0.1 M NaAc (pH 5.7), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ml400036z","1BZ","4I3L",95.3,"3.292","3.292","Crystal structure of a metabolic reductase with 6-benzyl-1-hydroxy-4-methylpyridin-2(1H)-one","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","4I3L"
"4I3Q",,"X-RAY DIFFRACTION",2.35,47.64,"microbatch under oil",6,"PEG 3350, sodium malonate, pH 6.0, microbatch under oil, temperature 298K",298,"10.1021/jm400288z",,"4I3Q",56.37,"2.602","2.602","Crystal structure of human CYP3A4 coordinated to a water molecule","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","4I3Q"
"4I41",,"X-RAY DIFFRACTION",3.49,64.79,"VAPOR DIFFUSION, HANGING DROP",,"0.4M sodium/potassium tartrate, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm400045y","MIX","4I41",33.43,"2.7","2.7","Crystal Structure of human Ser/Thr kinase Pim1 in complex with mitoxantrone","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4I41"
"4I4E",,"X-RAY DIFFRACTION",2.08,40.86,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG4000, 8% 2-Propanol, 12% Glycerol, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.01.047","1BQ","4I4E",32.59,"1.55","1.55","Structure of Focal Adhesion Kinase catalytic domain in complex with hinge binding pyrazolobenzothiazine compound.","GAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","4I4E"
"4I4F",,"X-RAY DIFFRACTION",2.08,40.89,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG4000, 8% 2-Propanol, 12% Glycerol, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.01.047","1BR","4I4F",32.59,"1.75","1.75","Structure of Focal Adhesion Kinase catalytic domain in complex with an allosteric binding pyrazolobenzothiazine compound.","GAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","4I4F"
"4I4G",,"X-RAY DIFFRACTION",2.16,43.13,"microbatch under oil",6,"PEG 3350, sodium malonate, pH 6.0, microbatch under oil, temperature 298K",298,"10.1021/jm400288z","Z8Z","4I4G",57.06,"2.718","2.718","Crystal structure of CYP3A4 ligated to oxazole-substituted desoxyritonavir","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","4I4G"
"4I4H",,"X-RAY DIFFRACTION",2.29,46.33,"microbatch under oil",5.9,"PEG3350, sodium malonate, pH 5.9, microbatch under oil, temperature 298K",298,"10.1021/jm400288z",,"4I4H",57.07,"2.9","2.9","Crystal structure of CYP3A4 ligated to pyridine-substituted desoxyritonavir","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","4I4H"
"4I5C",,"X-RAY DIFFRACTION",2.38,48.35,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M MES pH 5-6 and 25-35% PEG 6000, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.bmcl.2013.04.018","C5I","4I5C",70.36,"2.1","2.1","The Jak1 kinase domain in complex with inhibitor","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4I5C"
"4I5I",,"X-RAY DIFFRACTION",4.06,69.72,"VAPOR DIFFUSION, HANGING DROP",5.4,"300 mM NDSB-195 + 100 mM MES pH 5.4 + 1500 mM Sodium Potassium Tartrate, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/jm301431y","4I5","4I5I",67.02,"2.5","2.5","Crystal structure of the SIRT1 catalytic domain bound to NAD and an EX527 analog","MALNTIEDAVKLLQECKKIIVLTGAGVSVSCGIPDFRSRDGIYARLAVDFPDLPDPQAMFDIEYFRKDPRPFFKFAKEIYPGQFQPSLCHKFIALSDKEGKLLRNYTQNIDTLEQVAGIQRIIQCHGSFATASCLICKYKVDCEAVRGDIFNQVVPRCPRCPADEPLAIMKPEIVFFGENLPEQFHRAMKYDKDEVDLLIVIGSSLKVRPVALIPSSIPHEVPQILINREPLPHLHFDVELLGDCDVIINELCHRLGGEYAKLCCNPVKLSEITEKPPREGHHHHHH","Homo sapiens","SIRT1, SIR2L1","NAD-dependent protein deacetylase sirtuin-1","1","4I5I"
"4I5J",,"X-RAY DIFFRACTION",2.7,54.48,"VAPOR DIFFUSION, HANGING DROP",6.5,"50:50 (0.1 M NaH2PO4/0.1 M K2HPO4, 0.1 M MES, 2 M NaCl) 8 mg/ml protein , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1038/cr.2013.77",,"4I5J",34,"2.091","2.091","PP2A PR70 Holoenzyme","MWRKLLNNHHDDASKFICLLAKPNCSSLEQEDFIPLLQDVVDTHPGLTFLKDAPEFHSRYITTVIQRIFYTVNRSWSGKITSTEIRKSNFLQTLALLEEEEDINQITDYFSYEHFYVIYCKFWELDTDHDLYISQADLSRYNDQASSSRIIERIFSGAVTRGKTIQKEGRMSYADFVWFLISEEDKRNPTSIEYWFRCMDVDGDGVLSMYELEYFYEEQCERMEAMGIEPLPFHDLLCQMLDLVKPAVDGKITLRDLKRCRMAHIFYDTFFNLEKYLDHEQRDPF","Homo sapiens","PPP2R3A, PPP2R3","Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha","1","4I5J"
"4I5K",,"X-RAY DIFFRACTION",3.41,63.93,"VAPOR DIFFUSION, HANGING DROP",6.5,"50:50 (0.1 M NaH2PO4/0.1 M K2HPO4, 0.1 M MES, 2 M NaCl)   
8 mg/ml protein , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1038/cr.2013.77",,"4I5K",68.09,"2.9","2.9","PP2A PR70 Holoenzyme model3_diCa_rcsb.pdb bppnat5_extend.mtz","MWRKLLNNHHDDASKFICLLAKPNCSSLEQEDFIPLLQDVVDTHPGLTFLKDAPEFHSRYITTVIQRIFYTVNRSWSGKITSTEIRKSNFLQTLALLEEEEDINQITDYFSYEHFYVIYCKFWELDTDHDLYISQADLSRYNDQASSSRIIERIFSGAVTRGKTIQKEGRMSYADFVWFLISEEDKRNPTSIEYWFRCMDVDGDGVLSMYELEYFYEEQCERMEAMGIEPLPFHDLLCQMLDLVKPAVDGKITLRDLKRCRMAHIFYDTFFNLEKYLDHEQRDPF","Homo sapiens","PPP2R3A, PPP2R3","Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha","1","4I5K"
"4I5M",,"X-RAY DIFFRACTION",2.23,44.74,"EVAPORATION",5.5,"0.1 M Bis-Tris pH 5.5, 0.8 M sodium formate, 19% PEG 3350, EVAPORATION, temperature 277K",277,"10.1002/cmdc.201300166","R78","4I5M",36.35,"1.801","1.801","Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain","MMHHHHHHHHSHSGPEISRIIVDPTTGKRYSRGKTLGKGGFAKCYEMTDLTNNKVYAAKIIPHSRVSKPHQREKIDKEIELHRILHHKHVVQFYHYFEDKENIYILLEYCSRRSMAHILKARKVLTEPEVRYYLRQIVSGLKYLHEQEILHRDLKLGNFFINESMELKVGDFGLAARLEPLEHRRRTICGTPNYLSPEVLNKQGHGAESDIWALGCVMYTMLLGRPPFETTNLKETYRSIREARYTMPSSLLAPAKHLIASMLSKNPEDRPSLDDIIRHDFFTQGFTPDRLSSSCCHTVPDFHLSSPA","Homo sapiens","PLK2, SNK","Serine/threonine-protein kinase PLK2","1","4I5M"
"4I5P",,"X-RAY DIFFRACTION",2.21,44.31,"EVAPORATION",5.5,"0.1 M Bis-Tris pH 5.5, 0.8 M sodium formate, 19% PEG 3350, EVAPORATION, temperature 277K",277,"10.1002/cmdc.201300166","1D1","4I5P",36.16,"1.738","1.738","Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain","MMHHHHHHHHSHSGPEISRIIVDPTTGKRYSRGKTLGKGGFAKCYEMTDLTNNKVYAAKIIPHSRVSKPHQREKIDKEIELHRILHHKHVVQFYHYFEDKENIYILLEYCSRRSMAHILKARKVLTEPEVRYYLRQIVSGLKYLHEQEILHRDLKLGNFFINESMELKVGDFGLAARLEPLEHRRRTICGTPNYLSPEVLNKQGHGAESDIWALGCVMYTMLLGRPPFETTNLKETYRSIREARYTMPSSLLAPAKHLIASMLSKNPEDRPSLDDIIRHDFFTQGFTPDRLSSSCCHTVPDFHLSSPA","Homo sapiens","PLK2, SNK","Serine/threonine-protein kinase PLK2","1","4I5P"
"4I5X",,"X-RAY DIFFRACTION",2.48,50.33,"VAPOR DIFFUSION, HANGING DROP",9,"30-35%(w/v) PEG 6000, 100mM Tris-base, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.febslet.2013.09.031","FLF","4I5X",37.31,"2.1","2.1","Crystal Structure Of AKR1B10 Complexed With NADP+ And Flufenamic acid","AHMATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPKDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNVLQSSHLEDYPFDAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4I5X"
"4I6B",,"X-RAY DIFFRACTION",2.21,44.28,"EVAPORATION",5.5,"0.1 M Bis-Tris, 0.8 M sodium formate, 19% PEG 3350, pH 5.5, EVAPORATION, temperature 277K",277,"10.1002/cmdc.201300166","11G","4I6B",36.09,"1.8","1.8","Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain","MMHHHHHHHHSHSGPEISRIIVDPTTGKRYSRGKTLGKGGFAKCYEMTDLTNNKVYAAKIIPHSRVSKPHQREKIDKEIELHRILHHKHVVQFYHYFEDKENIYILLEYCSRRSMAHILKARKVLTEPEVRYYLRQIVSGLKYLHEQEILHRDLKLGNFFINESMELKVGDFGLAARLEPLEHRRRTICGTPNYLSPEVLNKQGHGAESDIWALGCVMYTMLLGRPPFETTNLKETYRSIREARYTMPSSLLAPAKHLIASMLSKNPEDRPSLDDIIRHDFFTQGFTPDRLSSSCCHTVPDFHLSSPA","Homo sapiens","PLK2, SNK","Serine/threonine-protein kinase PLK2","1","4I6B"
"4I6F",,"X-RAY DIFFRACTION",2.21,44.36,"EVAPORATION",5.5,"0.1 M Bis-Tris, 0.8 M sodium formate, 19% PEG 3350, pH 5.5, EVAPORATION, temperature 277K",277,"10.1002/cmdc.201300166","1C7","4I6F",36.23,"2.9","2.9","Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain","MMHHHHHHHHSHSGPEISRIIVDPTTGKRYSRGKTLGKGGFAKCYEMTDLTNNKVYAAKIIPHSRVSKPHQREKIDKEIELHRILHHKHVVQFYHYFEDKENIYILLEYCSRRSMAHILKARKVLTEPEVRYYLRQIVSGLKYLHEQEILHRDLKLGNFFINESMELKVGDFGLAARLEPLEHRRRTICGTPNYLSPEVLNKQGHGAESDIWALGCVMYTMLLGRPPFETTNLKETYRSIREARYTMPSSLLAPAKHLIASMLSKNPEDRPSLDDIIRHDFFTQGFTPDRLSSSCCHTVPDFHLSSPA","Homo sapiens","PLK2, SNK","Serine/threonine-protein kinase PLK2","1","4I6F"
"4I6H",,"X-RAY DIFFRACTION",2.27,45.72,"EVAPORATION",5.5,"0.1 M Bis-Tris, 0.8 M sodium formate, 19% PEG 3350, pH 5.5, EVAPORATION, temperature 277K",277,"10.1002/cmdc.201300166","1C8","4I6H",36.24,"1.91","1.91","Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce alpha-Synuclein Phosphorylation in Rat Brain","MMHHHHHHHHSHSGPEISRIIVDPTTGKRYSRGKTLGKGGFAKCYEMTDLTNNKVYAAKIIPHSRVSKPHQREKIDKEIELHRILHHKHVVQFYHYFEDKENIYILLEYCSRRSMAHILKARKVLTEPEVRYYLRQIVSGLKYLHEQEILHRDLKLGNFFINESMELKVGDFGLAARLEPLEHRRRTICGTPNYLSPEVLNKQGHGAESDIWALGCVMYTMLLGRPPFETTNLKETYRSIREARYTMPSSLLAPAKHLIASMLSKNPEDRPSLDDIIRHDFFTQGFTPDRLSSSCCHTVPDFHLSSPA","Homo sapiens","PLK2, SNK","Serine/threonine-protein kinase PLK2","1","4I6H"
"4I6O",,"X-RAY DIFFRACTION",2.9,57.58,"VAPOR DIFFUSION, HANGING DROP",8.5,"VAPOR DIFFUSION, HANGING DROP, 1 uL 5 mg/mL lyophilized C3a in 2 mM hydrochloric acid + 1 uL reservoir (0.1 M Tris-HCl, 0.2 M ammonium phosphate monobasic, 49-51% v/v MPD, pH 8.5) against 500 uL reservoir, prepared at 277K, incubated at 281K for 96 hours, stored at 277K, rhomboid-shaped crystals appeared after 6 days and grew to a final size of 0.5 x 0.2 x 0.2 mm",277,"10.1039/c3cc40537k",,"4I6O",9.23,"2.14","2.14","Crystal structure of chemically synthesized human anaphylatoxin C3a","SVQLTEKRMDKVGKYPKELRKCCEDGMRENPMRFSCQRRTRFISLGEACKKVFLDCCNYITELRRQHARASHLGLAR","Homo sapiens","C3, CPAMD1","Complement C3","1","4I6O"
"4I6Q",,"X-RAY DIFFRACTION",2.22,44.64,"VAPOR DIFFUSION, HANGING DROP",6,"30% PEG3350, 0.1M MES, 0.2M MgCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.03.015","1DT","4I6Q",36.07,"1.85","1.85","JAK3 kinase domain in complex with 2-Phenoxy-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((S)-1-cyclopropyl-ethyl)-amide","CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","4I6Q"
"4I6X",,"X-RAY DIFFRACTION",2.16,43.18,"VAPOR DIFFUSION, HANGING DROP",7,"0.15 M DL-malic acid, 20% PEG3350, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1371/journal.pone.0062021",,"4I6X",15.02,"1.5","1.5","Crystal Structure of Non-catalyic Domain of Protein Disulfide Isomerase-related (PDIr) Protein","MLIERISDPKDLKKLLRTRNNVLVLYSKSEVAAENHLRLLSTVAQAVKGQGTICWVDCGDAESRKLCKKMKVDLSPKDKKVELFHYQDGAFHTEYNRAVTFKSIVAFLKDPKGPPLWEEDPGALEHHHHHH","Homo sapiens","PDIA5, PDIR","Protein disulfide-isomerase A5","1","4I6X"
"4I85",,"X-RAY DIFFRACTION",2.08,40.89,"VAPOR DIFFUSION, SITTING DROP",7,"2 M ammonium sulfate, 0.1 M KCl, 0.05 M sodium phosphate, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.febslet.2013.06.016",,"4I85",28.21,"1.67","1.67","Crystal structure of transthyretin in complex with CHF5074 at neutral pH","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4I85"
"4I87",,"X-RAY DIFFRACTION",2.16,43.07,"VAPOR DIFFUSION, SITTING DROP",4.6,"15% (w/v) PEG 2000 monomethylether, 0.1 M 
ammonium sulfate, 0.05 M sodium acetate buffer, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.febslet.2013.06.016",,"4I87",28.15,"1.69","1.69","Crystal structure of TTR variant I84S in complex with CHF5074 at acidic pH","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGSSPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4I87"
"4I89",,"X-RAY DIFFRACTION",2.16,42.99,"VAPOR DIFFUSION, SITTING DROP",4.6,"15% (w/v) PEG 2000 monomethylether, 0.1 M ammonium sulfate, 0.05 M sodium acetate buffer, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.febslet.2013.06.016","1FL","4I89",28,"1.69","1.69","Crystal structure of transthyretin in complex with diflunisal at acidic pH","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGSSPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4I89"
"4I8A",,"X-RAY DIFFRACTION",2.69,54.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES (pH 7.5), 0.1 M LiSO4, 23 % [w/w] PEG4000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.24300",,"4I8A",175.11,"2.9","2.9","Alanine-glyoxylate aminotransferase variant S187F","GAMASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVAFLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL","Homo sapiens","AGXT, AGT1, SPAT","Serine-pyruvate aminotransferase","1","4I8A"
"4I8N",,"X-RAY DIFFRACTION",2.83,56.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES PH 7.5, 19% PEG4000 and 10 % v/v 2-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.2174/09298665113209990089","1CG","4I8N",41.29,"2.5","2.5","CRYSTAL STRUCTURE of PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN INHIBITOR [(4-{(2S)-2-(1,3-BENZOXAZOL-2-YL)-2-[(4-FLUOROPHENYL)SULFAMOYL]ETHYL}PHENYL)AMINO](OXO)ACETIC ACID","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSMEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPH","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","4I8N"
"4I8V",,"X-RAY DIFFRACTION",3.35,63.27,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG 3350, 0.1 M bis-tris propane/HCl, 200 mM sodium malonate, 14% glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.5K",277.5,"10.1074/jbc.M113.452953","BHF","4I8V",227.52,"2.6","2.6","Human Cytochrome P450 1A1 in complex with alpha-naphthoflavone","MAKKTSSKGLKNPPGPWGWPLIGHMLTLGKNPHLALSRMSQQYGDVLQIRIGSTPVVVLSGLDTIRQALVRQGDDFKGRPDLYTFTLISNGQSMSFSPDSGPVWAARRRLAQNGLKSFSIASDPASSTSCYLEEHVSKEAEVLISTLQELMAGPGHFNPYRYVVVSVTNVICAICFGRRYDHNHQELLSLVNLNNNFGEVVGSGNPADFIPILRYLPNPSLNAFKDLNEKFYSFMQKMVKEHYKTFEKGHIRDITDSLIEHCQEKQLDENANVQLSDEKIINIVLDLFGAGFDTVTTAISWSLMYLVMNPRVQRKIQEELDTVIGRSRRPRLSDRSHLPYMEAFILETFRHSSFVPFTIPHSTTRDTSLKGFYIPKGRCVFVNQWQINHDQKLWVNPSEFLPERFLTPDGAIDKVLSEKVIIFGMGKRKCIGETIARWEVFLFLAILLQRVEFSVPLGVKVDMTPIYGLTMKHACCEHFQMQLRSHHHHHH","Homo sapiens","CYP1A1","Cytochrome P450 1A1","1","4I8V"
"4I91",,"X-RAY DIFFRACTION",3.17,61.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES sodium pH 7.5 and 1.4 M sodium citrate tribasic dihydrate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ja403042k","TMH","4I91",57.06,"2","2","Crystal Structure of Cytochrome P450 2B6 (Y226H/K262R) in complex with alpha-Pinene.","MAKKTSSKGKLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKHFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPRHHHH","Homo sapiens","CYP2B6","Cytochrome P450 2B6","1","4I91"
"4I9I",,"X-RAY DIFFRACTION",2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 mM Sodium Acatate pH 4.6, 200 mM Ammonium Acatate, 30 % PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm301607v","1DY","4I9I",102.2,"2.4","2.4","Crystal structure of tankyrase 1 with compound 4","QGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEHHHHHH","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4I9I"
"4I9R",,"X-RAY DIFFRACTION",3.35,63.27,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, pH 7.5, 2% PEG400, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/ja404900k","RET","4I9R",15.92,"2.6","2.6","Crystal Structure of the R111K:R132L:Y134F:T54V:R59W:A32W Mutant of the Cellular Retinoic Acid Binding Protein Type II in Complex with All-Trans Retinal at 2.6 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIWVAAASKPAVEIKQEGDTFYIKVSTTVWTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTLVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4I9R"
"4I9S",,"X-RAY DIFFRACTION",3.21,61.64,"VAPOR DIFFUSION, SITTING DROP",4.6,"16% w/v PEG8000, 0.04 M potassium phosphate monobasic, 20% v/v glycerol, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/ja404900k","RET","4I9S",15.81,"2.58","2.58","Crystal Structure of the R111K:R132L:Y134F:T54V:R59W Mutant of the Cellular Retinoic Acid Binding Protein Type II in Complex with All-Trans Retinal at 2.58 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKVSTTVWTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTLVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4I9S"
"4I9Y",,"X-RAY DIFFRACTION",4.4,72.04,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.1 M TRIS-HCL, 0.2 M NaCl, 0.9 M K/Na Tartrate, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.jmb.2013.01.021",,"4I9Y",112.92,"1.75","1.75","Structure of the C-terminal domain of Nup358","GPHMTNPVVFFDVCADGEPLGRITMELFSNIVPRTAENFRALCTGEKGFGFKNSIFHRVIPDFVCQGGDITKHDGTGGQSIYGDKFEDENFDVKHTGPGLLSMANQGQNTNNSQFVITLKKAEHLDFKHVVFGFVKDGMDTVKKIESFGSPKGSVCRRITITECGQI","Homo sapiens","RANBP2, NUP358","E3 SUMO-protein ligase RanBP2","1","4I9Y"
"4I9Z",,"X-RAY DIFFRACTION",2.67,53.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"19-20%(w/v) PEG 3350, 200mM MgSO4, 100mM Tris-HCl, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmcl.2013.06.062","5BA","4I9Z",40.88,"2.08","2.08","Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors","MGSSHHHHHHSSGLVPRGSHMEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5, PDE5A","cGMP-specific 3',5'-cyclic phosphodiesterase","1","4I9Z"
"4IA0",,"X-RAY DIFFRACTION",2.62,53.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"19-20%(w/v) PEG 3350, 200mM MgSO4, 100mM Tris-HCl, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmcl.2013.06.062","5BB","4IA0",40.75,"2.17","2.17","Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors","MGSSHHHHHHSSGLVPRGSHMEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5, PDE5A","cGMP-specific 3',5'-cyclic phosphodiesterase","1","4IA0"
"4IA9",,"X-RAY DIFFRACTION",2.07,40.68,,5.5,"25% PEH 3500, 0.1 M Ammonium sulfate, 0.1 M BisTris pH5.5, vapor diffusion hanging drop, temperature 291K",291,"10.1021/ml300467n","IA9","4IA9",34.82,"1.66","1.66","Crystal structure of human WD REPEAT DOMAIN 5 in complex with 2-chloro-4-fluoro-3-methyl-N-[2-(4-methylpiperazin-1-yl)-5-nitrophenyl]benzamide","GTQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","4IA9"
"4IAA",,"X-RAY DIFFRACTION",3.41,63.91,"VAPOR DIFFUSION, HANGING DROP",7.9,"0.4M sodium/potassium tartrate, pH 7.9, vapor diffusion, hanging drop, temperature 291K",291,,,"4IAA",33.66,"2.85","2.85","Crystal structure of Ser/Thr kinase Pim1 in complex with thioridazine","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4IAA"
"4IAN",,"X-RAY DIFFRACTION",2.41,49.05,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M ammonium sulfate, 20-30% PEG 3350 and 0.1M HEPES pH7.0, vapor diffusion, hanging drop, temperature 291K",291,"10.1074/jbc.M113.473348",,"4IAN",84.44,"2.44","2.44","Crystal Structure of apo Human PRPF4B kinase domain","MDFKENPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARANQEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLCLVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASHVADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQEKIHHHHHH","Homo sapiens","KIAA0536, PRP4, PRP4H, PRP4K, PRPF4B","Serine/threonine-protein kinase PRP4 homolog","1","4IAN"
"4IAW",,"X-RAY DIFFRACTION",2.97,58.62,"VAPOR DIFFUSION, SITTING DROP",10.5,"2M dipotassium phosphate, 0.2M lithium sulfate, 0.1M CAPS/NaOH, pH 10.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.009","LIZ","4IAW",67.13,"2.4","2.4","Engineered human lipocalin 2 (C26) in complex with Y-DTPA","QDSTSDLIPAPPLSKVPLQQNFQDNQFHGKWYQVGRAGNAAPREDKDLLKMTAQTYELKEDKSYNVTAVRFRKKMCEYLTMTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVQQNREYFSISLLGRTKELASELKENFIRFSKSLGLPENHIVFPVPIDQCIDGSAWSHPQFEK","Homo sapiens","HNL, LCN2, NGAL","Neutrophil gelatinase-associated lipocalin","1","4IAW"
"4IAX",,"X-RAY DIFFRACTION",2.32,46.89,"VAPOR DIFFUSION, HANGING DROP",4.65,"17%(w/v) PEG3350, 0.4M potassium phosphate, pH 4.65, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2013.03.009","LIZ","4IAX",22.37,"1.9","1.9","Engineered human lipocalin 2 (CL31) in complex with Y-DTPA","QDSTSDLIPAPPLSKVPLQQNFQDNQFHGKWYQVGRAGNAAPPMDPELLLLTAQTYELKEDKSYDVTAVRFRKKMCEYLTMTFVPSPQPGEFTLGNIKNYPGLTSYFVRVVSTNYNQHAMVFFKKVQQNREYFSISLLGRTKELASELKENFIRFSKSLGLPENHIVFPVPIDQCIDGSAWSHPQFEK","Homo sapiens","HNL, LCN2, NGAL","Neutrophil gelatinase-associated lipocalin","1","4IAX"
"4IB5",,"X-RAY DIFFRACTION",2.46,50.1,,,,,"10.1021/cb3007133",,"4IB5",126.79,"2.2","2.2","Structure of human protein kinase CK2 catalytic subunit in complex with a CK2beta-competitive cyclic peptide","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","4IB5"
,,,,,,,,,,,,,,,,"GCRLYGFKIHGCG",,,"CK2beta-derived cyclic peptide","2","4IB5"
"4IBM",,"X-RAY DIFFRACTION",2.32,46.88,"VAPOR DIFFUSION",6.5,"0.1 M Sodium cacodylate pH 6.5, 23% PEG-4000, 10% Ethylene glycol, and 0.03 M Glycyl-glycyl-glycine, VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M113.505032","IR1","4IBM",70.27,"1.8","1.8","Crystal structure of insulin receptor kinase domain in complex with an inhibitor Irfin-1","VFPCSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEVSFFHSEENK","Homo sapiens","INSR","Insulin receptor","1","4IBM"
"4IBQ",,"X-RAY DIFFRACTION",2.23,44.79,"VAPOR DIFFUSION, HANGING DROP",6.1,"20% PEG 3350, 0.1M K-Acetate, 0.1M KF, pH 6.1, Vapor diffusion, hanging drop, temperature 293K",293,"10.1093/nar/gkt630",,"4IBQ",90.25,"1.8","1.8","Human p53 core domain with hot spot mutation R273C","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVCVCACPGRDRRTEEENLRKKG","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4IBQ"
"4IBS",,"X-RAY DIFFRACTION",2.25,45.31,"VAPOR DIFFUSION, HANGING DROP",6.1,"12% PEG 3350, 0.12M Mg-Formate, pH 6.1, Vapor diffusion, hanging drop, temperature 293K",293,"10.1093/nar/gkt630",,"4IBS",90.27,"1.78","1.78","Human p53 core domain with hot spot mutation R273H (form I)","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVHVCACPGRDRRTEEENLRKKG","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4IBS"
"4IBT",,"X-RAY DIFFRACTION",2.25,45.44,"VAPOR DIFFUSION, HANGING DROP",6.1,"20% PEG 3350, 0.2M NaF, pH 6.1, Vapor diffusion, hanging drop, temperature 293K",293,"10.1093/nar/gkt630",,"4IBT",90.43,"1.7","1.7","Human p53 core domain with hot spot mutation R273H and second-site suppressor mutation T284R","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVHVCACPGRDRRREEENLRKKG","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4IBT"
"4IBU",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION, HANGING DROP",6.1,"1:2 PROTEIN/DNA RATIO, 14% PEG 3350, 0.14M Li-Acetate, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/nar/gkt630",,"4IBU",106.06,"1.7","1.7","Human p53 core domain with hot spot mutation R273C and second-site suppressor mutation T284R in sequence-specific complex with DNA","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVCVCACPGRDRRREEENLRKKG","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4IBU"
,,,,,,,,,,,,,,,,"CGGGCATGCCCG",,,"DNA (5'-D(*CP*GP*GP*GP*CP*AP*TP*GP*CP*CP*CP*G)-3')","2","4IBU"
"4IBV",,"X-RAY DIFFRACTION",2.24,45.18,"VAPOR DIFFUSION, HANGING DROP",6.1,"1:2.4 PROTEIN/DNA RATIO, 16% PEG 3350, 0.18M NH4F, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/nar/gkt630",,"4IBV",26.69,"2.1","2.1","Human p53 core domain with hot spot mutation R273C and second-site suppressor mutation S240R in sequence-specific complex with DNA","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNRSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVCVCACPGRDRRTEEENLRKKG","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4IBV"
,,,,,,,,,,,,,,,,"CGGGCATGCCCG",,,"DNA (5'-D(*CP*GP*GP*GP*CP*AP*TP*GP*CP*CP*CP*G)-3')","2","4IBV"
"4IBW",,"X-RAY DIFFRACTION",2.24,45.05,"VAPOR DIFFUSION, HANGING DROP",6.1,"1:2.4 PROTEIN/DNA RATIO, 14% PEG 3350, 0.14M NH4F, pH 6.1, Vapor diffusion, hanging drop, temperature 293K",293,"10.1093/nar/gkt630",,"4IBW",27.33,"1.791","1.791","Human p53 core domain with hot spot mutation R273H and second-site suppressor mutation T284R in sequence-specific complex with DNA","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVHVCACPGRDRRREEENLRKKG","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4IBW"
,,,,,,,,,,,,,,,,"CGGGCATGCCCG",,,"DNA (5'-D(*CP*GP*GP*GP*CP*AP*TP*GP*CP*CP*CP*G)-3')","2","4IBW"
"4IBY",,"X-RAY DIFFRACTION",2.23,44.81,"VAPOR DIFFUSION, HANGING DROP",6.1,"20% PEG 3350, 0.2M Na2HPO4, pH 6.1, Vapor diffusion, hanging drop, temperature 293K",293,"10.1093/nar/gkt630",,"4IBY",45.68,"1.45","1.45","Human p53 core domain with hot spot mutation R273H and second-site suppressor mutation S240R","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNRSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVHVCACPGRDRRTEEENLRKKG","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4IBY"
"4IBZ",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, HANGING DROP",6.1,"12% PEG 3350, 0.12M NH4-Acetate, pH 6.1, Vapor diffusion, hanging drop, temperature 293K",293,"10.1093/nar/gkt630",,"4IBZ",91.59,"1.92","1.92","Human p53 core domain with hot spot mutation R273C and second-site suppressor mutation T284R","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVCVCACPGRDRRREEENLRKKG","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4IBZ"
"4IC0",,"X-RAY DIFFRACTION",2.67,53.88,"VAPOR DIFFUSION, SITTING DROP",6.1,"ammonium sulfate, pH 6.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"GDE","4IC0",171.52,"2.32","2.32","Crystal Structure of PAI-1 in Complex with Gallate","VHHPPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISHLLGTGAVQQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVVRHNPTGTVLFMGQVMEP","Homo sapiens","SERPINE1, PAI1, PLANH1","Plasminogen activator inhibitor 1","1","4IC0"
"4IC2",,"X-RAY DIFFRACTION",2.04,39.81,"VAPOR DIFFUSION, HANGING DROP",8,"100mM Tris-HCl, 20% MME PEG2000, 10mM NiCl2, 1mM TCEP, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1042/BJ20121702",,"4IC2",17.11,"2.2","2.2","Crystal structure of the XIAP RING domain","GPLGSTSLQKEISTEEQLRRLQEEKLCKICMDRNIAIVFVPCGHLVTCKQCAEAVDKCPMCYTVITFKQKIFMS","Homo sapiens","API3, BIR4, IAP3, XIAP, BIRC4","E3 ubiquitin-protein ligase XIAP","1","4IC2"
"4IC3",,"X-RAY DIFFRACTION",2.05,40.07,"VAPOR DIFFUSION, HANGING DROP",8,"100mM Tris-HCl, 20% MME PEG2000, 10mM NiCl2, 1mM TCEP, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1042/BJ20121702",,"4IC3",17.1,"1.783","1.783","Crystal structure of the F495L mutant XIAP RING domain","GPLGSTSLQKEISTEEQLRRLQEEKLCKICMDRNIAIVFVPCGHLVTCKQCAEAVDKCPMCYTVITFKQKILMS","Homo sapiens","API3, BIR4, IAP3, XIAP, BIRC4","E3 ubiquitin-protein ligase XIAP","1","4IC3"
"4IC8",,"X-RAY DIFFRACTION",1.94,36.64,"VAPOR DIFFUSION, SITTING DROP",4.5,"30% PEG 200, 100mM MIB, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 296K",296,"10.1074/jbc.M113.452235",,"4IC8",99.61,"2.8","2.8","Crystal structure of the apo ERK5 kinase domain","GSMAEPLKEEDGEDGSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGIRQQIRFQPSLQPVASEPGCPDVEMPSPWAPSGDCAMSGRHHHHHH","Homo sapiens","MAPK7, BMK1, ERK5, PRKM7","Mitogen-activated protein kinase 7","1","4IC8"
"4ICC",,"X-RAY DIFFRACTION",2.5,50.89,"VAPOR DIFFUSION, HANGING DROP",9,"30% PEG 6000, 100 mM sodium cacodylate, pH 9, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004713033452","64I","4ICC",37.48,"1.752","1.752","Crystal structure of human AKR1B10 complexed with NADP+ and JF0064","MATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPRDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNLLQSSHLEDYPFNAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4ICC"
"4ICK",,"X-RAY DIFFRACTION",2.43,49.47,"VAPOR DIFFUSION, HANGING DROP",8.4,"0.1M Tris (pH 8.4), 2.0M Ammonium phosphate monobasic, 5mM magnesium chloride, temperature 285K, VAPOR DIFFUSION, HANGING DROP",285,"10.1016/j.bbrc.2013.01.095",,"4ICK",35.94,"2.1","2.1","Crystal structure of human AP4A hydrolase E58A mutant","MALRACGLIIFRRCLIPKVDNNAIEFLLLQASDGIHHWTPPKGHVEPGEDDLETALRATQEEAGIEAGQLTIIEGFKRELNYVARNKPKTVIYWLAEVKDYDVEIRLSHEHQAYRWLGLEEACQLAQFKEMKAALQEGHQFLCSIEALEHHHHHH","Homo sapiens","NUDT2, APAH1","Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]","1","4ICK"
"4ICU",,"X-RAY DIFFRACTION",2.16,42.95,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris pH 8.5, 200 mM sodium acetate and 26% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1242/jcs.167387",,"4ICU",39.28,"2.4","2.4","Ubiquitin-like domain of human tubulin folding cofactor E - crystal from A","NQLLTLKIKYPHQLDQKVLEKQLPGSMTIQKVKGLLSRLLKVPVSDLLLSYESPKKPGREIELENDLKSLQFYSVENGDCLLVRW","Homo sapiens","TBCE","Tubulin-specific chaperone E","1","4ICU"
"4ICV",,"X-RAY DIFFRACTION",2.61,52.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM Bis Tris pH 6.5 and 43 % (v/v) PEG 400 and 10 mM praseodymium (III) acetate, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1242/jcs.167387",,"4ICV",10.24,"1.45","1.45","Ubiquitin-like domain of human tubulin folding cofactor E - crystal form B","NQLLTLKIKYPHQLDQKVLEKQLPGSMTIQKVKGLLSRLLKVPVSDLLLSYESPKKPGREIELENDLKSLQFYSVENGDCLLVRW","Homo sapiens","TBCE","Tubulin-specific chaperone E","1","4ICV"
"4ICW",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",9.5,"25% (v/w) PEG 3000 , pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,,,"4ICW",19.41,"2.2","2.2","N-terminal C2 domain of human CEP120","MAHHHHHHSSGLEVLFQGPMVSKSDQLLIVVSILEGRHFPKRPKHMLVVEAKFDGEQLATDPVDHTDQPEFATELAWEIDRKALHQHRLQRTPIKLQCFALDPVTSAKETIGYIVLDLRTAQETKQAPKWYQLLSNKYTKFKSEIQISIALETDTKPPVDSFKAKGAPPR","Homo sapiens","CEP120, CCDC100","Centrosomal protein of 120 kDa","1","4ICW"
"4ICX",,"X-RAY DIFFRACTION",2.72,54.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"200 mM sodium chloride and 23% (v/w) PEG 3350 , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,,,"4ICX",58.64,"2.7","2.7","N-terminal C2 domain of human CEP120","MAHHHHHHSSGLEVLFQGPMVSKSDQLLIVVSILEGRHFPKRPKHMLVVEAKFDGEQLATDPVDHTDQPEFATELAWEIDRKALHQHRLQRTPIKLQCFALDPVTSAKETIGYIVLDLRTAQETKQAPKWYQLLSNKYTKFKSEIQISIALETDTKPPVDSFKAKGAPPR","Homo sapiens","CEP120, CCDC100","Centrosomal protein of 120 kDa","1","4ICX"
"4ID7",,"X-RAY DIFFRACTION",3.41,64,"ligang replacement",,"ligang replacement",,"10.1016/j.bmcl.2012.12.042","1G0","4ID7",31.69,"3","3","ACK1 kinase in complex with the inhibitor cis-3-[8-amino-1-(4-phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol","LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ","Homo sapiens","ACK1, TNK2","Activated CDC42 kinase 1","1","4ID7"
"4IDN",,"X-RAY DIFFRACTION",2.48,50.42,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M imidazole, pH 7.0, 20% v/v Jeffamine ED-2001, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2012.353","GNP","4IDN",106.1,"2.252","2.252","Human atlastin-1 1-446, C-his6, GppNHp","MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARAAALEHHHHHH","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","4IDN"
"4IDO",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M ammonium phosphate dibasic, 20% PEG3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2012.353","GDP","4IDO",106.14,"2.091","2.091","human atlastin-1 1-446, C-his6, GDPAlF4-","MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARAAALEHHHHHH","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","4IDO"
"4IDP",,"X-RAY DIFFRACTION",2.67,53.88,"VAPOR DIFFUSION, HANGING DROP",8.4,"0.2 M lithium citrate tribasic tetrahydrate, 20% PEG3350, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2012.353",,"4IDP",209.23,"2.587","2.587","human atlastin-1 1-446, N440T, GppNHp","SMAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKTIFHAAR","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","4IDP"
"4IDQ",,"X-RAY DIFFRACTION",2.6,52.78,"VAPOR DIFFUSION, HANGING DROP",8.4,"0.2 M lithium citrate tribasic tetrahydrate, 20% PEG3350, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/emboj.2012.353",,"4IDQ",208.58,"2.295","2.295","human atlastin-1 1-446, N440T, GDPAlF4-","SMAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKTIFHAAR","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","4IDQ"
"4IDR",,"X-RAY DIFFRACTION",2.08,40.84,"VAPOR DIFFUSION, HANGING DROP",8,"1.25 M sodium citrate, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi301099k",,"4IDR",29.23,"1.6","1.6","Human Carbonic Anhydrase II Proton Transfer Double Mutant","HHWGFGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4IDR"
"4IDT",,"X-RAY DIFFRACTION",2.69,54.26,,,,,"10.1016/j.bmcl.2013.01.012","T28","4IDT",79.01,"2.4","2.4","Crystal Structure of NIK with 11-bromo-5,6,7,8-tetrahydropyrimido[4',5':3,4]cyclohepta[1,2-b]indol-2-amine (T28)","GAMGSKFSVEEYLVHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRHPPPNQA","Homo sapiens","MAP3K14, NIK","Mitogen-activated protein kinase kinase kinase 14","1","4IDT"
"4IDV",,"X-RAY DIFFRACTION",2.69,54.35,,,,,"10.1016/j.bmcl.2013.01.012","13V","4IDV",158.05,"2.9","2.9","Crystal Structure of NIK with compound 4-{3-[2-amino-5-(2-methoxyethoxy)pyrimidin-4-yl]-1H-indol-5-yl}-2-methylbut-3-yn-2-ol (13V)","GAMGSKFSVEEYLVHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRHPPPNQA","Homo sapiens","MAP3K14, NIK","Mitogen-activated protein kinase kinase kinase 14","1","4IDV"
"4IDZ",,"X-RAY DIFFRACTION",2.79,55.85,"VAPOR DIFFUSION, HANGING DROP",5.6,"14% PEG 3350, 85mM trisodium citrate pH5.6, 10% glycerol, 1mM NiCl2, 3mM NOG, 5mM 6-methyladenosine, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm400193d","OGA","4IDZ",57.12,"2.46","2.46","Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with N-oxalylglycine (NOG)","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","Alpha-ketoglutarate-dependent dioxygenase FTO","1","4IDZ"
"4IE0",,"X-RAY DIFFRACTION",2.86,57.07,"VAPOR DIFFUSION, HANGING DROP",5.6,"11% PEG 3350, 100mM trisodium citrate pH 5.6, 4% tert-butanol, 1mM ZnSO4, 1mM PD2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm400193d","PD2","4IE0",57.15,"2.53","2.53","Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with pyridine-2,4-dicarboxylate (2,4-PDCA)","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","Alpha-ketoglutarate-dependent dioxygenase FTO","1","4IE0"
"4IE1",,"X-RAY DIFFRACTION",2.39,48.56,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Malonic Acid, Imidazol, Boric system, 25% Polyethylene Glycol (PEG) 1500, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.02.024",,"4IE1",68.57,"2.0006","2.0006","Crystal structure of human Arginase-1 complexed with inhibitor 1h","SRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYL","Homo sapiens","ARG1","Arginase-1","1","4IE1"
"4IE2",,"X-RAY DIFFRACTION",3.27,62.42,"VAPOR DIFFUSION, HANGING DROP",7,"Crystals in condition H3 from Silver Bullet screen (Hampton Research) using Tacsimate in the reservoir, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.02.024","1EC","4IE2",101.6,"2.2082","2.2082","Crystal structure of human Arginase-2 complexed with inhibitor 1h","HSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREG","Homo sapiens","ARG2","Arginase-2, mitochondrial","1","4IE2"
"4IE3",,"X-RAY DIFFRACTION",3.27,62.41,"VAPOR DIFFUSION, HANGING DROP",7,"Crystals in condition H3 from Silver Bullet screen (Hampton Research) using Tacsimate in the reservoir, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.02.024","1EE","4IE3",101.66,"2.3522","2.3522","Crystal structure of human Arginase-2 complexed with inhbitor 1o","HSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREG","Homo sapiens","ARG2","Arginase-2, mitochondrial","1","4IE3"
"4IE4",,"X-RAY DIFFRACTION",2.87,57.2,"VAPOR DIFFUSION, HANGING DROP",5.6,"13% PEG 3350, 100mM trisodium citrate pH 5.6, 4% tert-butanol, 1mM ZnSO4, 2mM 8XQ , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm400193d","8XQ","4IE4",57.17,"2.5048","2.5048","Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with 5-carboxy-8-hydroxyquinoline (IOX1)","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","Alpha-ketoglutarate-dependent dioxygenase FTO","1","4IE4"
"4IE5",,"X-RAY DIFFRACTION",2.85,56.84,"VAPOR DIFFUSION, HANGING DROP",5.6,"9% PEG 3350, 100mM trisodium citrate pH5.6, 4% tert-butanol, 1mM ZnSO4, 1mM MD6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm400193d","MD6","4IE5",57.27,"1.95","1.95","Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with N-[(3-hydroxypyridin-2-yl)carbonyl]glycine (MD6)","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","Alpha-ketoglutarate-dependent dioxygenase FTO","1","4IE5"
"4IE6",,"X-RAY DIFFRACTION",2.84,56.69,"VAPOR DIFFUSION, HANGING DROP",5.6,"11.5% PEG 3350, 100mM trisodium citrate pH 5.6, 4% tert-butanol, 1mM ZnSO4, 1.5mM UN9, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm400193d","UN9","4IE6",57.17,"2.5036","2.5036","Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with N-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine (IOX3/UN9)","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","Alpha-ketoglutarate-dependent dioxygenase FTO","1","4IE6"
"4IE7",,"X-RAY DIFFRACTION",2.91,57.69,"VAPOR DIFFUSION, HANGING DROP",5.6,"11.5% PEG 3350, 100mM trisodium citrate pH5.6, 4% tert-butanol, 1mM ZnSO4, 2mM RHN, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm400193d","RHN","4IE7",57.36,"2.6004","2.6004","Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with citrate and rhein (RHN)","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","Alpha-ketoglutarate-dependent dioxygenase FTO","1","4IE7"
"4IEH",,"X-RAY DIFFRACTION",3.31,62.84,"VAPOR DIFFUSION",8.6,"0.05 M succinic acid, 0.25 M sodium malonate, 12% PEG3350, 0.1 M Tris-HCl, pH 8.6, VAPOR DIFFUSION, temperature 277.0K",277,"10.1021/ml300321d","1E9","4IEH",20.51,"2.1","2.1","Crystal Structure of human Bcl-2 in complex with a small molecule inhibitor targeting Bcl-2 BH3 domain interactions","GSHMAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDDVEENRTEAPEGTESEVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMR","Homo sapiens","BCL2, BCL2L, BCL2L1, BCLX","Apoptosis regulator Bcl-2, Bcl-2-like protein 1 chimera","1","4IEH"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2, BCL2L, BCL2L1, BCLX"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2, BCL2L, BCL2L1, BCLX"
"4IEJ",,"X-RAY DIFFRACTION",2.06,40.42,"VAPOR DIFFUSION, SITTING DROP",,"0.20M calcium chloride 20.00% polyethylene glycol 3350, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4IEJ",11.26,"1.45","1.45","Crystal structure of a DNA methyltransferase 1 associated protein 1 (DMAP1) from Homo sapiens at 1.45 A resolution","GGKDYPFARFNKTVQVPVYSEQEYQLYLHDDAWTKAETDHLFDLSRRFDLRFVVIHDRYDHQQFKKRSVEDLKERYYHICAKLANVRAVPGTD","Homo sapiens","BC008053, DMAP1, KIAA1425","DNA methyltransferase 1-associated protein 1","1","4IEJ"
"4IF5",,"X-RAY DIFFRACTION",2.12,41.88,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM Bis-Tris, 200 mM NaCl, 24 % PEG 3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.jmb.2014.05.009",,"4IF5",23.49,"1.7","1.7","Structure of human Mec17","GPHMEFPFDVDALFPERITVLDQHLRPPARRPGTTTPARVDLQQQIMTIIDELGKASAKAQNLSAPITSASRMQSNRHVVYILKDSSARPAGKGAIIGFIKVGYKKLFVLDDREAHNEVEPLCILDFYIHESVQRHGHGRELFQYMLQKERVEPHQLAIDRPSQKLLKFLNKHYNLETTVPQVNNFVIFEGFFAHQ","Homo sapiens","ATAT1, C6orf134, MEC17, Nbla00487","Alpha-tubulin N-acetyltransferase","1","4IF5"
"4IF6",,"X-RAY DIFFRACTION",3.42,64.06,"VAPOR DIFFUSION, HANGING DROP",7.4,"100 mM Tris-HCl, 10 % (w/v) PEG 20,000, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,,,"4IF6",36,"2.25","2.25","Structure of NAD-dependent protein deacetylase sirtuin-1 (closed state, 2.25 A)","GPHMRKKRKDINTIEDAVKLLQECKKIIVLTGAGVSVSCGIPDFRSRDGIYARLAVDFPDLPDPQAMFDIEYFRKDPRPFFKFAKEIYPGQFQPSLCHKFIALSDKEGKLLRNYTQNIDTLEQVAGIQRIIQCHGSFATASCLICKYKVDCEAVRGDIFNQVVPRCPRCPADEPLAIMKPEIVFFGENLPEQFHRAMKYDKDEVDLLIVIGSSLKVRPVALIPSSIPHEVPQILINREPLPHLHFDVELLGDCDVIINELCHRLGGEYAKLCCNPVKLSEI","Homo sapiens","SIR2L1, SIRT1","NAD-dependent protein deacetylase sirtuin-1","1","4IF6"
,,,,,,,,,,,,,,,,"GPHMGSQYLFLPPNRYIFHGAEVYSDSEDDV","Homo sapiens","SIRT1, SIR2L1","NAD-dependent protein deacetylase sirtuin-1","2","4IF6"
"4IF8",,"X-RAY DIFFRACTION",3.25,62.16,"VAPOR DIFFUSION, HANGING DROP",5.1,"0.1M NA CITRATE, 9% PEG4000, 0.1M Ammonia sulfate, pH 5.1, Vapor Diffusion, Hanging Drop, temperature 292K",292,"10.1007/s00018-013-1258-8",,"4IF8",95.38,"2.08","2.08","Structure Of Vaspin","GHHHHHHHHHHSSGHIEGRHMKPSFSPRNYKALSEVQGWKQRMAAKELARQNMDLGFKLLKKLAFYNPGRNIFLSPLSISTAFSMLCLGAQDSTLDEIKQGFNFRKMPEKDLHEGFHYIIHELTQKTQDLKLSIGNTLFIDQRLQPQRKFLEDAKNFYSAETILTNFQNLEMAQKQINDFISQKTHGKINNLIENIDPGTVMLLANYIFFRARWKHEFDPNVTKEEDFFLEKNSSVKVPMMFRSGIYQVGYDDKLSCTILEIPYQKNITAIFILPDEGKLKHLEKGLQVDTFSRWKTLLSRRVVDVSVPRLHMTGTFDLKKTLSYIGVSKIFEEHGDLTKIAPHRSLKVGEAVHKAELKMDERGTEGAAGTGAQTLPMETPLVVKIDKPYLLLIYSEKIPSVLFLGKIVNPIGK","Homo sapiens","SERPINA12","Serpin A12","1","4IF8"
"4IFB",,"X-RAY DIFFRACTION",3.32,63,"VAPOR DIFFUSION, SITTING DROP",4.2,"1.6M NaH2PO4/0.4M K2HPO4, 0.1M phosphate-citrate (pH 4.2), VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4IFB",68.89,"2.3","2.3","Crystal structure of SULT 2A1 LLGG mutant with PAPS","MSDDFLWFEGIAFPTMGFRSETLRKVRDEFVIRDEDVIILTYPKSGTNWLAEILCLMHSKGDAKWIQSVPIWERSPWVESEIGYTALSETESPRLFSSHLPIQLFPKSFFSSKAKVIYLMRNPRDVLVSGYFFWKNMKFIKKPKSWEEYFEWFCQGTVLYGSWFDHIHGWMPMREEKNFLLLSYEELKQDTGRTIEKICQFLGKTLEPEELNLILKNSSFQSMKENKMSNYSGGSVDYVVDKAQLLRKGVSGDWKNHFTVAQAEDFDKLFQEKMADLPRELFPWE","Homo sapiens","SULT2A1, HST, STD","Bile salt sulfotransferase","1","4IFB"
"4IFC",,"X-RAY DIFFRACTION",2.39,48.62,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M ammonium sulfate, 20-30% PEG 3350 and 0.1M HEPES pH7.0 
5 mM ADP final concentration added to cryo-protectant solution for soaking of apo crystals, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M113.473348",,"4IFC",85.01,"2.13","2.13","Crystal Structure of ADP-bound Human PRPF4B kinase domain","MDFKENPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARANQEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLCLVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASHVADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQEKIHHHHHH","Homo sapiens","KIAA0536, PRP4, PRP4H, PRP4K, PRPF4B","Serine/threonine-protein kinase PRP4 homolog","1","4IFC"
"4IFH",,"X-RAY DIFFRACTION",3.95,68.84,"VAPOR DIFFUSION, HANGING DROP",7,"10% PEG 5000, 100mM HEPES, 14% Tacsimate, 10% Dioxane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.1038/ncomms9250",,"4IFH",229.7,"3.286","3.286","Crystal structure of human insulin degrading enzyme (IDE) in complex with compound BDM44619","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLEHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4IFH"
"4IFJ",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M MMT Buffer pH 7.0, 25 % PEG1500 (MMT Buffer: Malic acid, MES and Tris)., VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4IFJ",31.83,"1.8","1.8","Crystal Structures of apo Keap1, Keap1-peptide, and Keap1-compound complexes","SSAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","4IFJ"
"4IFN",,"X-RAY DIFFRACTION",3.45,64.38,"VAPOR DIFFUSION, SITTING DROP",8.1,"0.6 M Sodium Formate, 0.2 M Ammonium Acetate, 0.1 M Tris pH 8.1, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"12O","4IFN",32.28,"2.4","2.4","Crystal Structures of apo Keap1, Keap1-peptide, and Keap1-compound complexes","SSAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","kelch-like ECH-associated protein 1","1","4IFN"
"4IFS",,"X-RAY DIFFRACTION",3.33,63.06,"VAPOR DIFFUSION, HANGING DROP",8.5,"15% PEG 6000, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 287.0K",287,,,"4IFS",28.51,"1.93","1.93","Crystal structure of the hSSRP1 Middle domain","MGHHHHHHGDAICIFRELQCLTPRGRYDIRIYPTFLHLHGKTFDYKIPYTTVLRLFLLPHKDQRQMFFVISLDPPIKQGQTRYHFLILLFSKDEDISLTLNMNEEEVEKRFEGRLTKNMSGSLYEMVSRVMKALVNRKITVPGNFQGHSGAQCITCSYKASSGLLYPLERGFIYVHKPPVHIRFDEISFVNFARGTTTTRSFDFEIETKQGTQYTFSSIEREEYGKLFDFVNAKKLNIKNRGL","Homo sapiens","FACT80, SSRP1","FACT complex subunit SSRP1","1","4IFS"
"4IG8",,"X-RAY DIFFRACTION",3.17,61.2,"VAPOR DIFFUSION",7.4,"10 mM HEPES (pH 7.4), 350 mM NaCl, and 5 mM MgCl2, VAPOR DIFFUSION, temperature 293K",293,"10.1073/pnas.1218528110",,"4IG8",52.14,"2.7","2.7","Structural basis for cytosolic double-stranded RNA surveillance by human OAS1","MMDLRNTPAKSLDKFIEDYLLPDTCFRMQINHAIDIICGFLKERCFRGSSYPVCVSKVVKGGSSGKGTTLRGRSDADLVVFLSPLTTFQDQLNRRGEFIQEIRRQLEACQRERAFSVKFEVQAPRWGNPRALSFVLSSLQLGEGVEFDVLPAFDALGQLTGGYKPNPQIYVKLIEECTDLQKEGEFSTCFTELQRDFLKQRPTKLKSLIRLVKHWYQNCKKKLGKLPPQYALELLTVYAWERGSMKTHFNTAQGFRTVLELVINYQQLCIYWTKYYDFKNPIIEKYLRRQLTKPRPVILDPADPTGNLGGGDPKGWRQLAQEAEAWLNYPCFKNWDGSPVSSWILLAGP","Homo sapiens","OAS1, OIAS","2'-5'-oligoadenylate synthase 1","1","4IG8"
,,,,,,,,,,,,,,,,"GGCUUUUGACCUUUAUGC",,,"RNA (5'-R(*GP*GP*CP*UP*UP*UP*UP*GP*AP*CP*CP*UP*UP*UP*AP*UP*GP*C)-3')","2","4IG8"
,,,,,,,,,,,,,,,,"GCAUAAAGGUCAAAAGCC",,,"RNA (5'-R(*GP*CP*AP*UP*AP*AP*AP*GP*GP*UP*CP*AP*AP*AP*AP*GP*CP*C)-3')","3","4IG8"
"4IG9",,"X-RAY DIFFRACTION",4.15,70.36,"VAPOR DIFFUSION, HANGING DROP",7.4,"20 mM TRIS-HCl, 10 % PEG 20,000, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.jmb.2013.10.009",,"4IG9",141.77,"2.64","2.64","Structure of NAD-dependent protein deacetylase sirtuin-1 (open state, 2.64 A)","GPHMRKKRKDINTIEDAVKLLQECKKIIVLTGAGVSVSCGIPDFRSRDGIYARLAVDFPDLPDPQAMFDIEYFRKDPRPFFKFAKEIYPGQFQPSLCHKFIALSDKEGKLLRNYTQNIDTLEQVAGIQRIIQCHGSFATASCLICKYKVDCEAVRGDIFNQVVPRCPRCPADEPLAIMKPEIVFFGENLPEQFHRAMKYDKDEVDLLIVIGSSLKVRPVALIPSSIPHEVPQILINREPLPHLHFDVELLGDCDVIINELCHRLGGEYAKLCCNPVKLSEI","Homo sapiens","SIR2L1, SIRT1","NAD-dependent protein deacetylase sirtuin-1","1","4IG9"
,,,,,,,,,,,,,,,,"GPHMGSQYLFLPPNRYIFHGAEVYSDSEDDV","Homo sapiens","SIR2L1, SIRT1","NAD-dependent protein deacetylase sirtuin-1","2","4IG9"
"4IGD",,"X-RAY DIFFRACTION",2.85,56.84,"VAPOR DIFFUSION, HANGING DROP",7,"20%(v/v) PEG400, 0.1M imidazole, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M112.446500",,"4IGD",45.67,"2.5","2.5","Crystal structure of the zymogen catalytic region of Human MASP-1","ASMTGNECPELQPPVHGKIEPSQAKYFFKDQVLVSCDTGYKVLKDNVEMDTFQIECLKDGTWSNKIPTCKIVDCRAPGELEHGLITFSTRNNLTTYKSEIKYSCQEPYYKMLNNNTGIYTCSAQGVWMNKVLGRSLPTCLPVCGLPKFSRKLMAQIFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPEDPTLRDSDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNAFVMPICLPEGPQQEGAMVIVSGWGKQFLQRFPETLMEIEIPIVDHSTCQKAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIHHNKDWIQRVTGVRN","Homo sapiens","MASP1, CRARF, CRARF1, PRSS5","Mannan-binding lectin serine protease 1","1","4IGD"
"4IGG",,"X-RAY DIFFRACTION",4.62,73.36,"VAPOR DIFFUSION",6.8,"0.9 M Na/K Phosphate, 0.3 M Na Malonate, pH 6.8, VAPOR DIFFUSION, temperature 295K",295,"10.1038/nsmb.2479",,"4IGG",184.61,"3.66","3.66","Full-length human alpha-catenin crystal structure","ESQFLKEELVAAVEDVRKQGDLMKAAAGEFADDPCSSVKRGNMVRAARALLSAVTRLLILADMADVYKLLVQLKVVEDGILKLRNAGNEQDLGIQYKALKPEVDKLNIMAAKRQQELKDVGHRDQMAAARGILQKNVPILYTASQACLQHPDVAAYKANRDLIYKQLQQAVTGISNAAQATASDDASQHQGGGGGELAYALNNFDKQIIVDPLSFSEERFRPSLEERLESIISGAALMADSSCTRDDRRERIVAECNAVRQALQDLLSEYMGNAGRKERSDALNSAIDKMTKKTRDLRRQLRKAVMDHVSDSFLETNVPLLVLIEAAKNGNEKEVKEYAQVFREHANKLIEVANLACSISNNEEGVKLVRMSASQLEALCPQVINAALALAAKPQSKLAQENMDLFKEQWEKQVRVLTDAVDDITSIDDFLAVSENHILEDVNKCVIALQEKDVDGLDRTAGAIRGRAARVIHVVTSEMDNYEPGVYTEKVLEATKLLSNTVMPRFTEQVEAAVEALSSDPAQPMDENEFIDASRLVYDGIRDIRKAVLMIRTPEELDDSDFETEDFDVRSRTSVQTEDDQLIAGQSARAIMAQLPQEQKAKIAEQVASFQEEKSKLDAEVSKWDDSGNDIIVLAKQMCMIMMEMTDFTRGKGPLKNTSDVISAAKKIAEAGSRMDKLGRTIADHCPDSACKQDLLAYLQRIALYCHQLNICSKVKAEVQNLGGELVVSGVDSAMSLIQAAKNLMNAVVQTVKASYVASTKYQKSQGMASLNLPAVSWKMKAPEKKPLVKREKQDETQTKIKRASQKKHVNPVQALSEFKAMDSIPHHHHHH","Homo sapiens","CTNNA1","Catenin alpha-1","1","4IGG"
"4IGH",,"X-RAY DIFFRACTION",3.6,65.8,"VAPOR DIFFUSION, HANGING DROP",5.4,"1.72 M ammonium sulfate, 0.1 M sodium acetate, pH 5.4, 1.5 M sodium chloride, 10 mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1021/ml300464h","1EA","4IGH",42.14,"1.3","1.3","High resolution crystal structure of human dihydroorotate dehydrogenase bound with 4-quinoline carboxylic acid analog","GDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRRLEHHHHHH","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4IGH"
"4IGM",,"X-RAY DIFFRACTION",2.35,47.7,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M Bis-Tris 7.0, 20% PEG 3350, 0.2 M lithium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"4IGM",225.7,"2.391","2.391","2.39 Angstrom X-ray Crystal structure of human ACMSD","MKIDIHSHILPKEWPDLKKRFGYGGWVQLQHHSKGEAKLLKDGKVFRVVRENCWDPEVRIREMDQKGVTVQALSTVPVMFSYWAKPEDTLNLCQLLNNDLASTVVSYPRRFVGLGTLPMQAPELAVKEMERCVKELGFPGVQIGTHVNEWDLNAQELFPVYAAAERLKCSLFVHPWDMQMDGRMAKYWLPWLVGMPAETTIAICSMIMGGVFEKFPKLKVCFAHGGGAFPFTVGRISHGFSMRPDLCAQDNPMNPKKYLGSFYTDALVHDPLSLKLLTDVIGKDKVILGTDYPFPLGELEPGKLIESMEEFDEETKNKLKAGNALAFLGLER","Homo sapiens","ACMSD, human","2-amino-3-carboxymuconate-6-semialdehyde decarboxylase","1","4IGM"
"4IGN",,"X-RAY DIFFRACTION",2.34,47.55,,,,,"10.1002/prot.24722",,"4IGN",225.18,"2.329","2.329","2.32 Angstrom X-ray Crystal structure of R47A mutant of human ACMSD","MKIDIHSHILPKEWPDLKKRFGYGGWVQLQHHSKGEAKLLKDGKVFAVVRENCWDPEVRIREMDQKGVTVQALSTVPVMFSYWAKPEDTLNLCQLLNNDLASTVVSYPRRFVGLGTLPMQAPELAVKEMERCVKELGFPGVQIGTHVNEWDLNAQELFPVYAAAERLKCSLFVHPWDMQMDGRMAKYWLPWLVGMPAETTIAICSMIMGGVFEKFPKLKVCFAHGGGAFPFTVGRISHGFSMRPDLCAQDNPMNPKKYLGSFYTDALVHDPLSLKLLTDVIGKDKVILGTDYPFPLGELEPGKLIESMEEFDEETKNKLKAGNALAFLGLER","Homo sapiens","ACMSD, human","2-amino-3-carboxymuconate-6-semialdehyde decarboxylase","1","4IGN"
"4IGS",,"X-RAY DIFFRACTION",2.19,43.89,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 6000, 100 mM MES, pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1107/S1399004713033452","64I","4IGS",36.97,"0.85","0.85","Crystal structure of human Aldose Reductase complexed with NADP+ and JF0064","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4IGS"
"4IH3",,"X-RAY DIFFRACTION",2.3,46.54,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M Lithium Sulfate Monohydrate, 0.1 M Bis-Tris, 25% PEG3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/prot.24722",,"4IH3",226.7,"2.493","2.493","2.5 Angstroms X-ray crystal structure of of human 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase in complex with dipicolinic acid","MKIDIHSHILPKEWPDLKKRFGYGGWVQLQHHSKGEAKLLKDGKVFRVVRENCWDPEVRIREMDQKGVTVQALSTVPVMFSYWAKPEDTLNLCQLLNNDLASTVVSYPRRFVGLGTLPMQAPELAVKEMERCVKELGFPGVQIGTHVNEWDLNAQELFPVYAAAERLKCSLFVHPWDMQMDGRMAKYWLPWLVGMPAETTIAICSMIMGGVFEKFPKLKVCFAHGGGAFPFTVGRISHGFSMRPDLCAQDNPMNPKKYLGSFYTDALVHDPLSLKLLTDVIGKDKVILGTDYPFPLGELEPGKLIESMEEFDEETKNKLKAGNALAFLGLER","Homo sapiens","ACMSD","2-amino-3-carboxymuconate-6-semialdehyde decarboxylase","1","4IH3"
"4IHB",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION, HANGING DROP",5.4,"2M Sodium Formate, pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 284K",284,"10.1016/j.str.2013.10.001",,"4IHB",89.22,"2.044","2.044","X-RAY STRUCTURE OF THE canonical C2A DOMAIN FROM HUMAN DYSFERLIN","GSPEFMLRVFILYAENVHTPDTDISDAYCSAVFAGVKKRTKVIKNSVNPVWNEGFEWDLKGIPLDQGSELHVVVKDHETMGRNRFLGEAKVPLREVLATPSLSASFNAPLLDTKKQPTGASLVLQVSYTAAAS","Homo sapiens","DYSF, FER1L1","Dysferlin","1","4IHB"
"4II1",,"X-RAY DIFFRACTION",2.44,49.52,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.2 M sodium citrate, 5% MPD, 0.1 M sodium HEPES, 3 molar equivalents of H3K4me3 peptide., pH 7.5, vapor diffusion, sitting drop, temperature 291K",291,,,"4II1",75.37,"2.65","2.65","Crystal structure of the zinc finger of ZGPAT","MHHHHHHSSGRENLYFQGEEEGEDEEELSGTKVSAPYYSSWGTLEYHNAMVVGTEEAEDGSAGVRVLYLYPTHKSLKPCPFFLEGKCRFKENCRFSHGQVVSLDELRPFQDPDLSSLQAGSACLAKHQDGLWHAARITDVDNGYYTVKFDSLLLREAVVEGDGILPP","Homo sapiens","ZGPAT, GPATC6, GPATCH6, KIAA1847, ZC3H9, ZC3HDC9, ZIP","Zinc finger CCCH-type with G patch domain-containing protein","1","4II1"
"4IIA",,"X-RAY DIFFRACTION",2.66,53.83,"VAPOR DIFFUSION, HANGING DROP",8,"1.6 M diammonium phosphate, 0.1 M MOPS, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0080947",,"4IIA",15.28,"3.3","3.3","Low resolution crystal structure of the NTF2-like domain of human G3BP1","GSHMVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKEIHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSVANKFYVHNDIFRYQDEVFG","Homo sapiens","G3BP1, G3BP","Ras GTPase-activating protein-binding protein 1","1","4IIA"
"4IIM",,"X-RAY DIFFRACTION",1.82,32.34,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.2 M NaCitrate and 0.1 M Tris, pH 8.5, vapor diffusion hanging drop, temperature 291K",291,,,"4IIM",20.09,"1.8","1.8","Crystal structure of the Second SH3 Domain of ITSN1 bound with a synthetic peptide","GAAQPAMAQGALLQAQALYPWRAKKDNHLNFNKNDVITVLEQQDMWWFGEVQGQKGWFPKSYVKLISAAA","Homo sapiens","ITSN1, ITSN, SH3D1A","Intersectin-1","1","4IIM"
,,,,,,,,,,,,,,,,"WRDSSGYVMGPW",,,"peptide ligand","2","4IIM"
"4IIO",,"X-RAY DIFFRACTION",2.32,47.06,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG 3350, 0.1 M (NH4)2SO4, and 0.1 M Tris 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4IIO",16.26,"1.7","1.7","Crystal Structure of the Second SH3 Domain of ITSN2 Bound with a Synthetic Peptide","GGMAQGALLKAQALCSWTAKKDNHLNFSKHDIITVLEQQENWWFGEVHGGRGWFPKSYVKIIPAAA","Homo sapiens","ITSN2, KIAA1256, SH3D1B, SWAP","Intersectin-2","1","4IIO"
,,,,,,,,,,,,,,,,"XWRGSLSYLKGPL",,,"Synthetic Peptide","2","4IIO"
"4IIR",,"X-RAY DIFFRACTION",2.42,49.08,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M ammonium sulfate, 20-30% PEG 3350 and 0.1M HEPES pH7.0, 5 mM AMPPNP final concentration added to cryo-protectant solution for soaking of apo crystals, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M113.473348",,"4IIR",85.29,"2","2","Crystal Structure of AMPPNP-bound Human PRPF4B kinase domain","MDFKENPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARANQEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLCLVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASHVADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQEKIHHHHHH","Homo sapiens","KIAA0536, PRP4, PRP4H, PRP4K, PRPF4B","Serine/threonine-protein kinase PRP4 homolog","1","4IIR"
"4IIZ",,"X-RAY DIFFRACTION",1.99,38.04,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4IIZ",28.14,"2.1","2.1","Crystal structure of wild-type human transthyretin in complex with lumiracoxib","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4IIZ"
"4IJD",,"X-RAY DIFFRACTION",2.04,39.74,"VAPOR DIFFUSION, HANGING DROP",5.5,"23% PEG 3350, 0.2 M AMMONIUM ACETATE, 0.1 M BisTris pH5.5, vapor diffusion hanging drop, temperature 291K",291,,,"4IJD",50.95,"2.15","2.15","Crystal structure of methyltransferase domain of human PR domain-containing protein 9","SEPQDDDYLYCEMCQNFFIDSCAAHGPPTFVKDSAVDKGHPNRSALSLPPGLRIGPSGIPQAGLGVWNEASDLPLGLHFGPYEGRITEDEEAANNGYSWLITKGRNCYEYVDGKDKSWANWMRYVNCARDDEEQNLVAFQYHRQIFYRTCRVIRPGCELLVWYGDEYGQELGIKWGSKWKKELMAGREPKPEIHPCPSCCLAFSSQKFLSQHVERNHSSQN","Homo sapiens","PRDM9, PFM6","Histone-lysine N-methyltransferase PRDM9","1","4IJD"
"4IJH",,"X-RAY DIFFRACTION",2.01,38.88,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 200 mM calcium acetate, 15% PEG8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/ml400032y","1EJ","4IJH",15.53,"1.498","1.498","Fragment-based Discovery of Protein-Protein Interaction Inhibitors of Replication Protein A","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","REPA1, RPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4IJH"
"4IJL",,"X-RAY DIFFRACTION",2.02,39.16,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 200 calcium acetate, 15% PEG8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/ml400032y","1EK","4IJL",14.3,"1.7","1.7","Fragment-based Discovery of Protein-Protein Interaction Inhibitors of Replication Protein A","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","REPA1, RPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4IJL"
"4IJO",,"X-RAY DIFFRACTION",2.12,41.93,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris-HCl, 30% PEG 6000, 200mM AHA, 1.0M LiCl2, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2013.04.009",,"4IJO",17.74,"1.9","1.9","Unraveling hidden allosteric regulatory sites in structurally homologues metalloproteases","GPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","4IJO"
"4IJP",,"X-RAY DIFFRACTION",2.42,49.19,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M ammonium sulfate, 20-30% PEG 3350 and 0.1M HEPES pH7.0 5 mM compound final concentration added to cryo-protectant solution for soaking of apo crystals, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M113.473348","1EH","4IJP",85.3,"2.25","2.25","Crystal Structure of Human PRPF4B kinase domain in complex with 4-{5-[(2-Chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}-benzo[b]thiophene-2-carboxylic acid amine","MDFKENPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARANQEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLCLVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASHVADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQEKIHHHHHH","Homo sapiens","KIAA0536, PRP4, PRP4H, PRP4K, PRPF4B","Serine/threonine-protein kinase PRP4 homolog","1","4IJP"
"4IJQ",,"X-RAY DIFFRACTION",2.26,45.52,"VAPOR DIFFUSION, HANGING DROP",8,"0.2M LiSO4, 30% PEG5000MME, 0.1M Tris-HCl, 0.88mM ligand, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301893b","SV2","4IJQ",103.53,"2.004","2.004","Human hypoxanthine-guanine phosphoribosyltransferase in complex with [(2-((Guanine-9H-yl)methyl)propane-1,3-diyl)bis(oxy)]bis(methylene))diphosphonic acid","HHHHHHATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA","Homo sapiens","HPRT1, HPRT","Hypoxanthine-guanine phosphoribosyltransferase","1","4IJQ"
"4IJT",,"X-RAY DIFFRACTION",2.64,53.45,"VAPOR DIFFUSION, HANGING DROP",6.1,"1:1.5 PROTEIN/DNA RATIO, 20% PEG 3350, 0.2M KCl, pH 6.1, Vapor diffusion, hanging drop, temperature 293K",293,"10.1093/nar/gkt630",,"4IJT",22.96,"1.78","1.78","Human p53 core domain with hot spot mutation R273H (form II)","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVHVCACPGRDRRTEEENLRKKG","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4IJT"
"4IJU",,"X-RAY DIFFRACTION",2.34,47.54,"VAPOR DIFFUSION, HANGING DROP",7.3,"200 mM potassium formate, pH 7.3, 22% (W/V) PEG3350, 1.5 mM Zwittergent 3-12, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/ml500144h","1EO","4IJU",129.79,"2.35","2.35","Crystal structure of 11b-HSD1 double mutant (L262R, F278E) in complex with (1S,4S)-4-[8-(2-fluorophenoxy)[1,2,4]triazolo[4,3-a]pyridin-3-yl]bicyclo[2.2.1]heptan-1-ol","GSHMASMTGGQQMGRGSNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPCRKILEELYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","4IJU"
"4IJV",,"X-RAY DIFFRACTION",2.34,47.43,"VAPOR DIFFUSION, HANGING DROP",7.3,"200 mM potassium formate, pH 7.3, 22% (W/V) PEG3350, 1.5 mM Zwittergent 3-12, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/ml500144h","1EN","4IJV",129.88,"2.35","2.35","Crystal structure of 11b-HSD1 double mutant (L262R, F278E) in complex with 3-[1-(4-chlorophenyl)cyclopropyl]-8-(2-fluorophenoxy)[1,2,4]triazolo[4,3-a]pyridine","GSHMASMTGGQQMGRGSNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPCRKILEELYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","4IJV"
"4IJW",,"X-RAY DIFFRACTION",2.34,47.54,"VAPOR DIFFUSION, HANGING DROP",7.3,"200 mM potassium formate, pH 7.3, 22% (W/V) PEG3350, 1.5 mM Zwittergent 3-12, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/ml500144h","1EQ","4IJW",129.6,"2.35","2.35","Crystal structure of 11b-HSD1 double mutant (L262R, F278E) in complex with 3-[1-(4-chlorophenyl)cyclopropyl]-8-cyclopropyl[1,2,4]triazolo[4,3-a]pyridine","GSHMASMTGGQQMGRGSNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPCRKILEELYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","4IJW"
"4IJX",,"X-RAY DIFFRACTION",2.44,49.67,"VAPOR DIFFUSION, HANGING DROP",8.4,"0.1M Tris, 2.0M Ammonium phosphate monobasic, 5mM magnesium chloride, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1016/j.bbrc.2013.01.095",,"4IJX",36.21,"2.1","2.1","Crystal structure of human Ap4A hydrolase E58A mutant complexed with DPO","MALRACGLIIFRRCLIPKVDNNAIEFLLLQASDGIHHWTPPKGHVEPGEDDLETALRATQEEAGIEAGQLTIIEGFKRELNYVARNKPKTVIYWLAEVKDYDVEIRLSHEHQAYRWLGLEEACQLAQFKEMKAALQEGHQFLCSIEALEHHHHHH","Homo sapiens","NUDT2, APAH1","Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]","1","4IJX"
"4IK6",,"X-RAY DIFFRACTION",1.99,38.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M Calcium chloride, 0.1M HEPES sodium pH 7.5, 28% v/v Polyethylene glycol 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4IK6",28.14,"2","2","Crystal structure of human transthyretin in complex with lumiracoxib","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4IK6"
"4IK7",,"X-RAY DIFFRACTION",2.01,38.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M Calcium chloride, 0.1M HEPES sodium pH 7.5, 28% v/v Polyethylene glycol 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4IK7",28.27,"2.1","2.1","Crystal structure of human transthyretin in complex with indomethacin","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4IK7"
"4IKB",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION",6.5,"0.2M ammonium sulfate, 0.1M Sodium cacodylate trihydrate pH 6.5, 30% PEG 8000, vapor diffusion, temperature 293K",293,,,"4IKB",37.18,"1.78","1.78","Crystal structure of SNX11 PX domain","MSENQEQEEVITVRVQDPRVQNEGSWNSYVDYKIFLHTNSKAFTAKTSCVRRRYREFVWLRKQLQRNAGLVPVPELPGKSTFFGTSDEFIEKRRQGLQHFLEKVLQSVVLLSDSQLHLFLQSQLSVPEIEACVQGRLEHHHHHH","Homo sapiens","SNX11","Sorting nexin-11","1","4IKB"
,,,,,,,,,,,,,,,,"MSENQEQEEVITVRVQDPRVQNEGSWNSYVDYKIFLHTNSKAFTAKTSCVRRRYREFVWLRKQLQRNAGLVPVPELPGKSTFFGTSDEFIEKRRQGLQHFLEKVLQSVVLLSDSQLHLFLQSQLSVPEIEACVQGRLEHHHHHH","Homo sapiens","SNX11","Sorting nexin-11","2","4IKB"
"4IKC",,"X-RAY DIFFRACTION",2.29,46.28,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1M sodium citrate, 0.2M magnesium acetate, 30% PEG4K, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1107/S0907444913010457",,"4IKC",32.47,"1.56","1.56","Crystal Structure of catalytic domain of PTPRQ","HMPISKKSFLQHVEELCTNNNLKFQEEFSELPKFLQDLSSTDADLPWNRAKNRFPNIKPYNNNRVKLIADASVPGSDYINASYISGYLCPNEFIATQGPLPGTVGDFWRMVWETRAKTLVMLTQCFEKGRIRCHQYWPEDNKPVTVFGDIVITKLMEDVQIDWTIRDLKIERHGDCMTVRQCNFTAWPEHGVPENSAPLIHFVKLVRASRAHDTTPMIVHSSAGVGRTGVFIALDHLTQHINDHDFVDIYGLVAELRSERMCMVQNLAQYIFLHQCILDLL","Homo sapiens","PTPRQ","Phosphotidylinositol phosphatase PTPRQ","1","4IKC"
"4IKD",,"X-RAY DIFFRACTION",2.05,39.89,"VAPOR DIFFUSION",7.5,"0.1M HEPES pH 7.5, 20% PEG 8000, vapor diffusion, temperature 293K",293,,,"4IKD",20.4,"1.6","1.6","Crystal structure of SNX11 PX domain","MSENQEQEEVITVRVQDPRVQNEGSWNSYVDYKIFLHTNSKAFTAKTSCVRRRYREFVWLRKQLQRNAGLVPVPELPGKSTFFGTSDEFIEKRRQGLQHFLEKVLQSVVLLSDSQLHLFLQSQLSVPEIEACVQGRSTMTVSDAILRYAMSNCGWAQEERQSSSLEHHHHHH","Homo sapiens","SNX11","Sorting nexin-11","1","4IKD"
"4IKI",,"X-RAY DIFFRACTION",2.14,42.49,"VAPOR DIFFUSION, HANGING DROP",7.4,"10mg/mL wtTTR, 22% peg 400, 100mM Tris pH 7.4, 100mM KCl, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4IKI",28.27,"2","2","Crystal structure of wild-type human transthyretin in complex with indomethacin","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4IKI"
"4IKJ",,"X-RAY DIFFRACTION",2.05,40.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"10mg/mL wtTTR, 0.2M Calcium chloride, 0.1M HEPES sodium pH 7.5, 28% v/v Polyethylene glycol 400 (Hampton Research's Crystal Screen I, #14), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4IKJ",28.27,"2.1","2.1","Crystal structure of wild-type human transthyretin in complex with sulindac","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4IKJ"
"4IKK",,"X-RAY DIFFRACTION",1.99,38.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"10mg/mL wtTTR, 0.2M Calcium chloride, 0.1M HEPES sodium pH 7.5, 28% v/v Polyethylene glycol 400  
(Hampton Research's Crystal Screen I, #14), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4IKK",28.27,"1.9","1.9","Crystal structure of wild-type human transthyretin in complex with sulindac","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4IKK"
"4IKL",,"X-RAY DIFFRACTION",2.14,42.63,"VAPOR DIFFUSION, HANGING DROP",7.4,"10mg/mL wtTTR, 22% peg 400, 100mM Tris pH 7.4, 100 mM KCl, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4IKL",28.27,"1.9","1.9","Crystal structure of wild-type human transthyretin in complex with sulindac","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4IKL"
"4IKP",,"X-RAY DIFFRACTION",2.47,50.26,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 0.2 M Di-AMMONIUM TARTRATE, vapor diffusion, hanging drop, temperature 291K",291,,,"4IKP",157.03,"2","2","Crystal structure of coactivator-associated arginine methyltransferase 1 with methylenesinefungin","RTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTT","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","4IKP"
"4IKR",,"X-RAY DIFFRACTION",2.38,48.37,"VAPOR DIFFUSION, HANGING DROP",6,"6% PEG 10000, 100mM HEPES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm400395p","PVP","4IKR",37.58,"1.78","1.78","Crystal structure of Type 1 human methionine aminopeptidase in complex with 2-(4-(5-chloro-6-methyl-2-(pyridin-2-yl)pyrimidin-4-yl)piperazin-1-yl)ethanol","MGSSHHHHHHSSGLVPRGSHMLEDPYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4IKR"
"4IKS",,"X-RAY DIFFRACTION",2.33,47.18,"VAPOR DIFFUSION, HANGING DROP",6,"6% PEG 10000, 100mM HEPES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm400395p","TFD","4IKS",37.65,"1.7","1.7","Crystal structure of truncated (delta 1-89) human methionine aminopeptidase Type 1 in complex with N1-(5-chloro-6-methyl-2-(pyridin-2-yl)pyrimidin-4-yl)-N2-(6-(trifluoromethyl)pyridin-2-yl)ethane-1,2-diamine","MGSSHHHHHHSSGLVPRGSHMLEDPYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4IKS"
"4IKT",,"X-RAY DIFFRACTION",2.36,47.79,"VAPOR DIFFUSION, HANGING DROP",6,"6% PEG 10000, 100mM HEPES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm400395p","TFV","4IKT",37.65,"1.6","1.6","Crystal structure of truncated (delta 1-89) human methionine aminopeptidase Type 1 in complex with N1-(5-chloro-6-methyl-2-(pyridin-2-yl)pyrimidin-4-yl)-N2-(5-(trifluoromethyl)pyridin-2-yl)ethane-1,2-diamine","MGSSHHHHHHSSGLVPRGSHMLEDPYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4IKT"
"4IKU",,"X-RAY DIFFRACTION",2.39,48.58,"VAPOR DIFFUSION, HANGING DROP",6,"6% PEG 10000, 100mM HEPES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm400395p","SHX","4IKU",37.52,"1.3","1.3","Crystal structure of truncated (delta 1-89) human methionine aminopeptidase Type 1 in complex with 2-((5-chloro-6-methyl-2-(pyridin-2-yl)pyrimidin-4-yl)amino)-3-phenylpropanamide","MGSSHHHHHHSSGLVPRGSHMLEDPYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4IKU"
"4ILE",,"X-RAY DIFFRACTION",2.02,39.14,"VAPOR DIFFUSION, SITTING DROP",7.4,"16% PEG 4000, 200mM NaCl, 100mM Tris-HCL (pH7.4), VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4ILE",21.9,"2.676","2.676","Structure of human ADP-ribosylation factor-like 8A binding to GDP","GSMIALFNKLLDWFKALFWKEEMELTLVGLQYSGKTTFVNVIASGQFNEDMIPTVGFNMRKITKGNVTIKLWDIGGQPRFRSMWERYCRGVSAIVYMVDAADQEKIEASKNELHNLLDKPQLQGIPVLVLGNKRDLPGALDEKELIEKMNLSAIQDREICCYSISCKEKDNIDITLQWLIQHSR","Homo sapiens","ARL8A, ARL10B, GIE2","ADP-ribosylation factor-like protein 8A","1","4ILE"
"4ILX",,"X-RAY DIFFRACTION",2.12,41.92,"VAPOR DIFFUSION, HANGING DROP",8,"1.6M sodium citrate tris buffer pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2013.02.022","1EZ","4ILX",29.61,"1.6","1.6","Structure of human carbonic anhydrase II in complex with an adamantyl sulfonamide inhibitor","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4ILX"
"4IM0",,"X-RAY DIFFRACTION",2.91,57.75,"VAPOR DIFFUSION, HANGING DROP",8.7,"4% (w/v) PEG8000, 100 mM Tris pH 8.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.celrep.2013.01.033","1FV","4IM0",76.65,"2.4001","2.4001","Structure of Tank-Binding Kinase 1","GSGSGSMQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","4IM0"
"4IM2",,"X-RAY DIFFRACTION",2.91,57.69,"VAPOR DIFFUSION, HANGING DROP",8.7,"4% (w/v) PEG8000, 100 mM Tris pH 8.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.celrep.2013.01.033",,"4IM2",76.81,"2.5001","2.5001","Structure of Tank-Binding Kinase 1","GSGSGSMQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","4IM2"
"4IM3",,"X-RAY DIFFRACTION",3.23,61.94,"VAPOR DIFFUSION, HANGING DROP",7,"4% MPD, 100 mM Hepes pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.celrep.2013.01.033",,"4IM3",77.81,"3.342","3.342","Structure of Tank-Binding Kinase 1","GSGSGSMQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","4IM3"
"4IM6",,"X-RAY DIFFRACTION",2.96,58.46,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris pH 8.0, 0.02 M MgCl2, 25 % (w/v) PAA 5100, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.febslet.2014.07.017",,"4IM6",22.9,"1.65","1.65","LRR domain from human NLRP1","GAMGGSPVTDAYWQILFSVLKVTRNLKELDLSGNSLSHSAVKSLCKTLRRPRCLLETLRLAGCGLTAEDCKDLAFGLRANQTLTELDLSFNVLTDAGAKHLCQRLRQPSCKLQRLQLVSCGLTSDCCQDLASVLSASPSLKELDLQQNNLDDVGVRLLCEGLRHPACKLIRLGLDQTTLSDEMRQELRALEQEKPQLLIFSRRKPS","Homo sapiens","CARD7, DEFCAP, KIAA0926, NAC, NALP1, NLRP1","NACHT, LRR and PYD domains-containing protein 1","1","4IM6"
"4IMA",,"X-RAY DIFFRACTION",3.11,60.41,"EVAPORATION",4.9,"5% PEG6000, 0.05 M potassium citrate, 2.64 uM manganese chloride, pH 4.9, EVAPORATION, temperature 277K",277,"10.1021/bi301341r",,"4IMA",236.93,"1.954","1.954","The structure of C436M-hLPYK in complex with Citrate/Mn/ATP/Fru-1,6-BP","MEGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKARPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCMAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR, PK1, PKL","Pyruvate kinase","1","4IMA"
"4IMK",,"X-RAY DIFFRACTION",3,59,"VAPOR DIFFUSION, HANGING DROP",7,"15%(w/v) PEG4000, 0.1 M Tri-Na-citrate, 15%(v/v) isopropanol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0061953",,"4IMK",98.37,"2.202","2.202","Uncrossed Fab binding to human Angiopoietin 2","QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARSPNPYYYDSSGYYYPGAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Heavy Chain","1","4IMK"
,,,,,,,,,,,,,,,,"QPGLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHYVFGTGTKVTVLRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECGSGHHHHHH","Homo sapiens",,"Light Chain","2","4IMK"
"4IML",,"X-RAY DIFFRACTION",2.45,49.75,"VAPOR DIFFUSION, HANGING DROP",5,"17.5-20 %(w/v) PEG6000, 0.1 M citric acid, 0.2 M NDSB-221, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0061953",,"4IML",98.78,"2.931","2.931","CrossFab binding to human Angiopoietin 2","QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARSPNPYYYDSSGYYYPGAFDIWGQGTMVTVSSASVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECGSGHHHHHH","Homo sapiens",,"Crossed heavy chain (VH-Ckappa)","1","4IML"
,,,,,,,,,,,,,,,,"QPGLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHYVFGTGTKVTVLSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"Crossed light chain (VL-CH1)","2","4IML"
"4IMN",,"X-RAY DIFFRACTION",1.9,35.2,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M potassium thiocyanate, 30% PEG MME 2000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1194/jlr.M035410",,"4IMN",20,"2.09","2.09","Crystal structure of wild type human Lipocalin PGDS bound with PEG MME 2000","MAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKKAALSMCKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQAHHHHHH","Homo sapiens","PDS, PTGDS","Lipocalin-type prostaglandin-D synthase","1","4IMN"
"4IMO",,"X-RAY DIFFRACTION",1.89,34.79,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M potassium thiocyanate, 30% PEG MME 2000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1194/jlr.M035410",,"4IMO",20.57,"1.88","1.88","Crystal structure of wild type human Lipocalin PGDS in complex with substrate analog U44069","MAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKKAALSMCKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQAHHHHHH","Homo sapiens","PDS, PTGDS","Lipocalin-type prostaglandin-D synthase","1","4IMO"
"4IN0",,"X-RAY DIFFRACTION",1.89,34.98,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG8000, 0.2 M magnesium acetate tetrahydate, 0.1 M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1744309113000973",,"4IN0",34.15,"1.327","1.327","Crystal Structure of human splicing factor dim2/TXNL4B","SFLLPKLTSKKEVDQAIKSTAEKVLVLRFGRDEDPVCLQLDDILSKTSSDLSKMAAIYLVDVDQTAVYTQYFDISYIPSTVFFFNGQHMKVDYGSPDHTKFVGSFKTKQDFIDLIEVIYRGAMRGKLIVQSPIDPKNIPKYDLLYQDI","Homo sapiens","DIM2, DLP, TXNL4B","Thioredoxin-like protein 4B","1","4IN0"
"4IN4",,"X-RAY DIFFRACTION",2.83,56.48,"VAPOR DIFFUSION, SITTING DROP",7,"3.5M Sodium Formate pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1016/j.bmc.2013.04.019","4ID","4IN4",101.78,"2.59","2.59","Crystal structure of cpd 15 bound to Keap1 Kelch domain","SGLVPRGSHMAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","INRF2, KEAP1, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","4IN4"
"4INC",,"X-RAY DIFFRACTION",2,38.41,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 40% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/febs.12330",,"4INC",28.19,"1.19","1.19","Human Histidine Triad Nucleotide Binding Protein 2","SNAGNEVAKAQQATPGGAAPTIFSRILDKSLPADILYEDQQCLVFRDVAPQAPVHFLVIPKKPIPRISQAEEEDQQLLGHLLLVAKQTAKAEGLGDGYRLVINDGKLGAQSVYHLHIHVLGGRQLQWPPG","Homo sapiens","HINT2","Histidine triad nucleotide-binding protein 2, mitochondrial","1","4INC"
"4INI",,"X-RAY DIFFRACTION",1.92,36.08,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 40% PEG 8000, pH 6.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1111/febs.12330",,"4INI",29.37,"1.65","1.65","Human Histidine Triad Nucleotide Binding Protein 2 with Bound AMP","SNAGNEVAKAQQATPGGAAPTIFSRILDKSLPADILYEDQQCLVFRDVAPQAPVHFLVIPKKPIPRISQAEEEDQQLLGHLLLVAKQTAKAEGLGDGYRLVINDGKLGAQSVYHLHIHVLGGRQLQWPPG","Homo sapiens","HINT2","Histidine triad nucleotide-binding protein 2, mitochondrial","1","4INI"
"4IO8",,"X-RAY DIFFRACTION",2.62,52.97,"VAPOR DIFFUSION, HANGING DROP",9,"0.1 M Tris HCl, 22% PEG 10000, 0.1 M NaCl, 20% Glycerol, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1371/journal.pone.0078443","3FD","4IO8",42.63,"2.58","2.58","Crystal structure of human HSP70 complexed with 4-{(2R,3S,4R)-5-[(R)-6-Amino-8-(3,4-dichloro-benzylamino)-purin-9-yl]-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxymethyl}-benzonitrile","MAKAAAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVALNPQNTVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKVQVSYKGDTKAFYPEEISSMVLTKMKEIAEAYLGYPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAAAIAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVNHFVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSITRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNGRDLNKSINPDEAVAYGAAVQAAILMG","Homo sapiens","HSPA1A, HSP72, HSPA1, HSX70","Heat shock 70kDa protein 1A variant","1","4IO8"
"4IOO",,"X-RAY DIFFRACTION",2.12,41.95,"VAPOR DIFFUSION",7.5,"16% PEG 3350, 20% ethylene glycol, pH 7.5, vapor diffusion, temperature 277K",277,"10.1107/S090744491301994X",,"4IOO",15.6,"1.25","1.25","Crystal Structure of the first bromodomain of BRD4 in complex with N-methyltrimethylacetamide","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4IOO"
"4IOQ",,"X-RAY DIFFRACTION",2.14,42.61,"VAPOR DIFFUSION",7.5,"16% PEG 3350, 20% ethylene glycol , pH 7.5, VAPOR DIFFUSION, temperature 277K",277,"10.1107/S090744491301994X",,"4IOQ",15.49,"1.5","1.5","Crystal Structure of the first bromodomain of BRD4 in complex with pyrrolidin-2-one","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4IOQ"
"4IOR",,"X-RAY DIFFRACTION",2.12,41.9,"VAPOR DIFFUSION",7.5,"16% PEG 3350, 20% ethylene glycol, pH 7.5, vapor diffusion, temperature 277K",277,"10.1107/S090744491301994X",,"4IOR",15.43,"1.4","1.4","Crystal Structure of the first bromodomain of BRD4 in complex with DMSO","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4IOR"
"4IOU",,"X-RAY DIFFRACTION",2.4,48.8,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris-HCl pH 8.0, 20% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1016/j.str.2013.04.010",,"4IOU",93.11,"2.751","2.751","Crystal structure of the HIV-1 Vif binding, catalytically active domain of APOBEC3F","GPLGSPGIPGKEILRNPMEAMDPHIFYFHFKNLRKAYGRNESWLCFTMEVVKHHSPVSWKRGVFRNQVDPETGRHAERCFLSWFADDILSPNTNYEVTWYTSWSPCPECAGEVAEFLARHSNVNLTIKTARLYYFDDTDAAEGLRSLSQEGASVEIMGYKDFKYCWENFVYNDDEPFKPWDGLDYNFLDLDSKLQEILE","Homo sapiens","APOBEC3F","DNA dC->dU-editing enzyme APOBEC-3F","1","4IOU"
"4IP7",,"X-RAY DIFFRACTION",2.71,54.67,"VAPOR DIFFUSION, HANGING DROP",4.9,"50 mM sodium citrate (pH 4.9), 26 mM MnCl2, 3-5% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi301341r",,"4IP7",238.31,"1.8","1.8","Structure of the S12D variant of human liver pyruvate kinase in complex with citrate and FBP.","MEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PK1, PKL, PKLR","Pyruvate kinase isozymes L","1","4IP7"
"4IP8",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.0M (NH4)2SO4, 0.1M Hepes, 6% PEG400, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1073/pnas.1322357111",,"4IP8",51.28,"2.193","2.193","Structure of human serum amyloid A1","MRSFFSFLGEAFDGARDMWRAYSDMREANYIGSDKYFHARGNYDAAKRGPGGVWAAEAISDARENIQRFFGHGAEDSLADQAANEWGRSGKDPNHFRPAGLPEKY","Homo sapiens","SAA1","Serum amyloid A-1 protein","1","4IP8"
"4IP9",,"X-RAY DIFFRACTION",2.18,43.69,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG2000 MME, 0.1M Tris (pH8.5) and 0.2 M Trimethylamine N-oxide, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1073/pnas.1322357111",,"4IP9",27.27,"2.5","2.5","Structure of native human serum amyloid A1","MHHHHHHRSFFSFLGEAFDGARDMWRAYSDMREANYIGSDKYFHARGNYDAAKRGPGGVWAAEAISDARENIQRFFGHGAEDSLADQAANEWGRSGKDPNHFRPAGLPEKY","Homo sapiens","SAA1","Serum amyloid A-1 protein","1","4IP9"
"4IPC",,"X-RAY DIFFRACTION",2.09,41.24,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 200 mM Calcium Acetate, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/bi400542z",,"4IPC",13.5,"1.22","1.22","Structure of the N-terminal domain of RPA70, E7R mutant","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4IPC"
"4IPD",,"X-RAY DIFFRACTION",1.9,35.24,"VAPOR DIFFUSION, HANGING DROP",5.5,"100 mM BIS-TRIS, 2M ammonium sulfate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/bi400542z",,"4IPD",13.5,"1.51","1.51","Structure of the N-terminal domain of RPA70, E100R mutant","GSHMVGQLSEGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELRVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4IPD"
"4IPG",,"X-RAY DIFFRACTION",2.08,40.89,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate, 200 mM NaCl, 30% PEG 8000, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/bi400542z",,"4IPG",13.53,"1.58","1.58","Structure of the N-terminal domain of RPA70, E7R, E100R mutant","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELRVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4IPG"
"4IPH",,"X-RAY DIFFRACTION",2.09,41.15,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 200 mM Calcium Acetate, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/bi400542z","1FJ","4IPH",14.27,"1.94","1.94","Structure of N-terminal domain of RPA70 in complex with VU079104 inhibitor","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4IPH"
"4IPX",,"X-RAY DIFFRACTION",2.19,43.8,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.7 M sodium malonate, pH 7.0, 0.1 M HEPES, pH 7.4, 5% MPD, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20130276",,"4IPX",12.03,"1.7","1.7","Analyzing the visible conformational substates of the FK506 binding protein FKBP12","GVQVETISPGDGRTFPKRGQTVVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGVPGIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","Peptidyl-prolyl cis-trans isomerase FKBP1A","1","4IPX"
"4IQ2",,"X-RAY DIFFRACTION",2.06,40.29,"VAPOR DIFFUSION, HANGING DROP",7,"2.0 M malonic acid, pH 7.0, 4% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1399004713032112",,"4IQ2",23.45,"1.7","1.7","P21 crystal form of FKBP12.6","GVEIETISPGDGRTFPKKGQTVVVHYTGMLQNGKKFDSSRDRNKPFKFRIGKQEVIKGFEEGAAQMSLGQRAKLTITPDVAYGATGHPGVIPPNATLIFDVELLNLE","Homo sapiens","FKBP1B, FKBP12.6, FKBP1L, FKBP9, OTK4","Peptidyl-prolyl cis-trans isomerase FKBP1B","1","4IQ2"
"4IQ6",,"X-RAY DIFFRACTION",3.31,62.84,"VAPOR DIFFUSION, HANGING DROP",7,"15% Peg 3350, 0.1 M Hepes pH 7.0, 5% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1021/ml300348c","IQ6","4IQ6",95.34,"3.12","3.12","Gsk-3beta with inhibitor 6-chloro-N-cyclohexyl-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-amine","GAMGSHMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","4IQ6"
"4IQA",,"X-RAY DIFFRACTION",2.37,48.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1 M HEPES 25% (w/v) PEG 3350, 0.02% azide, 5 mM DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4IQA",52.7,"2.49","2.49","Crystal Structure Analysis of the E228L Mutant of Human CLIC1","PQVELFVKAGSDGAKIGNCPFSQRLFMVLWLKGVTFNVTTVDTKRRTETVQKLCPGGQLPFLLYGTEVHTDTNKIEEFLEAVLCPPRYPKLAALNPESNTAGLDIFAKFSAYIKNSNPALNDNLEKGLLKALKVLDNYLTSPLPEEVDETSAEDEGVSQRKFLDGNELTLADCNLLPKLHIVQVVCKKYRGFTIPEAFRGVHRYLSNAYAREEFASTCPDDELIELAYEQVAKALK","Homo sapiens","CLIC1, G6, NCC27","Chloride intracellular channel protein 1","1","4IQA"
"4IQC",,"X-RAY DIFFRACTION",2.64,53.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"62% ammonium sulfate, 0.1 M HEPES, pH 7.5, 4% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1399004713032112",,"4IQC",23.35,"1.903","1.903","P3121 crystal form of FKBP12.6","GVEIETISPGDGRTFPKKGQTVVVHYTGMLQNGKKFDSSRDRNKPFKFRIGKQEVIKGFEEGAAQMSLGQRAKLTITPDVAYGATGHPGVIPPNATLIFDVELLNLE","Homo sapiens","FKBP1B, FKBP12.6, FKBP1L, FKBP9, OTK4","Peptidyl-prolyl cis-trans isomerase FKBP1B","1","4IQC"
"4IQH",,"X-RAY DIFFRACTION",2.34,47.37,"VAPOR DIFFUSION, HANGING DROP",6.2,"16% PEG 20000, 0.1M sodium citrate, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 280K",280,"10.1016/j.str.2013.10.001",,"4IQH",42.99,"1.764","1.764","Crystal Structure Analysis of Dysferlin C2A variant 1 (C2Av1)","GDITHMLACLLVRASNLPSAKKDRRSDPVASLTFRGVKKRTKVIKNSVNPVWNEGFEWDLKGIPLDQGSELHVVVKDHETMGRNRFLGEAKVPLREVLATPSLSASFNAPLLDTKKQPTGASLVLQVSYT","Homo sapiens","DYSF, Dysferlin, FER1L1","Dysferlin","1","4IQH"
"4IQK",,"X-RAY DIFFRACTION",3.39,63.77,"VAPOR DIFFUSION",7,"3.5M Na Formate, pH 7.0, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.bmc.2013.04.019","IQK","4IQK",33.06,"1.97","1.97","Crystal structure of cpd 16 bound to Keap1 Kelch domain","SGLVPRGSHMAPKVGRLIYTAGGYFRQSLSYLEAYNPSNGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVATATWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","INRF2, KEAP1, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","4IQK"
"4IQM",,"X-RAY DIFFRACTION",2.11,41.77,"VAPOR DIFFUSION, HANGING DROP",8.5,"28% w/v PEG4000, 0.2 M magnesium chloride, 0.1 M Tris-HCl pH 8.5, 1 mM spermine, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2013.05.014",,"4IQM",37.95,"1.8","1.8","Crystal structure of the catalytic domain of human Pus1","GPGSEFEKPPKRKIVLLMAYSGKGYHGMQRNVGSSQFKTIEDDLVSALVRSGCIPENHGEDMRKMSFQRCARTDKGVSAAGQVVSLKVWLIDDILEKINSHLPSHIRILGLKRVTGGFNSKNRCDARTYCYLLPTFAFAHKDRDVQDETYRLSAETLQQVNRLLACYKGTHNFHNFTSQKGPQDPSACRYILEMYCEEPFVREGLEFAVIRVKGQSFMMHQIRKMVGLVVAIVKGYAPESVLERSWGTEKVDVPKAPGLGLVLERVHFEKYNQRFGNDGLHEPLDWAQEEGKVAAFKEEHIYPTIIGTERDERSMAQWLSTLPIHNFSATALTAGG","Homo sapiens","PUS1, PP8985","tRNA pseudouridine synthase A, mitochondrial","1","4IQM"
"4IQY",,"X-RAY DIFFRACTION",2.25,45.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG3350, 0.1M HEPES, 0.1M MgFormate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2523",,"4IQY",55.31,"1.55","1.55","Crystal structure of the human protein-proximal ADP-ribosyl-hydrolase MacroD2","GHMKKKVWREEKERLLKMTLEERRKEYLRDYIPLNSILSWKEEMKGKGQNDEENTQETSQVKKSLTEKVSLYRGDITLLEVDAIVNAANASLLGGGGVDGCIHRAAGPCLLAECRNLNGCDTGHAKITCGYDLPAKYVIHTVGPIARGHINGSHKEDLANCYKSSLKLVKENNIRSVAFPCISTGIYGFPNEPAAVIALNTIKEWLAKNHHEVDRIIFCVFLEVDFKIYKKKMNEFFSVD","Homo sapiens","MACROD2, C20orf133","O-acetyl-ADP-ribose deacetylase MACROD2","1","4IQY"
"4IR3",,"X-RAY DIFFRACTION",4.19,70.67,"VAPOR DIFFUSION, SITTING DROP",7,"18% PEG 1000, 17% glycerol, 0.1M HEPES pH 7.0 (Ligand soaking performed in low-molecular-weight PEG smears stabilizing solution), VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1021/acs.jmedchem.5b00209",,"4IR3",14.24,"2","2","Crystal Structure of the bromodomain of human BAZ2B in complex with 1-[7-amino-1-(pyrimidin-2-yl)indolizin-3-yl]ethanone (GSK2833282A)","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4IR3"
"4IR4",,"X-RAY DIFFRACTION",4.23,70.91,"VAPOR DIFFUSION, SITTING DROP",6.25,"32% Low Molecular-Weight PEG Smears, 0.1M MES pH 6.25 (Ligand soaking performed in low-molecular-weight PEG smears stabilizing solution), VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1021/acs.jmedchem.5b00209",,"4IR4",14.44,"2.05","2.05","Crystal Structure of the bromodomain of human BAZ2B in complex with 1-[7-(morpholin-4-yl)-1-(pyridin-2-yl)indolizin-3-yl]ethanone (GSK2834113A)","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4IR4"
"4IR5",,"X-RAY DIFFRACTION",4.19,70.63,"VAPOR DIFFUSION, SITTING DROP",6.5,"28% Low Molecular-Weight PEG Smears, 0.1M MES pH 6.5 (Ligand soaking performed in low-molecular-weight PEG smears stabilizing solution), VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1021/acs.jmedchem.5b00209","IR5","4IR5",14.72,"1.7","1.7","Crystal Structure of the bromodomain of human BAZ2B in complex with 1-{1-[2-(hydroxymethyl)phenyl]-7-phenoxyindolizin-3-yl}ethanone (GSK2847449A)","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4IR5"
"4IR6",,"X-RAY DIFFRACTION",4.15,70.36,"VAPOR DIFFUSION, SITTING DROP",6.25,"28% Low Molecular-Weight PEG Smears, 0.1M MES pH 6.25 (Ligand soaking performed in low-molecular-weight PEG smears stabilizing solution), VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1021/acs.jmedchem.5b00209","IR6","4IR6",14.4,"1.8","1.8","Crystal Structure of the bromodomain of human BAZ2B in complex with 1-{1-[2-(METHYLSULFONYL)PHENYL]-7-PHENOXYINDOLIZIN-3-YL}ETHANONE (GSK2838097A)","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4IR6"
"4IRG",,"X-RAY DIFFRACTION",2.01,38.81,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.4M Sodium Citrate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1073/pnas.1301726110",,"4IRG",12.56,"1.7","1.7","Uninhibited DNA-binding domain of the Ets transcription factor ERG","GAMGSGIQRPGSGQIQLWQFLLELLSDSSNSSCITWEGTNGEFKMTDPDEVARRWGERKSKPNMNYDKLSRALRYYYDKNIMTKVHGKRYAYKFDFHGIAQALQPHPPE","Homo sapiens","ERG","Transcriptional regulator ERG","1","4IRG"
"4IRH",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.4M Sodium Citrate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1073/pnas.1301726110",,"4IRH",15.06,"2.1","2.1","Auto-inhibited ERG Ets domain","GAMVPKTEDQRPQLDPYQILGPTSSRLANPGSGQIQLWQFLLELLSDSSNSSCITWEGTNGEFKMTDPDEVARRWGERKSKPNMNYDKLSRALRYYYDKNIMTKVHGKRYAYKFDFHGIAQALQPHPPE","Homo sapiens","ERG","Transcriptional regulator ERG","1","4IRH"
"4IRI",,"X-RAY DIFFRACTION",2.11,41.69,"VAPOR DIFFUSION, SITTING DROP",,"0.2M ammonium chloride, 20% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1073/pnas.1301726110",,"4IRI",22.2,"2.77","2.77","Auto-inhibited ERG Ets Domain-DNA Complex","GAMVPKTEDQRPQLDPYQILGPTSSRLANPGSGQIQLWQFLLELLSDSSNSSCITWEGTNGEFKMTDPDEVARRWGERKSKPNMNYDKLSRALRYYYDKNIMTKVHGKRYAYKFDFHGIAQALQPHPPE","Homo sapiens","ERG","Transcriptional regulator ERG","1","4IRI"
,,,,,,,,,,,,,,,,"GACCGGAAGTGG",,,"DNA (5'-D(*GP*AP*CP*CP*GP*GP*AP*AP*GP*TP*GP*G)-3')","2","4IRI"
,,,,,,,,,,,,,,,,"CCACTTCCGGTC",,,"DNA (5'-D(*CP*CP*AP*CP*TP*TP*CP*CP*GP*GP*TP*C)-3')","3","4IRI"
"4IRP",,"X-RAY DIFFRACTION",2.93,57.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.7 to 1.0 M Sodium accetate, 100 mM imidazole.HCL pH 6.5 as precipating agent, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M113.509984",,"4IRP",59.77,"2.1","2.1","Crystal structure of catalytic domain of human beta1,4-galactosyltransferase-7 in open conformation with manganses and UDP","GSDIPEHWEEDASWGPHRLAVLVPFRERFEELLVFVPHMRRFLSRKKIRHHIYVLNQVDHFRFNRAALINVGFLESSNSTDYIAMHDVDLLPLNEELDYGFPEAGPFHVASPELHPLYHYKTYVGGILLLSKQHYRLCNGMSNRFWGWGREDDEFYRRIKGAGLQLFRPSGITTGYKTFRHLHDPAWRKRDQKRIAAQKQEQFKVDREGGLNTVKYHVASRTALSVGGAPCTVLNIMLDCDKTATPWCTFS","Homo sapiens","4galactosyltransferase, B4GALT7, beta1, UNQ748/PRO1478, XGALT1","Beta-1,4-galactosyltransferase 7","1","4IRP"
"4IRQ",,"X-RAY DIFFRACTION",3.38,63.57,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM Tri.HCl, pH 8.5, 8% PEG 8000 as precipitating agent, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M113.509984",,"4IRQ",119.19,"2.3","2.3","Crystal structure of catalytic domain of human beta1,4galactosyltransferase 7 in closed conformation in complex with manganese and UDP","GSDIPEHWEEDASWGPHRLAVLVPFRERFEELLVFVPHMRRFLSRKKIRHHIYVLNQVDHFRFNRAALINVGFLESSNSTDYIAMHDVDLLPLNEELDYGFPEAGPFHVASPELHPLYHYKTYVGGILLLSKQHYRLCNGMSNRFWGWGREDDEFYRRIKGAGLQLFRPSGITTGYKTFRHLHDPAWRKRDQKRIAAQKQEQFKVDREGGLNTVKYHVASRTALSVGGAPCTVLNIMLDCDKTATPWCTFS","Homo sapiens","4galactosyltransferase, B4GALT7, beta1, UNQ748/PRO1478, XGALT1","Beta-1,4-galactosyltransferase 7","1","4IRQ"
"4IS0",,"X-RAY DIFFRACTION",2.43,49.49,"VAPOR DIFFUSION, HANGING DROP",4.25,"2.2 M ammonium sulfate, 100 mM sodium acetate pH 4.25, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1371/journal.pone.0060324",,"4IS0",29,"1.721","1.721","Structural Insights into Omega-Class Glutathione Transferases: A Snapshot of Enzyme Reduction and Identification of the Non-Catalytic Ligandin Site.","MSGESARSLGKGSAPPGPVPEGSIRIYSMRFAPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","4IS0"
,,,,,"VAPOR DIFFUSION, HANGING DROP",4.75,"2.2 M ammonium sulfate, 100 mM sodium acetate pH 4.75, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277
"4IS5",,"X-RAY DIFFRACTION",2.29,46.21,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris-HCL , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1074/jbc.M113.454611",,"4IS5",27.43,"1.48","1.48","Crystal Structure of the ligand-free inactive Matriptase","VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDAGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV","Homo sapiens","PRSS14, SNC19, ST14, TADG15","Suppressor of tumorigenicity 14 protein","1","4IS5"
"4IS7",,"X-RAY DIFFRACTION",4.21,70.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.4 M NaF, 15% glycerol, 0.1 M Tris-HCl, 0.5 mM protein, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4IS7",19,"2.751","2.751","Crystal Structure of the CASKIN2 SAM Domain Tandem","GSSHHHHHHSSGLVPRGSHMEQLLEGADAQAIHNWLSEFQLEGYTAHFLQAGYDVPTISRMTPEDLTAIGVTKPGHRKKIASEIAQLSIAEWLPSYIPTDLLEWLCALGLPQYHKQLVSSGYDSMGLVADLTWEELQEIGVNKLGHQKKLMLGVKRLAELRRGLLQGEALS","Homo sapiens","CASKIN2, KIAA1139","Caskin-2","1","4IS7"
"4IS8",,"X-RAY DIFFRACTION",2.42,49.23,"VAPOR DIFFUSION, HANGING DROP",6.4,"9.5%-15% PEG3350, 5% GLYCEROL, 50 MM BIS-TRIS, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M113.472837",,"4IS8",55.69,"2.78","2.78","Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptors","SIPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYSIIASHTEVAFNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLVEGVQEQVNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYLYYKHLNGDVPYNNLLIEMLHA","Homo sapiens","B1F, CPF, FTF, NR5A2","Nuclear receptor subfamily 5 group A member 2","1","4IS8"
"4ISE",,"X-RAY DIFFRACTION",2.23,44.82,"VAPOR DIFFUSION, SITTING DROP",5.5,"15% PEG3350, 200 mM ammonium iodide, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.01.093","1FW","4ISE",52.1,"1.78","1.78","Human glucokinase in complex with novel activator (2S)-3-cyclohexyl-2-(6-fluoro-4-oxoquinazolin-3(4H)-yl)-N-(1,3-thiazol-2-yl)propanamide","MKPMPLTLVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK, HXK4 Isoform II","Glucokinase","1","4ISE"
"4ISF",,"X-RAY DIFFRACTION",2.22,44.59,"VAPOR DIFFUSION, SITTING DROP",5.5,"15% PEG3350, 200 mM ammonium iodide, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.01.093","1FX","4ISF",52.12,"2.09","2.09","Human glucokinase in complex with novel activator (2S)-3-cyclohexyl-2-(6-fluoro-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-N-(1,3-thiazol-2-yl)propanamide","MKPMPLTLVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK, HXK4 Isoform II","Glucokinase","1","4ISF"
"4ISG",,"X-RAY DIFFRACTION",2.26,45.46,"VAPOR DIFFUSION, SITTING DROP",5.5,"15% PEG3350, 200 mM ammonium iodide, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.01.093","1FY","4ISG",52.11,"2.645","2.645","Human glucokinase in complex with novel activator (2S)-3-cyclohexyl-2-[4-(methylsulfonyl)-2-oxopiperazin-1-yl]-N-(1,3-thiazol-2-yl)propanamide","MKPMPLTLVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK, HXK4 Isoform II","Glucokinase","1","4ISG"
"4ISH",,"X-RAY DIFFRACTION",3.88,68.31,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2013.02.013","1GE","4ISH",34.68,"1.82","1.82","Structure of FACTOR VIIA in complex with the inhibitor BMS-593214 also known as 2'-[(6R,6AR,11BR)-2-CARBAMIMIDOYL-6,6A,7,11B-TETRAHYDRO-5H-INDENO[2,1-C]QUINOLIN-6-YL]-5'-HYDROXY-4'-METHOXYBIPHENYL-4-CARBOXYLIC ACID","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VII heavy chain","1","4ISH"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VII light chain","2","4ISH"
"4ISI",,"X-RAY DIFFRACTION",3.9,68.5,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2013.01.094","1GG","4ISI",34.65,"1.94","1.94","Structure of FACTOR VIIA in complex with the inhibitor (6S)-N-(4-CARBAMIMIDOYLBENZYL)-1-CHLORO-3-(CYCLOBUTYLAMINO)-8,8-DIETHYL-4-OXO-4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VII heavy chain","1","4ISI"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VII light chain","2","4ISI"
"4ITE",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, 1.2-1.6M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ml400098w",,"4ITE",30.32,"2.49","2.49","Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(2H-tetrazol-2-yl)ethyl]vitamin D3","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR","Vitamin D3 receptor","1","4ITE"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR"
"4ITF",,"X-RAY DIFFRACTION",2.55,51.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, 1.2-1.6M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ml400098w",,"4ITF",30.32,"2.84","2.84","Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(1H-tetrazole-1-yl)ethyl]vitamin D3","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR","Vitamin D3 receptor","1","4ITF"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR"
"4ITH",,"X-RAY DIFFRACTION",2.13,42.16,"VAPOR DIFFUSION, HANGING DROP",5,"0.25 M NH4I, 20% polyethylene glycol (PEG) 3350, 0.03 M glycyl-glycyl-glycine, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.01.016","RCM","4ITH",68.81,"2.25","2.25","Crystal structure of RIP1 kinase in complex with necrostatin-1 analog","MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","4ITH"
"4ITI",,"X-RAY DIFFRACTION",2.91,57.8,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 15% PEG 20,000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.01.016","1HW","4ITI",67.81,"2.86","2.86","Crystal structure of RIP1 kinase in complex with necrostatin-3 analog","MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","4ITI"
"4ITJ",,"X-RAY DIFFRACTION",2.18,43.5,"VAPOR DIFFUSION, HANGING DROP",5,"0.15 M NH4I, 17% PEG 3,350, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.01.016","1HX","4ITJ",68.69,"1.8","1.8","Crystal structure of RIP1 kinase in complex with necrostatin-4","MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","4ITJ"
"4ITO",,"X-RAY DIFFRACTION",2.1,41.48,"VAPOR DIFFUSION, HANGING DROP",8,"0.8 M Na-citrate and 50 mM Tris-Cl in the drop mixed with 250 uM protein, calibrated against 1.6 M Na-citrate, 50 mM Tris-Cl pH 8.0 in the well, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4ITO",29.85,"1.162","1.162","Human CA II inhibition by novel sulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4ITO"
"4ITP",,"X-RAY DIFFRACTION",2.11,41.67,"VAPOR DIFFUSION, HANGING DROP",8,"1.6M citrate, Tris pH 8.0, VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmc.2013.08.011","1GD","4ITP",29.84,"1.697","1.697","Structure of human carbonic anhydrase II bound to a benzene sulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4ITP"
"4ITS",,"X-RAY DIFFRACTION",2.28,46.1,"VAPOR DIFFUSION, HANGING DROP",6.1,"18% (w/v) PEG8000, 0.1 M MES, 0.2 M AmSO4 , pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2013.05.014",,"4ITS",38.53,"1.85","1.85","Crystal structure of the catalytic domain of human Pus1 with MES in the active site","GPGSEFEKPPKRKIVLLMAYSGKGYHGMQRNVGSSQFKTIEDDLVSALVRSGCIPENHGEDMRKMSFQRCARTDKGVSAAGQVVSLKVWLIDDILEKINSHLPSHIRILGLKRVTGGFNSKNRCDARTYCYLLPTFAFAHKDRDVQDETYRLSAETLQQVNRLLACYKGTHNFHNFTSQKGPQDPSACRYILEMYCEEPFVREGLEFAVIRVKGQSFMMHQIRKMVGLVVAIVKGYAPESVLERSWGTEKVDVPKAPGLGLVLERVHFEKYNQRFGNDGLHEPLDWAQEEGKVAAFKEEHIYPTIIGTERDERSMAQWLSTLPIHNFSATALTAGG","Homo sapiens","PUS1, PP8985","tRNA pseudouridine synthase A, mitochondrial","1","4ITS"
"4IU6",,"X-RAY DIFFRACTION",2.03,39.52,"VAPOR DIFFUSION, HANGING DROP",6,"pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm400227z","FZ1","4IU6",43.81,"1.9","1.9","Human Methionine Aminopeptidase in complex with FZ1: Pyridinylquinazolines Selectively Inhibit Human Methionine Aminopeptidase-1","MAAVETRVCETDGCSSEAKLQCPTCIKLGIQGSYFCSQECFKGSWATHKLLHKKAKDEKAKREVSSWTVEGDINTDPWAGYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4IU6"
"4IUE",,"X-RAY DIFFRACTION",2.71,54.59,"vapour diffusion, hanging drop",8.5,"17% PEG 3350, 0.2M Ammonium sulphate, 0.1M Tris pH 8.5, vapour diffusion, hanging drop, temperature 277K",277,"10.1021/jm400211f","AJ4","4IUE",24.5,"2.38","2.38","Tankyrase in complex with 7-(2-fluorophenyl)-4-methyl-1,2-dihydroquinolin-2-one","GTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPE","Homo sapiens","PARP5B, TANK2, TNKL, TNKS2","Tankyrase-2","1","4IUE"
"4IUF",,"X-RAY DIFFRACTION",3.13,60.66,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.12M CH3COONH4, 0.05M Bis-Tris, 16% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gkt1407",,"4IUF",11.87,"2.752","2.752","Crystal Structure of Human TDP-43 RRM1 Domain in Complex with a Single-stranded DNA","TSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPN","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","4IUF"
,,,,,,,,,,,,,,,,"GTTGAGCGT",,,"5'-D(*GP*TP*TP*GP*(XUA)P*GP*CP*GP*T)-3'","2","4IUF"
"4IUL",,"X-RAY DIFFRACTION",2.67,53.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M ammonium sulfate and 18   20% (w/v) polyethylene glycol 5000 monomethyl ether, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.01.015",,"4IUL",61.96,"2.3","2.3","MIF4G domain of DAP5","GAMGSNSAANNSANEKERHDAIFRKVRGILNKLTPEKFDKLCLELLNVGVESKLILKGVILLIVDKALEEPKYSSLYAQLCLRLAEDAPNFDGPAAEGQPGQKQSTTFRRLLISKLQDEFENRTRNVDVYDKRENPLLPEEEEQRAIAKIKMLGNIKFIGELGKLDLIHESILHKCIKTLLEKKKRVQLKDMGEDLECLCQIMRTVGPRLDHERAKSLMDQYFARMCSLMLSKELPARIRFLLQDTVELREHHWVPRKAFLDNGPKTI","Homo sapiens","DAP5, EIF4G2, OK/SW-cl.75","Eukaryotic translation initiation factor 4 gamma 2","1","4IUL"
"4IUZ",,"X-RAY DIFFRACTION",1.61,23.79,"VAPOR DIFFUSION, HANGING DROP",3.6,"5 mg/mL protein, 0.05 M citric acid, 38% v/v PEG200, pH 3.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1021/ja311408y",,"4IUZ",6.1,"1.6","1.6","High resolution crystal structure of racemic ester insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4IUZ"
,,,,,,,,,,,,,,,,"FVNQHLCGSDLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin B chain","2","4IUZ"
"4IVA",,"X-RAY DIFFRACTION",2.13,42.34,"VAPOR DIFFUSION, SITTING DROP",6,"AMMONIUM SULFATE, SODIUM CITRATE, PEG 8000, pH 6, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1021/jm4004895","1J5","4IVA",35.65,"1.5","1.5","JAK2 kinase (JH1 domain) in complex with the inhibitor TRANS-4-[(8AS)-2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(8AH)-YL]CYCLOHEXANECARBONITRILE","SGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4IVA"
"4IVB",,"X-RAY DIFFRACTION",2.38,48.3,"VAPOR DIFFUSION, SITTING DROP",5.5,"MES/PEG6000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1021/jm4004895","1J5","4IVB",70.11,"1.9","1.9","JAK1 kinase (JH1 domain) in complex with the inhibitor TRANS-4-{2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(6H)-YL}CYCLOHEXANECARBONITRILE","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4IVB"
"4IVC",,"X-RAY DIFFRACTION",2.32,46.87,"VAPOR DIFFUSION, SITTING DROP",5.5,"MES/PEG6000   , pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1021/jm4004895","1J6","4IVC",70.14,"2.35","2.35","JAK1 kinase (JH1 domain) in complex with the inhibitor (TRANS-4-{2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(6H)-YL}CYCLOHEXYL)ACETONITRILE","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4IVC"
"4IVD",,"X-RAY DIFFRACTION",2.38,48.28,"VAPOR DIFFUSION, SITTING DROP",5.5,"MES/PEG6000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1021/jm4004895","15T","4IVD",70.17,"1.93","1.93","JAK1 kinase (JH1 domain) in complex with compound 34","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4IVD"
"4IVE",,"X-RAY DIFFRACTION",2.69,54.23,"VAPOR DIFFUSION, SITTING DROP",5.62,"26.00% polyethylene glycol 6000, 0.1M MES pH 5.62, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4IVE",42.91,"2.3","2.3","Crystal structure of a polyadenylate-binding protein 3 (PABPC3) from Homo sapiens at 2.30 A resolution","GQGQETLTASRLASAPPQKQKQMLGERLFPLIQAMHPTLAGKITGMLLEIDNSELLYMLESPESLRSKVDEAVAVLQAHQAKEATQKAVNSATGVPTV","Homo sapiens","BC027617, PABP3, PABPC3, PABPL3","Polyadenylate-binding protein 3","1","4IVE"
"4IVM",,"X-RAY DIFFRACTION",2.78,55.79,"VAPOR DIFFUSION, SITTING DROP",10,"ammonium citrate dibasic, PEG3350, pH 10.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M113.459768","ACJ","4IVM",52.88,"2.769","2.769","Structure of human protoporphyrinogen IX oxidase(R59G)","HHHHHHMGRTVVVLGGGISGLAASYHLSRAPCPPKVVLVESSERLGGWIRSVRGPNGAIFELGPGGIRPAGALGARTLLLVSELGLDSEVLPVRGDHPAAQNRFLYVGGALHALPTGLRGLLRPSPPFSKPLFWAGLRELTKPRGKEPDETVHSFAQRRLGPEVASLAMDSLCRGVFAGNSRELSIRSCFPSLFQAEQTHRSILLGLLLGAGRTPQPDSALIRQALAERWSQWSLRGGLEMLPQALETHLTSRGVSVLRGQPVCGLSLQAEGRWKVSLRDSSLEADHVISAIPASVLSELLPAEAAPLARALSAITAVSVAVVNLQYQGAHLPVQGFGHLVPSSEDPGVLGIVYDSVAFPEQDGSPPGLRVTVMLGGSWLQTLEASGCVLSQELFQQRAQEAAATQLGLKEMPSHCLVHLHKNCIPQYTLGHWQKLESARQFLTAHRLPLTLAGASYEGVAVNDCIESGRQAAVSVLGTEPNS","Homo sapiens","PPOX","Protoporphyrinogen oxidase","1","4IVM"
"4IVO",,"X-RAY DIFFRACTION",2.72,54.81,"VAPOR DIFFUSION, SITTING DROP",10,"ammonium citrate dibasic, PEG3350, pH 10.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M113.459768","ACJ","4IVO",52.95,"2.597","2.597","Structure of human protoporphyrinogen IX oxidase(R59Q)","HHHHHHMGRTVVVLGGGISGLAASYHLSRAPCPPKVVLVESSERLGGWIRSVRGPNGAIFELGPQGIRPAGALGARTLLLVSELGLDSEVLPVRGDHPAAQNRFLYVGGALHALPTGLRGLLRPSPPFSKPLFWAGLRELTKPRGKEPDETVHSFAQRRLGPEVASLAMDSLCRGVFAGNSRELSIRSCFPSLFQAEQTHRSILLGLLLGAGRTPQPDSALIRQALAERWSQWSLRGGLEMLPQALETHLTSRGVSVLRGQPVCGLSLQAEGRWKVSLRDSSLEADHVISAIPASVLSELLPAEAAPLARALSAITAVSVAVVNLQYQGAHLPVQGFGHLVPSSEDPGVLGIVYDSVAFPEQDGSPPGLRVTVMLGGSWLQTLEASGCVLSQELFQQRAQEAAATQLGLKEMPSHCLVHLHKNCIPQYTLGHWQKLESARQFLTAHRLPLTLAGASYEGVAVNDCIESGRQAAVSVLGTEPNS","Homo sapiens","PPOX","Protoporphyrinogen oxidase","1","4IVO"
"4IVS",,"X-RAY DIFFRACTION",2.72,54.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.6M Li2SO4, 100mM HEPES, 25% PEG3350, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.3390/molecules18055706","VSI","4IVS",48.68,"2.636","2.636","Crystal structure of BACE1 with its inhibitor","MGSSHHHHHHSAGENLYFQGTLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4IVS"
"4IVT",,"X-RAY DIFFRACTION",2.68,54.17,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.6M Li2SO4, 100mM HEPES, 25% PEG3350, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.3390/molecules18055706","VTI","4IVT",48.85,"1.6","1.6","Crystal structure of BACE1 with its inhibitor","MGSSHHHHHHSAGENLYFQGTLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4IVT"
"4IW0",,"X-RAY DIFFRACTION",4.89,74.82,"VAPOR DIFFUSION, HANGING DROP",7.5,"5% PEG8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.celrep.2013.01.034",,"4IW0",76.44,"4","4","Crystal structure and mechanism of activation of TBK1","GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","4IW0"
"4IW1",,"X-RAY DIFFRACTION",2.23,44.92,"VAPOR DIFFUSION, SITTING DROP",7.4,"25%-30% PEG 3350, 50mM potassium phosphate, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M113.467027",,"4IW1",67.03,"2.56","2.56","HSA-fructose complex","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","4IW1"
"4IW2",,"X-RAY DIFFRACTION",2.13,42.38,"VAPOR DIFFUSION, SITTING DROP",7.4,"25%-30% PEG 3350, 50mM potassium phosphate, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M113.467027",,"4IW2",67.03,"2.41","2.41","HSA-glucose complex","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","4IW2"
"4IWD",,"X-RAY DIFFRACTION",2.06,40.16,"VAPOR DIFFUSION, HANGING DROP",7,"15.6 mg/ml protein mixed in 1:1 ratio with reservoir containing 150 mM malic acid, 20% PEG3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301619u","1JC","4IWD",35.55,"1.99","1.99","Structure of dually phosphorylated c-MET receptor kinase in complex with an MK-8033 analog","XQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","4IWD"
"4IWO",,"X-RAY DIFFRACTION",3.1,60.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"5% PEG6000, pH 7.5, vapor diffusion, hanging drop, temperature 294K",294,"10.1016/j.celrep.2013.01.034",,"4IWO",76.37,"2.61","2.61","Crystal structure and mechanism of activation of TBK1","GAMGQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVALYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","NAK, TBK1","Serine/threonine-protein kinase TBK1","1","4IWO"
"4IWP",,"X-RAY DIFFRACTION",3.01,59.17,"VAPOR DIFFUSION, HANGING DROP",7.5,"5% PEG6000, pH 7.5, vapor diffusion, hanging drop, temperature 294K",294,"10.1016/j.celrep.2013.01.034",,"4IWP",76.46,"3.065","3.065","Crystal structure and mechanism of activation of TBK1","AMGQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVALYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","NAK, TBK1","Serine/threonine-protein kinase TBK1","1","4IWP"
"4IWQ",,"X-RAY DIFFRACTION",3.03,59.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"5% PEG6000, pH 7.5, vapor diffusion, hanging drop, temperature 294K",294,"10.1016/j.celrep.2013.01.034",,"4IWQ",76.33,"3","3","Crystal structure and mechanism of activation of TBK1","AMGQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVALYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","NAK, TBK1","Serine/threonine-protein kinase TBK1","1","4IWQ"
"4IWV",,"X-RAY DIFFRACTION",2.55,51.78,"VAPOR DIFFUSION, SITTING DROP",7.4,"20% glucose, 10-18% Peg8000, 200mM sodium acetate, MMT 100mM pH7.0-8.5, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,,,"4IWV",51.5,"2.1","2.1","Crystals structure of Human Glucokinase in complex with small molecule activator","GSSNSQVEQILAEFQLQAADLKKVMRRMQKEMDRGLRLETHAAASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase isoform 3","1","4IWV"
"4IWZ",,"X-RAY DIFFRACTION",2.11,41.57,"VAPOR DIFFUSION, HANGING DROP",8,"1.8M sodium citrate, 50mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2013.08.019","1GO","4IWZ",29.66,"1.598","1.598","structure of hCAII in complex with an acetazolamide derivative","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4IWZ"
"4IXC",,"X-RAY DIFFRACTION",2.54,51.67,"VAPOR DIFFUSION, SITTING DROP",7.4,"20% glucose, 10-18% Peg8000, 200mM sodium acetate, MMT 100mM pH7.0-8.5, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,,,"4IXC",51.48,"2","2","Crystal structure of Human Glucokinase in complex with a small molecule activator.","GSSNSQVEQILAEFQLQAADLKKVMRRMQKEMDRGLRLETHAAASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase isoform 3","1","4IXC"
"4IXD",,"X-RAY DIFFRACTION",2.33,47.14,"VAPOR DIFFUSION",4.6,"0.085M sodium acetate, pH4.6, 0.17M ammonium acetate, 15% glycerol and 25.5% (w/v) PEG4000 , VAPOR DIFFUSION, temperature 293.0K",293,,,"4IXD",21.88,"1.8","1.8","X-ray structure of lfa-1 i-domain in complex with ibe-667 at 1.8a resolution","MASKGNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKWKDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVKILDTFEKLKDLFTELQKKIYVIEG","Homo sapiens","ITGAL, CD11A","Integrin alpha-L","1","4IXD"
"4IXP",,"X-RAY DIFFRACTION",5.03,75.56,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Sodium Cacodylate, 0.7M Sodium Acetate, 2% PEG 400, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1371/journal.pone.0070031",,"4IXP",40.42,"2.749","2.749","Crystal structure of Maternal Embryonic Leucine Zipper Kinase (MELK)","MKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIRIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIAFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFSCGLEHHHHHH","Homo sapiens","MELK, KIAA0175","Maternal embryonic leucine zipper kinase","1","4IXP"
"4IXU",,"X-RAY DIFFRACTION",3.24,62.05,"VAPOR DIFFUSION, HANGING DROP",7,"Crystals in condition H3 from Silver Bullet screen (Hampton Research) using Tacsimate in the reservoir, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.06.092","38I","4IXU",102.23,"1.9","1.9","Crystal structure of human Arginase-2 complexed with inhibitor 11d: {(5R)-5-amino-5-carboxy-5-[(3-endo)-8-(3,4-dichlorobenzyl)-8-azabicyclo[3.2.1]oct-3-yl]pentyl}(trihydroxy)borate(1-)","HSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREG","Homo sapiens","ARG2","Arginase-2, mitochondrial","1","4IXU"
"4IXV",,"X-RAY DIFFRACTION",3.28,62.5,"VAPOR DIFFUSION, HANGING DROP",7,"Crystals in condition H3 from Silver Bullet screen (Hampton Research) using Tacsimate in the reservoir, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.06.092","XA1","4IXV",101.82,"2.3","2.3","Crystal structure of human Arginase-2 complexed with inhibitor 2d: {(5R)-5-amino-5-carboxy-5-[1-(4-chlorobenzyl)piperidin-4-yl]pentyl}(trihydroxy)borate(1-)","HSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREG","Homo sapiens","ARG2","Arginase-2, mitochondrial","1","4IXV"
"4IY0",,"X-RAY DIFFRACTION",3.86,68.17,"VAPOR DIFFUSION",4.6,"10mM magnesium chloride, 3M ammonium acetate, 100mM sodium acetate, pH 4.6, VAPOR DIFFUSION, temperature 291.15K",291.15,,,"4IY0",18.53,"1.9","1.9","Structural and ligand binding properties of the Bateman domain of human magnesium transporters CNNM2 and CNNM4","KEELNIIQGALELRTKTVEDVMTPLRDCFMITGEAILDFNTMSEIMESGYTRIPVFEGERSNIVDLLFVKDLAFVDPDDCTPLKTITKFYNHPLHFVFNDTKLDAMLEEFKKGKSHLAIVQRVNNEGEGDPFYEVLGIVTLEDVIEEIIKSEILDE","Homo sapiens","CNNM2, ACDP2","Metal transporter CNNM2","1","4IY0"
"4IY2",,"X-RAY DIFFRACTION",3.9,68.48,"VAPOR DIFFUSION, HANGING DROP",8,"250mM calcium acetate, 100mM imidazole , pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,,,"4IY2",36.3,"3.6","3.6","Structural and ligand binding properties of the Bateman domain of human magnesium transporters CNNM2 and CNNM4","MEELNIIQGALELRTKTVEDVMTPLRDCFMITGEAILDFNTMSEIMESGYTRIPVFEGERSNIVDLLFVKDLAFVDPDDCTPLKTITKFYNHPLHFVFNDTKLDAMLEEFKKGKSHLAIVQRVNNEGEGDPFYEVLGIVTLEDVIEEIIKSEILDE","Homo sapiens","CNNM2, ACDP2","Metal transporter CNNM2","1","4IY2"
"4IY4",,"X-RAY DIFFRACTION",3.73,67.03,"VAPOR DIFFUSION",4.6,"2.8M AMMONIUM CHLORIDE, 4mM MANGANESE (II) CHLORIDE, 100mM SODIUM ACETATE , pH 4.6, VAPOR DIFFUSION, temperature 291.15K",291.15,,,"4IY4",35.75,"2.9","2.9","Structural and ligand binding properties of the Bateman domain of human magnesium transporters CNNM2 and CNNM4","KEELNIIQGALELRTKTVEDVMTPLRDCFMITGEAILDFNTMSEIMESGYTRIPVFEGERSNIVDLLFVKDLAFVDPDDCTPLKTITKFYNHPLHFVFNDTKLDAMLEEFKKGKSHLAIVQRVNNEGEGDPFYEVLGIVILEDVIEEIIKSEILDE","Homo sapiens","CNNM2, ACDP2","Metal transporter CNNM2","1","4IY4"
"4IYD",,"X-RAY DIFFRACTION",3.4,63.86,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris, 30% PEG-400 v/v, 0.2 M sodium citrate dihydrate, pH 8.0, vapor diffusion, sitting drop, temperature 293K",293,,,"4IYD",5.66,"1.66","1.66","Insulin glargine crystal structure 1","GIVEQCCTSICSLYQLENYCG","Homo sapiens","INS","Insulin A chain","1","4IYD"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPK","Homo sapiens","INS","Insulin B chain","2","4IYD"
"4IYF",,"X-RAY DIFFRACTION",3.4,63.83,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris, 30% PEG-400 v/v, 0.2 M sodium citrate dihydrate, pH 8.0, vapor diffusion, sitting drop, temperature 293K",293,,,"4IYF",5.66,"1.8","1.8","Insulin glargine crystal structure 2","GIVEQCCTSICSLYQLENYCG","Homo sapiens","INS","Insulin A chain","1","4IYF"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPK","Homo sapiens","INS","Insulin B chain","2","4IYF"
"4IYR",,"X-RAY DIFFRACTION",2.86,56.99,"VAPOR DIFFUSION, SITTING DROP",6.2,"0.1M KH2PO4, 0.1M NaH2PO4, 0.1M Bis-tris, 1.75M NaCl, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1107/S1399004713024218",,"4IYR",69.3,"2.697","2.697","Crystal structure of full-length caspase-6 zymogen","MASMSSASGLRRGHPAGGEENMTETDAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSAGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNLEHHHHHH","Homo sapiens","CASP6, MCH2","Caspase-6","1","4IYR"
"4IYS",,"X-RAY DIFFRACTION",2.71,54.66,"VAPOR DIFFUSION",4.6,"60mM NaH2PO4, 1.34M K2HPO4, pH 4.6, VAPOR DIFFUSION, temperature 291.15K",291.15,,,"4IYS",17.87,"1.8","1.8","Structural and ligand binding properties of the Bateman domain of human magnesium transporters CNNM2 and CNNM4","MEELNIIQGALELRTKTVEDVMTPLRDCFMITGEAILDFNTMSEIMESGYTRIPVFEGERSNIVDLLFVKDLAFVDPDDCTPLKTITKFYNHPLHFVFNDTKLDAMLEEFKKGKSHLAIVQRVNNEGEGDPFYEVLGIVTLEDVIEEIIKSEILDE","Homo sapiens","CNNM2, ACDP2","Metal transporter CNNM2","1","4IYS"
"4IZE",,"X-RAY DIFFRACTION",2.21,44.24,"VAPOR DIFFUSION, HANGING DROP",4.5,"PEG 5000MME, NaAcetate, pH 4.5, vapor diffusion, hanging drop, temperature 298K",298,"10.4049/jimmunol.1400538",,"4IZE",17.12,"2","2","Crystal Structure of IL-36gamma","SMCKPITGTINDLNQQVWTLQGQNLVAVPRSDSVTPVTVAVITCKYPEALEQGRGDPIYLGIQNPEMCLYCEKVGEQPTLQLKEQKIMDLYGQPEPVKPFLFYRAKTGRTSTLESVAFPDWFIASSKRDQPIILTSELGKSYNTAFELNIND","Homo sapiens","IL1E, IL1F9, IL1H1, IL1RP2, IL36G, UNQ2456/PRO5737","Interleukin-36 gamma","1","4IZE"
"4J03",,"X-RAY DIFFRACTION",2.4,48.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 3350, 0-10% sucrose, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.04.083","FVS","4J03",63.41,"2.92","2.92","Crystal structure of human soluble epoxide hydrolase complexed with fulvestrant","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4J03"
"4J0P",,"X-RAY DIFFRACTION",2.83,56.51,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","1H8","4J0P",46.03,"1.97","1.97","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J0P"
"4J0R",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M NaI, 20% PEG3350, 10% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm301588r","1H2","4J0R",15.77,"1.72","1.72","Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4J0R"
"4J0S",,"X-RAY DIFFRACTION",2.19,43.79,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M Na/KPO4, 20% PEG 3350, 10% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm301588r","1H3","4J0S",15.64,"1.84","1.84","Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4J0S"
"4J0T",,"X-RAY DIFFRACTION",2.83,56.46,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","6T9","4J0T",46.09,"2.05","2.05","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Ethoxy-pyridine-2-carboxylic acid [3-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J0T"
"4J0U",,"X-RAY DIFFRACTION",2.35,47.74,"VAPOR DIFFUSION, HANGING DROP",6.9,"100mM HEPES, 150mM NaCl, 8% PEG3350, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"4J0U",55.93,"1.969","1.969","Crystal structure of IFIT5/ISG58","MSEIRKDTLKAILLELECHFTWNLLKEDIDLFEVEDTIGQQLEFLTTKSRLALYNLLAYVKHLKGQNKDALECLEQAEEIIQQEHSDKEEVRSLVTWGNYAWVYYHMDQLEEAQKYTGKIGNVCKKLSSPSNYKLECPETDCEKGWALLKFGGKYYQKAKAAFEKALEVEPDNPEFNIGYAITVYRLDDSDREGSVKSFSLGPLRKAVTLNPDNSYIKVFLALKLQDVHAEAEGEKYIEEILDQISSQPYVLRYAAKFYRRKNSWNKALELLKKALEVTPTSSFLHHQMGLCYRAQMIQIKKATHNRPKGKDKLKVDELISSAIFHFKAAMERDSMFAFAYTDLANMYAEGGQYSNAEDIFRKALRLENITDDHKHQIHYHYGRFQEFHRKSENTAIHHYLEALKVKDRSPLRTKLTSALKKLSTKRLCHNALDVQSLSALGFVYKLEGEKRQAAEYYEKAQKIDPENAEFLTALCELRLSI","Homo sapiens","IFIT5, ISG58, RI58","Interferon-induced protein with tetratricopeptide repeats 5","1","4J0U"
"4J0V",,"X-RAY DIFFRACTION",2.8,56.06,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","1H7","4J0V",46.05,"1.94","1.94","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R)-2-amino-5-fluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J0V"
"4J0W",,"X-RAY DIFFRACTION",2.14,42.56,"VAPOR DIFFUSION",8,"100mM HEPES-K, 25% (v/v) ethylene glycol, pH 8.0, VAPOR DIFFUSION, temperature 277K",277,"10.1261/rna.037580.112",,"4J0W",37.44,"1.7","1.7","Structure of U3-55K","GPEAADIRVLRGHQLSITCLVVTPDDSAIFSAAKDCSIIKWSVESGRKLHVIPRAKKGAEGKPPGHSSHVLCMAISSDGKYLASGDRSKLILIWEAQSCQHLYTFTGHRDAVSGLAFRRGTHQLYSTSHDRSVKVWNVAENSYVETLFGHQDAVAALDALSRECCVTAGGRDGTVRVWKIPEESQLVFYGHQGSIDCIHLINEEHMVSGADDGSVALWGLSKKRPLALQREAHGLRGEPGLEQPFWISSVAALLNTDLVATGSHSSCVRLWQCGEGFRQLDLLCDIPLVGFINSLKFSSSGDFLVAGVGQEHRLGRWWRIKEARNSVCIIPLRRVPVPPAAGS","Homo sapiens","RRP9, RNU3IP2, U355K","U3 small nucleolar RNA-interacting protein 2","1","4J0W"
"4J0Y",,"X-RAY DIFFRACTION",2.8,56.01,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","1H6","4J0Y",46.05,"1.77","1.77","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5S)-2-amino-5-fluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J0Y"
"4J0Z",,"X-RAY DIFFRACTION",2.86,56.94,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","1H5","4J0Z",46.07,"2.13","2.13","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,5R)-2-amino-5-fluoro-4-fluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J0Z"
"4J12",,"X-RAY DIFFRACTION",3.68,66.55,"EVAPORATION",5,"2.2 Mammonium sulfate and 200 mM sodium fluoride , pH 5, EVAPORATION, temperature 300K",300,"10.1074/jbc.M113.457689",,"4J12",25.33,"1.9","1.9","monomeric Fc","NGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVNLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLNSTLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens","IGHG1","human Fc fragment","1","4J12"
"4J14",,"X-RAY DIFFRACTION",2.54,51.65,"VAPOR DIFFUSION, SITTING DROP",5.8,"15% PEG 8000, 50 mM posaconazole, 50 mM potassium phosphate, 20% glycerol, pH 5.8, VAPOR DIFFUSION, SITTING DROP, temperature 290.K",290,"10.1124/mol.113.085902","X2N","4J14",53.53,"2.5","2.5","Crystal Structure of Human Cytochrome P450 CYP46A1 with Posaconazole Bound","MAKKDEVGGRVLQDVFLDWAKKYGPVVRVNVFHKTSVIVTSPESVKKFLMSTKYNKDSKMYRALQTVFGERLFGQGLVSECNYERWHKQRRVIDLAFSRSSLVSLMETFNEKAEQLVEILEAKADGQTPVSMQDMLTYTAMDILAKAAFGMETSMLLGAQKPLSQAVKLMLEGITASRNTLAKFLPGKRKQLREVRESIRFLRQVGRDWVQRRREALKRGEEVPADILTQILKAEEGAQDDEGLLDNFVTFFIAGHETSANHLAFTVMELSRQPEIVARLQAEVDEVIGSKRYLDFEDLGRLQYLSQVLKESLRLYPPAWGTFRLLEEETLIDGVRVPGNTPLLFSTYVMGRMDTYFEDPLTFNPDRFGPGAPKPRFTYFPFSLGHRSCIGQQFAQMEVKVVMAKLLQRLEFRLVPGQRFGLQEQATLKPLDPVLCTLRPRGWQPAPPPPPCHHHH","Homo sapiens","CP46A_HUMAN, CYP46, CYP46A1","Cholesterol 24-hydroxylase","1","4J14"
"4J15",,"X-RAY DIFFRACTION",2.2,43.99,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG3350, 8% tacsimate, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1002/prot.24306",,"4J15",119.51,"2.24","2.24","Crystal structure of human cytosolic aspartyl-tRNA synthetase, a component of multi-tRNA synthetase complex","MGSSHHHHHHSSGLVPRGSHMPSASASRKSQEKPREIMDAAEDYAKERYGISSMIQSQEKPDRVLVRVRDLTIQKADEVVWVRARVHTSRAKGKQCFLVLRQQQFNVQALVAVGDHASKQMVKFAANINKESIVDVEGVVRKVNQKIGSCTQQDVELHVQKIYVISLAEPRLPLQLDDAVRPEAEGEEEGRATVNQDTRLDNRVIDLRTSTSQAVFRLQSGICHLFRETLINKGFVEIQTPKIISAASEGGANVFTVSYFKNNAYLAQSPQLYKQMCICADFEKVFSIGPVFRAEDSNTHRHLTEFVGLDIEMAFNYHYHEVMEEIADTMVQIFKGLQERFQTEIQTVNKQFPCEPFKFLEPTLRLEYCEALAMLREAGVEMGDEDDLSTPNEKLLGHLVKEKYDTDFYILDKYPLAVRPFYTMPDPRNPKQSNSYDMFMRGEEILSGAQRIHDPQLLTERALHHGIDLEKIKAYIDSFRFGAPPHAGGGIGLERVTMLFLGLHNVRQTSMFPRDPKRLTP","Homo sapiens","DARS, DARS1, PIG40","Aspartate--tRNA ligase, cytoplasmic","1","4J15"
"4J17",,"X-RAY DIFFRACTION",2.82,56.39,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","1HQ","4J17",46.07,"1.81","1.81","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-difluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J17"
"4J19",,"X-RAY DIFFRACTION",3.25,62.1,"VAPOR DIFFUSION, SITTING DROP",4.5,"24% PEG 3350, 100 mM sodium acetate, 100 mM potassium sulfate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/emboj.2013.105",,"4J19",37.87,"2.9","2.9","Structure of a novel telomere repeat binding protein bound to DNA","GATLSMRPAPIPIEDPEWRQTPPPVSATSGTFRLRRGSRFTWRKECLAVMESYFNENQYPDEAKREEIANACNAVIQKPGKKLSDLERVTSLKVYNWFANRRKEIKRRANIEA","Homo sapiens","HMBOX1, HOT1, TAH1","Homeobox-containing protein 1","1","4J19"
,,,,,,,,,,,,,,,,"CTGTTAGGGTTAGGGTTAG",,,"DNA (5'-D(*CP*TP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*G)-3')","2","4J19"
,,,,,,,,,,,,,,,,"TCTAACCCTAACCCTAACA",,,"DNA (5'-D(*TP*CP*TP*AP*AP*CP*CP*CP*TP*AP*AP*CP*CP*CP*TP*AP*AP*CP*A)-3')","3","4J19"
"4J1C",,"X-RAY DIFFRACTION",2.82,56.36,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","1HO","4J1C",46.09,"2.01","2.01","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-5,5-difluoro-4-fluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J1C"
"4J1E",,"X-RAY DIFFRACTION",2.82,56.38,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","1HM","4J1E",46.12,"1.78","1.78","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-4-fluoromethyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J1E"
"4J1F",,"X-RAY DIFFRACTION",2.89,57.45,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","1HL","4J1F",46.1,"2.25","2.25","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J1F"
"4J1H",,"X-RAY DIFFRACTION",2.82,56.4,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","1HJ","4J1H",46.1,"2.2","2.2","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6R)-2-amino-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J1H"
"4J1I",,"X-RAY DIFFRACTION",2.83,56.52,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","1HH","4J1I",46.12,"2.05","2.05","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6R)-2-amino-5-fluoro-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J1I"
"4J1K",,"X-RAY DIFFRACTION",2.84,56.64,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400225m","1HG","4J1K",46.12,"2.18","2.18","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6S)-2-amino-5-fluoro-4-methyl-6-trifluoromethyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4J1K"
"4J1P",,"X-RAY DIFFRACTION",2.4,48.82,"VAPOR DIFFUSION, SITTING DROP",6.3,"25% (w/v) PEG 1500, pH 6.3, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1371/journal.pone.0083190","1K0","4J1P",13.81,"1.08","1.08","X-ray crystal structure of bromodomain 2 of human brd2 in complex with rvx208 to 1.08 A resolution","SMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, DKFZp313H139, hCG_17503, KIAA9001, RING3","Bromodomain containing 2, isoform CRA_a","1","4J1P"
"4J1R",,"X-RAY DIFFRACTION",2.78,55.68,"VAPOR DIFFUSION, SITTING DROP",9.2,"20% PEG-3350, 0.2M dipotassium phosphate, pH 9.2, VAPOR DIFFUSION, SITTING DROP, temperature 290.0K",290,,"I5R","4J1R",190.37,"2.702","2.702","Crystal Structure of GSK3b in complex with inhibitor 15R","GSPGMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","4J1R"
"4J1Y",,"X-RAY DIFFRACTION",2.68,54.05,"VAPOR DIFFUSION, HANGING DROP",7.4,"18% PEG 3350, 0.2M potassium nitrate., pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.464545",,"4J1Y",87.53,"2.6645","2.6645","The X-ray crystal structure of human complement protease C1s zymogen","MPCPKEDTPNSVWEPAKAKYVFRDVVQITCLDGFEVVEGRVGATSFYSTCQSNGKWSNSKLKCQPVDCGIPESIENGKVEDPESTLFGSVIRYTCEEPYYYMENGGGGEYHCAGNGSWVNEVLGPELPKCVPVCGVPREPFEEKARAIGGSDADIKNFPWQVFFDNPWAGGALINEYWVLTAAHVVEGNREPTMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLEVPEGRTNFDNDIALVRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLISGWGRTEKRDRAVRLKAARLPVAPLRKCKEVKVEKPTADAEAYVFTPNMICAGGEKGMDSCKGDSGGAFAVQDPNDKTKFYAAGLVSWGPQCGTYGLYTRVKNYVDWIMKTMQENSTPRED","Homo sapiens","C1S","Complement C1s subcomponent","1","4J1Y"
"4J1Z",,"X-RAY DIFFRACTION",2.72,54.78,"vapour diffusion, hanging drop",8.5,"17% PEG 3350, 0.2M Ammonium sulphate, 0.1M Tris pH 8.5, vapour diffusion, hanging drop, temperature 277K",277,"10.1021/jm400211f",,"4J1Z",48.86,"2","2","Tankyrase 2 in complex with 4-chloro-1,2-dihydrophatalzin-one","GTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPE","Homo sapiens","PARP5B, TANK2, TNKL, TNKS2","Tankyrase-2","1","4J1Z"
"4J21",,"X-RAY DIFFRACTION",2.78,55.78,"vapour diffusion, hanging drop",8.5,"17% PEG 3350, 0.2M Ammonium sulphate, 0.1M Tris pH 8.5, vapour diffusion, hanging drop, temperature 277K",277,"10.1021/jm400211f","AJ6","4J21",24.54,"1.93","1.93","Tankyrase 2 in complex with 7-(4-amino-2-chlorophenyl)-4-methylquinolin-2(1H)-one","GTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPE","Homo sapiens","PARP5B, TANK2, TNKL, TNKS2","Tankyrase-2","1","4J21"
"4J22",,"X-RAY DIFFRACTION",2.74,55.03,"vapour diffusion, hanging drop",8.5,"17% PEG 3350, 0.2M Ammonium sulphate, 0.1M Tris pH 8.5, vapour diffusion, hanging drop, temperature 277K",277,"10.1021/jm400211f","AJ7","4J22",49.35,"2.12","2.12","Tankyrase 2 in complex with 3-chloro-4-(4-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-N-[2-(morpholin-4-yl)ethyl]benzamide","GTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPE","Homo sapiens","PARP5B, TANK2, TNKL, TNKS2","Tankyrase-2","1","4J22"
"4J24",,"X-RAY DIFFRACTION",2.49,50.68,"VAPOR DIFFUSION",4.5,"0.2M Magnesium acetate, 20%(w/v) PEG3350, pH 4.5, VAPOR DIFFUSION, temperature 277K",277,"10.1021/ja311748r","EST","4J24",118.27,"2.1","2.1","Estrogen Receptor in complex with proline-flanked LXXLL peptides","DALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVYDLLLEMLNAHVL","Homo sapiens","ESR2, ESTRB, NR3A2","Estrogen receptor beta","1","4J24"
,,,,,,,,,,,,,,,,"LTARHPLLLRHLLQNSPSD",,,"19-mer peptide","2","4J24"
"4J26",,"X-RAY DIFFRACTION",2.49,50.62,"VAPOR DIFFUSION",5,"10%-20% PEG6000, 0.6M-2M LiCl, 100mM Citric Acid, pH 5.0, VAPOR DIFFUSION, temperature 277K",277,"10.1021/ja311748r","EST","4J26",57.67,"2.3","2.3","Estrogen Receptor in complex with proline-flanked LXXLL peptides","DALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVYDLLLEMLNAHVL","Homo sapiens","ESR2, ESTRB, NR3A2","Estrogen receptor beta","1","4J26"
,,,,,,,,,,,,,,,,"HPLLMRLLHHPS",,,"12-mer Peptide","2","4J26"
"4J37",,"X-RAY DIFFRACTION",2.29,46.2,,6.5,"18% PEG8000, 0.1 M MES, 0.3 M AmSO4, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2013.05.014",,"4J37",38.24,"1.75","1.75","Crystal structure of the catalytic domain of human Pus1","GPGSEFEKPPKRKIVLLMAYSGKGYHGMQRNVGSSQFKTIEDDLVSALVRSGCIPENHGEDMRKMSFQRCARTDKGVSAAGQVVSLKVWLIDDILEKINSHLPSHIRILGLKRVTGGFNSKNRCDARTYCYLLPTFAFAHKDRDVQDETYRLSAETLQQVNRLLACYKGTHNFHNFTSQKGPQDPSACRYILEMYCEEPFVREGLEFAVIRVKGQSFMMHQIRKMVGLVVAIVKGYAPESVLERSWGTEKVDVPKAPGLGLVLERVHFEKYNQRFGNDGLHEPLDWAQEEGKVAAFKEEHIYPTIIGTERDERSMAQWLSTLPIHNFSATALTAGG","Homo sapiens","PUS1, PP8985","tRNA pseudouridine synthase A, mitochondrial","1","4J37"
"4J3I",,"X-RAY DIFFRACTION",2.15,42.79,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% (W/V) PEG 3350, 0.1 M BIS-TRIS, 0.2 M LITHIUM SULFATE, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1371/journal.pone.0083190","1K0","4J3I",15.62,"1.24","1.24","X-ray crystal structure of bromodomain complex to 1.24 A resolution","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4J3I"
"4J3J",,"X-RAY DIFFRACTION",3.17,61.18,"VAPOR DIFFUSION, HANGING DROP",,"28%(w/v) PEG1500, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201300104",,"4J3J",169.79,"3.2","3.2","Crystal Structure of DPP-IV with Compound C3","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","4J3J"
"4J3L",,"X-RAY DIFFRACTION",2.72,54.86,"vapour diffusion, hanging drop",8.5,"17% PEG 3350, 0.2M Ammonium sulphate, 0.1M Tris pH 8.5, vapour diffusion, hanging drop, temperature 277K",277,"10.1021/jm400211f","AJ5","4J3L",24.62,"2.09","2.09","Tankyrase 2 in complex with 3-chloro-N-(2-methoxyethyl)-4-(4-methyl-2-oxo-1,2-dihydroquinolin-7-yl)benzamide","GTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPE","Homo sapiens","PARP5B, TANK2, TNKL, TNKS2","Tankyrase-2","1","4J3L"
"4J3M",,"X-RAY DIFFRACTION",2.65,53.66,"vapour diffusion, hanging drop",8.5,"17% PEG 3350, 0.2M Ammonium sulphate, 0.1M Tris pH 8.5, vapour diffusion, hanging drop, temperature 277K",277,"10.1021/jm400211f","AJ8","4J3M",49.22,"1.9","1.9","Tankyrase 2 in complex with 3-chloro-4-(4-methyl-2-oxo-1,2-dihydroquinolin-7-yl)benzoic acid","GTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPE","Homo sapiens","PARP5B, TANK2, TNKL, TNKS2","Tankyrase-2","1","4J3M"
"4J3N",,"X-RAY DIFFRACTION",3.14,60.84,"VAPOR DIFFUSION, HANGING DROP",5.8,"0.1M MAGNESIUM ACETATE, 50MM 2-(N-MORPHOLINO)ETHANESULFONIC ACID PH 5.8, 22% 2-METHYL-2,4-PENTANEDIOL (MPT), VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K",277,"10.1093/nar/gkt828",,"4J3N",196.21,"2.3","2.3","Human Topoisomerase Iibeta in complex with DNA","MASWSHPQFEKGADDDDKVPDPTSVDSVKYSKIKGIPKLDDANDAGGKHSLECTLILTEGDSAKSLAVSGLGVIGRDRYGVFPLRGKILNVREASHKQIMENAEINNIIKIVGLQYKKSYDDAESLKTLRYGKIMIMTDQDQDGSHIKGLLINFIHHNWPSLLKHGFLEEFITPIVKASKNKQELSFYSIPEFDEWKKHIENQKAWKIKYYKGLGTSTAKEAKEYFADMERHRILFRYAGPEDDAAITLAFSKKKIDDRKEWLTNFMEDRRQRRLHGLPEQFLYGTATKHLTYNDFINKELILFSNSDNERSIPSLVDGFKPGQRKVLFTCFKRNDKREVKVAQLAGSVAEMSAYHHGEQALMMTIVNLAQNFVGSNNINLLQPIGQFGTRLHGGKDAASPRYIFTMLSTLARLLFPAVDDNLLKFLYDDNQRVEPEWYIPIIPMVLINGAEGIGTGWACKLPNYDAREIVNNVRRMLDGLDPHPMLPNYKNFKGTIQELGQNQYAVSGEIFVVDRNTVEITELPVRTWTQVYKEQVLEPMLNGTDKTPALISDYKEYHTDTTVKFVVKMTEEKLAQAEAAGLHKVFKLQTTLTCNSMVLFDHMGCLKKYETVQDILKEFFDLRLSYYGLRKEWLVGMLGAESTKLNNQARFILEKIQGKITIENRSKKDLIQMLVQRGYESDPVKAWKEAQEKAAEEDETQNQHDDSSSDSGTPSGPDFNYILNMSLWSLTKEKVEELIKQRDAKGREVNDLKRKSPSDLWKEDLAAFVEELDKVESQEREDGAPGFSSISAHHHHHHHHHH","Homo sapiens","TOP2B","DNA topoisomerase 2-beta","1","4J3N"
,,,,,,,,,,,,,,,,"AGCCGAGC",,,"DNA (5'-D(P*AP*GP*CP*CP*GP*AP*GP*C)-3')","2","4J3N"
,,,,,,,,,,,,,,,,"TGCAGCTCGGCT",,,"DNA (5'-D(P*TP*GP*CP*AP*GP*CP*TP*CP*GP*GP*CP*T)-3')","3","4J3N"
"4J3Y",,"X-RAY DIFFRACTION",1.9,35.1,"VAPOR DIFFUSION, SITTING DROP",7,"1.7-1.9 M ammonium sulfate, 125 mM bis-tris propane, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1107/S0907444913016284",,"4J3Y",20,"1.45","1.45","Crystal structure of XIAP-BIR2 domain","GTIYPRNPAMYSEEARLKSFQNWPDYAHLTPRELASAGLYYTGIGDQVQCFACGGKLKNWEPGDRAWSEHRRHFPNCFFVLGRNLN","Homo sapiens","API3, BIRC4, IAP3, U32974, XIAP","E3 ubiquitin-protein ligase XIAP","1","4J3Y"
"4J4J",,"X-RAY DIFFRACTION",4.57,73.06,"VAPOR DIFFUSION, HANGING DROP",9,"18% (w/v) PEG 8000, 0.1 M CHES pH 9.0, 25% (w/v) glucose, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/ncomms3593",,"4J4J",49.97,"3.1","3.1","Crystal structure of the APOBEC3F Vif binding domain","MAHHHHHHVDDDDKMLVPRGSENLYFQGSAMDPPTFTFNFNNEPWVRGRHETYLCFTMEVVKHHSPVSWKRGVFRNQVDPETHCHAERCFLSWFCDDILSPNTNYEVTWYTSWSPCPECAGEVAEFLARHSNVNLTIFTARLYYFWDTDYQEGLRSLSQEGASVEIMGYKDFKYCWENFVYNDDEPFKPWKGLKYNFLFLDSKLQEILE","Homo sapiens","APOBEC3F","DNA dC->dU-editing enzyme APOBEC-3F","1","4J4J"
"4J51",,"X-RAY DIFFRACTION",2.18,43.47,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.2 M sodium formate (pH 7.2) and 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm400248c","N75","4J51",77.27,"2.3","2.3","Cyrstal structure of protein tyrosine phosphatase Lyp catalytic domain complex with small molecular inhibitor L75N04","MGSSHHHHHHSSGLVPRGSHMASMDQREILQKFLDEAQSKKITKEEFANEFLKLKRQSTKYKADKTYPTTVAEKPKNIKKNRYKDILPYDYSRVELSLITSDEDSSYINANFIKGVYGPKAYIATQGPLSTTLLDFWRMIWEYSVLIIVMACMEYEMGKKKCERYWAEPGEMQLEFGPFSVSCEAEKRKSDYIIRTLKVKFNSETRTIYQFHYKNWPDHDVPSSIDPILELIWDVRCYQEDDSVPICIHCSAGCGRTGVICAIDYTWMLLKDGIIPENFSVFSLIREMRTQRPSLVQTQEQYELVYNAVLELFKRQMDVIRDKHSG","Homo sapiens","PTPN22, PTPN8","Tyrosine-protein phosphatase non-receptor type 22","1","4J51"
"4J52",,"X-RAY DIFFRACTION",2.92,57.82,"VAPOR DIFFUSION, SITTING DROP",7,"0.95 mM succinic acid, 1.7% PEG2000 MME, 0.4 mM zinc acetate, 100 mM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.02.083","1J3","4J52",34.43,"2.3","2.3","Crystal structure of PLK1 in complex with a pyrimidodiazepinone inhibitor","KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4J52"
"4J53",,"X-RAY DIFFRACTION",2.92,57.94,"VAPOR DIFFUSION, SITTING DROP",7,"0.95 mM succinic acid, 1.7% PEG2000 MME, 0.4 mM zinc acetate, 100 mM HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.02.083","1J4","4J53",34.44,"2.5","2.5","Crystal structure of PLK1 in complex with TAK-960","KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4J53"
"4J58",,"X-RAY DIFFRACTION",2.03,39.5,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, vapor diffusion, hanging drop, temperature 291.0K",291,"10.1038/ncomms12777",,"4J58",18.02,"1.28","1.28","Human Cyclophilin D Complexed with an Inhibitor","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","CYP3, PPIF","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","4J58"
"4J59",,"X-RAY DIFFRACTION",2.02,39.09,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, vapor diffusion, hanging drop, temperature 291.0K",291,"10.1038/ncomms12777",,"4J59",18.05,"1.92","1.92","Human Cyclophilin D Complexed with an Inhibitor","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","4J59"
"4J5A",,"X-RAY DIFFRACTION",2.03,39.49,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, vapor diffusion, hanging drop, temperature 291.0K",291,,,"4J5A",18.14,"1.58","1.58","Human Cyclophilin D Complexed with an Inhibitor","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","CYP3, PPIF","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","4J5A"
"4J5B",,"X-RAY DIFFRACTION",2.1,41.46,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, vapor diffusion, hanging drop, temperature 291.0K",291,"10.1038/ncomms12777",,"4J5B",18.05,"2.01","2.01","Human Cyclophilin D Complexed with an Inhibitor","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","CYP3, PPIF","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","4J5B"
"4J5C",,"X-RAY DIFFRACTION",2.04,39.57,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, vapor diffusion, hanging drop, temperature 291.0K",291,"10.1038/ncomms12777",,"4J5C",18.12,"1.03","1.03","Human Cyclophilin D Complexed with an Inhibitor","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","CYP3, PPIF","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","4J5C"
"4J5D",,"X-RAY DIFFRACTION",1.98,37.81,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, vapor diffusion, hanging drop, temperature 291.0K",291,"10.1038/ncomms12777",,"4J5D",18.08,"1.32","1.32","Human Cyclophilin D Complexed with an Inhibitor","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","CYP3, PPIF","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","4J5D"
"4J5E",,"X-RAY DIFFRACTION",2.02,39.19,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, vapor diffusion, hanging drop, temperature 291.0K",291,"10.1038/ncomms12777",,"4J5E",18.03,"0.99","0.99","Human Cyclophilin D Complexed with an Inhibitor","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","CYP3, PPIF","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","4J5E"
"4J5L",,"X-RAY DIFFRACTION",2.23,44.72,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M bis-tris, 22% PEG 3350, 0.2M ammonium sulfate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M113.507202",,"4J5L",93.67,"2.2","2.2","Structure of the Cargo Binding Domain from Human Myosin Va","MENISPGQIIDEPIRPVNIPRKEKDFQGMLEYKKEDEQKLVKNLILELKPRGVAVNLIPGLPAYILFMCVRHADYLNDDQKVRSLLTSTINSIKKVLKKRGDDFETVSFWLSNTCRFLHCLKQYSGEEGFMKHNTSRQNEHCLTNFDLAEYRQVLSDLAIQIYQQLVRVLENILQPMIVSGMLEHETIQGVSGVKPTGLRKRTSSIADEGTYTLDSILRQLNSFHSVMCQHGMDPELIKQVVKQMFYIIGAITLNNLLLRKDMCSWSKGMQIRYNVSQLEEWLRDKNLMNSGAKETLEPLIQAAQLLQVKKKTDDDAEAICSMCNALTTAQIVKVLNLYTPVNEFEERVSVSFIRTIQMRLRDRKDSPQLLMDAKHIFPVTFPFNPSSLALETIQIPASLGLGFISRV","Homo sapiens","MYH12, MYO5A","Unconventional myosin-Va","1","4J5L"
"4J5M",,"X-RAY DIFFRACTION",2.25,45.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 0.2M sodium nitrate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M113.507202",,"4J5M",45.63,"2.07","2.07","Structure of the Cargo Binding Domain from Human Myosin Vb","LNRQVTVQRKEKDFQGMLEYHKEDEALLIRNLVTDLKPQMLSGTVPCLPAYILYMCIRHADYTNDDLKVHSLLTSTINGIKKVLKKHNDDFEMTSFWLSNTCRLLHCLKQYSGDEGFMTQNTAKQNEHCLKNFDLTEYRQVLSDLSIQIYQQLIKIAEGVLQPMIVSAMLENESIQGLSGVKPTGYRKRSSSMADGDNSYCLEAIIRQMNAFHTVMCDQGLDPEIILQVFKQLFYMINAVTLNNLLLRKDVCSWSTGMQLRYNISQLEEWLRGRNLHQSGAVQTMEPLIQAAQLLQLKKKTQEDAEAICSLCTSLSTQQIVKILNLYTPLNEFEERVTVAFIRTIQAQLQERNDPQQLLLDAKHMFPVLFPFNPSSLTMDSIHIPACLNLEFLNEV","Homo sapiens","KIAA1119, MYO5B","Unconventional myosin-Vb","1","4J5M"
"4J5Q",,"X-RAY DIFFRACTION",2.5,50.71,"VAPOR DIFFUSION",5.6,"100mM sodium citrate, 20% isopropanol, 20% PEG 4000 , pH 5.6, VAPOR DIFFUSION, temperature 277K",277,"10.1038/emboj.2013.51",,"4J5Q",16.45,"1.35","1.35","TARG1 (C6orf130), Terminal ADP-ribose Glycohydrolase 1, apo structure","EDPEGSRITYVKGDLFACPKTDSLAHCISEDCRMGAGIAVLFKKKFGGVQELLNQQKKSGEVAVLKRDGRYIYYLITKKRASHKPTYENLQKSLEAMKSHCLKNGVTDLSMPRIGCGLDRLQWENVSAMIEEVFEATDIKITVYTL","Homo sapiens","C6orf130, OARD1, TARG1","O-acetyl-ADP-ribose deacetylase 1","1","4J5Q"
"4J5R",,"X-RAY DIFFRACTION",2.29,46.18,"VAPOR DIFFUSION, SITTING DROP",8,"100mM Imidazole, 20% PEG3350, 200 mM NaCl , pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/emboj.2013.51",,"4J5R",34.4,"1.25","1.25","TARG1 (C6orf130), Terminal ADP-ribose Glycohydrolase 1 bound to ADP-HPD","GSHMGSRITYVKGDLFACPKTDSLAHCISEDCRMGAGIAVLFKKKFGGVQELLNQQKKSGEVAVLKRDGRYIYYLITKKRASHKPTYENLQKSLEAMKSHCLKNGVTDLSMPRIGCGLDRLQWENVSAMIEEVFEATDIKITVYTL","Homo sapiens","OARD1, C6orf130, TARG1","O-acetyl-ADP-ribose deacetylase 1","1","4J5R"
"4J5S",,"X-RAY DIFFRACTION",2.31,46.86,"VAPOR DIFFUSION, SITTING DROP",8,"100mM Imidazole, 20% PEG3350, 200 mM NaCl , pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/emboj.2013.51",,"4J5S",69.21,"1.55","1.55","TARG1 (C6orf130), Terminal ADP-ribose Glycohydrolase 1 ADP-ribose complex","GSHMGSRITYVKGDLFACPKTDSLAHCISEDCRMGAGIAVLFKKKFGGVQELLNQQKKSGEVAVLKRDGRYIYYLITKKRASHKPTYENLQKSLEAMKSHCLKNGVTDLSMPRIGCGLDRLQWENVSAMIEEVFEATDIKITVYTL","Homo sapiens","OARD1, C6orf130, TARG1","O-acetyl-ADP-ribose deacetylase 1","1","4J5S"
"4J6I",,"X-RAY DIFFRACTION",2.31,46.82,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3350, 0.2M NH4SO4, 0.1M Tris-HCl 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.bmcl.2013.02.102","1JV","4J6I",111.22,"2.9","2.9","Discovery of thiazolobenzoxepin PI3-kinase inhibitors that spare the PI3-kinase beta isoform","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","p110 gamma, PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4J6I"
"4J6J",,"X-RAY DIFFRACTION",2.58,52.25,"VAPOR DIFFUSION, SITTING DROP",4.7,"16 % (w/v) PEG 6,000, 2 % (v/v) 1,6-hexanediol, 0.05 M ammonium sulfate and 0.1 M sodium acetate pH 4.7 , VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.molimm.2013.07.005",,"4J6J",64.85,"1.9","1.9","Crystal structure of calcium2+-free wild-type CD23 lectin domain (crystal form A)","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","CD23A, CLEC4J, FCE2, FCER2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4J6J"
"4J6K",,"X-RAY DIFFRACTION",2.29,46.32,"VAPOR DIFFUSION, SITTING DROP",4.5,"18 % (w/v) PEG 6,000, 2 % (v/v) 1,6-hexanediol, 0.05 M ammonium sulfate and 0.1 M sodium acetate pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.molimm.2013.07.005",,"4J6K",129.7,"2.3","2.3","Crystal structure of calcium2+-free wild-type CD23 lectin domain (crystal form B)","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","CD23A, CLEC4J, FCE2, FCER2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4J6K"
"4J6L",,"X-RAY DIFFRACTION",2.79,55.99,"VAPOR DIFFUSION, SITTING DROP",5.5,"25 % (w/v) PEG 4,000, 0.15 M ammonium sulfate and 0.1 M MES pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.molimm.2013.07.005",,"4J6L",129.32,"3.15","3.15","Crystal structure of calcium2+-free wild-type CD23 lectin domain (crystal form C)","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","CD23A, CLEC4J, FCE2, FCER2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4J6L"
"4J6M",,"X-RAY DIFFRACTION",2.8,56.04,"VAPOR DIFFUSION, SITTING DROP",5.5,"22.5 % (w/v) PEG 3,350, 0.2 M ammonium sulfate and 0.1 M MES pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.molimm.2013.07.005",,"4J6M",129.7,"2.48","2.48","Crystal structure of calcium2+-free wild-type CD23 lectin domain (crystal form D)","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","CD23A, CLEC4J, FCE2, FCER2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4J6M"
"4J6N",,"X-RAY DIFFRACTION",2.07,40.61,"VAPOR DIFFUSION, SITTING DROP",4.25,"30 % (w/v) PEG 1,500 and 0.1 M Malic acid: MES: Tris (MMT) buffer pH 4.25, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.molimm.2013.07.005",,"4J6N",32.33,"2.85","2.85","Crystal structure of calcium2+-free wild-type CD23 lectin domain (crystal form E)","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","CD23A, CLEC4J, FCE2, FCER2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4J6N"
"4J6P",,"X-RAY DIFFRACTION",2.21,44.24,"VAPOR DIFFUSION, SITTING DROP",4.75,"22.5 % (w/v) PEG 4,000 and 0.1 M sodium citrate pH 4.75, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.molimm.2013.07.005",,"4J6P",64.66,"1.9","1.9","Crystal structure of calcium2+-free wild-type CD23 lectin domain (crystal form F)","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","CD23A, CLEC4J, FCE2, FCER2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4J6P"
"4J6Q",,"X-RAY DIFFRACTION",2.1,41.51,"VAPOR DIFFUSION, SITTING DROP",4.5,"3.7 M NaCl and 0.1 M citric acid pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.molimm.2013.07.005",,"4J6Q",16.16,"2.539","2.539","Crystal structure of calcium2+-free wild-type CD23 lectin domain (crystal form G)","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRNLDLKGEFIWVDGSHVDYSNWAPGEPTSRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","CD23A, CLEC4J, FCE2, FCER2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor","1","4J6Q"
"4J71",,"X-RAY DIFFRACTION",2.92,57.84,"VAPOR DIFFUSION, SITTING DROP",7.2,"20% PEG-3350, 0.2M Na Formate, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 290.0K",290,,"1JX, CL","4J71",95.01,"2.31","2.31","Crystal Structure of GSK3b in complex with inhibitor 1R","GSPGMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","4J71"
"4J7T",,"X-RAY DIFFRACTION",5.71,78.47,"VAPOR DIFFUSION",6.4,"1.9 M NH4SO4, 0.2 M NaCl, 0.1 M Na-cacodylate, pH 6.4, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M113.534628",,"4J7T",18.01,"3.203","3.203","Human LTC4 synthase in complex with product analogs - implications for enzyme catalysis","MHHHHHHKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWA","Homo sapiens","LTC4S","Leukotriene C4 synthase","1","4J7T"
"4J7U",,"X-RAY DIFFRACTION",4.52,72.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.70 M ammonium sulphate, 0.1 M HEPES, 2 % w/v PEG 1000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1126/science.1232972","YTZ","4J7U",130.34,"2.44","2.44","Crystal structure of human sepiapterin reductase in complex with sulfathiazole","MSYYHHHHHHLESTSLYKKAGLEGVRTMEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK","Homo sapiens","SPR","Sepiapterin reductase","1","4J7U"
"4J7X",,"X-RAY DIFFRACTION",4.63,73.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.70 M ammonium sulphate, 0.1 M HEPES, 2 % w/v PEG 1000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4J7X",131.51,"2.6","2.6","Crystal structure of human sepiapterin reductase in complex with sulfasalazine","MSYYHHHHHHLESTSLYKKAGLEGVRTMEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK","Homo sapiens","SPR","Sepiapterin reductase","1","4J7X"
"4J7Y",,"X-RAY DIFFRACTION",5.8,78.81,"VAPOR DIFFUSION",6.2,"1.8 M NH4SO4, 0.2 M NaCl, 0.1 M Na-cacadylate, pH 6.2, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M113.534628",,"4J7Y",18.02,"2.901","2.901","Human LTC4 synthase in complex with product analogs - implications for enzyme catalysis","MHHHHHHKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWA","Homo sapiens","LTC4S","Leukotriene C4 synthase","1","4J7Y"
"4J8M",,"X-RAY DIFFRACTION",2.22,44.51,"VAPOR DIFFUSION, HANGING DROP",6,"20 mg/ml Aurora A protein, 1 mM CD532, 20% (w/v) PEG8000, 0.2 M magnesium acetate tetrahydrate, 0.1 M sodium cacodylate trihydrate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.ccr.2014.07.015","CJ5","4J8M",33.34,"1.853","1.853","Aurora A in complex with CD532","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AIK, AIRK1, ARK1, AURA, AURKA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4J8M"
"4J8N",,"X-RAY DIFFRACTION",2.69,54.26,"Hanging drop vapor diffusion",7,"20 mg/ml Aurora A protein, 10% Tacsimate, 20% (w/v) PEG3350, pH 7.0, Hanging drop vapor diffusion, temperature 298K",298,"10.1016/j.ccr.2014.07.015",,"4J8N",129.44,"3.135","3.135","Aurora A Kinase Apo","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AIK, AIRK1, ARK1, AURA, AURKA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4J8N"
"4J8Z",,"X-RAY DIFFRACTION",2.36,47.89,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG3350, 17% isopropanol, 0.1M tris-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1107/S0907444913012687",,"4J8Z",46.73,"2.42","2.42","Crystal Structure of the Human SPOP BTB Domain","GPLGSNISGQNTMNMVKVPECRLADELGGLWENSRFTDCCLCVAGQEFQAHKAILAARSPVFSAMFEHEMEESKKNRVEINDVEPEVFKEMMCFIYTGKAPNLDKMADDLLAAADKYALERLKVMCEDALCSNLSVENAAEILILADLHSADQLKTQAVDFINYHASDVLETSGWKSMVVSHPHLVAEAERSLASAQCPFLGPPRKRLKQS","Homo sapiens","SPOP","Speckle-type POZ protein","1","4J8Z"
"4J95",,"X-RAY DIFFRACTION",2.61,52.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 25% PEG 4000, 200mM (NH4)2SO4, 3% v/v CH3CH2OH, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.celrep.2013.06.025",,"4J95",151.08,"2.3767","2.3767","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","BEK, FGFR2, KGFR, KSAM","Fibroblast growth factor receptor 2","1","4J95"
"4J96",,"X-RAY DIFFRACTION",2.85,56.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 25% PEG 4000, 200mM (NH4)2SO4, 100mM  HOC(COONa)(CH2COONa)2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.celrep.2013.06.025",,"4J96",75.42,"2.2972","2.2972","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKMTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","BEK, FGFR2, KGFR, KSAM","Fibroblast growth factor receptor 2","1","4J96"
"4J97",,"X-RAY DIFFRACTION",2.3,46.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 25% PEG 4000, 200mM (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.celrep.2013.06.025",,"4J97",150.94,"2.5482","2.5482","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKETTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","BEK, FGFR2, KGFR, KSAM","Fibroblast growth factor receptor 2","1","4J97"
"4J98",,"X-RAY DIFFRACTION",2.88,57.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 25% PEG 4000, 200mM (NH4)2SO4, 100mM HOC(COONa)(CH2COONa)2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.celrep.2013.06.025",,"4J98",75.2,"2.3067","2.3067","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Mutation.","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKQTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","BEK, FGFR2, KGFR, KSAM","Fibroblast growth factor receptor 2","1","4J98"
"4J99",,"X-RAY DIFFRACTION",2.64,53.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 25% PEG 4000, 200mM (NH4)2SO4, 100mM KCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.celrep.2013.06.025",,"4J99",151.1,"1.8474","1.8474","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKTTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","BEK, FGFR2, KGFR, KSAM","Fibroblast growth factor receptor 2","1","4J99"
"4J9B",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, HANGING DROP",5.6,"1.6 M AMS, 5% PEG 200,10% Glycerol, 40 mM LiSO4, 0.1 M AcONa , pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4J9B",7.2,"1.702","1.702","Crystal structure of the Abl-SH3 domain H59Q-N96T mutant","MENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNQTGEWCEAQTKNGQGWVPSNYITPVNS","Homo sapiens","ABL, ABL1, JTK7","Tyrosine-protein kinase ABL1","1","4J9B"
"4J9C",,"X-RAY DIFFRACTION",2.01,38.69,"VAPOR DIFFUSION, HANGING DROP",5.6,"1.5 M AMS, 5% PEG 200, 20 mM LiCl, 0.1 M AcONa , pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4J9C",8.31,"1.051","1.051","Crystal structure of the Abl-SH3 domain H59Q-N96T mutant complexed with the designed high-affinity peptide ligand P17","MENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNQTGEWCEAQTKNGQGWVPSNYITPVNS","Homo sapiens","ABL, ABL1, JTK7","Tyrosine-protein kinase ABL1","1","4J9C"
,,,,,,,,,,,,,,,,"XAPTYSPPLPP",,,"P17","2","4J9C"
"4J9D",,"X-RAY DIFFRACTION",2.01,38.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"2M Ammonium sulphate, 5% PEG200, 0.05M MgCl2, 0.1M Mes , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4J9D",24.22,"1.5","1.5","Crystal structure of the N114A mutant of the Abl-SH3 domain complexed with the high affinity peptide P0","MENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSAYITPVNS","Homo sapiens","ABL, ABL1, JTK7","Tyrosine-protein kinase ABL1","1","4J9D"
,,,,,,,,,,,,,,,,"XAPTYPPPLPP",,,"P0","2","4J9D"
"4J9E",,"X-RAY DIFFRACTION",2.01,38.7,"VAPOR DIFFUSION, HANGING DROP",7,"2M Ammonium sulphate, 5% PEG300 , 0.05M LiCl, 0.1M Hepes  , pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4J9E",24.19,"1.4","1.4","Crystal structure of the N114A mutant of the Abl-SH3 domain complexed with the high affinity peptide P17","MENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSAYITPVNS","Homo sapiens","ABL, ABL1, JTK7","Tyrosine-protein kinase ABL1","1","4J9E"
,,,,,,,,,,,,,,,,"XAPTYSPPLPP",,,"P17","2","4J9E"
"4J9F",,"X-RAY DIFFRACTION",2.01,38.73,,7,"2M Ammonium sulphate, 5% PEG300, 0.05M Litium Formate, 10 % glycerol, 0.1M MOPS , pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4J9F",24.44,"1.094","1.094","Crystal structure of the Abl-SH3 domain complexed with the high affinity peptide P0","MENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNS","Homo sapiens","ABL, ABL1, JTK7","Tyrosine-protein kinase ABL1","1","4J9F"
,,,,,,,,,,,,,,,,"XAPTYPPPLPP",,,"P0","2","4J9F"
"4J9G",,"X-RAY DIFFRACTION",2.01,38.78,"VAPOR DIFFUSION, HANGING DROP",7,"2M ammonium sulphate, 50 mM Litium Formiate, 10% glicerol, and 0.1 M MOPS , pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4J9G",24.39,"1.8","1.8","Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P7 at pH7","MENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNS","Homo sapiens","ABL, ABL1, JTK7","Tyrosine-protein kinase ABL1","1","4J9G"
,,,,,,,,,,,,,,,,"XAPTYPPPPPP",,,"P7","2","4J9G"
"4J9H",,"X-RAY DIFFRACTION",2.02,39.16,"VAPOR DIFFUSION, HANGING DROP",8,"2M ammonium sulphate, 10% glicerol and 0.1 M Tris-HCl  , pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,,,"4J9H",48.51,"1.7","1.7","Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P7 at pH 8","MENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNS","Homo sapiens","ABL, ABL1, JTK7","Tyrosine-protein kinase ABL1","1","4J9H"
,,,,,,,,,,,,,,,,"XAPTYPPPPPP",,,"P7","2","4J9H"
"4J9I",,"X-RAY DIFFRACTION",2.11,41.83,,7,"2.8 M ammonium sulphate, 5% PEG300, 0.1 M LiCl, 0.1 M Hepes, capillary, pH 7, LIQUID DIFFUSION, temperature 298K",298,,,"4J9I",24.41,"2.2","2.2","Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P17","MENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNS","Homo sapiens","ABL, ABL1, JTK7","Tyrosine-protein kinase ABL1","1","4J9I"
,,,,,,,,,,,,,,,,"XAPTYSPPLPP",,,"P17","2","4J9I"
"4J9K",,"X-RAY DIFFRACTION",2.07,40.64,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG2K-MME, KCl, MES, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1303126110",,"4J9K",56.9,"2.03","2.03","Human DNA polymerase eta-DNA ternary complex: misincorporation G opposite T after a T at the primer 3' end (TA/G)","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4J9K"
,,,,,,,,,,,,,,,,"TCATTATGACGCT",,,"DNA","2","4J9K"
,,,,,,,,,,,,,,,,"TAGCGTCAT",,,"DNA","3","4J9K"
"4J9L",,"X-RAY DIFFRACTION",2.08,40.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG2K-MME, KCl, MES, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1303126110",,"4J9L",55.91,"1.85","1.85","Human DNA polymerase eta-DNA ternary complex: misincorporation G opposite T after a C at the primer 3' end (CA/G)","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4J9L"
,,,,,,,,,,,,,,,,"TACTGATGACGT",,,"DNA","2","4J9L"
,,,,,,,,,,,,,,,,"TACGTCATC",,,"DNA","3","4J9L"
"4J9M",,"X-RAY DIFFRACTION",2.09,41.03,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG2K-MME, KCl, MES, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1303126110",,"4J9M",55.75,"2.25","2.25","Human DNA polymerase eta-DNA ternary complex: misincorporation G opposite T after an A at the primer 3' end (AA/G)","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4J9M"
,,,,,,,,,,,,,,,,"TACTTATGACGT",,,"DNA","2","4J9M"
,,,,,,,,,,,,,,,,"TACGTCATA",,,"DNA","3","4J9M"
"4J9N",,"X-RAY DIFFRACTION",2.09,41.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG2K-MME, KCl, MES, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1303126110",,"4J9N",55.73,"1.956","1.956","Human DNA polymerase eta-DNA ternary complex: misincorporation G opposite T after a G at the primer 3' end (GA/G)","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4J9N"
,,,,,,,,,,,,,,,,"CATTCTGACGCT",,,"DNA","2","4J9N"
,,,,,,,,,,,,,,,,"TAGCGTCAG",,,"DNA","3","4J9N"
"4J9O",,"X-RAY DIFFRACTION",2.12,41.97,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG2K-MME, KCl, MES, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1303126110",,"4J9O",55.69,"2.597","2.597","Human DNA polymerase eta-DNA ternary complex: primer extension after a T:G mispair","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4J9O"
,,,,,,,,,,,,,,,,"TACTTATGACGT",,,"DNA (5'-D(*T*AP*CP*TP*TP*AP*TP*GP*AP*CP*GP*T)-3')","2","4J9O"
,,,,,,,,,,,,,,,,"TACGTCATG",,,"DNA (5'-D(*T*AP*CP*GP*TP*CP*AP*TP*G)-3')","3","4J9O"
"4J9P",,"X-RAY DIFFRACTION",2.08,40.83,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG2K-MME, KCl, MES, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1303126110",,"4J9P",55.39,"2.3","2.3","Human DNA polymerase eta-DNA postinsertion binary complex with TA base pair","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4J9P"
,,,,,,,,,,,,,,,,"CATTATGACGCT",,,"DNA (5'-D(*C*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4J9P"
,,,,,,,,,,,,,,,,"TAGCGTCATA",,,"DNA (5'-D(*TP*AP*GP*CP*GP*TP*CP*AP*TP*A)-3')","3","4J9P"
"4J9Q",,"X-RAY DIFFRACTION",2.05,40.12,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG2K-MME, KCl, MES, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1303126110",,"4J9Q",55.83,"1.96","1.96","Human DNA polymerase eta-DNA postinsertion binary complex with TG mispair","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4J9Q"
,,,,,,,,,,,,,,,,"TCATTATGACGCT",,,"DNA (5'-D(*TP*C*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4J9Q"
,,,,,,,,,,,,,,,,"TAGCGTCATG",,,"DNA (5'-D(*TP*AP*GP*CP*GP*TP*CP*AP*TP*G)-3')","3","4J9Q"
"4J9R",,"X-RAY DIFFRACTION",2.08,40.83,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG2K-MME, KCl, MES, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1303126110",,"4J9R",55.09,"2.35","2.35","Human DNA polymerase eta-DNA translocated binary complex with TG mispair","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4J9R"
,,,,,,,,,,,,,,,,"TACTTATGACGT",,,"DNA (5'-D(*T*AP*CP*TP*TP*AP*TP*GP*AP*CP*GP*T)-3')","2","4J9R"
,,,,,,,,,,,,,,,,"TACGTCATG",,,"DNA (5'-D(P*TP*AP*CP*GP*TP*CP*AP*TP*G)-3')","3","4J9R"
"4J9S",,"X-RAY DIFFRACTION",2.08,40.83,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG2K-MME, KCl, MES, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1303126110",,"4J9S",55.18,"1.95","1.95","Human DNA polymerase eta-DNA translocated binary complex: with TA base pair","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4J9S"
,,,,,,,,,,,,,,,,"TATTTATGACGT",,,"DNA (5'-D(*T*AP*TP*TP*TP*AP*TP*GP*AP*CP*GP*T)-3')","2","4J9S"
,,,,,,,,,,,,,,,,"TACGTCATA",,,"DNA (5'-D(*TP*AP*CP*GP*TP*CP*AP*TP*A)-3')","3","4J9S"
"4JA1",,"X-RAY DIFFRACTION",2.02,39.11,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein 7-15mg/ml, 25-30% (w/v) PEG 8000, 10 mM CaCl2, 100 mM TRIS, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1039/c3cc41278d","NGH","4JA1",40.38,"1.96","1.96","Structure of MMP3 complexed with a platinum-based inhibitor","FRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGPPPDSPET","Homo sapiens","MMP3, STMY1","Stromelysin-1","1","4JA1"
"4JA8",,"X-RAY DIFFRACTION",2.34,47.36,"VAPOR DIFFUSION",8.5,"Crystals of the IDH2/R140Q:AGI-6780 complex were grown by hanging drop vapor diffusion at 18C after mixing the IDH2/R140Q:AGI-6780 sample with a 2 to 1 volume of protein to reservoir solution.  Reservoir solution was comprised of 0.2 M Calcium chloride, 0.1 M TRIS (pH 8.5) and 25 % w/v PEG 4000.  Seeding methods were used to grow diffraction quality crystals, VAPOR DIFFUSION, temperature 298K",298,"10.1126/science.1234769","1K9","4JA8",96.69,"1.55","1.55","Complex of Mitochondrial Isocitrate Dehydrogenase R140Q Mutant with AGI-6780 Inhibitor","DKRIKVAKPVVEMDGDEMTRIIWQFIKEKLILPHVDIQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIQNILGGTVFREPIICKNIPRLVPGWTKPITIGRHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHSCFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGFGSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKDLAGCIHGLSNVKLNEHFLNTTDFLDTIKSNLDRALGRQHHHH","Homo sapiens","IDH2","Isocitrate dehydrogenase [NADP], mitochondrial","1","4JA8"
"4JAA",,"X-RAY DIFFRACTION",3.2,61.56,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.6M AMMONIUM SULPHATE, 6% PEG 400, 0.1M HEPES PH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"OGA","4JAA",42.96,"2.39","2.39","Factor inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)LEU peptide","MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","Hypoxia-inducible factor 1-alpha inhibitor","1","4JAA"
,,,,,,,,,,,,,,,,"HLEVVKLLLEHGADVLAQDK",,,"CONSENSUS ANKYRIN REPEAT DOMAIN-(d)LEU","2","4JAA"
"4JAI",,"X-RAY DIFFRACTION",2.57,52.18,"VAPOR DIFFUSION, SITTING DROP",9,"20% PEG MME 550, 0.1 M Bicine, 0.1 M NaCl , pH 9, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.03.008","XU2","4JAI",33.45,"3.2","3.2","Crystal Structure of Aurora Kinase A in complex with N-{4-[(6-oxo-5,6-dihydrobenzo[c][1,8]naphthyridin-1-yl)amino]phenyl}benzamide","MHHHHHHGGESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4JAI"
"4JAJ",,"X-RAY DIFFRACTION",2.48,50.37,"VAPOR DIFFUSION, SITTING DROP",9,"20% PEG MME 550, 0.1 M Bicine pH 9.0, 0.1 M NaCl , VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.03.008","XU1","4JAJ",33.24,"2.7","2.7","Crystal Structure of Aurora Kinase A in complex with BENZO[C][1,8]NAPHTHYRIDIN-6(5H)-ONE","MHHHHHHGGESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4JAJ"
"4JAM",,"X-RAY DIFFRACTION",2.23,44.81,"VAPOR DIFFUSION, HANGING DROP",4.5,"170 mM ammonium sulfate, 25.5 % PEG 4000, 15% Glycerol, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature12053",,"4JAM",95.24,"1.65","1.65","Crystal structure of broadly neutralizing anti-hiv-1 antibody ch103","QVQLQESGPGVVKSSETLSLTCTVSGGSMGGTYWSWLRLSPGKGLEWIGYIFHTGETNYSPSLKGRVSISVDTSEDQFSLRLRSVTAADTAVYFCASLPRGQLVNAYFRNWGRGSLVSVTAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103","1","4JAM"
,,,,,,,,,,,,,,,,"YELTQPPSVSVSPGQTATITCSGASTNVCWYQVKPGQSPEVVIFENYKRPSGIPDRFSGSKSGSTATLTIRGTQAIDEADYYCQVWDSFSTFVFGSGTQVTVLRQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103","2","4JAM"
"4JAZ",,"X-RAY DIFFRACTION",2.65,53.62,"VAPOR DIFFUSION, SITTING DROP",8,"0.8M NA CITRATE, 0.15M TRIS, PH8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/cbic.201300754",,"4JAZ",65.62,"2.85","2.85","Crystal structure of the complex between PPARgamma LBD and trans-resveratrol","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4JAZ"
"4JBO",,"X-RAY DIFFRACTION",2.49,50.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"22% PEG 400, 0.1M ammonia sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1220523110","WPH","4JBO",32.9,"2.493","2.493","Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4JBO"
"4JBP",,"X-RAY DIFFRACTION",2.54,51.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"22% PEG 400, 0.1M ammonia sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1220523110","YPH","4JBP",32.95,"2.45","2.45","Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora Kinase A","1","4JBP"
"4JBQ",,"X-RAY DIFFRACTION",2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"22% PEG 400, 0.1M ammonia sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1220523110","VX6","4JBQ",32.82,"2.3","2.3","Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora Kinase A","1","4JBQ"
"4JBS",,"X-RAY DIFFRACTION",2.92,57.91,"VAPOR DIFFUSION, SITTING DROP",6.5,"10% PEG 8000, 20% ethylene glycol, 69 mM MES, 31 mM imidazole.Drops incubated at 277 K before being transferred to 289 K, pH 6.5, VAPOR DIFFUSION, SITTING DROP",289,"10.1073/pnas.1309781110","P52","4JBS",227.48,"2.789","2.789","Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 in complex with PHOSPHINIC PSEUDOTRIPEPTIDE inhibitor.","MVHSSAMVNSHRKPMFNIHRGFYCLTAILPQICICSQFSVPSSYHFTEDPGAFPVATNGERFPWQELRLPSVVIPLHYDLFVHPNLTSLDFVASEKIEVLVSNATQFIILHSKDLEITNATLQSEEDSRYMKPGKELKVLSYPAHEQIALLVPEKLTPHLKYYVAMDFQAKLGDGFEGFYKSTYRTLGGETRILAVTDFEPTQARMAFPCFDEPLFKANFSIKIRRESRHIALSNMPKVKTIELEGGLLEDHFETTVKMSTYLVAYIVCDFHSLSGFTSSGVKVSIYASPDKRNQTHYALQASLKLLDFYEKYFDIYYPLSKLDLIAIPDFAPGAMENWGLITYRETSLLFDPKTSSASDKLWVTRVIAHELAHQWFGNLVTMEWWNDIWLKEGFAKYMELIAVNATYPELQFDDYFLNVCFEVITKDSLNSSRPISKPAETPTQIQEMFDEVSYNKGACILNMLKDFLGEEKFQKGIIQYLKKFSYRNAKNDDLWSSLSNSCLESDFTSGGVCHSDPKMTSNMLAFLGENAEVKEMMTTWTLQKGIPLLVVKQDGCSLRLQQERFLQGVFQEDPEWRALQERYLWHIPLTYSTSSSNVIHRHILKSKTDTLDLPEKTSWVKFNVDSNGYYIVHYEGHGWDQLITQLNQNHTLLRPKDRVGLIHDVFQLVGAGRLTLDKALDMTYYLQHETSSPALLEGLSYLESFYHMMDRRNISDISENLKRYLLQYFKPVIDRQSWSDKGSVWDRMLRSALLKLACDLNHAPCIQKAAELFSQWMESSGKLNIPTDVLKIVYSVGAQTTAGWNYLLEQYELSMSSAEQNKILYALSTSKHQEKLLKLIELGMEGKVIKTQNLAALLHAIARRPKGQQLAWDFVRENWTHLLKKFDLGSYDIRMIISGTTAHFSSKDKLQEVKLFFESLEAQGSHLDIFQTVLETITKNIKWLEKNLPTLRTWLMVNTRHHHHHH","Homo sapiens","ERAP2, LRAP","Endoplasmic reticulum aminopeptidase 2","1","4JBS"
"4JC1",,"X-RAY DIFFRACTION",2.11,41.59,"VAPOR DIFFUSION, HANGING DROP",7,"Hanging drops consisting of 
equal volumes of protein solution (100 mM lactose in PBS pH 7.5 
supplemented with 2 mM CaCl2 and a protein concentration of 
10 mg ml 
 1) and reservoir solution [100 mM Tris HCl, 
31%(w/v) PEG 6000, 100 mM MgCl2 and 8 mM  -mercaptoethanol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/cbic.201300245",,"4JC1",16.59,"1.5","1.5","Galectin-3 carbohydrate recognition domain in complex with thiodigalactoside","GAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4JC1"
"4JC7",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION",6.4,"2.0 M NH4SO4, 0.2 M NaCl, 0.1 M Na-cacadylate, pH 6.4, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M113.534628",,"4JC7",19.5,"2.7","2.7","Human LTC4 synthase in complex with product analogs - implications for enzyme catalysis","MHHHHHHKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALALLVALAALGLLAHFLPAALRAALLGRLRTLLPWA","Homo sapiens","LTC4S","Leukotriene C4 synthase","1","4JC7"
"4JCK",,"X-RAY DIFFRACTION",2.02,39.09,"VAPOR DIFFUSION, HANGING DROP",7,"Reservoir solution (100 mM MgCl2, 100 mM Tris-HCl pH 7.0, 31% w/v polyethylene glycol 6000 and 5 mM   -mercaptoethanol) and a 4   L drop consisting of 2   L 70 mg mL-1 apo galectin-3 CRD protein in PBS and 2   L reservoir solution, supplemented with 100 mM TDT. , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/cbic.201300245",,"4JCK",16.45,"1.15","1.15","Galectin-3 carbohydrate recognition domain in complex with thioditaloside","GAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4JCK"
"4JCZ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION",6.4,"2.0 M NH4SO4, 0.2 M NaCl, 0.1 M Na-cacadylate, pH 6.4, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M113.534628",,"4JCZ",19.5,"2.75","2.75","Human LTC4 synthase in complex with product analogs - implications for enzyme catalysis","MHHHHHHKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWA","Homo sapiens","LTC4S","Leukotriene C4 synthase","1","4JCZ"
"4JDH",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 1.5 - 2.0 M Na acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.molcel.2013.11.013",,"4JDH",40.94,"2","2","Crystal structure of Serine/threonine-protein kinase PAK 4 in complex with Paktide T peptide substrate","MGSSHHHHHHSSGLVPRGSHMENLYFQGARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","KIAA1142, PAK4","Serine/threonine-protein kinase PAK 4","1","4JDH"
,,,,,,,,,,,,,,,,"GGRRRRRTWYFGGGK",,,"Paktide T","2","4JDH"
"4JDI",,"X-RAY DIFFRACTION",2.16,43.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 1.5 - 2.0 M Na acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.molcel.2013.11.013",,"4JDI",40.76,"1.85","1.85","Crystal structure of Serine/threonine-protein kinase PAK 4 in complex with Paktide S peptide substrate","MGSSHHHHHHSSGLVPRGSHMENLYFQGARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","KIAA1142, PAK4","Serine/threonine-protein kinase PAK 4","1","4JDI"
,,,,,,,,,,,,,,,,"RRRRSWY",,,"Paktide S","2","4JDI"
"4JDJ",,"X-RAY DIFFRACTION",2.12,41.89,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 1.5 - 2.0 M Na acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.molcel.2013.11.013",,"4JDJ",40.97,"2.3","2.3","Crystal structure of Serine/threonine-protein kinase PAK 4 F461V mutant in complex with Paktide T peptide substrate","MGSSHHHHHHSSGLVPRGSHMENLYFQGARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGVCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","KIAA1142, PAK4","Serine/threonine-protein kinase PAK 4","1","4JDJ"
,,,,,,,,,,,,,,,,"GGRRRRRTWYFGGGK",,,"Paktide T","2","4JDJ"
"4JDK",,"X-RAY DIFFRACTION",2.13,42.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 1.5 - 2.0 M Na acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.molcel.2013.11.013",,"4JDK",40.24,"2.4","2.4","Crystal structure of Serine/threonine-protein kinase PAK 4 F461V mutant in complex with Paktide S peptide substrate","MGSSHHHHHHSSGLVPRGSHMENLYFQGARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGVCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","KIAA1142, PAK4","Serine/threonine-protein kinase PAK 4","1","4JDK"
,,,,,,,,,,,,,,,,"RRRRSWY",,,"Paktide S","2","4JDK"
"4JDS",,"X-RAY DIFFRACTION",2.29,46.38,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG 3350, 0.1 M Ammonium Sulfate, 0.1 M BisTris pH6.5, vapor diffusion hanging drop, temperature 291K",291,,,"4JDS",122.16,"1.7","1.7","SETD7 in complex with inhibitor PF-5426 and S-adenosyl-methionine","QYKDNIRHGVCWIYYPDGGSLVGEVNEDGEMTGEKIAYVYPDERTALYGKFIDGEMIEGKLATLMSTEEGRPHFELMPGNSVYHFDKSTSSCISTNALLPDPYESERVYVAESLISSAGEGLFSKVAVGPNTVMSFYNGVRITHQEVDSRDWALNGNTLSLDEETVIDVPEPYNHVSKYCASLGHKANHSFTPNCIYDMFVHPRFGPIKCIRTLRAVEADEELTVAYGYDHSPPGKSGPEAPEWYQVELKAFQATQQKHHHHHH","Homo sapiens","SETD7, KIAA1717, KMT7, SET7, SET9","Histone-lysine N-methyltransferase SETD7","1","4JDS"
"4JDV",,"X-RAY DIFFRACTION",2.29,46.31,"VAPOR DIFFUSION",5.5,"PEG 3350, ammonium sulfate, Bis-Tris , pH 5.5, VAPOR DIFFUSION, temperature 298K",298,"10.1073/pnas.1303682110",,"4JDV",97.7,"1.65","1.65","Crystal structure of germ-line precursor of NIH45-46 Fab","QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGKYCTARDYYNWDFQHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"Fab heavy chain","1","4JDV"
,,,,,,,,,,,,,,,,"EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYEFFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab light chain","2","4JDV"
"4JDW",,"X-RAY DIFFRACTION",3.8,65,,7,"1 PART OF AT38H (13-16 MG/ML) 2 PARTS OF PRECIPITANT (3% PEG 6000, 40 MM HEPES, 1MM GLUTATHIONE, PH7.0), SEVERAL DAYS AT ROOM TEMPERATURE, MACRO SEEDING.

L-ARGININE WAS SOAKED INTO CRYSTAL AND IS BOUND TO ACTIVE
SITE.",,"10.1093/emboj/16.12.3373",,"4JDW",48.66,"2.5","2.5","CRYSTAL STRUCTURE AND MECHANISM OF L-ARGININE: GLYCINE AMIDINOTRANSFERASE: A MITOCHONDRIAL ENZYME INVOLVED IN CREATINE BIOSYNTHESIS","MLRVRCLRGGSRGAEAVHYIGSRLGRTLTGWVQRTFQSTQAATASSRNSCAADDKATEPLPKDCPVSSYNEWDPLEEVIVGRAENACVPPFTIEVKANTYEKYWPFYQKQGGHYFPKDHLKKAVAEIEEMCNILKTEGVTVRRPDPIDWSLKYKTPDFESTGLYSAMPRDILIVVGNEIIEAPMAWRSRFFEYRAYRSIIKDYFHRGAKWTTAPKPTMADELYNQDYPIHSVEDRHKLAAQGKFVTTEFEPCFDAADFIRAGRDIFAQRSQVTNYLGIEWMRRHLAPDYRVHIISFKDPNPMHIDATFNIIGPGIVLSNPDRPCHQIDLFKKAGWTIITPPTPIIPDDHPLWMSSKWLSMNVLMLDEKRVMVDANEVPIQKMFEKLGITTIKVNIRNANSLGGGFHAWTCDVRRRGTLQSYLD","Homo sapiens","AT38H, GATM, AGAT","L-ARGININE\:GLYCINE AMIDINOTRANSFERASE","1","4JDW"
"4JEF",,"X-RAY DIFFRACTION",3.34,63.13,"VAPOR DIFFUSION",6.5,"2.0 M ammonium sulphate, 20 uM beta-ME, 0.1 M Mes, 5% (w/v) Peg 400, pH 6.5, VAPOR DIFFUSION, temperature 293.0K",293,"10.1021/acs.jmedchem.5b00137",,"4JEF",33.21,"2.311","2.311","Crystal structure of human thymidylate synthase Y202A in inactive conformation.","PPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFAVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEM","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","4JEF"
"4JFI",,"X-RAY DIFFRACTION",2.29,46.38,"VAPOR DIFFUSION",7.5,"37.5% PEG3350, 0.1 M NH4OAc, 0.1 M HEPES pH 7.5, 10% DMSO, vapor diffusion, temperature 293K",293,"10.1021/jm400087k","1KT","4JFI",14.59,"1.05","1.05","Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational Control: Complex of FKBP51 with compound 1-[(9S,13R,13aR)-1,3-dimethoxy-8-oxo-5,8,9,10,11,12,13,13a-octahydro-6H-9,13-epiminoazocino[2,1-a]isoquinolin-14-yl]-2-(3,4,5-trimethoxyphenyl)ethane-1,2-dione","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKG","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4JFI"
"4JFJ",,"X-RAY DIFFRACTION",2.32,47.03,"VAPOR DIFFUSION",7.5,"37.5% PEG3350, 0.1 M NH4OAc, 0.1 M HEPES pH 7.5, 10% DMSO, vapor diffusion, temperature 293K",293,"10.1021/jm400087k","1KU","4JFJ",14.56,"1.08","1.08","Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational Control: Complex of FKBP51 with compound (1S,6R)-10-(1,3-benzothiazol-6-ylsulfonyl)-3-[2-(3,4-dimethoxyphenoxy)ethyl]-3,10-diazabicyclo[4.3.1]decan-2-one","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4JFJ"
"4JFK",,"X-RAY DIFFRACTION",2.31,46.85,"VAPOR DIFFUSION",7.5,"37.5% PEG3350, 0.1 M NH4OAc, 0.1 M HEPES pH 7.5, 10% DMSO, vapor diffusion, temperature 293K",293,"10.1021/jm400087k","JFK","4JFK",14.57,"1.15","1.15","Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational Control: Complex of FKBP51 with (1S,6R)-3-[2-(3,4-dimethoxyphenoxy)ethyl]-10-[(2-oxo-2,3-dihydro-1,3-benzothiazol-6-yl)sulfonyl]-3,10-diazabicyclo[4.3.1]decan-2-one","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4JFK"
"4JFL",,"X-RAY DIFFRACTION",2.29,46.28,"VAPOR DIFFUSION",7.5,"37.5% PEG3350, 0.1 M NH4OAc, 0.1 M HEPES pH 7.5, 10% DMSO, vapor diffusion, temperature 293K",293,"10.1021/jm400087k","1KY","4JFL",14.56,"1.2","1.2","Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational Control: Complex of FKBP51 with 6-({(1S,5R)-3-[2-(3,4-dimethoxyphenoxy)ethyl]-2-oxo-3,9-diazabicyclo[3.3.1]non-9-yl}sulfonyl)-1,3-benzothiazol-2(3H)-one","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4JFL"
"4JFM",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION",7.5,"37.5% PEG3350, 0.1 M NH4OAc, 0.1 M HEPES pH 7.5, 10% DMSO, vapor diffusion, temperature 293K",293,"10.1021/jm400087k","1KZ","4JFM",14.55,"1.02","1.02","Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational Control: Complex of FKBP51 with 2-(3,4-dimethoxyphenoxy)ethyl (2S)-1-[(2-oxo-2,3-dihydro-1,3-benzothiazol-6-yl)sulfonyl]piperidine-2-carboxylate","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4JFM"
"4JFN",,"X-RAY DIFFRACTION",1.48,17.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"6% (w/v) PEG 3350, 0.1 M Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1523/JNEUROSCI.0180-14.2014",,"4JFN",18.78,"1.75","1.75","Crystal structure of the N-terminal, growth factor-like domain of the amyloid precursor protein bound to copper","DGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQPVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFRGVEFV","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","4JFN"
"4JFX",,"X-RAY DIFFRACTION",2.94,58.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG3350, 0.2M KCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1038/nbt.2672",,"4JFX",98.3,"1.95","1.95","Structure of phosphotyrosine (pTyr) scaffold bound to pTyr peptide","DIVLTQSPATLSLSPGERATLSCMTSTDIDDDMNWYQQKPGQAPRLLISEGNTLRPGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCLQSFNVPLTFGQGTKVEIKRTVAAPSVFIFPPSDSQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab light chain","1","4JFX"
,,,,,,,,,,,,,,,,"EISEVQLVESGGGLVQPGGSLRLSCVTSGFTFRKFGMSWVRQAPGKGLEWVASIVTGGRKTYYSDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGYSSTSYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKSHTATGA","Homo sapiens",,"Fab heavy chain","2","4JFX"
,,,,,,,,,,,,,,,,"GEKKGNYVVTYA",,,"Phosphopeptide","3","4JFX"
"4JFY",,"X-RAY DIFFRACTION",2.9,57.54,"VAPOR DIFFUSION, HANGING DROP",4,"25% PEG1500, 0.1M MMT, pH 4, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1038/nbt.2672",,"4JFY",97.28,"2.63","2.63","Apo structure of phosphotyrosine (pYAb) scaffold","DIVLTQSPATLSLSPGERATLSCMTSTDIDDDMNWYQQKPGQAPRLLISEGNTLRPGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCLQSFNVPLTFGQGTKVEIKRTVAAPSVFIFPPSDSQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab light chain","1","4JFY"
,,,,,,,,,,,,,,,,"EISEVQLVESGGGLVQPGGSLRLSCVTSGFTFRKFGMSWVRQAPGKGLEWVASIVTGGRKTYYSDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGYSSTSYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKSHTATGA","Homo sapiens",,"Fab heavy chain","2","4JFY"
"4JFZ",,"X-RAY DIFFRACTION",2.51,50.99,"VAPOR DIFFUSION, HANGING DROP",6.8,"23% PEG1500, 0.1M PCB, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1038/nbt.2672",,"4JFZ",49.65,"1.75","1.75","Structure of phosphoserine (pSAb) scaffold bound to pSer peptide","DIVLTQSPATLSLSPGERATLSCMTSTDIDDDMNWYQQKPGQAPRLLISEGNTLRPGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCLQSFNVPLTFGQGTKVEIKRTVAAPSVFIFPPSDSQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab light chain","1","4JFZ"
,,,,,,,,,,,,,,,,"EISEVQLVESGGGLVQPGGSLRLSCVTSGFTFRKFGMSWVRQAPGKGLEWVASIATGGHTTYYSDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGYSSTSYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKSHTATGA","Homo sapiens",,"Fab heavy chain","2","4JFZ"
,,,,,,,,,,,,,,,,"GEKKGNYVVTSH",,,"Phosphopeptide","3","4JFZ"
"4JG0",,"X-RAY DIFFRACTION",2.54,51.58,"VAPOR DIFFUSION, HANGING DROP",6.4,"22% PEG1500, 0.1M PCB, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1038/nbt.2672",,"4JG0",49.81,"1.81","1.81","Structure of phosphoserine/threonine (pSTAb) scaffold bound to pSer peptide","DIVLTQSPATLSLSPGERATLSCMTSTDIDDDMNWYQQKPGQAPRLLISEGNTLRPGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCLQSFNVPLTFGQGTKVEIKRTVAAPSVFIFPPSDSQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab light chain","1","4JG0"
,,,,,,,,,,,,,,,,"EISEVQLVESGGGLVQPGGSLRLSCVTSGFTFRKFGMSWVRQAPGKGLEWVASISTPRGSTTYYSDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGYSSTSYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKSHTATGA","Homo sapiens",,"Fab heavy chain","2","4JG0"
,,,,,,,,,,,,,,,,"GEKKGNYVVTSH",,,"Phosphopeptide","3","4JG0"
"4JG1",,"X-RAY DIFFRACTION",2.53,51.45,"VAPOR DIFFUSION, HANGING DROP",6,"25% PEG1500, 0.1M PCB, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1038/nbt.2672",,"4JG1",49.58,"1.55","1.55","Structure of phosphoserine/threonine (pSTAb) scaffold bound to pThr peptide","DIVLTQSPATLSLSPGERATLSCMTSTDIDDDMNWYQQKPGQAPRLLISEGNTLRPGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCLQSFNVPLTFGQGTKVEIKRTVAAPSVFIFPPSDSQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab light chain","1","4JG1"
,,,,,,,,,,,,,,,,"EISEVQLVESGGGLVQPGGSLRLSCVTSGFTFRKFGMSWVRQAPGKGLEWVASISTPRGSTTYYSDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGYSSTSYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCSHTATGA","Homo sapiens",,"Fab heavy chain","2","4JG1"
,,,,,,,,,,,,,,,,"GEKKGNYVVTTH",,,"Phosphopeptide","3","4JG1"
"4JG6",,"X-RAY DIFFRACTION",2.04,39.65,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM HEPES, 50 mM Ammonium Sulfate, 7.5% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja401221b","1LB","4JG6",40.3,"2.6","2.6","RSK2 CTD bound to 2-cyano-3-(1H-indazol-5-yl)acrylamide","AHHHHHHVDDDDKMQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGIKKITSTAL","Homo sapiens","RPS6KA3, ISPK1, MAPKAPK1B, RSK2","Ribosomal protein S6 kinase alpha-3","1","4JG6"
"4JG7",,"X-RAY DIFFRACTION",2.07,40.58,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM HEPES, 50 mM Ammonium Sulfate, 7.5% PEG3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja401221b","1LC","4JG7",40.41,"3.0002","3.0002","Structure of RSK2 CTD bound to 3-(3-(1H-pyrrolo[2,3-b]pyridine-3-carbonyl)phenyl)-2-cyanoacrylamide","AHHHHHHVDDDDKMQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGIKKITSTAL","Homo sapiens","RPS6KA3, ISPK1, MAPKAPK1B, RSK2","Ribosomal protein S6 kinase alpha-3","1","4JG7"
"4JG8",,"X-RAY DIFFRACTION",1.96,37.18,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM HEPES, 50 mM Ammonium Sulfate, 7.5% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja401221b","1LE","4JG8",40.55,"3.1002","3.1002","Structure of RSK2 T493M CTD mutant bound to 2-cyano-N-(1-hydroxy-2-methylpropan-2-yl)-3-(3-(3,4,5-trimethoxyphenyl)-1H-indazol-5-yl)acrylamide","AHHHHHHVDDDDKMQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVMELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGIKKITSTAL","Homo sapiens","RPS6KA3, ISPK1, MAPKAPK1B, RSK2","Ribosomal protein S6 kinase alpha-3","1","4JG8"
"4JGC",,"X-RAY DIFFRACTION",2.49,50.58,"VAPOR DIFFUSION",4.6,"30% polyethylene glycol (PEG) 4000, 0.2 M ammonium acetate, 0.1 M sodium acetate, pH 4.6, VAPOR DIFFUSION, temperature 289K",289,"10.1016/j.dnarep.2013.04.003",,"4JGC",40.3,"2.582","2.582","Human TDG N140A mutant IN A COMPLEX WITH 5-carboxylcytosine (5caC)","GSHMASFNGVSEAELLTKTLPDILTFNLDIVIIGIAPGLMAAYKGHHYPGPGNHFWKCLFMSGLSEVQLNHMDDHTLPGKYGIGFTNMVERTTPGSKDLSSKEFREGGRILVQKLQKYQPRIAVFNGKCIYEIFSKEVFGVKVKNLEFGLQPHKIPDTETLCYVMPSSSARCAQFPRAQDKVHYYIKLKDLRDQLKGIERNMDV","Homo sapiens","TDG","G/T mismatch-specific thymine DNA glycosylase","1","4JGC"
,,,,,,,,,,,,,,,,"CAGCTCTGTACGTGAGCAGTGGACAGCT",,,"oligonucleotide","2","4JGC"
,,,,,,,,,,,,,,,,"AGCTGTCCACTGCTCAXGTACAGAGCTG",,,"oligonucleotide containing 5-carboxylcytosine","3","4JGC"
"4JGD",,"X-RAY DIFFRACTION",3.44,64.28,"VAPOR DIFFUSION, SITTING DROP",4.8,"0.1M acetate, 40mM UDAO, 20.8mM  N,N-dimethyldecylamine-N-oxide(DDAO), 2mM DHO, 2.4-2.6M ammonium sulfate., pH 4.8, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,"4JG","4JGD",44.61,"2.05","2.05","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A016","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4JGD"
"4JGF",,"X-RAY DIFFRACTION",1.93,36.19,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.17 M CH3COONH4, 0.085 M C2H3NaO2   3H2O, 25.5% (w/v) PEG 4000, and 15% (v/v) glycerol , pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1002/prot.24321",,"4JGF",40.81,"2.5","2.5","Crystal Structure of the Cataract-Causing P23T gamma D-Crystallin Mutant","GKITLYEDRGFQGRHYECSSDHTNLQPYLSRCNSARVDSGCWMLYEQPNYSGLQYFLRRGDYADHQQWMGLSDSVRSCRLIPHSGSHRIRLYEREDYRGQMIEFTEDCSCLQDRFRFNEIHSLNVLEGSWVLYELSNYRGRQYLLMPGDYRRYQDWGATNARVGSLRRVID","Homo sapiens","CRYGD, CRYG4","Gamma-crystallin D","1","4JGF"
"4JGT",,"X-RAY DIFFRACTION",3.07,59.98,"VAPOR DIFFUSION, SITTING DROP",4.5,"2 M ammonium sulfate, 0.1 M sodium acetate pH 4.5 and 0.02 M betaine hydrochloride, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.466177",,"4JGT",101.62,"2.161","2.161","Structure and kinetic analysis of H2S production by human Mercaptopyruvate Sulfurtransferase","MGSSHHHHHHSSGLVPRGSHVSAQWVAEALRAPRAGQPLQLLDASWYLPKLGRDARREFEERHIPGAAFFDIDQCSDRTSPYDHMLPGAEHFAEYAGRLGVGAATHVVIYDASDQGLYSAPRVWWMFRAFGHHAVSLLDGGLRHWLRQNLPLSSGKSQPAPAEFRAQLDPAFIKTYEDIKENLESRRFQVVDSRATGRFRGTEPEPRDGIEPGHIPGTVNIPFTDFLSQEGLEKSPEEIRHLFQEKKVDLSKPLVATCGSGVTACHVALGAYLCGKPDVPIYDGSWVEWYMRARPEDVI","Homo sapiens","MPST, TST2","3-mercaptopyruvate sulfurtransferase","1","4JGT"
"4JGV",,"X-RAY DIFFRACTION",3.3,62.76,"EVAPORATION",4.8,"7% PEG 6000, pH 4.8, VAPOR DIFFUSION, HANGING DROP, EVAPORATION, temperature 289K",289,"10.1038/nchembio.1406","T94","4JGV",56.17,"3.01","3.01","Crystal Structure of Human Nur77 Ligand-binding Domain in Complex with THPN","SSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPF","Homo sapiens","NR4A1, GFRP1, HMR, NAK1","Nuclear receptor subfamily 4 group A member 1","1","4JGV"
"4JH0",,"X-RAY DIFFRACTION",2.75,55.25,"VAPOR DIFFUSION, HANGING DROP",7.8,"100 mM Bis-Tris-Propane, pH 7.8, 200 mM MGCL2, 15.9%(W/V) PEG 3350, 15%(V/V) Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm4008906","1MD","4JH0",169.74,"2.35","2.35","Crystal structure of dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2) (DPP-IV-WT) complex with bms-767778 AKA 2-(3-(aminomethyl)-4-(2,4- dichlorophenyl)-2-methyl-5-oxo-5,7-dihydro-6h-pyrrolo[3,4- b]pyridin-6-yl)-n,n-dimethylacetamide","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","4JH0"
"4JHA",,"X-RAY DIFFRACTION",2.5,50.71,,4.6,"22% (w/v) PEG 4000, 0.1 M sodium acetate pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1126/science.1234914",,"4JHA",47.83,"1.6","1.6","Crystal Structure of RSV-Neutralizing Human Antibody D25","QVQLVQSGAEVKKPGSSVMVSCQASGGPLRNYIINWLRQAPGQGPEWMGGIIPVLGTVHYAPKFQGRVTITADESTDTAYIHLISLRSEDTAMYYCATETALVVSTTYLPHYFDNWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"D25 antigen-binding fragment heavy chain","1","4JHA"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSAAVGDRVTITCQASQDIVNYLNWYQQKPGKAPKLLIYVASNLETGVPSRFSGSGSGTDFSLTISSLQPEDVATYYCQQYDNLPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"D25 light chain","2","4JHA"
"4JHN",,"X-RAY DIFFRACTION",1.68,26.99,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M LiCl2 and 18% (w/v) PEG3350   
and microseeding, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/embor.2013.37",,"4JHN",183.86,"1.7","1.7","The crystal structure of the RPGR RCC1-like domain","MREPEELMPDSGAVFTFGKSKFAENNPGKFWFKNDVPVHLSCGDEHSAVVTGNNKLYMFGSNNWGQLGLGSKSAISKPTCVKALKPEKVKLAACGRNHTLVSTEGGNVYATGGNNEGQLGLGDTEERNTFHVISFFTSEHKIKQLSAGSNTSAALTEDGRLFMWGDNSEGQIGLKNVSNVCVPQQVTIGKPVSWISCGYYHSAFVTTDGELYVFGEPENGKLGLPNQLLGNHRTPQLVSEIPEKVIQVACGGEHTVVLTENAVYTFGLGQFGQLGLGTFLFETSEPKVIENIRDQTISYISCGENHTALITDIGLMYTFGDGRHGKLGLGLENFTNHFIPTLCSNFLRFIVKLVACGGCHMVVFAAPHRGVAKEIEFDEINDTCLSVATFLPPRRPPAYVEQKLISEEDLNSAVDHHHHHH","Homo sapiens","RPGR, RP3, XLRP3","X-linked retinitis pigmentosa GTPase regulator","1","4JHN"
"4JHS",,"X-RAY DIFFRACTION",3.95,68.86,"VAPOR DIFFUSION",4.6,"100mM sodium acetate trihydrate pH 4.6, 2.0M ammonium sulfate, vapor diffusion, temperature 294K",294,,,"4JHS",21.01,"3","3","Crystal structure of a C-terminal two domain fragment of human beta-2-glycoprotein 1","QDYKDDDDKHHHHHHHHHHENLYFQSHVLFIFPRTSGVKCPFPSRPDNGFVNYPAKPTLYYKDKATFGCHDGYSLDGPEEIECTKLGNWSAMPSCKASCKVPVKKATVVYQGERVKIQEKFKNGMLHGDKVSFFCKNKEKKCSYTEDAQCIDGTIEVPKCFKEHSSLAFWKTDASDVKPC","Homo sapiens","APOH, B2G1","Beta-2-glycoprotein 1","1","4JHS"
"4JI9",,"X-RAY DIFFRACTION",3.13,60.65,"VAPOR DIFFUSION, HANGING DROP",6,"ammonium acetate, PEG8000, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1016/j.bmcl.2013.06.008","1M3","4JI9",71.7,"2.4","2.4","JAK2 kinase (JH1 domain) in complex with TG101209","SGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4JI9"
"4JIA",,"X-RAY DIFFRACTION",2.66,53.81,"VAPOR DIFFUSION, HANGING DROP",6,"ammonium acetate, PEG 8000, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1016/j.bmcl.2013.06.008","1K3","4JIA",35.85,"1.85","1.85","JAK2 kinase (JH1 domain) in complex with compound 9","SGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4JIA"
"4JIB",,"X-RAY DIFFRACTION",2.22,44.7,,,,,"10.1016/j.bmcl.2013.03.072","1L6","4JIB",162.94,"1.72","1.72","Crystal structure of of PDE2-inhibitor complex","GSAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","4JIB"
"4JIH",,"X-RAY DIFFRACTION",2.45,49.76,"VAPOR DIFFUSION, HANGING DROP",9,"30-35% (w/v) PEG 6000 and 100 mM Tris-base (pH 9.0), VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.febslet.2013.09.031","EPR","4JIH",37.38,"2.3","2.3","Crystal Structure Of AKR1B10 Complexed With NADP+ And Epalrestat","SHMATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPKDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNVLQSSHLEDYPFDAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4JIH"
"4JII",,"X-RAY DIFFRACTION",2.53,51.39,"VAPOR DIFFUSION, HANGING DROP",9,"30-35% (w/v) PEG 6000 and 100 mM Tris-base (pH 9.0), VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.febslet.2013.09.031","ZST","4JII",37.48,"2.2","2.2","Crystal Structure Of AKR1B10 Complexed With NADP+ And Zopolrestat","SHMATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPKDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNVLQSSHLEDYPFDAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4JII"
"4JIJ",,"X-RAY DIFFRACTION",2.22,44.56,"VAPOR DIFFUSION, SITTING DROP",6,"Protein: 6 microL  hMMP9(E402A) at 181 micro-M   0.12 M acetohydroxamic acid and  0.3 microL IT34-I at 6.9 mill-M. Reservoir: 10% PEG 20K, 0.1 M MMT (L-malic acid, MES, Tris) 75% acid/25% basic, 0.8 M NaCl, 0.02 SrCl2, 0.01% azide.   Cryoprotectant: CryoProtX CM2, 0.8 M Li formate, 0.1 M (MMT 75% acid/25% basic), 9% PEG 10K, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.chembiol.2014.01.008",,"4JIJ",40.53,"1.698","1.698","Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic synthetic peptidic substrate","XPLGFXARX",,,"fluorogenic peptidic substrate (8MC)PLG(PHI)(DNW)AR(NH2)","1","4JIJ"
,,,,,,,,,,,,,,,,"GFQTFEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVGYSLFLVAAHAFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG","Homo sapiens","CLG4B, MMP9","Matrix metalloproteinase-9","2","4JIJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","CLG4B, MMP9"
"4JIK",,"X-RAY DIFFRACTION",2.52,51.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-Cl pH 7.5 1% v/v n-butanol 2.5% v/v DMSO 25% v/v Glycerol 6 to 12% PEG 3.25K 2.5 mM TCEP-Cl 10 mM Na2-Dithionite, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2013.03.100","1KO","4JIK",31.83,"1.9","1.9","X-RAY Crystal structure of compound 22a (R)-2-(4-chlorophenyl)-8-(piperidin-3-ylamino)imidazo[1,2-c]pyrimidine-5-carboxamide bound to human chk1 kinase domain","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4JIK"
"4JIR",,"X-RAY DIFFRACTION",2.22,44.51,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM ammonium citrate, pH5.0, 7.5% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.febslet.2013.09.031","EPR","4JIR",37.15,"2","2","Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And Epalrestat","MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4JIR"
"4JJ7",,"X-RAY DIFFRACTION",2.48,50.39,"VAPOR DIFFUSION, SITTING DROP",8,"1 M Sodium citrate, 0.1M HEPES pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/cb400209w",,"4JJ7",32.58,"1.178","1.178","Caspase-3 specific unnatural amino acid-based peptides","MSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEELHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQFTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVETDSEEQPYLEMDLSSPQTRYIPDEADFLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGKQMPQPTFTLRKKLVFPSDAAALEHHHHHH","Homo sapiens","CASP8, CASP8 MCH5, MCH5","Caspase-8","1","4JJ7"
,,,,,,,,,,,,,,,,"XXDXXX",,,"Caspase inhibitor","2","4JJ7"
"4JJ8",,"X-RAY DIFFRACTION",3.86,68.11,"VAPOR DIFFUSION, SITTING DROP",4,"0.15M Sodium citrate pH 4.0, 2.0 M Sodium formate, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/cb400209w",,"4JJ8",59.96,"2.937","2.937","Caspase-3 specific unnatural amino acid peptides","TYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQADSGPINDTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQQLHHHHHH","Homo sapiens","CASP7, Caspase-7 Mch-3, MCH3","Caspase-7","1","4JJ8"
,,,,,,,,,,,,,,,,"XXDXXX",,,"Caspase Inhibitor","2","4JJ8"
"4JJB",,"X-RAY DIFFRACTION",2.37,48.03,"capillary counterdiffusion",3,"3M ammonium sulphate, 5% PEG 200, 0.05M glycine, capillary counterdiffusion, temperature 298K",298,,,"4JJB",7.32,"1.65","1.65","Crystal structure of the Abl-SH3 domain at pH3","MENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNS","Homo sapiens","ABL, ABL1, JTK7","Tyrosine-protein kinase ABL1","1","4JJB"
"4JJC",,"X-RAY DIFFRACTION",2.35,47.7,"capillary counterdiffusion",5,"1.5M ammonium sulphate, 5% PEG 300, 0.1M acetate, capillary counterdiffusion, temperature 298K",298,,,"4JJC",7.12,"1.6","1.6","Crystal structure of the Abl-SH3 domain at pH5","MENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNS","Homo sapiens","ABL, ABL1, JTK7","Tyrosine-protein kinase ABL1","1","4JJC"
"4JJD",,"X-RAY DIFFRACTION",1.6,23.21,"VAPOR DIFFUSION, HANGING DROP",4,"1.5M ammonium sulphate, 5% PEG 300, 10% Glycerol, 0.1M sodium acetate, pH 4, vapor diffusion, hanging drop, temperature 298K",298,,,"4JJD",7.12,"1.6","1.6","Crystal structure of the N114A Abl-SH3 domain mutant at pH4","MENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSAYITPVNS","Homo sapiens","ABL, ABL1, JTK7","Tyrosine-protein kinase ABL1","1","4JJD"
"4JJE",,"X-RAY DIFFRACTION",2.41,49.02,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.05M Sodium citrate pH 5.5, 14% PEG 6000, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/cb400209w",,"4JJE",30.43,"1.481","1.481","Caspase-3 specific unnatural amino acid peptides","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHQLHHHHHH","Homo sapiens","CASP3, Caspase-3 CPP32, CPP32","Caspase-3","1","4JJE"
,,,,,,,,,,,,,,,,"XXDXXX",,,"Caspase inhibitor","2","4JJE"
"4JJH",,"X-RAY DIFFRACTION",2.2,44.13,"VAPOR DIFFUSION, SITTING DROP",7,"Protein (20 mM Hepes, pH 7.5, 150 mM NaCl, 10% glycerol; Reservoir (0.1M Sodium Chloride, 0.1M Bis-Tris:HCl, pH 6.5); Cryoprotection (Reservoir + final concentration of 20%(v/v) Ethylene glycol), Vapor Diffusion, Sitting Drop, temperature 298K",298,,,"4JJH",28.94,"2.25","2.25","Crystal structure of the D1 domain from human Nectin-4 extracellular fragment [PSI-NYSGRC-005624]","QDYGGGELETSDVVTVVLGQDAKLPCFYRGDSGEQVGQVAWARVDAGEGAQELALLHSKYGLHVSPAYEGRVEQPPPPRNPLDGSVLLRNAVQADEGEYECRVSTFPAGSFQARLRLRVLVPPLPSLAENLYF","Homo sapiens","LNIR, Nectin-4, PRR4, PVRL4, NECTIN4","Poliovirus receptor-related protein 4","1","4JJH"
"4JJY",,"X-RAY DIFFRACTION",5.71,78.45,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M sodium citrate pH 5, 6-8% PEG 8000, 5-10% ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.devcel.2013.04.007",,"4JJY",81.8,"6.503","6.503","Alix V domain","IDPFTFEKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFARKTERRDELLKD","Homo sapiens","PDCD6IP, AIP1, ALIX, KIAA1375","Programmed cell death 6-interacting protein","1","4JJY"
"4JK7",,"X-RAY DIFFRACTION",2.72,54.84,"VAPOR DIFFUSION",7.5,"15% PEG 4000, 300mM MgCl2, 100mM Tris, pH 7.5, VAPOR DIFFUSION, temperature 298K",298,"10.1038/nsmb.2556",,"4JK7",51.49,"1.4","1.4","Open and closed forms of wild-type human PRP8 RNase H-like domain with bound Mg ion","GELFSNQIIWFVDDTNVYRVTIHKTFEGNLTTKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTRKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","1","4JK7"
"4JK8",,"X-RAY DIFFRACTION",2.75,55.22,"VAPOR DIFFUSION",7.5,"15% PEG 4000, 300mM MgCl2, 100mM Tris, pH 7.5, vapor diffusion, temperature 298K",298,"10.1038/nsmb.2556",,"4JK8",51.35,"1.15","1.15","Open and closed forms of R1865A human PRP8 RNase H-like domain with bound Mg ion","GELFSNQIIWFVDDTNVYRVTIHKTFEGNLTTKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTAKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","1","4JK8"
"4JK9",,"X-RAY DIFFRACTION",2.75,55.25,"VAPOR DIFFUSION",7.5,"15% PEG 4000, 300mM MgCl2, 100mM Tris, pH 7.5, vapor diffusion, temperature 298K",298,"10.1038/nsmb.2556",,"4JK9",51.63,"1.5","1.5","Open and closed forms of wild-type human PRP8 RNase H-like domain with bound Co ion","GELFSNQIIWFVDDTNVYRVTIHKTFEGNLTTKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTRKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","1","4JK9"
"4JKA",,"X-RAY DIFFRACTION",2.76,55.5,"VAPOR DIFFUSION",7.5,"15% PEG 4000, 300mM MgCl2, 100mM Tris, pH 7.5, vapor diffusion, temperature 298K",298,"10.1038/nsmb.2556",,"4JKA",51.4,"1.32","1.32","Open and closed forms of R1865A human PRP8 RNase H-like domain with bound Co ion","GELFSNQIIWFVDDTNVYRVTIHKTFEGNLTTKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTAKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","1","4JKA"
"4JKB",,"X-RAY DIFFRACTION",2.7,54.47,"VAPOR DIFFUSION",7.5,"15% PEG 4000, 300mM MgCl2, 100mM Tris, pH 7.5, vapor diffusion, temperature 298K",298,"10.1038/nsmb.2556",,"4JKB",51.61,"1.3","1.3","Open and closed forms of V1788D human PRP8 RNase H-like domain with bound Mg ion","GELFSNQIIWFVDDTNVYRDTIHKTFEGNLTTKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTRKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","1","4JKB"
"4JKC",,"X-RAY DIFFRACTION",2.72,54.77,"VAPOR DIFFUSION",7.5,"15% PEG 4000, 300mM MgCl2, 100mM Tris, pH 7.5, vapor diffusion, temperature 298K",298,"10.1038/nsmb.2556",,"4JKC",51.51,"1.5","1.5","Open and closed forms of T1800E human PRP8 RNase H-like domain with bound Mg ion","GELFSNQIIWFVDDTNVYRVTIHKTFEGNLTEKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTRKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","1","4JKC"
"4JKD",,"X-RAY DIFFRACTION",2.7,54.4,"VAPOR DIFFUSION",7.5,"15% PEG 4000, 300mM MgCl2, 100mM Tris, pH 7.5, vapor diffusion, temperature 298K",298,"10.1038/nsmb.2556",,"4JKD",51.37,"1.55","1.55","Open and closed forms of I1790Y human PRP8 RNase H-like domain with bound Mg ion","GELFSNQIIWFVDDTNVYRVTYHKTFEGNLTTKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTRKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","1","4JKD"
"4JKE",,"X-RAY DIFFRACTION",2.67,54.01,"VAPOR DIFFUSION",7.5,"15% PEG 4000, 300mM MgCl2, 100mM Tris, pH 7.5, vapor diffusion, temperature 298K",298,"10.1038/nsmb.2556",,"4JKE",51.09,"1.65","1.65","Open and closed forms of T1789P human PRP8 RNase H-like domain with bound Mg ion","GELFSNQIIWFVDDTNVYRVPIHKTFEGNLTTKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTRKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","1","4JKE"
"4JKF",,"X-RAY DIFFRACTION",2.71,54.53,"VAPOR DIFFUSION",7.5,"15% PEG 4000, 300mM MgCl2, 100mM Tris, pH 7.5, vapor diffusion, temperature 298K",298,"10.1038/nsmb.2556",,"4JKF",50.92,"1.95","1.95","Open and closed forms of T1791P+R1865A human PRP8 RNase H-like domain with bound Mg ion","GELFSNQIIWFVDDTNVYRVPIHKTFEGNLTTKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTAKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","1","4JKF"
"4JKG",,"X-RAY DIFFRACTION",2.75,55.29,"VAPOR DIFFUSION",7.5,"15% PEG 4000, 300mM MgCl2, 100mM Tris, pH 7.5, vapor diffusion, temperature 298K",298,"10.1038/nsmb.2556",,"4JKG",50.93,"1.8","1.8","Open and closed forms of mixed T1789P+R1865A and R1865A human PRP8 RNase H-like domain with bound Mg ion","GELFSNQIIWFVDDTNVYRVTIHKTFEGNLTTKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTAKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","1","4JKG"
,,,,,,,,,,,,,,,,"GELFSNQIIWFVDDTNVYRVPIHKTFEGNLTTKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTAKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","2","4JKG"
"4JKH",,"X-RAY DIFFRACTION",2.7,54.52,"VAPOR DIFFUSION",7.5,"15% PEG 4000, 300mM MgCl2, 100mM Tris, pH 7.5, vapor diffusion, temperature 298K",298,"10.1038/nsmb.2556",,"4JKH",51.48,"1.8","1.8","Open and closed forms of D1781E human PRP8 RNase H-like domain with bound Mg ion","GELFSNQIIWFVEDTNVYRVTIHKTFEGNLTTKPINGAIFIFNPRTGQLFLKIIHTSVWAGQKRLGQLAKWKTAEEVAALIRSLPVEEQPKQIIVTRKGMLDPLEVHLLDFPNIVIKGSELQLPFQACLKVEKFGDLILKATEPQMVLFNLYDDWLKTISSYTAFSRLILILRALHVNNDRAKVILKPDKTTITEPHHIWPTLTDEEWIKVEVQLKDLILAD","Homo sapiens","PRP8, PRPC8, PRPF8","Pre-mRNA-processing-splicing factor 8","1","4JKH"
"4JKJ",,"X-RAY DIFFRACTION",2.36,47.9,"VAPOR DIFFUSION, HANGING DROP",7,"2.4M Ammonium sulfate, 0.1M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4JKJ",50.97,"2.151","2.151","Crystal Structure of the S18Y Variant of Ubiquitin Carboxy-terminal Hydrolase L1","GPLGSMQLKPMEINPEMLNKVLYRLGVAGQWRFVDVLGLEEESLGSVPAPACALLLLFPLTAQHENFRKKQIEELKGQEVSPKVYFMKQTIGNSCGTIGLIHAVANNQDKLGFEDGSVLKQFLSETEKMSPEDRAKCFEKNEAIQAAHDAVAQEGQCRVDDKVNFHFILFNNVDGHLYELDGRMPFPVNHGASSEDTLLKDAAKVCREFTEREQGEVRFSAVALCKAA","Homo sapiens","UCHL1","Ubiquitin carboxyl-terminal hydrolase isozyme L1","1","4JKJ"
"4JKQ",,"X-RAY DIFFRACTION",2.59,52.52,"VAPOR DIFFUSION, HANGING DROP",8,"20 mM TRIS-HCl, 150 mM NaCl, 10% glycerol, 7mM mercaptoethanol, 1 mM CHAPS, 0.1% betaine, 100 mM HEPES, 200 mM ammonium formate, 21% PEG 3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1107/S1399004714020343",,"4JKQ",67.92,"2.39","2.39","Crystal structure of the N-terminal region of the human ryanodine receptor 2","MADGGEGEDEIQFLRTDDEVVLQCTATIHKEQQKLCLAAEGFGNRLCFLESTSNSKNVPPDLSICTFVLEQSLSVRALQEMLANTVEKSEGQVDVEKWKFMMKTAQGGGHRTLLYGHAILLRHSYSGMYLCCLSTSRSSTDKLAFDVGLQEDTTGEACWWTIHPASKQRSEGEKVRVGDDLILVSVSSERYLHLSYGNGSLHVDAAFQQTLWSVAPISSGSEAAQGYLIGGDVLRLLHGHMDECLTVPSGEHGEEQRRTVHYEGGAVSVHARSLWRLETLRVAWSGSHIRWGQPFRLRHVTTGKYLSLMEDKNLLLMDKEKADVKSTAFTFRSSKEKLDVGVRKEVDGMGTSEIKYGDSVCYIQHVDTGLWLTYQSVDVKSVRMGSIQRKAIMHHEGHMDDGISLSRSQHEESRTARVIRSTVFLFNRFIRGLDALSKKAKASTVDLPIESVSLSLQDLIGYFHPPDEHLEHEDKQNRLRALKNRQNLFQEEGMINLVLECIDRLHVYSSAAHFADVAGREAGESWKSILNSLYELLAALIRGNRKNCAQFSGSLDWLISRLERLEASSGILEVLHCVLVESPEALNIIKEGHIKSIISLLDKHGR","Homo sapiens","RYR2","Ryanodine receptor 2","1","4JKQ"
"4JKW",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.12 M ethylene glycols, 0.1 M buffer system 1, 30% PEG 550 MME and PEG 20.000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ni.2665","IPE","4JKW",14.02,"2.01","2.01","Structure of the extracellular domain of butyrophilin BTN3A1 in complex with Isopentenyl pyrophosphate (IPP)","SAQFSVLGPSGPILAMVGEDADLPCHLFPTMSAETMELKWVSSSLRQVVNVYADGKEVEDRQSAPYRGRTSILRDGITAGKAALRIHNVTASDSGKYLCYFQDGDFYEKALVELKVLEHHHHHH","Homo sapiens","BT3.2, BTF3, BTF4, BTF5, BTN3A1, BTN3A2, Butyrophilin subfamily 3 member A1","Butyrophilin subfamily 3 member A1","1","4JKW"
"4JL4",,"X-RAY DIFFRACTION",2.59,52.46,"VAPOR DIFFUSION, SITTING DROP",8,"0.8 M Na Citrate, 0.15 M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"AXY","4JL4",65.78,"2.5","2.5","Crystal structure of the complex between PPARgamma LBD and the ligand LJ570 [(2S)-3-(biphenyl-4-yl)-2-(biphenyl-4-yloxy)propanoic acid]","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4JL4"
"4JL7",,"X-RAY DIFFRACTION",2.45,49.79,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 mM sodium acetate, 2.7 M sodium chloride, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0076219",,"4JL7",9.97,"1.16","1.16","Crystal Structure of the Chemokine Receptor CXCR2 in Complex with the First PDZ Domain of NHERF1","GMLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETSTTL","Homo sapiens","NHERF, NHERF1, SLC9A3R1","Na(+)/H(+) exchange regulatory cofactor NHE-RF1","1","4JL7"
"4JLG",,"X-RAY DIFFRACTION",2.66,53.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"23% PEG 3500, 0.2 M Lithium Sulfate, 0.1 M BisTris pH 6.5, vapor diffusion hanging drop, temperature 291K",291,"10.1073/pnas.1407358111","1L8","4JLG",61.16,"1.896","1.896","SETD7 in complex with inhibitor (R)-PFI-2 and S-adenosyl-methionine","QYKDNIRHGVCWIYYPDGGSLVGEVNEDGEMTGEKIAYVYPDERTALYGKFIDGEMIEGKLATLMSTEEGRPHFELMPGNSVYHFDKSTSSCISTNALLPDPYESERVYVAESLISSAGEGLFSKVAVGPNTVMSFYNGVRITHQEVDSRDWALNGNTLSLDEETVIDVPEPYNHVSKYCASLGHKANHSFTPNCIYDMFVHPRFGPIKCIRTLRAVEADEELTVAYGYDHSPPGKSGPEAPEWYQVELKAFQATQQKHHHHHH","Homo sapiens","SETD7, KIAA1717, KMT7, SET7, SET9","Histone-lysine N-methyltransferase SETD7","1","4JLG"
"4JLJ",,"X-RAY DIFFRACTION",2.24,45.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.9-1.5 M trisodium citrate dehydrate, 25 mM HEPES , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1107/S1399004713025030","1NM","4JLJ",67.84,"2","2","Human dCK C4S-S74E mutant in complex with UDP and the F2.1.1 inhibitor (2-[({2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE)","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4JLJ"
"4JLK",,"X-RAY DIFFRACTION",2.17,43.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.9-1.5 M trisodium citrate dehydrate, 25 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm400457y","1NO","4JLK",67.9,"1.89","1.89","Human dCK C4S-S74E mutant in complex with UDP and the F2.2.1 inhibitoR (2-[({2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-5-METHYL-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE)","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4JLK"
"4JLM",,"X-RAY DIFFRACTION",2.18,43.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.9-1.5 M trisodium citrate dehydrate, 25 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1107/S1399004713025030","1NN","4JLM",67.52,"2.18","2.18","Human dCK C4S-S74E mutant in complex with UDP and the F2.3.1 inhibitor (2-[({5-ETHYL-2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE)","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4JLM"
"4JLN",,"X-RAY DIFFRACTION",2.16,43.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.9-1.5 M trisodium citrate dehydrate, 25 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1107/S1399004713025030","18V","4JLN",67.11,"2.15","2.15","Human dCK C4S-S74E mutant in complex with UDP and the F2.4.1 inhibitor (2-[({2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-5-PROPYL-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE)","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4JLN"
"4JLR",,"X-RAY DIFFRACTION",2.78,55.69,"VAPOR DIFFUSION, HANGING DROP",4.2,"20% PEG 1000, 0.1M lithium sulfate, 0.04M phosphate-citrate, 2% glycerol, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nature12966",,"4JLR",123.78,"2.71","2.71","Crystal structure of a designed Respiratory Syncytial Virus Immunogen in complex with Motavizumab","QVTLRESGPALVKPTQTLTLTCTFSGFSLSTAGMSVGWIRQPPGKALEWLADIWWDDKKHYNPSLKDRLTISKDTSANQVVLKVTNMDPADTATYYCARDMIFNFYFDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"Motavizumab Fab heavy chain","1","4JLR"
,,,,,,,,,,,,,,,,"DIQMTQSPSTLSASVGDRVTITCSASSRVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTAFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Motavizumab Fab light chain","2","4JLR"
,,,,,,,,,,,,,,,,"GSRSDMRKDAERRFDKFVEAAKNKFDKFKAALRKGDIKEERRKDMKKLARKEAEQARRAVRNRLSELLSKINDMPITNDQKKLMSNDVLKFAAEAEKKIEALAADAEDKFTQGSWLEHHHHHH",,,"RSV_1Isea designed scaffold","3","4JLR"
"4JM4",,"X-RAY DIFFRACTION",2.54,51.65,"VAPOR DIFFUSION, SITTING DROP",9.5,"20% w/v PEG8000, 0.1 M CHES, pH 9.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nsmb.2594",,"4JM4",49.37,"1.751","1.751","Crystal Structure of PGT 135 Fab","QLQMQESGPGLVKPSETLSLSCTVSGDSIRGGEWGDKDYHWGWVRHSAGKGLEWIGSIHWRGTTHYKESLRRRVSMSIDTSRNWFSLRLASVTAADTAVYFCARHRHHDVFMLVPIAGWFDVWGPGVQVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"PGT 135 Heavy Chain","1","4JM4"
,,,,,,,,,,,,,,,,"EIVMTQSPDTLSVSPGETVTLSCRASQNINKNLAWYQYKPGQSPRLVIFETYSKIAAFPARFVASGSGTEFTLTINNMQSEDVAVYYCQQYEEWPRTFGQGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"PGT 135 Light Chain","2","4JM4"
"4JMI",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M MgSO4, Peg 5000 MME 18%, 0.1M Mes pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm4009357",,"4JMI",23.03,"1.5","1.5","Sec7 domain of ARNO, an exchange factor, at 1.5 Angstrom resolution","GSHMSKTLQRNRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKTAIGDYLGEREELNLAVLHAFVDLHEFTDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRYCLCNPGVFQSTDTCYVLSFAVIMLNTSLHNPNVRDKPGLERFVAMNRGINEGGDLPEELLRNLYDSIRNEPFKIPEDDGN","Homo sapiens","CYTH2, ARNO, PSCD2, PSCD2L","Cytohesin-2","1","4JMI"
"4JMJ",,"X-RAY DIFFRACTION",2.7,54.37,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 4000, HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S1399004713029866",,"4JMJ",21.44,"2.382","2.382","Structure of dusp11","GNHIPERWKDYLPVGQRMPGTRFIAFKVPLQKSFEKKLAPEECFSPLDLFNKIREQNEELGLIIDLTYTQRYYKPEDLPETVPYLKIFTVGHQVPDDETIFKFKHAVNGFLKENKDNDKLIGVHSTHGLNRTGYLICRYLIDVEGVRPDDAIELFNRCRGHCLERQNYIEDLQNGPIRKNW","Homo sapiens","DUSP11, PIR1","RNA/RNP complex-1-interacting phosphatase","1","4JMJ"
"4JMK",,"X-RAY DIFFRACTION",1.97,37.45,"VAPOR DIFFUSION, HANGING DROP",7,"Hepes, PEG 8000, pH 7., VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S1399004713029866",,"4JMK",34.7,"1.9","1.9","Structure of dusp8","MGLTRILPHLYLGSQKDVLNKDLMTQNGISYVLNASNSCPKPDFICESRFMRVPINDNYCEKLLPWLDKSIEFIDKAKLSSCQVIVHSLAGISRSATIAIAYIMKTMGMSSDDAYRFVKDRRPSISPNFNFLGQLLEYERSLKLLAALQGDP","Homo sapiens","DUSP8, C11orf81, VH5","Dual specificity protein phosphatase 8","1","4JMK"
"4JMO",,"X-RAY DIFFRACTION",2.63,53.28,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M MgSO4,Peg5K MME 18%, 0.1M Tris-HCl, pH 8.5 , VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm4009357","JAF","4JMO",23.34,"1.8","1.8","Complexe of ARNO Sec7 domain with the protein-protein interaction inhibitor N-(4-hydroxy-2,6-dimethylphenyl)-4-methoxybenzenesulfonamide","GSHMSKTLQRNRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKTAIGDYLGEREELNLAVLHAFVDLHEFTDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRYCLCNPGVFQSTDTCYVLSFAVIMLNTSLHNPNVRDKPGLERFVAMNRGINEGGDLPEELLRNLYDSIRNEPFKIPEDDGN","Homo sapiens","CYTH2, ARNO, PSCD2, PSCD2L","Cytohesin-2","1","4JMO"
"4JNB",,"X-RAY DIFFRACTION",3.38,63.58,"VAPOR DIFFUSION",8.5,"0.1M Tris pH 8.5, 1.9M Ammonium sulfate, VAPOR DIFFUSION, temperature 298K",298,"10.1107/S1399004713029866",,"4JNB",18.72,"3","3","Crystal structure of the Catalytic Domain of Human DUSP12","MLEVQPGLYFGGAAAVAEPDHLREAGITAVLTVDSEEPSFKAGPGVEDLWRLFVPALDKPETDLLSHLDRAVAFIGQARAEGRAVLVHSHAGVSRSVAIITAFLMKTDQLPFEKAYEKLQILKPEAKMNEGFEWQLKLYQAMGYEVDTSSAIYKQYRLQKVTEKYPE","Homo sapiens","DUSP12","Dual specificity protein phosphatase 12","1","4JNB"
"4JNC",,"X-RAY DIFFRACTION",2.34,47.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG3350, 0.1 M BisTris, 0.2M NH4OAc, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.04.019","1LF","4JNC",36.54,"1.96","1.96","Soluble Epoxide Hydrolase complexed with a carboxamide inhibitor","GSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPAD","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4JNC"
"4JNK",,"X-RAY DIFFRACTION",2.51,50.97,"VAPOR DIFFUSION, SITTING DROP",7,"PEG3350, malonate, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1016/j.bmcl.2013.04.001","ZHK","4JNK",151.74,"1.896","1.896","Lactate Dehydrogenase A in complex with inhibitor compound 22","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4JNK"
"4JNM",,"X-RAY DIFFRACTION",2.32,47.04,"VAPOR DIFFUSION, HANGING DROP",,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.04.040","1LJ","4JNM",115.65,"2.2","2.2","Discovery of Potent and Efficacious Urea-containing Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors with Reduced CYP2C9 Inhibition Properties","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4JNM"
"4JNU",,"X-RAY DIFFRACTION",2.02,39.13,"VAPOR DIFFUSION, HANGING DROP",5.3,"0.1 M sodium acetate, pH 5.3, 1.9 M sodium formate, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1126/science.aac9176",,"4JNU",18.92,"1.445","1.445","Crystal structure of the human Nup57CCS3* coiled-coil segment, space group P21","SYYIDADLLREIKQHLKQQQEGLSHLISIIKDDLEDIKLV","Homo sapiens","NUP54","Nucleoporin p54","1","4JNU"
"4JNV",,"X-RAY DIFFRACTION",2.06,40.29,"VAPOR DIFFUSION, HANGING DROP",5.3,"0.1 M sodium acetate, pH 5.3, 1.9 M sodium formate, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1126/science.aac9176",,"4JNV",19.18,"1.85","1.85","Crystal structure of the human Nup57CCS3* coiled-coil segment, space group C2","SYYIDADLLREIKQHLKQQQEGLSHLISIIKDDMEDIKLV","Homo sapiens","NUP54","Nucleoporin p54","1","4JNV"
"4JNW",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1098/rsob.140041",,"4JNW",75.04,"2.06","2.06","Bacterially expressed Titin Kinase","GAMKELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVASI","Homo sapiens","TTN","Titin","1","4JNW"
"4JOA",,"X-RAY DIFFRACTION",1.98,37.86,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes pH 7.5,  20% PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.06.071","3DK","4JOA",39.03,"2.7","2.7","Crystal Structure of Human Anaplastic Lymphoma Kinase in complex with 7-azaindole based inhibitor","GAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","4JOA"
"4JOB",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M sodium tartrate dibasic dihydrate, 20% PEG3350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1007/s13238-013-3031-z",,"4JOB",45.51,"2.171","2.171","Crystal structure of human lysophosphatidic acid phosphatase type 6 complexed with L-(+)-tartrate","ELQEADGQCPVDRSLLKLKMVQVVFRHGARSPLKPLPLEEQVEWNPQLLEVPPQTQFDYTVTNLAGGPKPYSPYDSQYHETTLKGGMFAGQLTKVGMQQMFALGERLRKNYVEDIPFLSPTFNPQEVFIRSTNIFRNLESTRCLLAGLFQCQKEGPIIIHTDEADSEVLYPNYQSCWSLRQRTRGRRQTASLQPGISEDLKKVKDRMGIDSSDKVDFFILLDNVAAEQAHNLPSCPMLKRFARMIEQRAVDTSLYILPKEDRESLQMAVGPFLHILESNLLKAMDSATAPDKIRKLYLYAAHDVTFIPLLMTLGIFDHKWPPFAVDLTMELYQHLESKEWFVQLYYHGKEQVPRGCPDGLCPLDMFLNAMSVYTLSPEKYHALCSQTQVMEVGNEE","Homo sapiens","ACP6, ACPL1, LPAP, UNQ205/PRO231","Lysophosphatidic acid phosphatase type 6","1","4JOB"
"4JOC",,"X-RAY DIFFRACTION",2.07,41,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M sodium malonate, 20% PEG3350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1007/s13238-013-3031-z",,"4JOC",45.47,"2.208","2.208","Crystal structure of human lysophosphatidic acid phosphatase type 6 complexed with Malonate","ELQEADGQCPVDRSLLKLKMVQVVFRHGARSPLKPLPLEEQVEWNPQLLEVPPQTQFDYTVTNLAGGPKPYSPYDSQYHETTLKGGMFAGQLTKVGMQQMFALGERLRKNYVEDIPFLSPTFNPQEVFIRSTNIFRNLESTRCLLAGLFQCQKEGPIIIHTDEADSEVLYPNYQSCWSLRQRTRGRRQTASLQPGISEDLKKVKDRMGIDSSDKVDFFILLDNVAAEQAHNLPSCPMLKRFARMIEQRAVDTSLYILPKEDRESLQMAVGPFLHILESNLLKAMDSATAPDKIRKLYLYAAHDVTFIPLLMTLGIFDHKWPPFAVDLTMELYQHLESKEWFVQLYYHGKEQVPRGCPDGLCPLDMFLNAMSVYTLSPEKYHALCSQTQVMEVGNEE","Homo sapiens","ACP6, ACPL1, LPAP, UNQ205/PRO231","Lysophosphatidic acid phosphatase type 6","1","4JOC"
"4JOD",,"X-RAY DIFFRACTION",2.66,54,"VAPOR DIFFUSION, HANGING DROP",8,"0.02M citric acid, 0.08M bis-tris propane, 16% PEG3350, pH 8.0, vapor diffusion, hanging drop, temperature 289K",289,"10.1007/s13238-013-3031-z",,"4JOD",45.49,"2.21","2.21","Crystal structure of human lysophosphatidic acid phosphatase type 6 complexed with Tris","ELQEADGQCPVDRSLLKLKMVQVVFRHGARSPLKPLPLEEQVEWNPQLLEVPPQTQFDYTVTNLAGGPKPYSPYDSQYHETTLKGGMFAGQLTKVGMQQMFALGERLRKNYVEDIPFLSPTFNPQEVFIRSTNIFRNLESTRCLLAGLFQCQKEGPIIIHTDEADSEVLYPNYQSCWSLRQRTRGRRQTASLQPGISEDLKKVKDRMGIDSSDKVDFFILLDNVAAEQAHNLPSCPMLKRFARMIEQRAVDTSLYILPKEDRESLQMAVGPFLHILESNLLKAMDSATAPDKIRKLYLYAAHDVTFIPLLMTLGIFDHKWPPFAVDLTMELYQHLESKEWFVQLYYHGKEQVPRGCPDGLCPLDMFLNAMSVYTLSPEKYHALCSQTQVMEVGNEE","Homo sapiens","ACP6, ACPL1, LPAP, UNQ205/PRO231","Lysophosphatidic acid phosphatase type 6","1","4JOD"
"4JOE",,"X-RAY DIFFRACTION",2.06,40.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"31% (w/v) polyethylene glycol (PEG) 3350, 0.05 M sodium chloride, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.09.019",,"4JOE",20.95,"1.14","1.14","CFTR Associated Ligand (CAL) PDZ domain bound to peptide A-iCAL36 (ANSRAPTSII)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4JOE"
,,,,,,,,,,,,,,,,"ANSRAPTSII",,,"A-iCAL36 peptide","2","4JOE"
"4JOF",,"X-RAY DIFFRACTION",2.01,38.83,"VAPOR DIFFUSION, HANGING DROP",7.95,"36% (w/v) polyethylene glycol (PEG)8000, 0.2 M sodium chloride, 0.01 M tris(hydroxymethyl)aminomethane (Tris) hydrochloride (HCl), pH 7.95, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.09.019",,"4JOF",21.04,"1.2","1.2","CFTR Associated Ligand (CAL) PDZ domain bound to peptide L-iCAL36 (ANSRLPTSII)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4JOF"
,,,,,,,,,,,,,,,,"ANSRLPTSII",,,"L-iCAL36 peptide","2","4JOF"
"4JOG",,"X-RAY DIFFRACTION",2.07,40.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"40% (w/v) polyethylene glycol (PEG), 0.2 M sodium chloride, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.09.019",,"4JOG",21.1,"1.465","1.465","CFTR Associated Ligand (CAL) PDZ domain bound to peptide V-iCAL36 (ANSRVPTSII)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4JOG"
,,,,,,,,,,,,,,,,"ANSRVPTSII",,,"V-iCAL36 peptide","2","4JOG"
"4JOH",,"X-RAY DIFFRACTION",2.01,38.81,"VAPOR DIFFUSION, HANGING DROP",7.5,"35% (w/v) polyethylene glycol (PEG), 0.15 M sodium chloride, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.09.019",,"4JOH",21.18,"1.47","1.47","CFTR Associated Ligand (CAL) PDZ domain bound to peptide H-iCAL36 (ANSRHPTSII)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4JOH"
,,,,,,,,,,,,,,,,"ANSRHPTSII",,,"H-iCAL36 peptide","2","4JOH"
"4JOJ",,"X-RAY DIFFRACTION",2.03,39.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"34% (w/v) polyethylene glycol (PEG), 0.15 M sodium chloride, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.09.019",,"4JOJ",21.2,"1.2","1.2","CFTR Associated Ligand (CAL) domain bound to peptide F-iCAL36 (ANSRFPTSII)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4JOJ"
,,,,,,,,,,,,,,,,"ANSRFPTSII",,,"F-iCAL36 peptide","2","4JOJ"
"4JOK",,"X-RAY DIFFRACTION",2.01,38.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"34% (w/v) polyethylene glycol (PEG), 0.05 M sodium chloride, 0.1 M Tris(hydroxymethyl)aminomethane (Tris), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.09.019",,"4JOK",21.23,"1.09","1.09","CFTR Associated Ligand (CAL) PDZ domain bound to peptide Y-iCAL36 (ANSRYPTSII)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4JOK"
,,,,,,,,,,,,,,,,"ANSRYPTSII",,,"Y-iCAL36 peptide","2","4JOK"
"4JON",,"X-RAY DIFFRACTION",2.91,57.66,"VAPOR DIFFUSION, SITTING DROP",8,"59% 2-methyl-2,4-pentanediol, 0.1M Bicine pH 8.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4JON",73.01,"2.15","2.15","Crystal structure of a centrosomal protein 170kDa, transcript variant beta (CEP170) from Homo sapiens at 2.15 A resolution (PSI Community Target, Sundstrom)","SMSLTSWFLVSSGGTRHRLPREMIFVGRDDCELMLQSRSVDKQHAVINYDASTDEHLVKDLGSLNGTFVNDVRIPEQTYITLKLEDKLRFGYDTNLFTVVQGEMRVPEEALKHEKFTIQLQLSQKSS","Homo sapiens","CEP170, FAM68A, KAB, KIAA0470, NM_001042404","Centrosomal protein of 170 kDa","1","4JON"
"4JOO",,"X-RAY DIFFRACTION",2.15,42.72,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M NaAcetate, 5% DMSO , pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm4002154","1M4","4JOO",45.9,"1.8","1.8","Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4JOO"
"4JP4",,"X-RAY DIFFRACTION",2.27,45.81,"VAPOR DIFFUSION, HANGING DROP",8.5,"27.5% PEG 4000, 1.25M AmFormate, 100mM TrisHCl pH 8.5 , VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.05.089",,"4JP4",40.53,"1.43","1.43","Mmp13 in complex with a reverse hydroxamate Zn-binder","MEYNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPN","Homo sapiens","MMP13","Collagenase 3","1","4JP4"
"4JP9",,"X-RAY DIFFRACTION",2.15,42.86,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M NaAcetate, 5% DMSO , pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm4002154","1M5","4JP9",45.93,"1.8","1.8","Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4JP9"
"4JPA",,"X-RAY DIFFRACTION",2.23,44.89,"VAPOR DIFFUSION, HANGING DROP",8.5,"27.5% PEG 4000 1.25M AmFormate, 100mM TrisHCl pH 8.5 , VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.05.089","AZ6","4JPA",40.43,"2","2","Mmp13 in complex with a piperazine hydantoin ligand","MEYNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPN","Homo sapiens","MMP13","Collagenase 3","1","4JPA"
"4JPC",,"X-RAY DIFFRACTION",2.15,42.79,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M Na Acetate, 5% DMSO , pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm4002154","1M6","4JPC",45.86,"1.8","1.8","Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4JPC"
"4JPE",,"X-RAY DIFFRACTION",2.16,43.08,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M NaAcetate, 5% DMSO , pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm4002154","1M7","4JPE",45.84,"1.8","1.8","Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4JPE"
"4JPG",,"X-RAY DIFFRACTION",2.32,46.96,"VAPOR DIFFUSION",6,"Well:  0.1 M Bis-Tris, pH 6.0; 0.1 M Ammonium acetate; 30% (w/v) PEG-3350. Compound soaked in to apo crystals, VAPOR DIFFUSION, temperature 286K",286,"10.1016/j.bmcl.2013.03.090",,"4JPG",245.73,"2.33","2.33","2-((1H-benzo[d]imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as Novel PKM2 Activators","GSMKHHHHHHDYGILTTENLYFQGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase isozymes M1/M2","1","4JPG"
"4JPI",,"X-RAY DIFFRACTION",2.67,53.87,"VAPOR DIFFUSION, SITTING DROP",8,"20% w/v PEG3350, 0.2 M lithium citrate, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1126/science.1234150",,"4JPI",99.65,"2.1","2.1","Crystal structure of a putative VRC01 germline precursor Fab","QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGKNCDYNWDFQHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTKLGGSGGHHHHHHGGSGHG","Homo sapiens",,"Putative VRC01 germline Fab heavy chain","1","4JPI"
,,,,,,,,,,,,,,,,"EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYEFFGQGTKLEIKRSTVAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Putative VRC01 germline Fab light chain","2","4JPI"
"4JQ1",,"X-RAY DIFFRACTION",2.66,53.69,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2 M diammonium-L-tartrate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,"NPS","4JQ1",78.03,"1.6","1.6","AKR1C2 complex with naproxen","MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEYLEHHHHHH","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","4JQ1"
"4JQ2",,"X-RAY DIFFRACTION",2.67,53.91,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2 M diammonium-L-tartrate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4JQ2",78.11,"1.75","1.75","AKR1C2 complex with sulindac","MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEYLEHHHHHH","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","4JQ2"
"4JQ3",,"X-RAY DIFFRACTION",2.67,53.99,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2 M diammonium-L-tartrate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4JQ3",78.49,"1.75","1.75","AKR1C2 complex with zomepirac","MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEYLEHHHHHH","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","4JQ3"
"4JQ4",,"X-RAY DIFFRACTION",2.66,53.78,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2 M diammonium-L-tartrate , VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,"IMN","4JQ4",78.53,"1.52","1.52","AKR1C2 complex with indomethacin","MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEYLEHHHHHH","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","4JQ4"
"4JQ5",,"X-RAY DIFFRACTION",2.7,54.49,"VAPOR DIFFUSION, HANGING DROP",8,"10% glycerol, 28% dioxane, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 294.0K",294,"10.1126/science.aac9176",,"4JQ5",121.66,"2.195","2.195","Crystal structure of the human Nup49CCS2+3* coiled-coil segment","SAPADYFRILVQQFEVQLQQYRQQIEELENHLATQANNSHITPQDLSMAMQKIYQTFVALAAQLQSIHENVKVLKEQYLGYRKMFL","Homo sapiens","NUPL1, KIAA0410, NUP58","Nucleoporin p58/p45","1","4JQ5"
"4JQ7",,"X-RAY DIFFRACTION",3.46,64.47,"VAPOR DIFFUSION, HANGING DROP",7,"1.0M Ammonium citrate tribase, 0.1M Bis-Tris propane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm400072p","KJQ","4JQ7",37.81,"2.73","2.73","Crystal structure of EGFR kinase domain in complex with compound 2a","GPGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQ","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4JQ7"
"4JQ8",,"X-RAY DIFFRACTION",3.52,65.06,"VAPOR DIFFUSION, HANGING DROP",7,"1.0M Ammonium citrate tribase, 0.1M Bis-Tris propane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm400072p","KJ8","4JQ8",37.92,"2.83","2.83","Crystal structure of EGFR kinase domain in complex with compound 4b","GPGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQ","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4JQ8"
"4JQA",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",5.9,"20% PEG 3350, 0.2M diammonium l-tartrate , pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,"ID8","4JQA",78.2,"1.45","1.45","AKR1C2 complex with mefenamic acid","MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEYLEHHHHHH","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","4JQA"
"4JQF",,"X-RAY DIFFRACTION",3.08,60.09,"VAPOR DIFFUSION",8.5,"1.6 M Ammonium phosphate dibasic, 100 mM Tris,    
3% Ethylene glycol, pH 8.5, VAPOR DIFFUSION, Microbatch Crystallization, temperature 289.15K",289.15,"10.1371/journal.pone.0066756",,"4JQF",20.47,"1.6","1.6","Structure of the C-terminal domain of human telomeric Stn1","AEALSNPGALDLPSLTSLLSEKAKEFLMENRVQSFYQQELEMVESLLSLANQPVIHSASSDQVNFKKDTTSKAIHSIFKNAIQLLQEKGLVFQKDDGFDNLYYVTREDKDLHRKIHRIIQQDCQKPNHMEKGCHFLHILACARLSIRPGLSEAVLQQVLELLEDQSDIVSTMEHYYTAF","Homo sapiens","OBFC1, STN1","CST complex subunit STN1","1","4JQF"
"4JQG",,"X-RAY DIFFRACTION",2.16,43.18,"VAPOR DIFFUSION, SITTING DROP",6,"Protein: hMMP9 E402A at 420 microM + AHA 120mM 0.12 M acetohydroxamic acid and 0.5 microL IT34-F at 10 milli-M.    
Reservoir: 10% PEG 20K, 0.1 M MMT (L-malic acid, MES, Tris) 75% acid/25% basic, 0.5 M NaCl, 0.02 SrCl2, 10% glycerol.  
Cryoprotectant: 10% Di-ethylene glycol, 5% glycerol, 10% propanediol, 5% dioxane, .8 M Li formate, 9% PEG 10,000 0.1M (MMT 75/25), pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.chembiol.2014.01.008",,"4JQG",40.33,"1.849","1.849","Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic synthetic peptidic substrate with a fluorine atom.","XPLGFXARX",,,"fluorogenic peptidic substrate (8MC)PLG(PFF)(DNW)AR(NH2)","1","4JQG"
,,,,,,,,,,,,,,,,"GFQTFEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVGYSLFLVAAHAFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG","Homo sapiens","CLG4B, MMP9","Matrix metalloproteinase-9","2","4JQG"
,,,,,,,,,,,,,,,,,"Homo sapiens","CLG4B, MMP9"
"4JQL",,"X-RAY DIFFRACTION",2.08,40.82,"VAPOR DIFFUSION",8.5,"0.1 M Tris HCl, 0.2 M MgCl2, 30% PEG4000, pH 8.5, VAPOR DIFFUSION, temperature 277K",277,"10.1002/anie.201301323","VJ6","4JQL",28.55,"1.72","1.72","Synthesis of Benzoquinone-Ansamycin-Inspired Macrocyclic Lactams from Shikimic Acid","MGSSHHHHHHSSGLVPRGSHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4JQL"
"4JQY",,"X-RAY DIFFRACTION",2.15,42.83,"VAPOR DIFFUSION, HANGING DROP",5,"10 mM Tris, pH 8.0, 10 mM DTT, 50 mM sodium chloride, 10% PEG3350, 200 mM ammonium citrate, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1306759110",,"4JQY",56.63,"2.495","2.495","Human procaspase-3, crystal form 1","SNADNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQAARGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Procaspase-3","1","4JQY"
"4JQZ",,"X-RAY DIFFRACTION",1.95,37.05,"VAPOR DIFFUSION, HANGING DROP",4.9,"10 mM Tris, pH 8.0, 10 mM DTT, 50 mM sodium chloride, 16% PEG3350, 150 mM ammonium citrate, pH 4.9, 1 mM 1541 derivative, 5% DMSO, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1306759110",,"4JQZ",56.63,"2.889","2.889","Human procaspase-3, crystal form 2","SNADNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQAARGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Procaspase-3","1","4JQZ"
"4JR0",,"X-RAY DIFFRACTION",2.34,47.49,"VAPOR DIFFUSION, HANGING DROP",8,"10 mM Tris, pH 8.0, 10 mM DTT, 50 mM sodium chloride, 10% PEG3350, 250 mM calcium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1306759110",,"4JR0",57.75,"1.796","1.796","Human procaspase-3 bound to Ac-DEVD-CMK","SNADNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETASGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Procaspase-3","1","4JR0"
,,,,,,,,,,,,,,,,"XDEVDX",,,"Ac-DEVD-CMK","2","4JR0"
"4JR1",,"X-RAY DIFFRACTION",2.01,38.67,"VAPOR DIFFUSION, HANGING DROP",8,"10 mM Tris, pH 8.0, 2 mM DTT, 50 mM sodium chloride, 200 mM ammonium formate, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1306759110",,"4JR1",57.78,"2.149","2.149","Human procaspase-7 bound to Ac-DEVD-CMK","SNATYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQAASGPINDTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Procaspase-7","1","4JR1"
,,,,,,,,,,,,,,,,"XDEVDX",,,"Ac-DEVD-CMK","2","4JR1"
"4JR2",,"X-RAY DIFFRACTION",2,38.42,"VAPOR DIFFUSION, HANGING DROP",6.5,"10 mM Tris, pH 8.0, 2 mM DTT, 50 mM sodium chloride, 200 mM sodium/potassium phosphate, 100 mM Bis-Tris propane, pH 6.5, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1306759110",,"4JR2",57.77,"1.65","1.65","Human procaspase-7/caspase-7 heterodimer bound to Ac-DEVD-CMK","SNATYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQAASGPINDTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Procaspase-7","1","4JR2"
,,,,,,,,,,,,,,,,"XDEVDX",,,"Ac-DEVD-CMK","2","4JR2"
"4JR3",,"X-RAY DIFFRACTION",3.44,64.3,"VAPOR DIFFUSION, HANGING DROP",7,"1.0M Ammonium citrate tribase, 0.1M Bis-Tris propane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm400072p","KJR","4JR3",37.87,"2.7","2.7","Crystal structure of EGFR kinase domain in complex with compound 3g","GPGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQ","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4JR3"
"4JR5",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, HANGING DROP",,"crystals were grown from 0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1021/jm400186h","1LS","4JR5",115.17,"1.906","1.906","Structure-based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4JR5"
"4JRV",,"X-RAY DIFFRACTION",3.49,64.81,"VAPOR DIFFUSION, HANGING DROP",7,"1.0M Ammonium citrate tribase, 0.1M Bis-Tris propane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm400072p","KJV","4JRV",37.94,"2.8","2.8","Crystal structure of EGFR kinase domain in complex with compound 4c","GPGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQ","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4JRV"
"4JRZ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION",6.4,"2.2 M NH4SO4, 0.2 M NaCl, 0.1 M Na-cacadylate, pH 6.4, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M113.534628",,"4JRZ",19.57,"2.4","2.4","Human LTC4 synthase in complex with product analogs - implications for enzyme catalysis","MHHHHHHKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALFLLVALAALGLLAHFLPAALRAALLGRLRTLLPWA","Homo sapiens","LTC4S","Leukotriene C4 synthase","1","4JRZ"
"4JS1",,"X-RAY DIFFRACTION",2.71,54.63,"VAPOR DIFFUSION, SITTING DROP",5.8,"0.1M MES/NaOH, pH 5.8, 20% PEG 2000 MME, 0.01M CaCl2, 0.01M MgCl2, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1107/S0907444913015412",,"4JS1",38.8,"2.09","2.09","crystal structure of human Beta-galactoside alpha-2,6-sialyltransferase 1 in complex with cytidine and phosphate","PEASFQVWNKDSSSKNLIPRLQKIWKNYLSMNKYKVSYKGPGPGIKFSAEALRCHLRDHVNVSMVEVTDFPFNTSEWEGYLPKESIRTKAGPWGRCAVVSSAGSLKSSQLGREIDDHDAVLRFNGAPTANFQQDVGTKTTIRLMNSQLVTTEKRFLKDSLYNEGILIVWDPSVYHSDIPKWYQNPDYNFFNNYKTYRKLHPNQPFYILKPQMPWELWDILQEISPEEIQPNPPSSGMLGIIIMMTLCDQVDIYEFLPSKRKTDVCYYYQKFFDSACTMGAYHPLLYEKNLVKHLNQGTDEDIYLLGKATLPGFRTIHC","Homo sapiens","ST6GAL1, SIAT1","Beta-galactoside alpha-2,6-sialyltransferase 1","1","4JS1"
"4JS2",,"X-RAY DIFFRACTION",2.58,52.33,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M HEPES/NaOH, pH 7.0, 20% PEG 550 MME, 0.01M CaCl2, 0.01M MgCl2, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1107/S0907444913015412","C","4JS2",38.93,"2.3","2.3","Crystal structure of human Beta-galactoside alpha-2,6-sialyltransferase 1 in complex with CMP","PEASFQVWNKDSSSKNLIPRLQKIWKNYLSMNKYKVSYKGPGPGIKFSAEALRCHLRDHVNVSMVEVTDFPFNTSEWEGYLPKESIRTKAGPWGRCAVVSSAGSLKSSQLGREIDDHDAVLRFNGAPTANFQQDVGTKTTIRLMNSQLVTTEKRFLKDSLYNEGILIVWDPSVYHSDIPKWYQNPDYNFFNNYKTYRKLHPNQPFYILKPQMPWELWDILQEISPEEIQPNPPSSGMLGIIIMMTLCDQVDIYEFLPSKRKTDVCYYYQKFFDSACTMGAYHPLLYEKNLVKHLNQGTDEDIYLLGKATLPGFRTIHC","Homo sapiens","ST6GAL1, SIAT1","Beta-galactoside alpha-2,6-sialyltransferase 1","1","4JS2"
"4JS3",,"X-RAY DIFFRACTION",3.44,64.27,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate pH 4.8, 40mM UDAO, 20.8mM  
      N,N-dimethyldecylamine-N-oxide(DDAO), 2mM DHO, 2.4-2.6M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4JS3",44.52,"2","2","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 057","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4JS3"
"4JS6",,"X-RAY DIFFRACTION",2.05,39.98,"VAPOR DIFFUSION, HANGING DROP",8,"3.0 M Ammonium Sulfate, 50 mM HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/ic400295f",,"4JS6",29.65,"1.55","1.55","Crystal structure of inhibitor-free hCAII H94D","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFDFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4JS6"
"4JS8",,"X-RAY DIFFRACTION",3.31,62.86,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M Ammonium Sulfate 
0.1M HEPES pH7.5 
25% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4JS8",33.63,"1.94","1.94","Crystal structure of TTK kinase domain with an inhibitor: 401348","NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","4JS8"
"4JSA",,"X-RAY DIFFRACTION",2.08,40.73,"VAPOR DIFFUSION, HANGING DROP",8,"3.0 M Ammonium Sulfate, 50 mM HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/ic400295f","FB2, SO4","4JSA",30.06,"1.5","1.5","Benzenesulfonamide complexed with hCAII H94D","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFDFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4JSA"
"4JSR",,"X-RAY DIFFRACTION",2.89,57.51,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH 8.0, 20% PEG 4000 or 20% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.1021/jm400204k","1NQ","4JSR",32.16,"1.7","1.7","Crystal Structure of human SIRT3 with ELT inhibitor 11c [N-{2-[1-(6-carbamoylthieno[3,2-d]pyrimidin-4-yl)piperidin-4-yl]ethyl}-N'-ethylthiophene-2,5-dicarboxamide]","SNASDKGKLSLQDVAELIRARACQRVVVMVGAGISTPSGIPDFRSPGSGLYSNLQQYDLPYPEAIFELPFFFHNPKPFFTLAKELYPGNYKPNVTHYFLRLLHDKGLLLRLYTQNIDGLERVSGIPASKLVEAHGTFASATCTVCQRPFPGEDIRADVMADRVPRCPVCTGVVKPDIVFFGEPLPQRFLLHVVDFPMADLLLILGTSLEVEPFASLTEAVRSSVPRLLINRDLVGPLAWHPRSRDVAQLGDVVHGVESLVELLGWTEEMRDLVQRETGKLDGPDK","Homo sapiens","SIRT3, SIR2L3","NAD-dependent protein deacetylase sirtuin-3, mitochondrial","1","4JSR"
"4JSS",,"X-RAY DIFFRACTION",2.08,40.97,"VAPOR DIFFUSION, HANGING DROP",8,"3.0 M ammonium sulfate, 50 mM HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/ic400295f","BEW, SO4","4JSS",29.88,"1.5","1.5","Human carbonic anhydrase II H94D bound to a bidentate inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFDFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4JSS"
"4JSW",,"X-RAY DIFFRACTION",2.04,39.78,"VAPOR DIFFUSION, SITTING DROP",8,"3.0 M ammonium sulfate, 50 mM HEPES, 1 mM DTT, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ic400295f",,"4JSW",29.32,"1.9","1.9","Human carbonic anhydrase II H94C","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFCFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4JSW"
"4JSZ",,"X-RAY DIFFRACTION",2.07,40.67,"VAPOR DIFFUSION, SITTING DROP",8,"3.0 M ammonium sulfate, 50 mM HEPES, 1 mM DTT, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ic400295f","FB2","4JSZ",29.63,"1.9","1.9","Benzenesulfonamide bound to hCAII H94C","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFCFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4JSZ"
"4JT3",,"X-RAY DIFFRACTION",3.26,62.29,"VAPOR DIFFUSION",5.53,"0.2M NaCl 
0.1M Na/K phosphate pH 5.53 
6% PEG5000 MME 
2.5% Glycerol 
3% ethylene glycol, VAPOR DIFFUSION, temperature 293K",293,,,"4JT3",33.87,"2.2","2.2","Crystal Structure of TTK kinase domain with an inhibitor: 400740","NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","4JT3"
"4JT8",,"X-RAY DIFFRACTION",2.86,57.04,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm400204k","1NR","4JT8",32.07,"2.26","2.26","Crystal Structure of human SIRT3 with ELT inhibitor 28 [4-(4-{2-[(2,2-dimethylpropanoyl)amino]ethyl}piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide[","SNASDKGKLSLQDVAELIRARACQRVVVMVGAGISTPSGIPDFRSPGSGLYSNLQQYDLPYPEAIFELPFFFHNPKPFFTLAKELYPGNYKPNVTHYFLRLLHDKGLLLRLYTQNIDGLERVSGIPASKLVEAHGTFASATCTVCQRPFPGEDIRADVMADRVPRCPVCTGVVKPDIVFFGEPLPQRFLLHVVDFPMADLLLILGTSLEVEPFASLTEAVRSSVPRLLINRDLVGPLAWHPRSRDVAQLGDVVHGVESLVELLGWTEEMRDLVQRETGKLDGPDK","Homo sapiens","SIRT3, SIR2L3","NAD-dependent protein deacetylase sirtuin-3, mitochondrial","1","4JT8"
"4JT9",,"X-RAY DIFFRACTION",2.95,58.25,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm400204k","1NS","4JT9",32.27,"2.24","2.24","Crystal Structure of human SIRT3 with ELT inhibitor 3 [14-(4-{2-[(methylsulfonyl)amino]ethyl}piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide]","SNASDKGKLSLQDVAELIRARACQRVVVMVGAGISTPSGIPDFRSPGSGLYSNLQQYDLPYPEAIFELPFFFHNPKPFFTLAKELYPGNYKPNVTHYFLRLLHDKGLLLRLYTQNIDGLERVSGIPASKLVEAHGTFASATCTVCQRPFPGEDIRADVMADRVPRCPVCTGVVKPDIVFFGEPLPQRFLLHVVDFPMADLLLILGTSLEVEPFASLTEAVRSSVPRLLINRDLVGPLAWHPRSRDVAQLGDVVHGVESLVELLGWTEEMRDLVQRETGKLDGPDK","Homo sapiens","SIRT3, SIR2L3","NAD-dependent protein deacetylase sirtuin-3, mitochondrial","1","4JT9"
"4JTQ",,"X-RAY DIFFRACTION",2.69,54.27,"VAPOR DIFFUSION, SITTING DROP",5.9,"20% peg 3350, 0.2 M diammonium tartrate, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"FLP","4JTQ",78.46,"1.6","1.6","AKR1C2 complex with flurbiprofen","MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEYLEHHHHHH","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","4JTQ"
"4JTR",,"X-RAY DIFFRACTION",2.71,54.56,"VAPOR DIFFUSION, SITTING DROP",5.9,"20% peg 3350, 0.2 M diammonium tartrate, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"IBP","4JTR",78.23,"1.3","1.3","AKR1C2 complex with ibuprofen","MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEYLEHHHHHH","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","4JTR"
"4JTS",,"X-RAY DIFFRACTION",3.44,64.23,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate pH 4.8, 40mM 
C11DAO, 20.8mM  N,N-dimethyldecylamine-N-oxide (DDAO), 2mM DHO 1.6-1.8 M ammonium sulfate, 2mM 072, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4JTS",44.31,"2.206","2.206","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 072","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4JTS"
"4JTT",,"X-RAY DIFFRACTION",3.44,64.3,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate pH 4.8, 40mM 
C11DAO, 20.8 mM  N,N-dimethyldecylamine-N-oxide(DDAO), 2mM DHO 1.6-1.8M ammonium sulfate, 2mM 072, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4JTT",44.28,"2.1","2.1","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 066","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4JTT"
"4JTU",,"X-RAY DIFFRACTION",3.42,64.09,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate pH 4.8, 40mM UDAO, 20.8mM N,N-dimethyldecylamine-N-oxide(DDAO), 2mM DHO, 1.6-1.8M ammonium sulfate, 1mM inhibitor., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4JTU",44.15,"1.9","1.9","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with brequinar analogue","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4JTU"
"4JU5",,"X-RAY DIFFRACTION",1.85,33.59,"VAPOR DIFFUSION, HANGING DROP",4,"25% (w/v) polyethylene glycol 1500, 25 mM sodium malonate, 37.5 mM imidazole, 37.5 mM boric acid, pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1002/pro.2444",,"4JU5",53.67,"2.28","2.28","Crystal structure of the dimeric form of the bb' domains of human protein disulfide isomerase","GPLGSPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAKQFLQAAEAIDDIPFGITSNSDVFSKYQLDKDGVVLFKKFDEGRNNFEGEVTKENLLDFIKHNQLPLVIEFTEQTAPKIFGGEIKTHILLFLPKSVSDYDGKLSNFKTAAESFKGKILFIFIDSDHTDNQRILEFFGLKKEECPAVRLITLEEEMTKYKPESEELTAERITEFCHRFLEGKIKPHLMSQELPEDWDKQ","Homo sapiens","P4HB, ERBA2L, PDI, PDIA1, PO4DB","Protein disulfide-isomerase","1","4JU5"
"4JUP",,"X-RAY DIFFRACTION",2.31,46.79,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG 5000 MME, 0.2M Ammonium sulfate, 0.1M sodium acetate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0079778",,"4JUP",24.81,"3.2","3.2","Dimeric structure of CARMA1 CARD","ALWDNVECNRHMLSRYINPAKLTPYLRQCKVIDEQDEDEVLNAPMLPSKINRAGRLLDILHTKGQRGYVVFLESLEFYYPELYKLVTGKEPTRRFSLEHHHHHH","Homo sapiens","CARD11, CARMA1","Caspase recruitment domain-containing protein 11","1","4JUP"
"4JUS",,"X-RAY DIFFRACTION",2.22,44.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES (pH 7.5), 0.2M ammonium citrate, 21% PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2013.12.009",,"4JUS",88.44,"2.5","2.5","Crystal structure of a fragment of Human HSPB6","APSVALPVAQVPTDPGHFSVLLDVKHFSPEEIAVKVVGEHVEVHARHEERPDEHGFVAREFHRRYRLPPGVDPAAVTSALSPEGVLSIQAAPASAQAPPPAAAK","Homo sapiens","HSPB6","Heat shock protein beta-6","1","4JUS"
"4JUT",,"X-RAY DIFFRACTION",2.78,55.71,"hanging drop vapor diffusion",7.5,"0.1M HEPES (pH 7.5), 0.2M litium nitrate, 20% PEG 3350, hanging drop vapor diffusion, temperature 277K",277,"10.1016/j.jsb.2013.12.009",,"4JUT",89.49,"2.196","2.196","Crystal structure of a mutant fragment of Human HSPB6","GGSAPSVALPVAQVPTDPGHFSVLLDVKHFSPEEIAVKVVGEHVEVHARHAARPDEHGFVAREFHRRYRLPPGVDPAAVTSALSPEGVLSIQAAPASAQAPPPAAAK","Homo sapiens","HSPB6","Heat shock protein beta-6","1","4JUT"
"4JUY",,"X-RAY DIFFRACTION",3.88,68.26,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.8M K/Na tartrate tetrahydrate, 0.5% PEG MME 5000, 0.1 M BisTris, pH 8.5, vapor diffusion, hanging drop, temperature 291K",291,,,"4JUY",45.35,"2.4","2.4","Crystal structure of the PUB domain of E3 ubiquitin ligase RNF31","MHHHHHHSSGRENLYFQGMPGEEEERAFLVAREELASALRRDSGQAFSLEQLRPLLASSLPLAARYLQLDAARLVRCNAHGEPRNYLNTLSTALNILEKYGRNLLSPQRPRYWRGVKFNNPVFRSTVDAVQGGRDVLRLYGYTEEQPDGLSFPEGQEEPDEHQVATVTLEVLLLRTELSLLLQNTHPRQQALEQLLED","Homo sapiens","RNF31, ZIBRA","E3 ubiquitin-protein ligase RNF31","1","4JUY"
"4JV6",,"X-RAY DIFFRACTION",2.91,57.69,"VAPOR DIFFUSION, SITTING DROP",4.6,"100mM Sodium Acetate, 2.0M NaCl, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature12205","18F","4JV6",18.15,"1.87","1.87","The crystal structure of PDE6D in complex to inhibitor-1","GSMSAKDERAREILRGFKLNWMNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSRELNFSSTEQMEKFRLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLIEAAPESQMMPASVLTGNVIIETKFFDDDLLVSTSRVRLFYV","Homo sapiens","PDE6D, PDED","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta","1","4JV6"
"4JV7",,"X-RAY DIFFRACTION",3.02,59.28,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM HEPES, pH 7.0, 2.1-2.6 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm400293z","1MN","4JV7",11.77,"2.2","2.2","Co-crystal structure of MDM2 with inhibitor (2S,5R,6S)-2-benzyl-5,6-bis(4-bromophenyl)-4-methylmorpholin-3-one","QIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNGS","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4JV7"
"4JV8",,"X-RAY DIFFRACTION",2.97,58.6,"VAPOR DIFFUSION, SITTING DROP",4.6,"100mM Sodium Acetate(pH4.6) 2.0M NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature12205","1M1","4JV8",18.18,"1.45","1.45","The crystal structure of PDE6D in complex with rac-S1","GSMSAKDERAREILRGFKLNWMNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSRELNFSSTEQMEKFRLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLIEAAPESQMMPASVLTGNVIIETKFFDDDLLVSTSRVRLFYV","Homo sapiens","PDE6D, PDED","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta","1","4JV8"
"4JV9",,"X-RAY DIFFRACTION",3.02,59.27,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM HEPES, pH 7.0, 2.1-2.6 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm400293z","1MO","4JV9",11.77,"2.5","2.5","Co-crystal structure of MDM2 with inhibitor (2S,5R,6S)-2-benzyl-5,6-bis(4-chlorophenyl)-4-methylmorpholin-3-one","QIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNGS","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4JV9"
"4JVB",,"X-RAY DIFFRACTION",2.97,58.53,"VAPOR DIFFUSION, SITTING DROP",4.6,"100mM Sodium Acetate, 2.0M NaCl, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature12205","1M0","4JVB",18.15,"1.75","1.75","Crystal structure of PDE6D in complex with the inhibitor rac-2","GSMSAKDERAREILRGFKLNWMNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSRELNFSSTEQMEKFRLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLIEAAPESQMMPASVLTGNVIIETKFFDDDLLVSTSRVRLFYV","Homo sapiens","PDE6D, PDED","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta","1","4JVB"
"4JVE",,"X-RAY DIFFRACTION",2.36,47.92,"VAPOR DIFFUSION, HANGING DROP",9,"100 mM Bicine, pH 9.0, 1.6 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm400293z","1MQ","4JVE",11.68,"2.3","2.3","Co-crystal structure of MDM2 with inhibitor (2R,3E)-2-[(2S,3R,6S)-2,3-bis(4-chlorophenyl)-6-(4-fluorobenzyl)-5-oxomorpholin-4-yl]pent-3-enoic acid","QIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNGS","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4JVE"
"4JVF",,"X-RAY DIFFRACTION",2.99,58.91,"VAPOR DIFFUSION, SITTING DROP",7.4,"18% PEG 4000, 25mM Sodium Acetate, 200mM Ammonium Sulphate, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature12205","17X","4JVF",18.22,"2.4","2.4","The Crystal structure of PDE6D in complex with the inhibitor (s)-5","GSMSAKDERAREILRGFKLNWMNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSRELNFSSTEQMEKFRLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLIEAAPESQMMPASVLTGNVIIETKFFDDDLLVSTSRVRLFYV","Homo sapiens","PDE6D, PDED","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta","1","4JVF"
"4JVG",,"X-RAY DIFFRACTION",2.1,41.45,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M BisTris propane, 30% PEG 3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nchembio.1257","B96","4JVG",131.11,"3.09","3.09","B-Raf Kinase in Complex with Birb796","GAMDRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4JVG"
"4JVH",,"X-RAY DIFFRACTION",2.73,54.87,"VAPOR DIFFUSION",7.5,"PEG, pH 7.5, VAPOR DIFFUSION, temperature 298.0K",298,"10.1101/gad.216531.113",,"4JVH",27.83,"3.501","3.501","Structure of the star domain of quaking protein in complex with RNA","STKEKPKPTPDYLMQLMNDKKLMSSLPNFCGIFNHLERLLDEEISRVRKDMYNDTLNGSTEKRSAELPDAVGPIVQLQEKLYVPVKEYPDFNFVGRILGPRGLTAKQLEAETGCKIMVRGKGSMRDKKKEEQNRGKPNWEHLNEDLHVLITVEDAQNRAEIKLKRAVEEVKKLLVPAAEGEDSLKKMQLMELAILNGTYRDANIKSPAL","Homo sapiens","QKI, HKQ","Protein quaking","1","4JVH"
,,,,,,,,,,,,,,,,"UUCACUAACAA",,,"RNA (5'-R(*UP*UP*CP*AP*CP*UP*AP*AP*CP*AP*A)-3')","2","4JVH"
"4JVJ",,"X-RAY DIFFRACTION",2.42,49.23,"VAPOR DIFFUSION, HANGING DROP",7,"8% PEG8000, 0.1 M TRIS, 0.2 M magnesium chloride, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295.15K",295.15,"10.1021/jm400946f","1MV","4JVJ",43.73,"2.8","2.8","Crystal structure of human FPPS in complex with magnesium, CL01131, and sulfate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4JVJ"
"4JVL",,"X-RAY DIFFRACTION",2.68,54.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, pH 7.5, 18-24% w/v PEG8000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1289/ehp.1306902",,"4JVL",72.13,"1.943","1.943","Crystal structure of human estrogen sulfotransferase (SULT1E1) in complex with inactive cofactor PAP and estradiol (E2)","MNSELDYYEKFEEVHGILMYKDFVKYWDNVEAFQARPDDLVIATYPKSGTTWVSEIVYMIYKEGDVEKCKEDVIFNRIPFLECRKENLMNGVKQLDEMNSPRIVKTHLPPELLPASFWEKDCKIIYLCRNAKDVAVSFYYFFLMVAGHPNPGSFPEFVEKFMQGQVPYGSWYKHVKSWWEKGKSPRVLFLFYEDLKEDIRKEVIKLIHFLERKPSEELVDRIIHHTSFQEMKNNPSTNYTTLPDEIMNQKLSPFMRKGITGDWKNHFTEALNEKFDKHYEQQMKESTLKFRTEI","Homo sapiens","STE, SULT1E1","Estrogen sulfotransferase","1","4JVL"
"4JVM",,"X-RAY DIFFRACTION",2.67,53.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, pH 7.5, 18-24% w/v PEG8000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1289/ehp.1306902","XDI","4JVM",72.67,"1.994","1.994","Crystal structure of human estrogen sulfotransferase (SULT1E1) in complex with inactive cofactor PAP and brominated flame retardant TBBPA (tetrabromobisphenol A)","MNSELDYYEKFEEVHGILMYKDFVKYWDNVEAFQARPDDLVIATYPKSGTTWVSEIVYMIYKEGDVEKCKEDVIFNRIPFLECRKENLMNGVKQLDEMNSPRIVKTHLPPELLPASFWEKDCKIIYLCRNAKDVAVSFYYFFLMVAGHPNPGSFPEFVEKFMQGQVPYGSWYKHVKSWWEKGKSPRVLFLFYEDLKEDIRKEVIKLIHFLERKPSEELVDRIIHHTSFQEMKNNPSTNYTTLPDEIMNQKLSPFMRKGITGDWKNHFTEALNEKFDKHYEQQMKESTLKFRTEI","Homo sapiens","STE, SULT1E1","Estrogen sulfotransferase","1","4JVM"
"4JVN",,"X-RAY DIFFRACTION",2.65,53.54,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M MES, pH 6.0, 17-22% PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 293KK",293,"10.1289/ehp.1306902","YUG","4JVN",72.44,"2.05","2.05","Crystal structure of human estrogen sulfotransferase (SULT1E1) in complex with inactive cofactor PAP and metabolite of brominated flame retardant 3OH BDE47 (3-hydroxyl bromodiphenyl ether)","MNSELDYYEKFEEVHGILMYKDFVKYWDNVEAFQARPDDLVIATYPKSGTTWVSEIVYMIYKEGDVEKCKEDVIFNRIPFLECRKENLMNGVKQLDEMNSPRIVKTHLPPELLPASFWEKDCKIIYLCRNAKDVAVSFYYFFLMVAGHPNPGSFPEFVEKFMQGQVPYGSWYKHVKSWWEKGKSPRVLFLFYEDLKEDIRKEVIKLIHFLERKPSEELVDRIIHHTSFQEMKNNPSTNYTTLPDEIMNQKLSPFMRKGITGDWKNHFTEALNEKFDKHYEQQMKESTLKFRTEI","Homo sapiens","STE, SULT1E1","Estrogen sulfotransferase","1","4JVN"
"4JVR",,"X-RAY DIFFRACTION",2.18,43.52,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM citrate, pH 5.0, 1.5-2.0 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm400293z","1MT","4JVR",34.99,"1.7","1.7","Co-crystal structure of MDM2 with inhibitor (2'S,3R,4'S,5'R)-N-(2-aminoethyl)-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-2-oxo-1,2-dihydrospiro[indole-3,3'-pyrrolidine]-5'-carboxamide","QIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNGS","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4JVR"
"4JWL",,"X-RAY DIFFRACTION",1.96,37.21,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MGSO4, 18% PEG 5000 MME, 0.1M MES PH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm4009357","HRC","4JWL",25.2,"1.95","1.95","Complexe of ARNO Sec7 domain with the protein-protein interaction inhibitor N-(4-hydroxy-2,6-dimethylphenyl)benzenesulfonamide at pH7.5","MGSSHHHHHHSSGLVPRGSHMSKTLQRNRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKTAIGDYLGEREELNLAVLHAFVDLHEFTDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRYCLCNPGVFQSTDTCYVLSFAVIMLNTSLHNPNVRDKPGLERFVAMNRGINEGGDLPEELLRNLYDSIRNEPFKIPEDDGN","Homo sapiens","CYTH2, ARNO, PSCD2, PSCD2L","Cytohesin-2","1","4JWL"
"4JWM",,"X-RAY DIFFRACTION",2.25,45.28,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, 350 mM Sodium Acetate, 18 % PEG3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ja403842j",,"4JWM",48.41,"2","2","Ternary complex of D256E mutant of DNA Polymerase Beta","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIEIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4JWM"
,,,,,,,,,,,,,,,,"CCGACAGCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*AP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","2","4JWM"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3')","3","4JWM"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","4","4JWM"
"4JWN",,"X-RAY DIFFRACTION",2.22,44.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, 350 mM Sodium Acetate, 18 % PEG3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ja403842j",,"4JWN",48.33,"2.39","2.39","Ternary complex of D256A mutant of DNA Polymerase Beta","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIAIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4JWN"
,,,,,,,,,,,,,,,,"CCGACAGCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*AP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","2","4JWN"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3')","3","4JWN"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","4","4JWN"
"4JWR",,"X-RAY DIFFRACTION",2.16,43.04,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM citrate, pH 5.0, 1.9-2.4 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm400293z","1MY","4JWR",34.65,"2.35","2.35","Co-crystal structure of MDM2 with inhibitor {(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl}acetic acid","SQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4JWR"
"4JX3",,"X-RAY DIFFRACTION",2.97,58.64,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.7 M sodium potassium tartrate, 0.1 M MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,"10.1371/journal.pone.0070358",,"4JX3",37.29,"2.5","2.5","Crystal structure of Pim1 kinase","MLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4JX3"
"4JXF",,"X-RAY DIFFRACTION",2.83,56.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"23% PEG 3350, 
0.1 M HEPES pH 7.5 
0.16 M MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4JXF",31.11,"2.4","2.4","Crystal Structure of PLK4 Kinase with an inhibitor: 400631 ((1R,2S)-2-{3-[(E)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}ETHENYL]-2H-INDAZOL-6-YL}-5'-METHOXYSPIRO[CYCLOPROPANE-1,3'-INDOL]-2'(1'H)-ONE)","CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS","Homo sapiens","PLK4, SAK, STK18","Serine/threonine-protein kinase PLK4","1","4JXF"
"4JXH",,"X-RAY DIFFRACTION",2.4,48.65,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M MgSO4, 18% PEG 5000 MME, 0.1M TRIS- HCL, PH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm4009357","HRC","4JXH",25.29,"1.47","1.47","Complexe of ARNO Sec7 domain with the protein-protein interaction inhibitor N-(4-hydroxy-2,6-dimethylphenyl)benzenesulfonamide at pH 8.5","MGSSHHHHHHSSGLVPRGSHMSKTLQRNRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKTAIGDYLGEREELNLAVLHAFVDLHEFTDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRYCLCNPGVFQSTDTCYVLSFAVIMLNTSLHNPNVRDKPGLERFVAMNRGINEGGDLPEELLRNLYDSIRNEPFKIPEDDGN","Homo sapiens","CYTH2, ARNO, PSCD2, PSCD2L","Cytohesin-2","1","4JXH"
"4JXM",,"X-RAY DIFFRACTION",2.08,40.74,"VAPOR DIFFUSION",7.5,"25% PEG3350, 0.2 M ammonium acetate, 0.1 M HEPES sodium, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,,,"4JXM",41.01,"1.92","1.92","Crystal structure of RRP9 WD40 repeats","MHHHHHHSSGRENLYFQGEQRGRLQKLVAKEIQAPASADIRVLRGHQLSITCLVVTPDDSAIFSAAKDCSIIKWSVESGRKLHVIPRAKKGAEGKPPGHSSHVLCMAISSDGKYLASGDRSKLILIWEAQSCQHLYTFTGHRDAVSGLAFRRGTHQLYSTSHDRSVKVWNVAENSYVETLFGHQDAVAALDALSRECCVTAGGRDGTVRVWKIPEESQLVFYGHQGSIDCIHLINEEHMVSGADDGSVALWGLSKKRPLALQREAHGLRGEPGLEQPFWISSVAALLNTDLVATGSHSSCVRLWQCGEGFRQLDLLCDIPLVGFINSLKFSSSGDFLVAGVGQEHRLGRWWRIKEARNSVCIIPLRRVPVP","Homo sapiens","RRP9, RNU3IP2, U355K","U3 small nucleolar RNA-interacting protein 2","1","4JXM"
"4JY4",,"X-RAY DIFFRACTION",3.56,65.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, pH 7.5, 30% v/v PEG400, 5% w/v PEG3000, 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.ppat.1003342",,"4JY4",49.73,"2.8","2.8","Crystal structure of human Fab PGT121, a broadly reactive and potent HIV-1 neutralizing antibody","QMQLQESGPGLVKPSETLSLTCSVSGASISDSYWSWIRRSPGKGLEWIGYVHKSGDTNYSPSLKSRVNLSLDTSKNQVSLSLVAATAADSGKYYCARTLHGRRIYGIVAFNEWFTYFYMDVWGNGTQVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"PGT121 heavy chain","1","4JY4"
,,,,,,,,,,,,,,,,"SDISVAPGETARISCGEKSLGSRAVQWYQHRAGQAPSLIIYNNQDRPSGIPERFSGSPDSPFGTTATLTITSVEAGDEADYYCHIWDSRVPTKWVFGGGTTLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"PGT121 light chain","2","4JY4"
"4JY5",,"X-RAY DIFFRACTION",2.04,39.56,"VAPOR DIFFUSION, SITTING DROP",10.5,"0.1 M CAPS, pH 10.5, 0.2 M sodium chloride, 20% w/v PEG8000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.ppat.1003342",,"4JY5",48.42,"1.75","1.75","Crystal structure of human Fab PGT122, a broadly reactive and potent HIV-1 neutralizing antibody","TFVSVAPGQTARITCGEESLGSRSVIWYQQRPGQAPSLIIYNNNDRPSGIPDRFSGSPGSTFGTTATLTITSVEAGDEADYYCHIWDSRRPTNWVFGEGTTLIVLSQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"PGT122 light chain","1","4JY5"
,,,,,,,,,,,,,,,,"QVHLQESGPGLVKPSETLSLTCNVSGTLVRDNYWSWIRQPLGKQPEWIGYVHDSGDTNYNPSLKSRVHLSLDKSKNLVSLRLTGVTAADSAIYYCATTKHGRRIYGVVAFKEWFTYFYMDVWGKGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"PGT122 heavy chain","2","4JY5"
"4JY6",,"X-RAY DIFFRACTION",3.21,61.69,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.16 M zinc acetate, 0.08 M sodium cacodylate, pH 6.5, 20% v/v glycerol, 20% w/v PEG8000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.ppat.1003342",,"4JY6",97.06,"2.5","2.5","Crystal structure of human Fab PGT123, a broadly reactive and potent HIV-1 neutralizing antibody","SSMSVSPGETAKISCGKESIGSRAVQWYQQKPGQPPSLIIYNNQDRPAGVPERFSASPDFRPGTTATLTITNVDAEDEADYYCHIYDARGGTNWVFDRGTTLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"PGT123 light chain","1","4JY6"
,,,,,,,,,,,,,,,,"QLHLQESGPGLVKPPETLSLTCSVSGASINDAYWSWIRQSPGKRPEWVGYVHHSGDTNYNPSLKRRVTFSLDTAKNEVSLKLVDLTAADSATYFCARALHGKRIYGIVALGELFTYFYMDVWGKGTAVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"PGT123 heavy chain","2","4JY6"
"4JYO",,"X-RAY DIFFRACTION",3.37,63.46,"VAPOR DIFFUSION, HANGING DROP",7,"1.0 M Na/K-tartate, 0.1 M Tris, 0.2 M LiSO4, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1216890110",,"4JYO",26.35,"2.5","2.5","Structural basis for angiopoietin-1 mediated signaling initiation","AELASEKPFRDCADVYQAGFNKSGIYTIYINNMPEPKKVFCNMDVNGGGWTVIQHREDGSLDFQRGWKEYKMGFGNPSGEYWLGNEFIFAITSQRQYMLRIELMDWEGNRAYSQYDRFHIGNEKQNYRLYLKGHTGTAGKQSSLILHGADFSTKDADNDNCMCKCALMLTGGWWFDACGPSNLNGMFYTAGQNHGKLNGIKWHYFKGPSYSLRSTTMMIRPLDFGSLVPR","Homo sapiens","ANGPT1, KIAA0003","Angiopoietin-1","1","4JYO"
"4JYT",,"X-RAY DIFFRACTION",2.26,45.7,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.1M Tris, 0.2M MgCl2, 20% PEG8000 , pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/ml400213v","N4A","4JYT",27.02,"2","2","Crystal Structure of Matriptase in complex with Inhibitor","VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV","Homo sapiens","ST14, PRSS14, SNC19, TADG15","Suppressor of tumorigenicity 14 protein","1","4JYT"
"4JYU",,"X-RAY DIFFRACTION",3.9,68.46,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2013.06.027","1OK","4JYU",35.46,"1.8","1.8","Structure of factor VIIA in complex with the inhibitor (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-(PHENYLSULFONYL)ETHANAMIDE","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VII light chain","1","4JYU"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VII heavy chain","2","4JYU"
"4JYV",,"X-RAY DIFFRACTION",3.9,68.46,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2013.06.027","1OJ","4JYV",35.53,"2.19","2.19","Structure of factor VIIA in complex with the inhibitor (2R)-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-2-(ISOQUINOLIN-6-YLAMINO)-N-[(3-SULFAMOYLPHENYL)SULFONYL]ETHANAMIDE","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VII light chain","1","4JYV"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VII heavy chain","2","4JYV"
"4JYW",,"X-RAY DIFFRACTION",3.31,62.89,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, 100mM Tris-HCl, pH 8.0 , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"T57","4JYW",84.13,"1.73","1.73","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with CTT1057","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4JYW"
"4JZ0",,"X-RAY DIFFRACTION",3.32,63.01,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5% (w/v) PEG 3350, 100mM Tris-HCl , pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4JZ0",83.32,"1.83","1.83","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with CTT1055","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4JZ0"
"4JZ1",,"X-RAY DIFFRACTION",2.3,46.59,,8.3,"0.1M Tris pH 8.3 0.2M MgCl2, 20% PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/ml400213v","F4D","4JZ1",26.98,"1.9","1.9","Crystal Structure of Matriptase in complex with Inhibitor","VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV","Homo sapiens","ST14, PRSS14, SNC19, TADG15","Suppressor of tumorigenicity 14 protein","1","4JZ1"
"4JZC",,"X-RAY DIFFRACTION",2.52,51.19,"VAPOR DIFFUSION, HANGING DROP",7,"1.0 M Na/K-tartate, 0.1 M Tris, 0.2 M LiSO4, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1216890110",,"4JZC",24.82,"1.9","1.9","Angiopoietin-2 fibrinogen domain TAG mutant","ISFRDCAEVFKSGHTTNGIYTLTFPNSTEEIKAYCDMEAGGGGWTIIQRREDGSVDFQRTWKEYKVGFGNPSGEYWLGNEFVSQLTNQQRYVLKIHLKDWEGNEAYSLYEHFYLSSEELNYRIHLKGLTGTAGKISSISQPGNDFSTKDGDNDKCICKCSQMLTGGWWFDACGPSNLNGMYYTAGQNTNKFNGIKWYYWKGSGYSLKATTMMIRPADF","Homo sapiens","ANGPT2","Angiopoietin-2","1","4JZC"
"4JZD",,"X-RAY DIFFRACTION",3.9,68.48,"VAPOR DIFFUSION, HANGING DROP",5.6,"100 mM bicine, pH 9.0, 1.4-1.9 M lithium sulfate, 5% v/v MPD, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.06.028","1NJ","4JZD",35.91,"2.2","2.2","Structure of factor VIIA in complex with the inhibitor 2-{2-[(4-carbamimidoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","4JZD"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","4JZD"
"4JZE",,"X-RAY DIFFRACTION",3.81,67.68,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM calcium chloride, 17.5% w/v PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.06.028","1NK","4JZE",35.39,"1.52","1.52","Structure of factor VIIA in complex with the inhibitor 2-{2-[(1-aminoisoquinolin-6-yl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","4JZE"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","4JZE"
"4JZF",,"X-RAY DIFFRACTION",3.8,67.59,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM calcium chloride, 17.5% w/v PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.06.028","1NL","4JZF",35.37,"1.84","1.84","Structure of factor VIIA in complex with the inhibitor 2-{2-[(3-carbamoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","4JZF"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","4JZF"
"4JZI",,"X-RAY DIFFRACTION",2.31,46.69,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.1M Tris pH 8.3 0.2M MgCl2, 20% PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/ml400213v","N4C","4JZI",26.95,"2","2","Crystal Structure of Matriptase in complex with Inhibitor"".","VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV","Homo sapiens","ST14, PRSS14, SNC19, TADG15","Suppressor of tumorigenicity 14 protein","1","4JZI"
"4JZL",,"X-RAY DIFFRACTION",2.19,43.84,"VAPOR DIFFUSION",8,"100 mM Tris-HCl, 34% PEG2000 monomethyl ether (mme) and 150 mM KBr, pH 8.0, VAPOR DIFFUSION, temperature 292K",292,"10.1371/journal.pone.0071111",,"4JZL",31.4,"2.2","2.2","Crystal structure of BAP31 vDED at alkaline pH","SMLDVGNAEVKLEEENRSLKADLQKLKDELASTKQKLEKAENQVLAMRKQSEGLTKEYDRLLEEHAKL","Homo sapiens","BCAP31, BAP31, DXS1357E","B-cell receptor-associated protein 31","1","4JZL"
"4JZP",,"X-RAY DIFFRACTION",3.64,66.21,"VAPOR DIFFUSION",4.2,"100 mM Na citrate, 33% PEG400 and 200 mM LiSO4, VAPOR DIFFUSION, temperature 292K, pH 4.2",292,"10.1371/journal.pone.0071111",,"4JZP",16.33,"2.1","2.1","Crystal structure of BAP31 vDED at acidic pH","SMLDVGNAEVKLEEENRSLKADLQKLKDELASTKQKLEKAENQVLAMRKQSEGLTKEYDRLLEEHAKL","Homo sapiens","BCAP31, BAP31, DXS1357E","B-cell receptor-associated protein 31","1","4JZP"
"4JZQ",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, SITTING DROP",6.5,"2% Tacsimate, 0.1M Bis-Tris, 20% PEG3350, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4JZQ",54.22,"1.35","1.35","Crystal structure of human CLIC1 C24D mutant","GSMAEEQPQVELFVKAGSDGAKIGNDPFSQRLFMVLWLKGVTFNVTTVDTKRRTETVQKLCPGGQLPFLLYGTEVHTDTNKIEEFLEAVLCPPRYPKLAALNPESNTAGLDIFAKFSAYIKNSNPALNDNLEKGLLKALKVLDNYLTSPLPEEVDETSAEDEGVSQRKFLDGNELTLADCNLLPKLHIVQVVCKKYRGFTIPEAFRGVHRYLSNAYAREEFASTCPDDEEIELAYEQVAKALK","Homo sapiens","CLIC1, CLIC1 G6 NCC27, G6, NCC27","Chloride intracellular channel protein 1","1","4JZQ"
"4JZR",,"X-RAY DIFFRACTION",2.96,58.42,"VAPOR DIFFUSION, HANGING DROP",4.8,"30% PEG3350, 200mM Ammonium Sulfate, 100mM Sodium Acetate, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmc.2013.08.046","4JR","4JZR",24.75,"2.1","2.1","Structure of Prolyl Hydroxylase Domain-containing Protein (PHD) with Inhibitors","GSFTMPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARA","Homo sapiens","C1orf12, EGLN1, PNAS-118, PNAS-137","Egl nine homolog 1","1","4JZR"
"4K07",,"X-RAY DIFFRACTION",2.28,46.13,"VAPOR DIFFUSION, HANGING DROP",5.5,"15% PEG8000, 443 mM ammonium nitrate, 100 mM sodium acetate, pH 5.5, 666 mM NDSB 201, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2013.10.016",,"4K07",140.58,"2.83","2.83","Crystal structure of the amyloid-forming immunoglobulin AL-103 cis-proline 95 mutant","MRAKLLGIVLTTPIAISSFASTDIQMTQSPSSLSASVGDRVTITCQASQDISNYLIWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYHNLPYTFGPGTKLEIK","Homo sapiens","IGKV1-33","Amyloidogenic immunoglobulin light chain protein AL-103","1","4K07"
"4K0G",,"X-RAY DIFFRACTION",2.29,46.21,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M Calcium acetate hydrate, 20% PEG3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4K0G",28.18,"1.4","1.4","Crystal structure of human CLIC1 C24S mutant","GSMDYKDDDDKAEEQPQVELFVKAGSDGAKIGNSPFSQRLFMVLWLKGVTFNVTTVDTKRRTETVQKLCPGGQLPFLLYGTEVHTDTNKIEEFLEAVLCPPRYPKLAALNPESNTAGLDIFAKFSAYIKNSNPALNDNLEKGLLKALKVLDNYLTSPLPEEVDETSAEDEGVSQRKFLDGNELTLADCNLLPKLHIVQVVCKKYRGFTIPEAFRGVHRYLSNAYAREEFASTCPDDEEIELAYEQVAKALK","Homo sapiens","CLIC1, CLIC1 G6 NCC27, G6, NCC27","Chloride intracellular channel protein 1","1","4K0G"
"4K0N",,"X-RAY DIFFRACTION",2.12,41.95,"VAPOR DIFFUSION, SITTING DROP",5,"0.2M Sodium malonate, 20% PEG3350, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4K0N",27.17,"1.25","1.25","Crystal structure of human CLIC1 C24A mutant","GSMAEEQPQVELFVKAGSDGAKIGNAPFSQRLFMVLWLKGVTFNVTTVDTKRRTETVQKLCPGGQLPFLLYGTEVHTDTNKIEEFLEAVLCPPRYPKLAALNPESNTAGLDIFAKFSAYIKNSNPALNDNLEKGLLKALKVLDNYLTSPLPEEVDETSAEDEGVSQRKFLDGNELTLADCNLLPKLHIVQVVCKKYRGFTIPEAFRGVHRYLSNAYAREEFASTCPDDEEIELAYEQVAKALK","Homo sapiens","CLIC1, CLIC1 G6 NCC27, G6, NCC27","Chloride intracellular channel protein 1","1","4K0N"
"4K0S",,"X-RAY DIFFRACTION",2.13,42.3,"VAPOR DIFFUSION, HANGING DROP",8,"1.7 M sodium citrate, 50 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"AZM","4K0S",29.19,"1.802","1.802","Structure of HCAIX mimic (HCAII with 5 mutations in active site) in complex with acetazolamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDLGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2, hCAII","Carbonic anhydrase 2","1","4K0S"
"4K0T",,"X-RAY DIFFRACTION",2.08,40.75,"VAPOR DIFFUSION, HANGING DROP",8,"1.6 M sodium citrate, 50 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"D9Z","4K0T",29.49,"1.78","1.78","Structure of HCAIX mimic (HCAII with 5 mutations in active site) in complex with chlorzolamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDLGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4K0T"
"4K0Y",,"X-RAY DIFFRACTION",3.46,64.41,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG4000, 0.2 M lithium sulfate, 0.1 M Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.bmcl.2013.04.020","1OA","4K0Y",32.06,"1.954","1.954","Structure of PIM-1 kinase bound to N-(4-fluorophenyl)-7-hydroxy-5-(piperidin-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide","PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS","Homo sapiens","PIM-1, PIM1","Serine/threonine-protein kinase pim-1","1","4K0Y"
"4K0Z",,"X-RAY DIFFRACTION",2.04,39.79,"VAPOR DIFFUSION, HANGING DROP",8,"1.6 M sodium citrate, 50 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"MZM","4K0Z",29.8,"1.799","1.799","Structure of HCAIX mimic (HCAII with 5 mutations in active site) in complex with methazolamide","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDLGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4K0Z"
"4K11",,"X-RAY DIFFRACTION",3.11,60.47,"VAPOR DIFFUSION, HANGING DROP",6.5,"50 mM PIPES, pH 6.5, 12% PEG4000, 10 mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,"0J9, PTR","4K11",51.53,"2.3","2.3","The structure of 1NA in complex with Src T338G","TTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE","Homo sapiens","SRC, SRC1","Proto-oncogene tyrosine-protein kinase Src","1","4K11"
"4K13",,"X-RAY DIFFRACTION",2.11,41.73,"VAPOR DIFFUSION, HANGING DROP",8,"1.6 M sodium citrate, 50 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"ETS","4K13",29.45,"1.6","1.6","Structure of HCAIX mimic (HCAII with 5 mutations in active site) in complex with dorzolamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDLGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4K13"
"4K18",,"X-RAY DIFFRACTION",3.3,62.76,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG4000, 0.2 M lithium sulfate, 0.1 M Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.bmcl.2013.04.020","1OB","4K18",32.42,"2.051","2.051","Structure of PIM-1 kinase bound to 5-(4-cyanobenzyl)-N-(4-fluorophenyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxamide","EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLS","Homo sapiens","PIM-1, PIM1","Serine/threonine-protein kinase pim-1","1","4K18"
"4K19",,"X-RAY DIFFRACTION",3.13,60.72,"VAPOR DIFFUSION, HANGING DROP",4.5,"1.2M ammonium sulfate, 0.2M lithium sulfate, 0.1M sodium chloride, 0.1M sodium acetate , pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/cb4002552","1OD","4K19",64.72,"2.74","2.74","The structure of Human Siderocalin bound to the bacterial siderophore fluvibactin","GSQDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","4K19"
"4K1B",,"X-RAY DIFFRACTION",3.54,65.27,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG4000, 0.2 M lithium sulfate, 0.1 M Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.bmcl.2013.04.020","1OC","4K1B",32.12,"2.082","2.082","Structure of PIM-1 kinase bound to N-(5-(2-fluorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-((((3R,4R)-3-fluoropiperidin-4-yl)methyl)amino)pyrazolo[1,5-a]pyrimidine-3-carboxamide","PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM-1, PIM1","Serine/threonine-protein kinase pim-1","1","4K1B"
"4K1L",,"X-RAY DIFFRACTION",2.52,51.11,"VAPOR DIFFUSION, HANGING DROP",6.5,"40% PEG300, 0.1M MES, pH 6.5, vapor diffusion, temperature 277K, VAPOR DIFFUSION, HANGING DROP",277,"10.1016/j.bmcl.2013.05.102","SFF","4K1L",131.47,"1.96","1.96","4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 beta-HSD1 inhibitors for the treatment of diabetes","MKHQHQHQHQHQHQQPLNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","4K1L"
"4K1Q",,"X-RAY DIFFRACTION",1.91,35.55,"VAPOR DIFFUSION, HANGING DROP",8,"1.6 M sodium citrate, 50 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4K1Q",29.17,"1.699","1.699","Structure of hCAIX mimic (hCAII with 5 mutations in active site)","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDLGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4K1Q"
"4K2C",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION",7,"25-30% PEG 3350, pH 7, VAPOR DIFFUSION, temperature 298K",298,"10.1074/jbc.M113.467027",,"4K2C",133.14,"3.23","3.23","HSA Ligand Free","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","4K2C"
"4K2O",,"X-RAY DIFFRACTION",2.32,47.02,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M calcium chloride, 0.1 M Tris, 20% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S1744309113014206",,"4K2O",31.18,"2.15","2.15","The Structure of a Triple Mutant of the Tiam1 PH-CC-Ex Domain","GAAAQGTVRKAGALAVKNFLVHKKNKKVESATRRKWKHYWVSLKGCTLFFYESDGRSGIDHNSIPKHAVWVENSIVQAVPEHPKKDFVFCLSNSLGDAFLFQTTSQTELENWITAIHSACATAVARHHHKEDTLRLLKSEIKKLEQKIDMDEKMKKMGEMQLSSVTDSKAAATILDQIFVWEQNLEQFQMDLFRFRCYLASLQGGELPNPKRLLAFASRPTKVAMGRLGIFSVSSFHALVAARTGETGVRRRTQAMSRSASKRRSRFSSLWGLDTT","Homo sapiens","TIAM1","T-lymphoma invasion and metastasis-inducing protein 1","1","4K2O"
"4K2P",,"X-RAY DIFFRACTION",1.99,38.09,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M lithium sulfate, 0.1 M Tris, 19% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S1744309113014206",,"4K2P",124.86,"1.98","1.98","The Structure of a Quintuple Mutant of the Tiam1 PH-CC-Ex Domain","GSAAQGTVRKAGALAVKNFLVHKKNKKVESATRRKWKHYWVSLKGCTLFFYESDGRSGIDHNSIPKHAVWVENSIVQAVPEHPKKDFVFCLSNSLGDAFLFQTTSQTELENWITAIHSACATAVARHHHKEDTLRLLKSEIKKLEQKIDMDEKLKKMGELQLSSVTDSKAAATILDQIFVWEQNLEQFQMDLFRFRCYLASLQGGELPNPKRLLAFASRPTKVAMGRLGIFSVSSFHALVAARTGETGVRRRTQAMSRSASKRRSRFSSLWGLDTT","Homo sapiens","TIAM1","T-lymphoma invasion and metastasis-inducing protein 1","1","4K2P"
"4K2R",,"X-RAY DIFFRACTION",2.36,47.84,"VAPOR DIFFUSION, SITTING DROP",9.5,"0.1 M Bis-Tris pH 6.5, 20% Polyethylene glycol monomethyl ether 5,000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1128/MCB.01637-12",,"4K2R",70.18,"3","3","Structural basis for activation of ZAP-70 by phosphorylation of the SH2-kinase linker","MPDPAAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVHDVRFHHFPIERQLNGTYAIAGGKAHCGPAELCEFYSRDPDGLPCNLRKPCNRPSGLEPQPGVFDCLRDAMVRDYVRQTWKLEGEALEQAIISQAPQVEKLIATTAHERMPWYHSSLTREEAERKLYSGAQTDGKFLLRPRKEQGTYALSLIYGKTVYHYLISQDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVYESPYSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSGLEVLF","Homo sapiens","ZAP70, SRK","Tyrosine-protein kinase ZAP-70","1","4K2R"
"4K2Y",,"X-RAY DIFFRACTION",2.75,55.31,"VAPOR DIFFUSION",8,"26-33% PEG8000, 0.1 M Tris, pH 8.0, 2 mM zinc sulfate, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm400138z","ES2","4K2Y",25.45,"2.3","2.3","Crystal Structure of Human Chymase in Complex with Fragment Inhibitor 6-chloro-1,3-dihydro-2H-indol-2-one","IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGAAQGIVSYGRSDAKPPAVFTRISHYQPWINQILQAN","Homo sapiens","CMA1, CYH, CYM","Chymase","1","4K2Y"
"4K30",,"X-RAY DIFFRACTION",2.52,51.29,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM Bis-tris, pH 6.5, 35% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1371/journal.pone.0070369",,"4K30",74.04,"2.103","2.103","Structure of the N-acetyltransferase domain of human N-acetylglutamate synthase","SHMLRVRSLDKLDQGRLVDLVNASFGKKLRDDYLASLRPRLHSIYVSEGYNAAAILTMEPVLGGTPYLDKFVVSSSRQGQGSGQMLWECLRRDLQTLFWRSRVTNPINPWYFKHSDGSFSNKQWIFFWFGLADIRDSYELVNHAKGLPDSFHKPASDPGS","Homo sapiens","NAGS","N-acetylglutamate synthase, mitochondrial","1","4K30"
"4K33",,"X-RAY DIFFRACTION",2.28,46.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 19% PEG 4000, 4% C4H10O2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2013.07.017",,"4K33",37.22,"2.3405","2.3405","Crystal Structure of FGF Receptor 3 (FGFR3) Kinase Domain Harboring the K650E Mutation, a Gain-of-Function Mutation Responsible for Thanatophoric Dysplasia Type II and Spermatocytic Seminoma","MGSSHHHHHHSQDPPTLANVSELELPADPKWELSRARLTLGKPLGEGAFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTSKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKETTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVEDLDRVLTVTSTDE","Homo sapiens","FGFR3, JTK4","Fibroblast growth factor receptor 3","1","4K33"
"4K3G",,"X-RAY DIFFRACTION",2.86,57.01,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M sodium acetate, 10% 2-methyl-2,3-pentanediol , pH 5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2013.08.014",,"4K3G",25.25,"1.93","1.93","Immunoglobulin lambda variable domain L5(L89S) fluorogen activating protein","QAVVTQEPSVTVSPGGTVILTCGSSTGAVTSGHYANWFQQKPGQAPRALIFETDKKYSWTPGRFSGSLLGAKAALTISDAQPEDEAEYYCSLSDVDGYLFGGGTQLTVLSTGHHHHHH","Homo sapiens",,"immunoglobulin lambda variable domain L5(L89S)","1","4K3G"
"4K3H",,"X-RAY DIFFRACTION",3.88,68.32,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.29M ammonium sulfate, 0.1M sodium acetate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.jmb.2013.08.014","1OM","4K3H",103.29,"2.45","2.45","Immunoglobulin lambda variable domain L5(L89S) fluorogen activationg protein in complex with malachite green","QAVVTQEPSVTVSPGGTVILTCGSSTGAVTSGHYANWFQQKPGQAPRALIFETDKKYSWTPGRFSGSLLGAKAALTISDAQPEDEAEYYCSLSDVDGYLFGGGTQLTVLSTGHHHHHH","Homo sapiens",,"Immunoglobulin lambda variable domain L5(L89S)","1","4K3H"
"4K4E",,"X-RAY DIFFRACTION",2.31,46.83,"VAPOR DIFFUSION, HANGING DROP",,"0.2/0.4 M Di Ammonium Tartarte, 12.5-25% PEG3350, pH 5.0/6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm4000038","K4E","4K4E",51.07,"2.3","2.3","Co-crystal structure of tnks1 with compound 52 [N~2-(5-chloro-2-methoxyphenyl)-N-[trans-4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)cyclohexyl]glycinamide]","QGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEHHHHHH","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4K4E"
"4K4F",,"X-RAY DIFFRACTION",2.38,48.4,"VAPOR DIFFUSION, HANGING DROP",5,"0.2/0.5 M LiCl, 7.5-20% PEG6K, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm4000038","K4F","4K4F",51.09,"2.9","2.9","Co-crystal structure of TNKS1 with compound 18 [4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(quinolin-8-yl)benzamide]","QGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEHHHHHH","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4K4F"
"4K4G",,"X-RAY DIFFRACTION",2.8,56.07,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M SODIUM CACODYLATE, 0.2 M CALCIUM ACETATE, 4% PEG 8000 , pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.1401286111",,"4K4G",181.64,"2.15","2.15","Ternary crystal structures of human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND L-DCTP.","MSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVSQEENGQQQKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGCKVGPGRVLPTPTEKDVFRLLGLPYREPAERDWLEHHHHHH","Homo sapiens","POLL","DNA polymerase lambda","1","4K4G"
,,,,,,,,,,,,,,,,"CGGCGGTACTG",,,"DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3')","2","4K4G"
,,,,,,,,,,,,,,,,"CAGTAC",,,"DNA (5'-D(*CP*AP*GP*TP*AP*C)-3')","3","4K4G"
,,,,,,,,,,,,,,,,"GCCG",,,"DNA (5'-D(P*GP*CP*CP*G)-3')","4","4K4G"
"4K4I",,"X-RAY DIFFRACTION",2.79,55.98,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M SODIUM CACODYLATE, 0.2 M CALCIUM ACETATE, 4% PEG 8000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.1401286111",,"4K4I",182.02,"2.25","2.25","Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)FTC-TP.","MSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVSQEENGQQQKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGCKVGPGRVLPTPTEKDVFRLLGLPYREPAERDWLEHHHHHH","Homo sapiens","POLL","DNA polymerase lambda","1","4K4I"
,,,,,,,,,,,,,,,,"CGGCGGTACTG",,,"DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3')","2","4K4I"
,,,,,,,,,,,,,,,,"CAGTAC",,,"DNA (5'-D(*CP*AP*GP*TP*AP*C)-3')","3","4K4I"
,,,,,,,,,,,,,,,,"GCCG",,,"DNA (5'-D(P*GP*CP*CP*G)-3')","4","4K4I"
"4K55",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.12 M ethylene glycols, 0.1 M buffer system 1, 30% PEG 550 MME and PEG 20,000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ni.2665","H6P","4K55",14.03,"1.91","1.91","Structure of the extracellular domain of butyrophilin BTN3A1 in complex with (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP)","SAQFSVLGPSGPILAMVGEDADLPCHLFPTMSAETMELKWVSSSLRQVVNVYADGKEVEDRQSAPYRGRTSILRDGITAGKAALRIHNVTASDSGKYLCYFQDGDFYEKALVELKVLEHHHHHH","Homo sapiens","BT3.2, BTF3, BTF4, BTF5, BTN3A1, BTN3A2, Butyrophilin subfamily 3 member A1","Butyrophilin subfamily 3 member A1","1","4K55"
"4K5Z",,"X-RAY DIFFRACTION",2.78,55.73,"VAPOR DIFFUSION",8,"26-33% PEG8000, 0.1 M Tris, pH 8.0, 2 mM zinc sulfate, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm400138z","1P7","4K5Z",25.45,"1.8","1.8","Crystal Structure of Human Chymase in Complex with Fragment Inhibitor 6-chloro-2,3-dihydro-1H-isoindol-1-one","IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGAAQGIVSYGRSDAKPPAVFTRISHYQPWINQILQAN","Homo sapiens","CMA1, CYH, CYM","Chymase","1","4K5Z"
"4K60",,"X-RAY DIFFRACTION",2.77,55.6,"VAPOR DIFFUSION",8,"26-33% PEG8000, 0.1 M Tris, pH 8.0, 2 mM zinc sulfate, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm400138z","1P8","4K60",25.49,"1.5","1.5","Crystal Structure of Human Chymase in Complex with Fragment 6-bromo-1,3-dihydro-2H-indol-2-one","IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGAAQGIVSYGRSDAKPPAVFTRISHYQPWINQILQAN","Homo sapiens","CMA1, CYH, CYM","Chymase","1","4K60"
"4K69",,"X-RAY DIFFRACTION",2.74,55.06,"VAPOR DIFFUSION",8,"26-33% PEG8000, 0.1 M Tris, pH 8.0, 2 mM zinc sulfate, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm400138z","1P9","4K69",25.82,"1.5","1.5","Crystal Structure of Human Chymase in Complex with Fragment Linked Benzimidazolone Inhibitor: (3S)-3-{3-[(6-bromo-2-oxo-2,3-dihydro-1H-indol-4-yl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}hexanoic acid","IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGAAQGIVSYGRSDAKPPAVFTRISHYQPWINQILQAN","Homo sapiens","CMA1, CYH, CYM","Chymase","1","4K69"
"4K6J",,"X-RAY DIFFRACTION",3.4,63.78,"VAPOR DIFFUSION, SITTING DROP",7.1,"1.4 M ammonium sulfate, 0.1 M HEPES pH 7.1, 10% glycerol, vapor diffusion, sitting drop, temperature 293K",293,"10.1073/pnas.1304594110",,"4K6J",129.32,"2.6205","2.6205","Human cohesin inhibitor WapL","GPLGSGRPELYTVVQHVKHFNDVVEFGENQEFTDDIEYLLSGLKSTQPLNTRCLSVISLATKCAMPSFRMHLRAHGMVAMVFKTLDDSQHHQNLSLCTAALMYILSRDRLNMDLDRASLDLMIRLLELEQDASSAKLLNEKDMNKIKEKIRRLCETVHNKHLDLENITTGHLAMETLLSLTSKRAGDWFKEELRLLGGLDHIVDKVKECVDHLSRDEDEEKLVASLWGAERCLRVLESVTVHNPENQSYLIAYKDSQLIVSSAKALQHCEELIQQYNRAEDSICLADSKPLPHQNVTNHVGKAVEDCMRAIIGVLLNLTNDNEWGSTKTGEQDGLIGTALNCVLQVPKYLPQEQRFDIRVLGLGLLINLVEYSARNRHCLVNMETSCSFDSSICSGEGDDSLRIGGQVHAVQALVQLFLERERAAQLAESKTDELIKDAPTTQHDKSGEWQETSGEIQWVSTEKTDGTEEKHKKEEEDEELDLNKALQHAGKHMEDCIVASYTALLLGCLCQESPINVTTVREYLPEGDFSIMTEMLKKFLSFMNLTCAVGTTGQKSISRVIEYLEHC","Homo sapiens","WAPAL, FOE, KIAA0261, WAPL","Wings apart-like protein homolog","1","4K6J"
"4K6Y",,"X-RAY DIFFRACTION",1.99,38.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"35% (w/v) polyethylene glycol, 0.1 M sodium chloride, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.09.019",,"4K6Y",21.24,"1.48","1.48","CFTR Associated Ligand (CAL) PDZ domain bound to peptide iCAL36-Q (ANSRWQTSII)","ANSRWQTSII",,,"iCAL36-Q peptide","2","4K6Y"
,,,,,,,,,,,,,,,,"GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4K6Y"
"4K6Z",,"X-RAY DIFFRACTION",2.29,46.39,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5-6 and 25-35% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.08.082","1Q3","4K6Z",35.07,"2.73","2.73","The Jak1 kinase domain in complex with compound 37","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4K6Z"
"4K72",,"X-RAY DIFFRACTION",2.32,46.95,"VAPOR DIFFUSION, HANGING DROP",8,"40% (w/v) polyethylene glycol (PEG) 1000, 0.1 M sodium thiosulfate pentahydrate, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.09.019",,"4K72",20.91,"1.9","1.9","CFTR Associated Ligand (CAL) PDZ domain bound to peptide iCAL36-VQD (ANSRVQDSII)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4K72"
,,,,,,,,,,,,,,,,"ANSRVQDSII",,,"iCAL36-VQD peptide","2","4K72"
"4K75",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION, HANGING DROP",8,"40% (w/v) polyethylene glycol (PEG) 1000, 0.09 M sodium thiosulfate pentahydrate, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.09.019",,"4K75",10.68,"1.5","1.5","CFTR Associated Ligand (CAL) PDZ domain bound to peptide iCAL36-QDTRL (ANSRWQDTRL)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4K75"
,,,,,,,,,,,,,,,,"ANSRWQDTRL",,,"iCAL36-QDTRL peptide","2","4K75"
"4K76",,"X-RAY DIFFRACTION",1.94,36.53,,,,,"10.1016/j.str.2013.09.019",,"4K76",42.32,"1.75","1.75","CFTR Associated Ligand (CAL) PDZ domain bound to peptide iCAL36-TRL (ANSRWPTTRL)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4K76"
,,,,,,,,,,,,,,,,"ANSRWPTTRL",,,"iCAL36-TRL peptide","2","4K76"
"4K77",,"X-RAY DIFFRACTION",2.36,47.92,"VAPOR DIFFUSION, SITTING DROP",5.5,"PEG 6000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1016/j.bmcl.2013.08.082","1Q4","4K77",69.98,"2.4","2.4","JAK1 kinase (JH1 domain) in complex with compound 6","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4K77"
"4K78",,"X-RAY DIFFRACTION",2.53,51.38,"VAPOR DIFFUSION, HANGING DROP",8,"40% (w/v) polyethylene glycol (PEG), 0.9 M sodium thiosulfate pentahydrate, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.09.019",,"4K78",10.62,"1.8","1.8","CFTR Associated Ligand (CAL) E317A PDZ domain bound to peptide iCAL36-QDTRL (ANSRWQDTRL)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISAIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4K78"
,,,,,,,,,,,,,,,,"ANSRWQDTRL",,,"iCAL36-QDTRL peptide","2","4K78"
"4K7A",,"X-RAY DIFFRACTION",2.21,44.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,"DHT","4K7A",29.46,"2.44","2.44","Crystal structure of the androgen receptor ligand binding domain in complex with minoxidil","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHT","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4K7A"
"4K7I",,"X-RAY DIFFRACTION",2.8,56.02,"VAPOR DIFFUSION, HANGING DROP",5.3,"22% PEG3350, 0.1M sodium citrate buffer, 0.2M potassium sodium tartrate, 5mM 1,4-dithio-dl-threitol, 0.02%(w/v) sodium azide, pH 5.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0102300","CAQ","4K7I",53.88,"2.25","2.25","HUMAN PEROXIREDOXIN 5 with a fragment","HHHHHHSAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL","Homo sapiens","PRDX5, ACR1, SBBI10","Peroxiredoxin-5, mitochondrial","1","4K7I"
"4K7N",,"X-RAY DIFFRACTION",2.96,58.39,"VAPOR DIFFUSION, HANGING DROP",5.3,"22% PEG3350, 0.1M sodium citrate buffer, 0.2M potassium sodium tartrate, 5mM 1,4-dithio-dl-threitol, 0.02%(w/v) sodium azide, pH 5.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0102300","MCT","4K7N",53.88,"2.3","2.3","HUMAN PEROXIREDOXIN 5 with a fragment","HHHHHHSAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL","Homo sapiens","PRDX5, ACR1, SBBI10","Peroxiredoxin-5, mitochondrial","1","4K7N"
"4K7O",,"X-RAY DIFFRACTION",3,58.96,"VAPOR DIFFUSION, HANGING DROP",5.3,"22% PEG3350, 0.1M sodium citrate buffer, 0.2M potassium sodium tartrate, 5mM 1,4-dithio-dl-threitol, 0.02%(w/v) sodium azide, pH 5.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0102300","EKZ","4K7O",54.32,"1.98","1.98","HUMAN PEROXIREDOXIN 5 with a fragment","HHHHHHSAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL","Homo sapiens","PRDX5, ACR1, SBBI10","Peroxiredoxin-5, mitochondrial","1","4K7O"
"4K7S",,"X-RAY DIFFRACTION",2.08,40.91,"VAPOR DIFFUSION, HANGING DROP",7,"25% (w/v) PEG 1450, 50mM HEPES pH 7.0, 35 mM zinc acetate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/chem.201302229",,"4K7S",26.37,"1.76","1.76","Crystal structure of Zn2-hUb (human ubiquitin) adduct from a solution 35 mM zinc acetate/1.3 mM hUb","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","ubiquitin","1","4K7S"
"4K7U",,"X-RAY DIFFRACTION",2.01,38.76,"VAPOR DIFFUSION, HANGING DROP",7,"25% (w/v) PEG 1450, 50mM HEPES pH 7.0, 70 mM zinc acetate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/chem.201302229",,"4K7U",26.85,"1.76","1.76","Crystal structure of Zn2.3-hUb (human ubiquitin) adduct from a solution 70 mM zinc acetate/1.3 mM hUb","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","ubiquitin","1","4K7U"
"4K7W",,"X-RAY DIFFRACTION",2.02,39.2,"VAPOR DIFFUSION, HANGING DROP",7,"25% (w/v) PEG 1450, 50mM HEPES pH 7.0, 100 mM zinc acetate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/chem.201302229",,"4K7W",26.56,"1.76","1.76","Crystal structure of Zn3-hUb(human ubiquitin) adduct from a solution 100 mM zinc acetate/1.3 mM hUb","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","ubiquitin","1","4K7W"
"4K80",,"X-RAY DIFFRACTION",2.98,58.74,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M Ammonium acetate, 0.1 M HEPES pH 7.5, 25% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature12332",,"4K80",24.91,"2.051","2.051","Crystal structure of human ceramide-1-phosphate transfer protein (CPTP) in complex with 2:0 ceramide-1-phosphate (2:0-C1P)","SMDDSETGFNLKVVLVSFKQCLDEKEEVLLDPYIASWKGLVRFLNSLGTIFSFISKDVVSKLRIMERLRGGPQSEHYRSLQAMVAHELSNRLVDLERRSHHPESGCRTVLRLHRALHWLQLFLEGLRTSPEDARTSALCADSYNASLAAYHPWVVRRAVTVAFCTLPTREVFLEAMNVGPPEQAVQMLGEALPFIQRVYNVSQKLYAEHSLLDLP","Homo sapiens","GLTPD1, CPTP","Glycolipid transfer protein domain-containing protein 1","1","4K80"
"4K84",,"X-RAY DIFFRACTION",1.99,38.18,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M MMT buffer pH 5.0, 25% PEG1500, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature12332",,"4K84",50.2,"1.897","1.897","Crystal structure of human ceramide-1-phosphate transfer protein (CPTP) in complex with 16:0 ceramide-1-phosphate (16:0-C1P)","SMDDSETGFNLKVVLVSFKQCLDEKEEVLLDPYIASWKGLVRFLNSLGTIFSFISKDVVSKLRIMERLRGGPQSEHYRSLQAMVAHELSNRLVDLERRSHHPESGCRTVLRLHRALHWLQLFLEGLRTSPEDARTSALCADSYNASLAAYHPWVVRRAVTVAFCTLPTREVFLEAMNVGPPEQAVQMLGEALPFIQRVYNVSQKLYAEHSLLDLP","Homo sapiens","GLTPD1, CPTP","Glycolipid transfer protein domain-containing protein 1","1","4K84"
"4K85",,"X-RAY DIFFRACTION",2.35,47.58,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M Ammonium chloride, 0.1 M Hepes pH 7.0, 20% PEG6000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature12332",,"4K85",100.18,"1.901","1.901","Crystal structure of human ceramide-1-phosphate transfer protein (CPTP) in complex with 12:0 Ceramide-1-Phosphate (12:0-C1P)","SMDDSETGFNLKVVLVSFKQCLDEKEEVLLDPYIASWKGLVRFLNSLGTIFSFISKDVVSKLRIMERLRGGPQSEHYRSLQAMVAHELSNRLVDLERRSHHPESGCRTVLRLHRALHWLQLFLEGLRTSPEDARTSALCADSYNASLAAYHPWVVRRAVTVAFCTLPTREVFLEAMNVGPPEQAVQMLGEALPFIQRVYNVSQKLYAEHSLLDLP","Homo sapiens","GLTPD1, CPTP","Glycolipid transfer protein domain-containing protein 1","1","4K85"
"4K86",,"X-RAY DIFFRACTION",3.28,62.47,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate, 1.0M sodium citrate dibasic trihydrate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444913020556",,"4K86",60.61,"2.4","2.4","Crystal structure of human prolyl-tRNA synthetase (apo form)","MGSSHHHHHHSSGLVPRGSHMASGAGEGQGPKKQTRLGLEAKKEENLADWYSQVITKSEMIEYHDISGCYILRPWAYAIWEAIKDFFDAEIKKLGVENCYFPMFVSQSALEKEKTHVADFAPEVAWVTRSGKTELAEPIAIRPTSETVMYPAYAKWVQSHRDLPIKLNQWCNVVRWEFKHPQPFLRTREFLWQEGHSAFATMEEAAEEVLQILDLYAQVYEELLAIPVVKGRKTEKEKFAGGDYTTTIEAFISASGRAIQGGTSHHLGQNFSKMFEIVFEDPKIPGEKQFAYQNSWGLTTRTIGVMTMVHGDNMGLVLPPRVACVQVVIIPCGITNALSEEDKEALIAKCNDYRRRLLSVNIRVRADLRDNYSPGWKFNHWELKGVPIRLEVGPRDMKSCQFVAVRRDTGEKLTVAENEAETKLQAILEDIQVTLFTRASEDLKTHMVVANTMEDFQKILDSGKIVQIPFCGEIDCEDWIKKTTARDQDLEPGAPSMGAKSLCIPFKPLCELQPGAKCVCGKNPAKYYTLFGRSY","Homo sapiens","EPRS, EPRS1, GLNS, PARS, QARS, QPRS, PIG32","Proline--tRNA ligase","1","4K86"
"4K87",,"X-RAY DIFFRACTION",3.69,66.63,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate, 1.0M sodium citrate dibasic trihydrate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444913020556",,"4K87",61,"2.301","2.301","Crystal structure of human prolyl-tRNA synthetase (substrate bound form)","MGSSHHHHHHSSGLVPRGSHMASGAGEGQGPKKQTRLGLEAKKEENLADWYSQVITKSEMIEYHDISGCYILRPWAYAIWEAIKDFFDAEIKKLGVENCYFPMFVSQSALEKEKTHVADFAPEVAWVTRSGKTELAEPIAIRPTSETVMYPAYAKWVQSHRDLPIKLNQWCNVVRWEFKHPQPFLRTREFLWQEGHSAFATMEEAAEEVLQILDLYAQVYEELLAIPVVKGRKTEKEKFAGGDYTTTIEAFISASGRAIQGGTSHHLGQNFSKMFEIVFEDPKIPGEKQFAYQNSWGLTTRTIGVMTMVHGDNMGLVLPPRVACVQVVIIPCGITNALSEEDKEALIAKCNDYRRRLLSVNIRVRADLRDNYSPGWKFNHWELKGVPIRLEVGPRDMKSCQFVAVRRDTGEKLTVAENEAETKLQAILEDIQVTLFTRASEDLKTHMVVANTMEDFQKILDSGKIVQIPFCGEIDCEDWIKKTTARDQDLEPGAPSMGAKSLCIPFKPLCELQPGAKCVCGKNPAKYYTLFGRSY","Homo sapiens","EPRS, EPRS1, GLNS, PARS, QARS, QPRS, PIG32","Proline--tRNA ligase","1","4K87"
"4K88",,"X-RAY DIFFRACTION",3.64,66.24,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate, 1.0M sodium citrate dibasic trihydrate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444913020556",,"4K88",61.03,"2.619","2.619","Crystal structure of human prolyl-tRNA synthetase (halofuginone bound form)","MGSSHHHHHHSSGLVPRGSHMASGAGEGQGPKKQTRLGLEAKKEENLADWYSQVITKSEMIEYHDISGCYILRPWAYAIWEAIKDFFDAEIKKLGVENCYFPMFVSQSALEKEKTHVADFAPEVAWVTRSGKTELAEPIAIRPTSETVMYPAYAKWVQSHRDLPIKLNQWCNVVRWEFKHPQPFLRTREFLWQEGHSAFATMEEAAEEVLQILDLYAQVYEELLAIPVVKGRKTEKEKFAGGDYTTTIEAFISASGRAIQGGTSHHLGQNFSKMFEIVFEDPKIPGEKQFAYQNSWGLTTRTIGVMTMVHGDNMGLVLPPRVACVQVVIIPCGITNALSEEDKEALIAKCNDYRRRLLSVNIRVRADLRDNYSPGWKFNHWELKGVPIRLEVGPRDMKSCQFVAVRRDTGEKLTVAENEAETKLQAILEDIQVTLFTRASEDLKTHMVVANTMEDFQKILDSGKIVQIPFCGEIDCEDWIKKTTARDQDLEPGAPSMGAKSLCIPFKPLCELQPGAKCVCGKNPAKYYTLFGRSY","Homo sapiens","EPRS, EPRS1, GLNS, PARS, QARS, QPRS, PIG32","Proline--tRNA ligase","1","4K88"
"4K8A",,"X-RAY DIFFRACTION",2.24,44.97,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M NaCitrat 6.0, 20% PEG MME 550, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.07.050","K8A","4K8A",64.37,"2.91","2.91","Fragment-based discovery of Focal Adhesion Kinase Inhibitors","GSPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ","Homo sapiens","FAK, FAK1, PTK2","Focal adhesion kinase 1","1","4K8A"
"4K8N",,"X-RAY DIFFRACTION",3.46,64.4,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M Sodium malonate, 0.1 M Bis-Tris Propane pH 6.5, 20% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature12332",,"4K8N",150.77,"3.102","3.102","Crystal structure of human ceramide-1-phosphate transfer protein (CPTP) in complex with 18:1 Ceramide-1-Phosphate (18:1-C1P)","SMDDSETGFNLKVVLVSFKQCLDEKEEVLLDPYIASWKGLVRFLNSLGTIFSFISKDVVSKLRIMERLRGGPQSEHYRSLQAMVAHELSNRLVDLERRSHHPESGCRTVLRLHRALHWLQLFLEGLRTSPEDARTSALCADSYNASLAAYHPWVVRRAVTVAFCTLPTREVFLEAMNVGPPEQAVQMLGEALPFIQRVYNVSQKLYAEHSLLDLP","Homo sapiens","GLTPD1, CPTP","Glycolipid transfer protein domain-containing protein 1","1","4K8N"
"4K8S",,"X-RAY DIFFRACTION",3.16,61.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"Well buffer is equal volume 1.7 M NaH2PO4 and 0.9M K2HPO4., pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bmcl.2013.05.028","1QT","4K8S",131.28,"2.39","2.39","Hydroxyethylamine-based inhibitors of BACE1: P1-P3 macrocyclization can improve potency, selectivity, and cell activity","SFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4K8S"
"4K8U",,"X-RAY DIFFRACTION",2.22,44.64,"VAPOR DIFFUSION, HANGING DROP",7,"13% PEG 3350, 0.14M Magnessium formate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S139900471302333X",,"4K8U",68.49,"2.302","2.302","Crystal structure of TRAF4 TRAF domain","MCALVSRQRQELQELRRELEELSVGSDGVLIWKIGSYGRRLQEAKAKPNLECFSPAFYTHKYGYKLQVSAFLNGNGSGEGTHLSLYIRVLPGAFDNLLEWPFARRVTFSLLDQSDPGLAKPQHVTETFHPDPNWKNFQKPGTWRGSLDESSLGFGYPKFISHQDIRKRNYVRDDAVFIRAAVELPRKILSLEHHHHHH","Homo sapiens","TRAF4, CART1, MLN62, RNF83","TNF receptor-associated factor 4","1","4K8U"
"4K92",,"X-RAY DIFFRACTION",2.33,47.18,"VAPOR DIFFUSION, HANGING DROP",8.25,"equal volume of 10 mg/ml hCLASP1 TOG2 and well solution containing 22% PEG3350, 200mM Sodium citrate, pH 8.25 were mixed together and equilibrated over 1 ml of well solution., VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1016/j.str.2013.04.018",,"4K92",61.77,"2.005","2.005","A Cryptic TOG Domain with a Distinct Architecture Underlies CLASP-Dependent Bipolar Spindle Formation","GSHMGSKSSAAKEGAGAVDEEDFIKAFDDVPVVQIYSSRDLEESINKIREILSDDKHDWEQRVNALKKIRSLLLAGAAEYDNFFQHLRLLDGAFKLSAKDLRSQVVREACITLGHLSSVLGNKFDHGAEAIMPTIFNLIPNSAKIMATSGVVAVRLIIRHTHIPRLIPVITSNCTSKSVAVRRRCFEFLDLLLQEWQTHSLERHISVLAETIKKGIHDADSEARIEARKCYWGFHSHFSREAEHLYHTLESSYQKALQSHLKNSDSIVSLPQS","Homo sapiens","CLASP1, KIAA0622, MAST1","CLIP-associating protein 1","1","4K92"
"4K9G",,"X-RAY DIFFRACTION",3.71,66.85,,7.5,"1.1 mM (14 mg/ml) MIF , 10 mM inhibitor in 10% DMSO, 18 mM NaCl, 18 mM tris(hydroxymethyl)aminomethane mixed 1:1 with reservoir containing 2 M ammonium sulfate, 0.1 M tris(hydroxymethyl)aminomethane, 3% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.3892/ijo.2014.2551","1Q1","4K9G",38.33,"1.55","1.55","1.55 A Crystal Structure of Macrophage Migration Inhibitory Factor bound to ISO-66 and a related compound","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","4K9G"
"4K9H",,"X-RAY DIFFRACTION",3.21,61.74,"VAPOR DIFFUSION, HANGING DROP",6.8,"Vapor diffusion - 1 ul protein at 15mg/ml added to 1 ul well buffer, 1.7M NaH2PO4 and 0.91 M K2HPO4., pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2013.05.028","1QU","4K9H",131.6,"2.29","2.29","Bace-1 inhibitor complex","SFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4K9H"
"4K9T",,"X-RAY DIFFRACTION",2.28,46.03,"mictobatch under oil",5.9,"PEG 3350, sodium malonate, pH 5.9, mictobatch under oil, temperature 298K",298,"10.1021/bi4005396","1RD","4K9T",57.42,"2.5","2.5","Complex of CYP3A4 with a desoxyritonavir analog","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A3, CYP3A4","Cytochrome P450 3A4","1","4K9T"
"4K9U",,"X-RAY DIFFRACTION",2.26,45.56,"microbatch under oil",5.5,"PEG 3350, sodium malonate, pH 5.5, microbatch under oil, temperature 298K",298,"10.1021/bi4005396",,"4K9U",57.48,"2.85","2.85","Complex of human CYP3A4 with a desoxyritonavir analog","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A3, CYP3A4","Cytochrome P450 3A4","1","4K9U"
"4K9V",,"X-RAY DIFFRACTION",2.28,45.94,"microbatch under oil",5.7,"PEG 3350, sodium malonate, pH 5.7, microbatch under oil, temperature 298K",298,"10.1021/bi4005396","6AW","4K9V",56.94,"2.6","2.6","Complex of CYP3A4 with a desoxyritonavir analog","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A3, CYP3A4","Cytochrome P450 3A4","1","4K9V"
"4K9W",,"X-RAY DIFFRACTION",2.28,46.09,"microbatch uinder oil",5.9,"PEG 3350, sodium malonate, pH 5.9, microbatch uinder oil, temperature 298K",298,"10.1021/bi4005396","7AW","4K9W",228.12,"2.399","2.399","Complex of human CYP3A4 with a desoxyritonavir analog","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A3, CYP3A4","Cytochrome P450 3A4","1","4K9W"
"4K9X",,"X-RAY DIFFRACTION",2.21,44.26,"microbatch uinder oil",5.9,"PEG 3350, sodium malonate, pH 5.9, microbatch uinder oil, temperature 298K",298,"10.1021/bi4005396","8AW","4K9X",56.87,"2.76","2.76","Complex of human CYP3A4 with a desoxyritonavir analog","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A3, CYP3A4","Cytochrome P450 3A4","1","4K9X"
"4K9Y",,"X-RAY DIFFRACTION",3.96,68.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 4.3 M NACL, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.07.050","K9Y","4K9Y",32.44,"2","2","FOCAL ADHESION KINASE Catalytic domain in complex with 1-[4-(6-Amino-purin-9-yl)-phenyl]-3-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-urea","GSPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","4K9Y"
"4KA4",,"X-RAY DIFFRACTION",1.93,36.37,"VAPOR DIFFUSION, HANGING DROP",4.5,"8% PEG 8000, 0.1M sodium acetate, 20% glycerol, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4KA4",41.46,"2.6","2.6","Crystal structure of a proteolytically defined Zbeta domain of human DAI (ZBP1, DLM-1)","TIPETPGPQFSQQREEDIYRFLKDNGPQRALVIAQALGMRTAKDVNRDLYRMKSRHLLDMDEQSKAWTIY","Homo sapiens","ZBP1, C20orf183, DLM1","Z-DNA-binding protein 1","1","4KA4"
,,,,,,,,,,,,,,,,"TCGCGCG",,,"DNA (5'-D(*TP*CP*GP*CP*GP*CP*G)-3')","2","4KA4"
"4KAB",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M sodium citrate, 18% PEG MME 2000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.07.050","4KA","4KAB",64.16,"2.71","2.71","FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 3-Methyl-1,4-dihydro-pyrazolo[4,5-c]pyrazole","GSPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","4KAB"
"4KAK",,"X-RAY DIFFRACTION",2.32,46.99,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris-HCl pH 7.4, 0.2M Lithium sulfate, 30% (w/v) PEG 4000, 8% (v/v) ethanol, 11mM CaCl2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi400852h","06U","4KAK",45.33,"1.8","1.8","Crystal structure of human dihydrofolate reductase complexed with NADPH and 6-ethyl-5-[(3S)-3-[3-methoxy-5-(pyridine-4-yl)phenyl]but-1-yn-1-yl]pyrimidine-2,4-diamine (UCP1006)","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR, huDHFR","Dihydrofolate reductase","1","4KAK"
"4KAO",,"X-RAY DIFFRACTION",2.37,48.11,"VAPOR DIFFUSION, HANGING DROP",9,"0.1 M TRIS, 16% PEG 3350, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.07.050","KAO","4KAO",65.56,"2.39","2.39","FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-(4-pyridin-3- yl-phenyl)-urea","GSGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","4KAO"
"4KAP",,"X-RAY DIFFRACTION",2.14,42.6,"VAPOR DIFFUSION, HANGING DROP",7.8,"100 MM TRIS-CL, 1.15 M SODIUM CITRATE, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/anie.201301813",,"4KAP",29.33,"1.45","1.45","The Binding of Benzoarylsulfonamide Ligands to Human Carbonic Anhydrase is Insensitive to Formal Fluorination of the Ligand","ANWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4KAP"
"4KB8",,"X-RAY DIFFRACTION",2.18,43.51,,,,,"10.1021/jm4006324","1QN","4KB8",156.03,"1.95","1.95","CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand","MHHHHHHSSGLVPRGSLRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRH","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","4KB8"
"4KBA",,"X-RAY DIFFRACTION",2.14,42.63,,,,,"10.1021/jm4006324","1QM","4KBA",156.31,"1.98","1.98","CK1d in complex with 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine inhibitor","MHHHHHHSSGLVPRGSLRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRH","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","4KBA"
"4KBC",,"X-RAY DIFFRACTION",2.61,52.89,,,,,"10.1021/jm4006324","1QJ","4KBC",75.36,"1.98","1.98","CK1d in complex with {4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}METHANOL inhibitor","MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRH","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","4KBC"
"4KBK",,"X-RAY DIFFRACTION",2.18,43.66,,,,,"10.1021/jm4006324","1QG","4KBK",156.75,"2.1","2.1","CK1d in complex with (3S)-3-{4-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]pyridin-2-yl}morpholine inhibitor","MHHHHHHSSGLVPRGSLRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRH","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","4KBK"
"4KBL",,"X-RAY DIFFRACTION",3.66,78,"VAPOR DIFFUSION, HANGING DROP",9.5,"0.92M potassium / sodium tartrate, 0.2M lithium sulfate, 0.1M CHES, 5% ethylene glycol, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2013.04.019",,"4KBL",129.47,"3.3","3.3","Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism","GSMDSDEGYNYEFDEDEECSEEDSGAEEEEDEDDDEPDDDTLDLGEVELVEPGLGVGGERDGLLCGETGGGGGSALGPGGGGGGGGGGGGGGPGHEQEEDYRYEVLTAEQILQHMVECIREVNEVIQNPATITRILLSHFNWDKEKLMERYFDGNLEKLFAECHVINPSKKSRTRQMNTRSSAQDMPCQICYLNYPNSYFTGLECGHKFCMQCWSEYLTTKIMEEGMGQTISCPAHGCDILVDDNTVMRLITDSKVKLKYQHLITNSFVECNRLLKWCPAPDCHHVVKVQYPDAKPVRCKCGRQFCFNCGENWHDPVKCKWLKKWIKKCDDDSETSNWIAANTKECPKCHVTIEKDGGCNHMVCRNQNCKAEFCWVCLGPWEPHGSAWYNCNRYNEDDAKAARDAQERSRAALQRYLFYCNRYMNHMQSLRFEHKLYAQVKQKMEEMQQHNMSWIEVQFLKKAVDVLCQCRATLMYTYVFAFYLKKNNQSIIFENNQADLENATEVLSGYLERDISQDSLQDIKQKVQDKYRYCESRRRVLLQHVHEGYEKDLWEYIED","Homo sapiens","ARIH1, ARI, MOP6, UBCH7BP, HUSSY-27","E3 ubiquitin-protein ligase ARIH1","1","4KBL"
"4KBN",,"X-RAY DIFFRACTION",2.31,46.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris-HCl, 0.2-0.3M Li2SO4, 25-32% (w/v) PEG 4000, 8% (v/v) ethanol, 11mM MgCl2, 11mM SrCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi400852h","25U","4KBN",45.6,"1.84","1.84","human dihydrofolate reductase complexed with NADPH and 5-{3-[3-(3,5-pyrimidine)]-phenyl-prop-1-yn-1-yl}-6-ethyl-pyrimidine-2,4diamine","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR, huDHFR","Dihydrofolate reductase","1","4KBN"
"4KBO",,"X-RAY DIFFRACTION",2.53,51.4,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG 3350, 0.2M di-ammonium tartrate, 0.02M HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/pro.2466",,"4KBO",41.44,"2.8","2.8","Crystal structure of the human Mortalin (GRP75) ATPase domain in the apo form","GAMGSKGAVVGIDLGTTNSCVAVMEGKQAKVLENAEGARTTPSVVAFTADGERLVGMPAKRQAVTNPNNTFYATKRLIGRRYDDPEVQKDIKNVPFKIVRASNGDAWVEAHGKLYSPSQIGAFVLMKMKETAENYLGHTAKNAVITVPAYFNDSQRQATKDAGQISGLNVLRVINEPTAAALAYGLDKSEDKVIAVYDLGGGTFDISILEIQKGVFEVKSTNGDTFLGGEDFDQALLRHIVKEFKRETGVDLTKDNMALQRVREAAEKAKCELSSSVQTDINLPYLTMDSSGPKHLNMKLTRAQFEGIVTDLIRRTIAPCQKAMQDAEVSKSDIGEVILVGGMTRMPKVQQTVQDLFGRAPSKAVNPDEAVAIGAAIQGGVLAGD","Homo sapiens","GRP75, HSPA9, HSPA9B, mt-HSP70","Stress-70 protein, mitochondrial","1","4KBO"
"4KBS",,"X-RAY DIFFRACTION",2.01,38.96,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M Sodium acetate, 0.1 M Bis-Tris propane pH 6.5, 20% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature12332",,"4KBS",50.16,"1.898","1.898","Crystal structure of human ceramide-1-phosphate transfer protein (CPTP) in complex with 12:0 phosphatidic acid (12:0 PA)","SMDDSETGFNLKVVLVSFKQCLDEKEEVLLDPYIASWKGLVRFLNSLGTIFSFISKDVVSKLRIMERLRGGPQSEHYRSLQAMVAHELSNRLVDLERRSHHPESGCRTVLRLHRALHWLQLFLEGLRTSPEDARTSALCADSYNASLAAYHPWVVRRAVTVAFCTLPTREVFLEAMNVGPPEQAVQMLGEALPFIQRVYNVSQKLYAEHSLLDLP","Homo sapiens","GLTPD1, CPTP","Glycolipid transfer protein domain-containing protein 1","1","4KBS"
"4KBZ",,"X-RAY DIFFRACTION",2.25,45.28,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.1M HEPES, 35% PEG8K, 0.2M ammonium sulfate, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,"1QA","4KBZ",27.42,"2.15","2.15","Crystal Structure of Hypoxia-Inducible Factor Prolyl Hydroxylase (PHD2) with (S)-{2-[2-(5-Cyano-3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetylamino}-phenyl-acetic acid","GSQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGLRVELNKPSD","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","4KBZ"
"4KC1",,"X-RAY DIFFRACTION",2.35,47.61,"VAPOR DIFFUSION, SITTING DROP",7,"13% or 15% PEG 3350, 50 mM or 150 mM ammonium sulfate and 50 mM MOPS pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/chem.201301871",,"4KC1",34.77,"1.5","1.5","Structure of the blood group glycosyltransferase AAglyB in complex with a pyridine inhibitor as a neutral pyrophosphate surrogate","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPK","Homo sapiens","ABO","Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase","1","4KC1"
"4KC2",,"X-RAY DIFFRACTION",2.35,47.67,"VAPOR DIFFUSION, SITTING DROP",7,"13% or 15% PEG 3350, 50 mM or 150 mM ammonium sulfate and 50 mM MOPS pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/chem.201301871",,"4KC2",34.77,"1.7","1.7","Structure of the blood group glycosyltransferase AAglyB in complex with a pyridine inhibitor as a neutral pyrophosphate surrogate","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPK","Homo sapiens","ABO","Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form","1","4KC2"
"4KC4",,"X-RAY DIFFRACTION",2.35,47.76,"VAPOR DIFFUSION, SITTING DROP",7,"13% or 15% PEG 3350, 50 mM or 150 mM ammonium sulfate and 50 mM MOPS pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/chem.201301871",,"4KC4",34.77,"1.6","1.6","Structure of the blood group glycosyltransferase AAglyB in complex with a pyridine inhibitor as a neutral pyrophosphate surrogate","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPK","Homo sapiens","ABO","Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase","1","4KC4"
"4KC9",,"X-RAY DIFFRACTION",3.1,60.33,"VAPOR DIFFUSION, HANGING DROP",5.2,"0.49M sodium citrate, 0.1M citric acid, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2013.04.019",,"4KC9",65.48,"3.603","3.603","Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism","GSMDSDEGYNYEFDEDEECSEEDSGAEEEEDEDDDEPDDDTLDLGEVELVEPGLGVGGERDGLLCGETGGGGGSALGPGGGGGGGGGGGGGGPGHEQEEDYRYEVLTAEQILQHMVECIREVNEVIQNPATITRILLSHFNWDKEKLMERYFDGNLEKLFAECHVINPSKKSRTRQMNTRSSAQDMPCQICYLNYPNSYFTGLECGHKFCMQCWSEYLTTKIMEEGMGQTISCPAHGCDILVDDNTVMRLITDSKVKLKYQHLITNSFVECNRLLKWCPAPDCHHVVKVQYPDAKPVRCKCGRQFCFNCGENWHDPVKCKWLKKWIKKCDDDSETSNWIAANTKECPKCHVTIEKDGGCNHMVCRNQNCKAEFCWVCLGPWEPHGSAWYNCNRYNEDDAKAARDAQERSRAALQRYLFYCNRYMNHMQSLRFEHKLYAQVKQKMEEMQQHNMSWIEVQFLKKAVDVLCQCRATLMYTYVFAFYLKKNNQSIIFENNQADLENATEVLSGYLERDISQDSLQDIKQKVQDKYRYCESRRRVLLQHVHEGYEKDLWEYIED","Homo sapiens","ARIH1, ARI, MOP6, UBCH7BP, HUSSY-27","E3 ubiquitin-protein ligase ARIH1","1","4KC9"
"4KCG",,"X-RAY DIFFRACTION",2.18,43.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.9-1.5 M trisodium citrate dehydrate, 25 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1084/jem.20131738","1QC","4KCG",67.26,"2.09","2.09","Human dCK C4S-S74E mutant in complex with UDP and the DI-39 inhibitor","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4KCG"
"4KCX",,"X-RAY DIFFRACTION",2.47,50.27,"VAPOR DIFFUSION, SITTING DROP",7.5,"25mM HEPES PH 7.5, 0.1M NaCl, 1mM DTT 0.1M KSCN, 7% PEG3350, 5% ETGLY, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/cb4003283","1QK","4KCX",28.73,"2","2","BRDT in complex with Dinaciclib","NTKKNGRLTNQLQYLQKVVLKDLWKHSFSWPFQRPVDAVKLQLPDYYTIIKNPMDLNTIKKRLENKYYAKASECIEDFNTMFSNCYLYNKPGDDIVLMAQALEKLFMQKLSQMPQEE","Homo sapiens","BRDT","Bromodomain testis-specific protein","1","4KCX"
"4KD1",,"X-RAY DIFFRACTION",2.06,40.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% (V/V) PEG 3350, 50 MM HEPES/NAOH (PH 7.5), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb4003283",,"4KD1",34.44,"1.7","1.7","CDK2 in complex with Dinaciclib","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4KD1"
"4KD7",,"X-RAY DIFFRACTION",4.69,73.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris-HCl, 0.2-0.3M Lithium sulfate, 25-32%(w/v) PEG 4000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi400852h","9DR","4KD7",45.29,"2.715","2.715","Human dihydrofolate reductase complexed with NADPH and 5-{3-[3-methoxy-5(pyridine-4-yl)phenyl]prop-1-yn-1-yl}-6-ethyl-pyrimidine-2,4-diamine","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR, huDHFR","Dihydrofolate reductase","1","4KD7"
"4KE0",,"X-RAY DIFFRACTION",3.01,59.2,"VAPOR DIFFUSION, HANGING DROP",5,"18% PEG 8000, 0.3 M lithium sulfate, 0.1 M sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2013.05.028","1R8","4KE0",139.22,"2.3","2.3","Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 13","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4KE0"
"4KE1",,"X-RAY DIFFRACTION",2.8,56.13,"VAPOR DIFFUSION, HANGING DROP",6.6,"21% PEG 5000 MME, 0.2 M sodium citrate, 0.2 M ammonium iodide, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2013.05.028","1R6","4KE1",46.85,"1.91","1.91","Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 19","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-Secretase 1","1","4KE1"
"4KEB",,"X-RAY DIFFRACTION",2.31,46.81,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris-HCl, 0.2-0.3M lithium sulfate, 25-32%(w/v) PEG 4000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi400852h","1QZ","4KEB",45.05,"1.45","1.45","Human dihydrofolate reductase complexed with NADPH and 5-{3-[3-methoxy-5-(isoquin-5-yl)phenyl]but-1-yn-1-yl}6-ethylpyrimidine-2,4-diamine","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR, huDHFR","Dihydrofolate reductase","1","4KEB"
"4KF6",,"X-RAY DIFFRACTION",2.56,51.92,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M Ammonium sulfate, 0.1 M Tris pH 8.0, 20% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature12332",,"4KF6",149.94,"3.195","3.195","Crystal structure of human ceramide-1-phosphate transfer protein (CPTP) in complex with 8:0 Ceramide-1-Phosphate (8:0-C1P)","SMDDSETGFNLKVVLVSFKQCLDEKEEVLLDPYIASWKGLVRFLNSLGTIFSFISKDVVSKLRIMERLRGGPQSEHYRSLQAMVAHELSNRLVDLERRSHHPESGCRTVLRLHRALHWLQLFLEGLRTSPEDARTSALCADSYNASLAAYHPWVVRRAVTVAFCTLPTREVFLEAMNVGPPEQAVQMLGEALPFIQRVYNVSQKLYAEHSLLDLP","Homo sapiens","GLTPD1, CPTP","Glycolipid transfer protein domain-containing protein 1","1","4KF6"
"4KFA",,"X-RAY DIFFRACTION",2.41,48.86,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M NH4CL, 20% PEG 6000, 10% Ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"ZOL","4KFA",43.52,"1.98","1.98","Crystal structure of human farnesyl pyrophosphate synthase (t201a mutant) complexed with mg and zoledronate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKAAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4KFA"
"4KFJ",,"X-RAY DIFFRACTION",2.33,47.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris-HCl, 0.2-0.3M Lithium sulfate, 25-30% (w/v) PEG 4000, 1% (v/v) trifluoroethanol, 11mM MgCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi400852h","1R0","4KFJ",45.28,"1.76","1.76","Human dihydrofolate reductase complexed with NADPH and 5-{3-[3-methoxy-5-(isoquin-5-yl)phenyl]prop-1-yn-1-yl}6-ethylprimidine-2,4-diamine","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR, huDHFR","Dihydrofolate reductase","1","4KFJ"
"4KFN",,"X-RAY DIFFRACTION",2.33,47.28,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1021/jm400186h","1QR","4KFN",115.87,"1.6","1.6","Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4KFN"
"4KFO",,"X-RAY DIFFRACTION",2.34,47.43,"VAPOR DIFFUSION, HANGING DROP",8.6,"rystals were grown from 0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1021/jm400186h","1QS","4KFO",115.74,"1.6","1.6","Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4KFO"
"4KFP",,"X-RAY DIFFRACTION",2.33,47.18,"VAPOR DIFFUSION, HANGING DROP",8.6,"crystals were grown from 0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.06.090","1R7","4KFP",115.66,"1.84","1.84","Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived Ureas as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4KFP"
"4KG8",,"X-RAY DIFFRACTION",1.89,34.95,"VAPOR DIFFUSION, SITTING DROP",5,"0.2M AMMONIUM CITRATE DIBASIC, 20% (W/V) PEG 3350, PH 5.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 290K",290,"10.1016/j.str.2014.06.013",,"4KG8",51.63,"2.25","2.25","Crystal structure of light mutant","LIQERRSHEVNPAAHLTGANSSLTGSGGPLLWETQLGLAFLRGLSYHDGALVVTKAGYYYIYSKVQLGGVGCPLGLASTITHGLYKRTPRYPEELELLVSQQSPCGRATSSSSNWFDSSFLGGVVHLEAGEEVVVRVLDERLVRLRDGTRSYFGAFMV","Homo sapiens","TNFSF14, HVEML, LIGHT, UNQ391/PRO726","Tumor necrosis factor ligand superfamily member 14","1","4KG8"
"4KGA",,"X-RAY DIFFRACTION",2.11,41.8,"VAPOR DIFFUSION, HANGING DROP",8,"10mM NiCl2, 100mM Tris, 20% PEG2000  , pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/srep35385",,"4KGA",48.21,"2.32","2.32","Crystal structure of kallikrein-related peptidase 4","IINGEDCSPHSQPWQAALVMENELFCSGVLVHPQWVLSAAHCFQNSYTIGLGLHSLEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISIASQCPTAGNSCLVSGWGLLANGRMPTVLQCVNVSVVSEEVCSKLYDPLYHPSMFCAGGGQDQKDSCNGDSGGPLICNGYLQGLVSFGKAPCGQVGVPGVYTNLCKFTEWIEKTVQA","Homo sapiens","KLK4, EMSP1, PRSS17, PSTS","Kallikrein-4","1","4KGA"
"4KGH",,"X-RAY DIFFRACTION",2.87,57.21,"VAPOR DIFFUSION",8.5,"8% PEG 400, .2 M tri-sodium citrate, .1 M Tris-HCl pH 8.5, vapor diffusion, temperature 298K",298,"10.1073/pnas.1311999110",,"4KGH",50.09,"2.806","2.806","Crystal Structure of human splunc1 lacking the secretion signal sequence","SNAQFGGLPVPLDQTLPLNVNPALPLSPTGLAGSLTNALSNGLLSGGLLGILENLPLLDILKPGGGTSGGLLGGLLGKVTSVIPGLNNVIDIKVTDPQLLELGLVQSPDGHRLYVTIPLGIKLQVNTPLVGASLLRLAVKLDITAEILAVRDKQERIHLVLGDCTHSPGSLQISLLDGLGPLPIQGLLDSLTGILNKVLPELVQGNVCPLVNEVLRGLDITLVHDIVNMLIHGLQFVIKV","Homo sapiens","BPIFA1, LUNX, NASG, PLUNC, SPURT, UNQ787/PRO1606, SPLUNC1","BPI fold-containing family A member 1","1","4KGH"
"4KGJ",,"X-RAY DIFFRACTION",3.29,62.66,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.01 M HEPES, pH 7.5, 0.26 M sodium potassium tartrate, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio.1357",,"4KGJ",145.28,"2.99","2.99","Crystal structure of human alpha-L-iduronidase complex with 5-fluoro-alpha-L-idopyranosyluronic acid fluoride","EAPHLVQVDAARALWPLRRFWRSTGFCPPLPHSQADPYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGQGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","1","4KGJ"
"4KGL",,"X-RAY DIFFRACTION",3.3,62.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.01 M HEPES, pH 7.5, 0.26 M sodium potassium tartrate, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio.1357",,"4KGL",144.83,"2.701","2.701","Crystal structure of human alpha-L-iduronidase complex with [2R,3R,4R,5S]-2-carboxy-3,4,5-trihydroxy-piperidine","EAPHLVQVDAARALWPLRRFWRSTGFCPPLPHSQADPYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGQGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","1","4KGL"
"4KGO",,"X-RAY DIFFRACTION",4.12,70.16,"VAPOR DIFFUSION",8.5,"8% PEG 400, .2 M tri-sodium citrate, .1 M Tris-HCl pH 8.5, vapor diffusion, temperature 298K",298,"10.1073/pnas.1311999110",,"4KGO",50.24,"3.194","3.194","Crystal Structure of double Leucine to Methionine mutant human splunc1 lacking the secretion signal sequence","SNAQFGGLPVPLDQTLPLNVNPALPLSPTGLAGSLTNALSNGLLSGGLLGIMENLPLLDILKPGGGTSGGLLGGLLGKVTSVIPGLNNVIDIKVTDPQLLELGLVQSPDGHRLYVTIPLGIKLQVNTPLVGASLLRLAVKMDITAEILAVRDKQERIHLVLGDCTHSPGSLQISLLDGLGPLPIQGLLDSLTGILNKVLPELVQGNVCPLVNEVLRGLDITLVHDIVNMLIHGLQFVIKV","Homo sapiens","BPIFA1, LUNX, NASG, PLUNC, SPURT, UNQ787/PRO1606, SPLUNC1","BPI fold-containing family A member 1","1","4KGO"
"4KH2",,"X-RAY DIFFRACTION",3.28,62.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.01 M HEPES, pH 7.5, 0.26 M sodium potassium tartrate, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio.1357",,"4KH2",145.15,"2.36","2.36","Crystal structure of human alpha-L-iduronidase complex with 2-deoxy-2-fluoro-alpha-L-idopyranosyluronic acid fluoride","EAPHLVQVDAARALWPLRRFWRSTGFCPPLPHSQADPYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGQGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","1","4KH2"
"4KI9",,"X-RAY DIFFRACTION",2.27,45.81,"VAPOR DIFFUSION",,"16% PEG 8000, 38% monopotassium phosphate, 20% glycerol, VAPOR DIFFUSION",,"10.1107/S1399004713029866",,"4KI9",18.2,"2","2","Crystal structure of the catalytic domain of human DUSP12 at 2.0 A resolution","MLEVQPGLYFGGAAAVAEPDHLREAGITAVLTVDSEEPSFKAGPGVEDLWRLFVPALDKPETDLLSHLDRAVAFIGQARAEGRAVLVHSHAGVSRSVAIITAFLMKTDQLPFEKAYEKLQILKPEAKMNEGFEWQLKLYQAMGYEVDTSSAIYKQYRLQKVTE","Homo sapiens","DUSP12","Dual specificity protein phosphatase 12","1","4KI9"
"4KIK",,"X-RAY DIFFRACTION",2.5,50.78,,,,,"10.1074/jbc.M113.482596",,"4KIK",157.52,"2.83","2.83","Human IkB kinase beta","MHHHHHHSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKSPGRPLN","Homo sapiens","IKBKB, IKKB","Inhibitor of nuclear factor kappa-B kinase subunit beta","1","4KIK"
,,,,,,,,,,,,,,,,"MHHHHHHSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKSPGRPLN","Homo sapiens","IKBKB, IKKB","Inhibitor of nuclear factor kappa-B kinase subunit beta","2","4KIK"
"4KIN",,"X-RAY DIFFRACTION",2.21,44.34,,6,"1-6% (W/V) PEG-4K 50 MM MES, PH 6.0, 5MM MAGNESIUM SULFATE",,"10.1016/j.bmcl.2013.05.047","1M8","4KIN",170.06,"1.97","1.97","Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 5-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-2-THIOPHENECARBOXAMIDE","MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","CSBP, CSBP1, CSBP2, CSPB1, MAPK14, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4KIN"
"4KIO",,"X-RAY DIFFRACTION",2.77,55.55,"VAPOR DIFFUSION, HANGING DROP",5.7,"0.85M ammonium sulphate, 0.2M magnesium acetate, 0.1M sodium citrate, 10mM dithiothreitol, pH 5.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.474114","G5K","4KIO",123.67,"2.18","2.18","Kinase domain mutant of human Itk in complex with a covalently-binding inhibitor","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQETSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4KIO"
"4KIP",,"X-RAY DIFFRACTION",2.05,40,,,,,"10.1016/j.bmcl.2013.05.047","1R9","4KIP",85.03,"2.27","2.27","Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 2-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-1,3-THIAZOLE-5-CARBOXAMIDE","MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","CSBP, CSBP1, CSBP2, CSPB1, MAPK14, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4KIP"
"4KIQ",,"X-RAY DIFFRACTION",2.2,44.16,,6,"1-6% (W/V) PEG-4K 50 MM MES, PH 6.0, 5MM MAGNESIUM SULFATE",,"10.1016/j.bmcl.2013.05.047","1RA","4KIQ",170.04,"2.5","2.5","Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with ETHYL 6-((5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)CARBAMOYL)-1H-INDOLE-1-CARBOXYLATE","MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","CSBP, CSBP1, CSBP2, CSPB1, MAPK14, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4KIQ"
"4KIV",,"X-RAY DIFFRACTION",1.56,22,,6.5,"pH 6.5",,"10.1021/bi9820558",,"4KIV",9.17,"2.2","2.2","RECOMBINANT KRINGLE IV-10/W72R MUTANT OF HUMAN APOLIPOPROTEIN(A)","QCYHGNGQSYRGTFSTTVTGRTCQSWSSMTPHRHQRTPENYPNDGLTMNYCRNPDADTGPWCFTMDPSIRREYCNLTRC","Homo sapiens","LPA","APOLIPOPROTEIN","1","4KIV"
"4KJU",,"X-RAY DIFFRACTION",1.96,37.39,"VAPOR DIFFUSION, SITTING DROP",7,"1.5 M ammonium sulfate, 125 mM Bis-tris-propane , pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/jm400732v","1RH","4KJU",20.55,"1.6","1.6","Crystal structure of XIAP-Bir2 with a bound benzodiazepinone inhibitor.","GTIYPRNPAMYSEEARLKSFQNWPDYAHLTPRELASAGLYYTGIGDQVQCFACGGKLKNWEPGDRAWSEHRRHFPNCFFVLGRNLN","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","4KJU"
"4KJV",,"X-RAY DIFFRACTION",1.88,34.56,"VAPOR DIFFUSION, SITTING DROP",7,"1.5 M ammonium sulfate, 125 mM Bis-tris-propane  , pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/jm400732v","1RK","4KJV",20.55,"1.7","1.7","Crystal structure of XIAP-Bir2 with a bound spirocyclic benzoxazepinone inhibitor.","GTIYPRNPAMYSEEARLKSFQNWPDYAHLTPRELASAGLYYTGIGDQVQCFACGGKLKNWEPGDRAWSEHRRHFPNCFFVLGRNLN","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","4KJV"
"4KKD",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.12 M NaCl, 18% (w/v) polyethylene glycol 4000 and 0.1 M imidazole pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M113.483875",,"4KKD",96.08,"2.5991","2.5991","The X-ray crystal structure of Mannose-binding lectin-associated serine proteinase-3 reveals the structural basis for enzyme inactivity associated with the 3MC syndrome","MAGNECPELQPPVHGKIEPSQAKYFFKDQVLVSCDTGYKVLKDNVEMDTFQIECLKDGTWSNKIPTCKIVDCRAPGELEHGLITFSTRNNLTTYKSEIKYSCQEPYYKMLNNNTGIYTCSAQGVWMNKVLGRSLPTCLPECGQPSRSLPSLVQRIIGGRNAEPGLFPWQALIVVEDTSRVPNDKWFGSGALLSASWILTAAHVLRSQRRDTTVIPVSKEHVTVYLGLHDVRDKSGAVNSSAARVVLHPDFNIQNYNHDIALVQLQEPVPLGPHVMPVCLPRLEPEGPAPHMLGLVAGWGISNPNVTVDEIISSGTRTLSDVLQYVKLPVVPHAECKTSYESRSGNYSVTENMFCAGYYEGGKDTCLGDSGEAFVIFDDLSQRWVVQGLVSWGGPEECGSKQVYGVYTKVSNYVDWVWEQMGLPQSVVEPQVER","Homo sapiens","CRARF, CRARF1, MASP1, PRSS5","Mannan-binding lectin serine protease 1","1","4KKD"
"4KKE",,"X-RAY DIFFRACTION",2.37,48.06,"VAPOR DIFFUSION, HANGING DROP",7.25,"16% PEG MME 550, 10% Ethylene glycol, 0.1 M Hepes, 10 mM TCEP, pH 7.25, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4KKE",42.46,"2.2","2.2","The crystal structure of AMP-bound JNK3","MGSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","4KKE"
"4KKG",,"X-RAY DIFFRACTION",2.32,46.92,"VAPOR DIFFUSION, HANGING DROP",7.25,"16% PEG MME 550, 10% Ethylene glycol, 0.1 M Hepes, 10 mM TCEP, pH 7.25, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4KKG",42.12,"2.4","2.4","Crystal structure of apo and AMP-bound JNK3","MGSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","4KKG"
"4KKH",,"X-RAY DIFFRACTION",2.38,48.27,"VAPOR DIFFUSION, HANGING DROP",7.25,"16% PEG MME 550, 10% Ethylene glycol, 0.1 M Hepes, 10 mM TCEP, pH 7.25, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,"1RQ","4KKH",42.62,"2","2","The crystal structure of inhibitor-bound JNK3","MGSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","4KKH"
"4KKI",,"X-RAY DIFFRACTION",3.57,65.56,,6.5,"50% PEG 400, 0.2M magnesium chloride, 0.1M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M113.483271",,"4KKI",56.31,"2.35","2.35","Crystal Structure of Haptocorrin in Complex with CNCbl","MRQSHQLPLVGLLLFSFIPSQLCEICEVSEENYIRLKPLLNTMIQSNYNRGTSAVNVVLSLKLVGIQIQTLMQKMIQQIKYNVKSRLSDVSSGELALIILALGVCRNAEENLIYDYHLIDKLENKFQAEIENMEAHNGTPLTNYYQLSLDVLALCLFNGNYSTAEVVNHFTPENKNYYFGSQFSVDTGAMAVLALTCVKKSLINGQIKADEGSLKNISIYTKSLVEKILSEKKENGLIGNTFSTGEAMQALFVSSDYYNENDWNCQQTLNTVLTEISQGAFSNPNAAAQVLPALMGKTFLDINKDSSCVSASGNFNISADEPITVTPPDSQSYISVNYSVRINETYFTNVTVLNGSVFLSVMEKAQKMNDTIFGFTMEERSWGPYITCIQGLCANNNDRTYWELLSGGEPLSQGAGSYVVRNGENLEVRWSKYLVPRGSLESRGPFEQKLISEEDLNMHTGHHHHHH","Homo sapiens","TC1, TCN1","Transcobalamin-1","1","4KKI"
"4KKJ",,"X-RAY DIFFRACTION",3.77,67.37,,6.5,"50% PEG 400, 0.2M magnesium chloride, 0.1M sodium cacodylate , pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M113.483271",,"4KKJ",54.79,"3","3","Crystal Structure of Haptocorrin in Complex with Cbi","MRQSHQLPLVGLLLFSFIPSQLCEICEVSEENYIRLKPLLNTMIQSNYNRGTSAVNVVLSLKLVGIQIQTLMQKMIQQIKYNVKSRLSDVSSGELALIILALGVCRNAEENLIYDYHLIDKLENKFQAEIENMEAHNGTPLTNYYQLSLDVLALCLFNGNYSTAEVVNHFTPENKNYYFGSQFSVDTGAMAVLALTCVKKSLINGQIKADEGSLKNISIYTKSLVEKILSEKKENGLIGNTFSTGEAMQALFVSSDYYNENDWNCQQTLNTVLTEISQGAFSNPNAAAQVLPALMGKTFLDINKDSSCVSASGNFNISADEPITVTPPDSQSYISVNYSVRINETYFTNVTVLNGSVFLSVMEKAQKMNDTIFGFTMEERSWGPYITCIQGLCANNNDRTYWELLSGGEPLSQGAGSYVVRNGENLEVRWSKYLVPRGSLESRGPFEQKLISEEDLNMHTGHHHHHH","Homo sapiens","TCN1, TC1","Transcobalamin-1","1","4KKJ"
"4KL1",,"X-RAY DIFFRACTION",2.82,56.31,"VAPOR DIFFUSION, HANGING DROP",5,"10-15% PEG3350, 200 mM sodium acetate buffer, 200 mM ammonium phosphate, 5-50mM cGMP, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1038/nchembio.1521",,"4KL1",96.74,"2.7","2.7","HCN4 CNBD in complex with cGMP","GPSSPMDSSRRQYQEKYKQVEQYMSFHKLPPDTRQRIHDYYEHRYQGKMFDEESILGELSEPLREEIINFNCRKLVASMPLFANADPNFVTSMLTKLRFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKGNKETKLADGSYFGEICLLTRGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVALDRLDR","Homo sapiens","HCN4","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4","1","4KL1"
"4KLA",,"X-RAY DIFFRACTION",2.79,55.91,,,,,,,"4KLA",84.56,"2.6","2.6","E343D variant of human ferrochelatase","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIDTLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase, mitochondrial","1","4KLA"
"4KLC",,"X-RAY DIFFRACTION",3.48,64.64,"VAPOR DIFFUSION, SITTING DROP",,"sitting drop at 18 degrees  
centigrade.  Precipitating solution consisted of 0.1 M Bis-Tris pH 6.8, 40  
% penterythritol ethoxylate (15/4 EO/OH), VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4KLC",86.29,"2.4","2.4","E343D/F110A Double mutant of human ferrochelatase","MGGSHHHHHHGRKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPAIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIDTLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase, mitochondrial","1","4KLC"
"4KLD",,"X-RAY DIFFRACTION",2.26,45.59,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLD",48.44,"1.916","1.916","DNA polymerase beta matched substrate complex with Ca2+, 0 s","CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4KLD"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3'","2","4KLD"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4KLD"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4KLD"
"4KLE",,"X-RAY DIFFRACTION",2.2,44.04,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLE",48.69,"1.97","1.97","DNA polymerase beta matched reactant complex with Mg2+, 10 s","CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4KLE"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3')","2","4KLE"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4KLE"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4KLE"
"4KLF",,"X-RAY DIFFRACTION",2.23,44.84,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLF",48.81,"1.85","1.85","DNA polymerase beta matched reactant complex with Mg2+, 20 s","CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4KLF"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3'","2","4KLF"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4KLF"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4KLF"
"4KLG",,"X-RAY DIFFRACTION",2.27,45.71,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLG",48.46,"1.701","1.701","DNA polymerase beta matched product complex with Mg2+, 40 s","CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4KLG"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3'","2","4KLG"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4KLG"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4KLG"
"4KLH",,"X-RAY DIFFRACTION",2.23,44.85,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLH",48.49,"1.876","1.876","DNA polymerase beta matched product complex with Mn2+, 40 s","CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4KLH"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3'","2","4KLH"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4KLH"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4KLH"
"4KLI",,"X-RAY DIFFRACTION",2.26,45.49,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLI",48.36,"1.597","1.597","DNA polymerase beta matched product complex with Mg2+, 90 s","CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4KLI"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3'","2","4KLI"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4KLI"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4KLI"
"4KLJ",,"X-RAY DIFFRACTION",2.25,45.37,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLJ",48.36,"1.799","1.799","DNA polymerase beta matched product complex with Mg2+, 5 min","CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4KLJ"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3'","2","4KLJ"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4KLJ"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4KLJ"
"4KLL",,"X-RAY DIFFRACTION",2.2,44.07,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLL",48.36,"1.841","1.841","DNA polymerase beta matched product complex with Mg2+, 45 min","CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4KLL"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3'","2","4KLL"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4KLL"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4KLL"
"4KLM",,"X-RAY DIFFRACTION",2.22,44.49,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLM",48.34,"1.747","1.747","DNA polymerase beta matched product complex with Mg2+, 11 h","CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4KLM"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3'","2","4KLM"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4KLM"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4KLM"
"4KLN",,"X-RAY DIFFRACTION",3.15,60.91,"VAPOR DIFFUSION, SITTING DROP",5.8,"0.1M citrate, pH 5.8, 0.3M NaCl, 13.6% PEG 3350, 20% glycerol, 0.525% benzamidine, VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1074/jbc.M113.488924","AGS","4KLN",331.12,"2.62","2.62","Structure of p97 N-D1 A232E mutant in complex with ATPgS","MASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDTCSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEESLNEVGYDDIGGCRKQLAQIKEMVELPLRHPALFKEIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIGGRSHHHHHH","Homo sapiens","p97, VCP","Transitional endoplasmic reticulum ATPase","1","4KLN"
"4KLO",,"X-RAY DIFFRACTION",2.23,44.91,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLO",48.29,"1.845","1.845","DNA polymerase beta matched nick complex with Mg2+ and PPi, 30 min","CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4KLO"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3'","2","4KLO"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4KLO"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4KLO"
"4KLQ",,"X-RAY DIFFRACTION",2.26,45.58,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLQ",48.92,"1.999","1.999","Observing a DNA polymerase choose right from wrong.","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4KLQ"
,,,,,,,,,,,,,,,,"CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","2","4KLQ"
,,,,,,,,,,,,,,,,"GCTGATGCGCA",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*A)-3'","3","4KLQ"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","4","4KLQ"
"4KLR",,"X-RAY DIFFRACTION",2.64,53.48,"VAPOR DIFFUSION, HANGING DROP",,"Crystals were grown using Hanging drop with a precipitating solution 
consisting of 0.1 Bis-Tris ph 6.5, 0.075 M Ammonium sulfate and 30 % 
pentaerythritol ethoxylate (15/4 EO/OH), VAPOR DIFFUSION, HANGING DROP",,,,"4KLR",88.81,"2.18","2.18","E343Q variant of human ferrochelatase","MGGSHHHHHHGRKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIQTLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase, mitochondrial","1","4KLR"
"4KLS",,"X-RAY DIFFRACTION",2.28,46.03,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLS",48.92,"1.978","1.978","DNA polymerase beta mismatched reactant complex with Mn2+, 10 min","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4KLS"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","2","4KLS"
,,,,,,,,,,,,,,,,"GCTGATGCGCA",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*A)-3'","3","4KLS"
,,,,,,,,,,,,,,,,"CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","4","4KLS"
"4KLT",,"X-RAY DIFFRACTION",2.29,46.31,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLT",48.45,"1.979","1.979","DNA polymerase beta mismatched product complex with Mn2+, 30 min","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4KLT"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","2","4KLT"
,,,,,,,,,,,,,,,,"GCTGATGCGCA",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*A)-3'","3","4KLT"
,,,,,,,,,,,,,,,,"CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","4","4KLT"
"4KLU",,"X-RAY DIFFRACTION",2.42,49.2,"VAPOR DIFFUSION",8,"50 mM imidazole, 350 mM sodium chloride, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4KLU",48.18,"1.97","1.97","DNA polymerase beta mismatched product complex with Mn2+, 15 h","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4KLU"
,,,,,,,,,,,,,,,,"CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","2","4KLU"
,,,,,,,,,,,,,,,,"GCTGATGCGCA",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*A)-3'","3","4KLU"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","4","4KLU"
"4KLZ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"11-14% w/v PEG4000, 5-8% v/v Jeffamine M600, imidazole , VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4KLZ",20.55,"2.3","2.3","Inhibition of Small GTPases by Stabilization of the GDP Complex, a Novel Approach applied to Rit1, a Target for Rheumatoid Arthritis","GSSREYKLVMLGAGGVGKSAMTMQFISHRFPEDHDPTIEDAYKIRIRIDDEPANLDILDTAGQAEFTAMRDQYMRAGEGFIICYSITDRRSFHEVREFKQLIYRVRRTDDTPVVLVGNKSDLKQLRQVTKEEGLALAREFSCPFFETSAAYRYYIDDVFHALVREIRRKEKEA","Homo sapiens","RIT1, RIBB, RIT, ROC1","GTP-binding protein Rit1","1","4KLZ"
"4KM5",,"X-RAY DIFFRACTION",2.57,52.09,"VAPOR DIFFUSION, HANGING DROP",7.8,"0.044M potassium chloride, 0.01M magnesium chloride, 0.025M Tris pH 7.0, 0.015M Tris pH 9.0, 6.9% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.celrep.2013.05.008",,"4KM5",43.06,"2.499","2.499","X-ray crystal structure of human cyclic GMP-AMP synthase (cGAS)","SGSDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","4KM5"
"4KM6",,"X-RAY DIFFRACTION",1.65,25.55,"VAPOR DIFFUSION, SITTING DROP",5.5,"12 mg/mL co-purified with methotrexate in 0.1 M sodium citrate, , 35 % (v/v) jeffamine ED-2001 (MTX not present in structure), pH 5.5, Vapor diffusion, sitting drop, temperature 293K",293,"10.1073/pnas.1308827110",,"4KM6",25.03,"1.55","1.55","Human folate receptor alpha (FOLR1) at acidic pH, orthorhombic form","GSSRTELLNVCMNAKHHKEKPGPEDKLHEQCRPWRKNACCSTNTSQEAHKDVSYLYRFNWNHCGEMAPACKRHFIQDTCLYECSPNLGPWIQQVDQSWRKERVLNVPLCKEDCEQWWEDCRTSYTCKSNWHKGWNWTSGFNKCAVGAACQPFHFYFPTPTVLCNEIWTHSYKVSNYSRGSGRCIQMWFDPAQGNPNEEVARFYAAAMS","Homo sapiens","FOLR, FOLR1, FOLR2","Folate receptor alpha","1","4KM6"
"4KM7",,"X-RAY DIFFRACTION",2.53,51.45,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.1 M Citrate, pH 4.5, 0.1 M LiCl, 17.5 % PEG 8000, 40% (v/v) 2,2,2-trifluoroethanol, Vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1308827110",,"4KM7",49.66,"1.801","1.801","Human folate receptor alpha (FOLR1) at acidic pH, triclinic form","WARTELLNVCMNAKHHKEKPGPEDKLHEQCRPWRKNACCSTNTSQEAHKDVSYLYRFNWNHCGEMAPACKRHFIQDTCLYECSPNLGPWIQQVDQSWRKERVLNVPLCKEDCEQWWEDCRTSYTCKSNWHKGWNWTSGFNKCAVGAACQPFHFYFPTPTVLCNEIWTHSYKVSNYSRGSGRCIQMWFDPAQGNPNEEVARFYAAAMS","Homo sapiens","FOLR1, FOLR","Folate receptor alpha","1","4KM7"
"4KM8",,"X-RAY DIFFRACTION",2.8,56.12,"VAPOR DIFFUSION, HANGING DROP",,"8% PEG 3350, 0.15M Ammonium Tartrate, vapor diffusion, hanging drop, temperature 287K",287,"10.1038/ncomms3608",,"4KM8",49.41,"2.26","2.26","Crystal structure of Sufud60","MGSSHHHHHHSSGLVPRGSHMAELRPSGAPGPTAPPAPGPTAPPAFASLFPPGLHAIYGECRRLYPDQPNPLQVTAIVKYWLGGPDPLDYVSMYRNVGSPSANIPEHWHYISFGLSDLYGDNRVHEFTGTDGPSGFGFELTFRLKRETGESAPPTWPAELMQGLARYVFQSENTFCSGDHVSWHSPLDNSESRIQHMLLTEDPQMQPVQTPFGVVTFLQIVGVCTEELHSAQQWNGQGILELLRTVPIAGGPWLITDMRRGETIFEIDPHLQERVDKGIETDGSNLSGVSAKCAWDDLSRPPEDDSLESDSSTAIIPHELIRTRQLESVHLKFNQESGALIPLCLRGRLLHGRHFTYKSITGDMAITFVSTGVEGAFATEEHPYAAHGPWLQILLTEEFVEKMLEDLEDLTSPEEFKLPKEYSWPEKKLKVSILPDVVFDSPLH","Homo sapiens","SUFU, UNQ650/PRO1280","Suppressor of fused homolog","1","4KM8"
,,,,,,,,,,,,,,,,,"Homo sapiens","SUFU, UNQ650/PRO1280"
"4KM9",,"X-RAY DIFFRACTION",2.41,49,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 0.2M Potassium chloride, vapor diffusion, hanging drop, temperature 281K",281,"10.1038/ncomms3608",,"4KM9",54.45,"3.19","3.19","Crystal structure of human Suppressor of Fused","GAMGQMAELRPSGAPGPTAPPAPGPTAPPAFASLFPPGLHAIYGECRRLYPDQPNPLQVTAIVKYWLGGPDPLDYVSMYRNVGSPSANIPEHWHYISFGLSDLYGDNRVHEFTGTDGPSGFGFELTFRLKRETGESAPPTWPAELMQGLARYVFQSENTFCSGDHVSWHSPLDNSESRIQHMLLTEDPQMQPVQTPFGVVTFLQIVGVCTEELHSAQQWNGQGILELLRTVPIAGGPWLITDMRRGETIFEIDPHLQERVDKGIETDGSNLSGVSAKCAWDDLSRPPEDDEDSRSICIGTQPRRLSGKDTEQIRETLRRGLEINSKPVLPPINPQRQNGLAHDRAPSRKDSLESDSSTAIIPHELIRTRQLESVHLKFNQESGALIPLCLRGRLLHGRHFTYKSITGDMAITFVSTGVEGAFATEEHPYAAHGPWLQILLTEEFVEKMLEDLEDLTSPEEFKLPKEYSWPEKKLKVSILPDVVFDSPLH","Homo sapiens","SUFU, UNQ650/PRO1280","Suppressor of fused homolog","1","4KM9"
"4KMH",,"X-RAY DIFFRACTION",2.48,50.44,"VAPOR DIFFUSION, HANGING DROP",,"16% PEG 3350, 0.1M Ammonium Tartrate, vapor diffusion, hanging drop, temperature 287K",287,"10.1038/ncomms3608",,"4KMH",107.69,"3.04","3.04","Crystal structure of Suppressor of Fused d20","MGSSHHHHHHSSGLVPRGSHMAELRPSGAPGPTAPPAPGPTAPPAFASLFPPGLHAIYGECRRLYPDQPNPLQVTAIVKYWLGGPDPLDYVSMYRNVGSPSANIPEHWHYISFGLSDLYGDNRVHEFTGTDGPSGFGFELTFRLKRETGESAPPTWPAELMQGLARYVFQSENTFCSGDHVSWHSPLDNSESRIQHMLLTEDPQMQPVQTPFGVVTFLQIVGVCTEELHSAQQWNGQGILELLRTVPIAGGPWLITDMRRGETIFEIDPHLQERVDKGIETDGSNLSGVSAKCAWDDLSRPPEDDEDSRSICIGTQPRRLSGKDTPINPQRQNGLAHDRAPSRKDSLESDSSTAIIPHELIRTRQLESVHLKFNQESGALIPLCLRGRLLHGRHFTYKSITGDMAITFVSTGVEGAFATEEHPYAAHGPWLQILLTEEFVEKMLEDLEDLTSPEEFKLPKEYSWPEKKLKVSILPDVVFDSPLH","Homo sapiens","SUFU, UNQ650/PRO1280","Suppressor of fused homolog","1","4KMH"
,,,,,,,,,,,,,,,,,"Homo sapiens","SUFU, UNQ650/PRO1280"
"4KMM",,"X-RAY DIFFRACTION",2.75,55.34,,,,,,,"4KMM",88.1,"2.6","2.6","M76H variant of human ferrochelatase","MGGSHHHHHHGRKPKTGILMLNHGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase, mitochondrial","1","4KMM"
"4KMN",,"X-RAY DIFFRACTION",3.75,67.16,"VAPOR DIFFUSION, HANGING DROP",6.9,"1M Na/K phosphate pH6.9, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4KMN",12.79,"1.523","1.523","Structure of cIAP1-BIR3 and inhibitor","AAASISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRYPHLLEAA","Homo sapiens","BIRC2, API1, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","4KMN"
"4KMP",,"X-RAY DIFFRACTION",1.87,34.1,"VAPOR DIFFUSION, HANGING DROP",5.8,"0.1M Bis-tri pH5.8, 2M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4KMP",23.56,"1.95","1.95","Structure of XIAP-BIR3 and inhibitor","ADSHMLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSL","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","4KMP"
"4KMT",,"X-RAY DIFFRACTION",2.53,51.42,"VAPOR DIFFUSION, SITTING DROP",9.5,"1.8 M ammonium sulfate, 0.1 M CHES, pH 9.5, 5% dioxane, cryoprotectant: 2.1 M ammonium sulfate, 0.1 M CHES, pH 9.5, 25% glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/prot.24554",,"4KMT",49.39,"2.1","2.1","Crystal structure of human germline antibody 5-51/O12","DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"light chain O12/KAPPA","1","4KMT"
,,,,,,,,,,,,,,,,"EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARYDGIYGELDFWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"heavy chain 5-51/CNTO888/IGG1","2","4KMT"
"4KMX",,"X-RAY DIFFRACTION",3.35,63.31,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Citrate, pH 4.5, 0.1 M LiCl, 17.5 % PEG 8000, Vapor diffusion, sitting drop, temperature 298K",298,"10.1073/pnas.1308827110",,"4KMX",25.21,"2.2","2.2","Human folate receptor alpha (FOLR1) at acidic pH, hexagonal form","WARTELLNVCMNAKHHKEKPGPEDKLHEQCRPWRKNACCSTNTSQEAHKDVSYLYRFNWNHCGEMAPACKRHFIQDTCLYECSPNLGPWIQQVDQSWRKERVLNVPLCKEDCEQWWEDCRTSYTCKSNWHKGWNWTSGFNKCAVGAACQPFHFYFPTPTVLCNEIWTHSYKVSNYSRGSGRCIQMWFDPAQGNPNEEVARFYAAAMS","Homo sapiens","FOLR1, FOLR","Folate receptor alpha","1","4KMX"
"4KMY",,"X-RAY DIFFRACTION",3.31,62.86,"VAPOR DIFFUSION, SITTING DROP",7.4,"1.0 M Ammonium citrate tribasic, pH 7.0, 0.1 M Bis-Tris Propane, pH 7.0, Vapor diffusion, sitting drop, temperature 293K",293,"10.1073/pnas.1308827110",,"4KMY",24.28,"1.795","1.795","Human folate receptor beta (FOLR2) at neutral pH","GSRTDLLNVCMDAKHHKTKPGPEDKLHDQCSPWKKNACCTASTSQELHKDTSRLYNFNWDHCGKMEPACKRHFIQDTCLYECSPNLGPWIQQVNQSWRKERFLDVPLCKEDCQRWWEDCHTSHTCKSNWHRGWDWTSGVNKCPAGALCRTFESYFPTPAALCEGLWSHSYKVSNYSRGSGRCIQMWFDSAQGNPNEEVARFYAAAMH","Homo sapiens","FOLR2","Folate receptor beta","1","4KMY"
"4KMZ",,"X-RAY DIFFRACTION",2.8,56.1,"VAPOR DIFFUSION, SITTING DROP",8,"2.4 M Ammonium phosphate diabasic, 0.1 M Hepes pH 7.5, Vapor diffusion, sitting drop, temperature 293K",293,"10.1073/pnas.1308827110","FOL","4KMZ",24.96,"2.3","2.3","Human folate receptor beta (FOLR2) in complex with the folate","GSRTDLLNVCMDAKHHKTKPGPEDKLHDQCSPWKKNACCTASTSQELHKDTSRLYNFNWDHCGKMEPACKRHFIQDTCLYECSPNLGPWIQQVNQSWRKERFLDVPLCKEDCQRWWEDCHTSHTCKSNWHRGWDWTSGVNKCPAGALCRTFESYFPTPAALCEGLWSHSYKVSNYSRGSGRCIQMWFDSAQGNPNEEVARFYAAAMH","Homo sapiens","FOLR2","Folate receptor beta","1","4KMZ"
"4KN0",,"X-RAY DIFFRACTION",2.88,57.22,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M Lithium sulfate, 0.1 M Tris-HCl pH 8.0, 20% (w/v) PEG 3350, Vapor diffusion, sitting drop, temperature 293K",293,"10.1073/pnas.1308827110","MTX","4KN0",25.44,"2.1","2.1","Human folate receptor beta (FOLR2) in complex with the antifolate methotrexate","GSRTDLLNVCMDAKHHKTKPGPEDKLHDQCSPWKKNACCTASTSQELHKDTSRLYNFNWDHCGKMEPACKRHFIQDTCLYECSPNLGPWIQQVNQSWRKERFLDVPLCKEDCQRWWEDCHTSHTCKSNWHRGWDWTSGVNKCPAGALCRTFESYFPTPAALCEGLWSHSYKVSNYSRGSGRCIQMWFDSAQGNPNEEVARFYAAAMH","Homo sapiens","FOLR2","Folate receptor beta","1","4KN0"
"4KN1",,"X-RAY DIFFRACTION",2.84,56.68,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M Lithium sulfate, 0.1 M Tris-HCl pH 8.0, 20% (w/v) PEG 3350, Vapor diffusion, sitting drop, temperature 293K",293,"10.1073/pnas.1308827110","04J","4KN1",25.19,"2.301","2.301","Human folate receptor beta (FOLR2) in complex with the antifolate aminopterin","GSRTDLLNVCMDAKHHKTKPGPEDKLHDQCSPWKKNACCTASTSQELHKDTSRLYNFNWDHCGKMEPACKRHFIQDTCLYECSPNLGPWIQQVNQSWRKERFLDVPLCKEDCQRWWEDCHTSHTCKSNWHRGWDWTSGVNKCPAGALCRTFESYFPTPAALCEGLWSHSYKVSNYSRGSGRCIQMWFDSAQGNPNEEVARFYAAAMH","Homo sapiens","FOLR2","Folate receptor beta","1","4KN1"
"4KN2",,"X-RAY DIFFRACTION",2.91,57.74,"VAPOR DIFFUSION, SITTING DROP",8.2,"1.5 M Ammonium phosphate dibasc, 0.1 M Tris pH 8.5, Vapor diffusion, sitting drop, temperature 293K",293,"10.1073/pnas.1308827110","LYA","4KN2",74.24,"2.6","2.6","Human folate receptor beta (FOLR2) in complex with antifolate pemetrexed","GSRTDLLNVCMDAKHHKTKPGPEDKLHDQCSPWKKNACCTASTSQELHKDTSRLYNFNWDHCGKMEPACKRHFIQDTCLYECSPNLGPWIQQVNQSWRKERFLDVPLCKEDCQRWWEDCHTSHTCKSNWHRGWDWTSGVNKCPAGALCRTFESYFPTPAALCEGLWSHSYKVSNYSRGSGRCIQMWFDSAQGNPNEEVARFYAAAMH","Homo sapiens","FOLR2","Folate receptor beta","1","4KN2"
"4KN6",,"X-RAY DIFFRACTION",1.92,36.01,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M sodium chloride, 1 M sodium/potassium tartrate, 0.1 M imidazole, pH 8.0, VAPOR DIFFUSION, HANGING DROP",,"10.1124/mol.113.087247",,"4KN6",24.78,"2.728","2.728","Crystal structure of human hypoxanthine-guanine phosphoribosyltransferase in complex with 6-fluoro-3-hydroxy-2-pyrazinecarboxamide (T-705) ribose-5'-monophosphate","TRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA","Homo sapiens","HPRT1, HPRT","Hypoxanthine-guanine phosphoribosyltransferase","1","4KN6"
"4KNB",,"X-RAY DIFFRACTION",2.31,46.7,"LIQUID DIFFUSION",,"LIQUID DIFFUSION",,"10.1016/j.bmcl.2013.05.074","1RU","4KNB",132.42,"2.4","2.4","C-Met in complex with OSI ligand","PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","4KNB"
"4KNI",,"X-RAY DIFFRACTION",2.1,40.4,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M sodium BICINE pH 9, 0.2M ammonium sulfate, 2M sodium malonate pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.bmc.2013.09.029","E1E","4KNI",30.08,"1.8","1.8","Crystal structure of human carbonic anhydrase isozyme II with 2-Chloro-4-{[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetyl}benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4KNI"
"4KNJ",,"X-RAY DIFFRACTION",2.1,39.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.2M sodium malonate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.bmc.2013.09.029","E1F","4KNJ",29.97,"2","2","Crystal structure of human carbonic anhydrase isozyme II with 2-Chloro-4-[(pyrimidin-2-ylsulfanyl)acetyl]benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4KNJ"
"4KNM",,"X-RAY DIFFRACTION",2,39.4,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M sodium citrate (pH 5.5), 0.1M sodium acetate (pH 4.5), 30% PEG4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.bmc.2013.09.029","E1E","4KNM",60.25,"1.9","1.9","Crystal structure of human carbonic anhydrase isozyme XIII with 2-Chloro-4-{[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetyl}benzenesulfonamide","MMSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH","Homo sapiens","CA13","Carbonic anhydrase 13","1","4KNM"
"4KNN",,"X-RAY DIFFRACTION",2.2,44.2,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M ammonium citrate (pH 7.0), 0.1M sodium acetate (pH 4.5) and 26% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.bmc.2013.09.029","E1F","4KNN",60.9,"1.404","1.404","Crystal structure of human carbonic anhydrase isozyme XIII with 2-Chloro-4-[(pyrimidin-2-ylsulfanyl)acetyl]benzenesulfonamide","MMSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH","Homo sapiens","CA13","Carbonic anhydrase 13","1","4KNN"
"4KNV",,"X-RAY DIFFRACTION",2.53,51.48,"VAPOR DIFFUSION, HANGING DROP",5.6,"1.6 M sodium/postassium phosphate, pH 5.6, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2013.05.052",,"4KNV",55.13,"1.993","1.993","The crystal structure of APO HUMAN HDHD4 FROM SE-MAD","MRAVFFDLDNTLIDTAGASRRGMLEVIKLLQSKYHYKEEAEIICDKVQVKLSKECFHPYNTCITDLRTSHWEEAIQETKGGAANRKLAEECYFLWKSTRLQHMTLAEDVKAMLTELRKEVRLLLLTNGDRQTQREKIEACACQSYFDAVVVGGEQREEKPAPSIFYYCCNLLGVQPGDCVMVGDTLETDIQGGLNAGLKATVWINKNGIVPLKSSPVPHYMVSSVLELPALLQSIDCLVPR","Homo sapiens","C20orf147, HDHD4, NANP","N-acylneuraminate-9-phosphatase","1","4KNV"
"4KNW",,"X-RAY DIFFRACTION",2.75,55.23,"VAPOR DIFFUSION, HANGING DROP",7.5,"500 mM postassium formate, 100 mM glycyl-glycine, pH 8.5, 20% (w/v) PEG 1500, 0.01%(w/v) N-dodecyl-b-D-maltoside, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2013.05.052",,"4KNW",86.79,"2.699","2.699","The crystal structure of human HDHD4 IN COMPLEX WITH MAGNESIUM AND THE PHOSPHATE MIMETIC VANADATE","MGSGLSRVRAVFFDLDNTLIDTAGASRRGMLEVIKLLQSKYHYKEEAEIICDKVQVKLSKECFHPYNTCITDLRTSHWEEAIQETKGGAANRKLAEECYFLWKSTRLQHMTLAEDVKAMLTELRKEVRLLLLTNGDRQTQREKIEACACQSYFDAVVVGGEQREEKPAPSIFYYCCNLLGVQPGDCVMVGDTLETDIQGGLNAGLKATVWINKNGIVPLKSSPVPHYMVSSVLELPALLQSIDCKVSMSTEFGLVPR","Homo sapiens","C20orf147, HDHD4, NANP","N-acylneuraminate-9-phosphatase","1","4KNW"
"4KO8",,"X-RAY DIFFRACTION",2.9,57.65,"VAPOR DIFFUSION, HANGING DROP",5.6,"100mM citrate buffer pH 5.6, 6% benzamidine, 7% PEG3350, and 20% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1074/jbc.M113.488924","AGS","4KO8",110.22,"1.98","1.98","Structure of p97 N-D1 R155H mutant in complex with ATPgS","MASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDTCSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVHGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEESLNEVGYDDIGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIGGRSHHHHHH","Homo sapiens","p97, VCP","Transitional endoplasmic reticulum ATPase","1","4KO8"
"4KOD",,"X-RAY DIFFRACTION",2.45,49.82,"VAPOR DIFFUSION, SITTING DROP",5.8,"0.1M citrate, pH 5.8, 0.3M NaCl, 13.6% EPG 3350, 20% glycerol, 0.625% benzamidine, VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1074/jbc.M113.488924","ADP","4KOD",659.87,"2.96","2.96","Structure of p97 N-D1 R155H mutant in complex with ADP","MASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDTCSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVHGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEESLNEVGYDDIGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIGGRSHHHHHH","Homo sapiens","p97, VCP","Transitional endoplasmic reticulum ATPase","1","4KOD"
"4KP0",,"X-RAY DIFFRACTION",2.87,57.11,"VAPOR DIFFUSION, HANGING DROP",5.5,"100mM sodium citrate, 15% PEG1500, 20% 2-propanol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0909049513020748","KPK","4KP0",25.46,"2.8","2.8","Crystal Structure of the human Chymase with TJK002","IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGVAQGIVSYGRSDAKPPAVFTRISHYRPWINQILQAN","Homo sapiens","CMA1, CYH, CYM","Chymase","1","4KP0"
"4KP5",,"X-RAY DIFFRACTION",2.1,40.7,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M ammonium citrate pH 7.0, 0.2M ammonium sulfate, 30% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.bmc.2013.09.029","E1F","4KP5",121.77,"1.45","1.45","Crystal structure of catalytic domain of human carbonic anhydrase isozyme XII with 2-Chloro-4-[(pyrimidin-2-ylsulfanyl)acetyl]benzenesulfonamide","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","4KP5"
"4KP6",,"X-RAY DIFFRACTION",2.09,41.04,"VAPOR DIFFUSION, SITTING DROP",5.9,"ethylene glycole, PEG1K, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.05.099","1S1","4KP6",40.59,"1.5","1.5","Crystal structure of human phosphodiesterase 4B (PDE4B) in complex with a [1,3,5]triazine derivative","GAMGSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQS","Homo sapiens","DPDE4, PDE4B","cAMP-specific 3',5'-cyclic phosphodiesterase 4B","1","4KP6"
"4KP8",,"X-RAY DIFFRACTION",2.1,41.46,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M ammonium citrate pH 5.0, 24% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.bmc.2013.09.029","E1G","4KP8",121.21,"1.8","1.8","Crystal structure of catalytic domain of human carbonic anhydrase isozyme XII with 3-[(Pyrimidin-2-ylsulfanyl)acetyl]benzenesulfonamide","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","4KP8"
"4KPD",,"X-RAY DIFFRACTION",2.42,49.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M NH4Cl, 20% PEG 6000, 10% Ethelene Glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"RIS","4KPD",43.73,"1.96","1.96","Crystal Structure of Human Farnesyl Pyrophosphate Synthase (Y204F) Mutant Complexed with Mg, Risedronate and Isopentenyl Pyrophosphate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFFSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4KPD"
"4KPJ",,"X-RAY DIFFRACTION",2.4,48.66,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M NH4Cl, 20% PEG6000, 10% Ethylene Glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"210","4KPJ",43.73,"1.95","1.95","Crystal Structure of Farnesyl Pyrophosphate Synthase (Y204A) Mutant complexed with Mg, Pamidronate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFASFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4KPJ"
"4KPW",,"X-RAY DIFFRACTION",2.96,58.5,"VAPOR DIFFUSION, HANGING DROP",8.8,"30 % saturated ammonium sulfate, 20 mM BETA-MERCAPTOETHANOL, and 0.1 M Tris-HCl, pH 8.8, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/acs.jmedchem.5b00137",,"4KPW",37.83,"2.03","2.03","Crystal structure of His-tagged human thymidylate synthase R175A mutant","MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDARIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","4KPW"
"4KQ3",,"X-RAY DIFFRACTION",2.12,42.03,"VAPOR DIFFUSION, SITTING DROP",6.5,"18% PEG3000, 0.2 M ammonium acetate, 0.1 M MES, pH 6.5, cryoprotectant: 20% PEG3000, 0.16 M ammonium acetate, 0.1 M MES, PH 6.5, 24% glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/prot.24522",,"4KQ3",47.96,"1.92","1.92","Crystal structure of Anti-IL-17A antibody CNTO3186","DIQMTQSPSSVSASVGDRVTITCRASQGISNWLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSDDPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CNTO3186 light chain","1","4KQ3"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGSIIPWFGTTNYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARDSEYYFDHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"CNTO3186 heavy chain","2","4KQ3"
"4KQ5",,"X-RAY DIFFRACTION",2.46,49.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M NH4Cl, 20% PEG6000, 10% Ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"ZOL","4KQ5",43.46,"2.4","2.4","Crystal Structure of Human Farnesyl Pyrophosphate Synthase Mutant (Y204A) Complexed with Mg and Zoledronate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFASFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4KQ5"
"4KQ8",,"X-RAY DIFFRACTION",6.1,79.82,"VAPOR DIFFUSION",7.4,"Crystallized from 24%-30% PEG4000, 0.5 M NaCl, 0.05M Tris-HCl and vapor diffused in sealed 24-well sitting drop plates. Crystals appeared after 1-6 week of initial set-up and continued to grow for an additional 2 to 6 weeks after first appearance, pH 7.4, VAPOR DIFFUSION, temperature 277K",277,"10.1021/bi400669h","ASD","4KQ8",55.68,"3.29","3.29","Structure of Recombinant Human Cytochrome P450 Aromatase","MAKKTSSKGRSSIPGPGYCMGIGPLISHGRFLWMGIGSACNYYNRVYGEFMRVWISGEETLIISKSSSMFHIMKHNHYSSRFGSKLGLQCIGMHEKGIIFNNNPELWKTTRPFFMKALSGPGLVRMVTVCAESLKTHLDRLEEVTNESGYVDVLTLLRRVMLDTSNTLFLRIPLDESAIVVKIQGYFDAWQALLIKPDIFFKISWLYKKYEKSVKDLKDAIEVLIAEKRRRISTEEKLEECMDFATELILAEKRGDLTRENVNQCILEMLIAAPDTMSVSLFFMLFLIAKHPNVEEAIIKEIQTVIGERDIKIDDIQKLKVMENFIYESMRYQPVVDLVMRKALEDDVIDGYPVKKGTNIILNIGRMHRLEFFPKPNEFTLENFAKNVPYRYFQPFGFGPRGCAGKYIAMVMMKAILVTLLRRFHVKTLQGQCVESIQKIHDLSLHPDETKNMLEMIFTPRNSDRCLEHHHHH","Homo sapiens","CYP19A1, ARO1, CYAR, CYP19","Cytochrome P450 19A1","1","4KQ8"
"4KQE",,"X-RAY DIFFRACTION",3.27,62.35,"VAPOR DIFFUSION, HANGING DROP",9,"0.1M ammonium citrate, 17% PEG3350, 0.1M Tris-HCl, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M115.679126",,"4KQE",78.72,"2.739","2.739","The mutant structure of the human glycyl-tRNA synthetase E71G","MDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMGDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEELEHHHHHH","Homo sapiens","GARS, GARS1","Glycine--tRNA ligase","1","4KQE"
"4KQS",,"X-RAY DIFFRACTION",2.39,48.53,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M NH4Cl, PEG6000, 10% Ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"RIS","4KQS",43.66,"1.97","1.97","Crystal Structure of Farnesyl Pyrophosphate Synthase Mutant (Y204A) Complexed with Mg, Risedronate and Isopentenyl Pyrophosphate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFASFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4KQS"
"4KQU",,"X-RAY DIFFRACTION",2.4,48.78,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M NH4Cl, PEG6000, 10% Ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4KQU",43.62,"2.07","2.07","Crystal Structure of Farnesyl Synthase Mutant (Y204A) Complexed with Mg, Alendronate and Isopentenyl Pyrophosphate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFASFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4KQU"
"4KRF",,"X-RAY DIFFRACTION",2.23,44.96,"VAPOR DIFFUSION, HANGING DROP",9,"13% PEG 3350, 9% iso-propanol, 0.1M Tris pH 9.0, vapor diffusion, hanging drop, temperature 291K",291,"10.1016/j.celrep.2013.05.033",,"4KRF",104.54,"2.101","2.101","Structure of Human Argonaute-1 let-7 complex","AMEAGPSGAAAGAYLPPLQQVFQAPRRPGIGTVGKPIKLLANYFEVDIPKIDVYHYEVDIKPDKCPRRVNREVVEYMVQHFKPQIFGDRKPVYDGKKNIYTVTALPIGNERVDFEVTIPGEGKDRIFKVSIKWLAIVSWRMLHEALVSGQIPVPLESVQALDVAMRHLASMRYTPVGRSFFSPPEGYYHPLGGGREVWFGFHQSVRPAMWKMMLNIDVSATAFYKAQPVIEFMCEVLDIRNIDEQPKPLTDSQRVRFTKEIKGLKVEVTHCGQMKRKYRVCNVTRRPASHQTFPLQLESGQTVECTVAQYFKQKYNLQLKYPHLPCLQVGQEQKHTYLPLEVCNIVAGQRCIKKLTDNQTSTMIKATARSAPDRQEEISRLMKNASYNLDPYIQEFGIKVKDDMTEVTGRVLPAPILQYGGRNRAIATPNQGVWDMRGKQFYNGIEIKVWAIACFAPQKQCREEVLKNFTDQLRKISKDAGMPIQGQPCFCKYAQGADSVEPMFRHLKNTYSGLQLIIVILPGKTPVYAEVKRVGDTLLGMATQCVQVKNVVKTSPQTLSNLCLKINVKLGGINNILVPHQRSAVFQQPVIFLGADVTHPPAGDGKKPSITAVVGSMDAHPSRYCATVRVQRPRQEIIEDLSYMVRELLIQFYKSTRFKPTRIIFYRDGVPEGQLPQILHYELLAIRDACIKLEKDYQPGITYIVVQKRHHTRLFCADKNERIGKSGNIPAGTTVDTNITHPFEFDFYLCSHAGIQGTSRPSHYYVLWDDNRFTADELQILTYQLCHTYVRCTRSVSIPAPAYYARLVAFRARYHLVDKEHDSGEGSHISGQSNGRDPQALAKAVQVHQDTLRTMYFA","Homo sapiens","AGO1, EIF2C1","Protein argonaute-1","1","4KRF"
,,,,,,,,,,,,,,,,"UGAGGUAGUAGGUUGUAUAGUU",,,"RNA (5'-R(P*UP*GP*AP*GP*GP*UP*AP*GP*UP*AP*GP*GP*UP*UP*GP*UP*AP*UP*AP*GP*UP*U)-3')","2","4KRF"
"4KRS",,"X-RAY DIFFRACTION",2.39,48.47,"VAPOR DIFFUSION, HANGING DROP",5.8,"RESERVOIR SOLUTION: 15% PEG3350, 100MM BIS-TRIS PH 5.8, 320MM AMMONIUM SULFATE. PROTEIN SOLUTION: 20 MG/ML IN 25 MM TRIS PH 8.0, 200MM NACL, 1MM TCEP, 1MM PJ34. EQUAL VOLUMES (2 UL) OF RESERVIOR SOLUTION AND PROTEIN SOLUTION WERE MIXED AND SET AS HANGING DROPS. CRYSTALS WERE THEN MOVED INTO A SOAKING SOLUTION CONTAINING 18% PEG 3350, 320MM AMMONIUM SULFATE, 100MM BIS-TRIS, 0.2 MM INHIBITOR, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm400826j","1SX","4KRS",51.92,"2.29","2.29","Tankyrase-1 complexed with small molecule inhibitor","GTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQKT","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4KRS"
"4KS7",,"X-RAY DIFFRACTION",2.19,43.81,"VAPOR DIFFUSION, SITTING DROP",8,"30% (v/v) isopropanol, 0.1M Bicine, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1371/journal.pone.0077818","7KC","4KS7",33.85,"1.4","1.4","PAK6 kinase domain in complex with PF-3758309","GSVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLY","Homo sapiens","PAK6, PAK5","Serine/threonine-protein kinase PAK 6","1","4KS7"
"4KS8",,"X-RAY DIFFRACTION",2.24,45.04,"VAPOR DIFFUSION, SITTING DROP",8,"30% (v/v) isopropanol, 0.1M MES, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1371/journal.pone.0077818","B49","4KS8",33.7,"1.95","1.95","PAK6 kinase domain in complex with sunitinib","GSVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLY","Homo sapiens","PAK6, PAK5","Serine/threonine-protein kinase PAK 6","1","4KS8"
"4KSJ",,"X-RAY DIFFRACTION",2.07,45.48,"VAPOR DIFFUSION, HANGING DROP",6,"100mM MES, 200mM MgCl2, 19% PEG3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP",,"10.1038/nature12296",,"4KSJ",32.76,"1.6","1.6","Crystal structure of the OTU domain of Gumby/Fam105B at 1.6 angstrom","GSRLSVAPEMDIMDYCKKEWRGNTQKATCMKMGYEEVSQKFTSIRRVRGDNYCALRATLFQAMSQAVGLPPWLQDPELMLLPEKLISKYNWIKQWKLGLKFDGKNEDLVDKIKESLTLLRKKWAGLAEMRTAEARQIACDELFTNEAEEYSLYEAVKFLMLNRAIELYNDKEKGKEVPFFSVLLFARDTSNDPGQLLRNHLNQVGHTGGLEQVEMFLLAYAVRHTIQVYRLSKYNTEEFITVYPTDPPKDWPVVTLIAEDDRHYNIPVRVCEETSL","Homo sapiens","FAM105B, OTULIN","Protein FAM105B","1","4KSJ"
"4KSP",,"X-RAY DIFFRACTION",3.5,64.83,"sitting drop, vapor diffusion",8.3,"9.6 % PEG 8000, 0.8M LiCl, 100 mM Tris pH 8.3, sitting drop, vapor diffusion, temperature 277K",277,"10.1021/jm400778d","1SU","4KSP",65.75,"2.93","2.93","Crystal Structure of Human B-raf bound to a DFG-out Inhibitor TAK-632","GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, P94, RAFB1, V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1","Serine/threonine-protein kinase B-raf","1","4KSP"
"4KSQ",,"X-RAY DIFFRACTION",3.43,64.18,"sitting drop, vapor diffusion",8.3,"7.8% PEG 8000, 0.8M LiCl, 100 mM Tris pH 8.3, sitting drop, vapor diffusion, temperature 277K",277,"10.1021/jm400778d","1SW","4KSQ",65.76,"3.3","3.3","Crystal Structure of Human B-raf bound to a DFG-out Inhibitor 5B","GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1, P94, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4KSQ"
"4KSY",,"X-RAY DIFFRACTION",2.29,46.32,"VAPOR DIFFUSION, HANGING DROP",6.8,"27% PEG 3,350, 0.1 M Bis-Tris, pH 6.8, 0.2 M NaCl, VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.molcel.2013.05.022","1SY","4KSY",27.86,"1.881","1.881","Crystal structure of STING in complex with cGAMP","GLAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","4KSY"
"4KTY",,"X-RAY DIFFRACTION",2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"170 mM ammonium sulfate  
85 mM sodium cacodylate  
25.5 % PEG8000  
15 % glycerol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/anie.201305133",,"4KTY",171.65,"1.98","1.98","Fibrin-stabilizing factor with a bound ligand","MHHHHHHSETSRTAFGGRRAVPPNNSNAAEDDLPTVELQGVVPRGVNLQEFLNVTSVHLFKERWDTNKVDHHTDKYENNKLIVRRGQSFYVQIDFSRPYDPRRDLFRVEYVIGRYPQENKGTYIPVPIVSELQSGKWGAKIVMREDRSVRLSIQSSPKCIVGKFRMYVAVWTPYGVLRTSRNPETDTYILFNPWCEDDAVYLDNEKEREEYVLNDIGVIFYGEVNDIKTRSWSYGQFEDGILDTCLYVMDRAQMDLSGRGNPIKVSRVGSAMVNAKDDEGVLVGSWDNIYAYGVPPSAWTGSVDILLEYRSSENPVRYGQCWVFAGVFNTFLRCLGIPARIVTNYFSAHDNDANLQMDIFLEEDGNVNSKLTKDSVWNYHCWNEAWMTRPDLPVGFGGWQAVDSTPQENSDGMYRCGPASVQAIKHGHVCFQFDAPFVFAEVNSDLIYITAKKDGTHVVENVDATHIGKLIVTKQIGGDGMMDITDTYKFQEGQEEERLALETALMYGAKKPLNTEGVMKSRSNVDMDFEVENAVLGKDFKLSITFRNNSHNRYTITAYLSANITFYTGVPKAEFKKETFDVTLEPLSFKKEAVLIQAGEYMGQLLEQASLHFFVTARINETRDVLAKQKSTVLTIPEIIIKVRGTQVVGSDMTVIVEFTNPLKETLRNVWVHLDGPGVTRPMKKMFREIRPNSTVQWEEVCRPWVSGHRKLIASMSSDSLRHVYGELDVQIQRRPSM","Homo sapiens","F13A, F13A1","Coagulation factor XIII A chain","1","4KTY"
,,,,,,,,,,,,,,,,"XDXALLPWP",,,"Peptide-like ligand","2","4KTY"
"4KU1",,"X-RAY DIFFRACTION",2.67,53.85,"VAPOR DIFFUSION, SITTING DROP",6.5,"Sitting drop 1:1 drop using 0.1 M sodium acetate and 30% polyethylene glycol 1,500, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.jmb.2014.01.011",,"4KU1",50.88,"1.9","1.9","Role of the hinge and C-gamma-2/C-gamma-3 interface in immunoglobin G1 Fc domain motions: implications for Fc engineering","GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4KU1"
"4KU7",,"X-RAY DIFFRACTION",1.67,26.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M trisodium citrate, 100mM sodium iodide, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.str.2013.09.021","PCG","4KU7",20.34,"1.65","1.65","Structures of PKGI Reveal a cGMP-Selective Activation Mechanism","GSTGLIKHTEYMEFLKSVPTFQSLPEEILSKLADVLEETHYENGEYIIRQGARGDTFFIISKGTVNVTREDSPSEDPVFLRTLGKGDWFGEKALQGEDVRTANVIAAEAVTCLVIDRDSFKHLIGGLDDVSNKAYEDAEAKAKYEAEAAFFAN","Homo sapiens","PRKG1, PRKG1B, PRKGR1A, PRKGR1B","cGMP-dependent protein kinase 1","1","4KU7"
"4KU8",,"X-RAY DIFFRACTION",2.59,52.5,"VAPOR DIFFUSION",5.5,"0.1M SPG buffer, 25% PEG1500, pH 5.5, VAPOR DIFFUSION, temperature 277K",277,"10.1016/j.str.2013.09.021",,"4KU8",51.06,"1.994","1.994","Structures of PKGI Reveal a cGMP-Selective Activation Mechanism","GSTGLIKHTEYMEFLKSVPTFQSLPEEILSKLADVLEETHYENGEYIIRQGARGDTFFIISKGTVNVTREDSPSEDPVFLRTLGKGDWFGEKALQGEDVRTANVIAAEAVTCLVIDRDSFKHLIGGLDDVSNKAYEDAEAKAKYEAEAAFFAN","Homo sapiens","PRKG1, PRKG1B, PRKGR1A, PRKGR1B","cGMP-dependent Protein Kinase 1","1","4KU8"
"4KUV",,"X-RAY DIFFRACTION",2.13,42.15,"VAPOR DIFFUSION",8,"1.5 M sodium citrate, Tris 50 mM, pH 8.0, VAPOR DIFFUSION, temperature 296K",296,,"MB6","4KUV",29.42,"1.35","1.35","Crystal structure of human carbonic anhydrase II in complex with the 5-(3-(4-chlorophenylsulfonyl)ureido)pyridine-2-sulfonamide inhibitor","WGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4KUV"
"4KUW",,"X-RAY DIFFRACTION",2.1,41.41,"VAPOR DIFFUSION",8,"1.5 M sodium citrate, Tris 50mM , pH 8.0, VAPOR DIFFUSION, temperature 296K",296,,"MB2","4KUW",29.54,"1.55","1.55","Crystal structure of human carbonic anhydrase II in complex with the 5-(3-(4-fluorophenylsulfonyl)ureido)pyridine-2-sulfonamide inhibitor","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4KUW"
"4KUY",,"X-RAY DIFFRACTION",2.1,41.31,"VAPOR DIFFUSION",8,"1.5 M sodium citrate, Tris 50 mM, pH 8.0, vapor diffusion, temperature 296K",296,,"MB4","4KUY",29.54,"1.65","1.65","Crystal structure of human carbonic anhydrase II in complex with the 5-(3-(o-tolylsulfonyl)ureido)pyridine-2-sulfonamide inhibitor","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4KUY"
"4KV0",,"X-RAY DIFFRACTION",2.1,41.56,"VAPOR DIFFUSION",8,"1.5 M sodium citrate, Tris 50 mM, pH 8.0, vapor diffusion, temperature 296K",296,"10.1016/j.bmc.2013.11.016","MB7","4KV0",29.54,"1.55","1.55","Crystal structure of human carbonic anhydrase II in complex with the 5-(3-tosylureido)pyridine-2-sulfonamide inhibitor","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4KV0"
"4KVP",,"X-RAY DIFFRACTION",2.04,39.7,"VAPOR DIFFUSION, HANGING DROP",7.6,"2 microliter protein solution (around 5.0-7.0 mg/ml protein in 20 mM Tris, 150 mM NaCl, 10 mM DTT) were mixed with 2 microliter reservoir buffer (25% (w/v) polyethylene glycol (PEG) 2000 monomethyl ether (MME)), pH 7.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1107/S0907444913020830",,"4KVP",99.09,"1.5","1.5","Human p53 Core Domain Mutant V157F","ASSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRFRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4KVP"
"4KWF",,"X-RAY DIFFRACTION",2.15,42.66,"sitting drop",6.4,"100 mM ACES, 100 mm guanidine-HCl, 10 mm MgCl2, and 14-19% PEG 6000, pH 6.4, sitting drop, temperature 300K",300,"10.1021/jm401377v","3AK","4KWF",433.8,"2.31","2.31","Crystal Structure Analysis of ALDH2+ALDiB33","AVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLAALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADMDWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGPQVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYKMSGSGRELGEYGLQAYTEVKTVTVKVPQKNS","Homo sapiens","ALDH2, ALDM","Aldehyde dehydrogenase, mitochondrial","1","4KWF"
"4KWG",,"X-RAY DIFFRACTION",2.1,41.3,"sitting drop",6.4,"100 mM ACES, 100 mm guanidine-HCl, 10 mm MgCl2, and 14-19% PEG 6000, pH 6.4, sitting drop, temperature 300K",300,"10.1021/jm401377v","2AK","4KWG",433.33,"2.1","2.1","Crystal Structure Analysis of ALDH2+ALDiB13","AVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLAALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADMDWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGPQVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYKMSGSGRELGEYGLQAYTEVKTVTVKVPQKNS","Homo sapiens","ALDH2, ALDM","Aldehyde dehydrogenase, mitochondrial","1","4KWG"
"4KWP",,"X-RAY DIFFRACTION",1.97,37.71,"VAPOR DIFFUSION",8.5,"0.1 M Tris-HCl, 0.2 M lithium sulphate, 32% w/v PEG 4000, pH 8.5, vapor diffusion, temperature 293K",293,"10.1007/s00018-013-1552-5","EXX","4KWP",41.61,"1.25","1.25","Crystal Structure of Human CK2-alpha in complex with a benzimidazole inhibitor (K164) at 1.25 A resolution","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","4KWP"
"4KWV",,"X-RAY DIFFRACTION",2.99,58.89,"VAPOR DIFFUSION, SITTING DROP",6.5,"50 mM MES, pH 6.5, 0.1 M sodium phosphate monobasic, 0.1 M potassium phosphate monobasic, 1.6-2.1 M sodium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1002/prot.24406",,"4KWV",187.04,"2.797","2.797","Crystal Structure of human apo-QPRT","GPGSMDAEGLALLLPPVTLAALVDSWLREDCPGLNYAALVSGAGPSQAALWAKSPGVLAGQPFFDAIFTQLNCQVSWFLPEGSKLVPVARVAEVRGPAHCLLLGERVALNTLARCSGIASAAAAAVEAARGAGWTGHVAGTRKTTPGFRLVEKYGLLVGGAASHRYDLGGLVMVKDNHVVAAGGVEKAVRAARQAADFTLKVEVECSSLQEAVQAAEAGADLVLLDNFKPEELHPTATVLKAQFPSVAVEASGGITLDNLPQFCGPHIDVISMGMLTQAAPALDFSLKLFAKEVAPVPKIH","Homo sapiens","QPRT","Nicotinate-nucleotide pyrophosphorylase [carboxylating]","1","4KWV"
"4KWW",,"X-RAY DIFFRACTION",3.03,59.39,"VAPOR DIFFUSION, SITTING DROP",6.5,"50 mM MES, pH 6.5, 0.1 M sodium phosphate monobasic, 0.1 M potassium phosphate monobasic, 1.6-2.1 M sodium chloride, 4 mM phthalic acid, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1002/prot.24406","PHT","4KWW",188.04,"2.55","2.55","The crystal structure of human quinolinic acid phosphoribosyltransferase in complex with its inhibitor phthalic acid","GPGSMDAEGLALLLPPVTLAALVDSWLREDCPGLNYAALVSGAGPSQAALWAKSPGVLAGQPFFDAIFTQLNCQVSWFLPEGSKLVPVARVAEVRGPAHCLLLGERVALNTLARCSGIASAAAAAVEAARGAGWTGHVAGTRKTTPGFRLVEKYGLLVGGAASHRYDLGGLVMVKDNHVVAAGGVEKAVRAARQAADFTLKVEVECSSLQEAVQAAEAGADLVLLDNFKPEELHPTATVLKAQFPSVAVEASGGITLDNLPQFCGPHIDVISMGMLTQAAPALDFSLKLFAKEVAPVPKIH","Homo sapiens","QPRT","Nicotinate-nucleotide pyrophosphorylase [carboxylating]","1","4KWW"
"4KX7",,"X-RAY DIFFRACTION",3.39,63.71,"VAPOR DIFFUSION, SITTING DROP",7,"1.6 M sodium citrate pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M113.494955",,"4KX7",105.98,"2.15","2.15","Crystal structure of human aminopeptidase A","DICPASEDESGQWKNFRLPDFVNPVHYDLHVKPLLEEDTYTGTVSISINLSAPTRYLWLHLRETRITRLPELKRPSGDQVQVRRCFEYKKQEYVVVEAEEELTPSSGDGLYLLTMEFAGWLNGSLVGFYRTTYTENGRVKSIAATDHEPTDARKSFPCFDEPNKKATYTISITHPKEYGALSNMPVAKEESVDDKWTRTTFEKSVPMSTYLVCFAVHQFDSVKRISNSGKPLTIYVQPEQKHTAEYAANITKSVFDYFEEYFAMNYSLPKLDKIAIPDFGTGAMENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRDQMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMDTWTRQMGYPVLNVNGVKNITQKRFLLDPRANPSQPPSDLGYTWNIPVKWTEDNITSSVLFNRSEKEGITLNSSNPSGNAFLKINPDHIGFYRVNYEVATWDSIATALSLNHKTFSSADRASLIDDAFALARAQLLDYKVALNLTKYLKREENFLPWQRVISAVTYIISMFEDDKELYPMIEEYFQGQVKPIADSLGWNDAGDHVTKLLRSSVLGFACKMGDREALNNASSLFEQWLNGTVSLPVNLRLLVYRYGMQNSGNEISWNYTLEQYQKTSLAQEKEKLLYGLASVKNVTLLSRYLDLLKDTNLIKTQDVFTVIRYISYNSYGKNMAWNWIQLNWDYLVNRYTLNNRNLGRIVTIAEPFNTELQLWQMESFFAKYPQAGAGEKPREQVLETVKNNIEWLKQHRNTIREWFFNLLESGHHHHHH","Homo sapiens","ENPEP","Glutamyl aminopeptidase","1","4KX7"
"4KX9",,"X-RAY DIFFRACTION",3.38,63.64,"VAPOR DIFFUSION, SITTING DROP",7,"1.6 M sodium citrate pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M113.494955",,"4KX9",106.36,"2.25","2.25","Crystal structure of human aminopeptidase A complexed with arginine","DICPASEDESGQWKNFRLPDFVNPVHYDLHVKPLLEEDTYTGTVSISINLSAPTRYLWLHLRETRITRLPELKRPSGDQVQVRRCFEYKKQEYVVVEAEEELTPSSGDGLYLLTMEFAGWLNGSLVGFYRTTYTENGRVKSIAATDHEPTDARKSFPCFDEPNKKATYTISITHPKEYGALSNMPVAKEESVDDKWTRTTFEKSVPMSTYLVCFAVHQFDSVKRISNSGKPLTIYVQPEQKHTAEYAANITKSVFDYFEEYFAMNYSLPKLDKIAIPDFGTGAMENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRDQMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMDTWTRQMGYPVLNVNGVKNITQKRFLLDPRANPSQPPSDLGYTWNIPVKWTEDNITSSVLFNRSEKEGITLNSSNPSGNAFLKINPDHIGFYRVNYEVATWDSIATALSLNHKTFSSADRASLIDDAFALARAQLLDYKVALNLTKYLKREENFLPWQRVISAVTYIISMFEDDKELYPMIEEYFQGQVKPIADSLGWNDAGDHVTKLLRSSVLGFACKMGDREALNNASSLFEQWLNGTVSLPVNLRLLVYRYGMQNSGNEISWNYTLEQYQKTSLAQEKEKLLYGLASVKNVTLLSRYLDLLKDTNLIKTQDVFTVIRYISYNSYGKNMAWNWIQLNWDYLVNRYTLNNRNLGRIVTIAEPFNTELQLWQMESFFAKYPQAGAGEKPREQVLETVKNNIEWLKQHRNTIREWFFNLLESGHHHHHH","Homo sapiens","ENPEP","Glutamyl aminopeptidase","1","4KX9"
"4KXA",,"X-RAY DIFFRACTION",3.38,63.58,"VAPOR DIFFUSION, SITTING DROP",7,"1.6 M sodium citrate pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M113.494955",,"4KXA",106.35,"2.4","2.4","Crystal structure of human aminopeptidase A complexed with aspartate and calcium","DICPASEDESGQWKNFRLPDFVNPVHYDLHVKPLLEEDTYTGTVSISINLSAPTRYLWLHLRETRITRLPELKRPSGDQVQVRRCFEYKKQEYVVVEAEEELTPSSGDGLYLLTMEFAGWLNGSLVGFYRTTYTENGRVKSIAATDHEPTDARKSFPCFDEPNKKATYTISITHPKEYGALSNMPVAKEESVDDKWTRTTFEKSVPMSTYLVCFAVHQFDSVKRISNSGKPLTIYVQPEQKHTAEYAANITKSVFDYFEEYFAMNYSLPKLDKIAIPDFGTGAMENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRDQMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMDTWTRQMGYPVLNVNGVKNITQKRFLLDPRANPSQPPSDLGYTWNIPVKWTEDNITSSVLFNRSEKEGITLNSSNPSGNAFLKINPDHIGFYRVNYEVATWDSIATALSLNHKTFSSADRASLIDDAFALARAQLLDYKVALNLTKYLKREENFLPWQRVISAVTYIISMFEDDKELYPMIEEYFQGQVKPIADSLGWNDAGDHVTKLLRSSVLGFACKMGDREALNNASSLFEQWLNGTVSLPVNLRLLVYRYGMQNSGNEISWNYTLEQYQKTSLAQEKEKLLYGLASVKNVTLLSRYLDLLKDTNLIKTQDVFTVIRYISYNSYGKNMAWNWIQLNWDYLVNRYTLNNRNLGRIVTIAEPFNTELQLWQMESFFAKYPQAGAGEKPREQVLETVKNNIEWLKQHRNTIREWFFNLLESGHHHHHH","Homo sapiens","ENPEP","Glutamyl aminopeptidase","1","4KXA"
"4KXB",,"X-RAY DIFFRACTION",3.36,63.4,"VAPOR DIFFUSION, SITTING DROP",7,"1.6 M sodium citrate pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M113.494955","BES","4KXB",106.27,"2.4","2.4","Crystal structure of human aminopeptidase A complexed with bestatin","DICPASEDESGQWKNFRLPDFVNPVHYDLHVKPLLEEDTYTGTVSISINLSAPTRYLWLHLRETRITRLPELKRPSGDQVQVRRCFEYKKQEYVVVEAEEELTPSSGDGLYLLTMEFAGWLNGSLVGFYRTTYTENGRVKSIAATDHEPTDARKSFPCFDEPNKKATYTISITHPKEYGALSNMPVAKEESVDDKWTRTTFEKSVPMSTYLVCFAVHQFDSVKRISNSGKPLTIYVQPEQKHTAEYAANITKSVFDYFEEYFAMNYSLPKLDKIAIPDFGTGAMENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRDQMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMDTWTRQMGYPVLNVNGVKNITQKRFLLDPRANPSQPPSDLGYTWNIPVKWTEDNITSSVLFNRSEKEGITLNSSNPSGNAFLKINPDHIGFYRVNYEVATWDSIATALSLNHKTFSSADRASLIDDAFALARAQLLDYKVALNLTKYLKREENFLPWQRVISAVTYIISMFEDDKELYPMIEEYFQGQVKPIADSLGWNDAGDHVTKLLRSSVLGFACKMGDREALNNASSLFEQWLNGTVSLPVNLRLLVYRYGMQNSGNEISWNYTLEQYQKTSLAQEKEKLLYGLASVKNVTLLSRYLDLLKDTNLIKTQDVFTVIRYISYNSYGKNMAWNWIQLNWDYLVNRYTLNNRNLGRIVTIAEPFNTELQLWQMESFFAKYPQAGAGEKPREQVLETVKNNIEWLKQHRNTIREWFFNLLESGHHHHHH","Homo sapiens","ENPEP","Glutamyl aminopeptidase","1","4KXB"
"4KXC",,"X-RAY DIFFRACTION",3.38,63.56,"VAPOR DIFFUSION, SITTING DROP",7,"1.6 M sodium citrate pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M113.494955",,"4KXC",106.53,"2.4","2.4","Crystal structure of human aminopeptidase A complexed with glutamate","DICPASEDESGQWKNFRLPDFVNPVHYDLHVKPLLEEDTYTGTVSISINLSAPTRYLWLHLRETRITRLPELKRPSGDQVQVRRCFEYKKQEYVVVEAEEELTPSSGDGLYLLTMEFAGWLNGSLVGFYRTTYTENGRVKSIAATDHEPTDARKSFPCFDEPNKKATYTISITHPKEYGALSNMPVAKEESVDDKWTRTTFEKSVPMSTYLVCFAVHQFDSVKRISNSGKPLTIYVQPEQKHTAEYAANITKSVFDYFEEYFAMNYSLPKLDKIAIPDFGTGAMENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRDQMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMDTWTRQMGYPVLNVNGVKNITQKRFLLDPRANPSQPPSDLGYTWNIPVKWTEDNITSSVLFNRSEKEGITLNSSNPSGNAFLKINPDHIGFYRVNYEVATWDSIATALSLNHKTFSSADRASLIDDAFALARAQLLDYKVALNLTKYLKREENFLPWQRVISAVTYIISMFEDDKELYPMIEEYFQGQVKPIADSLGWNDAGDHVTKLLRSSVLGFACKMGDREALNNASSLFEQWLNGTVSLPVNLRLLVYRYGMQNSGNEISWNYTLEQYQKTSLAQEKEKLLYGLASVKNVTLLSRYLDLLKDTNLIKTQDVFTVIRYISYNSYGKNMAWNWIQLNWDYLVNRYTLNNRNLGRIVTIAEPFNTELQLWQMESFFAKYPQAGAGEKPREQVLETVKNNIEWLKQHRNTIREWFFNLLESGHHHHHH","Homo sapiens","ENPEP","Glutamyl aminopeptidase","1","4KXC"
"4KXD",,"X-RAY DIFFRACTION",3.38,63.6,"VAPOR DIFFUSION, SITTING DROP",7,"1.6 M sodium citrate pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M113.494955",,"4KXD",106.37,"2.15","2.15","Crystal structure of human aminopeptidase A complexed with glutamate and calcium","DICPASEDESGQWKNFRLPDFVNPVHYDLHVKPLLEEDTYTGTVSISINLSAPTRYLWLHLRETRITRLPELKRPSGDQVQVRRCFEYKKQEYVVVEAEEELTPSSGDGLYLLTMEFAGWLNGSLVGFYRTTYTENGRVKSIAATDHEPTDARKSFPCFDEPNKKATYTISITHPKEYGALSNMPVAKEESVDDKWTRTTFEKSVPMSTYLVCFAVHQFDSVKRISNSGKPLTIYVQPEQKHTAEYAANITKSVFDYFEEYFAMNYSLPKLDKIAIPDFGTGAMENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRDQMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMDTWTRQMGYPVLNVNGVKNITQKRFLLDPRANPSQPPSDLGYTWNIPVKWTEDNITSSVLFNRSEKEGITLNSSNPSGNAFLKINPDHIGFYRVNYEVATWDSIATALSLNHKTFSSADRASLIDDAFALARAQLLDYKVALNLTKYLKREENFLPWQRVISAVTYIISMFEDDKELYPMIEEYFQGQVKPIADSLGWNDAGDHVTKLLRSSVLGFACKMGDREALNNASSLFEQWLNGTVSLPVNLRLLVYRYGMQNSGNEISWNYTLEQYQKTSLAQEKEKLLYGLASVKNVTLLSRYLDLLKDTNLIKTQDVFTVIRYISYNSYGKNMAWNWIQLNWDYLVNRYTLNNRNLGRIVTIAEPFNTELQLWQMESFFAKYPQAGAGEKPREQVLETVKNNIEWLKQHRNTIREWFFNLLESGHHHHHH","Homo sapiens","ENPEP","Glutamyl aminopeptidase","1","4KXD"
"4KXH",,"X-RAY DIFFRACTION",3.04,59.6,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 8000, 0.1M ammonium sulphate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444913020507",,"4KXH",57.85,"2.7","2.7","The X-ray crystal structure of a dimeric variant of human pancreatic ribonuclease","KESRAKKFQRQHMDSSSSTYCNQMMRRRNMTQGRCKPVNTFVHEPLVDVQNVCFQEKVTCKNGQGNCYKSNSSMHITDCRLTNGSRYPNCAYRTSPKERHIIVACEGSPYVPVHFDASVEDST","Homo sapiens","RNASE1, RIB1, RNS1","Ribonuclease pancreatic","1","4KXH"
"4KXO",,"X-RAY DIFFRACTION",2.29,46.38,"VAPOR DIFFUSION, HANGING DROP",10,"1% PEG 4000, 5% MPD, 5 mM manganese chloride, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM glycine, 30 mM sodium acetate with 20% MPD as cryoprotectant, pH 10.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/glycob/cwt098",,"4KXO",34.01,"2","2","Crystal Structure of BBBB at pH 10.0 with MPD as the cryoprotectant","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4KXO"
"4KXQ",,"X-RAY DIFFRACTION",3.44,64.23,,7.4,"100 mM Tris, pH 7.4, 13% PEG20000",,"10.1016/j.jmb.2013.10.009",,"4KXQ",36.06,"1.849","1.849","Structure of NAD-dependent protein deacetylase sirtuin-1 (closed state, 1.85 A)","GPHMRKKRKDINTIEDAVKLLQECKKIIVLTGAGVSVSCGIPDFRSRDGIYARLAVDFPDLPDPQAMFDIEYFRKDPRPFFKFAKEIYPGQFQPSLCHKFIALSDKEGKLLRNYTQNIDTLEQVAGIQRIIQCHGSFATASCLICKYKVDCEAVRGDIFNQVVPRCPRCPADEPLAIMKPEIVFFGENLPEQFHRAMKYDKDEVDLLIVIGSSLKVRPVALIPSSIPHEVPQILINREPLPHLHFDVELLGDCDVIINELCHRLGGEYAKLCCNPVKLSEI","Homo sapiens","SIRT1, SIR2L1","NAD-dependent protein deacetylase sirtuin-1","1","4KXQ"
,,,,,,,,,,,,,,,,"GPHMGSQYLFLPPNRYIFHGAEVYSDSEDV","Homo sapiens","SIRT1, SIR2L1","NAD-dependent protein deacetylase sirtuin-1","2","4KXQ"
"4KXU",,"X-RAY DIFFRACTION",2.13,42.3,"VAPOR DIFFUSION, HANGING DROP",7.9,"Reservoir mixture of 13.5-15 % PEG 6000 (w/v), 4% PEG 400 (v/v), 2 % glycerol (v/v)  , pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 279.0K",279,"10.1038/nchem.1728",,"4KXU",71.06,"0.98","0.98","Human transketolase in covalent complex with donor ketose D-fructose-6-phosphate","MESYHKPDQQKLQALKDTANRLRISSIQATTAAGSGHPTSCCSAAEIMAVLFFHTMRYKSQDPRNPHNDRFVLSKGHAAPILYAVWAEAGFLAEAELLNLRKISSDLDGHPVPKQAFTDVATGSLGQGLGAACGMAYTGKYFDKASYRVYCLLGDGELSEGSVWEAMAFASIYKLDNLVAILDINRLGQSDPAPLQHQMDIYQKRCEAFGWHAIIVDGHSVEELCKAFGQAKHQPTAIIAKTFKGRGITGVEDKESWHGKPLPKNMAEQIIQEIYSQIQSKKKILATPPQEDAPSVDIANIRMPSLPSYKVGDKIATRKAYGQALAKLGHASDRIIALDGDTKNSTFSEIFKKEHPDRFIECYIAEQNMVSIAVGCATRNRTVPFCSTFAAFFTRAFDQIRMAAISESNINLCGSHCGVSIGEDGPSQMALEDLAMFRSVPTSTVFYPSDGVATEKAVELAANTKGICFIRTSRPENAIIYNNNEDFQVGQAKVVLKSKDDQVTVIGAGVTLHEALAAAELLKKEKINIRVLDPFTIKPLDRKLILDSARATKGRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPRSGKPAELLKMFGIDRDAIAQAVRGLITKALVPRGSLEHHHHHH","Homo sapiens","TKT","Transketolase","1","4KXU"
"4KXV",,"X-RAY DIFFRACTION",2.13,42.3,"VAPOR DIFFUSION, HANGING DROP",7.9,"Reservoir mixture of 13.5-15 % PEG 6000 (w/v), 4% PEG 400 (v/v), 2 % glycerol (v/v)  , pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 279.0K",279,"10.1038/nchem.1728",,"4KXV",70.9,"0.97","0.97","Human transketolase in covalent complex with donor ketose D-xylulose-5-phosphate, crystal 1","MESYHKPDQQKLQALKDTANRLRISSIQATTAAGSGHPTSCCSAAEIMAVLFFHTMRYKSQDPRNPHNDRFVLSKGHAAPILYAVWAEAGFLAEAELLNLRKISSDLDGHPVPKQAFTDVATGSLGQGLGAACGMAYTGKYFDKASYRVYCLLGDGELSEGSVWEAMAFASIYKLDNLVAILDINRLGQSDPAPLQHQMDIYQKRCEAFGWHAIIVDGHSVEELCKAFGQAKHQPTAIIAKTFKGRGITGVEDKESWHGKPLPKNMAEQIIQEIYSQIQSKKKILATPPQEDAPSVDIANIRMPSLPSYKVGDKIATRKAYGQALAKLGHASDRIIALDGDTKNSTFSEIFKKEHPDRFIECYIAEQNMVSIAVGCATRNRTVPFCSTFAAFFTRAFDQIRMAAISESNINLCGSHCGVSIGEDGPSQMALEDLAMFRSVPTSTVFYPSDGVATEKAVELAANTKGICFIRTSRPENAIIYNNNEDFQVGQAKVVLKSKDDQVTVIGAGVTLHEALAAAELLKKEKINIRVLDPFTIKPLDRKLILDSARATKGRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPRSGKPAELLKMFGIDRDAIAQAVRGLITKALVPRGSLEHHHHHH","Homo sapiens","TKT","Transketolase","1","4KXV"
"4KXW",,"X-RAY DIFFRACTION",2.13,42.3,"VAPOR DIFFUSION, HANGING DROP",7.9,"Reservoir mixture of 13.5-15 % PEG 6000 (w/v), 4% PEG 400 (v/v), 2 % glycerol (v/v)  , pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 279.0K",279,"10.1038/nchem.1728",,"4KXW",71.33,"0.97","0.97","Human transketolase in covalent complex with donor ketose D-xylulose-5-phosphate, crystal 2","MESYHKPDQQKLQALKDTANRLRISSIQATTAAGSGHPTSCCSAAEIMAVLFFHTMRYKSQDPRNPHNDRFVLSKGHAAPILYAVWAEAGFLAEAELLNLRKISSDLDGHPVPKQAFTDVATGSLGQGLGAACGMAYTGKYFDKASYRVYCLLGDGELSEGSVWEAMAFASIYKLDNLVAILDINRLGQSDPAPLQHQMDIYQKRCEAFGWHAIIVDGHSVEELCKAFGQAKHQPTAIIAKTFKGRGITGVEDKESWHGKPLPKNMAEQIIQEIYSQIQSKKKILATPPQEDAPSVDIANIRMPSLPSYKVGDKIATRKAYGQALAKLGHASDRIIALDGDTKNSTFSEIFKKEHPDRFIECYIAEQNMVSIAVGCATRNRTVPFCSTFAAFFTRAFDQIRMAAISESNINLCGSHCGVSIGEDGPSQMALEDLAMFRSVPTSTVFYPSDGVATEKAVELAANTKGICFIRTSRPENAIIYNNNEDFQVGQAKVVLKSKDDQVTVIGAGVTLHEALAAAELLKKEKINIRVLDPFTIKPLDRKLILDSARATKGRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPRSGKPAELLKMFGIDRDAIAQAVRGLITKALVPRGSLEHHHHHH","Homo sapiens","TKT","Transketolase","1","4KXW"
"4KXX",,"X-RAY DIFFRACTION",2.13,42.3,"VAPOR DIFFUSION, HANGING DROP",7.9,"Reservoir mixture of 13.5-15 % PEG 6000 (W/V), 4% PEG 400 (V/V), 2 % glycerol (v/v), pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 279.0K",279,"10.1038/nchem.1728",,"4KXX",71.16,"1.03","1.03","Human transketolase in covalent complex with donor ketose D-sedoheptulose-7-phosphate","MESYHKPDQQKLQALKDTANRLRISSIQATTAAGSGHPTSCCSAAEIMAVLFFHTMRYKSQDPRNPHNDRFVLSKGHAAPILYAVWAEAGFLAEAELLNLRKISSDLDGHPVPKQAFTDVATGSLGQGLGAACGMAYTGKYFDKASYRVYCLLGDGELSEGSVWEAMAFASIYKLDNLVAILDINRLGQSDPAPLQHQMDIYQKRCEAFGWHAIIVDGHSVEELCKAFGQAKHQPTAIIAKTFKGRGITGVEDKESWHGKPLPKNMAEQIIQEIYSQIQSKKKILATPPQEDAPSVDIANIRMPSLPSYKVGDKIATRKAYGQALAKLGHASDRIIALDGDTKNSTFSEIFKKEHPDRFIECYIAEQNMVSIAVGCATRNRTVPFCSTFAAFFTRAFDQIRMAAISESNINLCGSHCGVSIGEDGPSQMALEDLAMFRSVPTSTVFYPSDGVATEKAVELAANTKGICFIRTSRPENAIIYNNNEDFQVGQAKVVLKSKDDQVTVIGAGVTLHEALAAAELLKKEKINIRVLDPFTIKPLDRKLILDSARATKGRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPRSGKPAELLKMFGIDRDAIAQAVRGLITKALVPRGSLEHHHHHH","Homo sapiens","TKT","Transketolase","1","4KXX"
"4KXY",,"X-RAY DIFFRACTION",2.09,41.14,"VAPOR DIFFUSION, HANGING DROP",7.9,"Reservoir mixture of 13.5-15 % PEG 6000 (W/V), 4% PEG 400 (v/v), 2 % glycerol (v/v), pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchem.1728",,"4KXY",142.26,"1.26","1.26","Human transketolase in complex with ThDP analogue (R)-2-(1,2-dihydroxyethyl)-3-deaza-ThDP","MESYHKPDQQKLQALKDTANRLRISSIQATTAAGSGHPTSCCSAAEIMAVLFFHTMRYKSQDPRNPHNDRFVLSKGHAAPILYAVWAEAGFLAEAELLNLRKISSDLDGHPVPKQAFTDVATGSLGQGLGAACGMAYTGKYFDKASYRVYCLLGDGELSEGSVWEAMAFASIYKLDNLVAILDINRLGQSDPAPLQHQMDIYQKRCEAFGWHAIIVDGHSVEELCKAFGQAKHQPTAIIAKTFKGRGITGVEDKESWHGKPLPKNMAEQIIQEIYSQIQSKKKILATPPQEDAPSVDIANIRMPSLPSYKVGDKIATRKAYGQALAKLGHASDRIIALDGDTKNSTFSEIFKKEHPDRFIECYIAEQNMVSIAVGCATRNRTVPFCSTFAAFFTRAFDQIRMAAISESNINLCGSHCGVSIGEDGPSQMALEDLAMFRSVPTSTVFYPSDGVATEKAVELAANTKGICFIRTSRPENAIIYNNNEDFQVGQAKVVLKSKDDQVTVIGAGVTLHEALAAAELLKKEKINIRVLDPFTIKPLDRKLILDSARATKGRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPRSGKPAELLKMFGIDRDAIAQAVRGLITKALVPRGSLEHHHHHH","Homo sapiens","TKT","Transketolase","1","4KXY"
"4KY1",,"X-RAY DIFFRACTION",3.1,60.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"23% PEG 3350 and 0.2 M ammoniumsulfate, VAPOR DIFFUSION, HANGING DROP, temperature 297K, pH 7.5",297,"10.1016/j.ymeth.2013.06.024",,"4KY1",46.75,"2.97","2.97","humanized HP1/2 Fab","DIVMTQSPDSLAVSLGERATINCKASQSVTNDVAWYQQKPGQPPKLLIYYASNRYTGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQDYSSPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN","1","4KY1"
,,,,,,,,,,,,,,,,"VQLVQSGAEVKKPGATVKISCKSSGYNIKDVYMHWVQQAPGKGLEWMGRIDPASGDTKYDPKFQVRVTITADTSTDTAYMELSSLRSEDTAVYYCATGMWVSTGYALDFWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP","Homo sapiens",,"IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN","2","4KY1"
"4KY2",,"X-RAY DIFFRACTION",2.11,41.8,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature using the vapor diffusion sitting drop method. Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, containing 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1039/c3cc44667k",,"4KY2",28.2,"1.13","1.13","Transthyretin in complex with the fluorescent folding sensor (E)-7-hydroxy-3-(4-hydroxy-3,5-dimethylstyryl)-4-methyl-2H-chromen-2-one","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4KY2"
"4KY9",,"X-RAY DIFFRACTION",2.15,42.77,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM BisTris pH 6.5, 18% PEG 3350, with 0.5% (w/v) octylglucoside, vapor diffusion, sitting drop, temperature 298K",298,"10.1074/jbc.M113.511865",,"4KY9",68.43,"2.23","2.23","Structural and Functional Analysis of a Putative Substrate Access Tunnel in the Cytosolic Domain of Human Anion Exchanger 1","HPGTHKVYVELQELVMDEKNQELRWMEAARWVQLEENLGENGAWGRPHLSHLTFWSLLELRRVFTKGTVLLDLQETSLAGVANQLLDRFIFEDQIRPQDREELLRALLLKHSHAGELEALGGVKPAVLTRSGDPSQPLLPQHSSLETQLFCEQGDGGTEGHSPSGILEKIPPDSEATLVLVGRADFLEQPVLGFVRLQEAAELEAVELPVPIRFLFVLLGPEAPHIDYTQLGRAAATLMSERVFRIDAYMAQSRGELLHSLEGFLDCSLVLPPTDAPSEQALLSLVPVQRELLRRRYQSSPAKPDS","Homo sapiens","SLC4A1, AE1, DI, EPB3","Band 3 anion transport protein","1","4KY9"
"4KZ0",,"X-RAY DIFFRACTION",2.29,46.31,"VAPOR DIFFUSION, HANGING DROP",8.5,"16-19% PEG 4000, 0.2M SODIUM ACETATE,0.1M SODIUM CITRATE, 0.1M TRIS PH 8.5 [PROTEIN] ~6MG/ML IN 20MM TRIS PH 
7.2, 50MM AMMSO4, 1% BETAINE, 1% ETHYLENE GLYCOL, 0.02% CHAPS, 5MM DTT DROP: 1UL + 1UL, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2013.06.010","1UJ","4KZ0",111.1,"2.87","2.87","Structure of PI3K gamma with Imidazopyridine inhibitors","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4KZ0"
"4KZC",,"X-RAY DIFFRACTION",2.43,49.41,"VAPOR DIFFUSION, HANGING DROP",8.5,"16-19% PEG 4000, 0.2M SODIUM ACETATE, 0.1M SODIUM CITRATE, 0.1M TRIS PH 8.5 [PROTEIN] 6MG/ML IN 20MM TRIS PH    
7.2, 50MM AMMSO4, 1% BETAINE, 1% ETHYLENE GLYCOL, 0.02% CHAPS, 5MM DTT DROP: 1UL + 1UL, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2013.06.010","1UK","4KZC",111.19,"3.25","3.25","Structure of PI3K gamma with Imidazopyridine inhibitors","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4KZC"
"4KZI",,"X-RAY DIFFRACTION",3.21,61.62,"VAPOR DIFFUSION",4.2,"PEG 4000, Sodium citrate, Glycerol, pH 4.2, vapor diffusion, temperature 277K",277,"10.1038/nchembio.1406",,"4KZI",58.06,"2.41","2.41","Crystal Structure of TR3 LBD in complex with DPDO","MSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","GFRP1, HMR, NAK1, NR4A1","Nuclear receptor subfamily 4 group A member 1","1","4KZI"
"4KZJ",,"X-RAY DIFFRACTION",3.15,60.93,"VAPOR DIFFUSION",4.2,"PEG 4000, Sodium citrate, Glycerol, pH 4.2, vapor diffusion, temperature 277K",277,"10.1038/nchembio.1406",,"4KZJ",57.91,"2.12","2.12","Crystal Structure of TR3 LBD L449W Mutant","MSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFIWRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","GFRP1, HMR, NAK1, NR4A1","Nuclear receptor subfamily 4 group A member 1","1","4KZJ"
"4KZL",,"X-RAY DIFFRACTION",2.44,49.67,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","20D","4KZL",55.72,"2","2","Crystal structure of human tankyrase 2 in complex with 4'-fluoro flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4KZL"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4KZL"
"4KZM",,"X-RAY DIFFRACTION",3.18,61.29,"VAPOR DIFFUSION",4.2,"PEG 4000, Sodium citrate, Glycerol, pH 4.2, vapor diffusion, temperature 277K",277,"10.1038/nchembio.1406",,"4KZM",57.73,"2.3","2.3","Crystal Structure of TR3 LBD S553A Mutant","MSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLARLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","GFRP1, HMR, NAK1, NR4A1","Nuclear receptor subfamily 4 group A member 1","1","4KZM"
"4KZN",,"X-RAY DIFFRACTION",2.7,54.2,"VAPOR DIFFUSION, SITTING DROP",7,"Li2SO4, PEG200, Tris buffer, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"4KZN",13.59,"1.7114","1.7114","crystal structure of human VEGF-A receptor binding domain","SHHHHHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKD","Homo sapiens","VEGFA, VEGF","Vascular endothelial growth factor A","1","4KZN"
"4KZO",,"X-RAY DIFFRACTION",2.66,53.7,"VAPOR DIFFUSION",6.9,"16-20% PEG MME 2000, 100mM MES, pH 6.9, vapor diffusion, temperature 298K",298,"10.1021/bi400514k","NAP","4KZO",147.26,"2.204","2.204","Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","4KZO"
"4KZQ",,"X-RAY DIFFRACTION",2.43,49.44,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","DFL","4KZQ",55.63,"2.25","2.25","Crystal structure of human tankyrase 2 in complex with 4' -hydroxy flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4KZQ"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4KZQ"
"4KZU",,"X-RAY DIFFRACTION",2.43,49.29,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","A73","4KZU",55.84,"2.1","2.1","Crystal structure of human tankyrase 2 in complex with 4' -bromo flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4KZU"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4KZU"
"4L00",,"X-RAY DIFFRACTION",2.06,40.31,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1038/nsmb.2673",,"4L00",69.84,"1.8","1.8","Crystal structure of the apo Jak1 pseudokinase domain","GSTSAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4L00"
"4L01",,"X-RAY DIFFRACTION",2.08,40.76,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1038/nsmb.2673",,"4L01",69.93,"1.9","1.9","Crystal structure of the V658F apo Jak1 pseudokinase domain","GSTSAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCFRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","4L01"
"4L02",,"X-RAY DIFFRACTION",2.39,48.6,"VAPOR DIFFUSION, SITTING DROP",6,"1.0-1.4M AMMONIUM SULFATE, 0.3-1.3M NACL, 0.1M BIS-TRIS, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 289KK",289,"10.1016/j.bmcl.2013.06.030","1V2","4L02",130.11,"2.75","2.75","Crystal Structure of SphK1 with inhibitor","MSYYHHHHHHDYDIPTTENLYFQGAMGSGVLPRPCRVLVLLNPRGGKGKALQLFRSHVQPLLAEAEISFTLMLTERRNHARELVRSEELGRWDALVVMSGDGLMHEVVNGLMERPDWETAIQKPLCSLPAGSGNALAASLNHYAGYEQVTNEDLLTNCTLLLCRRLLSPMNLLSLHTASGLRLFSVLSLAWGFIADVDLESEKYRRLGEMRFTLGTFLRLAALRTYRGRLAYLPVGRVGSKTPASPVVVQQGPVDAHLVPLEEPVPSHWTVVPDEDFVLVLALLHSHLGSEMFAAPMGRCAAGVMHLFYVRAGVSRAMLLRLFLAMEKGRHMEYECPYLVYVPVVAFRLEPKDGKGVFAVDGELMVSEAVQGQVHPNYFWMVSG","Homo sapiens","Sphingosine kinase 1, SPHK, SPHK1, SPK, SK1","Sphingosine kinase 1","1","4L02"
"4L03",,"X-RAY DIFFRACTION",2.66,53.81,"VAPOR DIFFUSION",6.9,"16-20% PEG MME 2000, 100mM MES, pH 6.9, vapor diffusion, temperature 298K",298,"10.1021/bi400514k","NAP","4L03",147.49,"2.1","2.1","Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNDTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","4L03"
"4L04",,"X-RAY DIFFRACTION",2.68,54.09,"VAPOR DIFFUSION",6.9,"16-20% PEG MME 2000, 100mM MES, pH 6.9, vapor diffusion, temperature 298K",298,"10.1021/bi400514k",,"4L04",294.85,"2.87","2.87","Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNNTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","4L04"
"4L06",,"X-RAY DIFFRACTION",2.68,54.07,"VAPOR DIFFUSION",6.9,"16-20% PEG MME 2000, 100mM MES, pH 6.9, vapor diffusion, temperature 298K",298,"10.1021/bi400514k","NAP","4L06",294.22,"2.282","2.282","Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQDRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","4L06"
"4L09",,"X-RAY DIFFRACTION",2.44,49.59,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","1UR","4L09",55.78,"2.05","2.05","Crystal structure of human tankyrase 2 in complex with 4-(4-oxo-4H-chromen-2-yl)benzoic acid","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L09"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L09"
"4L0B",,"X-RAY DIFFRACTION",2.42,49.17,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","1UT","4L0B",55.77,"1.8","1.8","Tankyrase 2 in complex with 4'-dimethylamino flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L0B"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L0B"
"4L0D",,"X-RAY DIFFRACTION",2.96,58.41,"VAPOR DIFFUSION, HANGING DROP",7.5,"1 M sodium acetate, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1313683110",,"4L0D",122.94,"2.97","2.97","Crystal structure of delta516-525 human cystathionine beta-synthase containing C-terminal 6xHis-tag","MGSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQQRQMVFGVVTAIDLLNFVAAQERDQKELHHHHHH","Homo sapiens","CBS","Cystathionine beta-synthase","1","4L0D"
"4L0I",,"X-RAY DIFFRACTION",2.44,49.64,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","1UW","4L0I",55.74,"2.3","2.3","Tankyrase 2 catalytic domain in complex with ethyl 4-(4-oxo-4H-chromen-2-yl)benzoate","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L0I"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L0I"
"4L0N",,"X-RAY DIFFRACTION",2.3,46.53,"VAPOR DIFFUSION, SITTING DROP",4.9,"30% MPD, 0.1M acetate pH 4.9, 0.2M calcium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"4L0N",61.68,"1.4","1.4","Crystal structure of STK3 (MST2) SARAH domain","SMDFDFLKNLSLEELQMRLKALDPMMEREIEELRQRYTAKRQPILDAMDAK","Homo sapiens","KRS1, MST2, STK3","Serine/threonine-protein kinase 3","1","4L0N"
"4L0R",,"X-RAY DIFFRACTION",2.52,51.28,"Microbatch under oil",6,"0.1 M KAcetate, 0.1 M MES, PEG 1000 40% (w/v), pH 6, Microbatch under oil, temperature 293K",293,,,"4L0R",25.38,"2.49","2.49","Crystal structure of FGF2-interacting protein from Homo sapiens. Northeast Structural Genomics Consortium Target HR9027A.","MGHHHHHHSHMKQVSSRGGKSKKLSVTPPSSNGINEELSEVLQTLQDEFGQMSFDHQQLAKLIQESPTVELKDKLECELEALVGRMEAKANQITKVRKYQAQLEKQKLEKQ","Homo sapiens","CEP57, KIAA0092, TSP57","Centrosomal protein of 57 kDa","1","4L0R"
"4L0S",,"X-RAY DIFFRACTION",2.45,49.88,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","1UZ","4L0S",55.74,"1.9","1.9","Tankyrase 2 in complex with 4'-cyano flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L0S"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L0S"
"4L0T",,"X-RAY DIFFRACTION",2.46,49.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","1V0","4L0T",55.78,"2.1","2.1","Tankyrase 2 in complex with 4'-nitro flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L0T"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L0T"
"4L0V",,"X-RAY DIFFRACTION",2.41,48.99,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","1V1","4L0V",55.76,"1.7","1.7","Tankyrase 2 in complex with 4'-chloro flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L0V"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L0V"
"4L10",,"X-RAY DIFFRACTION",2.42,49.15,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","A63","4L10",55.75,"1.7","1.7","Tankyrase 2 in complex with 4'-methoxy flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L10"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L10"
"4L19",,"X-RAY DIFFRACTION",2.32,46.93,,8.5,"0.1M Tris, 1.5M ammonium formate, 10%-14% PEG4000, 0.017M compound Q1, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm501284e","1UA","4L19",40.28,"1.66","1.66","Matrix metalloproteinase-13 complexed with selective inhibitor compound Q1","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPN","Homo sapiens","MMP13","Collagenase 3","1","4L19"
"4L1D",,"X-RAY DIFFRACTION",2.46,50,"VAPOR DIFFUSION, SITTING DROP",9.5,"1M Sodium citrate tribasic, 0.1M CHES/Sodium hydroxide pH9.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1074/jbc.M113.527994",,"4L1D",44.5,"2.5","2.5","Voltage-gated sodium channel beta3 subunit Ig domain","VCVEVPSETEAVQGNPMKLRCISCMKREEVEATTVVEWFYRPEGGKDFLIYEYRNGHQEVESPFQGRLQWNGSKDLQDVSITVLNVTLNDSGLYTCNVSREFEFEAHRPFVKTTRLIPLRVHHHHHH","Homo sapiens","KIAA1158, SCN3B","Sodium channel subunit beta-3","1","4L1D"
"4L1H",,"X-RAY DIFFRACTION",3.42,64.05,,,,,,,"4L1H",11.75,"1.68","1.68","Bence-Jones immunoglobulin REI variable portion with seven point mutations","DIQMTQSPSSLSASVGDRVTITCRASQDIIKYLAWYQQKPGKAPKLLIYEASNLQAGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYQSLPYTFGQGTKLEIT","Homo sapiens","IGKV1D-33","Ig kappa chain V-I region Rei","1","4L1H"
"4L1J",,"X-RAY DIFFRACTION",2.53,51.3,"microbatch under oil",6,"Protein solution: 100mM NaCl, 5mM DTT, 0.02% NaN3, 10mM Tris-HCl (pH 7.5) . Reservoir solution:Na2H2PO4 0.1M, MES 0.1M, 
PEG400 40%, microbatch under oil, temperature 277K",277,,,"4L1J",48.58,"1.824","1.824","Three dimensional structure of mutant D143A of human HD domain-containing protein 2, Northeast Structural Genomics Consortium (NESG) Target HR6723","MASVSSATFSGHGARSLLQFLRLVGQLKRVPRTGWVYRNVQRPESVSDHMYRMAVMAMVIKDDRLNKDRCVRLALVHDMAECIVGDIAPADNIPKEEKHRREEEAMKQITQLLPEDLRKELYELWEEYETQSSAEAKFVKQLAQCEMILQASEYEDLEHKPGRLQDFYDSTAGKFNHPEIVQLVSELEAERSTNIAAAASEPHS","Homo sapiens","HDDC2, C6orf74, NS5ATP2, CGI-130","HD domain-containing protein 2","1","4L1J"
,,,,,,,,,,,,,,,,"MASVSSATFSGHGARSLLQFLRLVGQLKRVPRTGWVYRNVQRPESVSDHMYRMAVMAMVIKDDRLNKDRCVRLALVHDMAECIVGDIAPADNIPKEEKHRREEEAMKQITQLLPEDLRKELYELWEEYETQSSAEAKFVKQLAQCEMILQASEYEDLEHKPGRLQDFYDSTAGKFNHPEIVQLVSELEAERSTNIAAAASEPHS","Homo sapiens","HDDC2, C6orf74, NS5ATP2, CGI-130","HD domain-containing protein 2 (Phosphorylate)","2","4L1J"
"4L1M",,"X-RAY DIFFRACTION",2.86,60.7,"VAPOR DIFFUSION",8.5,"1.5 M ammonium sulfate, 0.1 M Tris-hydrochloride, pH 8.5, vapor diffusion, temperature 291K",291,,,"4L1M",127.24,"2.6","2.6","Structure of the first RCC1-like domain of HERC2","MHHHHHHSSGRENLYFQGSHKGSLQEVIGWGLIGWKYYANVIGPIQCEGLANLGVTQIACAEKRFLILSRNGRVYTQAYNSDTLAPQLVQGLASRNIVKIAAHSDGHHYLALAATGEVYSWGCGDGGRLGHGDTVPLEEPKVISAFSGKQAGKHVVHIACGSTYSAAITAEGELYTWGRGNYGRLGHGSSEDEAIPMLVAGLKGLKVIDVACGSGDAQTLAVTENGQVWSWGDGDYGKLGRGGSDGCKTPKLIEKLQDLDVVKVRCGSQFSIALTKDGQVYSWGKGDNQRLGHGTEEHVRYPKLLEGLQGKKVIDVAAGSTHCLALTEDSEVHSWGSNDQCQHFDTLRVTKPEPAALPGLDTKHIVGIACGPAQSFAWSSCSEWSIGLRVPF","Homo sapiens","HERC2","E3 ubiquitin-protein ligase HERC2","1","4L1M"
"4L1O",,"X-RAY DIFFRACTION",2.16,42.93,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M Potassium Acetate, 20% PEG 3350, (3 microlitres of 3mg/ml of ALDH3A1+ 3 microlitres of mother liquor), pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.15K",298.15,,,"4L1O",105.53,"2.3","2.3","Crystal structure of human ALDH3A1 with inhibitor 1-{[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]methyl}-1H-indole-2,3-dione","HHHHHHSSGLVPRGSHMSKISEAVKRARAAFSSGRTRPLQFRIQQLEALQRLIQEQEQELVGALAADLHKNEWNAYYEEVVYVLEEIEYMIQKLPEWAADEPVEKTPQTQQDELYIHSEPLGVVLVIGTWNYPFNLTIQPMVGAIAAGNAVVLKPSELSENMASLLATIIPQYLDKDLYPVINGGVPETTELLKERFDHILYTGSTGVGKIIMTAAAKHLTPVTLELGGKSPCYVDKNCDLDVACRRIAWGKFMNSGQTCVAPDYILCDPSIQNQIVEKLKKSLKEFYGEDAKKSRDYGRIISARHFQRVMGLIEGQKVAYGGTGDAATRYIAPTILTDVDPQSPVMQEEIFGPVLPIVCVRSLEEAIQFINQREKPLALYMFSSNDKVIKKMIAETSSGGVAANDVIVHITLHSLPFGGVGNSGMGSYHGKKSFETFSHRRSCLVRPLMNDEGLKVRYPPSPAKMTQH","Homo sapiens","ALDH3, ALDH3A1","Aldehyde dehydrogenase","1","4L1O"
"4L1P",,"X-RAY DIFFRACTION",2.1,41.47,"VAPOR DIFFUSION, SITTING DROP",5.5,"Trisodium citrate, PEG 3000, pH 5.5, vapor diffusion, sitting drop, temperature 293K",293,"10.1073/pnas.1314754110",,"4L1P",32.3,"2.12","2.12","Crystal Structure of Human Rtf1 Plus3 domain","GDITHMVSLPEELNRVRLSRHKLERWCHMPFFAKTVTGCFVRIGIGNHNSKPVYRVAEITGVVETAKVYQLGGTRTNKGLQLRHGNDQRVFRLEFVSNQEFTESEFMKWKEAMFSAGMQLPTLDEINKKELSIKEALN","Homo sapiens","KIAA0252, RTF1","RNA polymerase-associated protein RTF1 homolog","1","4L1P"
"4L1S",,"X-RAY DIFFRACTION",2.04,39.75,"VAPOR DIFFUSION, SITTING DROP",5.5,"The wt-TTR was concentrated to 4 mg/ml in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature with inhibitors using the vapor-diffusion sitting drop method, crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at ph 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 m sodium citrate, ph 5.5, containing 10% v/v glycerol, vapor diffusion, sitting drop, temperature 298.0, VAPOR DIFFUSION, SITTING DROP",298,"10.1002/bip.22407",,"4L1S",28.4,"1.5","1.5","Covalent modification of transthyretin K15 by yielding the fluorescent conjugate (E)-3-(dimethylamino)-5-(4-hydroxy-3,5-dimethylstyryl)benzamide","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4L1S"
"4L1T",,"X-RAY DIFFRACTION",2.07,40.55,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature using the vapor diffusion sitting drop method. Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, containing 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1002/bip.22407",,"4L1T",28.18,"1.16","1.16","Transthyretin in complex with (E)-3-(dimethylamino)-5-(4-hydroxy-3,5-dimethylstyryl)benzoic acid","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4L1T"
"4L1W",,"X-RAY DIFFRACTION",2.28,46.06,"VAPOR DIFFUSION, HANGING DROP",6,"25% PEG3350, 0.1M Sodium Cacodylate, 0.2M Ammonium Sulfate, 0.8mM Progesterone, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jsbmb.2014.01.003",,"4L1W",76.22,"2.2","2.2","Crystal Structuer of Human 3-alpha Hydroxysteroid Dehydrogenase Type 3 in Complex with NADP+ and Progesterone","SVDDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEY","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","4L1W"
"4L1X",,"X-RAY DIFFRACTION",2.31,46.73,"VAPOR DIFFUSION, HANGING DROP",6,"25% PEG3350, 0.1M Sodium Cacodylate, 0.2M Ammonium Sulfate, 0.8mM Progesterone, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jsbmb.2014.01.003",,"4L1X",76.25,"2","2","Crystal Structuer of Human 3-alpha Hydroxysteroid Dehydrogenase Type 3 V54L Mutant in Complex with NADP+ and Progesterone","SVDDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEY","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","4L1X"
"4L27",,"X-RAY DIFFRACTION",3.05,59.62,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M ammonium citrate tribasic, 0.1 M imidazole, 20% w/v PEG2000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1313683110",,"4L27",245.51,"3.391","3.391","Crystal structure of delta1-39 and delta516-525 human cystathionine beta-synthase D444N mutant containing C-terminal 6xHis tag","PSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFNQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQQRQMVFGVVTAIDLLNFVAAQERDQKLEHHHHHH","Homo sapiens","CBS","Cystathionine beta-synthase","1","4L27"
"4L28",,"X-RAY DIFFRACTION",3.01,59.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.085 M HEPES, pH 7.5, 8.5% isopropanol, 17% w/v PEG4000, 15% v/v Glycerol anhydrous, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1313683110",,"4L28",249.87,"2.626","2.626","Crystal structure of delta516-525 human cystathionine beta-synthase D444N mutant containing C-terminal 6xHis tag","PSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFNQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQKLEHHHHHH","Homo sapiens","CBS","Cystathionine beta-synthase","1","4L28"
"4L2F",,"X-RAY DIFFRACTION",2.45,49.86,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","1V3","4L2F",55.5,"2.05","2.05","Tankyrase 2 in complex with 6-chloro flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L2F"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L2F"
"4L2G",,"X-RAY DIFFRACTION",2.45,49.7,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","1V4","4L2G",55.94,"2.05","2.05","Tankyrase 2 in complex with 6- fluoro flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L2G"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L2G"
"4L2K",,"X-RAY DIFFRACTION",2.44,49.5,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","1V8","4L2K",55.78,"2.1","2.1","Tankyrase 2 in complex with 2-(1,3-benzodioxol-5-yl)-4H-chromen-4-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L2K"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L2K"
"4L2L",,"X-RAY DIFFRACTION",2.43,49.43,"LIQUID DIFFUSION",6.5,"50 mM Sodium Acetate, 22% (v/v) PEG 8000, 5 mM YbCl3, pH 6.5, LIQUID DIFFUSION, temperature 277K",277,"10.1073/pnas.1402136111","1V6","4L2L",70.57,"1.648","1.648","Human Leukotriene A4 Hydrolase complexed with ligand 4-(4-benzylphenyl)thiazol-2-amine","MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4, LTA4H","Leukotriene A-4 hydrolase","1","4L2L"
"4L2O",,"X-RAY DIFFRACTION",2.26,45.5,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M Potassium acetate, 20% PEG 3350, (4 microlitres of 4 mg/mL of ALDH3A1 + 4 microlitres of mother liquor), 1 mM NAD+, 1 mM compound solution, 1  DMSO, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.15K",298.15,,"1DD","4L2O",213.31,"1.937","1.937","Crystal structure of human ALDH3A1 with its selective inhibitor 1-(4-fluorophenyl)sulfonyl-2-methylbenzimidazole","HHHHHHSSGLVPRGSHMSKISEAVKRARAAFSSGRTRPLQFRIQQLEALQRLIQEQEQELVGALAADLHKNEWNAYYEEVVYVLEEIEYMIQKLPEWAADEPVEKTPQTQQDELYIHSEPLGVVLVIGTWNYPFNLTIQPMVGAIAAGNAVVLKPSELSENMASLLATIIPQYLDKDLYPVINGGVPETTELLKERFDHILYTGSTGVGKIIMTAAAKHLTPVTLELGGKSPCYVDKNCDLDVACRRIAWGKFMNSGQTCVAPDYILCDPSIQNQIVEKLKKSLKEFYGEDAKKSRDYGRIISARHFQRVMGLIEGQKVAYGGTGDAATRYIAPTILTDVDPQSPVMQEEIFGPVLPIVCVRSLEEAIQFINQREKPLALYMFSSNDKVIKKMIAETSSGGVAANDVIVHITLHSLPFGGVGNSGMGSYHGKKSFETFSHRRSCLVRPLMNDEGLKVRYPPSPAKMTQH","Homo sapiens","ALDH3, ALDH3A1","Aldehyde dehydrogenase","1","4L2O"
"4L2W",,"X-RAY DIFFRACTION",3.5,64.91,"VAPOR DIFFUSION",6,"0.1M Citrate, 1.0M Ammonium Sulfate, pH 6.0, VAPOR DIFFUSION, temperature 277K",277,"10.1371/journal.pone.0081075",,"4L2W",40.3,"2.49","2.49","Crystal structure of the Shroom-Binding domain of human Rock1","GIDPFTGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNAAATLATQLDLAETKAESEQLARGLLEEQYF","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","4L2W"
"4L2X",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION, SITTING DROP",6.5,"16% PEG8000, 20% glycerol, 0.16 M magnesium acetate, 0.08 M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 295.15K",295.15,"10.1021/jm400946f","POP, YL2","4L2X",43.84,"2.55","2.55","Crystal structure of human FPPS in complex with magnesium, CL02134, and inorganic pyrophosphate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4L2X"
"4L31",,"X-RAY DIFFRACTION",2.42,49.18,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","F08","4L31",55.8,"2","2","Tankyrase 2 in complex with methyl 4-(4-oxochromen-2-yl)benzoate","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L31"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L31"
"4L32",,"X-RAY DIFFRACTION",2.4,48.82,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","1VF","4L32",55.94,"1.85","1.85","Tankyrase 2 in complex with 2-[4-(4-methylpiperazine-1-carbonyl)phenyl]chromen-4-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L32"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L32"
"4L33",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","F70","4L33",56.07,"2.1","2.1","Tankyrase 2 in complex with cyanomethyl 4-(4-oxo-4H-chromen-2-yl)benzoate","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L33"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L33"
"4L34",,"X-RAY DIFFRACTION",2.41,48.92,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Li2SO4, 0.1 M Tris HCl 24 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401463y","1VG","4L34",55.82,"1.8","1.8","Tankyrase 2 in complex with 4'-tetrazole flavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4L34"
,,,,,,,,,,,,,,,,"KMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","4L34"
"4L3I",,"X-RAY DIFFRACTION",5.92,79.22,"VAPOR DIFFUSION, HANGING DROP",8,"Concentration: 5-10 mg/ml Protein buffer: 80 mM PIPES (pH 6.8), 1 mM MgCl2, 1 mM EGTA, 150 mM KCl, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.cell.2013.06.021",,"4L3I",117.77,"3.6005","3.6005","Structure of the microtubule associated protein PRC1 (Protein Regulator of Cytokinesis 1)","GAAAMRRSEVLAEESIVCLQKALNHLREIWELIGIPEDQRLQRTEVVKKHIKELLDMMIAEEESLKERLIKSISVCQKELNTLCSELHVEPFQEEGETTILQLEKDLRTQVELMRKQKKERKQELKLLQEQDQELCEILCMPHYDIDSASVPSLEELNQFRQHVTTLRETKASRREEFVSIKRQIILCMEELDHTPDTSFERDVVCEDEDAFCLSLENIATLQKLLRQLEMQKSQNEAVCEGLRTQIRELWDRLQIPEEEREAVATIMSGSKAKVRKALQLEVDRLEELKMQNMKKVIEAIRVELVQYWDQCFYSQEQRQAFAPFCAEDYTESLLQLHDAEIVRLKNYYEVHKELFEGVQKWEETWRLFLEFERKASDPNRFTNRGGNLLKEEKQRAKLQKMLPKLEEELKARIELWEQEHSKAFMVNGQKFMEYVAEQWEMHRLEKERAKQERQLKNKKQTETEMLYGSAPRTPSKRRGLAPNTPGKAR","Homo sapiens","PRC1","Protein regulator of cytokinesis 1","1","4L3I"
"4L3J",,"X-RAY DIFFRACTION",2.82,56.34,,,,,"10.1042/BJ20121863",,"4L3J",34.79,"2.1","2.1","Crystal structures of human p70S6K1 kinase domain","GAMSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQS","Homo sapiens","RPS6KB1, hCG_1815774, STK14A","RPS6KB1 protein","1","4L3J"
"4L3L",,"X-RAY DIFFRACTION",2.61,52.88,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.5M sodium formate, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1042/BJ20121863",,"4L3L",34.79,"2.1","2.1","Crystal structures of human p70S6K1 kinase domain (Zinc anomalous)","GAMSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQS","Homo sapiens","RPS6KB1, hCG_1815774, STK14A","RPS6KB1 protein","1","4L3L"
"4L3O",,"X-RAY DIFFRACTION",3.17,61.22,"VAPOR DIFFUSION, SITTING DROP",7,"8.5% PEG 4000, 0.1M MES-NaOH, 0.1M Li2SO4, 0.1M NaCl, pH 7.0, vapor diffusion, sitting drop, temperature 277K",277,"10.1016/j.str.2013.12.001",,"4L3O",146.35,"2.518","2.518","Crystal Structure of SIRT2 in complex with the macrocyclic peptide S2iL5","KERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","4L3O"
,,,,,,,,,,,,,,,,"XYHTYHVKRRTNYYCX",,,"cyclic peptide S2iL5","2","4L3O"
"4L3P",,"X-RAY DIFFRACTION",3.97,68.98,"VAPOR DIFFUSION, HANGING DROP",7,"0.75 M sodium citrate, 0.2 M sodium chloride, 0.1 M Tris, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.06.053","1UH","4L3P",35.94,"2.68","2.68","Crystal Structure of 2-(1-benzothiophen-7-yl)-4-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]furo[2,3-c]pyridin-7-amine bound to TAK1-TAB1","GSLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDHGEQSVVTAP","Homo sapiens","MAP3K7, TAK1, MAP3K7IP1, TAB1","Mitogen-activated protein kinase kinase kinase 7, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera","1","4L3P"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP3K7, TAK1, MAP3K7IP1, TAB1"
"4L3Q",,"X-RAY DIFFRACTION",2.86,57.05,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.06.036","926","4L3Q",51.63,"2.7","2.7","Crystal structure of glucokinase-activator complex","GPMALTLVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","4L3Q"
"4L3T",,"X-RAY DIFFRACTION",2.82,56.39,"VAPOR DIFFUSION, HANGING DROP",6.5,"15.2% w/v PEG8000, 15 mM TCEP, 80 mM sodium cacodylate, pH 6.5, 160 mM calcium acetate, 20% v/v glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.1016/j.str.2014.05.003",,"4L3T",234.46,"2.03","2.03","Crystal Structure of Substrate-free Human Presequence Protease","MHHHHHHAAACERALQYKLGDKIHGFTVNQVTSVPELFLTAVKLTHDDTGARYLHLAREDTNNLFSVQFRTTPMDSTGVPHILQHTVLCGSQKYPCRDPFFKMLNRSLSTFMNAFTASDYTLYPFSTQNPKDFQNLLSVYLDATFFPCLRELDFWQEGWRLEHENPSDPQTPLVFKGVVFNEMKGAFTDNERIFSQHLQNRLLPDHTYSVVSGGDPLCIPELTWEQLKQFHATHYHPSNARFFTYGNFPLEQHLKQIHEEALSKFQKIEPSTVVPAQTPWDKPREFQITCGPDSFATDPSKQTTVSVSFLLPDITDTFEAFTLSLLSSLLTSGPNSPFYKALIESGLGTDFSPDVGYNGYTREAYFSVGLQGIVEKDIETVRSLIDRTIDEVVEKGFEDDRIEALLHKIEIQMKHQSTSFGLMLTSYIASCWNHDGDPVELLKLGNQLAKFRQCLQENPKFLQEKVKQYFKNNQHKLTLSMRPDDKYHEKQAQVEATKLKQKVEALSPGDRQQIYEKGLELRSQQSKPQDASCLPALKVSDIEPTIPVTELDVVLTAGDIPVQYCAQPTNGMVYFRAFSSLNTLPEELRPYVPLFCSVLTKLGCGLLDYREQAQQIELKTGGMSASPHVLPDDSHMDTYEQGVLFSSLCLDRNLPDMMQLWSEIFNNPCFEEEEHFKVLVKMTAQELANGIPDSGHLYASIRAGRTLTPAGDLQETFSGMDQVRLMKRIAEMTDIKPILRKLPRIKKHLLNGDNMRCSVNATPQQMPQTEKAVEDFLRSIGRSKKERRPVRPHTVEKPVPSSSGGDAHVPHGSQVIRKLVMEPTFKPWQMKTHFLMPFPVNYVGECIRTVPYTDPDHASLKILARLMTAKFLHTEIREKGGAYGGGAKLSHNGIFTLYSYRDPNTIETLQSFGKAVDWAKSGKFTQQDIDEAKLSVFSTVDAPVAPSDKGMDHFLYGLSDEMKQAHREQLFAVSHDKLLAVSDRYLGTGKSTHGLAILGPENPKIAKDPSWIIR","Homo sapiens","KIAA1104, MP1, PITRM1, PREP","Presequence protease, mitochondrial","1","4L3T"
,,,,,,,,,,,,,,,,"MHHHHHHAAACERALQYKLGDKIHGFTVNQVTSVPELFLTAVKLTHDDTGARYLHLAREDTNNLFSVQFRTTPMDSTGVPHILQHTVLCGSQKYPCRDPFFKMLNRSLSTFMNAFTASDYTLYPFSTQNPKDFQNLLSVYLDATFFPCLRELDFWQEGWRLEHENPSDPQTPLVFKGVVFNEMKGAFTDNERIFSQHLQNRLLPDHTYSVVSGGDPLCIPELTWEQLKQFHATHYHPSNARFFTYGNFPLEQHLKQIHEEALSKFQKIEPSTVVPAQTPWDKPREFQITCGPDSFATDPSKQTTVSVSFLLPDITDTFEAFTLSLLSSLLTSGPNSPFYKALIESGLGTDFSPDVGYNGYTREAYFSVGLQGIVEKDIETVRSLIDRTIDEVVEKGFEDDRIEALLHKIEIQMKHQSTSFGLMLTSYIASCWNHDGDPVELLKLGNQLAKFRQCLQENPKFLQEKVKQYFKNNQHKLTLSMRPDDKYHEKQAQVEATKLKQKVEALSPGDRQQIYEKGLELRSQQSKPQDASCLPALKVSDIEPTIPVTELDVVLTAGDIPVQYCAQPTNGMVYFRAFSSLNTLPEELRPYVPLFCSVLTKLGCGLLDYREQAQQIELKTGGMSASPHVLPDDSHMDTYEQGVLFSSLCLDRNLPDMMQLWSEIFNNPCFEEEEHFKVLVKMTAQELANGIPDSGHLYASIRAGRTLTPAGDLQETFSGMDQVRLMKRIAEMTDIKPILRKLPRIKKHLLNGDNMRCSVNATPQQMPQTEKAVEDFLRSIGRSKKERRPVRPHTVEKPVPSSSGGDAHVPHGSQVIRKLVMEPTFKPWQMKTHFLMPFPVNYVGECIRTVPYTDPDHASLKILARLMTAKFLHTEIREKGGAYGGGAKLSHNGIFTLYSYRDPNTIETLQSFGKAVDWAKSGKFTQQDIDEAKLSVFSTVDAPVAPSDKGMDHFLYGLSDEMKQAHREQLFAVSHDKLLAVSDRYLGTGKSTHGLAILGPENPKIAKDPSWIIR","Homo sapiens","KIAA1104, MP1, PITRM1, PREP","Presequence protease, mitochondrial","2","4L3T"
"4L3V",,"X-RAY DIFFRACTION",5.76,78.65,"VAPOR DIFFUSION, SITTING DROP",5,"30% v/v PEG550, 0.1 M sodium citrate tribasic dehydrate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1313683110",,"4L3V",184.19,"3.628","3.628","Crystal structure of delta516-525 human cystathionine beta-synthase","PSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK","Homo sapiens","CBS","Cystathionine beta-synthase","1","4L3V"
"4L42",,"X-RAY DIFFRACTION",3.26,62.3,"VAPOR DIFFUSION, HANGING DROP",6.2,"2.0M ammonium sulfate, 0.1M MES, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1042/BJ20121863",,"4L42",40.5,"2.8","2.8","Crystal structures of human p70S6K1-PIF","GAMSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSEEEQEMFRDFEYIADW","Homo sapiens","RPS6KB1, hCG_1815774, STK14A","RPS6KB1 protein","1","4L42"
"4L43",,"X-RAY DIFFRACTION",2.65,53.52,"VAPOR DIFFUSION, HANGING DROP",7,"1.6M ammonium citrate, 0.1M Bis-Tris propane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1042/BJ20121863",,"4L43",39.32,"3","3","Crystal structures of human p70S6K1-T389A (form I)","GAMSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFAYVAPS","Homo sapiens","RPS6KB1, hCG_1815774, STK14A","RPS6KB1 protein","1","4L43"
"4L44",,"X-RAY DIFFRACTION",2.56,52.04,"hanging drop",7.2,"2M lithium sulfate, 0.05M magnesium sulfate, 0.05M HEPES, pH 7.2, hanging drop, temperature 289K",289,"10.1042/BJ20121863",,"4L44",39.68,"2.9","2.9","Crystal structures of human p70S6K1-T389A (form II)","GAMSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFAYVAPS","Homo sapiens","RPS6KB1, hCG_1815774, STK14A","RPS6KB1 protein","1","4L44"
"4L45",,"X-RAY DIFFRACTION",2.7,54.48,"hanging drop",6.5,"1.4M sodium citrate, 0.1M sodium cacodylate, pH 6.5, hanging drop, temperature 289K",289,"10.1042/BJ20121863",,"4L45",39.38,"2.9","2.9","Crystal structures of human p70S6K1-T389E","GAMSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFEYVAPS","Homo sapiens","RPS6KB1, hCG_1815774, STK14A","RPS6KB1 protein","1","4L45"
"4L46",,"X-RAY DIFFRACTION",2.7,54.49,"hanging drop",6.8,"2.2M ammonium sulfate, 0.01M magnesium chloride, 0.1M HEPES, pH 6.8, hanging drop, temperature 289K",289,"10.1042/BJ20121863",,"4L46",39.6,"3.01","3.01","Crystal structures of human p70S6K1-WT","GAMSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPS","Homo sapiens","RPS6KB1, hCG_1815774, STK14A","RPS6KB1 protein","1","4L46"
"4L4J",,"X-RAY DIFFRACTION",2.71,54.64,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M SODIUM ACETATE, 18% PEG 3350, 0.2 M SODIUM FORMATE. CRYO CONDITIONS: 0.1 M SODIUM ACETATE, 20% PEG 3350, 0.2 M SODIUM FORMATE, 20% GLYCEROL, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.ymeth.2013.06.035",,"4L4J",51.93,"1.92","1.92","Crystal structure of fc-fragment of human IgG2-Sigma antibody","CPPCPAPPAAASSVFLFPPKPKDTLMISRTPEVTCVVVDVSAEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG2","Ig gamma-2 chain C region","1","4L4J"
"4L4L",,"X-RAY DIFFRACTION",2.33,47.21,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM ligand compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K, VAPOR DIFFUSION, SITTING DROP",292,"10.1002/cbic.201402023",,"4L4L",115.73,"2.122","2.122","Structural Analysis of a Phosphoribosylated Inhibitor in Complex with Human Nicotinamide Phosphoribosyltransferase","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4L4L"
"4L4M",,"X-RAY DIFFRACTION",2.35,47.62,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM ligand compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K, VAPOR DIFFUSION, SITTING DROP",292,"10.1002/cbic.201402023","1XD","4L4M",115.24,"2.445","2.445","Structural Analysis of a Phosphoribosylated Inhibitor in Complex with Human Nicotinamide Phosphoribosyltransferase","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4L4M"
"4L4R",,"X-RAY DIFFRACTION",3.28,62.51,"VAPOR DIFFUSION, SITTING DROP",7.5,"10% PEG 8000, 100 mM HEPES pH 7.5, 20 % ethylene glycol, 10 % Acetonitrile, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1107/S1399004714005422",,"4L4R",75.35,"2.1","2.1","Structural Characterisation of the Apo-form of Human Lactate Dehydrogenase M Isozyme","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQFLEHHHHHH","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4L4R"
"4L4S",,"X-RAY DIFFRACTION",3.26,62.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"10 % PEG 8000, 100 mM HEPES, 20 % ethylene glycol, 10 % acetonitrile, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1107/S1399004714005422",,"4L4S",76.68,"2.9","2.9","Structural characterisation of the NADH binary complex of human lactate dehydrogenase M isozyme","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQFLEHHHHHH","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4L4S"
"4L52",,"X-RAY DIFFRACTION",3.99,69.14,"VAPOR DIFFUSION, HANGING DROP",7,"0.75 M sodium citrate, 0.2 M sodium chloride, 0.1 M TRIS, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.06.053","1UL","4L52",35.17,"2.54","2.54","Crystal Structure of 1-(4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)furo[2,3-c]pyridin-4-yl]-1H-pyrazol-1-yl}piperidin-1-yl)ethan-1-one bound to TAK1-TAB1","GSLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDHG","Homo sapiens","MAP3K7, TAK1, MAP3K7IP1, TAB1","Mitogen-activated protein kinase kinase kinase 7, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera","1","4L52"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP3K7, TAK1, MAP3K7IP1, TAB1"
"4L53",,"X-RAY DIFFRACTION",4.08,69.83,"VAPOR DIFFUSION, HANGING DROP",7,"0.75 M sodium citrate, 0.2 M sodium chloride, 0.1 M TRIS, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.06.054","1UO","4L53",35.3,"2.55","2.55","Crystal Structure of (1R,4R)-4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)-3-chlorofuro[2,3-c]pyridin-4-yl]-1H-pyrazol-1-yl}cyclohexan-1-ol bound to TAK1-TAB1","GSLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDHG","Homo sapiens","MAP3K7, TAK1, MAP3K7IP1, TAB1","Mitogen-activated protein kinase kinase kinase 7, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera","1","4L53"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP3K7, TAK1, MAP3K7IP1, TAB1"
"4L57",,"X-RAY DIFFRACTION",2.19,43.96,,4.2,"40MM KH2PO4, 5% PEG 8000, 20% GLYCEROL, pH 4.2, VAPOR DIFFUSION, temperature 291K",291,"10.1107/S1399004713030502",,"4L57",46.42,"1.08","1.08","High resolutin structure of human cytosolic 5'(3')-deoxyribonucleotidase","MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQYRALRPDLADKVASVYEAPGFFLDLEPIPGALDAVREMNDLPDTQVFICTSPLLKYHHCVGEKYRWVEQHLGPQFVERIILTRDKTVVLGDLLIDDKDTVRGQEETPSWEHILFTCCHNRHLVLPPTRRRLLSWSDNWREILDSKR","Homo sapiens","DNT1, NT5C, UMPH2","5'(3')-deoxyribonucleotidase, cytosolic type","1","4L57"
"4L59",,"X-RAY DIFFRACTION",4.79,74.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5M Na Citrate, 0.1M HEPES pH7.5, temperature 291K, VAPOR DIFFUSION, HANGING DROP",291,"10.1039/C3MD00197K","1VZ","4L59",37.07,"2.29","2.29","Crystal structure of the 3-MBT repeat domain of L3MBTL3 and UNC2533 complex","GKKAWCWASYLEEEKAVAVPAKLFKEHQSFPYNKNGFKVGMKLEGVDPEHQSVYCVLTVAEVCGYRIKLHFDGYSDCYDFWVNADALDIHPVGWCEKTGHKLHPPKGYKEEEFNWQTYLKTCKAQAAPKSLFENQNITVIPSGFRVGMKLEAVDKKNPSFICVATVTDMVDNRFLVHFDNWDESYDYWCEASSPHIHPVGWCKEHRRTLITPPGYPNVKHFSWDKYLEETNSLPAPARAFKVKPPHGFQKKMKLEVVDKRNPMFIRVATVADTDDHRVKVHFDGWNNCYDYWIDADSPDIHPVGWCSKTGHPLQPPL","Homo sapiens","L3MBTL3, KIAA1798, MBT1","Lethal(3)malignant brain tumor-like protein 3","1","4L59"
"4L5B",,"X-RAY DIFFRACTION",2.16,43.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.9-1.5 M trisodium citrate dehydrate, 25 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm400457y","1UX","4L5B",67.16,"1.94","1.94","Human dCK C4S-S74E mutant in complex with UDP and the DI-43 inhibitor","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4L5B"
"4L5M",,"X-RAY DIFFRACTION",2.39,48.61,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Mes,  pH 6.5, 18% Peg 5000 MME, 0.1M MgSO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm4009357","HRC","4L5M",25.29,"1.8","1.8","Complexe of ARNO Sec7 domain with the protein-protein interaction inhibitor N-(4-hydroxy-2,6-dimethylphenyl)benzenesulfonamide at pH6.5","MGSSHHHHHHSSGLVPRGSHMSKTLQRNRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKTAIGDYLGEREELNLAVLHAFVDLHEFTDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRYCLCNPGVFQSTDTCYVLSFAVIMLNTSLHNPNVRDKPGLERFVAMNRGINEGGDLPEELLRNLYDSIRNEPFKIPEDDGN","Homo sapiens","CYTH2, ARNO, PSCD2, PSCD2L","Cytohesin-2","1","4L5M"
"4L5U",,"X-RAY DIFFRACTION",2.11,41.58,"VAPOR DIFFUSION, HANGING DROP",9,"1.4M sodium citrate, 50 mM Tris, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.abb.2013.09.001",,"4L5U",29.41,"2.05","2.05","The structural implications of the secondary CO2 binding pocket in human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKIRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4L5U"
"4L5V",,"X-RAY DIFFRACTION",2.1,41.35,"VAPOR DIFFUSION, HANGING DROP",9,"1.4M sodium citrate, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.abb.2013.09.001",,"4L5V",29.41,"1.63","1.63","The structural implications of the secondary CO2 binding pocket in human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKLRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4L5V"
"4L5W",,"X-RAY DIFFRACTION",2.07,40.55,"VAPOR DIFFUSION, HANGING DROP",9,"1.4 M sodium citrate, 50 mM Tris, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.abb.2013.09.001",,"4L5W",29.49,"1.7","1.7","Structural implications of the secondary CO2 binding pocket in human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKWRKLNFNGEGEPEELMVDNWRPAQPLKNREIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4L5W"
"4L67",,"X-RAY DIFFRACTION",2.73,54.93,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris pH 8.5, 12%(M/V) PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.bbrc.2013.07.047",,"4L67",35.91,"2.8","2.8","Crystal Structure of Catalytic Domain of PAK4","SHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","4L67"
,,,,,,,,,,,,,,,,"PRQWQSLIEESARRPKPLVDPACIT","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","2","4L67"
"4L6A",,"X-RAY DIFFRACTION",3.09,60.22,"VAPOR DIFFUSION, HANGING DROP",4.2,"8% PEG 8000, 20MM POTASSIUM PHOSPHATE, 10% GLYCEROL, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004713030502",,"4L6A",24.68,"1.4","1.4","Structure of human mitochondrial 5'(3')-deoxyribonucleotidase","SNAASGGRALRVLVDMDGVLADFEGGFLRKFRARFPDQPFIALEDRRGFWVSEQYGRLRPGLSEKAISIWESKNFFFELEPLPGAVEAVKEMASLQNTDVFICTSPIKMFKYCPYEKYAWVEKYFGPDFLEQIVLTRDKTVVSADLLIDDRPDITGAEPTPSWEHVLFTACHNQHLQLQPPRRRLHSWADDWKAILDSKRPC","Homo sapiens","DNT2, NT5M","5'(3')-deoxyribonucleotidase, mitochondrial","1","4L6A"
"4L6C",,"X-RAY DIFFRACTION",3.1,60.34,"VAPOR DIFFUSION, HANGING DROP",4.2,"8% PEG 8000, 20MM DIHYDROGEN POTASSIUM PHOSPHATE, 10% GLYCEROL, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1039/c4ob01332h","0BT","4L6C",24.7,"1.8","1.8","Crystal structure of human mitochondrial deoxyribonucleotidase in complex with the inhibitor pib-t","SNAASGGRALRVLVDMDGVLADFEGGFLRKFRARFPDQPFIALEDRRGFWVSEQYGRLRPGLSEKAISIWESKNFFFELEPLPGAVEAVKEMASLQNTDVFICTSPIKMFKYCPYEKYAWVEKYFGPDFLEQIVLTRDKTVVSADLLIDDRPDITGAEPTPSWEHVLFTACHNQHLQLQPPRRRLHSWADDWKAILDSKRPC","Homo sapiens","DNT2, NT5M","5'(3')-deoxyribonucleotidase, mitochondrial","1","4L6C"
"4L6E",,"X-RAY DIFFRACTION",2.84,56.7,"Microbatch crystallization under oil",7,"12% PEG 3350, 0.1M sodium acetate, pH 7.00, Microbatch crystallization under oil, temperature 277K",277,,,"4L6E",18.71,"2.496","2.496","Crystal Structure of the RanBD1 fourth domain of E3 SUMO-protein ligase RanBP2. Northeast Structural Genomics Consortium (NESG) Target HR9193b","MGHHHHHHSHMNEDIHFEPIVSLPEVEVKSGEEDEEILFKERAKLYRWDRDVSQWKERGVGDIKILWHTMKNYYRILMRRDQVFKVCANHVITKTMELKPLNVSNNALVWTASDYADGEAKVEQLAVRFKTKEVADCFKKTFEECQQNLMKLQKG","Homo sapiens","NUP358, RANBP2","E3 SUMO-protein ligase RanBP2","1","4L6E"
"4L6Q",,"X-RAY DIFFRACTION",4.15,70.37,"VAPOR DIFFUSION, HANGING DROP",6,"1.2 M sodium citrate and 2 mM DTT, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1124/jpet.113.207662",,"4L6Q",92.35,"2.79","2.79","ROCK2 in complex with benzoxaborole","GAAGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYR","Homo sapiens","ROCK2, KIAA0619","Rho-associated protein kinase 2","1","4L6Q"
"4L6S",,"X-RAY DIFFRACTION",2.36,47.89,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.4M tri-sodium citrate, 0.1M HEPES , pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.06.055","1WQ","4L6S",79.73,"2.2","2.2","PARP complexed with benzo[1,4]oxazin-3-one inhibitor","GHMKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","ADPRT, PARP 1, PARP1, PPOL","Poly [ADP-ribose] polymerase 1","1","4L6S"
"4L6Y",,"X-RAY DIFFRACTION",6.3,80.5,"VAPOR DIFFUSION, HANGING DROP",8,"Concentration: 5-10 mg/ml. Protein buffer: 80 mM PIPES (pH 6.8), 1 mM MgCl2, 1 mM EGTA, 150 mM KCl, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.cell.2013.06.021",,"4L6Y",116.37,"3.3015","3.3015","Structure of the microtubule associated protein PRC1 (Protein Regulator of Cytokinesis 1)","GAAAMRRSEVLAEESIVCLQKALNHLREIWELIGIPEDQRLQRTEVVKKHIKELLDMMIAEEESLKERLIKSISVCQKELNTLCSELHVEPFQEEGETTILQLEKDLRTQVELMRKQKKERKQELKLLQEQDQELCEILCMPHYDIDSASVPSLEELNQFRQHVTTLRETKASRREEFVSIKRQIILCMEELDHTPDTSFERDVVCEDEDAFCLSLENIATLQKLLRQLEMQKSQNEAVCEGLRTQIRELWDRLQIPEEEREAVATIMSGSKAKVRKALQLEVDRLEELKMQNMKKVIEAIRVELVQYWDQCFYSQEQRQAFAPFCAEDYTESLLQLHDAEIVRLKNYYEVHKELFEGVQKWEETWRLFLEFERKASDPNRFTNRGGNLLKEEKQRAKLQKMLPKLEEELKARIELWEQEHSKAFMVNGQKFMEYVAEQWEMHRLEKERAKQERQLKNKKQTETEMLYGSAPRTPSKRRGLAPNTPGKAR","Homo sapiens","PRC1","Protein regulator of cytokinesis 1","1","4L6Y"
"4L6Z",,"X-RAY DIFFRACTION",2.06,40.42,"VAPOR DIFFUSION, SITTING DROP",7,"1.7M DL-Malic Acid, 0.1M Bis-tris-propane , pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401394u",,"4L6Z",40.15,"2","2","Human artd3 (parp3) - catalytic domain in complex with inhibitor STO1168","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","ADPRT3, ADPRTL3, PARP3","Poly [ADP-ribose] polymerase 3","1","4L6Z"
"4L70",,"X-RAY DIFFRACTION",2.07,40.56,"VAPOR DIFFUSION, SITTING DROP",7,"1.6M DL-Malic Acid, 0.1M Bis-tris-propane , pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401394u","1V9","4L70",40.24,"2","2","Human artd3 (parp3) - catalytic domain in complex with inhibitor ME0352","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","ADPRT3, ADPRTL3, PARP3","Poly [ADP-ribose] polymerase 3","1","4L70"
"4L7B",,"X-RAY DIFFRACTION",4.47,72.48,"VAPOR DIFFUSION, HANGING DROP",4.6,"1 ul of protein at 12 mg/ml in 20 mM Tris-HCl pH 7.5, 5 mM DTT, 5 mM compound 1 + 2 ul of 2.15 M Sodium Acetate , VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1002/cmdc.201300525","1VV","4L7B",66.78,"2.41","2.41","Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-1-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}cyclohexanecarboxylic acid","MGHAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLDLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVTLEHHHHHH","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","4L7B"
"4L7C",,"X-RAY DIFFRACTION",3.21,61.66,"VAPOR DIFFUSION, HANGING DROP",4.6,"1 ul of protein at 12 mg/ml in 20 mM Tris-HCl pH 7.5, 5 mM DTT, 5 mM compound 1 + 2 ul of 2.15 M Sodium Acetate , VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1002/cmdc.201300525","1VW","4L7C",100.74,"2.4","2.4","Structure of keap1 kelch domain with 2-{[(1S)-2-{[(1R,2S)-2-(1H-tetrazol-5-yl)cyclohexyl]carbonyl}-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-1H-isoindole-1,3(2H)-dione","MGHAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLDLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVTLEHHHHHH","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","4L7C"
"4L7D",,"X-RAY DIFFRACTION",3.15,60.91,"VAPOR DIFFUSION, HANGING DROP",4.6,"1 ul of protein at 12 mg/ml in 20 mM Tris-HCl pH 7.5, 5 mM DTT, 5 mM compound 1 + 2 ul of 2.15 M Sodium Acetate , VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1002/cmdc.201300525","1VX","4L7D",100.96,"2.25","2.25","Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-5-methyl-1-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}cyclohexanecarboxylic acid","MGHAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLDLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVTLEHHHHHH","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","4L7D"
"4L7E",,"X-RAY DIFFRACTION",2.52,51.23,"microbatch under oil",5,"Protein solution: 100mM NaCl, 5mM DTT, 0.02% NaN3, 10mM Tris-HCl (pH 7.5) . Reservoir solution:0.1M LiCl, 0.1M sodium acetate, 40% PEG1000, microbatch under oil, temperature 277K",277,,,"4L7E",48.59,"2.229","2.229","Three dimensional structure of mutant D78A of human HD domain-containing protein 2, Genomics Consortium (NESG) Target HR6723","MASVSSATFSGHGARSLLQFLRLVGQLKRVPRTGWVYRNVQRPESVSDHMYRMAVMAMVIKDDRLNKDRCVRLALVHAMAECIVGDIAPADNIPKEEKHRREEEAMKQITQLLPEDLRKELYELWEEYETQSSAEAKFVKQLDQCEMILQASEYEDLEHKPGRLQDFYDSTAGKFNHPEIVQLVSELEAERSTNIAAAASEPHS","Homo sapiens","HDDC2, C6orf74, NS5ATP2, CGI-130","HD domain-containing protein 2","1","4L7E"
"4L7F",,"X-RAY DIFFRACTION",3.95,68.82,,,,,"10.1016/j.bmcl.2013.06.087","1V5","4L7F",42.84,"1.95","1.95","Co-crystal Structure of JNK1 and AX13587","SLDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDWRKGIITIT","Homo sapiens","MAPK8, JNK1, PRKM8, SAPK1, SAPK1C","Mitogen-activated protein kinase 8","1","4L7F"
"4L7G",,"X-RAY DIFFRACTION",2.08,40.77,"VAPOR DIFFUSION, SITTING DROP",4.9,"12% PEG 3350 and 0.1M NaOAc, pH 4.9, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,,"1W0","4L7G",45.98,"1.38","1.38","Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fused Bicyclic Aminooxazoline Compounds and Evaluation of Their Biochemical Activity Against Beta-Secretase-1 (BACE1)","MGSRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESGNSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4L7G"
"4L7H",,"X-RAY DIFFRACTION",2.09,41.1,"VAPOR DIFFUSION, SITTING DROP",4.9,"12% PEG 3350 and 0.1M NaOAc, pH 4.9, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,,"1W1","4L7H",46.1,"1.85","1.85","Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fused Bicyclic Aminooxazoline Compounds and Evaluation of Their Biochemical Activity Against Beta-Secretase-1 (BACE-1)","MGSRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESGNSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4L7H"
"4L7J",,"X-RAY DIFFRACTION",2.08,40.86,"VAPOR DIFFUSION, SITTING DROP",4.9,"12% PEG 3350 and 0.1M NaOAc, pH 4.9, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,,"1W2","4L7J",46.02,"1.651","1.651","Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fused Bicyclic Aminooxazoline Compounds and Evaluation of Their Biochemical Activity Against Beta-Secretase-1 (BACE-1)","MGSRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESGNSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4L7J"
"4L7L",,"X-RAY DIFFRACTION",2.06,40.32,"VAPOR DIFFUSION, SITTING DROP",7,"1.95M DL-Malic Acid, 0.1M Bis-tris-propane , pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401394u","1VA","4L7L",40.26,"2.1","2.1","Human artd3 (parp3) - catalytic domain in complex with inhibitor ME0368","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","ADPRT3, ADPRTL3, PARP3","Poly [ADP-ribose] polymerase 3","1","4L7L"
"4L7N",,"X-RAY DIFFRACTION",2.05,39.96,"VAPOR DIFFUSION, SITTING DROP",7,"1.7M DL-Malic Acid, 0.1M Bis-tris-propane , pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401394u","1VB","4L7N",40.15,"1.8","1.8","Human artd3 (parp3) - catalytic domain in complex with inhibitor STO1542","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","ADPRT3, ADPRTL3, PARP3","Poly [ADP-ribose] polymerase 3","1","4L7N"
"4L7O",,"X-RAY DIFFRACTION",2.05,40.02,"VAPOR DIFFUSION, SITTING DROP",7,"1.8M DL-Malic Acid, 0.1M Bis-tris-propane , pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401394u","1VD","4L7O",40.22,"2","2","Human artd3 (parp3) - catalytic domain in complex with inhibitor STO1542","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","ADPRT3, ADPRTL3, PARP3","Poly [ADP-ribose] polymerase 3","1","4L7O"
"4L7P",,"X-RAY DIFFRACTION",2.16,43.1,"VAPOR DIFFUSION, SITTING DROP",7,"1.9M DL-Malic Acid, 0.1M Bis-tris-propane , pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401394u",,"4L7P",40.1,"2.3","2.3","Human artd3 (parp3) - catalytic domain in complex with inhibitor ME0395","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","ADPRT3, ADPRTL3, PARP3","Poly [ADP-ribose] polymerase 3","1","4L7P"
"4L7R",,"X-RAY DIFFRACTION",2.04,39.79,"VAPOR DIFFUSION, SITTING DROP",7,"1.8M DL-Malic Acid, 0.1M Bis-tris-propane , pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401394u","M00","4L7R",40.04,"2.2","2.2","Human artd3 (parp3) - catalytic domain in complex with inhibitor ME0400","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","ADPRT3, ADPRTL3, PARP3","Poly [ADP-ribose] polymerase 3","1","4L7R"
"4L7S",,"X-RAY DIFFRACTION",2.75,55.33,"VAPOR DIFFUSION, HANGING DROP",5.7,"0.85M ammonium sulphate, 0.2M magnesium acetate, 0.1M sodium citrate, 10mM dithiothreitol (See citation for full details), pH 5.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ml400206q","G7K","4L7S",61.56,"2.03","2.03","Kinase domain mutant of human Itk in complex with an aminobenzothiazole inhibitor","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQETSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4L7S"
"4L7U",,"X-RAY DIFFRACTION",2.08,40.78,"VAPOR DIFFUSION, SITTING DROP",7,"1.9M DL-Malic Acid, 0.1M Bis-tris-propane , pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401394u","1VC","4L7U",40.13,"2.8","2.8","Human artd3 (parp3) - catalytic domain in complex with inhibitor ME0398","SMKRVQPCSLDPATQKLITNIFSKEMFKNTMALMDLDVKKMPLGKLSKQQIARGFEALEALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVH","Homo sapiens","ADPRT3, ADPRTL3, PARP3","Poly [ADP-ribose] polymerase 3","1","4L7U"
"4L7W",,"X-RAY DIFFRACTION",2.67,53.85,"microbatch under oil",8,"Protein solution: 100mM NaCl, 5mM DTT, 0.02% NaN3, 10mM Tris-HCl (pH 7.5) . Reservoir solution: 0.1M Mg(NO3)2, 0.1M Tris, 12% PEG 20000, microbatch under oil, temperature 277K",277,,,"4L7W",23.93,"2.305","2.305","Crystal structure mutant H77A of human HD domain-containing protein 2, Genomics Consortium (NESG) Target HR6723","MASVSSATFSGHGARSLLQFLRLVGQLKRVPRTGWVYRNVQRPESVSDHMYRMAVMAMVIKDDRLNKDRCVRLALVADMAECIVGDIAPADNIPKEEKHRREEEAMKQITQLLPEDLRKELYELWEEYETQSSAEAKFVKQLDQCEMILQASEYEDLEHKPGRLQDFYDSTAGKFNHPEIVQLVSELEAERSTNIAAAASEPHS","Homo sapiens","HDDC2, C6orf74, NS5ATP2, CGI-130","HD domain-containing protein 2","1","4L7W"
"4L87",,"X-RAY DIFFRACTION",4.82,74.46,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG3350, 0.2 M ammonium fluoride or ammonium formate, 0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2013.08.021",,"4L87",55.09,"2.897","2.897","Crystal structure of the human seryl-tRNA synthetase in complex with Ser-SA at 2.9 Angstrom resolution","VLDLDLFRVDKGGDPALIRETQEKRFKDPGLVDQLVKADSEWRRCRFRADNLNKLKNLCSKTIGEKMKKKEPVGDDESVPENVLSFDDLTADALANLKVSQIKKVRLLIDEAILKCDAERIKLEAERFENLREIGNLLHPSVPISNDEDVDNKVERIWGDCTVRKKYSHVDLVVMVDGFEGEKGAVVAGSRGYFLKGVLVFLEQALIQYALRTLGSRGYIPIYTPFFMRKEVMQEVAQLSQFDEELYKVIGKGSEKSDDNSYDEKYLIATSEQPIAALHRDEWLRPEDLPIKYAGLSTCFRQEVGSHGRDTRGIFRVHQFEKIEQFVYSSPHDNKSWEMFEEMITTAEEFYQSLGIPYHIVNIVSGSLNHAASKKLDLEAWFPGSGAFRELVSCSNCTDYQARRLRIRYGQTKKMMDKVEFVHMLNATMCATTRTICAILENYQTEKGITVPEKLKEFMPPGLQELIPFVKPAPIE","Homo sapiens","SARS, SERS, SARS1","Serine--tRNA ligase, cytoplasmic","1","4L87"
"4L8G",,"X-RAY DIFFRACTION",1.99,38.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"21% PEG3350, 0.2M CaCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature12796",,"4L8G",19.87,"1.521","1.521","Crystal Structure of K-Ras G12C, GDP-bound","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","GTPase KRas","1","4L8G"
"4L8M",,"X-RAY DIFFRACTION",2.2,44,"VAPOR DIFFUSION, HANGING DROP",6.1,"100 mM MES, 22% PEG4000, 50 mM n-BOG, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm401276h","F46","4L8M",42.42,"2.1","2.1","Human p38 MAP kinase in complex with a Dibenzoxepinone","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4L8M"
"4L8T",,"X-RAY DIFFRACTION",3.77,67.4,"VAPOR DIFFUSION, HANGING DROP",10.5,"0.1M CAPS, 2M NH4SO4, 0.2M Li2SO4, pH 10.5, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.1074/jbc.M113.507202",,"4L8T",51.52,"2.95","2.95","Structure of the Cargo Binding Domain from Human Myosin Vc","MHHHHHHSSGVDLGTENLYFQSMDLEEELDMKDRVIKKLQDQVKTLSKTIGKANDVHSSSGPKEYLGMLQYKREDEAKLIQNLILDLKPRGVVVNMIPGLPAHILFMCVRYADSLNDANMLKSLMNSTINGIKQVVKEHLEDFEMLSFWLSNTCHFLNCLKQYSGEEEFMKHNSPQQNKNCLNNFDLSEYRQILSDVAIRIYHQFIIIMEKNIQPIIVPGMLEYESLQGISGLKPTGFRKRSSSIDDTDGYTMTSVLQQLSYFYTTMCQNGLDPELVRQAVKQLFFLIGAVTLNSLFLRKDMCSCRKGMQIRCNISYLEEWLKDKNLQNSLAKETLEPLSQAAWLLQVKKTTDSDAKEIYERCTSLSAVQIIKILNSYTPIDDFEKRVTPSFVRKVQALLNSREDSSQLMLDTKYLFQVTFPFTPSPHALEMIQIPSSFKLGFLNRL","Homo sapiens","MYO5C","Unconventional myosin-Vc","1","4L8T"
"4L8U",,"X-RAY DIFFRACTION",2.3,46.56,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, POTASSIUM PHOSPHATE, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K. 
 
CRYSTALS OF THE COMPLEXES WERE OBTAINED BY STANDARD VAPOR EQUILIBRATION METHODS WITH CONDITIONS OPTIMIZED BY SCREENS VARYING PROTEIN CONCENTRATION, PH, DRUG MOLAR RATIOS, CENTERED  ON THE ORIGINAL CRYSTALLIZATION HIT USING PROTOCOLS DESCRIBED PREVIOUSLY FOR THE MONOCLINIC [CARTER, ET AL., EUR. J. BIOCHEMISTRY (1994) 226: 1049-1052] AND TRICLINIC [SUGO, ET AL., PROTEIN ENG (1999) 12: 439-446] CRYSTAL FORMS.",293,"10.1016/j.bbagen.2013.06.032",,"4L8U",68.09,"2.01","2.01","X-ray study of human serum albumin complexed with 9 amino camptothecin","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","4L8U"
"4L8Z",,"X-RAY DIFFRACTION",2.95,58.34,"VAPOR DIFFUSION, HANGING DROP",6.5,"25%(w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2014.03.100","RL1","4L8Z",26.12,"1.703","1.703","Crystal structure of Human Hsp90 with RL1","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4L8Z"
"4L90",,"X-RAY DIFFRACTION",2.96,58.38,,,,,,,"4L90",26.09,"2.001","2.001","Crystal structure of Human Hsp90 with RL3","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4L90"
"4L91",,"X-RAY DIFFRACTION",2.87,57.12,"VAPOR DIFFUSION, HANGING DROP",6.5,"25%(w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2014.03.100",,"4L91",26,"1.75","1.75","Crystal structure of Human Hsp90 with X29","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4L91"
"4L93",,"X-RAY DIFFRACTION",2.73,54.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"20%-25%(w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4L93",51.94,"1.845","1.845","Crystal structure of Human Hsp90 with S36","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4L93"
"4L94",,"X-RAY DIFFRACTION",2.83,56.52,"VAPOR DIFFUSION, HANGING DROP",6.5,"20%-25%(w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2014.03.100",,"4L94",25.88,"1.649","1.649","Crystal structure of Human Hsp90 with S46","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4L94"
"4L96",,"X-RAY DIFFRACTION",3.5,64.86,"VAPOR DIFFUSION, SITTING DROP",6.9,"0.35M Na-phosphate, 0.65 M K-phosphate., pH 6.9, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714009638","LRG","4L96",31.69,"2.38","2.38","Structure of the complex between the F360L PPARgamma mutant and the ligand LT175 (space group I222)","GSHMESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPLGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4L96"
"4L98",,"X-RAY DIFFRACTION",3.4,63.84,"VAPOR DIFFUSION, SITTING DROP",7,"3.3 M Sodium Formate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714009638","LRG","4L98",63.39,"2.28","2.28","Crystal structure of the complex of F360L PPARgamma mutant with the ligand LT175","GSHMESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPLGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4L98"
"4L9C",,"X-RAY DIFFRACTION",1.79,31.29,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 3350, MES 7.2, KBr , pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1399004713025820",,"4L9C",35.62,"2.1","2.1","Crystal structure of the FP domain of human F-box protein Fbxo7 (native)","GPSSPHSLETLYQSADCSDANDALIVLIHLLMLESGYIPQGTEAKALSMPEKWKLSGVYKLQYMHPLCEGSSATLTCVPLGNLIVVNATLKINNEIRSVKRLQLLPESFICKEKLGENVANIYKDLQKLSRLFKDQLVYPLLAFTRQALNLPDVFGLVVL","Homo sapiens","FBX7, FBXO7, HUMAN FBXO7","F-box only protein 7","1","4L9C"
"4L9H",,"X-RAY DIFFRACTION",2.07,40.66,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 3350, MOPS 7.0, KBr, pH 8.0, vapor diffusion, hanging drop, temperature 298K",298,"10.1107/S1399004713025820",,"4L9H",17.9,"2","2","Crystal structure of the FP domain of human F-box protein Fbxo7(SeMet)","GPSSPHSLETLYQSADCSDANDALIVLIHLLMLESGYIPQGTEAKALSMPEKWKLSGVYKLQYMHPLCEGSSATLTCVPLGNLIVVNATLKINNEIRSVKRLQLLPESFICKEKLGENVANIYKDLQKLSRLFKDQLVYPLLAFTRQALNLPDVFGLVVL","Homo sapiens","FBX7, FBXO7, HUMAN FBXO7","F-box only protein 7","1","4L9H"
"4L9K",,"X-RAY DIFFRACTION",2.36,47.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, POTASSIUM PHOSPHATE, Crystals of the complexes were obtained by standard vapor equilibration methods with conditions optimized by screens varying protein concentration, pH, drug molar ratios, centered on the original crystallization hit using protocols described previously for the monoclinic [Carter, et al., Eur. J. Biochemistry (1994) 226: 1049-1052] and triclinic [Sugo, et al., Protein Eng (1999) 12: 439-446] crystal forms., pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bbagen.2013.06.032",,"4L9K",133.88,"2.4","2.4","X-ray study of human serum albumin complexed with camptothecin","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","4L9K"
"4L9M",,"X-RAY DIFFRACTION",2.68,54.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.15 M sodium citrate tribasic, 22% PEG 3350, 1 mM MnCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.7554/eLife.00813",,"4L9M",64.63,"3","3","Autoinhibited state of the Ras-specific exchange factor RasGRP1","SMVSLGHLAKGASLDDLIDSCIQSFDADGNLCRSNQLLQVMLTMHRIVISSAELLQKVITLYKDALAKNSPGLCLKICYFVRYWITEFWVMFKMDASLTDTMEEFQELVKAKGEELHCRLIDTTQINARDWSRKLTQRIKSNTSKKRKVSLLFDHLEPEELSEHLTYLEFKSFRRISFSDYQNYLVNSCVKENPTMERSIALCNGISQWVQLMVLSRPTPQLRAEVFIKFIQVAQKLHQLQNFNTLMAVIGGLCHSSISRLKETSSHVPHEINKVLGEMTELLSSSRNYDNYRRAYGECTDFKIPILGVHLKDLISLYEAMPDYLEDGKVNVHKLLALYNHISELVQLQEVAPPLEANKDLVHLLTLSLDLYYTEDEIYELSYAREPRNHRAPPLTPSKPPVVVDWASGVSPKPDPKTISKHVQRMVDSVFKNYDHDQDGYISQEEFEKIAASFPFSFCVMDKDREGLISRDEITAYFMRASSIYSKLGLGFPHNFQETTYLKPTFCDNCAGFLWGVIKQGYRCKDCGMNCHKQCKDLVVFECKKRAKNPVAPTENNTS","Homo sapiens","RASGRP1, RASGRP","RAS guanyl-releasing protein 1","1","4L9M"
"4L9Q",,"X-RAY DIFFRACTION",2.21,44.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, POTASSIUM PHOSPHATE, Crystals of the complexes were obtained by standard vapor equilibration methods with conditions optimized by screens varying protein concentration, pH, drug molar ratios, centered on the original crystallization hit using protocols described previously for the monoclinic [Carter, et al., Eur. J. Biochemistry (1994) 226: 1049-1052] and triclinic [Sugo, et al., Protein Eng (1999) 12: 439-446] crystal forms., pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bbagen.2013.06.032",,"4L9Q",134.46,"2.7","2.7","X-ray study of human serum albumin complexed with teniposide","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","4L9Q"
"4L9S",,"X-RAY DIFFRACTION",2.61,52.86,"VAPOR DIFFUSION, HANGING DROP",7.5,"17% PEG8000, 0.1M CaCl2, 0.1M TRIS, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature12796",,"4L9S",19.92,"1.606","1.606","Crystal Structure of H-Ras G12C, GDP-bound","GAMGSMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4L9S"
"4L9U",,"X-RAY DIFFRACTION",2.19,43.9,"VAPOR DIFFUSION, SITTING DROP",3.6,"20 mM sodium acetate, 22% PEG 3350, 100 mM lithium sulfate, 0.4% formamide, pH 3.6, VAPOR DIFFUSION, SITTING DROP, temperature 296K",296,"10.7554/eLife.00813",,"4L9U",13.63,"1.6014","1.6014","Structure of C-terminal coiled coil of RasGRP1","SELRHLRLPTYQELEQEINTLKADNDALKIQLKYAQKKIESLQLEKSNHVLAQMEQ","Homo sapiens","RASGRP1, RASGRP","RAS guanyl-releasing protein 1","1","4L9U"
"4L9W",,"X-RAY DIFFRACTION",2.7,54.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"19% PEG3350, 0.2M CaCl2, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4L9W",19.95,"1.952","1.952","Crystal Structure of H-Ras G12C, GMPPNP-bound","GAMGSMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4L9W"
"4LA0",,"X-RAY DIFFRACTION",2.23,44.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, POTASSIUM PHOSPHATE, Crystals of the complexes were obtained by standard vapor equilibration methods with conditions optimized by screens varying protein concentration, pH, drug molar ratios, centered on the original crystallization hit using protocols described previously for the monoclinic [Carter, et al., Eur. J. Biochemistry (1994) 226: 1049-1052] and triclinic [Sugo, et al., Protein Eng (1999) 12: 439-446] crystal forms., pH 7.5, vapor diffusion, SITTING DROP, temperature 293K",293,"10.1016/j.bbagen.2013.06.032",,"4LA0",134,"2.4","2.4","X-ray study of human serum albumin complexed with bicalutamide","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","4LA0"
"4LAU",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM ammonium citrate, 20% PEG 6000, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb400526n","W8X","4LAU",37.04,"0.843","0.843","Crystal structure of human AR complexed with NADP+ and {2-[(4-bromobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4LAU"
"4LAV",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION",8,"2 M ammonium sulfate, 0.1 M Bis-Tris, pH 6.5, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.jmb.2013.07.041",,"4LAV",55.78,"1.8","1.8","Crystal Structure Analysis of FKBP52, Crystal Form II","GAPLPMEGVDISPKQDEGVLKVIKREGTGTEMPMIGDRVFVHYTGWLLDGTKFDSSLDRKDKFSFDLGKGEVIKAWDIAIATMKVGEVCHITCKPEYAYGSAGSPPKIPPNATLVFEVELFEFKGEDLTEEEDGGIIRRIQTRGEGYAKPNEGAIVEVALEGYYKDKLFDQRELRFEIGEGENLDLPYGLERAIQRMEKGEHSIVYLKPSYAFGSVGKEKFQIPPNAELKYELHLKSFEKAKESWE","Homo sapiens","FKBP4, FKBP52","Peptidyl-prolyl cis-trans isomerase FKBP4","1","4LAV"
"4LAW",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION",8,"25% PEG6000, 0.1 M Tris-HCl, pH 8.0, 5% DMSO, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.jmb.2013.07.041",,"4LAW",56.1,"2.4","2.4","Crystal Structure Analysis of FKBP52, Crystal Form III","GAPLPMEGVDISPKQDEGVLKVIKREGTGTEMPMIGDRVFVHYTGWLLDGTKFDSSLDRKDKFSFDLGKGEVIKAWDIAIATMKVGEVCHITCKPEYAYGSAGSPPKIPPNATLVFEVELFEFKGEDLTEEEDGGIIRRIQTRGEGYAKPNEGAIVEVALEGYYKDKLFDQRELRFEIGEGENLDLPYGLERAIQRMEKGEHSIVYLKPSYAFGSVGKEKFQIPPNAELKYELHLKSFEKAKESWE","Homo sapiens","FKBP4, FKBP52","Peptidyl-prolyl cis-trans isomerase FKBP4","1","4LAW"
"4LAX",,"X-RAY DIFFRACTION",2.62,53.03,"VAPOR DIFFUSION",8,"25% PEG6000, 0.1 M Tris-HCl, pH 8.0, 5% DMSO, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.jmb.2013.07.041",,"4LAX",31.8,"2.007","2.007","Crystal Structure Analysis of FKBP52, Complex with FK506","MSYYHHHHHHDYDIPTTENLYFQGAPLPMEGVDISPKQDEGVLKVIKREGTGTEMPMIGDRVFVHYTGWLLDGTKFDSSLDRKDKFSFDLGKGEVIKAWDIAIATMKVGEVCHITCKPEYAYGSAGSPPKIPPNATLVFEVELFEFKGEDLTEEEDGGIIRRIQTRGEGYAKPNEGAIVEVALEGYYKDKLFDQRELRFEIGEGENLDLPYGLERAIQRMEKGEHSIVYLKPSYAFGSVGKEKFQIPPNAELKYELHLKSFEKAKESWE","Homo sapiens","FKBP4, FKBP52","Peptidyl-prolyl cis-trans isomerase FKBP4","1","4LAX"
"4LAY",,"X-RAY DIFFRACTION",2.38,48.22,"VAPOR DIFFUSION",8,"25% PEG6000, 0.1 M Tris-HCl, pH 8.0, 4% DMSO, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.jmb.2013.07.041","I63","4LAY",31.95,"1.7","1.7","Crystal Structure Analysis of FKBP52, Complex with I63","MGSSHHHHHHSSGLVPRGSHMTAEEMKATESGAQSAPLPMEGVDISPKQDEGVLKVIKREGTGTEMPMIGDRVFVHYTGWLLDGTKFDSSLDRKDKFSFDLGKGEVIKAWDIAIATMKVGEVCHITCKPEYAYGSAGSPPKIPPNATLVFEVELFEFKGEDLTEEEDGGIIRRIQTRGEGYAKPNEGAIVEVALEGYYKDKLFDQRELRFEIGEGENLDLPYGLERAIQRMEKGEHSIVYLKPSYAFGSVGKEKFQIPPNAELKYELHLKSFEKAKESWE","Homo sapiens","FKBP4, FKBP52","Peptidyl-prolyl cis-trans isomerase FKBP4","1","4LAY"
"4LAZ",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM ammonium citrate, 20% PEG 6000, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb400526n","1WW","4LAZ",37.09,"0.85","0.85","Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(4-iodobenzyl)carbamoyl]phenoxy}acetic acid","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4LAZ"
"4LB1",,"X-RAY DIFFRACTION",3.11,60.43,"VAPOR DIFFUSION, HANGING DROP",8.5,"2 M ammonium phosphate monobasic, 0.1 M Tris-HCl pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1371/journal.pone.0078937",,"4LB1",13.14,"2","2","Crystal structure of human alpha-defensin 1 (HNP1) Y16A/F28A mutant","ACYCRIPACIAGERRAGTCIYQGRLWAACC","Homo sapiens","DEFA1, DEF1, DEFA2, MRS, DEFA1B","Neutrophil defensin 1","1","4LB1"
"4LB2",,"X-RAY DIFFRACTION",2.28,46.11,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, POTASSIUM PHOSPHATE, Crystals of the complexes were obtained by standard vapor equilibration methods with conditions optimized by screens varying protein concentration, pH, drug molar ratios, centered on the original crystallization hit using protocols described previously for the monoclinic [Carter, et al., Eur. J. Biochemistry (1994) 226: 1049-1052] and triclinic [Sugo, et al., Protein Eng (1999) 12: 439-446] crystal forms., pH 7.5, vapor diffusion, SITTING DROP, temperature 293K",293,"10.1016/j.bbagen.2013.06.032",,"4LB2",135.13,"2.8","2.8","X-ray study of human serum albumin complexed with idarubicin","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","4LB2"
"4LB3",,"X-RAY DIFFRACTION",2.16,43.16,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM ammonium citrate, 20% PEG 6000, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb400526n","M15","4LB3",37.11,"0.8","0.8","Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2-fluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4LB3"
"4LB4",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM ammonium citrate, 20% PEG 6000, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb400526n","1WX","4LB4",37.11,"0.8","0.8","Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4LB4"
"4LB7",,"X-RAY DIFFRACTION",2.71,54.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8 M sodium phosphate monobasic, 0.8 M potassium phosphate monobasic, 0.1 M HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1371/journal.pone.0078937",,"4LB7",12.8,"1.902","1.902","Crystal structure of human alpha-defensin 1 (HNP1) Y16A/I20A/L25A/F28A mutant.","ACYCRIPACIAGERRAGTCAYQGRAWAACC","Homo sapiens","DEFA1, DEF1, DEFA2, MRS, DEFA1B","Neutrophil defensin 1","1","4LB7"
"4LB9",,"X-RAY DIFFRACTION",2.41,48.89,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, POTASSIUM PHOSPHATE, Crystals of the complexes were obtained by standard vapor equilibration methods with conditions optimized by screens varying protein concentration, pH, drug molar ratios, centered on the original crystallization hit using protocols described previously for the monoclinic [Carter, et al., Eur. J. Biochemistry (1994) 226: 1049-1052] and triclinic [Sugo, et al., Protein Eng (1999) 12: 439-446] crystal forms., pH 7.5, vapor diffusion, SITTING DROP, temperature 293K",293,"10.1016/j.bbagen.2013.06.032",,"4LB9",68.07,"2.7","2.7","X-ray study of human serum albumin complexed with etoposide","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","4LB9"
"4LBB",,"X-RAY DIFFRACTION",2.12,41.86,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG 4000, 0.1 M Tris-HCl pH 8.5, 0.2 M lithium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1371/journal.pone.0078937",,"4LBB",7.03,"1.719","1.719","Crystal structure of human alpha-defensin 1 (HNP1) I20A mutant","ACYCRIPACIAGERRYGTCAYQGRLWAFCC","Homo sapiens","DEFA1, DEF1, DEFA2, MRS, DEFA1B","Neutrophil defensin 1","1","4LBB"
"4LBD",,"X-RAY DIFFRACTION",2.36,33,,7,"pH 7.0",,"10.1038/nsb0398-199",,"4LBD",30.59,"2.5","2.5","LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO THE SYNTHETIC AGONIST BMS961","MGSSHHHHHHSSGLVPRGSHMDSYELSPQLEELITKVSKAHQETFPSLCQLGKYTTNSSADHRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERAITLKMEIPGPMPPLIREMLENPEMFE","Homo sapiens","HRARGAMMA, RARG, NR1B3","RETINOIC ACID RECEPTOR GAMMA","1","4LBD"
"4LBF",,"X-RAY DIFFRACTION",1.82,32.58,"VAPOR DIFFUSION, HANGING DROP",8.5,"2 M ammonium sulfate, 0.1 M Tris-HCl pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1371/journal.pone.0078937",,"4LBF",27.04,"1.7","1.7","Crystal structure of HUMAN ALPHA-DEFENSIN 1 (HNP1) I20A/L25A mutant","ACYCRIPACIAGERRYGTCAYQGRAWAFCC","Homo sapiens","DEFA1, DEF1, DEFA2, MRS, DEFA1B","Neutrophil defensin 1","1","4LBF"
"4LBJ",,"X-RAY DIFFRACTION",2.09,41.01,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG 6000, 100MM MGCL2, 8MM BETA MERCEPTOETHANOL, 100MM TRIS HCL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2013.12.004",,"4LBJ",16.46,"1.8","1.8","Crystal structure of Human galectin-3 CRD K176L mutant in complex with LNT","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTLLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4LBJ"
"4LBK",,"X-RAY DIFFRACTION",2.05,39.92,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG 6000, 100MM MGCL2, 8MM BETA MERCEPTOETHANOL, 100MM TRIS HCL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2013.12.004",,"4LBK",16.46,"1.6","1.6","Crystal structure of Human galectin-3 CRD K176L mutant in complex with LNnT","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTLLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4LBK"
"4LBL",,"X-RAY DIFFRACTION",2.06,40.19,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG 6000, 100MM MGCL2, 8MM BETA MERCEPTOETHANOL, 100MM TRIS HCL, pH 7.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.jmb.2013.12.004",,"4LBL",16.42,"1.58","1.58","Crystal structure of Human galectin-3 CRD K176L mutant in complex with a-GM3","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTLLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4LBL"
"4LBM",,"X-RAY DIFFRACTION",2.15,42.81,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG 6000, 100MM MGCL2, 8MM BETA MERCEPTOETHANOL, 100MM TRIS HCL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2013.12.004",,"4LBM",16.64,"1.55","1.55","Crystal structure of Human galectin-3 CRD in complex with LNT","GPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4LBM"
"4LBN",,"X-RAY DIFFRACTION",2.13,42.29,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG 6000, 100MM MGCL2, 8MM BETA MERCEPTOETHANOL, 100MM TRIS HCL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2013.12.004",,"4LBN",16.61,"1.7","1.7","Crystal structure of Human galectin-3 CRD in complex with LNnT","GPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4LBN"
"4LBO",,"X-RAY DIFFRACTION",2.19,43.84,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG 6000, 100MM MGCL2, 8MM BETA MERCEPTOETHANOL, 100MM TRIS HCL, pH 7.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.jmb.2013.12.004",,"4LBO",16.44,"1.65","1.65","Crystal structure of Human galectin-3 CRD in complex with a-GM3","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4LBO"
"4LBR",,"X-RAY DIFFRACTION",2.16,43.09,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM ammonium citrate, 20% PEG 6000, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb400526n","4O9","4LBR",37.12,"0.8","0.8","Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2,6-difluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4LBR"
"4LBS",,"X-RAY DIFFRACTION",2.17,43.34,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM ammonium citrate, 20% PEG 6000, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb400526n","4O8","4LBS",37.08,"0.76","0.76","Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4LBS"
"4LC2",,"X-RAY DIFFRACTION",2.48,50.45,"VAPOR DIFFUSION, SITTING DROP",7.8,"20% PEG3350  
0.1 M bis tris propane, 10% ethylene glycol  
0.15 M sodium nitrate, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4LC2",13.83,"1.65","1.65","Crystal structure of the bromodomain of human BRPF1B","SMEMQLTPFLILLRKTLEQLQEKDTGNIFSEPVPLSEVPDYLDHIKKPMDFFTMKQNLEAYRYLNFDDFEEDFNLIVSNCLKYNAKDTIFYRAAVRLREQGGAVLRQARRQAEKMG","Homo sapiens","BR140, BRPF1, BRPF1B","Peregrin","1","4LC2"
"4LC7",,"X-RAY DIFFRACTION",2.15,42.85,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M NaAcetate pH 4.5, 5% DMSO, VAPOR DIFFUSION, HANGING DROP, temperature 279K",279,,"1WP","4LC7",45.83,"1.7","1.7","Aminooxazoline inhibitor of BACE-1","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-Secretase-1","1","4LC7"
"4LCE",,"X-RAY DIFFRACTION",2.42,49.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"250 mM magnesium chloride, 140 mM sodium formate, 100 mM hepes, 2.5 mM NAD+, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.febslet.2014.03.026","KMT","4LCE",38.95,"2.38","2.38","CtBP1 in complex with substrate MTOB","MGSSHHHHHHSSGLVPRGSHMPLVALLDGRDCTVEMPILKDVATVAFCDAQSTQEIHEKVLNEAVGALMYHTITLTREDLEKFKALRIIVRIGSGFDNIDIKSAGDLGIAVCNVPAASVEETADSTLCHILNLYRRATWLHQALREGTRVQSVEQIREVASGAARIRGETLGIIGLGRVGQAVALRAKAFGFNVLFYDPYLSDGVERALGLQRVSTLQDLLFHSDCVTLHCGLNEHNHHLINDFTVKQMRQGAFLVNTARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFSQGPLKDAPNLICTPHAAWYSEQASIEMREEAAREIRRAITGRIPDSLKNCVNK","Homo sapiens","CTBP, CTBP1","C-terminal-binding protein 1","1","4LCE"
"4LCJ",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, HANGING DROP",7,"200 mM potassium nitrate, 15-20% PEG 3350, 100 mM bis tris propane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.febslet.2014.03.026","KMT","4LCJ",314.65,"2.86","2.86","CtBP2 in complex with substrate MTOB","GSHMASMTGGQQMGRGSHPRPLVALLDGRDCTVEMPILKDLATVAFCDAQSTQEIHEKVLNEAVGAMMYHTITLTREDLEKFKALRVIVRIGSGYDNVDIKAAGELGIAVCNIPSAAVEETADSTICHILNLYRRNTWLYQALREGTRVQSVEQIREVASGAARIRGETLGLIGFGRTGQAVAVRAKAFGFSVIFYDPYLQDGIERSLGVQRVYTLQDLLYQSDCVSLHCNLNEHNHHLINDFTIKQMRQGAFLVNAARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFAQGPLKDAPNLICTPHTAWYSEQASLEMREAAATEIRRAITGRIPESLRNCVNKEFF","Homo sapiens","CTBP2","C-terminal-binding protein 2","1","4LCJ"
"4LD6",,"X-RAY DIFFRACTION",1.94,36.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% PEG3350, 0.2 M ammonium acetate, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4LD6",13.36,"1.7","1.7","PWWP domain of human PWWP Domain-Containing Protein 2B","GQSVSECITEDGRTVAVGDIVWGKIHGFPWWPARVLDISLGQKEDGEPSWREAKVSWFGSPTTSFLSISKLSPFSEFFKLRFNRKKKGMYRKAITEAANAARHVAPEIRELLTQFET","Homo sapiens","PWWP2B, PWWP2","PWWP domain-containing protein 2B","1","4LD6"
"4LDJ",,"X-RAY DIFFRACTION",1.88,34.47,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Sodium Acetate pH4.5, 0.1M Tris pH 8.5, 28% PEG 3350, Vapor Diffusion, Hanging Drop, temperature 293K, VAPOR DIFFUSION, HANGING DROP",293,"10.1073/pnas.1404639111",,"4LDJ",19.84,"1.15","1.15","Crystal Structure of a GDP-bound G12C Oncogenic Mutant of Human GTPase KRas","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4LDJ"
"4LDK",,"X-RAY DIFFRACTION",2.06,40.28,"VAPOR DIFFUSION",6.5,"VAPOR DIFFUSION, Hanging drop, pH 6.5, temperature 298K",298,,,"4LDK",15.89,"2.04","2.04","FAD-linked sulfhydryl oxidase ALR mutation","SMRTQQKRDTKFREDCPPDREELGRHSWAVLHTLAAYYPDLPTPEQQQDMAQFIHLFSKFYPAEECAEDLRKRLARNHPDTRTRAAFTQWLCHLHNEVNRKLGKPDFDCSKVDERWRDGWKDGSCD","Homo sapiens","GFER, ALR, HERV1, HPO","FAD-linked sulfhydryl oxidase ALR","1","4LDK"
"4LDQ",,"X-RAY DIFFRACTION",2.28,46.03,,,,,"10.1021/bi400556e",,"4LDQ",78.39,"2.496","2.496","Crystal Structure of the Mediator of Rho Dependent Invasion","MTLEAIRYSRGSLQILDQLLLPKQSRYEAVGSVHQAWEAIRAMKVRGAPAIALVGCLSLAVELQAGAGGPGLAALVAFVRDKLSFLVTARPTAVNMARAARDLADVAAREAEREGATEEAVRERVICCTEDMLEKDLRDNRSIGDLGARHLLERVAPSGGKVTVLTHCNTGALATAGYGTALGVIRSLHSLGRLEHAFCTETRPYNQGARLTAFELVYEQIPATLITDSMVAAAMAHRGVSAVVVGADRVVANGDTANKVGTYQLAIVAKHHGIPFYVAAPSSSCDLRLETGKEIIIEERPGQELTDVNGVRIAAPGIGVWNPAFDVTPHDLITGGIITELGVFAPEELRTALTTTISSRDGTLDGPQM","Homo sapiens","MRI1, MRDI, UNQ6390/PRO21135","Methylthioribose-1-phosphate isomerase","1","4LDQ"
"4LDR",,"X-RAY DIFFRACTION",2.23,44.76,,,,,"10.1021/bi400556e",,"4LDR",78.54,"2.292","2.292","Structure of the S283Y mutant of MRDI","MTLEAIRYSRGSLQILDQLLLPKQSRYEAVGSVHQAWEAIRAMKVRGAPAIALVGCLSLAVELQAGAGGPGLAALVAFVRDKLSFLVTARPTAVNMARAARDLADVAAREAEREGATEEAVRERVICCTEDMLEKDLRDNRSIGDLGARHLLERVAPSGGKVTVLTHCNTGALATAGYGTALGVIRSLHSLGRLEHAFCTETRPYNQGARLTAFELVYEQIPATLITDSMVAAAMAHRGVSAVVVGADRVVANGDTANKVGTYQLAIVAKHHGIPFYVAAPSYSCDLRLETGKEIIIEERPGQELTDVNGVRIAAPGIGVWNPAFDVTPHDLITGGIITELGVFAPEELRTALTTTISSRDGTLDGPQM","Homo sapiens","MRI1, MRDI, UNQ6390/PRO21135","Methylthioribose-1-phosphate isomerase","1","4LDR"
"4LEC",,"X-RAY DIFFRACTION",3.24,62.04,"VAPOR DIFFUSION, HANGING DROP",7,"15% PEG 3350, 0.1 M Succinate Acid, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4LEC",48.54,"2.28","2.28","Human Methyltransferase-Like Protein 21A","GETTEFGLQKFHKPLATFSFANHTIQIRQDWRHLGVAAVVWDAAIVLSTYLEMGAVELRGRSAVELGAGTGLVGIVAALLGAHVTITDRKVALEFLKSNVQANLPPHIQTKTVVKELTWGQNLGSFSPGEFDLILGADIIYLEETFTDLLQTLEHLCSNHSVILLACRIRYERDNNFLAMLERQFTVRKVHYDPEKDVHIYEAQKRNQKEDL","Homo sapiens","METTL21A, FAM119A, HCA557B","Protein-lysine methyltransferase METTL21A","1","4LEC"
"4LEV",,"X-RAY DIFFRACTION",2.33,47.11,"VAPOR DIFFUSION, HANGING DROP",6,"20-30% Jeffamine M-600, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.immuni.2013.10.019",,"4LEV",86.9,"1.952","1.952","Structure of human cGAS","FELDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","4LEV"
"4LEW",,"X-RAY DIFFRACTION",2.32,46.9,"VAPOR DIFFUSION, HANGING DROP",7,"15-20% PEG 3350, 0.2 M A.S., pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.immuni.2013.10.019",,"4LEW",86.12,"2.04","2.04","Structure of human cGAS","DAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","4LEW"
"4LFV",,"X-RAY DIFFRACTION",2.39,48.62,"VAPOR DIFFUSION, SITTING DROP",7.5,"30% PEG400, 0.2 M magnesium chloride, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295.15K",295.15,"10.1107/S2053230X14002106","YS4","4LFV",43.85,"2","2","Crystal structure of human FPPS in complex with YS0470 and two molecules of inorganic phosphate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4LFV"
"4LG1",,"X-RAY DIFFRACTION",2.98,58.71,"VAPOR DIFFUSION, HANGING DROP",6.5,"23% PEG 3350, 0.2 M Lithium Sulfate, 0.1 M BisTris pH6.5, vapor diffusion hanging drop, temperature 291K",291,,,"4LG1",77.02,"1.8","1.8","Human Methyltransferase-Like Protein 21D","GSSLEDPLRSFVRVLEKRDGTVLRLQQYSSGGVGCVVWDAAIVLSKYLETPEFSGDGAHALSRRSVLELGSGTGAVGLMAATLGADVVVTDLEELQDLLKMNINMNKHLVTGSVQAKVLKWGEEIEGFPSPPDFILMADCIYYEESLEPLLKTLKDISGFETCIICCYEQRTMGKNPEIEKKYFELLQLDFDFEKIPLEKHDEEYRSEDIHIIYIRKKKSKFPS","Homo sapiens","METTL21D, C14orf138, VCPKMT","Protein-lysine methyltransferase METTL21D","1","4LG1"
"4LG4",,"X-RAY DIFFRACTION",2.73,54.92,,7.7,"0.2 M sodium citrate, 15% (w/v) PEG 3350, 0.1 M HEPES, pH 7.7, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.str.2013.07.008",,"4LG4",204.2,"2.42","2.42","Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5","GEDSLTKQPEEVFDVLEKLGEGSYGSVFKAIHKESGQVVAIKQVPVESDLQEIIKEISIMQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLIEDEIATILKSTLKGLEYLHFMRKIHRNIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKNPEQRATATQLLQHPFIKNAKPVSILRDLITEAMEIKAKRHEEQQRELEEEE","Homo sapiens","STK3, KRS1, MST2","Serine/threonine-protein kinase 3","1","4LG4"
"4LG7",,"X-RAY DIFFRACTION",2.7,54.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"30% PEG400, 5% MPD, 0.2 M sodium chloride, 0.1 M HEPES. protein:dna 1:1.2., pH 7.5, vapor diffusion, sitting drop, temperature 291K",291,,,"4LG7",15.18,"2.5","2.5","Crystal structure MBD4 MBD domain in complex with methylated CpG DNA","GRKSVPCGWERVVKQRLFGKTAGRFDVYFISPQGLKFRSKSSLANYLHKNGETSLKPEDFDFTVLSKR","Homo sapiens","MBD4, MED1","Methyl-CpG-binding domain protein 4","1","4LG7"
,,,,,,,,,,,,,,,,"GCCAACGTTGGC",,,"DNA (5'-D(*GP*CP*CP*AP*AP*(5CM)P*GP*TP*TP*GP*GP*C)-3')","2","4LG7"
"4LG8",,"X-RAY DIFFRACTION",2.2,44.2,"VAPOR DIFFUSION",,"20% PEG-3350, 0.2 M disodium tartrate, vapor diffusion, temperature 291K",291,"10.1016/j.bbrc.2017.09.145",,"4LG8",39.11,"1.89","1.89","Crystal structure of PRPF19 WD40 repeats","MHHHHHHSSGRENLYFQGTPEIIQKLQDKATVLTTERKERGKTVPEELVKPEELSKYRQVASHVGLHSASIPGILALDLCPSDTNKILTGGADKNVVVFDKSSEQILATLKGHTKKVTSVVFHPSQDLVFSASPDATIRIWSVPNASCVQVVRAHESAVTGLSLHATGDYLLSSSDDQYWAFSDIQTGRVLTKVTDETSGCSLTCAQFHPDGLIFGTGTMDSQIKIWDLKERTNVANFPGHSGPITSIAFSENGYYLATAADDSSVKLWDLRKLKNFKTLQLDNNFEVKSLIFDQSGTYLALGGTDVQIYICKQWTEILHFTEHSGLTTGVAFGHHAKFIASTGMDRSLKFYSL","Homo sapiens","PRPF19, NMP200, PRP19, SNEV","Pre-mRNA-processing factor 19","1","4LG8"
"4LG9",,"X-RAY DIFFRACTION",2.86,56.95,"VAPOR DIFFUSION",,"vapor diffusion",,,,"4LG9",43.65,"2.28","2.28","Crystal structure of TBL1XR1 WD40 repeats","MGSSHHHHHHSSGLVPRGSEENGAHTIANNHTDMMEVDGDVEIPPNKAVVLRGHESEVFICAWNPVSDLLASGSGDSTARIWNLSENSTSGSTQLVLRHCIREGGQDVPSNKDVTSLDWNSEGTLLATGSYDGFARIWTKDGNLASTLGQHKGPIFALKWNKKGNFILSAGVDKTTIIWDAHTGEAKQQFPFHSAPALDVDWQSNNTFASCSTDMCIHVCKLGQDRPIKTFQGHTNEVNAIKWDPTGNLLASCSDDMTLKIWSMKQDNCVHDLQAHNKEIYTIKWSPTGPGTNNPNANLMLASASFDSTVRLWDVDRGICIHTMTKHQEPVYSVAFSPDGRYLASGSFDKCVHIWNTQTGALVHSYRGTGGIFEVCWNAAGDKVGASASDGSVCVLDLRK","Homo sapiens","TBL1XR1, IRA1, TBLR1","F-box-like/WD repeat-containing protein TBL1XR1","1","4LG9"
"4LGE",,"X-RAY DIFFRACTION",2.44,49.64,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M NaCl,1OOmM Tris,0.2M MgCl2, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.bmc.2013.07.020","1Y0","4LGE",27.8,"1.55","1.55","Crystal structure of clAP1 BIR3 bound to T3261256","MGSSHHHHHHSSGENLYFQGGSSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRY","Homo sapiens","API1, BIRC2, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","4LGE"
"4LGU",,"X-RAY DIFFRACTION",2.43,49.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"3.0M NaCl,100mM Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.bmc.2013.07.020","1YH","4LGU",27.77,"2","2","Crystal structure of clAP1 BIR3 bound to T3226692","MGSSHHHHHHSSGENLYFQGGSSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRY","Homo sapiens","API1, BIRC2, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","4LGU"
"4LHI",,"X-RAY DIFFRACTION",2.1,40,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M sodium BICINE (pH 9), 2M sodium malonate (pH 7), VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4LHI",29.81,"1.6","1.6","Crystal structure of human carbonic anhydrase isozyme II with 5-(phenylsulfonyl)thiophene-2-sulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4LHI"
"4LHV",,"X-RAY DIFFRACTION",2.36,47.96,"VAPOR DIFFUSION, HANGING DROP",7,"All crystals were obtained by mixing 1 ul protein and 1 ul reservoir solution. Crystals of Rab8a6-176:GDP were obtained by mixing of 1 ul  protein (20 mg/ml, buffer: 25 mM HEPES pH 7.5, 40 mM NaCl, 1 mM MgCl2, 10   M GDP and 5 mM   beta-mercaptoethanol) with 1 ul of reservoir consisting of 16% (w/v) PEG4000, 0.1 M CaAc2, 0.1 M HEPES. The crystal was protected with cryo solution containing 30% (w/v) PEG4000, 0.1 M CaAc2, 0.1 M HEPES pH 7.0 before data collection, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.498329","GDP","4LHV",102.18,"1.95","1.95","Crystal structure of Rab8 in its inactive GDP-bound form","GSHDYLFKLLLIGDSGVGKTCVLFRFSEDAFNSTFISTIGIDFKIRTIELDGKRIKLQIWDTAGQERFRTITTAYYRGAMGIMLVYDITNEKSFDNIRNWIRNIEEHASADVEKMILGNKCDVNDKRQVSKERGEKLALDYGIKFMETSAKANINVENAFFTLARDIKAKMDKK","Homo sapiens","RAB8A, MEL, RAB8","Ras-related protein Rab-8A","1","4LHV"
"4LHW",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, HANGING DROP",6.8,"Rab8a6-176:GppNHp (15 mg/ml; buffer: 25 mM HEPES, 40 mM NaCl, 1 mM MgCl2, 10   M GppNHp and 5 mM   -mercaptoethanol) crystals were produced in 15% (w/v) PEG8000, 7.5 %(v/v) MPD, 0.1 M HEPES, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.498329",,"4LHW",102.69,"1.55","1.55","Crystal structure of Rab8 in its active GppNHp-bound form","GSHDYLFKLLLIGDSGVGKTCVLFRFSEDAFNSTFISTIGIDFKIRTIELDGKRIKLQIWDTAGQERFRTITTAYYRGAMGIMLVYDITNEKSFDNIRNWIRNIEEHASADVEKMILGNKCDVNDKRQVSKERGEKLALDYGIKFMETSAKANINVENAFFTLARDIKAKMDKK","Homo sapiens","RAB8A, MEL, RAB8","Ras-related protein Rab-8A","1","4LHW"
"4LI5",,"X-RAY DIFFRACTION",3.66,66,"VAPOR DIFFUSION",4.6,"The protein at 6 mg/ml was crystallized from 0.2 M NH4Cl, 1.2 M Na-K-tartrate buffered with 10mM acetate at pH 4.6 and 0.15M Hepes pH 7.0, VAPOR DIFFUSION, temperature 293K",293,"10.1021/jm400822z","1WY","4LI5",37.84,"2.64","2.64","EGFR-K IN COMPLEX WITH N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] Prop-2-enamide","GSMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQ","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4LI5"
"4LI6",,"X-RAY DIFFRACTION",2.4,48.81,"VAPOR DIFFUSION, HANGING DROP",5.8,"EQUAL VOLUMES (2 UL) OF RESERVIOR SOLUTION AND PROTEIN SOLUTION WERE MIXED AND SET AS HANGING DROPS. 15% PEG3350, 100MM BIS-TRIS PH5.8, 310MM AMMONIUM SULFATE. PROTEIN SOLUTION: 20 MG/ML IN 25 MM TRIS PH8, 200MM NACL, 1MM TCEP, 1MM PJ34. CRYSTALS WERE THEN MOVED INTO A SOAKING SOLUTION CONTAINING 18% PEG 3350, 320MM AMMONIUM SULFATE, 100MM BIS-TRIS PH 5.8, 0.2 MM inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm400807n","1XO","4LI6",52.24,"2.05","2.05","TANKYRASE-1 Complexed with small molecule inhibitor N-[(4-oxo-3,4-dihydroquinazolin-2-yl)methyl]-3-phenyl-N-(thiophen-2-ylmethyl)propanamide","GGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQKT","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4LI6"
"4LI7",,"X-RAY DIFFRACTION",2.35,47.73,"VAPOR DIFFUSION, SITTING DROP",6.2,"17% PEG 3350, 100mM bis-tris, pH 6.2, 100 mM Ammonium Sulfate, 9 mg/ml TNKS1, 1 mM inhibitor, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm400807n","1XP","4LI7",52.23,"2.2","2.2","TANKYRASE-1 complexed with small molecule inhibitor 4-chloro-5-cyano-N-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-2-methoxybenzamide","GGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQKT","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4LI7"
"4LI8",,"X-RAY DIFFRACTION",2.33,47.18,"VAPOR DIFFUSION, HANGING DROP",5.8,"EQUAL VOLUMES (2 UL) OF RESERVIOR SOLUTION AND PROTEIN SOLUTION WERE MIXED AND SET AS HANGING DROPS. 15% PEG3350, 100MM BIS-TRIS PH5.8, 310MM AMMONIUM SULFATE.  PROTEIN SOLUTION: 20 MG/ML IN 25 MM TRIS PH8, 200MM NACL, 1MM TCEP, 1MM PJ34. CRYSTALS WERE THEN MOVED INTO A SOAKING SOLUTION CONTAINING 18% PEG 3350, 320MM AMMONIUM SULFATE, 100MM BIS- TRIS PH 5.8, 0.2 MM inhibitor. , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm400807n","1XQ","4LI8",52.38,"2.521","2.521","TANKYRASE-1 complexed with small molecule inhibitor 2-[4-(4-fluorobenzoyl)piperidin-1-yl]-N-[(4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrimidin-2-yl)methyl]-N-(thiophen-2-ylmethyl)acetamide","GGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQKT","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4LI8"
"4LII",,"X-RAY DIFFRACTION",2.44,49.58,"VAPOR DIFFUSION, SITTING DROP",6,"20.00% polyethylene glycol 6000, 0.1M MES pH 6.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4LII",57.13,"1.88","1.88","Crystal structure of an apoptosis-inducing factor, mitochondrion-associated, 1 (AIFM1) from Homo sapiens at 1.88 A resolution","GSGLGLTPEQKQKKAALSASEGEEVPQDKAPSHVPFLLIGGGTAAFAAARSIRARDPGARVLIVSEDPELPYMRPPLSKELWFSDDPNVTKTLRFKQWNGKERSIYFQPPSFYVSAQDLPHIENGGVAVLTGKKVVQLDVRDNMVKLNDGSQITYEKCLIATGGTPRSLSAIDRAGAEVKSRTTLFRKIGDFRSLEKISREVKSITIIGGGFLGSELACALGRKARALGTEVIQLFPEKGNMGKILPEYLSNWTMEKVRREGVKVMPNAIVQSVGVSSGKLLIKLKDGRKVETDHIVAAVGLEPNVELAKTGGLEIDSDFGGFRVNAELQARSNIWVAGDAACFYDIKLGRRRVEHHDHAVVSGRLAGENMTGAAKPYWHQSMFWSDLGPDVGYEAIGLVDSSLPTVGVFAKATAQDNPKSATEQSGTGIRSESETESEASEITIPPSTPAVPQAPVQGEDYGKGVIFYLRDKVVVGIVLWNIFNRMPIARKIIKDGEQHEDLNEVAKLFNIH","Homo sapiens","AIF, AIFM1, BC111065, PDCD8","Apoptosis-inducing factor 1, mitochondrial","1","4LII"
"4LIJ",,"X-RAY DIFFRACTION",2.66,53.84,"VAPOR DIFFUSION, SITTING DROP",8.5,"20.00% Glycerol, 1.60M ammonium dihydrogen phosphate, 0.1M TRIS pH 8.5, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4LIJ",29.94,"1.8","1.8","Crystal structure of a far upstream element (FUSE) binding protein 1 (FUBP1) from Homo sapiens at 1.95 A resolution","GGTQLPPMHQQQRSVMTEEYKVPDGMVGFIIGRGGEQISRIQQESGCKIQIAPDSGGLPERSCMLTGTPESVQSAKRLLDQIVEKGRPAP","Homo sapiens","BC017247, FUBP1","Far upstream element-binding protein 1","1","4LIJ"
"4LIK",,"X-RAY DIFFRACTION",2.84,56.7,"VAPOR DIFFUSION, SITTING DROP",8,"200 mM Sodium Citrate and 20% PEG3350, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1016/j.jmb.2013.11.007",,"4LIK",47.11,"1.7","1.7","Crystal structure of the catalytic subunit of human primase","GPGSMETFDPTELPELLKLYYRRLFPYSQYYRWLNYGGVIKNYFQHREFSFTLKDDIYIRYQSFNNQSDLEKEMQKMNPYKIDIGAVYSHRPNQHNTVKLGAFQAQEKELVFDIDMTDYDDVRRCCSSADICPKCWTLMTMAIRIIDRALKEDFGFKHRLWVYSGRRGVHCWVCDESVRKLSSAVRSGIVEYLSLVKGGQDVKKKVHLSEKIHPFIRKSINIIKKYFEEYALVNQDILENKESWDKILALVPETIHDELQQSFQKSHNSLQRWEHLKKVASRYQNNIKNDKYGPWLEWEIMLQYCFPRLDINVSKGINHLLKSPFSVHPKTGRISVPIDLQKVDQFDPFTVPTISFICRELDATRDYKKTSLAPYVKVFEHFLENLDKSRKG","Homo sapiens","PRIM1","DNA primase small subunit","1","4LIK"
"4LIL",,"X-RAY DIFFRACTION",2.52,51.15,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M K/Na Tartrate and 20% PEG 3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1016/j.jmb.2013.11.007","UTP","4LIL",47.13,"2.6","2.6","Crystal structure of the catalytic subunit of human primase bound to UTP and Mn","GPGSMETFDPTELPELLKLYYRRLFPYSQYYRWLNYGGVIKNYFQHREFSFTLKDDIYIRYQSFNNQSDLEKEMQKMNPYKIDIGAVYSHRPNQHNTVKLGAFQAQEKELVFDIDMTDYDDVRRCCSSADICPKCWTLMTMAIRIIDRALKEDFGFKHRLWVYSGRRGVHCWVCDESVRKLSSAVRSGIVEYLSLVKGGQDVKKKVHLSEKIHPFIRKSINIIKKYFEEYALVNQDILENKESWDKILALVPETIHDELQQSFQKSHNSLQRWEHLKKVASRYQNNIKNDKYGPWLEWEIMLQYCFPRLDINVSKGINHLLKSPFSVHPKTGRISVPIDLQKVDQFDPFTVPTISFICRELDATRDYKKTSLAPYVKVFEHFLENLDKSRKG","Homo sapiens","PRIM1","DNA primase small subunit","1","4LIL"
"4LIR",,"X-RAY DIFFRACTION",2.19,43.9,"VAPOR DIFFUSION, SITTING DROP",4,"20.0% MPD, 0.1M Citrate pH 4.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4LIR",26.27,"2.46","2.46","Crystal structure of a nucleoporin 35kDa (NUP35) from Homo sapiens at 2.46 A resolution","GSPAQLDPFYTQGDSLTSEDHLDDSWVTVFGFPQASASYILLQFAQYGNILKHVMSNTGNWMHIRYQSKLQARKALSKDGRIFGESIMIGVKPCIDKSVMESSDRCALSSPSLAFTP","Homo sapiens","BC047029, MP44, NUP35, NUP53","Nucleoporin NUP53","1","4LIR"
"4LJM",,"X-RAY DIFFRACTION",6.348,80.625,"VAPOR DIFFUSION, HANGING DROP",4.6,"1.8M Ammonium citrate dibasic, 0.1M Sodium acetate trihydrate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4LJM",21.86,"3","3","Crystal structure of C-terminal RNA recognition motif of human ETR3","GSHMQKEGPEGANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDKQTNLSKCFGFVSYDNPVSAQAAIQAMNGFQIGMKRLKVQLKRSKNDSKPY","Homo sapiens","CELF2, BRUNOL3, CUGBP2, ETR3, NAPOR","CUGBP Elav-like family member 2","1","4LJM"
"4LJN",,"X-RAY DIFFRACTION",2.53,51.29,"VAPOR DIFFUSION",7,"60% tacsimate, pH 7, VAPOR DIFFUSION, temperature 293K",293,"10.1093/nar/gkt931",,"4LJN",15.76,"3","3","Crystal Structure of MOZ double PHD finger","GSHMLELPHEKDKPVAEPIPICSFCLGTKEQNREKKPEELISCADCGNSGHPSCLKFSPELTVRVKALRWQCIECKTCSSCRDQGKNADNMLFCDSCDRGFHMECCDPPLTRMPKGMWICQICRPRKKGRKLLQKK","Homo sapiens","KAT6A, MOZ, MYST3, RUNXBP2, ZNF220","Histone acetyltransferase KAT6A","1","4LJN"
"4LJQ",,"X-RAY DIFFRACTION",2.25,45.34,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1038/nature12638",,"4LJQ",102.14,"2.45","2.45","Crystal structure of the catalytic core of E3 ligase HOIP","GPGPEYQAQGLAMYLQENGIDCPKCKFSYALARGGCMHFHCTQCRHQFCSGCYNAFYAKNKCPEPNCRVKKSLHGHHPRDCLFYLRDWTALRLQKLLQDNNVMFNTEPPAGARAVPGGGCRVIEQKEVPNGLRDEACGKETPAGYAGLCQAHYKEYLVSLINAHSLDPATLYEVEELETATERYLHVRPQPLAGEDPPAYQARLLQKLTEEVPLGQSIPRRRK","Homo sapiens","RNF31, ZIBRA","E3 ubiquitin-protein ligase RNF31","1","4LJQ"
"4LJX",,"X-RAY DIFFRACTION",1.95,36.77,"VAPOR DIFFUSION, SITTING DROP",5,"20.00% PEG-6000, 0.1M Citrate pH 5.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4LJX",32.52,"2.21","2.21","Crystal structure of an AT-rich interactive domain-containing protein 3A (ARID3A) from Homo sapiens at 2.21 A resolution","GQPPDHGDWTYEEQFKQLYELDGDPKRKEFLDDLFSFMQKRGTPVNRIPIMAKQVLDLFMLYVLVTEKGGLVEVINKKLWREITKGLNLPTSITSAAFTLRTQYMEYLYPYECEKRGLSNPNELQAAIDSNRREGRR","Homo sapiens","ARID3A, BC060828, DRIL1, DRIL3, DRX, E2FBP1","AT-rich interactive domain-containing protein 3A","1","4LJX"
"4LK3",,"X-RAY DIFFRACTION",2.47,50.1,,5.4,"0.1 M ammonium sulfate, 0.1 M succinate, 10% DMSO, pH 5.4, Vapor diffusion, hanging drop, temperature 293K",293,"10.1021/bi501357c",,"4LK3",237.1,"2.64","2.64","Crystal structure of Human UDP-xylose synthase R236A substitution","EKDRKRILITGGAGFVGSHLTDKLMMDGHEVTVVDNFFTGRKRNVEHWIGHENFELINHDVVEPLYIEVDQIYHLASPASPPNYMYNPIKTLKTNTIGTLNMLGLAKRVGARLLLASTSEVYGDPEVHPQSEDYWGHVNPIGPRACYDEGKAVAETMCYAYMKQEGVEVRVARIFNTFGPRMHMNDGRVVSNFILQALQGEPLTVYGSGSQTRAFQYVSDLVNGLVALMNSNVSSPVNLGNPEEHTILEFAQLIKNLVGSGSEIQFLSEAQDDPQKRKPDIKKAKLMLGWEPVVPLEEGLNKAIHYFRKELEYQANNQYIPKPKPARIKKGRTRHS","Homo sapiens","UNQ2538/PRO6079, UXS, UXS1","UDP-glucuronic acid decarboxylase 1","1","4LK3"
"4LKC",,"X-RAY DIFFRACTION",2.5,50.89,"VAPOR DIFFUSION, HANGING DROP",5,"12.6% PEG 3350, 0.01 M spermine tetrahydrochloride, 0.0126 M trisodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2013.11.011",,"4LKC",48.13,"2.2","2.2","An Antibody Against the C-terminal Domain of PCSK9 lowers LDL Cholesterol Levels in vivo","AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYLITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab fragment of PCSK9 antibody","1","4LKC"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDTYYPDSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCVREGTYYHDSGSDNYYSYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPSCDKTH","Homo sapiens",,"Fab fragment of PCSK9 antibody","2","4LKC"
"4LKL",,"X-RAY DIFFRACTION",2.03,39.36,"VAPOR DIFFUSION",7.5,"0.2M calcium acetate, 20% PEG3350, pH 7.5, vapor diffusion, temperature 293K",293,"10.1371/journal.pone.0080043",,"4LKL",26.62,"1.58","1.58","Crystal structure of Plk1 Polo-box domain in complex with PL-55","CHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4LKL"
,,,,,,,,,,,,,,,,"XPLHSTMX",,,"PL-55","2","4LKL"
"4LKM",,"X-RAY DIFFRACTION",2.25,45.31,"VAPOR DIFFUSION",4,"0.2M sodium citrate, 500mM ammonium sulfate, pH 4.0, vapor diffusion, temperature 293K",293,"10.1371/journal.pone.0080043",,"4LKM",55.67,"2","2","Crystal structure of Plk1 Polo-box domain in complex with PL-74","DCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLK","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4LKM"
,,,,,,,,,,,,,,,,"XPLHSTMX",,,"PL-74","2","4LKM"
"4LKO",,"X-RAY DIFFRACTION",2.81,56.19,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Bis-Tris-Propane, pH 7.8?, 200 mM MGCL2, 15.9%(W/V) PEG 3350, 15%(V/V) Glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm4008906","1WH","4LKO",169.69,"2.43","2.43","Crystal structure of human DPP-IV in complex with BMS-744891","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","4LKO"
"4LKP",,"X-RAY DIFFRACTION",2.39,48.51,"VAPOR DIFFUSION, HANGING DROP",5.6,"2.0M ammonium sulfate, 300mM Na/K tartrate, 100mM Na citrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M113.514646",,"4LKP",15.76,"1.67","1.67","Crystal Structure of Apo Human Epidermal Fatty Acid Binding Protein (FABP5)","SNAMATVQQLEGRWRLVDSKGFDEYMKELGVGIALRKMGAMAKPDCIITCDGKNLTIKTESTLKTTQFSCTLGEKFEETTADGRKTQTVCNFTDGALVQHQEWDGKESTITRKLKDGKLVVECVMNNVTCTRIYEKVE","Homo sapiens","FABP5","Fatty acid-binding protein, epidermal","1","4LKP"
"4LKQ",,"X-RAY DIFFRACTION",2.06,40.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","1XM","4LKQ",79.36,"1.62","1.62","Crystal structure of PDE10A2 with fragment ZT017","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4LKQ"
"4LKT",,"X-RAY DIFFRACTION",4.03,69.47,"VAPOR DIFFUSION, HANGING DROP",5.6,"2.4M Ammonium Sulfate, 200mM Na/K Tartrate, 100mM Na Citrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M113.514646","EIC","4LKT",64.8,"2.57","2.57","Crystal Structure of Human Epidermal Fatty Acid Binding Protein (FABP5) in Complex with Linoleic Acid","SNAMATVQQLEGRWRLVDSKGFDEYMKELGVGIALRKMGAMAKPDCIITCDGKNLTIKTESTLKTTQFSCTLGEKFEETTADGRKTQTVCNFTDGALVQHQEWDGKESTITRKLKDGKLVVECVMNNVTCTRIYEKVE","Homo sapiens","FABP5","Fatty acid-binding protein, epidermal","1","4LKT"
"4LL0",,"X-RAY DIFFRACTION",2.48,50.44,"VAPOR DIFFUSION, HANGING DROP",9,"0.1M Bicine, 0.5M NaCl, 18% PEG4000, 5mM TCEP, pH 9, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1220050110","YUN","4LL0",76.16,"4","4","EGFR L858R/T790M in complex with PD168393","GSPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4LL0"
"4LL5",,"X-RAY DIFFRACTION",3.3,62.7,"VAPOR DIFFUSION, HANGING DROP",5.5,"100mM CITRATE BUFFER PH 5.5, 200mM NACL, 1M NH4HPO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004713028654",,"4LL5",34.89,"2","2","Crystal Structure of Pim-1 in complex with the fluorescent compound SKF86002","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPSSGENLYFQ","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4LL5"
"4LL9",,"X-RAY DIFFRACTION",2.55,51.72,"VAPOR DIFFUSION, SITTING DROP",6.9,"0.2M NaI, pH 6.9, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1007/s13238-013-3908-x",,"4LL9",65.52,"2.686","2.686","Crystal structure of D3D4 domain of the LILRB1 molecule","VSKKPSLSVQPGPIVAPEETLTLQCGSDAGYNRFVLYKDGERDFLQLAGAQPQAGLSQANFTLGPVSRSYGGQYRCYGAHNLSSEWSAPSDPLDILIAGQFYDRVSLSVQPGPTVASGENVTLLCQSQGWMQTFLLTKEGAADDPWRLRSTYQSQKYQAEFPMGPVTSAHAGTYRCYGSQSSKPYLLTHPSDPLEL","Homo sapiens","LILRB1, ILT2, LIR1, MIR7","Leukocyte immunoglobulin-like receptor subfamily B member 1","1","4LL9"
"4LLA",,"X-RAY DIFFRACTION",2.45,49.82,"VAPOR DIFFUSION, SITTING DROP",8,"3.5M sodium formate, 0.1M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1007/s13238-013-3908-x",,"4LLA",64.57,"2.502","2.502","Crystal structure of D3D4 domain of the LILRB2 molecule","SKKPSLSVQPGPVMAPGESLTLQCVSDVGYDRFVLYKEGERDLRQLPGRQPQAGLSQANFTLGPVSRSYGGQYRCYGAHNLSSECSAPSDPLDILITGQIRGTPFISVQPGPTVASGENVTLLCQSWRQFHTFLLTKAGAADAPLRLRSIHEYPKYQAEFPMSPVTSAHAGTYRCYGSLNSDPYLLSHPSEPLELVVS","Homo sapiens","LILRB2, ILT4, LIR2, MIR10","Leukocyte immunoglobulin-like receptor subfamily B member 2","1","4LLA"
"4LLI",,"X-RAY DIFFRACTION",2.34,47.38,"VAPOR DIFFUSION, HANGING DROP",7,"0.112-0.125 M succinic acid pH 7.0. 16-18% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1371/journal.pone.0082065",,"4LLI",90.33,"2.2","2.2","Crystal Structure of human Myosin 5a globular domain","GPLGSMPRKEKDFQGMLEYKKEDEQKLVKNLILELKPRGVAVNLIPGLPAYILFMCVRHADYLNDDQKVRSLLTSTINSIKKVLKKRGDDFETVSFWLSNTCRFLHCLKQYSGEEGFMKHNTSRQNEHCLTNFDLAEYRQVLSDLAIQIYQQLVRVLENILQPMIVSGMLEHETIQGVSGVKPTGLRKRTSSIADEGTYTLDSILRQLNSFHSVMCQHGMDPELIKQVVKQMFYIIGAITLNNLLLRKDMCSWSKGMQIRYNVSQLEEWLRDKNLMNSGAKETLEPLIQAAQLLQVKKKTDDDAEAICSMCNALTTAQIVKVLNLYTPVNEFEERVSVSFIRTIQMRLRDRKDSPQLLMDAKHIFPVTFPFNPSSLALETIQIPASLGLGFISRV","Homo sapiens","MYH12, MYO5A","Unconventional myosin-Va","1","4LLI"
"4LLJ",,"X-RAY DIFFRACTION",2.05,40.03,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","1XN","4LLJ",79.34,"1.56","1.56","Crystal structure of PDE10A2 with fragment ZT214","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4LLJ"
"4LLK",,"X-RAY DIFFRACTION",2.08,40.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450,0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","MEW","4LLK",79.35,"1.55","1.55","Crystal structure of PDE10A2 with fragment ZT217","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4LLK"
"4LLP",,"X-RAY DIFFRACTION",2.04,39.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","4ZE","4LLP",79.44,"1.75","1.75","Crystal structure of PDE10A2 with fragment ZT401","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4LLP"
"4LLV",,"X-RAY DIFFRACTION",2.83,56.59,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1M NaOAc, 0.8M Li2SO4, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.ppat.1003639",,"4LLV",104.85,"2.39","2.39","The structure of the unbound form of anti-HIV antibody 4E10 Fv","GSQVQLVQSGAEVKRPGSSVTVSCKASGGSFSTYALSWVRQAPGRGLEWMGGVIPLLTITNYAPRFQGRITITADRSTSTAYLELNSLRPEDTAVYYCAREGTTGWGWLGKPIGAFAHWGQGTLVTVSS","Homo sapiens",,"4E10 Fv heavy chain","1","4LLV"
,,,,,,,,,,,,,,,,"EIVLTQSPGTQSLSPGERATLSCRASQSVGNNKLAWYQQRPGQAPRLLIYGASSRPSGVADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGQSLSTFGQGTKVEVKLVPR","Homo sapiens",,"4E10 Fv light chain","2","4LLV"
"4LLX",,"X-RAY DIFFRACTION",2.09,41.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","5ZE","4LLX",79.32,"1.75","1.75","Crystal structure of PDE10A2 with fragment ZT434","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4LLX"
"4LM0",,"X-RAY DIFFRACTION",2.05,39.89,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate,50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","5NI","4LM0",79.36,"1.66","1.66","Crystal structure of PDE10A2 with fragment ZT448","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4LM0"
"4LM1",,"X-RAY DIFFRACTION",2.1,41.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","7ZE","4LM1",79.37,"1.6","1.6","Crystal structure of PDE10A2 with fragment ZT450","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4LM1"
"4LM2",,"X-RAY DIFFRACTION",2.11,41.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","8ZE","4LM2",79.36,"1.55","1.55","Crystal structure of PDE10A2 with fragment ZT462","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4LM2"
"4LM3",,"X-RAY DIFFRACTION",2.09,41.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG4450, 0.2m calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","9ZE","4LM3",79.56,"1.49","1.49","Crystal structure of PDE10A2 with fragment ZT464","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4LM3"
"4LM4",,"X-RAY DIFFRACTION",2.06,40.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","JPZ","4LM4",79.34,"1.48","1.48","Crystal structure of PDE10A2 with fragment ZT902","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4LM4"
"4LM5",,"X-RAY DIFFRACTION",3.25,62.18,"VAPOR DIFFUSION, HANGING DROP",5.5,"100MM CITRATE BUFFER PH 5.5, 200MM NACL, 1M NH4HPO4. Co-crystallised in the presence of 2mM SKF86002. Then these crystals were soaked with 2mM inhibitor dissolved in DMSO., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004713028654",,"4LM5",34.77,"2.25","2.25","Crystal structure of Pim1 in complex with 2-{4-[(3-aminopropyl)amino]quinazolin-2-yl}phenol (resulting from displacement of SKF86002)","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPSSGENLYFQ","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4LM5"
"4LMF",,"X-RAY DIFFRACTION",3.07,59.88,"VAPOR DIFFUSION, SITTING DROP",8.5,"pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.1311113110",,"4LMF",125.03,"2.921","2.921","C1s CUB1-EGF-CUB2","PTMYGEILSPNYPQAYPSEVEKSWDIEVPEGYGIHLYFTHLDIELSENCAYDSVQIISGDTEEGRLCGQRSSNNPHSPIVEEFQVPYNKLQVIFKSDFSNEERFTGFAAYYVATDINECTDFVDVPCSHFCNNFIGGYFCSCPPEYFLHDDMKNCGVNCSGDVFTALIGEIASPNYPKPYPENSRCEYQIRLEKGFQVVVTLRREDFDVEAADSAGNCLDSLVFVAGDRQFGPYCGHGFPGPLNIETKSNALDIIFQTDLTGQKKGWKLRYHGDPM","Homo sapiens","C1S","Complement C1s subcomponent heavy chain","1","4LMF"
"4LMM",,"X-RAY DIFFRACTION",1.93,36.34,"VAPOR DIFFUSION, HANGING DROP",4.8,"100 mM sodium acetate, 0.2 M ammonium acetate, 24% PEG4000, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0081904",,"4LMM",9.96,"1.1","1.1","Crystal structure of NHERF1 PDZ1 domain complexed with the CXCR2 C-terminal tail in P21 space group","GMLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETSTTL","Homo sapiens","NHERF, NHERF1, SLC9A3R1","Na(+)/H(+) exchange regulatory cofactor NHE-RF1","1","4LMM"
"4LMN",,"X-RAY DIFFRACTION",3.29,62.61,"VAPOR DIFFUSION, HANGING DROP",6.9,"12% w/v PEG 8000, 0.4M NH4H2PO4, 0.1M HEPES, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/nature12441","EUI","4LMN",38.99,"2.8","2.8","Crystal Structure of MEK1 kinase bound to GDC0973","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGVLEHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","4LMN"
"4LMU",,"X-RAY DIFFRACTION",3.23,61.9,"VAPOR DIFFUSION, HANGING DROP",5.5,"100MM CITRATE BUFFER PH 5.5, 200MM REMARK 280 NACL, 1M NH4HPO4. Co-crystallised in the presence of 2mM SKF86002. Then these crystals were soaked with 2mM inhibitor dissolved in DMSO., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004713028654","QUE","4LMU",34.58,"2.38","2.38","Crystal structure of Pim1 in complex with the inhibitor Quercetin (resulting from displacement of SKF86002)","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPSSGENLYFQ","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4LMU"
"4LMZ",,"X-RAY DIFFRACTION",2.2,43.97,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M NaCl, Tris-HCl, 35% (v/v) 2-methyl 2,4-pentandiol, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4LMZ",24.98,"2.78","2.78","Structural insight into RNA recognition by RRM1+2 domain of human ETR-3 protein","GCUGCGUAUUGUUUG",,,"RNA (5'-R(*GP*CP*UP*GP*CP*GP*UP*AP*UP*UP*GP*UP*UP*UP*G)-3')","1","4LMZ"
,,,,,,,,,,,,,,,,"GSHMDPDAIKMFVGQIPRSWSEKELKELFEPYGAVYQINVLRDRSQNPPQSKGCCFVTFYTRKAALEAQNALHNIKTLPGMHHPIQMKPADSEKSNAVEDRKLFIGMVSKKCNENDIRVMFSPFGQIEECRILRGPDGLSRGCAFVTFSTRAMAQNAIKAMHQSQTMEGCSSPIVVKFAD","Homo sapiens","CELF2, BRUNOL3, CUGBP2, ETR3, NAPOR","CUGBP Elav-like family member 2","2","4LMZ"
"4LND",,"X-RAY DIFFRACTION",3.08,60.05,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES pH 6.5, 30% (v/v) PEG 300, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1107/S0907444913027042",,"4LND",96.37,"1.92","1.92","Crystal structure of human apurinic/apyrimidinic endonuclease 1 with essential Mg2+ cofactor","GSHMASGEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQCPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL","Homo sapiens","APE, APE1, APEX, APEX1, APX, HAP1, REF1","DNA-(apurinic or apyrimidinic site) lyase","1","4LND"
"4LNW",,"X-RAY DIFFRACTION",4.02,69.43,"VAPOR DIFFUSION, HANGING DROP",7.2,"1.0 M sodium cacodylate and 0.1 M sodium acetate threehydrate, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1210/me.2013-1359","T3","4LNW",32.08,"1.9","1.9","Crystal structure of TR-alpha bound to T3 in a second site","GSHMEEMIRSLQQRPEPTPEEWDLIHIATEAHRSTNAQGSHWKQRRKFLPDDIGQSPIVSMPDGDKVDLEAFSEFTKIITPAITRVVDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVRYDPESDTLTLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMSTDRSGLLCVDKIEKSQEAYLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGACHASRFLHMKVECPTELFPPLFLEVFEDQEV","Homo sapiens","THRA, EAR7, ERBA1, NR1A1, THRA1, THRA2","Thyroid hormone receptor alpha","1","4LNW"
"4LNX",,"X-RAY DIFFRACTION",3.99,69.18,"VAPOR DIFFUSION, HANGING DROP",7.2,"1.0 M sodium cacodylate and 0.1 M sodium acetate threehydrate, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1210/me.2013-1359","T3, T44","4LNX",32.21,"2.05","2.05","Crystal structure of TR-alpha bound to T4 in a second site","GSHMEEMIRSLQQRPEPTPEEWDLIHIATEAHRSTNAQGSHWKQRRKFLPDDIGQSPIVSMPDGDKVDLEAFSEFTKIITPAITRVVDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVRYDPESDTLTLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMSTDRSGLLCVDKIEKSQEAYLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGACHASRFLHMKVECPTELFPPLFLEVFEDQEV","Homo sapiens","THRA, EAR7, ERBA1, NR1A1, THRA1, THRA2","Thyroid hormone receptor alpha","1","4LNX"
